,Sentence,ESG BERT Topic 1,ESG BERT Topic 2,ESG BERT Topic 3,Mapped Criteria Topic 1,Mapped Criteria Topic 2,Mapped Criteria Topic 3
Line 1,"Engineering impact Medtronic 2022 Integrated Performance ReportContents About this report  Letters to our stakeholders  5The year at a glance  7Our business  9Our impact: Employee   stories  13Material issues and targets  16   Sustainability  governance  18  Stakeholder engagement  20   C ontribution to the UN  Sustainable Development   Goals  23 FY22 environmental sustainability highlights  Climate risk and resilience  28Reducing our operational  footprint  Product stewardship  37FY22 social impact highlights  41Global healthcare access  42Philanthropy  51 Inclusion, diversity, and   equity  57 Supporting a global   workforce  64  Patient safety and product  quality  72   Data privacy and security  78 Supply chain responsibility  80FY22 governance and   accountability highlights  Corporate governance  88    Ethical business conduct   91    Ethics in sales and mark eting  Our economic impact  98Global Reporting   Initiative index   Sustainability  Accounting  Standards Board index  Task Force on Climate-Related  Financial Disclosures  World Economic Forum  Stakeholder Capitalism  Metrics  Employee data summary  138Governance and  accountabilityESG disclosure index  Social impact Environmental sustainabilityESG strategy Introduction 2022 Integrated Performance Report 2 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction Introduction In a time of significant global challenge and change, we  remain dedicated to our Mission to alleviate pain, restore health, and extend life — guided by environmental, social, and governance (ESG) priorities that put people first.
","('Business_Model_Resilience', 0.8637229800224304)","('Product_Design_And_Lifecycle_Management', 0.027474919334053993)","('Supply_Chain_Management', 0.016874678432941437)","(['Codes of Business Conduct'], 0.8637229800224304)","('NON-ESG', 0.027474919334053993)","('NON-ESG', 0.016874678432941437)"
Line 2,"Engineering impact Medtronic 2022 Integrated Performance ReportContents About this report  Letters to our stakeholders  5The year at a glance  7Our business  9Our impact: Employee   stories  13Material issues and targets  16   Sustainability  governance  18  Stakeholder engagement  20   C ontribution to the UN  Sustainable Development   Goals  23 FY22 environmental sustainability highlights  Climate risk and resilience  28Reducing our operational  footprint  Product stewardship  37FY22 social impact highlights  41Global healthcare access  42Philanthropy  51 Inclusion, diversity, and   equity  57 Supporting a global   workforce  64  Patient safety and product  quality  72   Data privacy and security  78 Supply chain responsibility  80FY22 governance and   accountability highlights  Corporate governance  88    Ethical business conduct   91    Ethics in sales and mark eting  Our economic impact  98Global Reporting   Initiative index   Sustainability  Accounting  Standards Board index  Task Force on Climate-Related  Financial Disclosures  World Economic Forum  Stakeholder Capitalism  Metrics  Employee data summary  138Governance and  accountabilityESG disclosure index  Social impact Environmental sustainabilityESG strategy Introduction 2022 Integrated Performance Report 2 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction Introduction In a time of significant global challenge and change, we  remain dedicated to our Mission to alleviate pain, restore health, and extend life — guided by environmental, social, and governance (ESG) priorities that put people first.
","('Business_Ethics', 0.8844577670097351)","('Product_Quality_And_Safety', 0.02384074218571186)","('Employee_Engagement_Inclusion_And_Diversity', 0.015169055201113224)","(['Business Ethics'], 0.8844577670097351)","('NON-ESG', 0.02384074218571186)","('NON-ESG', 0.015169055201113224)"
Line 3,"Engineering impact Medtronic 2022 Integrated Performance ReportContents About this report  Letters to our stakeholders  5The year at a glance  7Our business  9Our impact: Employee   stories  13Material issues and targets  16   Sustainability  governance  18  Stakeholder engagement  20   C ontribution to the UN  Sustainable Development   Goals  23 FY22 environmental sustainability highlights  Climate risk and resilience  28Reducing our operational  footprint  Product stewardship  37FY22 social impact highlights  41Global healthcare access  42Philanthropy  51 Inclusion, diversity, and   equity  57 Supporting a global   workforce  64  Patient safety and product  quality  72   Data privacy and security  78 Supply chain responsibility  80FY22 governance and   accountability highlights  Corporate governance  88    Ethical business conduct   91    Ethics in sales and mark eting  Our economic impact  98Global Reporting   Initiative index   Sustainability  Accounting  Standards Board index  Task Force on Climate-Related  Financial Disclosures  World Economic Forum  Stakeholder Capitalism  Metrics  Employee data summary  138Governance and  accountabilityESG disclosure index  Social impact Environmental sustainabilityESG strategy Introduction 2022 Integrated Performance Report 2 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction Introduction In a time of significant global challenge and change, we  remain dedicated to our Mission to alleviate pain, restore health, and extend life — guided by environmental, social, and governance (ESG) priorities that put people first.
","('Management_Of_Legal_And_Regulatory_Framework', 0.37804365158081055)","('Business_Model_Resilience', 0.11873576045036316)","('Human_Rights_And_Community_Relations', 0.0946810245513916)","('NON-ESG', 0.37804365158081055)","('NON-ESG', 0.11873576045036316)","('NON-ESG', 0.0946810245513916)"
Line 4,"Engineering impact Medtronic 2022 Integrated Performance ReportContents About this report  Letters to our stakeholders  5The year at a glance  7Our business  9Our impact: Employee   stories  13Material issues and targets  16   Sustainability  governance  18  Stakeholder engagement  20   C ontribution to the UN  Sustainable Development   Goals  23 FY22 environmental sustainability highlights  Climate risk and resilience  28Reducing our operational  footprint  Product stewardship  37FY22 social impact highlights  41Global healthcare access  42Philanthropy  51 Inclusion, diversity, and   equity  57 Supporting a global   workforce  64  Patient safety and product  quality  72   Data privacy and security  78 Supply chain responsibility  80FY22 governance and   accountability highlights  Corporate governance  88    Ethical business conduct   91    Ethics in sales and mark eting  Our economic impact  98Global Reporting   Initiative index   Sustainability  Accounting  Standards Board index  Task Force on Climate-Related  Financial Disclosures  World Economic Forum  Stakeholder Capitalism  Metrics  Employee data summary  138Governance and  accountabilityESG disclosure index  Social impact Environmental sustainabilityESG strategy Introduction 2022 Integrated Performance Report 2 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction Introduction In a time of significant global challenge and change, we  remain dedicated to our Mission to alleviate pain, restore health, and extend life — guided by environmental, social, and governance (ESG) priorities that put people first.
","('Human_Rights_And_Community_Relations', 0.8593092560768127)","('Management_Of_Legal_And_Regulatory_Framework', 0.016642984002828598)","('Ecological_Impacts', 0.01438187062740326)","(['Community Relations'], 0.8593092560768127)","('NON-ESG', 0.016642984002828598)","('NON-ESG', 0.01438187062740326)"
Line 5,"Our 95,000+ full-time employees share our vision to boldly attack the most challenging health problems facing humanity through innovative technological solutions.
","('Employee_Health_And_Safety', 0.9343355894088745)","('Access_And_Affordability', 0.00817573070526123)","('Critical_Incident_Risk_Management', 0.0070120892487466335)","(['Operational Eco-Efficiency'], 0.9343355894088745)","('NON-ESG', 0.00817573070526123)","('NON-ESG', 0.0070120892487466335)"
Line 6,"Together, we engineer the extraordinary.
","('Product_Design_And_Lifecycle_Management', 0.20227773487567902)","('Employee_Engagement_Inclusion_And_Diversity', 0.12309539318084717)","('Business_Model_Resilience', 0.07624867558479309)","('NON-ESG', 0.20227773487567902)","('NON-ESG', 0.12309539318084717)","('NON-ESG', 0.07624867558479309)"
Line 7,"About this report  Letters to our stakeholders  5The year at a glance  7Our business  9Our impact: Employee stories  2022 Integrated Performance Report 3 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction 2022 Integrated Performance Report 4 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction About this report The Medtronic 2022 Integrated Performance  Report reflects the Medtronic material environmental, social, and governance (ESG) topics in alignment with leading reporting frameworks and standards, including the Global Reporting Initiative; the Sustainability Accounting Standards Board; the Task Force on Climate-Related Financial Disclosures; and the World Economic Forum Stakeholder Capitalism Metrics, which are detailed in our ESG disclosure index.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2249373346567154)","('Business_Model_Resilience', 0.19742941856384277)","('Business_Ethics', 0.11173755675554276)","('NON-ESG', 0.2249373346567154)","('NON-ESG', 0.19742941856384277)","('NON-ESG', 0.11173755675554276)"
Line 8,"About this report  Letters to our stakeholders  5The year at a glance  7Our business  9Our impact: Employee stories  2022 Integrated Performance Report 3 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction 2022 Integrated Performance Report 4 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction About this report The Medtronic 2022 Integrated Performance  Report reflects the Medtronic material environmental, social, and governance (ESG) topics in alignment with leading reporting frameworks and standards, including the Global Reporting Initiative; the Sustainability Accounting Standards Board; the Task Force on Climate-Related Financial Disclosures; and the World Economic Forum Stakeholder Capitalism Metrics, which are detailed in our ESG disclosure index.
","('Business_Model_Resilience', 0.2857050597667694)","('Physical_Impacts_Of_Climate_Change', 0.261819452047348)","('Management_Of_Legal_And_Regulatory_Framework', 0.07983538508415222)","('NON-ESG', 0.2857050597667694)","('NON-ESG', 0.261819452047348)","('NON-ESG', 0.07983538508415222)"
Line 9,"Unless otherwise stated, all performance reporting  covers our fiscal year (FY) 2022 (FY22), which was May 1, 2021 through April 29, 2022.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4302511215209961)","('Business_Model_Resilience', 0.11591235548257828)","('GHG_Emissions', 0.06601870805025101)","('NON-ESG', 0.4302511215209961)","('NON-ESG', 0.11591235548257828)","('NON-ESG', 0.06601870805025101)"
Line 10,"This report includes data from Medtronic plc and its  consolidated subsidiaries.
","('Systemic_Risk_Management', 0.2860858738422394)","('Business_Model_Resilience', 0.13792522251605988)","('Customer_Privacy', 0.07699021697044373)","('NON-ESG', 0.2860858738422394)","('NON-ESG', 0.13792522251605988)","('NON-ESG', 0.07699021697044373)"
Line 11,"Environmental, health, and safety data are from our manufacturing and research  and development facilities.
","('Employee_Health_And_Safety', 0.6758308410644531)","('Product_Quality_And_Safety', 0.18561382591724396)","('Product_Design_And_Lifecycle_Management', 0.020146287977695465)","(['Operational Eco-Efficiency'], 0.6758308410644531)","('NON-ESG', 0.18561382591724396)","('NON-ESG', 0.020146287977695465)"
Line 12,"A third party, ERM CVS, has assured our FY20, FY21, and FY22 health and safety data as well as our FY22 greenhouse gas and water data.
","('GHG_Emissions', 0.8744336366653442)","('Air_Quality', 0.029906146228313446)","('Physical_Impacts_Of_Climate_Change', 0.011807077564299107)","(['Climate Change'], 0.8744336366653442)","('NON-ESG', 0.029906146228313446)","('NON-ESG', 0.011807077564299107)"
Line 13,"In some instances, reported data may be best estimated  or rounded.
","('Employee_Engagement_Inclusion_And_Diversity', 0.10020951181650162)","('Customer_Privacy', 0.09384404867887497)","('Access_And_Affordability', 0.08914843946695328)","('NON-ESG', 0.10020951181650162)","('NON-ESG', 0.09384404867887497)","('NON-ESG', 0.08914843946695328)"
Line 14,"All financial information is reported in  U.S. dollars.This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties, including risks related to difficulties and delays inherent in the development and implementation of plans to achieve our environmental sustainability and social impact goals and objectives; government regulation and general economic conditions; and other risks and uncertainties described in our periodic reports.
","('Systemic_Risk_Management', 0.49683907628059387)","('Management_Of_Legal_And_Regulatory_Framework', 0.3126984238624573)","('Physical_Impacts_Of_Climate_Change', 0.03359823673963547)","('NON-ESG', 0.49683907628059387)","('NON-ESG', 0.3126984238624573)","('NON-ESG', 0.03359823673963547)"
Line 15,"All financial information is reported in  U.S. dollars.This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties, including risks related to difficulties and delays inherent in the development and implementation of plans to achieve our environmental sustainability and social impact goals and objectives; government regulation and general economic conditions; and other risks and uncertainties described in our periodic reports.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9076720476150513)","('Director_Removal', 0.007174304686486721)","('Business_Ethics', 0.007013668306171894)","(['Corporate Governance'], 0.9076720476150513)","('NON-ESG', 0.007174304686486721)","('NON-ESG', 0.007013668306171894)"
Line 16,"These reports are on file with the U.S. Securities and Exchange Commission, including our most recent Annual Report on Form 10-K.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9399162530899048)","('Director_Removal', 0.006942242383956909)","('Systemic_Risk_Management', 0.005614216905087233)","(['Corporate Governance'], 0.9399162530899048)","('NON-ESG', 0.006942242383956909)","('NON-ESG', 0.005614216905087233)"
Line 17,"In some cases, you can identify the forward-looking statements by words or expressions, such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “intend,” “looking ahead,” “may,” “plan,” “possible,” “potential,” “project,” “should,” “going to,” “will,” and similar words or expressions, the negative or plural of such words or expressions, and other comparable terminology.
","('Business_Model_Resilience', 0.31429627537727356)","('Competitive_Behavior', 0.162336066365242)","('Systemic_Risk_Management', 0.09388508647680283)","('NON-ESG', 0.31429627537727356)","('NON-ESG', 0.162336066365242)","('NON-ESG', 0.09388508647680283)"
Line 18,"Actual results may differ materially from anticipated results.
","('Competitive_Behavior', 0.31018584966659546)","('Management_Of_Legal_And_Regulatory_Framework', 0.13230739533901215)","('Business_Model_Resilience', 0.10175710171461105)","('NON-ESG', 0.31018584966659546)","('NON-ESG', 0.13230739533901215)","('NON-ESG', 0.10175710171461105)"
Line 19,"We do not update our forward-looking statements or any of the information contained in this report, including updates to reflect future events or circumstances.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3771090507507324)","('Physical_Impacts_Of_Climate_Change', 0.1395666003227234)","('Business_Model_Resilience', 0.13478262722492218)","('NON-ESG', 0.3771090507507324)","('NON-ESG', 0.1395666003227234)","('NON-ESG', 0.13478262722492218)"
Line 20,"To provide feedback or request further information,  please email integratedreport@medtronic.com.
","('Access_And_Affordability', 0.1385074406862259)","('Management_Of_Legal_And_Regulatory_Framework', 0.13541068136692047)","('Product_Quality_And_Safety', 0.11060399562120438)","('NON-ESG', 0.1385074406862259)","('NON-ESG', 0.13541068136692047)","('NON-ESG', 0.11060399562120438)"
Line 21,"2022 Integrated Performance Report 5 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction Letters to our stakeholders Chairman and CEO address  The Medtronic Mission — to alleviate pain, restore health,  and extend life — unites a diverse, global team of more than 95,000 people whose work transforms the lives of two people every second.
","('Human_Rights_And_Community_Relations', 0.48373711109161377)","('Employee_Health_And_Safety', 0.19192451238632202)","('Access_And_Affordability', 0.08979348093271255)","('NON-ESG', 0.48373711109161377)","('NON-ESG', 0.19192451238632202)","('NON-ESG', 0.08979348093271255)"
Line 22,"And despite the challenges faced over the past year – war in Ukraine, climate change, supply chain disruption, and the ongoing COVID-19 pandemic – we maintained our steadfast commitment to carrying out the Mission and increasing our environmental, social, and governance (ESG) efforts.
","('Supply_Chain_Management', 0.8880541920661926)","('Physical_Impacts_Of_Climate_Change', 0.034739136695861816)","('Business_Model_Resilience', 0.011285476386547089)","(['Supply Chain Management'], 0.8880541920661926)","('NON-ESG', 0.034739136695861816)","('NON-ESG', 0.011285476386547089)"
Line 23,"I am proud to share our FY22 ESG progress and  performance, which recaps our work across important areas, including accelerating patient access and equity; creating life-transforming healthcare; fostering inclusion, diversity, and equity (ID&E); and furthering our environmental sustainability.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9615381956100464)","('Human_Rights_And_Community_Relations', 0.004401547368615866)","('Access_And_Affordability', 0.0036561607848852873)","(['Human Capital Development'], 0.9615381956100464)","('NON-ESG', 0.004401547368615866)","('NON-ESG', 0.0036561607848852873)"
Line 24,"Accelerating patient access and equity In the past year, Medtronic therapies improved the lives of more than 76 million people, yet many communities around the world still lack access to care.
","('Access_And_Affordability', 0.9115810990333557)","('Human_Rights_And_Community_Relations', 0.012314573861658573)","('Critical_Incident_Risk_Management', 0.007094770669937134)","(['Health Outcome Contribution'], 0.9115810990333557)","('NON-ESG', 0.012314573861658573)","('NON-ESG', 0.007094770669937134)"
Line 25,"We use data and technology to address this global crisis of health inequity, streamlining detection, diagnosis, and treatment to fill the gap between the number of people who need care and the number of practitioners who offer it.
","('Employee_Health_And_Safety', 0.5553386211395264)","('Access_And_Affordability', 0.14205509424209595)","('Critical_Incident_Risk_Management', 0.06725215166807175)","(['Operational Eco-Efficiency'], 0.5553386211395264)","('NON-ESG', 0.14205509424209595)","('NON-ESG', 0.06725215166807175)"
Line 26,"This democratizes healthcare and enables healthcare workers to reach more patients with a more personalized approach while increasing accessibility throughout the world.
","('Access_And_Affordability', 0.6438355445861816)","('Employee_Health_And_Safety', 0.05761544406414032)","('Energy_Management', 0.0390433743596077)","(['Health Outcome Contribution'], 0.6438355445861816)","('NON-ESG', 0.05761544406414032)","('NON-ESG', 0.0390433743596077)"
Line 27,"In service of this effort, we dedicated more than $69 million to healthcare capacity training in FY22, reaching 350,000+ global medical professionals who drive access to quality care in their communities.
","('Access_And_Affordability', 0.8690050840377808)","('Critical_Incident_Risk_Management', 0.013773515820503235)","('Customer_Welfare', 0.011853063479065895)","(['Health Outcome Contribution'], 0.8690050840377808)","('NON-ESG', 0.013773515820503235)","('NON-ESG', 0.011853063479065895)"
Line 28,"Creating life-transforming healthcare As a global healthcare technology leader, we use the power of advanced computing, smallest-size-solutions, and hyper-personalization to address unmet patient needs.
","('Product_Design_And_Lifecycle_Management', 0.18460971117019653)","('Energy_Management', 0.15751153230667114)","('Data_Security', 0.10560623556375504)","('NON-ESG', 0.18460971117019653)","('NON-ESG', 0.15751153230667114)","('NON-ESG', 0.10560623556375504)"
Line 29,"Our life-transforming technologies treat and diagnose 70 conditions in the areas of cardiovascular, medical surgical, neuroscience, and diabetes care.
","('Access_And_Affordability', 0.2289297729730606)","('Employee_Health_And_Safety', 0.15579761564731598)","('Customer_Welfare', 0.10651545971632004)","('NON-ESG', 0.2289297729730606)","('NON-ESG', 0.15579761564731598)","('NON-ESG', 0.10651545971632004)"
Line 30,"The past two and a half years have highlighted the challenges facing healthcare systems, but also the opportunities for technology to play a role in a better path forward.
","('Supply_Chain_Management', 0.2476274073123932)","('Business_Model_Resilience', 0.12443730235099792)","('Product_Design_And_Lifecycle_Management', 0.09593719989061356)","('NON-ESG', 0.2476274073123932)","('NON-ESG', 0.12443730235099792)","('NON-ESG', 0.09593719989061356)"
Line 31,"Today, we’re integrating powerful tech capabilities like data science, machine learning, and AI into our devices and solutions to collect data to help clinicians and patients make more informed decisions and drive better outcomes.
","('Access_And_Affordability', 0.13979439437389374)","('Competitive_Behavior', 0.13418051600456238)","('Data_Security', 0.10485349595546722)","('NON-ESG', 0.13979439437389374)","('NON-ESG', 0.13418051600456238)","('NON-ESG', 0.10485349595546722)"
Line 32,"To continue evolving our product portfolio, in FY22, we  invested an all-time high of $2.7 billion in research and development, a 10% increase compared to the previous fiscal year.
","('Product_Design_And_Lifecycle_Management', 0.9414779543876648)","('Customer_Welfare', 0.008217180147767067)","('Product_Quality_And_Safety', 0.0066605801694095135)","(['Product Stewardship'], 0.9414779543876648)","('NON-ESG', 0.008217180147767067)","('NON-ESG', 0.0066605801694095135)"
Line 33,"Fostering ID&E is key to innovation Innovation is a people-powered business.
","('Product_Design_And_Lifecycle_Management', 0.33756256103515625)","('Competitive_Behavior', 0.14128588140010834)","('Business_Model_Resilience', 0.13560234010219574)","('NON-ESG', 0.33756256103515625)","('NON-ESG', 0.14128588140010834)","('NON-ESG', 0.13560234010219574)"
Line 34,"An inclusive workforce unites diverse experiences and perspectives in an environment where they are valued and shared — driving technology forward and empowering all to reach their highest potential.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9680461883544922)","('Human_Rights_And_Community_Relations', 0.003489407245069742)","('Business_Model_Resilience', 0.0021502075251191854)","(['Human Capital Development'], 0.9680461883544922)","('NON-ESG', 0.003489407245069742)","('NON-ESG', 0.0021502075251191854)"
Line 35,"A convergence of backgrounds and experiences allows  us to create life-saving products and therapies that benefit all patients while expanding the number of conditions we can treat.
","('Product_Design_And_Lifecycle_Management', 0.481880247592926)","('Customer_Welfare', 0.12284917384386063)","('Access_And_Affordability', 0.11039482802152634)","('NON-ESG', 0.481880247592926)","('NON-ESG', 0.12284917384386063)","('NON-ESG', 0.11039482802152634)"
Line 36,"Diversity in leadership is key to this.
","('Employee_Engagement_Inclusion_And_Diversity', 0.971236526966095)","('Business_Model_Resilience', 0.0020217273849993944)","('Employee_Health_And_Safety', 0.0019949080888181925)","(['Human Capital Development'], 0.971236526966095)","('NON-ESG', 0.0020217273849993944)","('NON-ESG', 0.0019949080888181925)"
Line 37,"In FY22, women held 42% of manager-and-above positions globally and people from ethnically diverse groups held 27% of manager-and-above positions in  the United States, which is strong progress toward our FY26 goals of 45% and 30%, respectively.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9758406281471252)","('Human_Rights_And_Community_Relations', 0.0017262662295252085)","('Employee_Health_And_Safety', 0.0015249785501509905)","(['Human Capital Development'], 0.9758406281471252)","('NON-ESG', 0.0017262662295252085)","('NON-ESG', 0.0015249785501509905)"
Line 38,"Furthering environmental sustainability  A healthy planet is essential to human health and we’re setting bold new goals and steadily marching toward them.
","('Human_Rights_And_Community_Relations', 0.237140953540802)","('Employee_Health_And_Safety', 0.22451037168502808)","('Ecological_Impacts', 0.10910269618034363)","('NON-ESG', 0.237140953540802)","('NON-ESG', 0.22451037168502808)","('NON-ESG', 0.10910269618034363)"
Line 39,"Our environmental sustainability efforts directly advance our Mission to be a good corporate citizen while also supporting our sustainable business growth.
","('Business_Model_Resilience', 0.28855112195014954)","('Product_Design_And_Lifecycle_Management', 0.27389732003211975)","('Supply_Chain_Management', 0.10009261220693588)","('NON-ESG', 0.28855112195014954)","('NON-ESG', 0.27389732003211975)","('NON-ESG', 0.10009261220693588)"
Line 40,"In FY22, we joined forces with the National Academy of Medicine’s Grand Challenge on Climate Change and the United Kingdom National Health Service to work with organizations around the world to transform systems, such as healthcare, that contribute to, and are impacted by, climate change by building resiliency and minimizing carbon footprints.
","('Physical_Impacts_Of_Climate_Change', 0.940683901309967)","('Business_Model_Resilience', 0.016307558864355087)","('GHG_Emissions', 0.0052819461561739445)","(['Climate Change'], 0.940683901309967)","('NON-ESG', 0.016307558864355087)","('NON-ESG', 0.0052819461561739445)"
Line 41,"Last fall, we announced our ambition to achieve net zero emissions across our value chain by FY45.
","('GHG_Emissions', 0.6364938020706177)","('Air_Quality', 0.21516691148281097)","('Energy_Management', 0.05540057271718979)","(['Climate Change'], 0.6364938020706177)","('NON-ESG', 0.21516691148281097)","('NON-ESG', 0.05540057271718979)"
Line 42,"In FY22 alone, we reduced our operational greenhouse gas emissions intensity by 35% compared  to our FY20 baseline.
","('GHG_Emissions', 0.9675456285476685)","('Air_Quality', 0.004276955500245094)","('Ecological_Impacts', 0.003258713986724615)","(['Climate Change'], 0.9675456285476685)","('NON-ESG', 0.004276955500245094)","('NON-ESG', 0.003258713986724615)"
Line 43,"Looking forward At Medtronic, we are engineering the extraordinary for patients around the world.
","('Access_And_Affordability', 0.4506916403770447)","('Customer_Welfare', 0.06882815062999725)","('Product_Quality_And_Safety', 0.054965805262327194)","('NON-ESG', 0.4506916403770447)","('NON-ESG', 0.06882815062999725)","('NON-ESG', 0.054965805262327194)"
Line 44,"It’s a tremendous opportunity and responsibility we carry.
","('Human_Rights_And_Community_Relations', 0.5593336820602417)","('Employee_Engagement_Inclusion_And_Diversity', 0.1448495090007782)","('Employee_Health_And_Safety', 0.06453932076692581)","(['Community Relations'], 0.5593336820602417)","('NON-ESG', 0.1448495090007782)","('NON-ESG', 0.06453932076692581)"
Line 45,"The impact we’re making across all areas of our work inspires me every day as  we push for even more progress.
","('Human_Rights_And_Community_Relations', 0.5948899984359741)","('Business_Model_Resilience', 0.08436165004968643)","('Access_And_Affordability', 0.0273007620126009)","(['Community Relations'], 0.5948899984359741)","('NON-ESG', 0.08436165004968643)","('NON-ESG', 0.0273007620126009)"
Line 46,"While I know we  have a long way to go, I’m proud of the meaningful progress we’re making.
","('Business_Model_Resilience', 0.22066336870193481)","('Human_Rights_And_Community_Relations', 0.1948462426662445)","('Director_Removal', 0.07750574499368668)","('NON-ESG', 0.22066336870193481)","('NON-ESG', 0.1948462426662445)","('NON-ESG', 0.07750574499368668)"
Line 47,"We boldly endeavor to create  a healthier, brighter future for millions.
","('Product_Design_And_Lifecycle_Management', 0.31240785121917725)","('Access_And_Affordability', 0.16781556606292725)","('Customer_Welfare', 0.10563632845878601)","('NON-ESG', 0.31240785121917725)","('NON-ESG', 0.16781556606292725)","('NON-ESG', 0.10563632845878601)"
Line 48,"I invite you to  join us on the journey.
","('Employee_Engagement_Inclusion_And_Diversity', 0.13381993770599365)","('Business_Model_Resilience', 0.11925361305475235)","('Employee_Health_And_Safety', 0.09324640780687332)","('NON-ESG', 0.13381993770599365)","('NON-ESG', 0.11925361305475235)","('NON-ESG', 0.09324640780687332)"
Line 49,"Geoff Martha Chairman and CEO, MedtronicA message from our CFO  Our employees share our vision to boldly tackle the  most challenging health problems facing humanity while upholding our reputation as a company of dedication, honesty, integrity, and service.
","('Business_Ethics', 0.5563111305236816)","('Employee_Health_And_Safety', 0.14914843440055847)","('Human_Rights_And_Community_Relations', 0.05180518701672554)","(['Business Ethics'], 0.5563111305236816)","('NON-ESG', 0.14914843440055847)","('NON-ESG', 0.05180518701672554)"
Line 50,"Our ESG priorities directly reflect our vision and values.
","('Business_Model_Resilience', 0.4502318799495697)","('Human_Rights_And_Community_Relations', 0.18763092160224915)","('Director_Removal', 0.03782346099615097)","('NON-ESG', 0.4502318799495697)","('NON-ESG', 0.18763092160224915)","('NON-ESG', 0.03782346099615097)"
Line 51,"The Medtronic Sustainability Steering Committee (SSC)  embeds ESG priorities throughout our operations.
","('Business_Model_Resilience', 0.7120593190193176)","('Physical_Impacts_Of_Climate_Change', 0.0358332134783268)","('Supply_Chain_Management', 0.02758769690990448)","(['Codes of Business Conduct'], 0.7120593190193176)","('NON-ESG', 0.0358332134783268)","('NON-ESG', 0.02758769690990448)"
Line 52,"As the leader of the SSC, I see our social and environmental progress firsthand.
","('Human_Rights_And_Community_Relations', 0.9344546794891357)","('Management_Of_Legal_And_Regulatory_Framework', 0.0049845632165670395)","('Business_Model_Resilience', 0.004824919626116753)","(['Community Relations'], 0.9344546794891357)","('NON-ESG', 0.0049845632165670395)","('NON-ESG', 0.004824919626116753)"
Line 53,"In last year’s report, I announced that we set a number of new ESG performance targets.
","('Business_Model_Resilience', 0.5077292919158936)","('Systemic_Risk_Management', 0.19550356268882751)","('Physical_Impacts_Of_Climate_Change', 0.0335259884595871)","(['Codes of Business Conduct'], 0.5077292919158936)","('NON-ESG', 0.19550356268882751)","('NON-ESG', 0.0335259884595871)"
Line 54,"I’m proud to share our progress toward these targets throughout this report, along with our plans to continue driving progress in FY23 and beyond.
","('Business_Model_Resilience', 0.27471086382865906)","('Human_Rights_And_Community_Relations', 0.11796632409095764)","('Management_Of_Legal_And_Regulatory_Framework', 0.09334543347358704)","('NON-ESG', 0.27471086382865906)","('NON-ESG', 0.11796632409095764)","('NON-ESG', 0.09334543347358704)"
Line 55,"Remaining transparent on our ESG progress and  performance is key to the success of our ESG priorities and preserving shareholder confidence.
","('Business_Model_Resilience', 0.6664119362831116)","('Systemic_Risk_Management', 0.07645581662654877)","('Competitive_Behavior', 0.0309824850410223)","(['Codes of Business Conduct'], 0.6664119362831116)","('NON-ESG', 0.07645581662654877)","('NON-ESG', 0.0309824850410223)"
Line 56,"In addition to reporting on all of our ESG material topics, we also supply responses to best practice reporting frameworks in the ESG Disclosure Index.
","('Business_Model_Resilience', 0.29590466618537903)","('Systemic_Risk_Management', 0.26792392134666443)","('Management_Of_Legal_And_Regulatory_Framework', 0.1153227686882019)","('NON-ESG', 0.29590466618537903)","('NON-ESG', 0.26792392134666443)","('NON-ESG', 0.1153227686882019)"
Line 57,"These frameworks include the Global Reporting Initiative, the Sustainability Accounting Standards Board, the Task Force on Climate-Related Financial Disclosures, and the World Economic Stakeholder Capitalism Metrics.
","('Physical_Impacts_Of_Climate_Change', 0.9151144623756409)","('Business_Model_Resilience', 0.020462555810809135)","('GHG_Emissions', 0.011642271652817726)","(['Climate Change'], 0.9151144623756409)","('NON-ESG', 0.020462555810809135)","('NON-ESG', 0.011642271652817726)"
Line 58,"Our Mission empowers insight-driven care and better  outcomes for our world.
","('Access_And_Affordability', 0.7558484673500061)","('Employee_Health_And_Safety', 0.03188643231987953)","('Human_Rights_And_Community_Relations', 0.025270206853747368)","(['Health Outcome Contribution'], 0.7558484673500061)","('NON-ESG', 0.03188643231987953)","('NON-ESG', 0.025270206853747368)"
Line 59,"Our ESG efforts support us in this and in our long-term business success by ensuring we deliver results the right way.
","('Business_Model_Resilience', 0.8034120798110962)","('Systemic_Risk_Management', 0.024952778592705727)","('Product_Design_And_Lifecycle_Management', 0.022968441247940063)","(['Codes of Business Conduct'], 0.8034120798110962)","('NON-ESG', 0.024952778592705727)","('NON-ESG', 0.022968441247940063)"
Line 60,"I am inspired by the progress our employees made in FY22 and look forward to sharing their continued progress in next year’s report.
","('Human_Rights_And_Community_Relations', 0.45392516255378723)","('Business_Model_Resilience', 0.08403301984071732)","('Management_Of_Legal_And_Regulatory_Framework', 0.0778031200170517)","('NON-ESG', 0.45392516255378723)","('NON-ESG', 0.08403301984071732)","('NON-ESG', 0.0778031200170517)"
Line 61,"2022 Integrated Performance Report 6 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction Letters to our stakeholders Karen L.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4821356534957886)","('Business_Model_Resilience', 0.10699523240327835)","('Human_Rights_And_Community_Relations', 0.08221469819545746)","('NON-ESG', 0.4821356534957886)","('NON-ESG', 0.10699523240327835)","('NON-ESG', 0.08221469819545746)"
Line 62,"Parkhill Executive Vice President and  Chief Financial Officer, Medtronic30 % of board members were  women at the end of FY22; this  increased to 36% following a  new appointment in June 2022  20 % of board members were from  ethnically diverse backgrounds  at the end of FY22; this  increased to 27% following a  new appointment in June 2022$31.7B  revenue generated and 92%  of free cash flow returned to  shareholders $1.7B total strategic investment   and acquisition spend Includes acquisitions, additions to property, plant and  equipment, and net purchases of investments.Net zero announced our ambition  to balance our greenhouse  gas emissions produced and  removed from the atmosphere across Scopes 1,2, and 3 by FY35 % reduction in our operational  greenhouse gas emissions  intensity compared to our FY20  baseline, toward our goal of   50% by FY25 $2.7B invested in research and  development, a 10% increase  compared to FY21  $97.
","('Employee_Engagement_Inclusion_And_Diversity', 0.963674008846283)","('Business_Model_Resilience', 0.0037755025550723076)","('Human_Rights_And_Community_Relations', 0.002567785792052746)","(['Human Capital Development'], 0.963674008846283)","('NON-ESG', 0.0037755025550723076)","('NON-ESG', 0.002567785792052746)"
Line 63,"Parkhill Executive Vice President and  Chief Financial Officer, Medtronic30 % of board members were  women at the end of FY22; this  increased to 36% following a  new appointment in June 2022  20 % of board members were from  ethnically diverse backgrounds  at the end of FY22; this  increased to 27% following a  new appointment in June 2022$31.7B  revenue generated and 92%  of free cash flow returned to  shareholders $1.7B total strategic investment   and acquisition spend Includes acquisitions, additions to property, plant and  equipment, and net purchases of investments.Net zero announced our ambition  to balance our greenhouse  gas emissions produced and  removed from the atmosphere across Scopes 1,2, and 3 by FY35 % reduction in our operational  greenhouse gas emissions  intensity compared to our FY20  baseline, toward our goal of   50% by FY25 $2.7B invested in research and  development, a 10% increase  compared to FY21  $97.
","('GHG_Emissions', 0.9689184427261353)","('Air_Quality', 0.003920470364391804)","('Ecological_Impacts', 0.00340785994194448)","(['Climate Change'], 0.9689184427261353)","('NON-ESG', 0.003920470364391804)","('NON-ESG', 0.00340785994194448)"
Line 64,"1M combined philanthropic   investment by Medtronic and   the Medtronic Foundation9% reduction in our energy intensity  compared to our FY20 baseline,  toward our goal of 20% by FY16,500  MWh of energy and $2.9M in operating costs saved annually  through energy efficiency  projects 100 % ethnically diverse and gender  pay equity achieved in the   U.S. and 99% gender pay   equity globally 36 % of our U.S. supplier spend,  totaling nearly $2.7 billion,   went to small and diverse-  owned companiesGovernance and accountability Social impact Environmental sustainability 2022 Integrated Performance Report 7 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction The year at a glance2022 Integrated Performance Report 8 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction FY22 RECOGNITION  Organization Awards 3BL Media 2022 100 Best Corporate Citizens: 41st Asia Society (2020 Asian  Corporate Survey, awarded in FY22)Winner — Outreach and Inclusion to Asian Pacific American (APA) Employees during the COVID-19 Crisis; Outreach and Inclusion to APA Employees related to Racial Equity & Social Justice; Supporting the Development of Workforce Skills of APA Employees Under 40; Most Innovative Employer Runner-up — Overall Best Employer for Asian Pacific Americans Best Place to Work and  Great Place to Work® awards Multiple awards in the United States and globally, including  Fast Company 2021 Best Workplaces for Innovators, Forbes Best Employer for New Graduates, various Great Place to Work® awards, and Glassdoor Best Places to Work in 2022 — see a full list here DiversityInc 2022 Top 50 Companies for Diversity: Top 10 for the first time 2022 Top Companies for Supplier Diversity: 5th 2022 Top Companies for Environmental, Social, and Corporate Governance: 11th Dow Jones Sustainability  Indices (DJSI)DJSI World Index  DJSI North America Composite Index Forbes 2021 World’s Best Employers2022 America’s Best Employers for Diversity Fortune Most Admired Companies Human Rights Campaign 2022 Corporate Equality Index Just Capital 2022 America’s Most JUST Companies Secretary of Defense 2021 Employer Support Freedom AwardTHE YEAR AT A GLANCEWe are a global medical technology leader,  boldly tackling the world’s most challenging healthcare problems with groundbreaking innovation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.44438374042510986)","('Energy_Management', 0.2348669320344925)","('Labor_Practices', 0.07125355303287506)","('NON-ESG', 0.44438374042510986)","('NON-ESG', 0.2348669320344925)","('NON-ESG', 0.07125355303287506)"
Line 65,"1M combined philanthropic   investment by Medtronic and   the Medtronic Foundation9% reduction in our energy intensity  compared to our FY20 baseline,  toward our goal of 20% by FY16,500  MWh of energy and $2.9M in operating costs saved annually  through energy efficiency  projects 100 % ethnically diverse and gender  pay equity achieved in the   U.S. and 99% gender pay   equity globally 36 % of our U.S. supplier spend,  totaling nearly $2.7 billion,   went to small and diverse-  owned companiesGovernance and accountability Social impact Environmental sustainability 2022 Integrated Performance Report 7 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction The year at a glance2022 Integrated Performance Report 8 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction FY22 RECOGNITION  Organization Awards 3BL Media 2022 100 Best Corporate Citizens: 41st Asia Society (2020 Asian  Corporate Survey, awarded in FY22)Winner — Outreach and Inclusion to Asian Pacific American (APA) Employees during the COVID-19 Crisis; Outreach and Inclusion to APA Employees related to Racial Equity & Social Justice; Supporting the Development of Workforce Skills of APA Employees Under 40; Most Innovative Employer Runner-up — Overall Best Employer for Asian Pacific Americans Best Place to Work and  Great Place to Work® awards Multiple awards in the United States and globally, including  Fast Company 2021 Best Workplaces for Innovators, Forbes Best Employer for New Graduates, various Great Place to Work® awards, and Glassdoor Best Places to Work in 2022 — see a full list here DiversityInc 2022 Top 50 Companies for Diversity: Top 10 for the first time 2022 Top Companies for Supplier Diversity: 5th 2022 Top Companies for Environmental, Social, and Corporate Governance: 11th Dow Jones Sustainability  Indices (DJSI)DJSI World Index  DJSI North America Composite Index Forbes 2021 World’s Best Employers2022 America’s Best Employers for Diversity Fortune Most Admired Companies Human Rights Campaign 2022 Corporate Equality Index Just Capital 2022 America’s Most JUST Companies Secretary of Defense 2021 Employer Support Freedom AwardTHE YEAR AT A GLANCEWe are a global medical technology leader,  boldly tackling the world’s most challenging healthcare problems with groundbreaking innovation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.27783504128456116)","('Business_Ethics', 0.18097032606601715)","('Business_Model_Resilience', 0.11025379598140717)","('NON-ESG', 0.27783504128456116)","('NON-ESG', 0.18097032606601715)","('NON-ESG', 0.11025379598140717)"
Line 66,"1M combined philanthropic   investment by Medtronic and   the Medtronic Foundation9% reduction in our energy intensity  compared to our FY20 baseline,  toward our goal of 20% by FY16,500  MWh of energy and $2.9M in operating costs saved annually  through energy efficiency  projects 100 % ethnically diverse and gender  pay equity achieved in the   U.S. and 99% gender pay   equity globally 36 % of our U.S. supplier spend,  totaling nearly $2.7 billion,   went to small and diverse-  owned companiesGovernance and accountability Social impact Environmental sustainability 2022 Integrated Performance Report 7 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction The year at a glance2022 Integrated Performance Report 8 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction FY22 RECOGNITION  Organization Awards 3BL Media 2022 100 Best Corporate Citizens: 41st Asia Society (2020 Asian  Corporate Survey, awarded in FY22)Winner — Outreach and Inclusion to Asian Pacific American (APA) Employees during the COVID-19 Crisis; Outreach and Inclusion to APA Employees related to Racial Equity & Social Justice; Supporting the Development of Workforce Skills of APA Employees Under 40; Most Innovative Employer Runner-up — Overall Best Employer for Asian Pacific Americans Best Place to Work and  Great Place to Work® awards Multiple awards in the United States and globally, including  Fast Company 2021 Best Workplaces for Innovators, Forbes Best Employer for New Graduates, various Great Place to Work® awards, and Glassdoor Best Places to Work in 2022 — see a full list here DiversityInc 2022 Top 50 Companies for Diversity: Top 10 for the first time 2022 Top Companies for Supplier Diversity: 5th 2022 Top Companies for Environmental, Social, and Corporate Governance: 11th Dow Jones Sustainability  Indices (DJSI)DJSI World Index  DJSI North America Composite Index Forbes 2021 World’s Best Employers2022 America’s Best Employers for Diversity Fortune Most Admired Companies Human Rights Campaign 2022 Corporate Equality Index Just Capital 2022 America’s Most JUST Companies Secretary of Defense 2021 Employer Support Freedom AwardTHE YEAR AT A GLANCEWe are a global medical technology leader,  boldly tackling the world’s most challenging healthcare problems with groundbreaking innovation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.973640501499176)","('Human_Rights_And_Community_Relations', 0.002759418683126569)","('Employee_Health_And_Safety', 0.0022640149109065533)","(['Human Capital Development'], 0.973640501499176)","('NON-ESG', 0.002759418683126569)","('NON-ESG', 0.0022640149109065533)"
Line 67,"1M combined philanthropic   investment by Medtronic and   the Medtronic Foundation9% reduction in our energy intensity  compared to our FY20 baseline,  toward our goal of 20% by FY16,500  MWh of energy and $2.9M in operating costs saved annually  through energy efficiency  projects 100 % ethnically diverse and gender  pay equity achieved in the   U.S. and 99% gender pay   equity globally 36 % of our U.S. supplier spend,  totaling nearly $2.7 billion,   went to small and diverse-  owned companiesGovernance and accountability Social impact Environmental sustainability 2022 Integrated Performance Report 7 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction The year at a glance2022 Integrated Performance Report 8 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction FY22 RECOGNITION  Organization Awards 3BL Media 2022 100 Best Corporate Citizens: 41st Asia Society (2020 Asian  Corporate Survey, awarded in FY22)Winner — Outreach and Inclusion to Asian Pacific American (APA) Employees during the COVID-19 Crisis; Outreach and Inclusion to APA Employees related to Racial Equity & Social Justice; Supporting the Development of Workforce Skills of APA Employees Under 40; Most Innovative Employer Runner-up — Overall Best Employer for Asian Pacific Americans Best Place to Work and  Great Place to Work® awards Multiple awards in the United States and globally, including  Fast Company 2021 Best Workplaces for Innovators, Forbes Best Employer for New Graduates, various Great Place to Work® awards, and Glassdoor Best Places to Work in 2022 — see a full list here DiversityInc 2022 Top 50 Companies for Diversity: Top 10 for the first time 2022 Top Companies for Supplier Diversity: 5th 2022 Top Companies for Environmental, Social, and Corporate Governance: 11th Dow Jones Sustainability  Indices (DJSI)DJSI World Index  DJSI North America Composite Index Forbes 2021 World’s Best Employers2022 America’s Best Employers for Diversity Fortune Most Admired Companies Human Rights Campaign 2022 Corporate Equality Index Just Capital 2022 America’s Most JUST Companies Secretary of Defense 2021 Employer Support Freedom AwardTHE YEAR AT A GLANCEWe are a global medical technology leader,  boldly tackling the world’s most challenging healthcare problems with groundbreaking innovation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9704737067222595)","('Employee_Health_And_Safety', 0.0030622377526015043)","('Human_Rights_And_Community_Relations', 0.0022100636269897223)","(['Human Capital Development'], 0.9704737067222595)","('NON-ESG', 0.0030622377526015043)","('NON-ESG', 0.0022100636269897223)"
Line 68,"1M combined philanthropic   investment by Medtronic and   the Medtronic Foundation9% reduction in our energy intensity  compared to our FY20 baseline,  toward our goal of 20% by FY16,500  MWh of energy and $2.9M in operating costs saved annually  through energy efficiency  projects 100 % ethnically diverse and gender  pay equity achieved in the   U.S. and 99% gender pay   equity globally 36 % of our U.S. supplier spend,  totaling nearly $2.7 billion,   went to small and diverse-  owned companiesGovernance and accountability Social impact Environmental sustainability 2022 Integrated Performance Report 7 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction The year at a glance2022 Integrated Performance Report 8 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction FY22 RECOGNITION  Organization Awards 3BL Media 2022 100 Best Corporate Citizens: 41st Asia Society (2020 Asian  Corporate Survey, awarded in FY22)Winner — Outreach and Inclusion to Asian Pacific American (APA) Employees during the COVID-19 Crisis; Outreach and Inclusion to APA Employees related to Racial Equity & Social Justice; Supporting the Development of Workforce Skills of APA Employees Under 40; Most Innovative Employer Runner-up — Overall Best Employer for Asian Pacific Americans Best Place to Work and  Great Place to Work® awards Multiple awards in the United States and globally, including  Fast Company 2021 Best Workplaces for Innovators, Forbes Best Employer for New Graduates, various Great Place to Work® awards, and Glassdoor Best Places to Work in 2022 — see a full list here DiversityInc 2022 Top 50 Companies for Diversity: Top 10 for the first time 2022 Top Companies for Supplier Diversity: 5th 2022 Top Companies for Environmental, Social, and Corporate Governance: 11th Dow Jones Sustainability  Indices (DJSI)DJSI World Index  DJSI North America Composite Index Forbes 2021 World’s Best Employers2022 America’s Best Employers for Diversity Fortune Most Admired Companies Human Rights Campaign 2022 Corporate Equality Index Just Capital 2022 America’s Most JUST Companies Secretary of Defense 2021 Employer Support Freedom AwardTHE YEAR AT A GLANCEWe are a global medical technology leader,  boldly tackling the world’s most challenging healthcare problems with groundbreaking innovation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9302539825439453)","('Employee_Health_And_Safety', 0.011207672767341137)","('Labor_Practices', 0.009448285214602947)","(['Human Capital Development'], 0.9302539825439453)","('NON-ESG', 0.011207672767341137)","('NON-ESG', 0.009448285214602947)"
Line 69,"Our Mission — to alleviate pain, restore health, and extend life — empowers our diverse global team to develop healthcare technologies that transform the lives of two people every second of every hour of every day.We work to solve unmet patient and healthcare needs by engineering extraordinary solutions and therapies that improve or redefine outcomes for more than 70 conditions.
","('Employee_Health_And_Safety', 0.806997537612915)","('Access_And_Affordability', 0.03766648471355438)","('Critical_Incident_Risk_Management', 0.03633260726928711)","(['Operational Eco-Efficiency'], 0.806997537612915)","('NON-ESG', 0.03766648471355438)","('NON-ESG', 0.03633260726928711)"
Line 70,"We combine a deep understanding of the human body with the power of advanced computing, the smallest-size solutions, and hyper-personalization to develop a range of consumable and implantable products, together with innovative tools and services.
","('Product_Design_And_Lifecycle_Management', 0.9377322793006897)","('Customer_Welfare', 0.007025409955531359)","('Employee_Health_And_Safety', 0.0060603003948926926)","(['Product Stewardship'], 0.9377322793006897)","('NON-ESG', 0.007025409955531359)","('NON-ESG', 0.0060603003948926926)"
Line 71,"As the world continues to grapple with new and evolving healthcare challenges and a growing crisis of health inequity, our commitment is steadfast: create life-transforming technology; empower patient-centric, insight-driven care; and provide experiences that put people first to deliver better outcomes for our world.
","('Access_And_Affordability', 0.4942106008529663)","('Critical_Incident_Risk_Management', 0.07923610508441925)","('Employee_Health_And_Safety', 0.061074428260326385)","('NON-ESG', 0.4942106008529663)","('NON-ESG', 0.07923610508441925)","('NON-ESG', 0.061074428260326385)"
Line 72,"Who we are What we do 2022 Integrated Performance Report 9 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction Our business    In pursuit of our Mission, we act across six interrelated tenets:   T o contribute to human welfare by application  of biomedical engineering in the research,  design, manufacture, and sale of instruments or appliances that alleviate pain, restore health, and extend life.
","('Employee_Health_And_Safety', 0.9406177997589111)","('Human_Rights_And_Community_Relations', 0.006254915613681078)","('Access_And_Affordability', 0.0062222848646342754)","(['Operational Eco-Efficiency'], 0.9406177997589111)","('NON-ESG', 0.006254915613681078)","('NON-ESG', 0.0062222848646342754)"
Line 73,"T o direct our growth in the areas of biomedical  engineering where we display maximum strength and ability; to gather people and facilities that tend to augment these areas; to continuously build on these areas through education and knowledge assimilation; to avoid participation in areas where we cannot make unique and worthy contributions.
","('Access_And_Affordability', 0.5987818241119385)","('Employee_Engagement_Inclusion_And_Diversity', 0.10331740975379944)","('Ecological_Impacts', 0.03315400704741478)","(['Health Outcome Contribution'], 0.5987818241119385)","('NON-ESG', 0.10331740975379944)","('NON-ESG', 0.03315400704741478)"
Line 74,"T o strive without reserve for the greatest  possible reliability and quality in our products; to be the unsurpassed standard of comparison and to be recognized as a company of dedication, honesty, integrity, and service.
","('Product_Design_And_Lifecycle_Management', 0.29731228947639465)","('Product_Quality_And_Safety', 0.21646876633167267)","('Business_Ethics', 0.13589240610599518)","('NON-ESG', 0.29731228947639465)","('NON-ESG', 0.21646876633167267)","('NON-ESG', 0.13589240610599518)"
Line 75,"T o make a fair profit on current operations to  meet our obligations, sustain our growth, and reach our goals.
","('Business_Model_Resilience', 0.5958232879638672)","('Systemic_Risk_Management', 0.09484092891216278)","('Supply_Chain_Management', 0.06397517025470734)","(['Codes of Business Conduct'], 0.5958232879638672)","('NON-ESG', 0.09484092891216278)","('NON-ESG', 0.06397517025470734)"
Line 76,"To recognize the personal worth of all  employees by providing an employment framework that allows personal satisfaction in work accomplished, security, advancement opportunity, and means to share in  the company’s success.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6796531677246094)","('Labor_Practices', 0.10401727259159088)","('Human_Rights_And_Community_Relations', 0.04595915600657463)","(['Human Capital Development'], 0.6796531677246094)","('NON-ESG', 0.10401727259159088)","('NON-ESG', 0.04595915600657463)"
Line 77,"To maintain good citizenship as a company.For more than 60 years, we have been guided by our Mission to alleviate pain,  restore health, and extend life.
","('Employee_Health_And_Safety', 0.9339022636413574)","('Critical_Incident_Risk_Management', 0.007076811511069536)","('Access_And_Affordability', 0.006776758935302496)","(['Operational Eco-Efficiency'], 0.9339022636413574)","('NON-ESG', 0.007076811511069536)","('NON-ESG', 0.006776758935302496)"
Line 78,"The Medtronic Mission 2022 Integrated Performance Report 10 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction GLOBAL FOOTPRINT FY22 net sales to customersOur structure, footprint,  and strategy  Our corporate structure consists of three  portfolios, each containing a range of operating units focused on different disease states or physician specialties, alongside the standalone diabetes operating unit.
","('Business_Model_Resilience', 0.4966000020503998)","('Systemic_Risk_Management', 0.1728658825159073)","('Customer_Welfare', 0.03720545396208763)","('NON-ESG', 0.4966000020503998)","('NON-ESG', 0.1728658825159073)","('NON-ESG', 0.03720545396208763)"
Line 79,"This structure is designed to enable autonomous decision-making and promote innovation, leading to timely delivery of effective therapies.
","('Access_And_Affordability', 0.19654345512390137)","('Management_Of_Legal_And_Regulatory_Framework', 0.1484445333480835)","('Competitive_Behavior', 0.08939570188522339)","('NON-ESG', 0.19654345512390137)","('NON-ESG', 0.1484445333480835)","('NON-ESG', 0.08939570188522339)"
Line 80,"Our operating unit presidents play a critical role in driving the development of new therapies and solutions and overseeing the work of each business.
","('Product_Design_And_Lifecycle_Management', 0.2843233644962311)","('Access_And_Affordability', 0.14603500068187714)","('Customer_Welfare', 0.08176281303167343)","('NON-ESG', 0.2843233644962311)","('NON-ESG', 0.14603500068187714)","('NON-ESG', 0.08176281303167343)"
Line 81,"2022 Integrated Performance Report 11 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction $11.4 B Cardiovascular portfolio $16.1 B United States (51%) Includes the United States   and U.S. territories.$5.4B Emerging markets (17%) Includes the countries of Africa, Eastern Europe,   the Middle East, Latin America, and the   countries of Asia not included in the non-U.S.  developed markets, as defined right.$10.1B Non-U.S. developed markets (32%) Includes Australia, Canada, Japan, Korea,   New Zealand, and the countries   of Western Europe.$2.3B Diabetes operating unit $9.1B Medical surgical portfolio$31.7B Total net FY22 sales $8.8B Neuroscience portfolioMEDTRONIC OPERATING STRUCTURE AND NET FY22 SALES† InPen requires a  prescription and proper settings, or you could experience highs/lows.
","('Systemic_Risk_Management', 0.3744608163833618)","('Business_Model_Resilience', 0.30185332894325256)","('Management_Of_Legal_And_Regulatory_Framework', 0.06038084998726845)","('NON-ESG', 0.3744608163833618)","('NON-ESG', 0.30185332894325256)","('NON-ESG', 0.06038084998726845)"
Line 82,"2022 Integrated Performance Report 11 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction $11.4 B Cardiovascular portfolio $16.1 B United States (51%) Includes the United States   and U.S. territories.$5.4B Emerging markets (17%) Includes the countries of Africa, Eastern Europe,   the Middle East, Latin America, and the   countries of Asia not included in the non-U.S.  developed markets, as defined right.$10.1B Non-U.S. developed markets (32%) Includes Australia, Canada, Japan, Korea,   New Zealand, and the countries   of Western Europe.$2.3B Diabetes operating unit $9.1B Medical surgical portfolio$31.7B Total net FY22 sales $8.8B Neuroscience portfolioMEDTRONIC OPERATING STRUCTURE AND NET FY22 SALES† InPen requires a  prescription and proper settings, or you could experience highs/lows.
","('Customer_Welfare', 0.2697236239910126)","('Product_Quality_And_Safety', 0.12013967335224152)","('Selling_Practices_And_Product_Labeling', 0.11726441979408264)","('NON-ESG', 0.2697236239910126)","('NON-ESG', 0.12013967335224152)","('NON-ESG', 0.11726441979408264)"
Line 83,"See bit.ly/InPen-Risks.
","('Systemic_Risk_Management', 0.9000943899154663)","('Competitive_Behavior', 0.01294025033712387)","('Data_Security', 0.012904893606901169)","(['Risk & Crisis Management'], 0.9000943899154663)","('NON-ESG', 0.01294025033712387)","('NON-ESG', 0.012904893606901169)"
Line 84,"† T otals do not add up due to rounding.Across every operating unit, we encourage  and enable our employees to share diverse perspectives, bold thinking, and  a desire to win.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9696774482727051)","('Business_Model_Resilience', 0.002573150908574462)","('Human_Rights_And_Community_Relations', 0.0021971995010972023)","(['Human Capital Development'], 0.9696774482727051)","('NON-ESG', 0.002573150908574462)","('NON-ESG', 0.0021971995010972023)"
Line 85,"We leverage our business structure to: •   Acceler ate innovation-driven growth —   by delivering technology and services that  better address patient needs.
","('Product_Design_And_Lifecycle_Management', 0.3665977418422699)","('Business_Model_Resilience', 0.1393556296825409)","('Customer_Welfare', 0.12391726672649384)","('NON-ESG', 0.3665977418422699)","('NON-ESG', 0.1393556296825409)","('NON-ESG', 0.12391726672649384)"
Line 86,"•   Bring our technologies to emer ging markets  — by providing targeted support, along with broad autonomy for regional teams to respond quickly to local needs.
","('Business_Model_Resilience', 0.39925968647003174)","('Systemic_Risk_Management', 0.2206309586763382)","('Competitive_Behavior', 0.07420085370540619)","('NON-ESG', 0.39925968647003174)","('NON-ESG', 0.2206309586763382)","('NON-ESG', 0.07420085370540619)"
Line 87,"•   Cr eate better experiences for patients,  customers, and employees — by listening more closely to understand challenges and using that insight to shape solutions.
","('Business_Model_Resilience', 0.13441628217697144)","('Access_And_Affordability', 0.12707816064357758)","('Human_Rights_And_Community_Relations', 0.12323755025863647)","('NON-ESG', 0.13441628217697144)","('NON-ESG', 0.12707816064357758)","('NON-ESG', 0.12323755025863647)"
Line 88,"•   T urn data, artificial intelligence, and  automation into action — by tailoring therapies in real time, facilitating remote monitoring and care delivery, and bringing robotics to more surgical suites around the world.
","('Access_And_Affordability', 0.23259900510311127)","('Employee_Health_And_Safety', 0.14585120975971222)","('Customer_Welfare', 0.09711924940347672)","('NON-ESG', 0.23259900510311127)","('NON-ESG', 0.14585120975971222)","('NON-ESG', 0.09711924940347672)"
Line 89,"2022 Integrated Performance Report 12 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction OUR COMPANY — FY22 SNAPSHOT 76M+ patients served150+ countries 95,000+ full-time employeesactive clinical trials $2.7B invested in R&D49,000+ patents in our portfolioInspired to expand healthcare access  Karen Shehade, a long-time Physician Assistant, marvels at the  groundbreaking innovation engineered at Medtronic and is proud to work for a company that improves lives at scale.
","('Access_And_Affordability', 0.39844831824302673)","('Employee_Engagement_Inclusion_And_Diversity', 0.08622551709413528)","('Business_Model_Resilience', 0.08179935067892075)","('NON-ESG', 0.39844831824302673)","('NON-ESG', 0.08622551709413528)","('NON-ESG', 0.08179935067892075)"
Line 90,"2022 Integrated Performance Report 12 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction OUR COMPANY — FY22 SNAPSHOT 76M+ patients served150+ countries 95,000+ full-time employeesactive clinical trials $2.7B invested in R&D49,000+ patents in our portfolioInspired to expand healthcare access  Karen Shehade, a long-time Physician Assistant, marvels at the  groundbreaking innovation engineered at Medtronic and is proud to work for a company that improves lives at scale.
","('Access_And_Affordability', 0.4846411943435669)","('Product_Design_And_Lifecycle_Management', 0.08194711059331894)","('Employee_Health_And_Safety', 0.07879851013422012)","('NON-ESG', 0.4846411943435669)","('NON-ESG', 0.08194711059331894)","('NON-ESG', 0.07879851013422012)"
Line 91,"But the global crisis of health inequity, where many around the world lack access to needed technologies and healthcare, troubles her.
","('Access_And_Affordability', 0.7273069620132446)","('Critical_Incident_Risk_Management', 0.06700709462165833)","('Employee_Health_And_Safety', 0.022896409034729004)","(['Health Outcome Contribution'], 0.7273069620132446)","('NON-ESG', 0.06700709462165833)","('NON-ESG', 0.022896409034729004)"
Line 92,"She channeled her concern into action by taking on a new role designed to marshal Medtronic resources and address the crisis.
","('Critical_Incident_Risk_Management', 0.9024200439453125)","('Physical_Impacts_Of_Climate_Change', 0.0246582068502903)","('Employee_Health_And_Safety', 0.011054208502173424)","(['Risk & Crisis Management'], 0.9024200439453125)","('NON-ESG', 0.0246582068502903)","('NON-ESG', 0.011054208502173424)"
Line 93,"As part of her responsibility as senior director of medical affairs in the Americas region, she chairs the newly formed Medtronic Health Equity Advisory Committee (HEAC) in the United States.
","('Access_And_Affordability', 0.2691950798034668)","('Management_Of_Legal_And_Regulatory_Framework', 0.14895956218242645)","('Systemic_Risk_Management', 0.07961753755807877)","('NON-ESG', 0.2691950798034668)","('NON-ESG', 0.14895956218242645)","('NON-ESG', 0.07961753755807877)"
Line 94,"Karen oversees the HEAC in its community-focused approach to  improving health equity, accelerating access, and overcoming structural and social barriers to quality care.
","('Access_And_Affordability', 0.9041894674301147)","('Human_Rights_And_Community_Relations', 0.012551169842481613)","('Product_Quality_And_Safety', 0.008189759217202663)","(['Health Outcome Contribution'], 0.9041894674301147)","('NON-ESG', 0.012551169842481613)","('NON-ESG', 0.008189759217202663)"
Line 95,"A key part of this work involves gathering robust data on equity of access and outcomes so we can prioritize our efforts, take effective action, and measure our impact.
","('Access_And_Affordability', 0.7105370759963989)","('Human_Rights_And_Community_Relations', 0.04701319336891174)","('Management_Of_Legal_And_Regulatory_Framework', 0.04302636533975601)","(['Health Outcome Contribution'], 0.7105370759963989)","('NON-ESG', 0.04701319336891174)","('NON-ESG', 0.04302636533975601)"
Line 96,"Karen has the clinical experience and skills to help  the HEAC interpret the data and translate learnings into  actions to create a more equitable world.
","('Access_And_Affordability', 0.381930410861969)","('Employee_Engagement_Inclusion_And_Diversity', 0.23779135942459106)","('Human_Rights_And_Community_Relations', 0.06290695816278458)","('NON-ESG', 0.381930410861969)","('NON-ESG', 0.23779135942459106)","('NON-ESG', 0.06290695816278458)"
Line 97,"Read more about the HEAC in Global healthcare access.
","('Access_And_Affordability', 0.8116544485092163)","('Product_Quality_And_Safety', 0.018706059083342552)","('Energy_Management', 0.018239302560687065)","(['Health Outcome Contribution'], 0.8116544485092163)","('NON-ESG', 0.018706059083342552)","('NON-ESG', 0.018239302560687065)"
Line 98,"“Improving patient access and equity  is pivotal to fulfilling our Mission.
","('Access_And_Affordability', 0.8406215906143188)","('Employee_Engagement_Inclusion_And_Diversity', 0.024553069844841957)","('Human_Rights_And_Community_Relations', 0.01876225508749485)","(['Health Outcome Contribution'], 0.8406215906143188)","('NON-ESG', 0.024553069844841957)","('NON-ESG', 0.01876225508749485)"
Line 99,"I’m confident that the work we’re  undertaking as the HEAC will set a  foundation for others to use to drive  equity in quality care and ensure that  our life-saving technology is accessible  to all who need it.”  Karen Shehade  Chair of the Medtronic Health Equity Advisory Committee  Senior Director of Medical Affairs, Americas“I feel good being a woman community  healthcare worker because I start from  my own family and then go into the  community.
","('Access_And_Affordability', 0.7165814638137817)","('Employee_Health_And_Safety', 0.05902586504817009)","('Employee_Engagement_Inclusion_And_Diversity', 0.0394965261220932)","(['Health Outcome Contribution'], 0.7165814638137817)","('NON-ESG', 0.05902586504817009)","('NON-ESG', 0.0394965261220932)"
Line 100,"Empower one woman,  and you empower the entire nation.” Jane Muthoni  Patient Engagement Lead,   Medtronic LABS  Leading new approaches to patient-first  healthcare tech Jane Muthoni, Patient Engagement Lead for Medtronic LABS in  Kenya, knows firsthand the importance of empowering patients to learn about their conditions and access healthcare services.
","('Access_And_Affordability', 0.7799132466316223)","('Human_Rights_And_Community_Relations', 0.04024963453412056)","('Employee_Engagement_Inclusion_And_Diversity', 0.023475848138332367)","(['Health Outcome Contribution'], 0.7799132466316223)","('NON-ESG', 0.04024963453412056)","('NON-ESG', 0.023475848138332367)"
Line 101,"She has lived with type 1 diabetes since she was six years old and made it her life’s work to educate others living with the disease.
","('Employee_Health_And_Safety', 0.2629834711551666)","('Access_And_Affordability', 0.2557167410850525)","('Employee_Engagement_Inclusion_And_Diversity', 0.12825772166252136)","('NON-ESG', 0.2629834711551666)","('NON-ESG', 0.2557167410850525)","('NON-ESG', 0.12825772166252136)"
Line 102,"Channeling this passion into her career, Jane works to improve  health outcomes for people living with non-communicable diseases.
","('Employee_Health_And_Safety', 0.8467786908149719)","('Access_And_Affordability', 0.04685711860656738)","('Product_Quality_And_Safety', 0.014695958234369755)","(['Operational Eco-Efficiency'], 0.8467786908149719)","('NON-ESG', 0.04685711860656738)","('NON-ESG', 0.014695958234369755)"
Line 103,"She is helping to train more than 300 community health workers (CHWs) — nearly all of whom are women — to screen patients for hypertension and diabetes.
","('Access_And_Affordability', 0.41870757937431335)","('Employee_Health_And_Safety', 0.1935013085603714)","('Employee_Engagement_Inclusion_And_Diversity', 0.07023392617702484)","('NON-ESG', 0.41870757937431335)","('NON-ESG', 0.1935013085603714)","('NON-ESG', 0.07023392617702484)"
Line 104,"The training includes use of LABS’ digital health platform, SPICE,  which was designed for CHWs and healthcare providers operating in low-resource settings.
","('Access_And_Affordability', 0.7171980738639832)","('Employee_Engagement_Inclusion_And_Diversity', 0.034270402044057846)","('Customer_Welfare', 0.03315585479140282)","(['Health Outcome Contribution'], 0.7171980738639832)","('NON-ESG', 0.034270402044057846)","('NON-ESG', 0.03315585479140282)"
Line 105,"The platform is the first of its kind to track health outcomes and overall population health indicators in real time.
","('Employee_Health_And_Safety', 0.7162063121795654)","('Access_And_Affordability', 0.06531254202127457)","('Critical_Incident_Risk_Management', 0.046377070248126984)","(['Operational Eco-Efficiency'], 0.7162063121795654)","('NON-ESG', 0.06531254202127457)","('NON-ESG', 0.046377070248126984)"
Line 106,"Most importantly, it helps to drive sustainable patient outcomes through technology features such as:  •   Da ta-driven patient engagement via SMS, WhatsApp, and more.
","('Access_And_Affordability', 0.776953935623169)","('Employee_Health_And_Safety', 0.027549544349312782)","('Customer_Welfare', 0.02050544135272503)","(['Health Outcome Contribution'], 0.776953935623169)","('NON-ESG', 0.027549544349312782)","('NON-ESG', 0.02050544135272503)"
Line 107,"•  T ele-counseling and telemedicine for remote follow-ups.
","('Management_Of_Legal_And_Regulatory_Framework', 0.32316458225250244)","('Access_And_Affordability', 0.23908160626888275)","('Product_Quality_And_Safety', 0.04921397566795349)","('NON-ESG', 0.32316458225250244)","('NON-ESG', 0.23908160626888275)","('NON-ESG', 0.04921397566795349)"
Line 108,"•   P atient education and care journeys customized for every patient.
","('Access_And_Affordability', 0.8865673542022705)","('Employee_Engagement_Inclusion_And_Diversity', 0.011371390894055367)","('Product_Quality_And_Safety', 0.009171601384878159)","(['Health Outcome Contribution'], 0.8865673542022705)","('NON-ESG', 0.011371390894055367)","('NON-ESG', 0.009171601384878159)"
Line 109,"The power of CHWs lies in their ability to develop one-on-one  relationships with patients and providers.
","('Access_And_Affordability', 0.6153039336204529)","('Human_Rights_And_Community_Relations', 0.11171849071979523)","('Employee_Health_And_Safety', 0.03823036327958107)","(['Health Outcome Contribution'], 0.6153039336204529)","('NON-ESG', 0.11171849071979523)","('NON-ESG', 0.03823036327958107)"
Line 110,"Pairing this patient-first approach with the power of tech amplifies the positive impact Jane and the people she trains can have in underserved communities.
","('Access_And_Affordability', 0.9463748335838318)","('Human_Rights_And_Community_Relations', 0.004917098209261894)","('Product_Quality_And_Safety', 0.0046189529821276665)","(['Health Outcome Contribution'], 0.9463748335838318)","('NON-ESG', 0.004917098209261894)","('NON-ESG', 0.0046189529821276665)"
Line 111,"Read more about Medtronic LABS in Global healthcare access.
","('Access_And_Affordability', 0.7246475219726562)","('Energy_Management', 0.03227976709604263)","('Customer_Welfare', 0.02745993621647358)","(['Health Outcome Contribution'], 0.7246475219726562)","('NON-ESG', 0.03227976709604263)","('NON-ESG', 0.02745993621647358)"
Line 112,"2022 Integrated Performance Report 13 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction Our impact: Employee stories Our employees are the heart of our company.
","('Business_Model_Resilience', 0.24411927163600922)","('Human_Rights_And_Community_Relations', 0.17980492115020752)","('Business_Ethics', 0.08864147961139679)","('NON-ESG', 0.24411927163600922)","('NON-ESG', 0.17980492115020752)","('NON-ESG', 0.08864147961139679)"
Line 113,"Their  diverse backgrounds and perspectives bring passion to our work, spark innovation, and drive opportunity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9661991596221924)","('Business_Model_Resilience', 0.0033032679930329323)","('Human_Rights_And_Community_Relations', 0.002659022342413664)","(['Human Capital Development'], 0.9661991596221924)","('NON-ESG', 0.0033032679930329323)","('NON-ESG', 0.002659022342413664)"
Line 114,"They empower one another to reach their highest potential and create positive change — helping us fulfill our Mission.
","('Human_Rights_And_Community_Relations', 0.7561973929405212)","('Business_Model_Resilience', 0.0495431162416935)","('Employee_Engagement_Inclusion_And_Diversity', 0.02540416643023491)","(['Community Relations'], 0.7561973929405212)","('NON-ESG', 0.0495431162416935)","('NON-ESG', 0.02540416643023491)"
Line 115,"Here, we share stories from employees who are at the forefront of our efforts  to enable healthier people and a healthier planet  by engineering the extraordinary.
","('Employee_Health_And_Safety', 0.8858906030654907)","('Access_And_Affordability', 0.028439100831747055)","('Human_Rights_And_Community_Relations', 0.012027876451611519)","(['Operational Eco-Efficiency'], 0.8858906030654907)","('NON-ESG', 0.028439100831747055)","('NON-ESG', 0.012027876451611519)"
Line 116,"Catalyzing environmental sustainability  Driven by a passion for the environment, Shona Kamps, a business process improvement  analyst for Medtronic Canada, set out to join a group of like-minded colleagues to bolster the company’s sustainability efforts.
","('Ecological_Impacts', 0.5666629672050476)","('Business_Model_Resilience', 0.09117898344993591)","('Human_Rights_And_Community_Relations', 0.07378090173006058)","(['Natural Capital'], 0.5666629672050476)","('NON-ESG', 0.09117898344993591)","('NON-ESG', 0.07378090173006058)"
Line 117,"But when she realized no such organization existed, she and two coworkers founded the employee-led Medtronic Environmental Action Group (EAG).
","('Human_Rights_And_Community_Relations', 0.17795297503471375)","('Labor_Practices', 0.16945238411426544)","('Employee_Health_And_Safety', 0.13542187213897705)","('NON-ESG', 0.17795297503471375)","('NON-ESG', 0.16945238411426544)","('NON-ESG', 0.13542187213897705)"
Line 118,"Within seven months, the group grew from the three cofounders to more than 1,000  Medtronic employees globally, and it continues to expand.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4198424220085144)","('Labor_Practices', 0.07069084793329239)","('Director_Removal', 0.06359908729791641)","('NON-ESG', 0.4198424220085144)","('NON-ESG', 0.07069084793329239)","('NON-ESG', 0.06359908729791641)"
Line 119,"The EAG is a space for employees to foster environmental sustainability at work and in their personal lives.
","('Human_Rights_And_Community_Relations', 0.653701663017273)","('Employee_Health_And_Safety', 0.08298087865114212)","('Ecological_Impacts', 0.03182592615485191)","(['Community Relations'], 0.653701663017273)","('NON-ESG', 0.08298087865114212)","('NON-ESG', 0.03182592615485191)"
Line 120,"Volunteers organize events, projects, and workshops on various topics, such as designing more sustainable products and packaging solutions and curtailing digital waste.
","('Waste_And_Hazardous_Materials_Management', 0.8993173241615295)","('Product_Design_And_Lifecycle_Management', 0.04326193407177925)","('Supply_Chain_Management', 0.0047143325209617615)","(['Operational Eco-Efficiency'], 0.8993173241615295)","('NON-ESG', 0.04326193407177925)","('NON-ESG', 0.0047143325209617615)"
Line 121,"The global group also collaborates with local Medtronic environmental employee groups around the world, like Ireland‘s Parkmore Eco Team and the Central and Eastern Europe team Together We Care.
","('Ecological_Impacts', 0.354870468378067)","('Human_Rights_And_Community_Relations', 0.2559380829334259)","('Access_And_Affordability', 0.05509638413786888)","('NON-ESG', 0.354870468378067)","('NON-ESG', 0.2559380829334259)","('NON-ESG', 0.05509638413786888)"
Line 122,"The EAG is powered by a dedicated core team of volunteer employees who work together across countries and functions to inspire and engage fellow employees to make integrating sustainability a priority within and beyond Medtronic.
","('Human_Rights_And_Community_Relations', 0.23354478180408478)","('Employee_Health_And_Safety', 0.2105504274368286)","('Employee_Engagement_Inclusion_And_Diversity', 0.19513197243213654)","('NON-ESG', 0.23354478180408478)","('NON-ESG', 0.2105504274368286)","('NON-ESG', 0.19513197243213654)"
Line 123,"Shona illustrates the power of each individual employee.
","('Labor_Practices', 0.24858590960502625)","('Competitive_Behavior', 0.18529757857322693)","('Business_Ethics', 0.13951192796230316)","('NON-ESG', 0.24858590960502625)","('NON-ESG', 0.18529757857322693)","('NON-ESG', 0.13951192796230316)"
Line 124,"Her idea and her energy made the EAG  a reality.
","('Energy_Management', 0.41611364483833313)","('Management_Of_Legal_And_Regulatory_Framework', 0.11004012078046799)","('Product_Design_And_Lifecycle_Management', 0.07608574628829956)","('NON-ESG', 0.41611364483833313)","('NON-ESG', 0.11004012078046799)","('NON-ESG', 0.07608574628829956)"
Line 125,"The work of its members plays an important part in Medtronic’s sustainability efforts.
","('Business_Model_Resilience', 0.3054473400115967)","('Product_Design_And_Lifecycle_Management', 0.1432458460330963)","('Supply_Chain_Management', 0.06892527639865875)","('NON-ESG', 0.3054473400115967)","('NON-ESG', 0.1432458460330963)","('NON-ESG', 0.06892527639865875)"
Line 126,"Turning barriers into  opportunities Sarah Nieters has faced barriers in her career  in science, technology, engineering, and math (STEM) that are all too common for underrepresented groups.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9136433005332947)","('Employee_Health_And_Safety', 0.007239419035613537)","('Business_Model_Resilience', 0.0066057732328772545)","(['Human Capital Development'], 0.9136433005332947)","('NON-ESG', 0.007239419035613537)","('NON-ESG', 0.0066057732328772545)"
Line 127,"She knows how it feels to be the only woman at a conference for information technology (IT) executives, and she watched a high school advisor dismiss her daughter’s desire to apply to a top engineering school.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6980088949203491)","('Business_Model_Resilience', 0.06288279592990875)","('Product_Design_And_Lifecycle_Management', 0.020716089755296707)","(['Human Capital Development'], 0.6980088949203491)","('NON-ESG', 0.06288279592990875)","('NON-ESG', 0.020716089755296707)"
Line 128,"These experiences might have left her dispirited, but instead, she was inspired.
","('Employee_Health_And_Safety', 0.08749113976955414)","('Competitive_Behavior', 0.08014249801635742)","('Employee_Engagement_Inclusion_And_Diversity', 0.07894856482744217)","('NON-ESG', 0.08749113976955414)","('NON-ESG', 0.08014249801635742)","('NON-ESG', 0.07894856482744217)"
Line 129,"Sarah — an IT vice president at Medtronic —  was instrumental in developing an internship partnership with Genesys Works — a nonprofit that expands career pathways for talented high school students from underrepresented groups.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8535724878311157)","('Access_And_Affordability', 0.02644360065460205)","('Employee_Health_And_Safety', 0.01151853147894144)","(['Human Capital Development'], 0.8535724878311157)","('NON-ESG', 0.02644360065460205)","('NON-ESG', 0.01151853147894144)"
Line 130,"Veronica Venegas is one of many who have  found the internship pivotal.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7423418760299683)","('Employee_Health_And_Safety', 0.030652280896902084)","('Labor_Practices', 0.027580076828598976)","(['Human Capital Development'], 0.7423418760299683)","('NON-ESG', 0.030652280896902084)","('NON-ESG', 0.027580076828598976)"
Line 131,"After completing her IT internship, she was the first in her family to graduate college and will soon begin a full-time position at Medtronic.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2632351517677307)","('Labor_Practices', 0.2372322380542755)","('Access_And_Affordability', 0.0712093636393547)","('NON-ESG', 0.2632351517677307)","('NON-ESG', 0.2372322380542755)","('NON-ESG', 0.0712093636393547)"
Line 132,"To date, more than 300 high school students  have completed IT internships at Medtronic.
","('Labor_Practices', 0.29539960622787476)","('Employee_Engagement_Inclusion_And_Diversity', 0.19442889094352722)","('Access_And_Affordability', 0.14007380604743958)","('NON-ESG', 0.29539960622787476)","('NON-ESG', 0.19442889094352722)","('NON-ESG', 0.14007380604743958)"
Line 133,"In FY22, 57% were women and 98% were Black, Indigenous, and people of color.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9293935894966125)","('Human_Rights_And_Community_Relations', 0.01995721273124218)","('Labor_Practices', 0.004892786033451557)","(['Human Capital Development'], 0.9293935894966125)","('NON-ESG', 0.01995721273124218)","('NON-ESG', 0.004892786033451557)"
Line 134,"Learn more  about Sarah’s contribution here.“One of the real barriers  that I see is access.
","('Access_And_Affordability', 0.5170150399208069)","('Human_Rights_And_Community_Relations', 0.06023282930254936)","('Employee_Engagement_Inclusion_And_Diversity', 0.04984647408127785)","(['Health Outcome Contribution'], 0.5170150399208069)","('NON-ESG', 0.06023282930254936)","('NON-ESG', 0.04984647408127785)"
Line 135,"Once  the door is opened, it’s  up to the student to take  advantage of that, and  you can see that they do.” Sarah Nieters  Medtronic executive sponsor of   the Genesys Works partnership  IT Vice President   “This kind of experience  is life-changing to  students like me.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5805608630180359)","('Access_And_Affordability', 0.05931433290243149)","('Business_Model_Resilience', 0.04838162660598755)","(['Human Capital Development'], 0.5805608630180359)","('NON-ESG', 0.05931433290243149)","('NON-ESG', 0.04838162660598755)"
Line 136,"I think  that it’s an awesome   way to get students of  color and women into  STEM fields.” Veronica Venegas  previous participant in the   Medtronic IT internship program“The Environmental Action Group gives Medtronic  employees a launching pad to learn about environmental  sustainability and empower their ideas for impact within  our company and their work.
","('Employee_Engagement_Inclusion_And_Diversity', 0.42476987838745117)","('Human_Rights_And_Community_Relations', 0.2097044438123703)","('Employee_Health_And_Safety', 0.05136914178729057)","('NON-ESG', 0.42476987838745117)","('NON-ESG', 0.2097044438123703)","('NON-ESG', 0.05136914178729057)"
Line 137,"The global engagement  we are seeing showcases the shift in culture needed  to integrate environmental sustainability in the core of  businesses in every industry.” Shona Kamps  EAG cofounder, Business Process Improvement Analyst, Medtronic Canada 2022 Integrated Performance Report 14 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction OUR IMPACT: EMPLOYEE STORIES ESG strategy Our environmental, social, and governance (ESG) strategy defines and  drives our sustainability efforts.
","('Business_Model_Resilience', 0.34783464670181274)","('Human_Rights_And_Community_Relations', 0.2539222836494446)","('Ecological_Impacts', 0.043687839061021805)","('NON-ESG', 0.34783464670181274)","('NON-ESG', 0.2539222836494446)","('NON-ESG', 0.043687839061021805)"
Line 138,"The global engagement  we are seeing showcases the shift in culture needed  to integrate environmental sustainability in the core of  businesses in every industry.” Shona Kamps  EAG cofounder, Business Process Improvement Analyst, Medtronic Canada 2022 Integrated Performance Report 14 ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index  Introduction OUR IMPACT: EMPLOYEE STORIES ESG strategy Our environmental, social, and governance (ESG) strategy defines and  drives our sustainability efforts.
","('Product_Design_And_Lifecycle_Management', 0.22314098477363586)","('Business_Model_Resilience', 0.19869588315486908)","('Ecological_Impacts', 0.11866790056228638)","('NON-ESG', 0.22314098477363586)","('NON-ESG', 0.19869588315486908)","('NON-ESG', 0.11866790056228638)"
Line 139,"We prioritize action on our most material issues, supported by robust governance, risk assessment, accountability,  and ongoing dialogue with our stakeholders.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6856085062026978)","('Human_Rights_And_Community_Relations', 0.05254053696990013)","('Business_Ethics', 0.041660308837890625)","(['Corporate Governance'], 0.6856085062026978)","('NON-ESG', 0.05254053696990013)","('NON-ESG', 0.041660308837890625)"
Line 140,"Material issues and targets  16   Sustainability governance   18  Stakeholder engagement  20   C ontribution to the UN Sustainable Development Goals  23  2022 Integrated Performance Report Introduction 15 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Our material issues We focus our ESG strategy on the issues that: •  Ar e aligned with our Mission.
","('Business_Model_Resilience', 0.3162212371826172)","('Management_Of_Legal_And_Regulatory_Framework', 0.16911037266254425)","('Human_Rights_And_Community_Relations', 0.14368867874145508)","('NON-ESG', 0.3162212371826172)","('NON-ESG', 0.16911037266254425)","('NON-ESG', 0.14368867874145508)"
Line 141,"•  Ar e important to our stakeholders.
","('Human_Rights_And_Community_Relations', 0.6981680393218994)","('Management_Of_Legal_And_Regulatory_Framework', 0.10457071661949158)","('Director_Removal', 0.02005542442202568)","(['Community Relations'], 0.6981680393218994)","('NON-ESG', 0.10457071661949158)","('NON-ESG', 0.02005542442202568)"
Line 142,"•   Have potential to significantly affect our business  gr owth, finances, or reputation.
","('Systemic_Risk_Management', 0.46492499113082886)","('Business_Model_Resilience', 0.2026742547750473)","('Business_Ethics', 0.08148498088121414)","('NON-ESG', 0.46492499113082886)","('NON-ESG', 0.2026742547750473)","('NON-ESG', 0.08148498088121414)"
Line 143,"We regularly review material issues1 by monitoring  and assessing internal and external expectations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6580577492713928)","('Business_Ethics', 0.06501474231481552)","('Human_Rights_And_Community_Relations', 0.057685788720846176)","(['Corporate Governance'], 0.6580577492713928)","('NON-ESG', 0.06501474231481552)","('NON-ESG', 0.057685788720846176)"
Line 144,"During our most recent materiality assessment in FY19, we consulted with key stakeholders to update and prioritize our list of material issues.
","('Management_Of_Legal_And_Regulatory_Framework', 0.26207441091537476)","('Systemic_Risk_Management', 0.12391223758459091)","('Physical_Impacts_Of_Climate_Change', 0.11053328216075897)","('NON-ESG', 0.26207441091537476)","('NON-ESG', 0.12391223758459091)","('NON-ESG', 0.11053328216075897)"
Line 145,"These stakeholders included Medtronic leaders, investors, policymakers, governments, customers, industry association representatives, and nongovernmental organizations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9370542168617249)","('Human_Rights_And_Community_Relations', 0.0072070700116455555)","('GHG_Emissions', 0.006743120029568672)","(['Corporate Governance'], 0.9370542168617249)","('NON-ESG', 0.0072070700116455555)","('NON-ESG', 0.006743120029568672)"
Line 146,"Our materiality assessment highlighted three significant  areas where we can drive positive change: innovation and healthcare access; patient safety and product quality; and inclusion, diversity, and equity (ID&E).
","('Employee_Engagement_Inclusion_And_Diversity', 0.8049690127372742)","('Access_And_Affordability', 0.034842561930418015)","('Product_Quality_And_Safety', 0.03136492893099785)","(['Human Capital Development'], 0.8049690127372742)","('NON-ESG', 0.034842561930418015)","('NON-ESG', 0.03136492893099785)"
Line 147,"Each area has a senior executive who sets companywide performance objectives and collaborates internally to monitor and advance progress.
","('Business_Model_Resilience', 0.43884462118148804)","('Systemic_Risk_Management', 0.09723038971424103)","('Human_Rights_And_Community_Relations', 0.09651562571525574)","('NON-ESG', 0.43884462118148804)","('NON-ESG', 0.09723038971424103)","('NON-ESG', 0.09651562571525574)"
Line 148,"The following table shows how our full list of material  issues aligns with the tenets of our Mission.MATERIAL SUSTAINABILITY ISSUES AND OUR MISSION  Mission Material issue Tenet 1: Contribute to human welfare by alleviating pain,  restoring health, and extending life Tenet 2: Direct growth in areas of biomedical engineering  through education and knowledge assimilation•  Innova tion and access •  Integr ated care Tenet 3: Strive without reserve for the greatest possible reliability and quality in our products and recognition as a company of dedication, honesty, integrity, and service•  P atient safety and product quality •  T echnology and device security •  Da ta privacy and security •  Ethics in sales and mark eting •  C orruption and bribery •  T ransparency Tenet 4: Make a fair profit by meeting our obligations, sustaining our growth, and reaching our goals•  Affor dability and fair pricing •  Clima te risk and resilience •  R esponsible supply management •  P roduct stewardship Tenet 5: Recognize the personal worth of all employees by advancing opportunity•  ID&E •  T alent Tenet 6: Maintain good citizenship as a company As a good corporate citizen, we use all of our resources, including philanthropy and community investment, to address our material ESG issues.
","('Access_And_Affordability', 0.22428317368030548)","('Human_Rights_And_Community_Relations', 0.19110190868377686)","('Employee_Health_And_Safety', 0.15955844521522522)","('NON-ESG', 0.22428317368030548)","('NON-ESG', 0.19110190868377686)","('NON-ESG', 0.15955844521522522)"
Line 149,"The following table shows how our full list of material  issues aligns with the tenets of our Mission.MATERIAL SUSTAINABILITY ISSUES AND OUR MISSION  Mission Material issue Tenet 1: Contribute to human welfare by alleviating pain,  restoring health, and extending life Tenet 2: Direct growth in areas of biomedical engineering  through education and knowledge assimilation•  Innova tion and access •  Integr ated care Tenet 3: Strive without reserve for the greatest possible reliability and quality in our products and recognition as a company of dedication, honesty, integrity, and service•  P atient safety and product quality •  T echnology and device security •  Da ta privacy and security •  Ethics in sales and mark eting •  C orruption and bribery •  T ransparency Tenet 4: Make a fair profit by meeting our obligations, sustaining our growth, and reaching our goals•  Affor dability and fair pricing •  Clima te risk and resilience •  R esponsible supply management •  P roduct stewardship Tenet 5: Recognize the personal worth of all employees by advancing opportunity•  ID&E •  T alent Tenet 6: Maintain good citizenship as a company As a good corporate citizen, we use all of our resources, including philanthropy and community investment, to address our material ESG issues.
","('Business_Ethics', 0.9367400407791138)","('Product_Quality_And_Safety', 0.009883077815175056)","('Data_Security', 0.006606285460293293)","(['Business Ethics'], 0.9367400407791138)","('NON-ESG', 0.009883077815175056)","('NON-ESG', 0.006606285460293293)"
Line 150,"The following table shows how our full list of material  issues aligns with the tenets of our Mission.MATERIAL SUSTAINABILITY ISSUES AND OUR MISSION  Mission Material issue Tenet 1: Contribute to human welfare by alleviating pain,  restoring health, and extending life Tenet 2: Direct growth in areas of biomedical engineering  through education and knowledge assimilation•  Innova tion and access •  Integr ated care Tenet 3: Strive without reserve for the greatest possible reliability and quality in our products and recognition as a company of dedication, honesty, integrity, and service•  P atient safety and product quality •  T echnology and device security •  Da ta privacy and security •  Ethics in sales and mark eting •  C orruption and bribery •  T ransparency Tenet 4: Make a fair profit by meeting our obligations, sustaining our growth, and reaching our goals•  Affor dability and fair pricing •  Clima te risk and resilience •  R esponsible supply management •  P roduct stewardship Tenet 5: Recognize the personal worth of all employees by advancing opportunity•  ID&E •  T alent Tenet 6: Maintain good citizenship as a company As a good corporate citizen, we use all of our resources, including philanthropy and community investment, to address our material ESG issues.
","('Human_Rights_And_Community_Relations', 0.7679417729377747)","('Employee_Engagement_Inclusion_And_Diversity', 0.08118117600679398)","('Access_And_Affordability', 0.02213507890701294)","(['Community Relations'], 0.7679417729377747)","('NON-ESG', 0.08118117600679398)","('NON-ESG', 0.02213507890701294)"
Line 151,"1  T hroughout this report, we use the Global Reporting Initiative (GRI) definition of  materiality, which is different from the definition used for filings with the Securities  and Exchange Commission (SEC).
","('Systemic_Risk_Management', 0.44532233476638794)","('Management_Of_Legal_And_Regulatory_Framework', 0.24504779279232025)","('Business_Ethics', 0.06118151545524597)","('NON-ESG', 0.44532233476638794)","('NON-ESG', 0.24504779279232025)","('NON-ESG', 0.06118151545524597)"
Line 152,"Topics identified as material for purposes of this report may not be considered material for SEC reporting purposes.Material issues and targets 2022 Integrated Performance Report Introduction 16 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy In early FY22, we set new ESG performance targets to  drive progress on our material issues.
","('Business_Model_Resilience', 0.31494981050491333)","('Management_Of_Legal_And_Regulatory_Framework', 0.20340879261493683)","('Human_Rights_And_Community_Relations', 0.07889699190855026)","('NON-ESG', 0.31494981050491333)","('NON-ESG', 0.20340879261493683)","('NON-ESG', 0.07889699190855026)"
Line 153,"We also announced a new ambition to be net zero across our value chain by FY45.
","('Business_Model_Resilience', 0.39706265926361084)","('Systemic_Risk_Management', 0.2682795524597168)","('Supply_Chain_Management', 0.06926187872886658)","('NON-ESG', 0.39706265926361084)","('NON-ESG', 0.2682795524597168)","('NON-ESG', 0.06926187872886658)"
Line 154,"Alongside the targets listed here, we have two product  stewardship targets focused on packaging: •   By FY25,  reduce packaging waste by 25% for targeted  high-volume products (tied to weight, material  selection, and sourcing) compared to an FY21 baseline.
","('Product_Design_And_Lifecycle_Management', 0.8265941143035889)","('Waste_And_Hazardous_Materials_Management', 0.06952132284641266)","('Product_Quality_And_Safety', 0.017944999039173126)","(['Product Stewardship'], 0.8265941143035889)","('NON-ESG', 0.06952132284641266)","('NON-ESG', 0.017944999039173126)"
Line 155,"•   By FY27,  minimize the impact of Instructions for   Use through a 35% paper reduction, compared to an FY21 baseline.
","('Product_Design_And_Lifecycle_Management', 0.38875865936279297)","('Energy_Management', 0.09271835535764694)","('Customer_Welfare', 0.08942945301532745)","('NON-ESG', 0.38875865936279297)","('NON-ESG', 0.09271835535764694)","('NON-ESG', 0.08942945301532745)"
Line 156,"These targets are quantitative but require us to achieve qualitative milestones first to enable accurate measurement of progress.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4753965139389038)","('Business_Model_Resilience', 0.0844535306096077)","('Human_Rights_And_Community_Relations', 0.08209487050771713)","('NON-ESG', 0.4753965139389038)","('NON-ESG', 0.0844535306096077)","('NON-ESG', 0.08209487050771713)"
Line 157,"We will begin reporting on progress toward these targets in future reports.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35602712631225586)","('Human_Rights_And_Community_Relations', 0.11297815293073654)","('GHG_Emissions', 0.07087402790784836)","('NON-ESG', 0.35602712631225586)","('NON-ESG', 0.11297815293073654)","('NON-ESG', 0.07087402790784836)"
Line 158,"Read more about our packaging efforts in Product stewardship.ESG TARGETS AND PROGRESS Category Target Baseline  dateEnd  dateCurrent status  toward target Climate risk and resilience Reduce greenhouse gas emissions intensity by 50% FY20 FY25 35% Innovation and access 20% of Medtronic revenue will flow from products and  therapies released in the prior 36 monthsPrior 36   monthsFY25 19% Innovation and access Serve 85 million patients annually N/A FY25 76.3 million Patient safety and   product qualityAchieve 10% reduction in aggregate product  complaint rate for identified product families†FY20 FY25 10% ID&E 45% of global manager-and-above positions held by womenN/A FY26 42% ID&E 30% of U.S. manager-and-above positions held by ethnically diverse talentN/A FY26 27% Responsible supply  managementAssess suppliers representing 80% of our annual  managed spend on sustainability performanceN/A FY26 66% Responsible supply  managementGrow our procurement with U.S. diverse-owned  suppliers by 5% year-over-year through FY26 FY22 FY22 29% †  The goal covers the following products: Transcatheter Aortic valves and delivery systems, Venous Closure Systems, Spinal Cord Stimulation systems, Mazor Robot, SigniaTM handles, Puritan BennettTM 980 ventilator, and Diabetes NGP pumps and sensors.
","('Product_Design_And_Lifecycle_Management', 0.5813242197036743)","('Product_Quality_And_Safety', 0.22766754031181335)","('Customer_Welfare', 0.03204149752855301)","(['Product Stewardship'], 0.5813242197036743)","('NON-ESG', 0.22766754031181335)","('NON-ESG', 0.03204149752855301)"
Line 159,"Read more about our packaging efforts in Product stewardship.ESG TARGETS AND PROGRESS Category Target Baseline  dateEnd  dateCurrent status  toward target Climate risk and resilience Reduce greenhouse gas emissions intensity by 50% FY20 FY25 35% Innovation and access 20% of Medtronic revenue will flow from products and  therapies released in the prior 36 monthsPrior 36   monthsFY25 19% Innovation and access Serve 85 million patients annually N/A FY25 76.3 million Patient safety and   product qualityAchieve 10% reduction in aggregate product  complaint rate for identified product families†FY20 FY25 10% ID&E 45% of global manager-and-above positions held by womenN/A FY26 42% ID&E 30% of U.S. manager-and-above positions held by ethnically diverse talentN/A FY26 27% Responsible supply  managementAssess suppliers representing 80% of our annual  managed spend on sustainability performanceN/A FY26 66% Responsible supply  managementGrow our procurement with U.S. diverse-owned  suppliers by 5% year-over-year through FY26 FY22 FY22 29% †  The goal covers the following products: Transcatheter Aortic valves and delivery systems, Venous Closure Systems, Spinal Cord Stimulation systems, Mazor Robot, SigniaTM handles, Puritan BennettTM 980 ventilator, and Diabetes NGP pumps and sensors.
","('Supply_Chain_Management', 0.4355425238609314)","('Product_Design_And_Lifecycle_Management', 0.2279473841190338)","('Employee_Engagement_Inclusion_And_Diversity', 0.08088909834623337)","('NON-ESG', 0.4355425238609314)","('NON-ESG', 0.2279473841190338)","('NON-ESG', 0.08088909834623337)"
Line 160,"Read more about our packaging efforts in Product stewardship.ESG TARGETS AND PROGRESS Category Target Baseline  dateEnd  dateCurrent status  toward target Climate risk and resilience Reduce greenhouse gas emissions intensity by 50% FY20 FY25 35% Innovation and access 20% of Medtronic revenue will flow from products and  therapies released in the prior 36 monthsPrior 36   monthsFY25 19% Innovation and access Serve 85 million patients annually N/A FY25 76.3 million Patient safety and   product qualityAchieve 10% reduction in aggregate product  complaint rate for identified product families†FY20 FY25 10% ID&E 45% of global manager-and-above positions held by womenN/A FY26 42% ID&E 30% of U.S. manager-and-above positions held by ethnically diverse talentN/A FY26 27% Responsible supply  managementAssess suppliers representing 80% of our annual  managed spend on sustainability performanceN/A FY26 66% Responsible supply  managementGrow our procurement with U.S. diverse-owned  suppliers by 5% year-over-year through FY26 FY22 FY22 29% †  The goal covers the following products: Transcatheter Aortic valves and delivery systems, Venous Closure Systems, Spinal Cord Stimulation systems, Mazor Robot, SigniaTM handles, Puritan BennettTM 980 ventilator, and Diabetes NGP pumps and sensors.
","('Employee_Health_And_Safety', 0.7495867013931274)","('Access_And_Affordability', 0.04345330595970154)","('Product_Quality_And_Safety', 0.02698514610528946)","(['Operational Eco-Efficiency'], 0.7495867013931274)","('NON-ESG', 0.04345330595970154)","('NON-ESG', 0.02698514610528946)"
Line 161,"We are focusing on these product families because they represent strategic opportunities to positively influence complaint rate and patient experience through new product introductions and post-release changes.
","('Product_Design_And_Lifecycle_Management', 0.38628122210502625)","('Customer_Welfare', 0.20968173444271088)","('Selling_Practices_And_Product_Labeling', 0.1307787299156189)","('NON-ESG', 0.38628122210502625)","('NON-ESG', 0.20968173444271088)","('NON-ESG', 0.1307787299156189)"
Line 162,"We continuously evaluate opportunities   to reduce complaints and improve the patient experience.
","('Access_And_Affordability', 0.1678372025489807)","('Business_Ethics', 0.16755245625972748)","('Employee_Health_And_Safety', 0.09577442705631256)","('NON-ESG', 0.1678372025489807)","('NON-ESG', 0.16755245625972748)","('NON-ESG', 0.09577442705631256)"
Line 163,"As opportunities are identified we may expand the scope of this commitment in future years.
","('Business_Model_Resilience', 0.3575637638568878)","('Systemic_Risk_Management', 0.1950204074382782)","('Management_Of_Legal_And_Regulatory_Framework', 0.0624077171087265)","('NON-ESG', 0.3575637638568878)","('NON-ESG', 0.1950204074382782)","('NON-ESG', 0.0624077171087265)"
Line 164,"This target is an aggregate percent reduction from FY20 to FY25.
","('GHG_Emissions', 0.1394914835691452)","('Business_Model_Resilience', 0.13789775967597961)","('Management_Of_Legal_And_Regulatory_Framework', 0.11311997473239899)","('NON-ESG', 0.1394914835691452)","('NON-ESG', 0.13789775967597961)","('NON-ESG', 0.11311997473239899)"
Line 165,"Therefore, annual progress toward  this target prior to FY25 does not represent achieving or missing the target.MATERIAL ISSUES AND TARGETS Net zero In FY22, we announced a new  ambition to be net zero across   our value chain by FY45.
","('Systemic_Risk_Management', 0.49175918102264404)","('Business_Model_Resilience', 0.28175774216651917)","('Supply_Chain_Management', 0.051784221082925797)","('NON-ESG', 0.49175918102264404)","('NON-ESG', 0.28175774216651917)","('NON-ESG', 0.051784221082925797)"
Line 166,"2022 Integrated Performance Report Introduction 17 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Robust governance structures and processes underpin our sustainability strategy: •   T he Nominating and Corporate Governance Committee of our board of  directors oversees our environmental, social, and governance (ESG) practices  and regularly reviews ESG topics that are a priority for the company, as do other board committees, as appropriate.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2607521414756775)","('Business_Model_Resilience', 0.1462400257587433)","('Director_Removal', 0.1355898380279541)","('NON-ESG', 0.2607521414756775)","('NON-ESG', 0.1462400257587433)","('NON-ESG', 0.1355898380279541)"
Line 167,"•   Our  Sustainability Steering Committee (SSC) works to embed sustainability  throughout our operations.
","('Business_Model_Resilience', 0.33288297057151794)","('Product_Design_And_Lifecycle_Management', 0.24546585977077484)","('Supply_Chain_Management', 0.06650541722774506)","('NON-ESG', 0.33288297057151794)","('NON-ESG', 0.24546585977077484)","('NON-ESG', 0.06650541722774506)"
Line 168,"Led by our chief financial officer, the SSC comprises executive committee members from across the company who oversee our ESG progress and performance, alongside vice presidents  who lead ESG focus areas or whose work is informed by ESG.
","('Business_Model_Resilience', 0.6813337206840515)","('Systemic_Risk_Management', 0.10088633000850677)","('Human_Rights_And_Community_Relations', 0.02268984355032444)","(['Codes of Business Conduct'], 0.6813337206840515)","('NON-ESG', 0.10088633000850677)","('NON-ESG', 0.02268984355032444)"
Line 169,"•   An  SSC subcommittee governs ESG disclosures and strengthens data   controls to aid more robust and effective reporting.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5480173826217651)","('Data_Security', 0.16965210437774658)","('Systemic_Risk_Management', 0.04961743578314781)","(['Corporate Governance'], 0.5480173826217651)","('NON-ESG', 0.16965210437774658)","('NON-ESG', 0.04961743578314781)"
Line 170,"We also partner with external organizations working to strengthen  sustainability governance, data, and disclosure practices.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8506051898002625)","('Systemic_Risk_Management', 0.016530634835362434)","('Business_Ethics', 0.012470261193811893)","(['Corporate Governance'], 0.8506051898002625)","('NON-ESG', 0.016530634835362434)","('NON-ESG', 0.012470261193811893)"
Line 171,"In FY22, for example, we participated in an Enterprise Data Management Council project on best practices in ESG data management and were part of the working group  drafting a white paper on the same topic.
","('Business_Model_Resilience', 0.3893391788005829)","('Systemic_Risk_Management', 0.16375869512557983)","('Data_Security', 0.09734385460615158)","('NON-ESG', 0.3893391788005829)","('NON-ESG', 0.16375869512557983)","('NON-ESG', 0.09734385460615158)"
Line 172,"In FY22, we enhanced our remuneration practices to link executive   compensation to inclusion, diversity, and equity (ID&E) performance.
","('Employee_Engagement_Inclusion_And_Diversity', 0.97027987241745)","('Labor_Practices', 0.003163740271702409)","('Employee_Health_And_Safety', 0.002451906679198146)","(['Human Capital Development'], 0.97027987241745)","('NON-ESG', 0.003163740271702409)","('NON-ESG', 0.002451906679198146)"
Line 173,"Read more here.
","('Data_Security', 0.17439018189907074)","('Management_Of_Legal_And_Regulatory_Framework', 0.1024290919303894)","('Access_And_Affordability', 0.09254051744937897)","('NON-ESG', 0.17439018189907074)","('NON-ESG', 0.1024290919303894)","('NON-ESG', 0.09254051744937897)"
Line 174,"Managing risks and creating opportunities By continually monitoring emerging sustainability issues, we can anticipate business risks and create value from opportunities.
","('Systemic_Risk_Management', 0.8949507474899292)","('Business_Model_Resilience', 0.026089254766702652)","('Supply_Chain_Management', 0.013455124571919441)","(['Risk & Crisis Management'], 0.8949507474899292)","('NON-ESG', 0.026089254766702652)","('NON-ESG', 0.013455124571919441)"
Line 175,"The following tables summarize our current key ESG risk and opportunity areas, along with  our response.
","('Systemic_Risk_Management', 0.42885661125183105)","('Business_Model_Resilience', 0.40863072872161865)","('Physical_Impacts_Of_Climate_Change', 0.029576770961284637)","('NON-ESG', 0.42885661125183105)","('NON-ESG', 0.40863072872161865)","('NON-ESG', 0.029576770961284637)"
Line 176,"More detail about our most significant business risks is included in our   2022 Form 10-K and quarterly 10-Q filings with the U.S. Securities and  Exchange Commission.MANAGING RISK THROUGH ESG  Risk Response  Patient safety and   product quality issuesAligned with our commitment to produce safe and effective healthcare technologies for patients, we examined end-to-end quality performance and are making sustainable improvements to ensure we deliver on our Mission.
","('Product_Quality_And_Safety', 0.7852789163589478)","('Product_Design_And_Lifecycle_Management', 0.10265456885099411)","('Selling_Practices_And_Product_Labeling', 0.01428254321217537)","(['Product Quality & Recall Management'], 0.7852789163589478)","('NON-ESG', 0.10265456885099411)","('NON-ESG', 0.01428254321217537)"
Line 177,"In FY22, we launched an updated cross-functional, enterprise quality plan established to drive improvement  and enhance our quality performance — including driving consistency and increased rigor across the areas  of risk assessment, product design, and quality systems.
","('Product_Design_And_Lifecycle_Management', 0.8569828271865845)","('Product_Quality_And_Safety', 0.06011170893907547)","('Business_Model_Resilience', 0.009280643425881863)","(['Product Stewardship'], 0.8569828271865845)","('NON-ESG', 0.06011170893907547)","('NON-ESG', 0.009280643425881863)"
Line 178,"Climate risk and resilience We manage transitional risks by monitoring climate change regulation and treaties, as well as regulations on carbon emissions (including carbon taxes), and continue to install renewable and alternative energy sources as they become more cost-effective and readily available.
","('Physical_Impacts_Of_Climate_Change', 0.9256106019020081)","('Business_Model_Resilience', 0.019800912588834763)","('GHG_Emissions', 0.008967543952167034)","(['Climate Change'], 0.9256106019020081)","('NON-ESG', 0.019800912588834763)","('NON-ESG', 0.008967543952167034)"
Line 179,"In preparation for the global transition to a zero-carbon economy, we announced a new ambition to be net zero across our value chain by FY45.
","('Systemic_Risk_Management', 0.44748827815055847)","('Business_Model_Resilience', 0.23870371282100677)","('Supply_Chain_Management', 0.07883048802614212)","('NON-ESG', 0.44748827815055847)","('NON-ESG', 0.23870371282100677)","('NON-ESG', 0.07883048802614212)"
Line 180,"We manage physical location risks through business continuity management, including hurricane readiness  planning, infrastructure improvement, and risk-exposure analyses that encompass hurricanes, earthquakes, and water stress impacts.
","('Physical_Impacts_Of_Climate_Change', 0.7193852663040161)","('Critical_Incident_Risk_Management', 0.07054050266742706)","('Business_Model_Resilience', 0.035528507083654404)","(['Climate Change'], 0.7193852663040161)","('NON-ESG', 0.07054050266742706)","('NON-ESG', 0.035528507083654404)"
Line 181,"Business impact of unforeseen ethical,  social, and environmental regulationsOur Government Affairs; Human Resources; Communications; Environmental, Health and Safety; and Procurement groups monitor relevant regulations in global markets.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9636091589927673)","('Human_Rights_And_Community_Relations', 0.004267450887709856)","('Business_Ethics', 0.002816670574247837)","(['Corporate Governance'], 0.9636091589927673)","('NON-ESG', 0.004267450887709856)","('NON-ESG', 0.002816670574247837)"
Line 182,"Our legal and compliance teams advise on compliance.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9137166738510132)","('Business_Ethics', 0.02765221707522869)","('Director_Removal', 0.005998694803565741)","(['Corporate Governance'], 0.9137166738510132)","('NON-ESG', 0.02765221707522869)","('NON-ESG', 0.005998694803565741)"
Line 183,"We share our perspectives with industry organizations and regulators and prepare for potential and emerging regulations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9675745368003845)","('Competitive_Behavior', 0.0031348918564617634)","('Director_Removal', 0.0025481192860752344)","(['Corporate Governance'], 0.9675745368003845)","('NON-ESG', 0.0031348918564617634)","('NON-ESG', 0.0025481192860752344)"
Line 184,"Failure to meet stakeholder  or regulatory expectations  of our ESG performance We strive to meet or surpass expectations and requirements of our ESG and sustainability performance.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4092089831829071)","('Business_Model_Resilience', 0.19069649279117584)","('Systemic_Risk_Management', 0.12151385843753815)","('NON-ESG', 0.4092089831829071)","('NON-ESG', 0.19069649279117584)","('NON-ESG', 0.12151385843753815)"
Line 185,"We actively solicit input from stakeholders concerning our performance related to product stewardship, human rights, ethical conduct, environmental responsibility, climate change, healthcare access, ID&E,  and more.
","('Human_Rights_And_Community_Relations', 0.6831409931182861)","('Business_Ethics', 0.06506144255399704)","('Supply_Chain_Management', 0.024395737797021866)","(['Community Relations'], 0.6831409931182861)","('NON-ESG', 0.06506144255399704)","('NON-ESG', 0.024395737797021866)"
Line 186,"Annual and transparent communications on our ESG performance are key to meeting stakeholder  expectations.
","('Business_Model_Resilience', 0.2783963978290558)","('Business_Ethics', 0.15918244421482086)","('Management_Of_Legal_And_Regulatory_Framework', 0.10712726414203644)","('NON-ESG', 0.2783963978290558)","('NON-ESG', 0.15918244421482086)","('NON-ESG', 0.10712726414203644)"
Line 187,"During the development of our annual Integrated Performance Report, we assess our  ESG disclosures for alignment with best practice and evolving stakeholder needs.
","('Business_Model_Resilience', 0.4409548044204712)","('Human_Rights_And_Community_Relations', 0.11736289411783218)","('Systemic_Risk_Management', 0.10348761826753616)","('NON-ESG', 0.4409548044204712)","('NON-ESG', 0.11736289411783218)","('NON-ESG', 0.10348761826753616)"
Line 188,"We are enhancing our  data collection and reporting processes in preparation to meet emerging regulatory expectations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9711819291114807)","('Competitive_Behavior', 0.0021211346611380577)","('Director_Removal', 0.0019445711513981223)","(['Corporate Governance'], 0.9711819291114807)","('NON-ESG', 0.0021211346611380577)","('NON-ESG', 0.0019445711513981223)"
Line 189,"Sustainability governance 2022 Integrated Performance Report Introduction 18 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy DRIVING VALUE THROUGH ESG  Opportunity Response  Leading the industry in meaningful  innovation, patient-centered, insight-driven healthcare, value-based partnerships, and business efficiencyWe stay alert to emerging technological innovations and invest in research and development to bring effective, value-driven products and services to market.
","('Product_Design_And_Lifecycle_Management', 0.8335396647453308)","('Business_Model_Resilience', 0.0389130637049675)","('Product_Quality_And_Safety', 0.013778840191662312)","(['Product Stewardship'], 0.8335396647453308)","('NON-ESG', 0.0389130637049675)","('NON-ESG', 0.013778840191662312)"
Line 190,"Sustainability governance 2022 Integrated Performance Report Introduction 18 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy DRIVING VALUE THROUGH ESG  Opportunity Response  Leading the industry in meaningful  innovation, patient-centered, insight-driven healthcare, value-based partnerships, and business efficiencyWe stay alert to emerging technological innovations and invest in research and development to bring effective, value-driven products and services to market.
","('Business_Model_Resilience', 0.18220335245132446)","('Product_Design_And_Lifecycle_Management', 0.14542631804943085)","('Customer_Welfare', 0.10443814843893051)","('NON-ESG', 0.18220335245132446)","('NON-ESG', 0.14542631804943085)","('NON-ESG', 0.10443814843893051)"
Line 191,"We work across healthcare pathways to develop efficient, effective systems and business models.We combine scientific and medical intelligence to advance innovation that impacts patients’ lives.We continue to increase our operational efficiency, sharing our learning with partners and suppliers.
","('Product_Design_And_Lifecycle_Management', 0.2910860478878021)","('Energy_Management', 0.26052260398864746)","('Supply_Chain_Management', 0.1728982776403427)","('NON-ESG', 0.2910860478878021)","('NON-ESG', 0.26052260398864746)","('NON-ESG', 0.1728982776403427)"
Line 192,"Increasing accessibility and availability   of our products and servicesWe form bold, impactful partnerships with local, national, and international organizations to accelerate global access to lifesaving therapies.
","('Product_Design_And_Lifecycle_Management', 0.8242244720458984)","('Product_Quality_And_Safety', 0.03936696797609329)","('Selling_Practices_And_Product_Labeling', 0.030022962018847466)","(['Product Stewardship'], 0.8242244720458984)","('NON-ESG', 0.03936696797609329)","('NON-ESG', 0.030022962018847466)"
Line 193,"We invest in programs to improve healthcare infrastructure and educate patients and healthcare professionals.
","('Access_And_Affordability', 0.7558237314224243)","('Critical_Incident_Risk_Management', 0.048876382410526276)","('Energy_Management', 0.028094109147787094)","(['Health Outcome Contribution'], 0.7558237314224243)","('NON-ESG', 0.048876382410526276)","('NON-ESG', 0.028094109147787094)"
Line 194,"Deepening support and expanding  growth opportunities for our employeesWe make robust and broad-ranging professional development programs available to all employees, and we champion ID&E throughout our organization and in our communities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8953538537025452)","('Employee_Health_And_Safety', 0.014792187139391899)","('Access_And_Affordability', 0.008849896490573883)","(['Human Capital Development'], 0.8953538537025452)","('NON-ESG', 0.014792187139391899)","('NON-ESG', 0.008849896490573883)"
Line 195,"We recognize and reward employees’ talents and dedication through competitive pay and comprehensive benefits.
","('Labor_Practices', 0.7534526586532593)","('Employee_Engagement_Inclusion_And_Diversity', 0.10683301836252213)","('Business_Ethics', 0.021707331761717796)","(['Labor Practice Indicators'], 0.7534526586532593)","('NON-ESG', 0.10683301836252213)","('NON-ESG', 0.021707331761717796)"
Line 196,"These efforts help us attract and retain diverse top talent so we can continue to offer innovative healthcare solutions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.913555383682251)","('Business_Model_Resilience', 0.008893868885934353)","('Customer_Welfare', 0.008606002666056156)","(['Human Capital Development'], 0.913555383682251)","('NON-ESG', 0.008893868885934353)","('NON-ESG', 0.008606002666056156)"
Line 197,"Capturing cost savings and building organizational resilience through environmentally responsible operationsWe work to increase the proportion of our operational energy supply from renewable sources and on-site generation.
","('Energy_Management', 0.8221112489700317)","('Product_Design_And_Lifecycle_Management', 0.04081673547625542)","('Supply_Chain_Management', 0.039803676307201385)","(['Operational Eco-Efficiency'], 0.8221112489700317)","('NON-ESG', 0.04081673547625542)","('NON-ESG', 0.039803676307201385)"
Line 198,"Doing so delivers cost savings, reduces our carbon footprint, and makes our business more resilient  to external shifts in energy pricing and supply.
","('Business_Model_Resilience', 0.7119016051292419)","('Supply_Chain_Management', 0.11774522811174393)","('Product_Design_And_Lifecycle_Management', 0.03416413813829422)","(['Codes of Business Conduct'], 0.7119016051292419)","('NON-ESG', 0.11774522811174393)","('NON-ESG', 0.03416413813829422)"
Line 199,"We implement new programs and improved practices targeting water conservation and reducing the amount of  waste generated by our manufacturing and commercial locations.
","('Water_And_Wastewater_Management', 0.581850528717041)","('Waste_And_Hazardous_Materials_Management', 0.3375970423221588)","('Air_Quality', 0.00940762646496296)","(['Operational Eco-Efficiency'], 0.581850528717041)","('NON-ESG', 0.3375970423221588)","('NON-ESG', 0.00940762646496296)"
Line 200,"Maintaining open engagement with community organizations, nonprofits, patients, and health systemsWe work to open the dialogue across our value chain to listen, learn, and adapt our response to what is right for the community and address issues of inequity worldwide.
","('Human_Rights_And_Community_Relations', 0.8130089640617371)","('Access_And_Affordability', 0.055140938609838486)","('Employee_Engagement_Inclusion_And_Diversity', 0.015165319666266441)","(['Community Relations'], 0.8130089640617371)","('NON-ESG', 0.055140938609838486)","('NON-ESG', 0.015165319666266441)"
Line 201,"Our new Health Equity Advisory Committee (HEAC) in the U.S. shares best practices on customer engagement and  collaborates to help shape strategy and solutions that will be scalable and sustainable and have a measurable impact.
","('Business_Model_Resilience', 0.7366084456443787)","('Systemic_Risk_Management', 0.056617457419633865)","('Customer_Welfare', 0.026260510087013245)","(['Codes of Business Conduct'], 0.7366084456443787)","('NON-ESG', 0.056617457419633865)","('NON-ESG', 0.026260510087013245)"
Line 202,"Meeting customer demand for more sustainable products and servicesWe prioritize product quality, safety, and reliability and seek opportunities to reduce product environmental  footprint at every life cycle stage.
","('Product_Design_And_Lifecycle_Management', 0.948877215385437)","('Product_Quality_And_Safety', 0.013525832444429398)","('Selling_Practices_And_Product_Labeling', 0.003594392677769065)","(['Product Stewardship'], 0.948877215385437)","('NON-ESG', 0.013525832444429398)","('NON-ESG', 0.003594392677769065)"
Line 203,"We align our product stewardship activities with relevant standards and regulations, including working to minimize  the use of materials of concern as defined under a variety of global regulatory requirements.SUSTAINABILITY GOVERNANCE 2022 Integrated Performance Report Introduction 19 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Collaboration and communication are essential to  carrying out our Mission.
","('Product_Design_And_Lifecycle_Management', 0.5910488963127136)","('Product_Quality_And_Safety', 0.19834111630916595)","('Management_Of_Legal_And_Regulatory_Framework', 0.03627198562026024)","(['Product Stewardship'], 0.5910488963127136)","('NON-ESG', 0.19834111630916595)","('NON-ESG', 0.03627198562026024)"
Line 204,"We talk to, work with, and learn from our stakeholders and peers in several ways to amplify our impact, understand and share expectations, and be held accountable for our actions and outcomes.
","('Human_Rights_And_Community_Relations', 0.6264439225196838)","('Management_Of_Legal_And_Regulatory_Framework', 0.07508524507284164)","('Business_Model_Resilience', 0.05786510929465294)","(['Community Relations'], 0.6264439225196838)","('NON-ESG', 0.07508524507284164)","('NON-ESG', 0.05786510929465294)"
Line 205,"Specifically, we: •   Shar e information, hold ourselves accountable, and  seek feedback on our approach and performance.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5081589221954346)","('Business_Ethics', 0.17280714213848114)","('Systemic_Risk_Management', 0.05137347802519798)","(['Corporate Governance'], 0.5081589221954346)","('NON-ESG', 0.17280714213848114)","('NON-ESG', 0.05137347802519798)"
Line 206,"•   C ommunicate our expectations and standards to  employees, suppliers, and partners.
","('Labor_Practices', 0.4513660967350006)","('Business_Ethics', 0.1422576606273651)","('Product_Quality_And_Safety', 0.07953673601150513)","('NON-ESG', 0.4513660967350006)","('NON-ESG', 0.1422576606273651)","('NON-ESG', 0.07953673601150513)"
Line 207,"•   Shar e expertise and knowledge through training and  capacity building.
","('Employee_Engagement_Inclusion_And_Diversity', 0.34465357661247253)","('Human_Rights_And_Community_Relations', 0.2002030611038208)","('Access_And_Affordability', 0.12016983330249786)","('NON-ESG', 0.34465357661247253)","('NON-ESG', 0.2002030611038208)","('NON-ESG', 0.12016983330249786)"
Line 208,"•   P rovide support through Medtronic Foundation  programs, volunteerism, giving, disaster relief, and  other channels.
","('Critical_Incident_Risk_Management', 0.9639051556587219)","('Employee_Health_And_Safety', 0.005935106426477432)","('Access_And_Affordability', 0.003930349368602037)","(['Risk & Crisis Management'], 0.9639051556587219)","('NON-ESG', 0.005935106426477432)","('NON-ESG', 0.003930349368602037)"
Line 209,"•   W ork with others to develop new products and  broaden healthcare access.
","('Product_Design_And_Lifecycle_Management', 0.8362523913383484)","('Customer_Welfare', 0.048471152782440186)","('Product_Quality_And_Safety', 0.021547485142946243)","(['Product Stewardship'], 0.8362523913383484)","('NON-ESG', 0.048471152782440186)","('NON-ESG', 0.021547485142946243)"
Line 210,"The following tables share examples of stakeholder engagement in FY22 and resulting outcomes.
","('Human_Rights_And_Community_Relations', 0.3474431037902832)","('Business_Model_Resilience', 0.20807239413261414)","('Competitive_Behavior', 0.10082458704710007)","('NON-ESG', 0.3474431037902832)","('NON-ESG', 0.20807239413261414)","('NON-ESG', 0.10082458704710007)"
Line 211,"Further examples are provided throughout this report.KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Healthcare professionals   and administratorsInvested $69 million in healthcare professional training Trained more than 350,000 medical professionals Trained physicians on our life-saving technologies, even  when travel was restricted, with Medtronic Mobile Labs Patients and patient  advocacy groupsSpent $6.7 million on education for patients Launched the Medtronic Discovery app, designed to recruit  participants, communicate with them, and collect data throughout large-scale clinical studies conducted remotelyHelped patients stay up to date with current treatments and technology to help them achieve better outcomes Shareholders Held quarterly calls about business health, including updates to our innovation pipeline and ongoing response to global issues Conducted ongoing dialogue with many of our institutional  investors and held specific conversations regarding input on governance, executive compensation, and strategic issues Hosted our inaugural ESG Investor Briefing event, where  Medtronic leaders discussed key ESG areas important to the company and its investors Incorporated feedback into our decision-making processes Suppliers and distributors Became a member of CDP Supply Chain, a consortium of global companies working to help 40,000 suppliers quantify their greenhouse gas (GHG) emissions and other components of their environmental sustainability measures Piloted a new Supplier Risk Mapping technology tool that allows  us to analyze suppliers on risks related to their geographic location, industry, and the amount we spend with them annually Involved 46 suppliers and 21 category managers in inaugural CDP Supply Chain training programs Evaluated and assigned inherent risk scores to 6,000 of our   Tier 1 suppliers Stakeholder engagement 2022 Integrated Performance Report Introduction 20 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Employees Developed flexible working models for employees Invested $49 million in employee learning and  development, up from $45 million in FYCreated Environmental Action Group led by  employees to educate and share resources on individual behaviors and systemic changes that can improve our environmental footprint Supported learning, community events, and tailored  development activities for all dimensions of diversity through our ERGs and Diversity Networks, with  34,000 employees engaged across 75 countriesOffered hybrid-working arrangements to employees as  offices reopen Provided employees access to 32,000 learning resourcesAchieved world class scores for employee engagement   and inclusion Received survey feedback that 90% of responding employees  feel proud to work at Medtronic Registered 1,000 Environmental Action Group members in  seven months Government regulators and policymakersParticipated in FDA Sterilization Master File  Pilot Program Continued working with governments, peers, and  other stakeholders to help shape the digital health policy landscape and inform public policies aimed  at narrowing disparities in healthcare access Signed a memorandum of understanding with   the Vietnam Ministry of Health to elevate healthcare professionals’ clinical skill sets in ICU departments and centers, with the aim to train more than  4,000 healthcare professionals in 12 months Participated in a meeting about the Cancer   Moonshot initiative launched by U.S. President BidenReceived FDA approval to implement new ethylene oxide process at Steri-Tech site in Puerto Rico Helped with the treatment of over 500,000 patients annually  through our partnership with the National Institute of Cardiovascular Diseases in Pakistan Nongovernmental organizationsMedtronic and the Medtronic Foundation partnered with others to support COVID-19 relief efforts and respond to needs arising from the conflict in Ukraine Impacted more than 2.2 million people positively through the distribution of over 34 million items of medical supplies, equipment, and personal protective equipment (PPE) to support COVID-19 relief efforts with Medtronic Foundation partners Contributed $97.1 million, including $6.7 million to support  Ukraine, through Medtronic and the Medtronic Foundation 2022 Integrated Performance Report Introduction 21 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Local communities Continued to cocreate healthcare  delivery with local stakeholders and underserved communities through Medtronic LABS Drove equity within our communities  through Medtronic and the Medtronic Foundation partnerships and initiatives led by our employee resource groups (ERGs) Developed a pipeline for STEM  careers in local communities through investments in OneTen, the Thurgood Marshall College Fund (TMCF), Multiple Pathways Initiative (MPI), and the Society of Hispanic Professional Engineers (SHPE) Enabled employee volunteerism  through the Medtronic Foundation Became members of MedTech Color  to expand diversity in clinical trialsExpanded Medtronic LABS Empower Health program throughout Kenya, nearly doubling its current patient  impact in the country Created new internship opportunities  and removed four-year degree requirements for some STEM careers Peers and partners Partnered with peers, academics,  and others to increase access to,  and security of, vital therapies  and solutions  Teamed with Optum, Boston  Scientific, and Abbott Laboratories to help launch the new Center for Medical Device Cybersecurity at the University of Minnesota, which will serve as a hub for discovery, outreach, and workforce trainingLaunched a pilot with Mpirik and Vizient to help more female  and ethnically diverse patients receive preventative treatment for cardiac issues 2022 Integrated Performance Report Introduction 22 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Contribution to the UN Sustainable  Development Goals We align our ESG efforts to the   UN Sustainable Development Goals (SDGs) where we can make the greatest impact.
","('Access_And_Affordability', 0.3585575520992279)","('Human_Rights_And_Community_Relations', 0.3156871795654297)","('Management_Of_Legal_And_Regulatory_Framework', 0.03634466603398323)","('NON-ESG', 0.3585575520992279)","('NON-ESG', 0.3156871795654297)","('NON-ESG', 0.03634466603398323)"
Line 212,"Further examples are provided throughout this report.KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Healthcare professionals   and administratorsInvested $69 million in healthcare professional training Trained more than 350,000 medical professionals Trained physicians on our life-saving technologies, even  when travel was restricted, with Medtronic Mobile Labs Patients and patient  advocacy groupsSpent $6.7 million on education for patients Launched the Medtronic Discovery app, designed to recruit  participants, communicate with them, and collect data throughout large-scale clinical studies conducted remotelyHelped patients stay up to date with current treatments and technology to help them achieve better outcomes Shareholders Held quarterly calls about business health, including updates to our innovation pipeline and ongoing response to global issues Conducted ongoing dialogue with many of our institutional  investors and held specific conversations regarding input on governance, executive compensation, and strategic issues Hosted our inaugural ESG Investor Briefing event, where  Medtronic leaders discussed key ESG areas important to the company and its investors Incorporated feedback into our decision-making processes Suppliers and distributors Became a member of CDP Supply Chain, a consortium of global companies working to help 40,000 suppliers quantify their greenhouse gas (GHG) emissions and other components of their environmental sustainability measures Piloted a new Supplier Risk Mapping technology tool that allows  us to analyze suppliers on risks related to their geographic location, industry, and the amount we spend with them annually Involved 46 suppliers and 21 category managers in inaugural CDP Supply Chain training programs Evaluated and assigned inherent risk scores to 6,000 of our   Tier 1 suppliers Stakeholder engagement 2022 Integrated Performance Report Introduction 20 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Employees Developed flexible working models for employees Invested $49 million in employee learning and  development, up from $45 million in FYCreated Environmental Action Group led by  employees to educate and share resources on individual behaviors and systemic changes that can improve our environmental footprint Supported learning, community events, and tailored  development activities for all dimensions of diversity through our ERGs and Diversity Networks, with  34,000 employees engaged across 75 countriesOffered hybrid-working arrangements to employees as  offices reopen Provided employees access to 32,000 learning resourcesAchieved world class scores for employee engagement   and inclusion Received survey feedback that 90% of responding employees  feel proud to work at Medtronic Registered 1,000 Environmental Action Group members in  seven months Government regulators and policymakersParticipated in FDA Sterilization Master File  Pilot Program Continued working with governments, peers, and  other stakeholders to help shape the digital health policy landscape and inform public policies aimed  at narrowing disparities in healthcare access Signed a memorandum of understanding with   the Vietnam Ministry of Health to elevate healthcare professionals’ clinical skill sets in ICU departments and centers, with the aim to train more than  4,000 healthcare professionals in 12 months Participated in a meeting about the Cancer   Moonshot initiative launched by U.S. President BidenReceived FDA approval to implement new ethylene oxide process at Steri-Tech site in Puerto Rico Helped with the treatment of over 500,000 patients annually  through our partnership with the National Institute of Cardiovascular Diseases in Pakistan Nongovernmental organizationsMedtronic and the Medtronic Foundation partnered with others to support COVID-19 relief efforts and respond to needs arising from the conflict in Ukraine Impacted more than 2.2 million people positively through the distribution of over 34 million items of medical supplies, equipment, and personal protective equipment (PPE) to support COVID-19 relief efforts with Medtronic Foundation partners Contributed $97.1 million, including $6.7 million to support  Ukraine, through Medtronic and the Medtronic Foundation 2022 Integrated Performance Report Introduction 21 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Local communities Continued to cocreate healthcare  delivery with local stakeholders and underserved communities through Medtronic LABS Drove equity within our communities  through Medtronic and the Medtronic Foundation partnerships and initiatives led by our employee resource groups (ERGs) Developed a pipeline for STEM  careers in local communities through investments in OneTen, the Thurgood Marshall College Fund (TMCF), Multiple Pathways Initiative (MPI), and the Society of Hispanic Professional Engineers (SHPE) Enabled employee volunteerism  through the Medtronic Foundation Became members of MedTech Color  to expand diversity in clinical trialsExpanded Medtronic LABS Empower Health program throughout Kenya, nearly doubling its current patient  impact in the country Created new internship opportunities  and removed four-year degree requirements for some STEM careers Peers and partners Partnered with peers, academics,  and others to increase access to,  and security of, vital therapies  and solutions  Teamed with Optum, Boston  Scientific, and Abbott Laboratories to help launch the new Center for Medical Device Cybersecurity at the University of Minnesota, which will serve as a hub for discovery, outreach, and workforce trainingLaunched a pilot with Mpirik and Vizient to help more female  and ethnically diverse patients receive preventative treatment for cardiac issues 2022 Integrated Performance Report Introduction 22 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Contribution to the UN Sustainable  Development Goals We align our ESG efforts to the   UN Sustainable Development Goals (SDGs) where we can make the greatest impact.
","('Access_And_Affordability', 0.4289425313472748)","('Management_Of_Legal_And_Regulatory_Framework', 0.14905916154384613)","('Customer_Welfare', 0.04076995328068733)","('NON-ESG', 0.4289425313472748)","('NON-ESG', 0.14905916154384613)","('NON-ESG', 0.04076995328068733)"
Line 213,"Further examples are provided throughout this report.KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Healthcare professionals   and administratorsInvested $69 million in healthcare professional training Trained more than 350,000 medical professionals Trained physicians on our life-saving technologies, even  when travel was restricted, with Medtronic Mobile Labs Patients and patient  advocacy groupsSpent $6.7 million on education for patients Launched the Medtronic Discovery app, designed to recruit  participants, communicate with them, and collect data throughout large-scale clinical studies conducted remotelyHelped patients stay up to date with current treatments and technology to help them achieve better outcomes Shareholders Held quarterly calls about business health, including updates to our innovation pipeline and ongoing response to global issues Conducted ongoing dialogue with many of our institutional  investors and held specific conversations regarding input on governance, executive compensation, and strategic issues Hosted our inaugural ESG Investor Briefing event, where  Medtronic leaders discussed key ESG areas important to the company and its investors Incorporated feedback into our decision-making processes Suppliers and distributors Became a member of CDP Supply Chain, a consortium of global companies working to help 40,000 suppliers quantify their greenhouse gas (GHG) emissions and other components of their environmental sustainability measures Piloted a new Supplier Risk Mapping technology tool that allows  us to analyze suppliers on risks related to their geographic location, industry, and the amount we spend with them annually Involved 46 suppliers and 21 category managers in inaugural CDP Supply Chain training programs Evaluated and assigned inherent risk scores to 6,000 of our   Tier 1 suppliers Stakeholder engagement 2022 Integrated Performance Report Introduction 20 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Employees Developed flexible working models for employees Invested $49 million in employee learning and  development, up from $45 million in FYCreated Environmental Action Group led by  employees to educate and share resources on individual behaviors and systemic changes that can improve our environmental footprint Supported learning, community events, and tailored  development activities for all dimensions of diversity through our ERGs and Diversity Networks, with  34,000 employees engaged across 75 countriesOffered hybrid-working arrangements to employees as  offices reopen Provided employees access to 32,000 learning resourcesAchieved world class scores for employee engagement   and inclusion Received survey feedback that 90% of responding employees  feel proud to work at Medtronic Registered 1,000 Environmental Action Group members in  seven months Government regulators and policymakersParticipated in FDA Sterilization Master File  Pilot Program Continued working with governments, peers, and  other stakeholders to help shape the digital health policy landscape and inform public policies aimed  at narrowing disparities in healthcare access Signed a memorandum of understanding with   the Vietnam Ministry of Health to elevate healthcare professionals’ clinical skill sets in ICU departments and centers, with the aim to train more than  4,000 healthcare professionals in 12 months Participated in a meeting about the Cancer   Moonshot initiative launched by U.S. President BidenReceived FDA approval to implement new ethylene oxide process at Steri-Tech site in Puerto Rico Helped with the treatment of over 500,000 patients annually  through our partnership with the National Institute of Cardiovascular Diseases in Pakistan Nongovernmental organizationsMedtronic and the Medtronic Foundation partnered with others to support COVID-19 relief efforts and respond to needs arising from the conflict in Ukraine Impacted more than 2.2 million people positively through the distribution of over 34 million items of medical supplies, equipment, and personal protective equipment (PPE) to support COVID-19 relief efforts with Medtronic Foundation partners Contributed $97.1 million, including $6.7 million to support  Ukraine, through Medtronic and the Medtronic Foundation 2022 Integrated Performance Report Introduction 21 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Local communities Continued to cocreate healthcare  delivery with local stakeholders and underserved communities through Medtronic LABS Drove equity within our communities  through Medtronic and the Medtronic Foundation partnerships and initiatives led by our employee resource groups (ERGs) Developed a pipeline for STEM  careers in local communities through investments in OneTen, the Thurgood Marshall College Fund (TMCF), Multiple Pathways Initiative (MPI), and the Society of Hispanic Professional Engineers (SHPE) Enabled employee volunteerism  through the Medtronic Foundation Became members of MedTech Color  to expand diversity in clinical trialsExpanded Medtronic LABS Empower Health program throughout Kenya, nearly doubling its current patient  impact in the country Created new internship opportunities  and removed four-year degree requirements for some STEM careers Peers and partners Partnered with peers, academics,  and others to increase access to,  and security of, vital therapies  and solutions  Teamed with Optum, Boston  Scientific, and Abbott Laboratories to help launch the new Center for Medical Device Cybersecurity at the University of Minnesota, which will serve as a hub for discovery, outreach, and workforce trainingLaunched a pilot with Mpirik and Vizient to help more female  and ethnically diverse patients receive preventative treatment for cardiac issues 2022 Integrated Performance Report Introduction 22 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Contribution to the UN Sustainable  Development Goals We align our ESG efforts to the   UN Sustainable Development Goals (SDGs) where we can make the greatest impact.
","('Supply_Chain_Management', 0.79618239402771)","('GHG_Emissions', 0.08312783390283585)","('Physical_Impacts_Of_Climate_Change', 0.012597518973052502)","(['Supply Chain Management'], 0.79618239402771)","('NON-ESG', 0.08312783390283585)","('NON-ESG', 0.012597518973052502)"
Line 214,"Further examples are provided throughout this report.KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Healthcare professionals   and administratorsInvested $69 million in healthcare professional training Trained more than 350,000 medical professionals Trained physicians on our life-saving technologies, even  when travel was restricted, with Medtronic Mobile Labs Patients and patient  advocacy groupsSpent $6.7 million on education for patients Launched the Medtronic Discovery app, designed to recruit  participants, communicate with them, and collect data throughout large-scale clinical studies conducted remotelyHelped patients stay up to date with current treatments and technology to help them achieve better outcomes Shareholders Held quarterly calls about business health, including updates to our innovation pipeline and ongoing response to global issues Conducted ongoing dialogue with many of our institutional  investors and held specific conversations regarding input on governance, executive compensation, and strategic issues Hosted our inaugural ESG Investor Briefing event, where  Medtronic leaders discussed key ESG areas important to the company and its investors Incorporated feedback into our decision-making processes Suppliers and distributors Became a member of CDP Supply Chain, a consortium of global companies working to help 40,000 suppliers quantify their greenhouse gas (GHG) emissions and other components of their environmental sustainability measures Piloted a new Supplier Risk Mapping technology tool that allows  us to analyze suppliers on risks related to their geographic location, industry, and the amount we spend with them annually Involved 46 suppliers and 21 category managers in inaugural CDP Supply Chain training programs Evaluated and assigned inherent risk scores to 6,000 of our   Tier 1 suppliers Stakeholder engagement 2022 Integrated Performance Report Introduction 20 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Employees Developed flexible working models for employees Invested $49 million in employee learning and  development, up from $45 million in FYCreated Environmental Action Group led by  employees to educate and share resources on individual behaviors and systemic changes that can improve our environmental footprint Supported learning, community events, and tailored  development activities for all dimensions of diversity through our ERGs and Diversity Networks, with  34,000 employees engaged across 75 countriesOffered hybrid-working arrangements to employees as  offices reopen Provided employees access to 32,000 learning resourcesAchieved world class scores for employee engagement   and inclusion Received survey feedback that 90% of responding employees  feel proud to work at Medtronic Registered 1,000 Environmental Action Group members in  seven months Government regulators and policymakersParticipated in FDA Sterilization Master File  Pilot Program Continued working with governments, peers, and  other stakeholders to help shape the digital health policy landscape and inform public policies aimed  at narrowing disparities in healthcare access Signed a memorandum of understanding with   the Vietnam Ministry of Health to elevate healthcare professionals’ clinical skill sets in ICU departments and centers, with the aim to train more than  4,000 healthcare professionals in 12 months Participated in a meeting about the Cancer   Moonshot initiative launched by U.S. President BidenReceived FDA approval to implement new ethylene oxide process at Steri-Tech site in Puerto Rico Helped with the treatment of over 500,000 patients annually  through our partnership with the National Institute of Cardiovascular Diseases in Pakistan Nongovernmental organizationsMedtronic and the Medtronic Foundation partnered with others to support COVID-19 relief efforts and respond to needs arising from the conflict in Ukraine Impacted more than 2.2 million people positively through the distribution of over 34 million items of medical supplies, equipment, and personal protective equipment (PPE) to support COVID-19 relief efforts with Medtronic Foundation partners Contributed $97.1 million, including $6.7 million to support  Ukraine, through Medtronic and the Medtronic Foundation 2022 Integrated Performance Report Introduction 21 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Local communities Continued to cocreate healthcare  delivery with local stakeholders and underserved communities through Medtronic LABS Drove equity within our communities  through Medtronic and the Medtronic Foundation partnerships and initiatives led by our employee resource groups (ERGs) Developed a pipeline for STEM  careers in local communities through investments in OneTen, the Thurgood Marshall College Fund (TMCF), Multiple Pathways Initiative (MPI), and the Society of Hispanic Professional Engineers (SHPE) Enabled employee volunteerism  through the Medtronic Foundation Became members of MedTech Color  to expand diversity in clinical trialsExpanded Medtronic LABS Empower Health program throughout Kenya, nearly doubling its current patient  impact in the country Created new internship opportunities  and removed four-year degree requirements for some STEM careers Peers and partners Partnered with peers, academics,  and others to increase access to,  and security of, vital therapies  and solutions  Teamed with Optum, Boston  Scientific, and Abbott Laboratories to help launch the new Center for Medical Device Cybersecurity at the University of Minnesota, which will serve as a hub for discovery, outreach, and workforce trainingLaunched a pilot with Mpirik and Vizient to help more female  and ethnically diverse patients receive preventative treatment for cardiac issues 2022 Integrated Performance Report Introduction 22 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Contribution to the UN Sustainable  Development Goals We align our ESG efforts to the   UN Sustainable Development Goals (SDGs) where we can make the greatest impact.
","('Supply_Chain_Management', 0.956748366355896)","('Labor_Practices', 0.0033419793471693993)","('Systemic_Risk_Management', 0.003318274859338999)","(['Supply Chain Management'], 0.956748366355896)","('NON-ESG', 0.0033419793471693993)","('NON-ESG', 0.003318274859338999)"
Line 215,"Further examples are provided throughout this report.KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Healthcare professionals   and administratorsInvested $69 million in healthcare professional training Trained more than 350,000 medical professionals Trained physicians on our life-saving technologies, even  when travel was restricted, with Medtronic Mobile Labs Patients and patient  advocacy groupsSpent $6.7 million on education for patients Launched the Medtronic Discovery app, designed to recruit  participants, communicate with them, and collect data throughout large-scale clinical studies conducted remotelyHelped patients stay up to date with current treatments and technology to help them achieve better outcomes Shareholders Held quarterly calls about business health, including updates to our innovation pipeline and ongoing response to global issues Conducted ongoing dialogue with many of our institutional  investors and held specific conversations regarding input on governance, executive compensation, and strategic issues Hosted our inaugural ESG Investor Briefing event, where  Medtronic leaders discussed key ESG areas important to the company and its investors Incorporated feedback into our decision-making processes Suppliers and distributors Became a member of CDP Supply Chain, a consortium of global companies working to help 40,000 suppliers quantify their greenhouse gas (GHG) emissions and other components of their environmental sustainability measures Piloted a new Supplier Risk Mapping technology tool that allows  us to analyze suppliers on risks related to their geographic location, industry, and the amount we spend with them annually Involved 46 suppliers and 21 category managers in inaugural CDP Supply Chain training programs Evaluated and assigned inherent risk scores to 6,000 of our   Tier 1 suppliers Stakeholder engagement 2022 Integrated Performance Report Introduction 20 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Employees Developed flexible working models for employees Invested $49 million in employee learning and  development, up from $45 million in FYCreated Environmental Action Group led by  employees to educate and share resources on individual behaviors and systemic changes that can improve our environmental footprint Supported learning, community events, and tailored  development activities for all dimensions of diversity through our ERGs and Diversity Networks, with  34,000 employees engaged across 75 countriesOffered hybrid-working arrangements to employees as  offices reopen Provided employees access to 32,000 learning resourcesAchieved world class scores for employee engagement   and inclusion Received survey feedback that 90% of responding employees  feel proud to work at Medtronic Registered 1,000 Environmental Action Group members in  seven months Government regulators and policymakersParticipated in FDA Sterilization Master File  Pilot Program Continued working with governments, peers, and  other stakeholders to help shape the digital health policy landscape and inform public policies aimed  at narrowing disparities in healthcare access Signed a memorandum of understanding with   the Vietnam Ministry of Health to elevate healthcare professionals’ clinical skill sets in ICU departments and centers, with the aim to train more than  4,000 healthcare professionals in 12 months Participated in a meeting about the Cancer   Moonshot initiative launched by U.S. President BidenReceived FDA approval to implement new ethylene oxide process at Steri-Tech site in Puerto Rico Helped with the treatment of over 500,000 patients annually  through our partnership with the National Institute of Cardiovascular Diseases in Pakistan Nongovernmental organizationsMedtronic and the Medtronic Foundation partnered with others to support COVID-19 relief efforts and respond to needs arising from the conflict in Ukraine Impacted more than 2.2 million people positively through the distribution of over 34 million items of medical supplies, equipment, and personal protective equipment (PPE) to support COVID-19 relief efforts with Medtronic Foundation partners Contributed $97.1 million, including $6.7 million to support  Ukraine, through Medtronic and the Medtronic Foundation 2022 Integrated Performance Report Introduction 21 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Local communities Continued to cocreate healthcare  delivery with local stakeholders and underserved communities through Medtronic LABS Drove equity within our communities  through Medtronic and the Medtronic Foundation partnerships and initiatives led by our employee resource groups (ERGs) Developed a pipeline for STEM  careers in local communities through investments in OneTen, the Thurgood Marshall College Fund (TMCF), Multiple Pathways Initiative (MPI), and the Society of Hispanic Professional Engineers (SHPE) Enabled employee volunteerism  through the Medtronic Foundation Became members of MedTech Color  to expand diversity in clinical trialsExpanded Medtronic LABS Empower Health program throughout Kenya, nearly doubling its current patient  impact in the country Created new internship opportunities  and removed four-year degree requirements for some STEM careers Peers and partners Partnered with peers, academics,  and others to increase access to,  and security of, vital therapies  and solutions  Teamed with Optum, Boston  Scientific, and Abbott Laboratories to help launch the new Center for Medical Device Cybersecurity at the University of Minnesota, which will serve as a hub for discovery, outreach, and workforce trainingLaunched a pilot with Mpirik and Vizient to help more female  and ethnically diverse patients receive preventative treatment for cardiac issues 2022 Integrated Performance Report Introduction 22 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Contribution to the UN Sustainable  Development Goals We align our ESG efforts to the   UN Sustainable Development Goals (SDGs) where we can make the greatest impact.
","('Employee_Engagement_Inclusion_And_Diversity', 0.962738573551178)","('Human_Rights_And_Community_Relations', 0.005102908704429865)","('Access_And_Affordability', 0.002894844627007842)","(['Human Capital Development'], 0.962738573551178)","('NON-ESG', 0.005102908704429865)","('NON-ESG', 0.002894844627007842)"
Line 216,"Further examples are provided throughout this report.KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Healthcare professionals   and administratorsInvested $69 million in healthcare professional training Trained more than 350,000 medical professionals Trained physicians on our life-saving technologies, even  when travel was restricted, with Medtronic Mobile Labs Patients and patient  advocacy groupsSpent $6.7 million on education for patients Launched the Medtronic Discovery app, designed to recruit  participants, communicate with them, and collect data throughout large-scale clinical studies conducted remotelyHelped patients stay up to date with current treatments and technology to help them achieve better outcomes Shareholders Held quarterly calls about business health, including updates to our innovation pipeline and ongoing response to global issues Conducted ongoing dialogue with many of our institutional  investors and held specific conversations regarding input on governance, executive compensation, and strategic issues Hosted our inaugural ESG Investor Briefing event, where  Medtronic leaders discussed key ESG areas important to the company and its investors Incorporated feedback into our decision-making processes Suppliers and distributors Became a member of CDP Supply Chain, a consortium of global companies working to help 40,000 suppliers quantify their greenhouse gas (GHG) emissions and other components of their environmental sustainability measures Piloted a new Supplier Risk Mapping technology tool that allows  us to analyze suppliers on risks related to their geographic location, industry, and the amount we spend with them annually Involved 46 suppliers and 21 category managers in inaugural CDP Supply Chain training programs Evaluated and assigned inherent risk scores to 6,000 of our   Tier 1 suppliers Stakeholder engagement 2022 Integrated Performance Report Introduction 20 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Employees Developed flexible working models for employees Invested $49 million in employee learning and  development, up from $45 million in FYCreated Environmental Action Group led by  employees to educate and share resources on individual behaviors and systemic changes that can improve our environmental footprint Supported learning, community events, and tailored  development activities for all dimensions of diversity through our ERGs and Diversity Networks, with  34,000 employees engaged across 75 countriesOffered hybrid-working arrangements to employees as  offices reopen Provided employees access to 32,000 learning resourcesAchieved world class scores for employee engagement   and inclusion Received survey feedback that 90% of responding employees  feel proud to work at Medtronic Registered 1,000 Environmental Action Group members in  seven months Government regulators and policymakersParticipated in FDA Sterilization Master File  Pilot Program Continued working with governments, peers, and  other stakeholders to help shape the digital health policy landscape and inform public policies aimed  at narrowing disparities in healthcare access Signed a memorandum of understanding with   the Vietnam Ministry of Health to elevate healthcare professionals’ clinical skill sets in ICU departments and centers, with the aim to train more than  4,000 healthcare professionals in 12 months Participated in a meeting about the Cancer   Moonshot initiative launched by U.S. President BidenReceived FDA approval to implement new ethylene oxide process at Steri-Tech site in Puerto Rico Helped with the treatment of over 500,000 patients annually  through our partnership with the National Institute of Cardiovascular Diseases in Pakistan Nongovernmental organizationsMedtronic and the Medtronic Foundation partnered with others to support COVID-19 relief efforts and respond to needs arising from the conflict in Ukraine Impacted more than 2.2 million people positively through the distribution of over 34 million items of medical supplies, equipment, and personal protective equipment (PPE) to support COVID-19 relief efforts with Medtronic Foundation partners Contributed $97.1 million, including $6.7 million to support  Ukraine, through Medtronic and the Medtronic Foundation 2022 Integrated Performance Report Introduction 21 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Local communities Continued to cocreate healthcare  delivery with local stakeholders and underserved communities through Medtronic LABS Drove equity within our communities  through Medtronic and the Medtronic Foundation partnerships and initiatives led by our employee resource groups (ERGs) Developed a pipeline for STEM  careers in local communities through investments in OneTen, the Thurgood Marshall College Fund (TMCF), Multiple Pathways Initiative (MPI), and the Society of Hispanic Professional Engineers (SHPE) Enabled employee volunteerism  through the Medtronic Foundation Became members of MedTech Color  to expand diversity in clinical trialsExpanded Medtronic LABS Empower Health program throughout Kenya, nearly doubling its current patient  impact in the country Created new internship opportunities  and removed four-year degree requirements for some STEM careers Peers and partners Partnered with peers, academics,  and others to increase access to,  and security of, vital therapies  and solutions  Teamed with Optum, Boston  Scientific, and Abbott Laboratories to help launch the new Center for Medical Device Cybersecurity at the University of Minnesota, which will serve as a hub for discovery, outreach, and workforce trainingLaunched a pilot with Mpirik and Vizient to help more female  and ethnically diverse patients receive preventative treatment for cardiac issues 2022 Integrated Performance Report Introduction 22 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Contribution to the UN Sustainable  Development Goals We align our ESG efforts to the   UN Sustainable Development Goals (SDGs) where we can make the greatest impact.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9710519313812256)","('Employee_Health_And_Safety', 0.0029088747687637806)","('Human_Rights_And_Community_Relations', 0.00245367968454957)","(['Human Capital Development'], 0.9710519313812256)","('NON-ESG', 0.0029088747687637806)","('NON-ESG', 0.00245367968454957)"
Line 217,"Further examples are provided throughout this report.KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Healthcare professionals   and administratorsInvested $69 million in healthcare professional training Trained more than 350,000 medical professionals Trained physicians on our life-saving technologies, even  when travel was restricted, with Medtronic Mobile Labs Patients and patient  advocacy groupsSpent $6.7 million on education for patients Launched the Medtronic Discovery app, designed to recruit  participants, communicate with them, and collect data throughout large-scale clinical studies conducted remotelyHelped patients stay up to date with current treatments and technology to help them achieve better outcomes Shareholders Held quarterly calls about business health, including updates to our innovation pipeline and ongoing response to global issues Conducted ongoing dialogue with many of our institutional  investors and held specific conversations regarding input on governance, executive compensation, and strategic issues Hosted our inaugural ESG Investor Briefing event, where  Medtronic leaders discussed key ESG areas important to the company and its investors Incorporated feedback into our decision-making processes Suppliers and distributors Became a member of CDP Supply Chain, a consortium of global companies working to help 40,000 suppliers quantify their greenhouse gas (GHG) emissions and other components of their environmental sustainability measures Piloted a new Supplier Risk Mapping technology tool that allows  us to analyze suppliers on risks related to their geographic location, industry, and the amount we spend with them annually Involved 46 suppliers and 21 category managers in inaugural CDP Supply Chain training programs Evaluated and assigned inherent risk scores to 6,000 of our   Tier 1 suppliers Stakeholder engagement 2022 Integrated Performance Report Introduction 20 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Employees Developed flexible working models for employees Invested $49 million in employee learning and  development, up from $45 million in FYCreated Environmental Action Group led by  employees to educate and share resources on individual behaviors and systemic changes that can improve our environmental footprint Supported learning, community events, and tailored  development activities for all dimensions of diversity through our ERGs and Diversity Networks, with  34,000 employees engaged across 75 countriesOffered hybrid-working arrangements to employees as  offices reopen Provided employees access to 32,000 learning resourcesAchieved world class scores for employee engagement   and inclusion Received survey feedback that 90% of responding employees  feel proud to work at Medtronic Registered 1,000 Environmental Action Group members in  seven months Government regulators and policymakersParticipated in FDA Sterilization Master File  Pilot Program Continued working with governments, peers, and  other stakeholders to help shape the digital health policy landscape and inform public policies aimed  at narrowing disparities in healthcare access Signed a memorandum of understanding with   the Vietnam Ministry of Health to elevate healthcare professionals’ clinical skill sets in ICU departments and centers, with the aim to train more than  4,000 healthcare professionals in 12 months Participated in a meeting about the Cancer   Moonshot initiative launched by U.S. President BidenReceived FDA approval to implement new ethylene oxide process at Steri-Tech site in Puerto Rico Helped with the treatment of over 500,000 patients annually  through our partnership with the National Institute of Cardiovascular Diseases in Pakistan Nongovernmental organizationsMedtronic and the Medtronic Foundation partnered with others to support COVID-19 relief efforts and respond to needs arising from the conflict in Ukraine Impacted more than 2.2 million people positively through the distribution of over 34 million items of medical supplies, equipment, and personal protective equipment (PPE) to support COVID-19 relief efforts with Medtronic Foundation partners Contributed $97.1 million, including $6.7 million to support  Ukraine, through Medtronic and the Medtronic Foundation 2022 Integrated Performance Report Introduction 21 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Local communities Continued to cocreate healthcare  delivery with local stakeholders and underserved communities through Medtronic LABS Drove equity within our communities  through Medtronic and the Medtronic Foundation partnerships and initiatives led by our employee resource groups (ERGs) Developed a pipeline for STEM  careers in local communities through investments in OneTen, the Thurgood Marshall College Fund (TMCF), Multiple Pathways Initiative (MPI), and the Society of Hispanic Professional Engineers (SHPE) Enabled employee volunteerism  through the Medtronic Foundation Became members of MedTech Color  to expand diversity in clinical trialsExpanded Medtronic LABS Empower Health program throughout Kenya, nearly doubling its current patient  impact in the country Created new internship opportunities  and removed four-year degree requirements for some STEM careers Peers and partners Partnered with peers, academics,  and others to increase access to,  and security of, vital therapies  and solutions  Teamed with Optum, Boston  Scientific, and Abbott Laboratories to help launch the new Center for Medical Device Cybersecurity at the University of Minnesota, which will serve as a hub for discovery, outreach, and workforce trainingLaunched a pilot with Mpirik and Vizient to help more female  and ethnically diverse patients receive preventative treatment for cardiac issues 2022 Integrated Performance Report Introduction 22 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Contribution to the UN Sustainable  Development Goals We align our ESG efforts to the   UN Sustainable Development Goals (SDGs) where we can make the greatest impact.
","('Access_And_Affordability', 0.8207253813743591)","('Product_Quality_And_Safety', 0.020530998706817627)","('Employee_Engagement_Inclusion_And_Diversity', 0.016948388889431953)","(['Health Outcome Contribution'], 0.8207253813743591)","('NON-ESG', 0.020530998706817627)","('NON-ESG', 0.016948388889431953)"
Line 218,"Further examples are provided throughout this report.KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Healthcare professionals   and administratorsInvested $69 million in healthcare professional training Trained more than 350,000 medical professionals Trained physicians on our life-saving technologies, even  when travel was restricted, with Medtronic Mobile Labs Patients and patient  advocacy groupsSpent $6.7 million on education for patients Launched the Medtronic Discovery app, designed to recruit  participants, communicate with them, and collect data throughout large-scale clinical studies conducted remotelyHelped patients stay up to date with current treatments and technology to help them achieve better outcomes Shareholders Held quarterly calls about business health, including updates to our innovation pipeline and ongoing response to global issues Conducted ongoing dialogue with many of our institutional  investors and held specific conversations regarding input on governance, executive compensation, and strategic issues Hosted our inaugural ESG Investor Briefing event, where  Medtronic leaders discussed key ESG areas important to the company and its investors Incorporated feedback into our decision-making processes Suppliers and distributors Became a member of CDP Supply Chain, a consortium of global companies working to help 40,000 suppliers quantify their greenhouse gas (GHG) emissions and other components of their environmental sustainability measures Piloted a new Supplier Risk Mapping technology tool that allows  us to analyze suppliers on risks related to their geographic location, industry, and the amount we spend with them annually Involved 46 suppliers and 21 category managers in inaugural CDP Supply Chain training programs Evaluated and assigned inherent risk scores to 6,000 of our   Tier 1 suppliers Stakeholder engagement 2022 Integrated Performance Report Introduction 20 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Employees Developed flexible working models for employees Invested $49 million in employee learning and  development, up from $45 million in FYCreated Environmental Action Group led by  employees to educate and share resources on individual behaviors and systemic changes that can improve our environmental footprint Supported learning, community events, and tailored  development activities for all dimensions of diversity through our ERGs and Diversity Networks, with  34,000 employees engaged across 75 countriesOffered hybrid-working arrangements to employees as  offices reopen Provided employees access to 32,000 learning resourcesAchieved world class scores for employee engagement   and inclusion Received survey feedback that 90% of responding employees  feel proud to work at Medtronic Registered 1,000 Environmental Action Group members in  seven months Government regulators and policymakersParticipated in FDA Sterilization Master File  Pilot Program Continued working with governments, peers, and  other stakeholders to help shape the digital health policy landscape and inform public policies aimed  at narrowing disparities in healthcare access Signed a memorandum of understanding with   the Vietnam Ministry of Health to elevate healthcare professionals’ clinical skill sets in ICU departments and centers, with the aim to train more than  4,000 healthcare professionals in 12 months Participated in a meeting about the Cancer   Moonshot initiative launched by U.S. President BidenReceived FDA approval to implement new ethylene oxide process at Steri-Tech site in Puerto Rico Helped with the treatment of over 500,000 patients annually  through our partnership with the National Institute of Cardiovascular Diseases in Pakistan Nongovernmental organizationsMedtronic and the Medtronic Foundation partnered with others to support COVID-19 relief efforts and respond to needs arising from the conflict in Ukraine Impacted more than 2.2 million people positively through the distribution of over 34 million items of medical supplies, equipment, and personal protective equipment (PPE) to support COVID-19 relief efforts with Medtronic Foundation partners Contributed $97.1 million, including $6.7 million to support  Ukraine, through Medtronic and the Medtronic Foundation 2022 Integrated Performance Report Introduction 21 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Local communities Continued to cocreate healthcare  delivery with local stakeholders and underserved communities through Medtronic LABS Drove equity within our communities  through Medtronic and the Medtronic Foundation partnerships and initiatives led by our employee resource groups (ERGs) Developed a pipeline for STEM  careers in local communities through investments in OneTen, the Thurgood Marshall College Fund (TMCF), Multiple Pathways Initiative (MPI), and the Society of Hispanic Professional Engineers (SHPE) Enabled employee volunteerism  through the Medtronic Foundation Became members of MedTech Color  to expand diversity in clinical trialsExpanded Medtronic LABS Empower Health program throughout Kenya, nearly doubling its current patient  impact in the country Created new internship opportunities  and removed four-year degree requirements for some STEM careers Peers and partners Partnered with peers, academics,  and others to increase access to,  and security of, vital therapies  and solutions  Teamed with Optum, Boston  Scientific, and Abbott Laboratories to help launch the new Center for Medical Device Cybersecurity at the University of Minnesota, which will serve as a hub for discovery, outreach, and workforce trainingLaunched a pilot with Mpirik and Vizient to help more female  and ethnically diverse patients receive preventative treatment for cardiac issues 2022 Integrated Performance Report Introduction 22 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Contribution to the UN Sustainable  Development Goals We align our ESG efforts to the   UN Sustainable Development Goals (SDGs) where we can make the greatest impact.
","('Critical_Incident_Risk_Management', 0.45721113681793213)","('Access_And_Affordability', 0.1116165742278099)","('Employee_Health_And_Safety', 0.10796080529689789)","('NON-ESG', 0.45721113681793213)","('NON-ESG', 0.1116165742278099)","('NON-ESG', 0.10796080529689789)"
Line 219,"Further examples are provided throughout this report.KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Healthcare professionals   and administratorsInvested $69 million in healthcare professional training Trained more than 350,000 medical professionals Trained physicians on our life-saving technologies, even  when travel was restricted, with Medtronic Mobile Labs Patients and patient  advocacy groupsSpent $6.7 million on education for patients Launched the Medtronic Discovery app, designed to recruit  participants, communicate with them, and collect data throughout large-scale clinical studies conducted remotelyHelped patients stay up to date with current treatments and technology to help them achieve better outcomes Shareholders Held quarterly calls about business health, including updates to our innovation pipeline and ongoing response to global issues Conducted ongoing dialogue with many of our institutional  investors and held specific conversations regarding input on governance, executive compensation, and strategic issues Hosted our inaugural ESG Investor Briefing event, where  Medtronic leaders discussed key ESG areas important to the company and its investors Incorporated feedback into our decision-making processes Suppliers and distributors Became a member of CDP Supply Chain, a consortium of global companies working to help 40,000 suppliers quantify their greenhouse gas (GHG) emissions and other components of their environmental sustainability measures Piloted a new Supplier Risk Mapping technology tool that allows  us to analyze suppliers on risks related to their geographic location, industry, and the amount we spend with them annually Involved 46 suppliers and 21 category managers in inaugural CDP Supply Chain training programs Evaluated and assigned inherent risk scores to 6,000 of our   Tier 1 suppliers Stakeholder engagement 2022 Integrated Performance Report Introduction 20 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Employees Developed flexible working models for employees Invested $49 million in employee learning and  development, up from $45 million in FYCreated Environmental Action Group led by  employees to educate and share resources on individual behaviors and systemic changes that can improve our environmental footprint Supported learning, community events, and tailored  development activities for all dimensions of diversity through our ERGs and Diversity Networks, with  34,000 employees engaged across 75 countriesOffered hybrid-working arrangements to employees as  offices reopen Provided employees access to 32,000 learning resourcesAchieved world class scores for employee engagement   and inclusion Received survey feedback that 90% of responding employees  feel proud to work at Medtronic Registered 1,000 Environmental Action Group members in  seven months Government regulators and policymakersParticipated in FDA Sterilization Master File  Pilot Program Continued working with governments, peers, and  other stakeholders to help shape the digital health policy landscape and inform public policies aimed  at narrowing disparities in healthcare access Signed a memorandum of understanding with   the Vietnam Ministry of Health to elevate healthcare professionals’ clinical skill sets in ICU departments and centers, with the aim to train more than  4,000 healthcare professionals in 12 months Participated in a meeting about the Cancer   Moonshot initiative launched by U.S. President BidenReceived FDA approval to implement new ethylene oxide process at Steri-Tech site in Puerto Rico Helped with the treatment of over 500,000 patients annually  through our partnership with the National Institute of Cardiovascular Diseases in Pakistan Nongovernmental organizationsMedtronic and the Medtronic Foundation partnered with others to support COVID-19 relief efforts and respond to needs arising from the conflict in Ukraine Impacted more than 2.2 million people positively through the distribution of over 34 million items of medical supplies, equipment, and personal protective equipment (PPE) to support COVID-19 relief efforts with Medtronic Foundation partners Contributed $97.1 million, including $6.7 million to support  Ukraine, through Medtronic and the Medtronic Foundation 2022 Integrated Performance Report Introduction 21 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Local communities Continued to cocreate healthcare  delivery with local stakeholders and underserved communities through Medtronic LABS Drove equity within our communities  through Medtronic and the Medtronic Foundation partnerships and initiatives led by our employee resource groups (ERGs) Developed a pipeline for STEM  careers in local communities through investments in OneTen, the Thurgood Marshall College Fund (TMCF), Multiple Pathways Initiative (MPI), and the Society of Hispanic Professional Engineers (SHPE) Enabled employee volunteerism  through the Medtronic Foundation Became members of MedTech Color  to expand diversity in clinical trialsExpanded Medtronic LABS Empower Health program throughout Kenya, nearly doubling its current patient  impact in the country Created new internship opportunities  and removed four-year degree requirements for some STEM careers Peers and partners Partnered with peers, academics,  and others to increase access to,  and security of, vital therapies  and solutions  Teamed with Optum, Boston  Scientific, and Abbott Laboratories to help launch the new Center for Medical Device Cybersecurity at the University of Minnesota, which will serve as a hub for discovery, outreach, and workforce trainingLaunched a pilot with Mpirik and Vizient to help more female  and ethnically diverse patients receive preventative treatment for cardiac issues 2022 Integrated Performance Report Introduction 22 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Contribution to the UN Sustainable  Development Goals We align our ESG efforts to the   UN Sustainable Development Goals (SDGs) where we can make the greatest impact.
","('Employee_Health_And_Safety', 0.5588306784629822)","('Critical_Incident_Risk_Management', 0.14177781343460083)","('Access_And_Affordability', 0.07296691089868546)","(['Operational Eco-Efficiency'], 0.5588306784629822)","('NON-ESG', 0.14177781343460083)","('NON-ESG', 0.07296691089868546)"
Line 220,"Further examples are provided throughout this report.KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Healthcare professionals   and administratorsInvested $69 million in healthcare professional training Trained more than 350,000 medical professionals Trained physicians on our life-saving technologies, even  when travel was restricted, with Medtronic Mobile Labs Patients and patient  advocacy groupsSpent $6.7 million on education for patients Launched the Medtronic Discovery app, designed to recruit  participants, communicate with them, and collect data throughout large-scale clinical studies conducted remotelyHelped patients stay up to date with current treatments and technology to help them achieve better outcomes Shareholders Held quarterly calls about business health, including updates to our innovation pipeline and ongoing response to global issues Conducted ongoing dialogue with many of our institutional  investors and held specific conversations regarding input on governance, executive compensation, and strategic issues Hosted our inaugural ESG Investor Briefing event, where  Medtronic leaders discussed key ESG areas important to the company and its investors Incorporated feedback into our decision-making processes Suppliers and distributors Became a member of CDP Supply Chain, a consortium of global companies working to help 40,000 suppliers quantify their greenhouse gas (GHG) emissions and other components of their environmental sustainability measures Piloted a new Supplier Risk Mapping technology tool that allows  us to analyze suppliers on risks related to their geographic location, industry, and the amount we spend with them annually Involved 46 suppliers and 21 category managers in inaugural CDP Supply Chain training programs Evaluated and assigned inherent risk scores to 6,000 of our   Tier 1 suppliers Stakeholder engagement 2022 Integrated Performance Report Introduction 20 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Employees Developed flexible working models for employees Invested $49 million in employee learning and  development, up from $45 million in FYCreated Environmental Action Group led by  employees to educate and share resources on individual behaviors and systemic changes that can improve our environmental footprint Supported learning, community events, and tailored  development activities for all dimensions of diversity through our ERGs and Diversity Networks, with  34,000 employees engaged across 75 countriesOffered hybrid-working arrangements to employees as  offices reopen Provided employees access to 32,000 learning resourcesAchieved world class scores for employee engagement   and inclusion Received survey feedback that 90% of responding employees  feel proud to work at Medtronic Registered 1,000 Environmental Action Group members in  seven months Government regulators and policymakersParticipated in FDA Sterilization Master File  Pilot Program Continued working with governments, peers, and  other stakeholders to help shape the digital health policy landscape and inform public policies aimed  at narrowing disparities in healthcare access Signed a memorandum of understanding with   the Vietnam Ministry of Health to elevate healthcare professionals’ clinical skill sets in ICU departments and centers, with the aim to train more than  4,000 healthcare professionals in 12 months Participated in a meeting about the Cancer   Moonshot initiative launched by U.S. President BidenReceived FDA approval to implement new ethylene oxide process at Steri-Tech site in Puerto Rico Helped with the treatment of over 500,000 patients annually  through our partnership with the National Institute of Cardiovascular Diseases in Pakistan Nongovernmental organizationsMedtronic and the Medtronic Foundation partnered with others to support COVID-19 relief efforts and respond to needs arising from the conflict in Ukraine Impacted more than 2.2 million people positively through the distribution of over 34 million items of medical supplies, equipment, and personal protective equipment (PPE) to support COVID-19 relief efforts with Medtronic Foundation partners Contributed $97.1 million, including $6.7 million to support  Ukraine, through Medtronic and the Medtronic Foundation 2022 Integrated Performance Report Introduction 21 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Local communities Continued to cocreate healthcare  delivery with local stakeholders and underserved communities through Medtronic LABS Drove equity within our communities  through Medtronic and the Medtronic Foundation partnerships and initiatives led by our employee resource groups (ERGs) Developed a pipeline for STEM  careers in local communities through investments in OneTen, the Thurgood Marshall College Fund (TMCF), Multiple Pathways Initiative (MPI), and the Society of Hispanic Professional Engineers (SHPE) Enabled employee volunteerism  through the Medtronic Foundation Became members of MedTech Color  to expand diversity in clinical trialsExpanded Medtronic LABS Empower Health program throughout Kenya, nearly doubling its current patient  impact in the country Created new internship opportunities  and removed four-year degree requirements for some STEM careers Peers and partners Partnered with peers, academics,  and others to increase access to,  and security of, vital therapies  and solutions  Teamed with Optum, Boston  Scientific, and Abbott Laboratories to help launch the new Center for Medical Device Cybersecurity at the University of Minnesota, which will serve as a hub for discovery, outreach, and workforce trainingLaunched a pilot with Mpirik and Vizient to help more female  and ethnically diverse patients receive preventative treatment for cardiac issues 2022 Integrated Performance Report Introduction 22 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Contribution to the UN Sustainable  Development Goals We align our ESG efforts to the   UN Sustainable Development Goals (SDGs) where we can make the greatest impact.
","('Access_And_Affordability', 0.8002341389656067)","('Human_Rights_And_Community_Relations', 0.08306887745857239)","('Employee_Engagement_Inclusion_And_Diversity', 0.0154489791020751)","(['Health Outcome Contribution'], 0.8002341389656067)","('NON-ESG', 0.08306887745857239)","('NON-ESG', 0.0154489791020751)"
Line 221,"Further examples are provided throughout this report.KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Healthcare professionals   and administratorsInvested $69 million in healthcare professional training Trained more than 350,000 medical professionals Trained physicians on our life-saving technologies, even  when travel was restricted, with Medtronic Mobile Labs Patients and patient  advocacy groupsSpent $6.7 million on education for patients Launched the Medtronic Discovery app, designed to recruit  participants, communicate with them, and collect data throughout large-scale clinical studies conducted remotelyHelped patients stay up to date with current treatments and technology to help them achieve better outcomes Shareholders Held quarterly calls about business health, including updates to our innovation pipeline and ongoing response to global issues Conducted ongoing dialogue with many of our institutional  investors and held specific conversations regarding input on governance, executive compensation, and strategic issues Hosted our inaugural ESG Investor Briefing event, where  Medtronic leaders discussed key ESG areas important to the company and its investors Incorporated feedback into our decision-making processes Suppliers and distributors Became a member of CDP Supply Chain, a consortium of global companies working to help 40,000 suppliers quantify their greenhouse gas (GHG) emissions and other components of their environmental sustainability measures Piloted a new Supplier Risk Mapping technology tool that allows  us to analyze suppliers on risks related to their geographic location, industry, and the amount we spend with them annually Involved 46 suppliers and 21 category managers in inaugural CDP Supply Chain training programs Evaluated and assigned inherent risk scores to 6,000 of our   Tier 1 suppliers Stakeholder engagement 2022 Integrated Performance Report Introduction 20 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Employees Developed flexible working models for employees Invested $49 million in employee learning and  development, up from $45 million in FYCreated Environmental Action Group led by  employees to educate and share resources on individual behaviors and systemic changes that can improve our environmental footprint Supported learning, community events, and tailored  development activities for all dimensions of diversity through our ERGs and Diversity Networks, with  34,000 employees engaged across 75 countriesOffered hybrid-working arrangements to employees as  offices reopen Provided employees access to 32,000 learning resourcesAchieved world class scores for employee engagement   and inclusion Received survey feedback that 90% of responding employees  feel proud to work at Medtronic Registered 1,000 Environmental Action Group members in  seven months Government regulators and policymakersParticipated in FDA Sterilization Master File  Pilot Program Continued working with governments, peers, and  other stakeholders to help shape the digital health policy landscape and inform public policies aimed  at narrowing disparities in healthcare access Signed a memorandum of understanding with   the Vietnam Ministry of Health to elevate healthcare professionals’ clinical skill sets in ICU departments and centers, with the aim to train more than  4,000 healthcare professionals in 12 months Participated in a meeting about the Cancer   Moonshot initiative launched by U.S. President BidenReceived FDA approval to implement new ethylene oxide process at Steri-Tech site in Puerto Rico Helped with the treatment of over 500,000 patients annually  through our partnership with the National Institute of Cardiovascular Diseases in Pakistan Nongovernmental organizationsMedtronic and the Medtronic Foundation partnered with others to support COVID-19 relief efforts and respond to needs arising from the conflict in Ukraine Impacted more than 2.2 million people positively through the distribution of over 34 million items of medical supplies, equipment, and personal protective equipment (PPE) to support COVID-19 relief efforts with Medtronic Foundation partners Contributed $97.1 million, including $6.7 million to support  Ukraine, through Medtronic and the Medtronic Foundation 2022 Integrated Performance Report Introduction 21 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Local communities Continued to cocreate healthcare  delivery with local stakeholders and underserved communities through Medtronic LABS Drove equity within our communities  through Medtronic and the Medtronic Foundation partnerships and initiatives led by our employee resource groups (ERGs) Developed a pipeline for STEM  careers in local communities through investments in OneTen, the Thurgood Marshall College Fund (TMCF), Multiple Pathways Initiative (MPI), and the Society of Hispanic Professional Engineers (SHPE) Enabled employee volunteerism  through the Medtronic Foundation Became members of MedTech Color  to expand diversity in clinical trialsExpanded Medtronic LABS Empower Health program throughout Kenya, nearly doubling its current patient  impact in the country Created new internship opportunities  and removed four-year degree requirements for some STEM careers Peers and partners Partnered with peers, academics,  and others to increase access to,  and security of, vital therapies  and solutions  Teamed with Optum, Boston  Scientific, and Abbott Laboratories to help launch the new Center for Medical Device Cybersecurity at the University of Minnesota, which will serve as a hub for discovery, outreach, and workforce trainingLaunched a pilot with Mpirik and Vizient to help more female  and ethnically diverse patients receive preventative treatment for cardiac issues 2022 Integrated Performance Report Introduction 22 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Contribution to the UN Sustainable  Development Goals We align our ESG efforts to the   UN Sustainable Development Goals (SDGs) where we can make the greatest impact.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9624955654144287)","('Employee_Health_And_Safety', 0.0036656467709690332)","('Access_And_Affordability', 0.0029003957752138376)","(['Human Capital Development'], 0.9624955654144287)","('NON-ESG', 0.0036656467709690332)","('NON-ESG', 0.0029003957752138376)"
Line 222,"Further examples are provided throughout this report.KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Healthcare professionals   and administratorsInvested $69 million in healthcare professional training Trained more than 350,000 medical professionals Trained physicians on our life-saving technologies, even  when travel was restricted, with Medtronic Mobile Labs Patients and patient  advocacy groupsSpent $6.7 million on education for patients Launched the Medtronic Discovery app, designed to recruit  participants, communicate with them, and collect data throughout large-scale clinical studies conducted remotelyHelped patients stay up to date with current treatments and technology to help them achieve better outcomes Shareholders Held quarterly calls about business health, including updates to our innovation pipeline and ongoing response to global issues Conducted ongoing dialogue with many of our institutional  investors and held specific conversations regarding input on governance, executive compensation, and strategic issues Hosted our inaugural ESG Investor Briefing event, where  Medtronic leaders discussed key ESG areas important to the company and its investors Incorporated feedback into our decision-making processes Suppliers and distributors Became a member of CDP Supply Chain, a consortium of global companies working to help 40,000 suppliers quantify their greenhouse gas (GHG) emissions and other components of their environmental sustainability measures Piloted a new Supplier Risk Mapping technology tool that allows  us to analyze suppliers on risks related to their geographic location, industry, and the amount we spend with them annually Involved 46 suppliers and 21 category managers in inaugural CDP Supply Chain training programs Evaluated and assigned inherent risk scores to 6,000 of our   Tier 1 suppliers Stakeholder engagement 2022 Integrated Performance Report Introduction 20 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Employees Developed flexible working models for employees Invested $49 million in employee learning and  development, up from $45 million in FYCreated Environmental Action Group led by  employees to educate and share resources on individual behaviors and systemic changes that can improve our environmental footprint Supported learning, community events, and tailored  development activities for all dimensions of diversity through our ERGs and Diversity Networks, with  34,000 employees engaged across 75 countriesOffered hybrid-working arrangements to employees as  offices reopen Provided employees access to 32,000 learning resourcesAchieved world class scores for employee engagement   and inclusion Received survey feedback that 90% of responding employees  feel proud to work at Medtronic Registered 1,000 Environmental Action Group members in  seven months Government regulators and policymakersParticipated in FDA Sterilization Master File  Pilot Program Continued working with governments, peers, and  other stakeholders to help shape the digital health policy landscape and inform public policies aimed  at narrowing disparities in healthcare access Signed a memorandum of understanding with   the Vietnam Ministry of Health to elevate healthcare professionals’ clinical skill sets in ICU departments and centers, with the aim to train more than  4,000 healthcare professionals in 12 months Participated in a meeting about the Cancer   Moonshot initiative launched by U.S. President BidenReceived FDA approval to implement new ethylene oxide process at Steri-Tech site in Puerto Rico Helped with the treatment of over 500,000 patients annually  through our partnership with the National Institute of Cardiovascular Diseases in Pakistan Nongovernmental organizationsMedtronic and the Medtronic Foundation partnered with others to support COVID-19 relief efforts and respond to needs arising from the conflict in Ukraine Impacted more than 2.2 million people positively through the distribution of over 34 million items of medical supplies, equipment, and personal protective equipment (PPE) to support COVID-19 relief efforts with Medtronic Foundation partners Contributed $97.1 million, including $6.7 million to support  Ukraine, through Medtronic and the Medtronic Foundation 2022 Integrated Performance Report Introduction 21 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Local communities Continued to cocreate healthcare  delivery with local stakeholders and underserved communities through Medtronic LABS Drove equity within our communities  through Medtronic and the Medtronic Foundation partnerships and initiatives led by our employee resource groups (ERGs) Developed a pipeline for STEM  careers in local communities through investments in OneTen, the Thurgood Marshall College Fund (TMCF), Multiple Pathways Initiative (MPI), and the Society of Hispanic Professional Engineers (SHPE) Enabled employee volunteerism  through the Medtronic Foundation Became members of MedTech Color  to expand diversity in clinical trialsExpanded Medtronic LABS Empower Health program throughout Kenya, nearly doubling its current patient  impact in the country Created new internship opportunities  and removed four-year degree requirements for some STEM careers Peers and partners Partnered with peers, academics,  and others to increase access to,  and security of, vital therapies  and solutions  Teamed with Optum, Boston  Scientific, and Abbott Laboratories to help launch the new Center for Medical Device Cybersecurity at the University of Minnesota, which will serve as a hub for discovery, outreach, and workforce trainingLaunched a pilot with Mpirik and Vizient to help more female  and ethnically diverse patients receive preventative treatment for cardiac issues 2022 Integrated Performance Report Introduction 22 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Contribution to the UN Sustainable  Development Goals We align our ESG efforts to the   UN Sustainable Development Goals (SDGs) where we can make the greatest impact.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9401406645774841)","('Access_And_Affordability', 0.009610935114324093)","('Employee_Health_And_Safety', 0.005396832246333361)","(['Human Capital Development'], 0.9401406645774841)","('NON-ESG', 0.009610935114324093)","('NON-ESG', 0.005396832246333361)"
Line 223,"Further examples are provided throughout this report.KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Healthcare professionals   and administratorsInvested $69 million in healthcare professional training Trained more than 350,000 medical professionals Trained physicians on our life-saving technologies, even  when travel was restricted, with Medtronic Mobile Labs Patients and patient  advocacy groupsSpent $6.7 million on education for patients Launched the Medtronic Discovery app, designed to recruit  participants, communicate with them, and collect data throughout large-scale clinical studies conducted remotelyHelped patients stay up to date with current treatments and technology to help them achieve better outcomes Shareholders Held quarterly calls about business health, including updates to our innovation pipeline and ongoing response to global issues Conducted ongoing dialogue with many of our institutional  investors and held specific conversations regarding input on governance, executive compensation, and strategic issues Hosted our inaugural ESG Investor Briefing event, where  Medtronic leaders discussed key ESG areas important to the company and its investors Incorporated feedback into our decision-making processes Suppliers and distributors Became a member of CDP Supply Chain, a consortium of global companies working to help 40,000 suppliers quantify their greenhouse gas (GHG) emissions and other components of their environmental sustainability measures Piloted a new Supplier Risk Mapping technology tool that allows  us to analyze suppliers on risks related to their geographic location, industry, and the amount we spend with them annually Involved 46 suppliers and 21 category managers in inaugural CDP Supply Chain training programs Evaluated and assigned inherent risk scores to 6,000 of our   Tier 1 suppliers Stakeholder engagement 2022 Integrated Performance Report Introduction 20 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Employees Developed flexible working models for employees Invested $49 million in employee learning and  development, up from $45 million in FYCreated Environmental Action Group led by  employees to educate and share resources on individual behaviors and systemic changes that can improve our environmental footprint Supported learning, community events, and tailored  development activities for all dimensions of diversity through our ERGs and Diversity Networks, with  34,000 employees engaged across 75 countriesOffered hybrid-working arrangements to employees as  offices reopen Provided employees access to 32,000 learning resourcesAchieved world class scores for employee engagement   and inclusion Received survey feedback that 90% of responding employees  feel proud to work at Medtronic Registered 1,000 Environmental Action Group members in  seven months Government regulators and policymakersParticipated in FDA Sterilization Master File  Pilot Program Continued working with governments, peers, and  other stakeholders to help shape the digital health policy landscape and inform public policies aimed  at narrowing disparities in healthcare access Signed a memorandum of understanding with   the Vietnam Ministry of Health to elevate healthcare professionals’ clinical skill sets in ICU departments and centers, with the aim to train more than  4,000 healthcare professionals in 12 months Participated in a meeting about the Cancer   Moonshot initiative launched by U.S. President BidenReceived FDA approval to implement new ethylene oxide process at Steri-Tech site in Puerto Rico Helped with the treatment of over 500,000 patients annually  through our partnership with the National Institute of Cardiovascular Diseases in Pakistan Nongovernmental organizationsMedtronic and the Medtronic Foundation partnered with others to support COVID-19 relief efforts and respond to needs arising from the conflict in Ukraine Impacted more than 2.2 million people positively through the distribution of over 34 million items of medical supplies, equipment, and personal protective equipment (PPE) to support COVID-19 relief efforts with Medtronic Foundation partners Contributed $97.1 million, including $6.7 million to support  Ukraine, through Medtronic and the Medtronic Foundation 2022 Integrated Performance Report Introduction 21 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy STAKEHOLDER ENGAGEMENT KEY FY22 STAKEHOLDER ENGAGEMENT  Stakeholder Activities Outcomes  Local communities Continued to cocreate healthcare  delivery with local stakeholders and underserved communities through Medtronic LABS Drove equity within our communities  through Medtronic and the Medtronic Foundation partnerships and initiatives led by our employee resource groups (ERGs) Developed a pipeline for STEM  careers in local communities through investments in OneTen, the Thurgood Marshall College Fund (TMCF), Multiple Pathways Initiative (MPI), and the Society of Hispanic Professional Engineers (SHPE) Enabled employee volunteerism  through the Medtronic Foundation Became members of MedTech Color  to expand diversity in clinical trialsExpanded Medtronic LABS Empower Health program throughout Kenya, nearly doubling its current patient  impact in the country Created new internship opportunities  and removed four-year degree requirements for some STEM careers Peers and partners Partnered with peers, academics,  and others to increase access to,  and security of, vital therapies  and solutions  Teamed with Optum, Boston  Scientific, and Abbott Laboratories to help launch the new Center for Medical Device Cybersecurity at the University of Minnesota, which will serve as a hub for discovery, outreach, and workforce trainingLaunched a pilot with Mpirik and Vizient to help more female  and ethnically diverse patients receive preventative treatment for cardiac issues 2022 Integrated Performance Report Introduction 22 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Contribution to the UN Sustainable  Development Goals We align our ESG efforts to the   UN Sustainable Development Goals (SDGs) where we can make the greatest impact.
","('Human_Rights_And_Community_Relations', 0.29645588994026184)","('Business_Model_Resilience', 0.2041783481836319)","('Management_Of_Legal_And_Regulatory_Framework', 0.17726166546344757)","('NON-ESG', 0.29645588994026184)","('NON-ESG', 0.2041783481836319)","('NON-ESG', 0.17726166546344757)"
Line 224,"Highlights of FY22 ESG initiatives relevant to the SDGs are shared throughout the report and summarized in the tables.KEY FY22 CONTRIBUTIONS TO THE SDGs SDG What we do Our FY22 impact We create breakthrough medical  outcomes for patients and health systems and improve access to vital treatments and therapies, transforming the lives of   two people every second   of every hour of every day.
","('Access_And_Affordability', 0.8300796151161194)","('Employee_Health_And_Safety', 0.0276204664260149)","('Critical_Incident_Risk_Management', 0.0167555995285511)","(['Health Outcome Contribution'], 0.8300796151161194)","('NON-ESG', 0.0276204664260149)","('NON-ESG', 0.0167555995285511)"
Line 225,"Our efforts transform standards of quality care, drive economic value, and dismantle structural and social barriers to health equity.•   Served mor e than 76 million patients, helping to address some of the world’s most complex noncommunicable diseases •   Spent $69 million on educa tion for medical professionals, training more than 350,000 individuals on cardiovascular disease, cancer,  diabetes, respiratory disease, and more •   Scr eened more than 1.2 million patients globally since FY16 through Medtronic LABS, working to diagnose and treat   chronic conditions such as hypertension, diabetes, and ear disease •   Advoca ted for universal healthcare coverage by participating in the UHC2030 Private Sector Constituency and UHC2030   Steering Committee  •   Developed a pr ogram with Mpirik and Vizient to help more female and ethnically diverse patients access preventative treatment   for cardiac issues We innovate to improve the health of all women through our therapy design and research.
","('Access_And_Affordability', 0.5515933036804199)","('Employee_Health_And_Safety', 0.08696866780519485)","('Product_Quality_And_Safety', 0.08459319174289703)","(['Health Outcome Contribution'], 0.5515933036804199)","('NON-ESG', 0.08696866780519485)","('NON-ESG', 0.08459319174289703)"
Line 226,"Our efforts transform standards of quality care, drive economic value, and dismantle structural and social barriers to health equity.•   Served mor e than 76 million patients, helping to address some of the world’s most complex noncommunicable diseases •   Spent $69 million on educa tion for medical professionals, training more than 350,000 individuals on cardiovascular disease, cancer,  diabetes, respiratory disease, and more •   Scr eened more than 1.2 million patients globally since FY16 through Medtronic LABS, working to diagnose and treat   chronic conditions such as hypertension, diabetes, and ear disease •   Advoca ted for universal healthcare coverage by participating in the UHC2030 Private Sector Constituency and UHC2030   Steering Committee  •   Developed a pr ogram with Mpirik and Vizient to help more female and ethnically diverse patients access preventative treatment   for cardiac issues We innovate to improve the health of all women through our therapy design and research.
","('Employee_Engagement_Inclusion_And_Diversity', 0.542474627494812)","('Employee_Health_And_Safety', 0.14539501070976257)","('Access_And_Affordability', 0.12459314614534378)","(['Human Capital Development'], 0.542474627494812)","('NON-ESG', 0.14539501070976257)","('NON-ESG', 0.12459314614534378)"
Line 227,"We support female talent through our hiring practices and in our broader ID&E efforts.•   Achieved 42% women r epresentation in global manager-and-above positions in FY22, toward our goal of 45% by FY•   Achieved 100% ethnically diverse and gender pay equity in the U .S.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9755457639694214)","('Labor_Practices', 0.0018634602893143892)","('Employee_Health_And_Safety', 0.0014880006201565266)","(['Human Capital Development'], 0.9755457639694214)","('NON-ESG', 0.0018634602893143892)","('NON-ESG', 0.0014880006201565266)"
Line 228,"and 99% gender pay equity globally  •   Had 30% women r epresentation on our board of directors at the end of FY22; this increased to 36% following a new appointment   in June 2022  •  R eceived employee engagement scores of 81% for women and 80% for men on our Organizational Health Survey •   Had 20% ethnically diverse r epresentation on our board of directors at the end of FY22; this increased to 27% following  a new appointment in June •   Held inaugur al Medtronic Supplier Diversity Conference with more than 200 attendees and approximately 150 one-to-one   sessions between diverse-owned suppliers and Medtronic sourcing managers •  Suppor ted retention of women leaders through third cohort of VP Women’s Sponsorship program •  Alloca ted 70% of Medtronic Foundation grants to diverse-led nonprofit partners 2022 Integrated Performance Report Introduction 23 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy CONTRIBUTION TO THE UN SUSTAINABLE DEVELOPMENT GOALS KEY FY22 CONTRIBUTIONS TO THE SDGs SDG What we do Our FY22 impact We work to eliminate  economic inequities by contributing to sustainable economic growth.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9742000699043274)","('Business_Model_Resilience', 0.0017983667785301805)","('Employee_Health_And_Safety', 0.0017956607043743134)","(['Human Capital Development'], 0.9742000699043274)","('NON-ESG', 0.0017983667785301805)","('NON-ESG', 0.0017956607043743134)"
Line 229,"and 99% gender pay equity globally  •   Had 30% women r epresentation on our board of directors at the end of FY22; this increased to 36% following a new appointment   in June 2022  •  R eceived employee engagement scores of 81% for women and 80% for men on our Organizational Health Survey •   Had 20% ethnically diverse r epresentation on our board of directors at the end of FY22; this increased to 27% following  a new appointment in June •   Held inaugur al Medtronic Supplier Diversity Conference with more than 200 attendees and approximately 150 one-to-one   sessions between diverse-owned suppliers and Medtronic sourcing managers •  Suppor ted retention of women leaders through third cohort of VP Women’s Sponsorship program •  Alloca ted 70% of Medtronic Foundation grants to diverse-led nonprofit partners 2022 Integrated Performance Report Introduction 23 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy CONTRIBUTION TO THE UN SUSTAINABLE DEVELOPMENT GOALS KEY FY22 CONTRIBUTIONS TO THE SDGs SDG What we do Our FY22 impact We work to eliminate  economic inequities by contributing to sustainable economic growth.
","('Supply_Chain_Management', 0.7348558306694031)","('Business_Model_Resilience', 0.036618202924728394)","('Product_Design_And_Lifecycle_Management', 0.028959885239601135)","(['Supply Chain Management'], 0.7348558306694031)","('NON-ESG', 0.036618202924728394)","('NON-ESG', 0.028959885239601135)"
Line 230,"and 99% gender pay equity globally  •   Had 30% women r epresentation on our board of directors at the end of FY22; this increased to 36% following a new appointment   in June 2022  •  R eceived employee engagement scores of 81% for women and 80% for men on our Organizational Health Survey •   Had 20% ethnically diverse r epresentation on our board of directors at the end of FY22; this increased to 27% following  a new appointment in June •   Held inaugur al Medtronic Supplier Diversity Conference with more than 200 attendees and approximately 150 one-to-one   sessions between diverse-owned suppliers and Medtronic sourcing managers •  Suppor ted retention of women leaders through third cohort of VP Women’s Sponsorship program •  Alloca ted 70% of Medtronic Foundation grants to diverse-led nonprofit partners 2022 Integrated Performance Report Introduction 23 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy CONTRIBUTION TO THE UN SUSTAINABLE DEVELOPMENT GOALS KEY FY22 CONTRIBUTIONS TO THE SDGs SDG What we do Our FY22 impact We work to eliminate  economic inequities by contributing to sustainable economic growth.
","('Business_Model_Resilience', 0.4242943823337555)","('Systemic_Risk_Management', 0.36177992820739746)","('Physical_Impacts_Of_Climate_Change', 0.027928810566663742)","('NON-ESG', 0.4242943823337555)","('NON-ESG', 0.36177992820739746)","('NON-ESG', 0.027928810566663742)"
Line 231,"We employ and develop talent from underrepresented communities, protect human rights in our supply chain, support diverse suppliers, and extend our economic impact through volunteerism.•  Spent $2.7 billion with small and diverse-owned suppliers in th e United States and Puerto Rico,  supporting more than 29,000 jobs and generating $4.9 billion in economic production activity •   Employed 95,000+ people full-time in mor e than 150 countries, adding more than $6.3 billion in salary  and wages to local economies •   Achieved 27% ethnically diverse talent in global manager -and-above positions in the United States,  toward our goal of 30% by FY•   C ontinued to bring greater attention and a more powerful voice to our employees from underserved  populations through our Diversity Networks — in FY22, one in three Medtronic employees were part of a Diversity Network or ERG •   P rovided Responsible Supply Management training to more than 1,300 employees on topics that  included labor, human rights, human trafficking, and slavery •   Audited select high-risk suppliers against our labor standar ds, including wages and health and safety •   Joined the  Minnesota Business Coalition for Racial Equity to support Black Minnesotans   in the workplace •   Cr eated internships and removed barriers to STEM careers through investments in OneTen, MPI, TMCF,  and SHPE We partner with community experts to build cutting-edge healthcare technologies and promote inclusive and sustainable local innovation.
","('Supply_Chain_Management', 0.5394550561904907)","('Labor_Practices', 0.28686609864234924)","('Human_Rights_And_Community_Relations', 0.025541525334119797)","(['Supply Chain Management'], 0.5394550561904907)","('NON-ESG', 0.28686609864234924)","('NON-ESG', 0.025541525334119797)"
Line 232,"We employ and develop talent from underrepresented communities, protect human rights in our supply chain, support diverse suppliers, and extend our economic impact through volunteerism.•  Spent $2.7 billion with small and diverse-owned suppliers in th e United States and Puerto Rico,  supporting more than 29,000 jobs and generating $4.9 billion in economic production activity •   Employed 95,000+ people full-time in mor e than 150 countries, adding more than $6.3 billion in salary  and wages to local economies •   Achieved 27% ethnically diverse talent in global manager -and-above positions in the United States,  toward our goal of 30% by FY•   C ontinued to bring greater attention and a more powerful voice to our employees from underserved  populations through our Diversity Networks — in FY22, one in three Medtronic employees were part of a Diversity Network or ERG •   P rovided Responsible Supply Management training to more than 1,300 employees on topics that  included labor, human rights, human trafficking, and slavery •   Audited select high-risk suppliers against our labor standar ds, including wages and health and safety •   Joined the  Minnesota Business Coalition for Racial Equity to support Black Minnesotans   in the workplace •   Cr eated internships and removed barriers to STEM careers through investments in OneTen, MPI, TMCF,  and SHPE We partner with community experts to build cutting-edge healthcare technologies and promote inclusive and sustainable local innovation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9687681794166565)","('Human_Rights_And_Community_Relations', 0.0034519981127232313)","('Labor_Practices', 0.0034104620572179556)","(['Human Capital Development'], 0.9687681794166565)","('NON-ESG', 0.0034519981127232313)","('NON-ESG', 0.0034104620572179556)"
Line 233,"We employ and develop talent from underrepresented communities, protect human rights in our supply chain, support diverse suppliers, and extend our economic impact through volunteerism.•  Spent $2.7 billion with small and diverse-owned suppliers in th e United States and Puerto Rico,  supporting more than 29,000 jobs and generating $4.9 billion in economic production activity •   Employed 95,000+ people full-time in mor e than 150 countries, adding more than $6.3 billion in salary  and wages to local economies •   Achieved 27% ethnically diverse talent in global manager -and-above positions in the United States,  toward our goal of 30% by FY•   C ontinued to bring greater attention and a more powerful voice to our employees from underserved  populations through our Diversity Networks — in FY22, one in three Medtronic employees were part of a Diversity Network or ERG •   P rovided Responsible Supply Management training to more than 1,300 employees on topics that  included labor, human rights, human trafficking, and slavery •   Audited select high-risk suppliers against our labor standar ds, including wages and health and safety •   Joined the  Minnesota Business Coalition for Racial Equity to support Black Minnesotans   in the workplace •   Cr eated internships and removed barriers to STEM careers through investments in OneTen, MPI, TMCF,  and SHPE We partner with community experts to build cutting-edge healthcare technologies and promote inclusive and sustainable local innovation.
","('Labor_Practices', 0.9465853571891785)","('Employee_Health_And_Safety', 0.011386203579604626)","('Employee_Engagement_Inclusion_And_Diversity', 0.0093314778059721)","(['Labor Practice Indicators'], 0.9465853571891785)","('NON-ESG', 0.011386203579604626)","('NON-ESG', 0.0093314778059721)"
Line 234,"The infrastructure we invest in contributes to a resilient, sustainable health system and fosters the next generation of talent in emerging markets.• Invested $2.7 billion in R&D •   Invested in a new innova tion campus in Colorado, United States that will bring together 1,100 employees  to further expand our R&D capabilities •   R eceived Best in Show at the 2021 Medical Design Excellence Awards for the LINQ IITM Insertable  Cardiac Monitoring (ICM) System, and the Medical Device and Diagnostic Industry Readers’ Choice award for the CareLink SmartSync Device Manager •   Signed a memor andum of understanding with the Vietnam Ministry of Health to elevate healthcare  professionals’ clinical skill sets in ICU departments and centers, with the aim to train more than 4,000 healthcare professionals in 12 months •  Advanced our pr oduct pipeline with 200-plus product regulatory approvals in major geographies† •  Developed a pr ogram with Mpirik and Vizient to help more female and ethnically diverse patients access  preventative treatment for cardiac issues † Major geographies include China, Europe, Japan, and the United States.
","('Business_Model_Resilience', 0.6608231663703918)","('Product_Design_And_Lifecycle_Management', 0.07869671285152435)","('Employee_Engagement_Inclusion_And_Diversity', 0.044222958385944366)","(['Codes of Business Conduct'], 0.6608231663703918)","('NON-ESG', 0.07869671285152435)","('NON-ESG', 0.044222958385944366)"
Line 235,"The infrastructure we invest in contributes to a resilient, sustainable health system and fosters the next generation of talent in emerging markets.• Invested $2.7 billion in R&D •   Invested in a new innova tion campus in Colorado, United States that will bring together 1,100 employees  to further expand our R&D capabilities •   R eceived Best in Show at the 2021 Medical Design Excellence Awards for the LINQ IITM Insertable  Cardiac Monitoring (ICM) System, and the Medical Device and Diagnostic Industry Readers’ Choice award for the CareLink SmartSync Device Manager •   Signed a memor andum of understanding with the Vietnam Ministry of Health to elevate healthcare  professionals’ clinical skill sets in ICU departments and centers, with the aim to train more than 4,000 healthcare professionals in 12 months •  Advanced our pr oduct pipeline with 200-plus product regulatory approvals in major geographies† •  Developed a pr ogram with Mpirik and Vizient to help more female and ethnically diverse patients access  preventative treatment for cardiac issues † Major geographies include China, Europe, Japan, and the United States.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9449217319488525)","('Access_And_Affordability', 0.007171391509473324)","('Customer_Welfare', 0.004930994473397732)","(['Human Capital Development'], 0.9449217319488525)","('NON-ESG', 0.007171391509473324)","('NON-ESG', 0.004930994473397732)"
Line 236,"The infrastructure we invest in contributes to a resilient, sustainable health system and fosters the next generation of talent in emerging markets.• Invested $2.7 billion in R&D •   Invested in a new innova tion campus in Colorado, United States that will bring together 1,100 employees  to further expand our R&D capabilities •   R eceived Best in Show at the 2021 Medical Design Excellence Awards for the LINQ IITM Insertable  Cardiac Monitoring (ICM) System, and the Medical Device and Diagnostic Industry Readers’ Choice award for the CareLink SmartSync Device Manager •   Signed a memor andum of understanding with the Vietnam Ministry of Health to elevate healthcare  professionals’ clinical skill sets in ICU departments and centers, with the aim to train more than 4,000 healthcare professionals in 12 months •  Advanced our pr oduct pipeline with 200-plus product regulatory approvals in major geographies† •  Developed a pr ogram with Mpirik and Vizient to help more female and ethnically diverse patients access  preventative treatment for cardiac issues † Major geographies include China, Europe, Japan, and the United States.
","('Employee_Health_And_Safety', 0.4891129434108734)","('Critical_Incident_Risk_Management', 0.10727422684431076)","('Access_And_Affordability', 0.07277953624725342)","('NON-ESG', 0.4891129434108734)","('NON-ESG', 0.10727422684431076)","('NON-ESG', 0.07277953624725342)"
Line 237,"2022 Integrated Performance Report Introduction 24 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy CONTRIBUTION TO THE UN SUSTAINABLE DEVELOPMENT GOALS KEY FY22 CONTRIBUTIONS TO THE SDGs SDG What we do Our FY22 impact We strive to maximize  patient safety and reduce the environmental footprint of our operations, product design, and manufacture.•    C ollected more than 6.2 million products and diverted 280 metric tons of product  waste from landfill •   Empower ed each facility to set and achieve their own energy reduction goals   in line with overall corporate goals •  Launched Sustainability Development C enter to reduce packaging waste  •   F ormed a new Patient Safety and Risk Board — composed of senior medical,   quality, and regulatory corporate leaders — to evaluate and advise on safety  and quality issues We recognize the connection between a healthy planet and human health, and we work to find innovative ways to reduce our carbon footprint.•   Set new ambition to be net zer o across our value chain by FY•   Developed a Decarboniza tion Roadmap to plan for carbon reductions over time •   R educed operational carbon emissions intensity 35% compared to our   FY20 baseline •   C ontinued working toward carbon neutrality in our operations by FY30, including  sourcing 16% of our energy from renewable and alternative sources compared to  our FY20 baseline To drive greater collective change inside and outside the health system, we partner with businesses, the UN, health systems, and local governments.
","('Product_Design_And_Lifecycle_Management', 0.7909959554672241)","('Product_Quality_And_Safety', 0.06690631061792374)","('Waste_And_Hazardous_Materials_Management', 0.0549272783100605)","(['Product Stewardship'], 0.7909959554672241)","('NON-ESG', 0.06690631061792374)","('NON-ESG', 0.0549272783100605)"
Line 238,"2022 Integrated Performance Report Introduction 24 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy CONTRIBUTION TO THE UN SUSTAINABLE DEVELOPMENT GOALS KEY FY22 CONTRIBUTIONS TO THE SDGs SDG What we do Our FY22 impact We strive to maximize  patient safety and reduce the environmental footprint of our operations, product design, and manufacture.•    C ollected more than 6.2 million products and diverted 280 metric tons of product  waste from landfill •   Empower ed each facility to set and achieve their own energy reduction goals   in line with overall corporate goals •  Launched Sustainability Development C enter to reduce packaging waste  •   F ormed a new Patient Safety and Risk Board — composed of senior medical,   quality, and regulatory corporate leaders — to evaluate and advise on safety  and quality issues We recognize the connection between a healthy planet and human health, and we work to find innovative ways to reduce our carbon footprint.•   Set new ambition to be net zer o across our value chain by FY•   Developed a Decarboniza tion Roadmap to plan for carbon reductions over time •   R educed operational carbon emissions intensity 35% compared to our   FY20 baseline •   C ontinued working toward carbon neutrality in our operations by FY30, including  sourcing 16% of our energy from renewable and alternative sources compared to  our FY20 baseline To drive greater collective change inside and outside the health system, we partner with businesses, the UN, health systems, and local governments.
","('Product_Quality_And_Safety', 0.7081456184387207)","('Employee_Health_And_Safety', 0.1371830552816391)","('Waste_And_Hazardous_Materials_Management', 0.028987383469939232)","(['Product Quality & Recall Management'], 0.7081456184387207)","('NON-ESG', 0.1371830552816391)","('NON-ESG', 0.028987383469939232)"
Line 239,"2022 Integrated Performance Report Introduction 24 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy CONTRIBUTION TO THE UN SUSTAINABLE DEVELOPMENT GOALS KEY FY22 CONTRIBUTIONS TO THE SDGs SDG What we do Our FY22 impact We strive to maximize  patient safety and reduce the environmental footprint of our operations, product design, and manufacture.•    C ollected more than 6.2 million products and diverted 280 metric tons of product  waste from landfill •   Empower ed each facility to set and achieve their own energy reduction goals   in line with overall corporate goals •  Launched Sustainability Development C enter to reduce packaging waste  •   F ormed a new Patient Safety and Risk Board — composed of senior medical,   quality, and regulatory corporate leaders — to evaluate and advise on safety  and quality issues We recognize the connection between a healthy planet and human health, and we work to find innovative ways to reduce our carbon footprint.•   Set new ambition to be net zer o across our value chain by FY•   Developed a Decarboniza tion Roadmap to plan for carbon reductions over time •   R educed operational carbon emissions intensity 35% compared to our   FY20 baseline •   C ontinued working toward carbon neutrality in our operations by FY30, including  sourcing 16% of our energy from renewable and alternative sources compared to  our FY20 baseline To drive greater collective change inside and outside the health system, we partner with businesses, the UN, health systems, and local governments.
","('GHG_Emissions', 0.6673473715782166)","('Energy_Management', 0.13265393674373627)","('Air_Quality', 0.05173192173242569)","(['Climate Change'], 0.6673473715782166)","('NON-ESG', 0.13265393674373627)","('NON-ESG', 0.05173192173242569)"
Line 240,"2022 Integrated Performance Report Introduction 24 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy CONTRIBUTION TO THE UN SUSTAINABLE DEVELOPMENT GOALS KEY FY22 CONTRIBUTIONS TO THE SDGs SDG What we do Our FY22 impact We strive to maximize  patient safety and reduce the environmental footprint of our operations, product design, and manufacture.•    C ollected more than 6.2 million products and diverted 280 metric tons of product  waste from landfill •   Empower ed each facility to set and achieve their own energy reduction goals   in line with overall corporate goals •  Launched Sustainability Development C enter to reduce packaging waste  •   F ormed a new Patient Safety and Risk Board — composed of senior medical,   quality, and regulatory corporate leaders — to evaluate and advise on safety  and quality issues We recognize the connection between a healthy planet and human health, and we work to find innovative ways to reduce our carbon footprint.•   Set new ambition to be net zer o across our value chain by FY•   Developed a Decarboniza tion Roadmap to plan for carbon reductions over time •   R educed operational carbon emissions intensity 35% compared to our   FY20 baseline •   C ontinued working toward carbon neutrality in our operations by FY30, including  sourcing 16% of our energy from renewable and alternative sources compared to  our FY20 baseline To drive greater collective change inside and outside the health system, we partner with businesses, the UN, health systems, and local governments.
","('Human_Rights_And_Community_Relations', 0.29143503308296204)","('Management_Of_Legal_And_Regulatory_Framework', 0.20343126356601715)","('Access_And_Affordability', 0.17707926034927368)","('NON-ESG', 0.29143503308296204)","('NON-ESG', 0.20343126356601715)","('NON-ESG', 0.17707926034927368)"
Line 241,"•    C ontinued using the UN Economic Commission for Europe self-assessment tool  for “people first” public-private partnerships to help us evaluate our partnerships against key issues, such as access and equity, fiscal and environmental sustainability, replicability, and stakeholder engagement •   Engaged in par tnerships with nonprofits and governments via Medtronic  Foundation to improve lives for underserved and underrepresented populations worldwide and supported communities in which Medtronic employees live and give, including the investment of $16 million to address racial disparities and advance social justice in the United States •   C ontinued partnering with peers, innovators, healthcare systems, and others  globally to deliver solutions matched to local need and develop new approaches to increasing access to our treatments, for example, our affiliation with MedTech Color through which we foster racial and ethnic diversity in Medtronic clinical trials  2022 Integrated Performance Report Introduction 25 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Environmental  sustainability Staying true to our Mission to improve human welfare depends on a healthy environment  that can sustainably support human life.
","('Access_And_Affordability', 0.94179368019104)","('Human_Rights_And_Community_Relations', 0.005900823511183262)","('Product_Quality_And_Safety', 0.00522207235917449)","(['Health Outcome Contribution'], 0.94179368019104)","('NON-ESG', 0.005900823511183262)","('NON-ESG', 0.00522207235917449)"
Line 242,"•    C ontinued using the UN Economic Commission for Europe self-assessment tool  for “people first” public-private partnerships to help us evaluate our partnerships against key issues, such as access and equity, fiscal and environmental sustainability, replicability, and stakeholder engagement •   Engaged in par tnerships with nonprofits and governments via Medtronic  Foundation to improve lives for underserved and underrepresented populations worldwide and supported communities in which Medtronic employees live and give, including the investment of $16 million to address racial disparities and advance social justice in the United States •   C ontinued partnering with peers, innovators, healthcare systems, and others  globally to deliver solutions matched to local need and develop new approaches to increasing access to our treatments, for example, our affiliation with MedTech Color through which we foster racial and ethnic diversity in Medtronic clinical trials  2022 Integrated Performance Report Introduction 25 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Environmental  sustainability Staying true to our Mission to improve human welfare depends on a healthy environment  that can sustainably support human life.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9744802713394165)","('Human_Rights_And_Community_Relations', 0.0024598969612270594)","('Employee_Health_And_Safety', 0.0021904727909713984)","(['Human Capital Development'], 0.9744802713394165)","('NON-ESG', 0.0024598969612270594)","('NON-ESG', 0.0021904727909713984)"
Line 243,"•    C ontinued using the UN Economic Commission for Europe self-assessment tool  for “people first” public-private partnerships to help us evaluate our partnerships against key issues, such as access and equity, fiscal and environmental sustainability, replicability, and stakeholder engagement •   Engaged in par tnerships with nonprofits and governments via Medtronic  Foundation to improve lives for underserved and underrepresented populations worldwide and supported communities in which Medtronic employees live and give, including the investment of $16 million to address racial disparities and advance social justice in the United States •   C ontinued partnering with peers, innovators, healthcare systems, and others  globally to deliver solutions matched to local need and develop new approaches to increasing access to our treatments, for example, our affiliation with MedTech Color through which we foster racial and ethnic diversity in Medtronic clinical trials  2022 Integrated Performance Report Introduction 25 Environmental sustainability Social impact Governance and accountability ESG disclosure index  ESG strategy Environmental  sustainability Staying true to our Mission to improve human welfare depends on a healthy environment  that can sustainably support human life.
","('Human_Rights_And_Community_Relations', 0.5301712155342102)","('Management_Of_Legal_And_Regulatory_Framework', 0.099606454372406)","('Ecological_Impacts', 0.0707654282450676)","(['Community Relations'], 0.5301712155342102)","('NON-ESG', 0.099606454372406)","('NON-ESG', 0.0707654282450676)"
Line 244,"We are committed to doing our part to reduce our environmental impact by setting ambitious goals to achieve net zero emissions and minimize our natural resource consumption.
","('Ecological_Impacts', 0.5170890092849731)","('GHG_Emissions', 0.15613044798374176)","('Supply_Chain_Management', 0.12021102756261826)","(['Natural Capital'], 0.5170890092849731)","('NON-ESG', 0.15613044798374176)","('NON-ESG', 0.12021102756261826)"
Line 245,"Our facilities and sustainability programs streamline our operational resource use.
","('Supply_Chain_Management', 0.5267103314399719)","('Energy_Management', 0.06168564781546593)","('Product_Design_And_Lifecycle_Management', 0.050695981830358505)","(['Supply Chain Management'], 0.5267103314399719)","('NON-ESG', 0.06168564781546593)","('NON-ESG', 0.050695981830358505)"
Line 246,"Externally, we are working with our suppliers to help them measure and reduce their emissions.
","('GHG_Emissions', 0.6492186784744263)","('Supply_Chain_Management', 0.09949754923582077)","('Energy_Management', 0.0342327319085598)","(['Climate Change'], 0.6492186784744263)","('NON-ESG', 0.09949754923582077)","('NON-ESG', 0.0342327319085598)"
Line 247,"FY22 environmental sustainability highlights  Climate risk and resilience  28Reducing our operational footprint  30Product stewardship  2022 Integrated Performance Report Introduction 26 ESG strategy Social impact Governance and accountability ESG disclosure index  Environmental sustainability Net zero announced our ambition to balance our  greenhouse gas emissions produced and  removed from the atmosphere across  Scopes 1,2, and 3 by FY35 % reduction in our operational greenhouse gas  emissions intensity compared to our FY20  baseline, toward our goal of 50% by FY25  9% reduction in our energy intensity compared   to our FY20 baseline, toward our goal of   20% by FY25 14 % reduction in our water use intensity   compared to our FY20 baseline,   achieving our goal of 15% by FY25  15 % reduction in our waste intensity   compared to our FY20 baseline, nearing   our goal of 15% by FY25  16,500  MWh of energy and $2.9M in operating costs saved annually through energy efficiency projectsAssurance  completed by a third-party of our FY22 greenhouse gas and water data completed contracts for new renewable generation projects that will provide   an additional capacity of 56,700 MWh  per year 6M+ products taken back, diverting  more than 280 metric tons of   waste from landfillsScope 3  emissions management and tracking   by joining the CDP Supply Chain,   a consortium of global companies  aimed at helping quantify the   environmental footprint of suppliers Partnered with England’s National Health  Service and the U.S. National Academy  of Medicine to find ways to reduce the  healthcare industry’s carbon emissions Launched the Sustainability Development  Center to lead efforts to reduce waste and  eliminate targeted chemicals of concern in  product packagingFY22 highlightsENVIRONMENTAL SUSTAINABILITY 2022 Integrated Performance Report       27 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexClimate risk  and resilience Adding business value Understanding the potential impacts of climate change helps us  adapt as global circumstances evolve and prepare for possible business disruption, making us more resilient in the long term.
","('GHG_Emissions', 0.9625880122184753)","('Ecological_Impacts', 0.004744616337120533)","('Physical_Impacts_Of_Climate_Change', 0.003754077246412635)","(['Climate Change'], 0.9625880122184753)","('NON-ESG', 0.004744616337120533)","('NON-ESG', 0.003754077246412635)"
Line 248,"FY22 environmental sustainability highlights  Climate risk and resilience  28Reducing our operational footprint  30Product stewardship  2022 Integrated Performance Report Introduction 26 ESG strategy Social impact Governance and accountability ESG disclosure index  Environmental sustainability Net zero announced our ambition to balance our  greenhouse gas emissions produced and  removed from the atmosphere across  Scopes 1,2, and 3 by FY35 % reduction in our operational greenhouse gas  emissions intensity compared to our FY20  baseline, toward our goal of 50% by FY25  9% reduction in our energy intensity compared   to our FY20 baseline, toward our goal of   20% by FY25 14 % reduction in our water use intensity   compared to our FY20 baseline,   achieving our goal of 15% by FY25  15 % reduction in our waste intensity   compared to our FY20 baseline, nearing   our goal of 15% by FY25  16,500  MWh of energy and $2.9M in operating costs saved annually through energy efficiency projectsAssurance  completed by a third-party of our FY22 greenhouse gas and water data completed contracts for new renewable generation projects that will provide   an additional capacity of 56,700 MWh  per year 6M+ products taken back, diverting  more than 280 metric tons of   waste from landfillsScope 3  emissions management and tracking   by joining the CDP Supply Chain,   a consortium of global companies  aimed at helping quantify the   environmental footprint of suppliers Partnered with England’s National Health  Service and the U.S. National Academy  of Medicine to find ways to reduce the  healthcare industry’s carbon emissions Launched the Sustainability Development  Center to lead efforts to reduce waste and  eliminate targeted chemicals of concern in  product packagingFY22 highlightsENVIRONMENTAL SUSTAINABILITY 2022 Integrated Performance Report       27 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexClimate risk  and resilience Adding business value Understanding the potential impacts of climate change helps us  adapt as global circumstances evolve and prepare for possible business disruption, making us more resilient in the long term.
","('Energy_Management', 0.9798774123191833)","('Water_And_Wastewater_Management', 0.001904177712276578)","('Air_Quality', 0.0018807938322424889)","(['Operational Eco-Efficiency'], 0.9798774123191833)","('NON-ESG', 0.001904177712276578)","('NON-ESG', 0.0018807938322424889)"
Line 249,"FY22 environmental sustainability highlights  Climate risk and resilience  28Reducing our operational footprint  30Product stewardship  2022 Integrated Performance Report Introduction 26 ESG strategy Social impact Governance and accountability ESG disclosure index  Environmental sustainability Net zero announced our ambition to balance our  greenhouse gas emissions produced and  removed from the atmosphere across  Scopes 1,2, and 3 by FY35 % reduction in our operational greenhouse gas  emissions intensity compared to our FY20  baseline, toward our goal of 50% by FY25  9% reduction in our energy intensity compared   to our FY20 baseline, toward our goal of   20% by FY25 14 % reduction in our water use intensity   compared to our FY20 baseline,   achieving our goal of 15% by FY25  15 % reduction in our waste intensity   compared to our FY20 baseline, nearing   our goal of 15% by FY25  16,500  MWh of energy and $2.9M in operating costs saved annually through energy efficiency projectsAssurance  completed by a third-party of our FY22 greenhouse gas and water data completed contracts for new renewable generation projects that will provide   an additional capacity of 56,700 MWh  per year 6M+ products taken back, diverting  more than 280 metric tons of   waste from landfillsScope 3  emissions management and tracking   by joining the CDP Supply Chain,   a consortium of global companies  aimed at helping quantify the   environmental footprint of suppliers Partnered with England’s National Health  Service and the U.S. National Academy  of Medicine to find ways to reduce the  healthcare industry’s carbon emissions Launched the Sustainability Development  Center to lead efforts to reduce waste and  eliminate targeted chemicals of concern in  product packagingFY22 highlightsENVIRONMENTAL SUSTAINABILITY 2022 Integrated Performance Report       27 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexClimate risk  and resilience Adding business value Understanding the potential impacts of climate change helps us  adapt as global circumstances evolve and prepare for possible business disruption, making us more resilient in the long term.
","('GHG_Emissions', 0.6593741178512573)","('Supply_Chain_Management', 0.10740184783935547)","('Energy_Management', 0.03911752998828888)","(['Climate Change'], 0.6593741178512573)","('NON-ESG', 0.10740184783935547)","('NON-ESG', 0.03911752998828888)"
Line 250,"FY22 environmental sustainability highlights  Climate risk and resilience  28Reducing our operational footprint  30Product stewardship  2022 Integrated Performance Report Introduction 26 ESG strategy Social impact Governance and accountability ESG disclosure index  Environmental sustainability Net zero announced our ambition to balance our  greenhouse gas emissions produced and  removed from the atmosphere across  Scopes 1,2, and 3 by FY35 % reduction in our operational greenhouse gas  emissions intensity compared to our FY20  baseline, toward our goal of 50% by FY25  9% reduction in our energy intensity compared   to our FY20 baseline, toward our goal of   20% by FY25 14 % reduction in our water use intensity   compared to our FY20 baseline,   achieving our goal of 15% by FY25  15 % reduction in our waste intensity   compared to our FY20 baseline, nearing   our goal of 15% by FY25  16,500  MWh of energy and $2.9M in operating costs saved annually through energy efficiency projectsAssurance  completed by a third-party of our FY22 greenhouse gas and water data completed contracts for new renewable generation projects that will provide   an additional capacity of 56,700 MWh  per year 6M+ products taken back, diverting  more than 280 metric tons of   waste from landfillsScope 3  emissions management and tracking   by joining the CDP Supply Chain,   a consortium of global companies  aimed at helping quantify the   environmental footprint of suppliers Partnered with England’s National Health  Service and the U.S. National Academy  of Medicine to find ways to reduce the  healthcare industry’s carbon emissions Launched the Sustainability Development  Center to lead efforts to reduce waste and  eliminate targeted chemicals of concern in  product packagingFY22 highlightsENVIRONMENTAL SUSTAINABILITY 2022 Integrated Performance Report       27 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexClimate risk  and resilience Adding business value Understanding the potential impacts of climate change helps us  adapt as global circumstances evolve and prepare for possible business disruption, making us more resilient in the long term.
","('Product_Design_And_Lifecycle_Management', 0.9047178626060486)","('Supply_Chain_Management', 0.014982747845351696)","('Business_Model_Resilience', 0.011652179062366486)","(['Product Stewardship'], 0.9047178626060486)","('NON-ESG', 0.014982747845351696)","('NON-ESG', 0.011652179062366486)"
Line 251,"FY22 environmental sustainability highlights  Climate risk and resilience  28Reducing our operational footprint  30Product stewardship  2022 Integrated Performance Report Introduction 26 ESG strategy Social impact Governance and accountability ESG disclosure index  Environmental sustainability Net zero announced our ambition to balance our  greenhouse gas emissions produced and  removed from the atmosphere across  Scopes 1,2, and 3 by FY35 % reduction in our operational greenhouse gas  emissions intensity compared to our FY20  baseline, toward our goal of 50% by FY25  9% reduction in our energy intensity compared   to our FY20 baseline, toward our goal of   20% by FY25 14 % reduction in our water use intensity   compared to our FY20 baseline,   achieving our goal of 15% by FY25  15 % reduction in our waste intensity   compared to our FY20 baseline, nearing   our goal of 15% by FY25  16,500  MWh of energy and $2.9M in operating costs saved annually through energy efficiency projectsAssurance  completed by a third-party of our FY22 greenhouse gas and water data completed contracts for new renewable generation projects that will provide   an additional capacity of 56,700 MWh  per year 6M+ products taken back, diverting  more than 280 metric tons of   waste from landfillsScope 3  emissions management and tracking   by joining the CDP Supply Chain,   a consortium of global companies  aimed at helping quantify the   environmental footprint of suppliers Partnered with England’s National Health  Service and the U.S. National Academy  of Medicine to find ways to reduce the  healthcare industry’s carbon emissions Launched the Sustainability Development  Center to lead efforts to reduce waste and  eliminate targeted chemicals of concern in  product packagingFY22 highlightsENVIRONMENTAL SUSTAINABILITY 2022 Integrated Performance Report       27 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexClimate risk  and resilience Adding business value Understanding the potential impacts of climate change helps us  adapt as global circumstances evolve and prepare for possible business disruption, making us more resilient in the long term.
","('Physical_Impacts_Of_Climate_Change', 0.7800368666648865)","('Business_Model_Resilience', 0.1341325044631958)","('Supply_Chain_Management', 0.010137627832591534)","(['Climate Change'], 0.7800368666648865)","('NON-ESG', 0.1341325044631958)","('NON-ESG', 0.010137627832591534)"
Line 252,"At the same time, we are committed to doing our part to combat climate change.
","('Physical_Impacts_Of_Climate_Change', 0.9524920582771301)","('Business_Model_Resilience', 0.008506013080477715)","('GHG_Emissions', 0.005224925000220537)","(['Climate Change'], 0.9524920582771301)","('NON-ESG', 0.008506013080477715)","('NON-ESG', 0.005224925000220537)"
Line 253,"We are working to reduce emissions and have set an ambition to be net zero by FY45.
","('GHG_Emissions', 0.7529341578483582)","('Air_Quality', 0.15287461876869202)","('Energy_Management', 0.01800820231437683)","(['Climate Change'], 0.7529341578483582)","('NON-ESG', 0.15287461876869202)","('NON-ESG', 0.01800820231437683)"
Line 254,"Through identifying the most efficient roadmap to net zero, we can reduce the cost of this transition to our business while continuing to develop life-saving technologies.ENVIRONMENTAL SUSTAINABILITY Image taken by Andrew Juelich in Torres Del Paine, Chile.
","('Product_Design_And_Lifecycle_Management', 0.5356271862983704)","('Energy_Management', 0.1883472204208374)","('Supply_Chain_Management', 0.07020696997642517)","(['Product Stewardship'], 0.5356271862983704)","('NON-ESG', 0.1883472204208374)","('NON-ESG', 0.07020696997642517)"
Line 255,"Andrew is an EHS Specialist at  Medtronic and winner of our Environmental Action Group Earth Week photo contest.
","('Human_Rights_And_Community_Relations', 0.6109452843666077)","('Ecological_Impacts', 0.03963175043463707)","('Physical_Impacts_Of_Climate_Change', 0.03948282450437546)","(['Community Relations'], 0.6109452843666077)","('NON-ESG', 0.03963175043463707)","('NON-ESG', 0.03948282450437546)"
Line 256,"Medtronic serves over 150 countries around the  world, addressing pervasive health problems with our innovative technologies.
","('Employee_Health_And_Safety', 0.761947512626648)","('Access_And_Affordability', 0.04641774669289589)","('Product_Quality_And_Safety', 0.03598051890730858)","(['Operational Eco-Efficiency'], 0.761947512626648)","('NON-ESG', 0.04641774669289589)","('NON-ESG', 0.03598051890730858)"
Line 257,"The acceleration of climate change poses serious threats to communities worldwide and exacerbates poor health outcomes.
","('Physical_Impacts_Of_Climate_Change', 0.9394250512123108)","('Critical_Incident_Risk_Management', 0.01170167326927185)","('Business_Model_Resilience', 0.006688862107694149)","(['Climate Change'], 0.9394250512123108)","('NON-ESG', 0.01170167326927185)","('NON-ESG', 0.006688862107694149)"
Line 258,"These include disease, migration, and food scarcity caused by more extreme droughts, floods, storms, and fires.
","('Supply_Chain_Management', 0.6073461771011353)","('Physical_Impacts_Of_Climate_Change', 0.12813158333301544)","('Water_And_Wastewater_Management', 0.033357180655002594)","(['Supply Chain Management'], 0.6073461771011353)","('NON-ESG', 0.12813158333301544)","('NON-ESG', 0.033357180655002594)"
Line 259,"In its most recent Global Risks Report, the World Economic Forum found that “climate action failure” ranked as the most severe global risk throughout the next 10 years.
","('Physical_Impacts_Of_Climate_Change', 0.8644242286682129)","('Systemic_Risk_Management', 0.048287853598594666)","('Business_Model_Resilience', 0.025798363611102104)","(['Climate Change'], 0.8644242286682129)","('NON-ESG', 0.048287853598594666)","('NON-ESG', 0.025798363611102104)"
Line 260,"To reduce our environmental footprint and  mitigate these risks to our business, we adopted an enterprise strategy to drive coordinated action across the company to help address climate change.
","('Physical_Impacts_Of_Climate_Change', 0.950309157371521)","('Business_Model_Resilience', 0.010800573043525219)","('Supply_Chain_Management', 0.004682860802859068)","(['Climate Change'], 0.950309157371521)","('NON-ESG', 0.010800573043525219)","('NON-ESG', 0.004682860802859068)"
Line 261,"2022 Integrated Performance Report       28 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexAs a global healthcare technology leader committed  to delivering better outcomes for patients around the world, we are mindful of how climate change can affect our business, the healthcare industry, and the millions of patients we serve, both today and in the future.
","('Physical_Impacts_Of_Climate_Change', 0.9515388011932373)","('Business_Model_Resilience', 0.008843698538839817)","('Supply_Chain_Management', 0.004292953759431839)","(['Climate Change'], 0.9515388011932373)","('NON-ESG', 0.008843698538839817)","('NON-ESG', 0.004292953759431839)"
Line 262,"Limiting our impact on the environment is a priority.
","('Ecological_Impacts', 0.7062006592750549)","('GHG_Emissions', 0.08992049843072891)","('Physical_Impacts_Of_Climate_Change', 0.036332353949546814)","(['Natural Capital'], 0.7062006592750549)","('NON-ESG', 0.08992049843072891)","('NON-ESG', 0.036332353949546814)"
Line 263,"In FY22, we announced our ambition to achieve net  zero emissions across Scopes 1, 2, and 3 by FY45.
","('GHG_Emissions', 0.6853045225143433)","('Air_Quality', 0.20711664855480194)","('Energy_Management', 0.026965338736772537)","(['Climate Change'], 0.6853045225143433)","('NON-ESG', 0.20711664855480194)","('NON-ESG', 0.026965338736772537)"
Line 264,"This decision was driven, in part, by our partnerships with England’s National Health Service and the U.S. National Academy of Medicine to help reduce the healthcare industry’s impact on the environment.
","('Supply_Chain_Management', 0.27717095613479614)","('Systemic_Risk_Management', 0.27484697103500366)","('Physical_Impacts_Of_Climate_Change', 0.08856639266014099)","('NON-ESG', 0.27717095613479614)","('NON-ESG', 0.27484697103500366)","('NON-ESG', 0.08856639266014099)"
Line 265,"To achieve this ambition, we created a Decarbonization Roadmap that outlines our focus areas — operations, supply chain, and logistics — where we intend to set reduction targets through the Science-Based Targets initiative (SBTi).
","('Supply_Chain_Management', 0.952573835849762)","('Business_Model_Resilience', 0.003967429976910353)","('Product_Design_And_Lifecycle_Management', 0.0037392403464764357)","(['Supply Chain Management'], 0.952573835849762)","('NON-ESG', 0.003967429976910353)","('NON-ESG', 0.0037392403464764357)"
Line 266,"Read more about the roadmap and the steps we are taking to reduce our emissions on page 31.
","('GHG_Emissions', 0.536227285861969)","('Air_Quality', 0.26779988408088684)","('Energy_Management', 0.05205604061484337)","(['Climate Change'], 0.536227285861969)","('NON-ESG', 0.26779988408088684)","('NON-ESG', 0.05205604061484337)"
Line 267,"To learn more about our climate-related risks and  opportunities, read our FY22 Task Force on Climate-Related Financial Disclosures (TCFD) report, 2022 CDP Climate disclosure, and Corporate Climate Change Statement.CLIMATE RISK AND RESILIENCE Leading for a greener healthcare industry Globally, the healthcare industry is responsible for 4.5% of carbon emissions, and that percentage  jumps to 8.5% in the United States.
","('Physical_Impacts_Of_Climate_Change', 0.9460832476615906)","('Business_Model_Resilience', 0.012897142209112644)","('GHG_Emissions', 0.005655333865433931)","(['Climate Change'], 0.9460832476615906)","('NON-ESG', 0.012897142209112644)","('NON-ESG', 0.005655333865433931)"
Line 268,"Recognizing the need to be part of a collaborative solution, Medtronic partnered with England’s National Health Service (NHS) and the U.S. National Academy of Medicine (NAM) in FY22 on initiatives to reduce carbon emissions in the healthcare industry.
","('GHG_Emissions', 0.83852219581604)","('Air_Quality', 0.05038931965827942)","('Physical_Impacts_Of_Climate_Change', 0.026139024645090103)","(['Climate Change'], 0.83852219581604)","('NON-ESG', 0.05038931965827942)","('NON-ESG', 0.026139024645090103)"
Line 269,"Through our memberships in the International Leadership Group for a Net Zero NHS and the NAM Action Collaborative to Decarbonize the U.S. Health Sector, we are actively fostering climate ambitions and sharing learnings that drive broader greenhouse gas emissions reductions.
","('GHG_Emissions', 0.9644361734390259)","('Physical_Impacts_Of_Climate_Change', 0.004897004924714565)","('Ecological_Impacts', 0.003747696755453944)","(['Climate Change'], 0.9644361734390259)","('NON-ESG', 0.004897004924714565)","('NON-ESG', 0.003747696755453944)"
Line 270,"Net zero In FY22, we announced our  ambition to achieve net zero  emissions across Scopes 1,2,  and 3 by FY45.
","('GHG_Emissions', 0.6031954288482666)","('Air_Quality', 0.28484755754470825)","('Energy_Management', 0.030227020382881165)","(['Climate Change'], 0.6031954288482666)","('NON-ESG', 0.28484755754470825)","('NON-ESG', 0.030227020382881165)"
Line 271,"Lord Prior (left) and Geoff Martha,   Medtronic Chairman and CEO (right) 2022 Integrated Performance Report       29 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index35 % reduction in operational greenhouse   gas (GHG) emissions intensity   compared to our FY20 baseline,   toward our goal of 50% by FY9% reduction in energy intensity   compared to our FY20 baseline,   toward our goal of 20% by FY2514 % reduction in water use intensity   compared to our FY20 baseline, nearly  achieving our goal of 15% by FY16,500  MWh of energy saved per year   through our energy reduction   efforts, reducing our annual  operating costs by $2.9M Reducing our  operational footprintAdding business value Proactively managing our carbon footprint  and natural resource use enables us to manufacture products more efficiently; increase the resiliency of our supply chain; and meet the expectations of our global stakeholders on environmental issues.ENVIRONMENTAL SUSTAINABILITY We are committed to implementing policies  and responsible practices to minimize operational impacts on the environment and play our part in safeguarding the planet.
","('GHG_Emissions', 0.9690886735916138)","('Ecological_Impacts', 0.004260160960257053)","('Physical_Impacts_Of_Climate_Change', 0.002783874748274684)","(['Climate Change'], 0.9690886735916138)","('NON-ESG', 0.004260160960257053)","('NON-ESG', 0.002783874748274684)"
Line 272,"Lord Prior (left) and Geoff Martha,   Medtronic Chairman and CEO (right) 2022 Integrated Performance Report       29 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index35 % reduction in operational greenhouse   gas (GHG) emissions intensity   compared to our FY20 baseline,   toward our goal of 50% by FY9% reduction in energy intensity   compared to our FY20 baseline,   toward our goal of 20% by FY2514 % reduction in water use intensity   compared to our FY20 baseline, nearly  achieving our goal of 15% by FY16,500  MWh of energy saved per year   through our energy reduction   efforts, reducing our annual  operating costs by $2.9M Reducing our  operational footprintAdding business value Proactively managing our carbon footprint  and natural resource use enables us to manufacture products more efficiently; increase the resiliency of our supply chain; and meet the expectations of our global stakeholders on environmental issues.ENVIRONMENTAL SUSTAINABILITY We are committed to implementing policies  and responsible practices to minimize operational impacts on the environment and play our part in safeguarding the planet.
","('Product_Design_And_Lifecycle_Management', 0.5079200267791748)","('Supply_Chain_Management', 0.2249603271484375)","('Energy_Management', 0.11734435707330704)","(['Product Stewardship'], 0.5079200267791748)","('NON-ESG', 0.2249603271484375)","('NON-ESG', 0.11734435707330704)"
Line 273,"Lord Prior (left) and Geoff Martha,   Medtronic Chairman and CEO (right) 2022 Integrated Performance Report       29 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index35 % reduction in operational greenhouse   gas (GHG) emissions intensity   compared to our FY20 baseline,   toward our goal of 50% by FY9% reduction in energy intensity   compared to our FY20 baseline,   toward our goal of 20% by FY2514 % reduction in water use intensity   compared to our FY20 baseline, nearly  achieving our goal of 15% by FY16,500  MWh of energy saved per year   through our energy reduction   efforts, reducing our annual  operating costs by $2.9M Reducing our  operational footprintAdding business value Proactively managing our carbon footprint  and natural resource use enables us to manufacture products more efficiently; increase the resiliency of our supply chain; and meet the expectations of our global stakeholders on environmental issues.ENVIRONMENTAL SUSTAINABILITY We are committed to implementing policies  and responsible practices to minimize operational impacts on the environment and play our part in safeguarding the planet.
","('Ecological_Impacts', 0.9528392553329468)","('GHG_Emissions', 0.008397084660828114)","('Human_Rights_And_Community_Relations', 0.005992395803332329)","(['Natural Capital'], 0.9528392553329468)","('NON-ESG', 0.008397084660828114)","('NON-ESG', 0.005992395803332329)"
Line 274,"Guided by our Environmental Health and Safety (EHS) Policy and EHS management system, our Global EHS and Energy teams lead our coordinated enterprise strategy focused on using resources responsibly and reducing the energy, emissions, water, and waste footprints of our operations.
","('Waste_And_Hazardous_Materials_Management', 0.9573761224746704)","('Water_And_Wastewater_Management', 0.0075805531814694405)","('Employee_Health_And_Safety', 0.0056036957539618015)","(['Operational Eco-Efficiency'], 0.9573761224746704)","('NON-ESG', 0.0075805531814694405)","('NON-ESG', 0.0056036957539618015)"
Line 275,"2022 Integrated Performance Report       30 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexPROGRESS TOWARD OUR GOALS  (Compared to FY20 baseline†)  FY22   progressFY25  goal Reduction in GHG  emissions intensity‡ 35% 50% Reduction in  energy intensity9% 20% Energy sourced from renewable and alternative sources 16% 50% Reduction in  waste intensity15% 15% Reduction in water usage intensity14% 15% †   FY20 baselines ar e: GHG emissions intensity 10.67 metric tons CO 2e/$ million  revenues; energy use intensity 29.43 MWh/$ million revenues; energy sourced from  renewable and alternative sources 121 MWh/14% (excluding RECs/offsets); total waste intensity 1,170 metric tons/$ billion revenues; and water use intensity 65 cubic meters/$ million revenues.
","('GHG_Emissions', 0.967891275882721)","('Air_Quality', 0.004619239829480648)","('Ecological_Impacts', 0.003144376678392291)","(['Climate Change'], 0.967891275882721)","('NON-ESG', 0.004619239829480648)","('NON-ESG', 0.003144376678392291)"
Line 276,"2022 Integrated Performance Report       30 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexPROGRESS TOWARD OUR GOALS  (Compared to FY20 baseline†)  FY22   progressFY25  goal Reduction in GHG  emissions intensity‡ 35% 50% Reduction in  energy intensity9% 20% Energy sourced from renewable and alternative sources 16% 50% Reduction in  waste intensity15% 15% Reduction in water usage intensity14% 15% †   FY20 baselines ar e: GHG emissions intensity 10.67 metric tons CO 2e/$ million  revenues; energy use intensity 29.43 MWh/$ million revenues; energy sourced from  renewable and alternative sources 121 MWh/14% (excluding RECs/offsets); total waste intensity 1,170 metric tons/$ billion revenues; and water use intensity 65 cubic meters/$ million revenues.
","('Water_And_Wastewater_Management', 0.5264304876327515)","('Energy_Management', 0.3339337110519409)","('Waste_And_Hazardous_Materials_Management', 0.025809520855545998)","(['Operational Eco-Efficiency'], 0.5264304876327515)","('NON-ESG', 0.3339337110519409)","('NON-ESG', 0.025809520855545998)"
Line 277,"‡  T he percent reduction includes actual reductions and purchased credits, normalized  by revenue.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5089063048362732)","('Energy_Management', 0.17916914820671082)","('Competitive_Behavior', 0.0531061515212059)","(['Corporate Governance'], 0.5089063048362732)","('NON-ESG', 0.17916914820671082)","('NON-ESG', 0.0531061515212059)"
Line 278,"Note: In FY22, we adjusted our FY20 GHG baseline from 9.60 metric tons CO 2e/$  million to 10.67 metric tons CO 2e/$ million to reflect the corrections found during our  program assessment and assurance review.
","('GHG_Emissions', 0.964516818523407)","('Air_Quality', 0.0053638587705791)","('Water_And_Wastewater_Management', 0.003447870025411248)","(['Climate Change'], 0.964516818523407)","('NON-ESG', 0.0053638587705791)","('NON-ESG', 0.003447870025411248)"
Line 279,"Our FY22 data was assured by ERM CVS.REDUCING OUR OPERATIONAL FOOTPRINT Environmental goals We continue to pursue our FY25 performance goals  to reduce our environmental footprint.
","('Business_Model_Resilience', 0.6431362628936768)","('Physical_Impacts_Of_Climate_Change', 0.06870423257350922)","('Supply_Chain_Management', 0.06459785997867584)","(['Codes of Business Conduct'], 0.6431362628936768)","('NON-ESG', 0.06870423257350922)","('NON-ESG', 0.06459785997867584)"
Line 280,"Our goals are focused on the areas of GHG emissions, energy, water, and waste intensities – measured against an FY20 baseline.
","('GHG_Emissions', 0.967630922794342)","('Ecological_Impacts', 0.0034967779647558928)","('Physical_Impacts_Of_Climate_Change', 0.003445184789597988)","(['Climate Change'], 0.967630922794342)","('NON-ESG', 0.0034967779647558928)","('NON-ESG', 0.003445184789597988)"
Line 281,"Curbing emissions and energy use Net zero and decarbonization  In FY22, we announced our ambition to achieve net  zero GHG emissions across our value chain by FY45.
","('GHG_Emissions', 0.965272843837738)","('Air_Quality', 0.0070071155205369)","('Energy_Management', 0.0027292475569993258)","(['Climate Change'], 0.965272843837738)","('NON-ESG', 0.0070071155205369)","('NON-ESG', 0.0027292475569993258)"
Line 282,"This aspiration builds on the goals we set in FY20 to be carbon neutral in our owned and operated facilities by FY30.
","('Management_Of_Legal_And_Regulatory_Framework', 0.269732803106308)","('GHG_Emissions', 0.16676059365272522)","('Energy_Management', 0.12743109464645386)","('NON-ESG', 0.269732803106308)","('NON-ESG', 0.16676059365272522)","('NON-ESG', 0.12743109464645386)"
Line 283,"Our FY30 carbon neutral goal covers our Scope 1 emissions (facility and fleet fuel use) and Scope 2 emissions (operational electricity consumption), while our FY45 net zero ambition includes the Scope 1 and 2 emissions plus the Scope 3 emissions generated by activities outside our direct control that are related  to our business.
","('Air_Quality', 0.4525182247161865)","('GHG_Emissions', 0.44284936785697937)","('Energy_Management', 0.023610007017850876)","('NON-ESG', 0.4525182247161865)","('NON-ESG', 0.44284936785697937)","('NON-ESG', 0.023610007017850876)"
Line 284,"A coordinated enterprise strategy to meet our net  zero ambition is in development, guided by our Decarbonization Roadmap.
","('Business_Model_Resilience', 0.614591658115387)","('Systemic_Risk_Management', 0.141100212931633)","('Supply_Chain_Management', 0.032788895070552826)","(['Codes of Business Conduct'], 0.614591658115387)","('NON-ESG', 0.141100212931633)","('NON-ESG', 0.032788895070552826)"
Line 285,"Established in FY22, this roadmap aims to reduce emissions across our value chain through three focus areas: 1.
","('GHG_Emissions', 0.6030703186988831)","('Energy_Management', 0.11287464201450348)","('Air_Quality', 0.09933709353208542)","(['Climate Change'], 0.6030703186988831)","('NON-ESG', 0.11287464201450348)","('NON-ESG', 0.09933709353208542)"
Line 286,"Oper ational carbon neutrality by FY30 – we plan   to neutralize our Scope 1 and 2 emissions by  increasing energy efficiency and transitioning to cleaner electricity.
","('Energy_Management', 0.6100278496742249)","('GHG_Emissions', 0.1897655725479126)","('Management_Of_Legal_And_Regulatory_Framework', 0.056993965059518814)","(['Operational Eco-Efficiency'], 0.6100278496742249)","('NON-ESG', 0.1897655725479126)","('NON-ESG', 0.056993965059518814)"
Line 287,"2.
","('Competitive_Behavior', 0.15795664489269257)","('Customer_Welfare', 0.10852150619029999)","('Energy_Management', 0.08616163581609726)","('NON-ESG', 0.15795664489269257)","('NON-ESG', 0.10852150619029999)","('NON-ESG', 0.08616163581609726)"
Line 288,"Supply chain GHG emissions r eduction – we will  reduce our Scope 3 emissions by establishing science-based targets, adjusting purchasing criteria, collaborating with suppliers through CDP Supply Chain, and more.
","('GHG_Emissions', 0.6838593482971191)","('Supply_Chain_Management', 0.1521536409854889)","('Energy_Management', 0.021206021308898926)","(['Climate Change'], 0.6838593482971191)","('NON-ESG', 0.1521536409854889)","('NON-ESG', 0.021206021308898926)"
Line 289,"3.
","('Competitive_Behavior', 0.1465800553560257)","('Customer_Welfare', 0.10041514039039612)","('Product_Design_And_Lifecycle_Management', 0.07025990635156631)","('NON-ESG', 0.1465800553560257)","('NON-ESG', 0.10041514039039612)","('NON-ESG', 0.07025990635156631)"
Line 290,"Ongoing logistics impr ovements – we will reduce our  Scope 3 emissions through innovation in packaging, shipping, fuels, and vehicles and by working with aligned carriers.
","('Energy_Management', 0.5959718227386475)","('Product_Design_And_Lifecycle_Management', 0.10988400876522064)","('GHG_Emissions', 0.05962159484624863)","(['Operational Eco-Efficiency'], 0.5959718227386475)","('NON-ESG', 0.10988400876522064)","('NON-ESG', 0.05962159484624863)"
Line 291,"2022 Integrated Performance Report       31 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index SCOPE 1, 2, AND 3 EMISSIONS l  Scope 1    All dir ect GHG emissions from  fuels and refrigerants l  Scope 2    Indir ect GHG emissions from  consumption of purchased  electricity, heat, or steam   Sour ce: Greenhouse Gas   (GHG) Protocoll  Scope 3    Other indir ect emissions, such  as the extraction and production of purchased materials and fuels, procured transport-related services, electricity-related activities (e.g., T&D losses) that are not covered in Scope 2, outsourced activities, waste disposal, etc.electricity,  steam,  heating and  cooling for  own usecompany facilities company  vehicles Upstream activities Reporting company Downstream activitiespurchased  goods  and servicesfuel and energy relatedtransportation and  distributionwaste from operationsbusiness travelemployee commutingleased assetsScope indirectScope indirectScope directCH 2N2O SF 6PFCsHFCs CO 2Scope indirect capital goodsprocessing of sold productstransportation and  distribution use of sold productsend-of-life treatment of sold productsleased assetsfranchises investmentsl Energy efficiency l On-site renewables l  Electric utility renewables l  e-green certified credit (electric) l Carbon offset (fuel) l Virtual power-purchase agreements l Fossil fuel energyFY25100% 80% 60% 40% 20% 0% FY20Percent of our total energy use FY21 FY22 FY23 FY24 FY26 FY27 FY28 FY29 FY30REDUCING OUR OPERATIONAL FOOTPRINT GHG emissions Our combined Scope 1 and 2 GHG for FY22 were  approximately 285,000 MT CO2e — a nearly 5% absolute  decrease from last year and approximately a 10% decrease in intensity over the same period.
","('GHG_Emissions', 0.9707382917404175)","('Ecological_Impacts', 0.003672304330393672)","('Air_Quality', 0.0032650267239660025)","(['Climate Change'], 0.9707382917404175)","('NON-ESG', 0.003672304330393672)","('NON-ESG', 0.0032650267239660025)"
Line 292,"2022 Integrated Performance Report       31 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index SCOPE 1, 2, AND 3 EMISSIONS l  Scope 1    All dir ect GHG emissions from  fuels and refrigerants l  Scope 2    Indir ect GHG emissions from  consumption of purchased  electricity, heat, or steam   Sour ce: Greenhouse Gas   (GHG) Protocoll  Scope 3    Other indir ect emissions, such  as the extraction and production of purchased materials and fuels, procured transport-related services, electricity-related activities (e.g., T&D losses) that are not covered in Scope 2, outsourced activities, waste disposal, etc.electricity,  steam,  heating and  cooling for  own usecompany facilities company  vehicles Upstream activities Reporting company Downstream activitiespurchased  goods  and servicesfuel and energy relatedtransportation and  distributionwaste from operationsbusiness travelemployee commutingleased assetsScope indirectScope indirectScope directCH 2N2O SF 6PFCsHFCs CO 2Scope indirect capital goodsprocessing of sold productstransportation and  distribution use of sold productsend-of-life treatment of sold productsleased assetsfranchises investmentsl Energy efficiency l On-site renewables l  Electric utility renewables l  e-green certified credit (electric) l Carbon offset (fuel) l Virtual power-purchase agreements l Fossil fuel energyFY25100% 80% 60% 40% 20% 0% FY20Percent of our total energy use FY21 FY22 FY23 FY24 FY26 FY27 FY28 FY29 FY30REDUCING OUR OPERATIONAL FOOTPRINT GHG emissions Our combined Scope 1 and 2 GHG for FY22 were  approximately 285,000 MT CO2e — a nearly 5% absolute  decrease from last year and approximately a 10% decrease in intensity over the same period.
","('Waste_And_Hazardous_Materials_Management', 0.7040879726409912)","('Energy_Management', 0.14189767837524414)","('Water_And_Wastewater_Management', 0.030020855367183685)","(['Operational Eco-Efficiency'], 0.7040879726409912)","('NON-ESG', 0.14189767837524414)","('NON-ESG', 0.030020855367183685)"
Line 293,"2022 Integrated Performance Report       31 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index SCOPE 1, 2, AND 3 EMISSIONS l  Scope 1    All dir ect GHG emissions from  fuels and refrigerants l  Scope 2    Indir ect GHG emissions from  consumption of purchased  electricity, heat, or steam   Sour ce: Greenhouse Gas   (GHG) Protocoll  Scope 3    Other indir ect emissions, such  as the extraction and production of purchased materials and fuels, procured transport-related services, electricity-related activities (e.g., T&D losses) that are not covered in Scope 2, outsourced activities, waste disposal, etc.electricity,  steam,  heating and  cooling for  own usecompany facilities company  vehicles Upstream activities Reporting company Downstream activitiespurchased  goods  and servicesfuel and energy relatedtransportation and  distributionwaste from operationsbusiness travelemployee commutingleased assetsScope indirectScope indirectScope directCH 2N2O SF 6PFCsHFCs CO 2Scope indirect capital goodsprocessing of sold productstransportation and  distribution use of sold productsend-of-life treatment of sold productsleased assetsfranchises investmentsl Energy efficiency l On-site renewables l  Electric utility renewables l  e-green certified credit (electric) l Carbon offset (fuel) l Virtual power-purchase agreements l Fossil fuel energyFY25100% 80% 60% 40% 20% 0% FY20Percent of our total energy use FY21 FY22 FY23 FY24 FY26 FY27 FY28 FY29 FY30REDUCING OUR OPERATIONAL FOOTPRINT GHG emissions Our combined Scope 1 and 2 GHG for FY22 were  approximately 285,000 MT CO2e — a nearly 5% absolute  decrease from last year and approximately a 10% decrease in intensity over the same period.
","('Energy_Management', 0.873883068561554)","('Product_Design_And_Lifecycle_Management', 0.06638015061616898)","('Customer_Welfare', 0.005296945106238127)","(['Operational Eco-Efficiency'], 0.873883068561554)","('NON-ESG', 0.06638015061616898)","('NON-ESG', 0.005296945106238127)"
Line 294,"2022 Integrated Performance Report       31 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index SCOPE 1, 2, AND 3 EMISSIONS l  Scope 1    All dir ect GHG emissions from  fuels and refrigerants l  Scope 2    Indir ect GHG emissions from  consumption of purchased  electricity, heat, or steam   Sour ce: Greenhouse Gas   (GHG) Protocoll  Scope 3    Other indir ect emissions, such  as the extraction and production of purchased materials and fuels, procured transport-related services, electricity-related activities (e.g., T&D losses) that are not covered in Scope 2, outsourced activities, waste disposal, etc.electricity,  steam,  heating and  cooling for  own usecompany facilities company  vehicles Upstream activities Reporting company Downstream activitiespurchased  goods  and servicesfuel and energy relatedtransportation and  distributionwaste from operationsbusiness travelemployee commutingleased assetsScope indirectScope indirectScope directCH 2N2O SF 6PFCsHFCs CO 2Scope indirect capital goodsprocessing of sold productstransportation and  distribution use of sold productsend-of-life treatment of sold productsleased assetsfranchises investmentsl Energy efficiency l On-site renewables l  Electric utility renewables l  e-green certified credit (electric) l Carbon offset (fuel) l Virtual power-purchase agreements l Fossil fuel energyFY25100% 80% 60% 40% 20% 0% FY20Percent of our total energy use FY21 FY22 FY23 FY24 FY26 FY27 FY28 FY29 FY30REDUCING OUR OPERATIONAL FOOTPRINT GHG emissions Our combined Scope 1 and 2 GHG for FY22 were  approximately 285,000 MT CO2e — a nearly 5% absolute  decrease from last year and approximately a 10% decrease in intensity over the same period.
","('GHG_Emissions', 0.9672631621360779)","('Air_Quality', 0.004825649783015251)","('Ecological_Impacts', 0.003376319771632552)","(['Climate Change'], 0.9672631621360779)","('NON-ESG', 0.004825649783015251)","('NON-ESG', 0.003376319771632552)"
Line 295,"FY22 is the first year our emissions data has been externally assured by ERM CVS.
","('Air_Quality', 0.8135212659835815)","('GHG_Emissions', 0.10908081382513046)","('Energy_Management', 0.011999902315437794)","(['Operational Eco-Efficiency'], 0.8135212659835815)","('NON-ESG', 0.10908081382513046)","('NON-ESG', 0.011999902315437794)"
Line 296,"Supply chain In FY22, we became members of CDP Supply Chain, a consortium of more than 280 global companies, representing a combined spend of $6.4 trillion, working to help 40,000 suppliers quantify their GHG emissions.
","('GHG_Emissions', 0.6525247693061829)","('Supply_Chain_Management', 0.18001964688301086)","('Physical_Impacts_Of_Climate_Change', 0.02289816178381443)","(['Climate Change'], 0.6525247693061829)","('NON-ESG', 0.18001964688301086)","('NON-ESG', 0.02289816178381443)"
Line 297,"We asked our top 101 suppliers by managed spend to measure and disclose their GHG emissions through CDP , with support from CDP and Medtronic.
","('GHG_Emissions', 0.9681503176689148)","('Air_Quality', 0.003926310688257217)","('Ecological_Impacts', 0.0034260395914316177)","(['Climate Change'], 0.9681503176689148)","('NON-ESG', 0.003926310688257217)","('NON-ESG', 0.0034260395914316177)"
Line 298,"The CDP membership will help us better understand our Scope 3 emissions related to our suppliers and inform the development of our science-based targets.
","('GHG_Emissions', 0.8085221648216248)","('Management_Of_Legal_And_Regulatory_Framework', 0.03464680165052414)","('Energy_Management', 0.02059667743742466)","(['Climate Change'], 0.8085221648216248)","('NON-ESG', 0.03464680165052414)","('NON-ESG', 0.02059667743742466)"
Line 299,"The  process will also help suppliers identify climate risks  and opportunities to reduce their climate impact.
","('Physical_Impacts_Of_Climate_Change', 0.9242478013038635)","('Supply_Chain_Management', 0.01248343288898468)","('Business_Model_Resilience', 0.012040268629789352)","(['Climate Change'], 0.9242478013038635)","('NON-ESG', 0.01248343288898468)","('NON-ESG', 0.012040268629789352)"
Line 300,"More broadly, it will improve supply chain transparency and encourage broader GHG emissions disclosure  and reduction.
","('GHG_Emissions', 0.9470170736312866)","('Physical_Impacts_Of_Climate_Change', 0.005782532040029764)","('Supply_Chain_Management', 0.005154379177838564)","(['Climate Change'], 0.9470170736312866)","('NON-ESG', 0.005782532040029764)","('NON-ESG', 0.005154379177838564)"
Line 301,"In early FY23, we held training webinars to support  suppliers as they began the CDP disclosure process.
","('Supply_Chain_Management', 0.9104931950569153)","('Product_Design_And_Lifecycle_Management', 0.0077233645133674145)","('GHG_Emissions', 0.007394372019916773)","(['Supply Chain Management'], 0.9104931950569153)","('NON-ESG', 0.0077233645133674145)","('NON-ESG', 0.007394372019916773)"
Line 302,"The next steps in the process include calculating and disclosing emissions, setting reduction targets, and facilitating collaboration between suppliers and customers to reduce emissions.
","('GHG_Emissions', 0.7562448978424072)","('Air_Quality', 0.10298878699541092)","('Management_Of_Legal_And_Regulatory_Framework', 0.026990815997123718)","(['Climate Change'], 0.7562448978424072)","('NON-ESG', 0.10298878699541092)","('NON-ESG', 0.026990815997123718)"
Line 303,"We look forward to sharing more about this initiative as it develops.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4060693085193634)","('Human_Rights_And_Community_Relations', 0.2485656440258026)","('Access_And_Affordability', 0.06574206054210663)","('NON-ESG', 0.4060693085193634)","('NON-ESG', 0.2485656440258026)","('NON-ESG', 0.06574206054210663)"
Line 304,"To learn more about how we assess the environmental footprint of our suppliers, read Supply chain responsibility.GHG emissions   (absolute)† MT CO 2e (thousands) l  Scope 1   (natural gas, fuels, refrigerants)‡  l  Scope 2  (electricity, district cooling)299.284.7308.FY20 FY21 FY2292.94.989.206.9189.8218.79.9.010.FY20 FY21 FY223.3.03.6.96.07.†  Totals may not add up due to rounding.
","('GHG_Emissions', 0.9402072429656982)","('Supply_Chain_Management', 0.007587520871311426)","('Physical_Impacts_Of_Climate_Change', 0.007086904253810644)","(['Climate Change'], 0.9402072429656982)","('NON-ESG', 0.007587520871311426)","('NON-ESG', 0.007086904253810644)"
Line 305,"FY22 data has been externally assured by ERM CVS.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3959571421146393)","('Customer_Privacy', 0.1155584529042244)","('Data_Security', 0.10269549489021301)","('NON-ESG', 0.3959571421146393)","('NON-ESG', 0.1155584529042244)","('NON-ESG', 0.10269549489021301)"
Line 306,"‡  FY20 and FY21 da ta has been recast due  to improvements in how we track and calculate our GHG emissions.35 % reduction in GHG emissions   intensity compared to   our FY20 baselineGHG emissions   (intensity)† MT CO 2e/$ million revenue 2022 Integrated Performance Report       32 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index OUR PATH TO CARBON NEUTRALITYENERGY CONSERVATION  FY20 FY21 FYEnergy conservation projects (#) 79 82 Energy conservation savings (MWh/year) 20,920 18,450 16,500  GHG emissions avoided (MT) 14,791 12,657  11,Savings from energy rebates ($ million) 1.1 0.9 0.Operating cost savings ($ million) 2.8 2.2  2.9 Medtronic Switzerland  turns water into energy Our facility in Tolochenaz, Switzerland,  completed and launched its aquathermal energy project in FY22.
","('GHG_Emissions', 0.9694455862045288)","('Air_Quality', 0.0043493942357599735)","('Ecological_Impacts', 0.003123634262010455)","(['Climate Change'], 0.9694455862045288)","('NON-ESG', 0.0043493942357599735)","('NON-ESG', 0.003123634262010455)"
Line 307,"‡  FY20 and FY21 da ta has been recast due  to improvements in how we track and calculate our GHG emissions.35 % reduction in GHG emissions   intensity compared to   our FY20 baselineGHG emissions   (intensity)† MT CO 2e/$ million revenue 2022 Integrated Performance Report       32 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index OUR PATH TO CARBON NEUTRALITYENERGY CONSERVATION  FY20 FY21 FYEnergy conservation projects (#) 79 82 Energy conservation savings (MWh/year) 20,920 18,450 16,500  GHG emissions avoided (MT) 14,791 12,657  11,Savings from energy rebates ($ million) 1.1 0.9 0.Operating cost savings ($ million) 2.8 2.2  2.9 Medtronic Switzerland  turns water into energy Our facility in Tolochenaz, Switzerland,  completed and launched its aquathermal energy project in FY22.
","('GHG_Emissions', 0.9199663996696472)","('Energy_Management', 0.023219257593154907)","('Air_Quality', 0.009646899066865444)","(['Climate Change'], 0.9199663996696472)","('NON-ESG', 0.023219257593154907)","('NON-ESG', 0.009646899066865444)"
Line 308,"Medtronic partnered with an energy firm and the municipality to carry out the highly sophisticated project, which involved installing a complex system of underwater and underground pipes.
","('Water_And_Wastewater_Management', 0.33129334449768066)","('Energy_Management', 0.19245143234729767)","('Ecological_Impacts', 0.08304121345281601)","('NON-ESG', 0.33129334449768066)","('NON-ESG', 0.19245143234729767)","('NON-ESG', 0.08304121345281601)"
Line 309,"The system pumps water from a nearby lake through the pipes to provide renewable heating and cooling to Medtronic facilities.Powering up in Galway One of our newest on-site renewable projects launched at our Mervue facility in Galway, Ireland.
","('Water_And_Wastewater_Management', 0.9421030282974243)","('Energy_Management', 0.015849659219384193)","('GHG_Emissions', 0.004694585222750902)","(['Operational Eco-Efficiency'], 0.9421030282974243)","('NON-ESG', 0.015849659219384193)","('NON-ESG', 0.004694585222750902)"
Line 310,"The facility boasts 1,000 solar panels, a rooftop array that will generate 340 MWh of electricity annually — enough to cover approximately 20% of the site’s total electricity demand.
","('Energy_Management', 0.9731897115707397)","('Management_Of_Legal_And_Regulatory_Framework', 0.004397286102175713)","('GHG_Emissions', 0.002069704933091998)","(['Operational Eco-Efficiency'], 0.9731897115707397)","('NON-ESG', 0.004397286102175713)","('NON-ESG', 0.002069704933091998)"
Line 311,"REDUCING OUR OPERATIONAL FOOTPRINT Energy management We continuously look for opportunities to improve  energy efficiency, identifying ways to reduce energy use across operations globally.
","('Energy_Management', 0.9801464676856995)","('Product_Design_And_Lifecycle_Management', 0.0021185653749853373)","('Management_Of_Legal_And_Regulatory_Framework', 0.001869005267508328)","(['Operational Eco-Efficiency'], 0.9801464676856995)","('NON-ESG', 0.0021185653749853373)","('NON-ESG', 0.001869005267508328)"
Line 312,"In FY22, we completed more than 60 energy efficiency projects, including updating HVAC systems and chilled water pumps and installing variable frequency drive pumps to more efficiently power pumps and fans in our buildings.
","('Energy_Management', 0.9770632982254028)","('Water_And_Wastewater_Management', 0.002618956845253706)","('Critical_Incident_Risk_Management', 0.002061448758468032)","(['Operational Eco-Efficiency'], 0.9770632982254028)","('NON-ESG', 0.002618956845253706)","('NON-ESG', 0.002061448758468032)"
Line 313,"These projects resulted in an annual savings of 16,500 MWh of energy and $2.9 million in operating costs.
","('Energy_Management', 0.9732232093811035)","('Management_Of_Legal_And_Regulatory_Framework', 0.004179009702056646)","('GHG_Emissions', 0.0026857999619096518)","(['Operational Eco-Efficiency'], 0.9732232093811035)","('NON-ESG', 0.004179009702056646)","('NON-ESG', 0.0026857999619096518)"
Line 314,"As our energy management work has matured, we  have completed many near-term priority efficiency projects.
","('Energy_Management', 0.9786079525947571)","('Management_Of_Legal_And_Regulatory_Framework', 0.002126918639987707)","('Air_Quality', 0.0021025240421295166)","(['Operational Eco-Efficiency'], 0.9786079525947571)","('NON-ESG', 0.002126918639987707)","('NON-ESG', 0.0021025240421295166)"
Line 315,"We are now turning our focus to longer-term projects, leveraging the wealth of data we collect on our operational energy use.
","('Energy_Management', 0.8538146018981934)","('Data_Security', 0.020609885454177856)","('Management_Of_Legal_And_Regulatory_Framework', 0.01712147332727909)","(['Operational Eco-Efficiency'], 0.8538146018981934)","('NON-ESG', 0.020609885454177856)","('NON-ESG', 0.01712147332727909)"
Line 316,"Teams on-site at our facilities include energy reduction in their overall site goals, informed by monthly scorecards they receive on their energy usage.
","('Energy_Management', 0.9802120923995972)","('Air_Quality', 0.0022390196099877357)","('Critical_Incident_Risk_Management', 0.0016531868604943156)","(['Operational Eco-Efficiency'], 0.9802120923995972)","('NON-ESG', 0.0022390196099877357)","('NON-ESG', 0.0016531868604943156)"
Line 317,"The Global Energy and Corporate EHS teams oversee the program, providing each facility with guidance on best practices and sharing success stories.
","('Management_Of_Legal_And_Regulatory_Framework', 0.248492032289505)","('Systemic_Risk_Management', 0.09479295462369919)","('Human_Rights_And_Community_Relations', 0.08591142296791077)","('NON-ESG', 0.248492032289505)","('NON-ESG', 0.09479295462369919)","('NON-ESG', 0.08591142296791077)"
Line 318,"We expect this data-driven phase to deliver significant efficiency gains over time.Renewables and on-site generation Our long-standing commitment to sourcing and generating renewable energy predates our net zero strategy and forms a key component of our path to carbon neutrality.
","('Energy_Management', 0.9671371579170227)","('Product_Design_And_Lifecycle_Management', 0.006593566387891769)","('Management_Of_Legal_And_Regulatory_Framework', 0.003622769843786955)","(['Operational Eco-Efficiency'], 0.9671371579170227)","('NON-ESG', 0.006593566387891769)","('NON-ESG', 0.003622769843786955)"
Line 319,"We have adopted a diversified portfolio of low-carbon energy sources by purchasing green electricity from the grid, generating our own renewable electricity on-site, leveraging renewable energy credits and carbon offsets, and pursuing virtual power-purchase agreements (VPPAs).
","('Energy_Management', 0.9791562557220459)","('Management_Of_Legal_And_Regulatory_Framework', 0.003048120066523552)","('Critical_Incident_Risk_Management', 0.0016495054587721825)","(['Operational Eco-Efficiency'], 0.9791562557220459)","('NON-ESG', 0.003048120066523552)","('NON-ESG', 0.0016495054587721825)"
Line 320,"In FY22, we used more than 136,600 MWh of renewable  electricity — accounting for nearly 26% of our total electricity usage.
","('Energy_Management', 0.9689708352088928)","('Management_Of_Legal_And_Regulatory_Framework', 0.005796452052891254)","('GHG_Emissions', 0.002739011077210307)","(['Operational Eco-Efficiency'], 0.9689708352088928)","('NON-ESG', 0.005796452052891254)","('NON-ESG', 0.002739011077210307)"
Line 321,"One of our newest on-site renewable projects in Galway, Ireland, generates roughly 20% of its total energy demand through a rooftop solar array.
","('Energy_Management', 0.9805582165718079)","('Management_Of_Legal_And_Regulatory_Framework', 0.0021587242372334003)","('Critical_Incident_Risk_Management', 0.0014432438183575869)","(['Operational Eco-Efficiency'], 0.9805582165718079)","('NON-ESG', 0.0021587242372334003)","('NON-ESG', 0.0014432438183575869)"
Line 322,"In FY22, we completed contracts for 18 new renewable generation projects that will go live in FY23, providing an additional capacity of 56,700 MWh per year.
","('Energy_Management', 0.9506851434707642)","('Management_Of_Legal_And_Regulatory_Framework', 0.008373635821044445)","('GHG_Emissions', 0.006575275212526321)","(['Operational Eco-Efficiency'], 0.9506851434707642)","('NON-ESG', 0.008373635821044445)","('NON-ESG', 0.006575275212526321)"
Line 323,"We also generated more than 70,000 MWh of energy on-site,  a decrease of 13% compared to FY21.
","('Energy_Management', 0.9714179635047913)","('Management_Of_Legal_And_Regulatory_Framework', 0.004494741093367338)","('GHG_Emissions', 0.0027955949772149324)","(['Operational Eco-Efficiency'], 0.9714179635047913)","('NON-ESG', 0.004494741093367338)","('NON-ESG', 0.0027955949772149324)"
Line 324,"This decrease  is primarily due to the temporary retirement of our North Haven, Connecticut, cogeneration capability while it is updated to increase the site’s power resiliency.
","('Business_Model_Resilience', 0.9158889055252075)","('Supply_Chain_Management', 0.008541730232536793)","('Physical_Impacts_Of_Climate_Change', 0.008421975187957287)","(['Codes of Business Conduct'], 0.9158889055252075)","('NON-ESG', 0.008541730232536793)","('NON-ESG', 0.008421975187957287)"
Line 325,"Our carbon offset and renewable energy credit purchases amounted to more than 25,600 MT CO 2e  and 108,200 MWh, respectively.
","('Energy_Management', 0.9663199186325073)","('Management_Of_Legal_And_Regulatory_Framework', 0.009394371882081032)","('GHG_Emissions', 0.0028265935834497213)","(['Operational Eco-Efficiency'], 0.9663199186325073)","('NON-ESG', 0.009394371882081032)","('NON-ESG', 0.0028265935834497213)"
Line 326,"We continue to deepen our commitment to clean energy  through longer-term projects, such as funding larger on-site renewable projects and accelerating our transition to PPAs and VPPAs. In FY22, we added a new approach to our sourcing strategy: transitioning fossil-fuel-powered equipment, like HVAC and refrigeration systems, to electric power.
","('Energy_Management', 0.9530590772628784)","('Product_Design_And_Lifecycle_Management', 0.00948318187147379)","('Supply_Chain_Management', 0.004187277518212795)","(['Operational Eco-Efficiency'], 0.9530590772628784)","('NON-ESG', 0.00948318187147379)","('NON-ESG', 0.004187277518212795)"
Line 327,"Energy use MWh (thousands) 888.4 901.6 896.FY20 FY21 FY2212.3% 15.2% 12.1%   Percent of total  energy that is renewable electricity 2022 Integrated Performance Report       33 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexOn-site energy  generation MWhOperating on-site energy generation MWh – by source 80,  76,100† 76,FY20 FY21 FY†  The decrease in on-site energy  generation from FY21 to FY22 is primarily a result of the temporary retirement of our North Haven, Connecticut, cogeneration capability.
","('Energy_Management', 0.9803649187088013)","('Management_Of_Legal_And_Regulatory_Framework', 0.0024098833091557026)","('Air_Quality', 0.001706275506876409)","(['Operational Eco-Efficiency'], 0.9803649187088013)","('NON-ESG', 0.0024098833091557026)","('NON-ESG', 0.001706275506876409)"
Line 328,"Energy use MWh (thousands) 888.4 901.6 896.FY20 FY21 FY2212.3% 15.2% 12.1%   Percent of total  energy that is renewable electricity 2022 Integrated Performance Report       33 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexOn-site energy  generation MWhOperating on-site energy generation MWh – by source 80,  76,100† 76,FY20 FY21 FY†  The decrease in on-site energy  generation from FY21 to FY22 is primarily a result of the temporary retirement of our North Haven, Connecticut, cogeneration capability.
","('Business_Model_Resilience', 0.3816191852092743)","('Supply_Chain_Management', 0.0950908362865448)","('Product_Design_And_Lifecycle_Management', 0.08209735155105591)","('NON-ESG', 0.3816191852092743)","('NON-ESG', 0.0950908362865448)","('NON-ESG', 0.08209735155105591)"
Line 329,"We are currently repurposing these units to increase the site’s energy resiliency and  reduce power disruptions.
","('Business_Model_Resilience', 0.8599684834480286)","('Physical_Impacts_Of_Climate_Change', 0.023819146677851677)","('Supply_Chain_Management', 0.018897293135523796)","(['Codes of Business Conduct'], 0.8599684834480286)","('NON-ESG', 0.023819146677851677)","('NON-ESG', 0.018897293135523796)"
Line 330,"United StatesIreland ItalySwitzerland MexicoPuerto Rico Dominican RepublicREDUCING OUR OPERATIONAL FOOTPRINT OPERATING ON-SITE ENERGY CAPABILITIES  Type of  projectInstallation dateEnergy  generated  (per year)  (MWh)Location Cogen 2011 3,723 Athlone, Ireland Cogen 2012 2,234 Mirandola, Italy Trigen 2020 8,322 Mirandola-Bellco, Italy Solar 2013 286 Santa Rosa, CA Solar 2018 112 Tijuana, Mexico Solar 2018 130 Mirandola-Bellco, Italy Solar 2020 29 Galway, Ireland Solar 2020 130 Tolochenaz, Switzerland Solar 2020 585 Mystic, CT Solar 2020 7,500 Juncos, Puerto Rico Fuel cell 2013 3,329 Santa Rosa, CA Fuel cell 2017 12,483 Northridge, CA Fuel cell 2018 4,161 North Haven, CT Fuel cell 2020 17,520 North Haven, CT Aquathermy 2022 9,986 Tolochenaz, SwitzerlandUNDER CONSTRUCTION OR IN DEVELOPMENT,   ON-SITE ENERGY CAPABILITIES  Type of projectInstallation dateEnergy  generated  (per year)  (MWh)Location Trigen 2022 7,446 Juncos, Puerto Rico Trigen 2022 7,446 Humacao, Puerto Rico Trigen 2022 7,446 Villalba, Puerto Rico Trigen 2022 7,446 Ponce, Puerto Rico Solar 2022 1,300 Mounds View, MN Solar 2022 260 Tolochenaz, Switzerland Solar 2022 455 Galway, Ireland Solar 2022 1,300 Fridley, MN Solar 2022 450 San Isidro,  Dominican Republic Solar 2022 2,600 Rice Creek, MN  (On-site gardens) Solar 2023 1,300 North Haven, CT Solar 2023 1,350 Santa Ana, CA Solar 2023 650 Danvers, MA Solar 2024 1,500 Humacao, Puerto Rico Solar 2024 1,500 Villalba, Puerto Rico Solar 2024 3,000 Ponce, Puerto Rico5,Cogen 37,Fuel cells 8,Solar 10,Aquathermy 8,Trigen Cogen: Cogeneration plants produce electricity and heat, creating two useful  forms of energy from a single fuel source.
","('Energy_Management', 0.9744958877563477)","('Management_Of_Legal_And_Regulatory_Framework', 0.0031319682020694017)","('GHG_Emissions', 0.0023937115911394358)","(['Operational Eco-Efficiency'], 0.9744958877563477)","('NON-ESG', 0.0031319682020694017)","('NON-ESG', 0.0023937115911394358)"
Line 331,"United StatesIreland ItalySwitzerland MexicoPuerto Rico Dominican RepublicREDUCING OUR OPERATIONAL FOOTPRINT OPERATING ON-SITE ENERGY CAPABILITIES  Type of  projectInstallation dateEnergy  generated  (per year)  (MWh)Location Cogen 2011 3,723 Athlone, Ireland Cogen 2012 2,234 Mirandola, Italy Trigen 2020 8,322 Mirandola-Bellco, Italy Solar 2013 286 Santa Rosa, CA Solar 2018 112 Tijuana, Mexico Solar 2018 130 Mirandola-Bellco, Italy Solar 2020 29 Galway, Ireland Solar 2020 130 Tolochenaz, Switzerland Solar 2020 585 Mystic, CT Solar 2020 7,500 Juncos, Puerto Rico Fuel cell 2013 3,329 Santa Rosa, CA Fuel cell 2017 12,483 Northridge, CA Fuel cell 2018 4,161 North Haven, CT Fuel cell 2020 17,520 North Haven, CT Aquathermy 2022 9,986 Tolochenaz, SwitzerlandUNDER CONSTRUCTION OR IN DEVELOPMENT,   ON-SITE ENERGY CAPABILITIES  Type of projectInstallation dateEnergy  generated  (per year)  (MWh)Location Trigen 2022 7,446 Juncos, Puerto Rico Trigen 2022 7,446 Humacao, Puerto Rico Trigen 2022 7,446 Villalba, Puerto Rico Trigen 2022 7,446 Ponce, Puerto Rico Solar 2022 1,300 Mounds View, MN Solar 2022 260 Tolochenaz, Switzerland Solar 2022 455 Galway, Ireland Solar 2022 1,300 Fridley, MN Solar 2022 450 San Isidro,  Dominican Republic Solar 2022 2,600 Rice Creek, MN  (On-site gardens) Solar 2023 1,300 North Haven, CT Solar 2023 1,350 Santa Ana, CA Solar 2023 650 Danvers, MA Solar 2024 1,500 Humacao, Puerto Rico Solar 2024 1,500 Villalba, Puerto Rico Solar 2024 3,000 Ponce, Puerto Rico5,Cogen 37,Fuel cells 8,Solar 10,Aquathermy 8,Trigen Cogen: Cogeneration plants produce electricity and heat, creating two useful  forms of energy from a single fuel source.
","('Energy_Management', 0.9630799889564514)","('GHG_Emissions', 0.005516975186765194)","('Management_Of_Legal_And_Regulatory_Framework', 0.005003125406801701)","(['Operational Eco-Efficiency'], 0.9630799889564514)","('NON-ESG', 0.005516975186765194)","('NON-ESG', 0.005003125406801701)"
Line 332,"United StatesIreland ItalySwitzerland MexicoPuerto Rico Dominican RepublicREDUCING OUR OPERATIONAL FOOTPRINT OPERATING ON-SITE ENERGY CAPABILITIES  Type of  projectInstallation dateEnergy  generated  (per year)  (MWh)Location Cogen 2011 3,723 Athlone, Ireland Cogen 2012 2,234 Mirandola, Italy Trigen 2020 8,322 Mirandola-Bellco, Italy Solar 2013 286 Santa Rosa, CA Solar 2018 112 Tijuana, Mexico Solar 2018 130 Mirandola-Bellco, Italy Solar 2020 29 Galway, Ireland Solar 2020 130 Tolochenaz, Switzerland Solar 2020 585 Mystic, CT Solar 2020 7,500 Juncos, Puerto Rico Fuel cell 2013 3,329 Santa Rosa, CA Fuel cell 2017 12,483 Northridge, CA Fuel cell 2018 4,161 North Haven, CT Fuel cell 2020 17,520 North Haven, CT Aquathermy 2022 9,986 Tolochenaz, SwitzerlandUNDER CONSTRUCTION OR IN DEVELOPMENT,   ON-SITE ENERGY CAPABILITIES  Type of projectInstallation dateEnergy  generated  (per year)  (MWh)Location Trigen 2022 7,446 Juncos, Puerto Rico Trigen 2022 7,446 Humacao, Puerto Rico Trigen 2022 7,446 Villalba, Puerto Rico Trigen 2022 7,446 Ponce, Puerto Rico Solar 2022 1,300 Mounds View, MN Solar 2022 260 Tolochenaz, Switzerland Solar 2022 455 Galway, Ireland Solar 2022 1,300 Fridley, MN Solar 2022 450 San Isidro,  Dominican Republic Solar 2022 2,600 Rice Creek, MN  (On-site gardens) Solar 2023 1,300 North Haven, CT Solar 2023 1,350 Santa Ana, CA Solar 2023 650 Danvers, MA Solar 2024 1,500 Humacao, Puerto Rico Solar 2024 1,500 Villalba, Puerto Rico Solar 2024 3,000 Ponce, Puerto Rico5,Cogen 37,Fuel cells 8,Solar 10,Aquathermy 8,Trigen Cogen: Cogeneration plants produce electricity and heat, creating two useful  forms of energy from a single fuel source.
","('Energy_Management', 0.8020510077476501)","('Management_Of_Legal_And_Regulatory_Framework', 0.05103013291954994)","('Product_Design_And_Lifecycle_Management', 0.017273690551519394)","(['Operational Eco-Efficiency'], 0.8020510077476501)","('NON-ESG', 0.05103013291954994)","('NON-ESG', 0.017273690551519394)"
Line 333,"United StatesIreland ItalySwitzerland MexicoPuerto Rico Dominican RepublicREDUCING OUR OPERATIONAL FOOTPRINT OPERATING ON-SITE ENERGY CAPABILITIES  Type of  projectInstallation dateEnergy  generated  (per year)  (MWh)Location Cogen 2011 3,723 Athlone, Ireland Cogen 2012 2,234 Mirandola, Italy Trigen 2020 8,322 Mirandola-Bellco, Italy Solar 2013 286 Santa Rosa, CA Solar 2018 112 Tijuana, Mexico Solar 2018 130 Mirandola-Bellco, Italy Solar 2020 29 Galway, Ireland Solar 2020 130 Tolochenaz, Switzerland Solar 2020 585 Mystic, CT Solar 2020 7,500 Juncos, Puerto Rico Fuel cell 2013 3,329 Santa Rosa, CA Fuel cell 2017 12,483 Northridge, CA Fuel cell 2018 4,161 North Haven, CT Fuel cell 2020 17,520 North Haven, CT Aquathermy 2022 9,986 Tolochenaz, SwitzerlandUNDER CONSTRUCTION OR IN DEVELOPMENT,   ON-SITE ENERGY CAPABILITIES  Type of projectInstallation dateEnergy  generated  (per year)  (MWh)Location Trigen 2022 7,446 Juncos, Puerto Rico Trigen 2022 7,446 Humacao, Puerto Rico Trigen 2022 7,446 Villalba, Puerto Rico Trigen 2022 7,446 Ponce, Puerto Rico Solar 2022 1,300 Mounds View, MN Solar 2022 260 Tolochenaz, Switzerland Solar 2022 455 Galway, Ireland Solar 2022 1,300 Fridley, MN Solar 2022 450 San Isidro,  Dominican Republic Solar 2022 2,600 Rice Creek, MN  (On-site gardens) Solar 2023 1,300 North Haven, CT Solar 2023 1,350 Santa Ana, CA Solar 2023 650 Danvers, MA Solar 2024 1,500 Humacao, Puerto Rico Solar 2024 1,500 Villalba, Puerto Rico Solar 2024 3,000 Ponce, Puerto Rico5,Cogen 37,Fuel cells 8,Solar 10,Aquathermy 8,Trigen Cogen: Cogeneration plants produce electricity and heat, creating two useful  forms of energy from a single fuel source.
","('Energy_Management', 0.9762663841247559)","('Product_Design_And_Lifecycle_Management', 0.0022609515581279993)","('Water_And_Wastewater_Management', 0.0021960774902254343)","(['Operational Eco-Efficiency'], 0.9762663841247559)","('NON-ESG', 0.0022609515581279993)","('NON-ESG', 0.0021960774902254343)"
Line 334,"Trigen: Trigeneration plants function similarly to cogen, but additionally channel  energy into cooling.
","('Energy_Management', 0.9721270799636841)","('Water_And_Wastewater_Management', 0.003239477751776576)","('Product_Design_And_Lifecycle_Management', 0.002493480686098337)","(['Operational Eco-Efficiency'], 0.9721270799636841)","('NON-ESG', 0.003239477751776576)","('NON-ESG', 0.002493480686098337)"
Line 335,"Also called combined chilling, heat, and power.
","('Energy_Management', 0.8771181702613831)","('Water_And_Wastewater_Management', 0.013304156251251698)","('Critical_Incident_Risk_Management', 0.011295570991933346)","(['Operational Eco-Efficiency'], 0.8771181702613831)","('NON-ESG', 0.013304156251251698)","('NON-ESG', 0.011295570991933346)"
Line 336,"Fuel cell: A fuel cell converts the energy from a chemical reaction into electricity.Aquathermy: Aquathermy systems use thermal energy from bodies of water to  heat or cool.
","('Energy_Management', 0.969773530960083)","('Water_And_Wastewater_Management', 0.005736836697906256)","('Air_Quality', 0.002030475065112114)","(['Operational Eco-Efficiency'], 0.969773530960083)","('NON-ESG', 0.005736836697906256)","('NON-ESG', 0.002030475065112114)"
Line 337,"2022 Integrated Performance Report       34 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexRecycling e-waste in Australia  Medtronic ANZ partnered with Hoxton Industries,   an e-waste recycler and social enterprise that employs disadvantaged individuals to safely dismantle and repurpose obsolete Medtronic equipment.
","('Waste_And_Hazardous_Materials_Management', 0.9808900356292725)","('Water_And_Wastewater_Management', 0.0018701956141740084)","('Data_Security', 0.0014470935566350818)","(['Operational Eco-Efficiency'], 0.9808900356292725)","('NON-ESG', 0.0018701956141740084)","('NON-ESG', 0.0014470935566350818)"
Line 338,"In our first  full year, we diverted over 220 metric tons of equipment from landfill through the partnership.Total waste generated   Metric tonsTotal water use Cubic meters  (thousands) 1,763 1,7602,FY20 FY21 FY2230,33031,97233,FY20 FY21 FYNote: Nonregulated waste  accounts for nearly 90% of total waste, so in FY20, Medtronic moved to a total waste reduction goal by FY25.
","('Waste_And_Hazardous_Materials_Management', 0.9847651720046997)","('Water_And_Wastewater_Management', 0.0013268692418932915)","('Data_Security', 0.0011412297608330846)","(['Operational Eco-Efficiency'], 0.9847651720046997)","('NON-ESG', 0.0013268692418932915)","('NON-ESG', 0.0011412297608330846)"
Line 339,"Note: FY22 water data was externally assured by ERM CVS.
","('Water_And_Wastewater_Management', 0.9697527885437012)","('Waste_And_Hazardous_Materials_Management', 0.004255255218595266)","('Energy_Management', 0.002280451590195298)","(['Operational Eco-Efficiency'], 0.9697527885437012)","('NON-ESG', 0.004255255218595266)","('NON-ESG', 0.002280451590195298)"
Line 340,"REDUCING OUR OPERATIONAL FOOTPRINT Water use and waste We are always looking for ways to reduce water use and  waste footprints by focusing on efficiency, minimization, and infrastructure projects across our operations.
","('Waste_And_Hazardous_Materials_Management', 0.8932340145111084)","('Water_And_Wastewater_Management', 0.05458502471446991)","('Supply_Chain_Management', 0.005629248917102814)","(['Operational Eco-Efficiency'], 0.8932340145111084)","('NON-ESG', 0.05458502471446991)","('NON-ESG', 0.005629248917102814)"
Line 341,"Conserving water Although our operations are not generally water intensive, we recognize the global issue of water scarcity and the potential for water availability to become a critical issue in some regions.
","('Water_And_Wastewater_Management', 0.9770578145980835)","('GHG_Emissions', 0.0024010406341403723)","('Ecological_Impacts', 0.0017445008270442486)","(['Operational Eco-Efficiency'], 0.9770578145980835)","('NON-ESG', 0.0024010406341403723)","('NON-ESG', 0.0017445008270442486)"
Line 342,"For this reason, we track water use at all our owned sites.
","('Water_And_Wastewater_Management', 0.9757451415061951)","('Waste_And_Hazardous_Materials_Management', 0.002375414129346609)","('GHG_Emissions', 0.0021423473954200745)","(['Operational Eco-Efficiency'], 0.9757451415061951)","('NON-ESG', 0.002375414129346609)","('NON-ESG', 0.0021423473954200745)"
Line 343,"In FY22, we used  1.76 million cubic meters (m 3) of water, achieving a   14% reduction in water use intensity compared to  our FY20 baseline toward our goal of 15% by FY25.
","('Water_And_Wastewater_Management', 0.9764046669006348)","('GHG_Emissions', 0.002328519942238927)","('Energy_Management', 0.002127833664417267)","(['Operational Eco-Efficiency'], 0.9764046669006348)","('NON-ESG', 0.002328519942238927)","('NON-ESG', 0.002127833664417267)"
Line 344,"FY22 is the first year our water data has been externally assured by ERM CVS.
","('Water_And_Wastewater_Management', 0.9726267457008362)","('Waste_And_Hazardous_Materials_Management', 0.0026035429909825325)","('Energy_Management', 0.0025469674728810787)","(['Operational Eco-Efficiency'], 0.9726267457008362)","('NON-ESG', 0.0026035429909825325)","('NON-ESG', 0.0025469674728810787)"
Line 345,"To help us focus our water conservation efforts in the  locations with the highest water risk, we conduct a biennial water stress assessment using WRI’s Aqueduct tools to identify locations that may be impacted by water stress now or in the future.
","('Water_And_Wastewater_Management', 0.9766512513160706)","('Ecological_Impacts', 0.0022850523237138987)","('Waste_And_Hazardous_Materials_Management', 0.002022668719291687)","(['Operational Eco-Efficiency'], 0.9766512513160706)","('NON-ESG', 0.0022850523237138987)","('NON-ESG', 0.002022668719291687)"
Line 346,"In FY22, we conducted our third assessment on sites that use three million or more gallons of water per year.
","('Water_And_Wastewater_Management', 0.969906747341156)","('Energy_Management', 0.0036977650597691536)","('GHG_Emissions', 0.0034239855594933033)","(['Operational Eco-Efficiency'], 0.969906747341156)","('NON-ESG', 0.0036977650597691536)","('NON-ESG', 0.0034239855594933033)"
Line 347,"The results of this assessment were shared with relevant internal stakeholders from facilities, EHS, and business continuity and risk management for planning purposes.
","('Systemic_Risk_Management', 0.7242276072502136)","('Business_Model_Resilience', 0.07761814445257187)","('Physical_Impacts_Of_Climate_Change', 0.034274935722351074)","(['Risk & Crisis Management'], 0.7242276072502136)","('NON-ESG', 0.07761814445257187)","('NON-ESG', 0.034274935722351074)"
Line 348,"All of our manufacturing facilities have set water reduction goals.
","('Water_And_Wastewater_Management', 0.9673522710800171)","('GHG_Emissions', 0.005316040012985468)","('Energy_Management', 0.004276638850569725)","(['Operational Eco-Efficiency'], 0.9673522710800171)","('NON-ESG', 0.005316040012985468)","('NON-ESG', 0.004276638850569725)"
Line 349,"More detail on our water use is available in our   2022 CDP water disclosure.
","('Water_And_Wastewater_Management', 0.975975751876831)","('GHG_Emissions', 0.0023189689964056015)","('Waste_And_Hazardous_Materials_Management', 0.0020402316004037857)","(['Operational Eco-Efficiency'], 0.975975751876831)","('NON-ESG', 0.0023189689964056015)","('NON-ESG', 0.0020402316004037857)"
Line 350,"Reducing waste We continue to follow all local, regional, and national laws and regulations governing the management of hazardous and non-hazardous waste.
","('Waste_And_Hazardous_Materials_Management', 0.9850065112113953)","('Data_Security', 0.0011591434013098478)","('Water_And_Wastewater_Management', 0.0009906318737193942)","(['Operational Eco-Efficiency'], 0.9850065112113953)","('NON-ESG', 0.0011591434013098478)","('NON-ESG', 0.0009906318737193942)"
Line 351,"In FY22, we generated approximately 32,000 MT of waste, a 15% reduction in waste intensity compared to our FY20 baseline, reaching our FY25 goal.
","('Waste_And_Hazardous_Materials_Management', 0.982871413230896)","('Water_And_Wastewater_Management', 0.0016442041378468275)","('Air_Quality', 0.0013561405939981341)","(['Operational Eco-Efficiency'], 0.982871413230896)","('NON-ESG', 0.0016442041378468275)","('NON-ESG', 0.0013561405939981341)"
Line 352,"Although we made significant progress toward  our FY20 waste intensity goal, our absolute waste increased 5.4% over FY21.
","('Waste_And_Hazardous_Materials_Management', 0.9821394085884094)","('Water_And_Wastewater_Management', 0.0015802256530150771)","('Air_Quality', 0.0014776285970583558)","(['Operational Eco-Efficiency'], 0.9821394085884094)","('NON-ESG', 0.0015802256530150771)","('NON-ESG', 0.0014776285970583558)"
Line 353,"The increase is primarily due to manufacturing locations continuing to operate throughout the pandemic with increased frequency of cleaning activities and the added use of personal protective equipment.
","('Employee_Health_And_Safety', 0.5948953628540039)","('Product_Design_And_Lifecycle_Management', 0.1643487513065338)","('Product_Quality_And_Safety', 0.04251818358898163)","(['Operational Eco-Efficiency'], 0.5948953628540039)","('NON-ESG', 0.1643487513065338)","('NON-ESG', 0.04251818358898163)"
Line 354,"Our recycling rate remained consistent in FY22 compared with the previous year,  at 49% of the total waste generated.
","('Waste_And_Hazardous_Materials_Management', 0.9799112677574158)","('Water_And_Wastewater_Management', 0.0023492760956287384)","('Product_Design_And_Lifecycle_Management', 0.0014895210042595863)","(['Operational Eco-Efficiency'], 0.9799112677574158)","('NON-ESG', 0.0023492760956287384)","('NON-ESG', 0.0014895210042595863)"
Line 355,"We proactively manage hazardous waste to prevent  negative impact to the environment and reduce liability risks.
","('Waste_And_Hazardous_Materials_Management', 0.9843395948410034)","('Data_Security', 0.0011272089323028922)","('Employee_Health_And_Safety', 0.0010560833616182208)","(['Operational Eco-Efficiency'], 0.9843395948410034)","('NON-ESG', 0.0011272089323028922)","('NON-ESG', 0.0010560833616182208)"
Line 356,"For example, our Australia and New Zealand (ANZ) region recently partnered with an e-waste recycler to repurpose obsolete equipment.
","('Waste_And_Hazardous_Materials_Management', 0.9818724989891052)","('Water_And_Wastewater_Management', 0.002350982977077365)","('Air_Quality', 0.0014013814507052302)","(['Operational Eco-Efficiency'], 0.9818724989891052)","('NON-ESG', 0.002350982977077365)","('NON-ESG', 0.0014013814507052302)"
Line 357,"To ensure our vendors meet or exceed our standards, we monitor their waste management processes before contracting and throughout our relationship.
","('Waste_And_Hazardous_Materials_Management', 0.9291411638259888)","('Product_Quality_And_Safety', 0.010615689679980278)","('Product_Design_And_Lifecycle_Management', 0.0064010354690253735)","(['Operational Eco-Efficiency'], 0.9291411638259888)","('NON-ESG', 0.010615689679980278)","('NON-ESG', 0.0064010354690253735)"
Line 358,"2022 Integrated Performance Report       35 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexREDUCING OUR OPERATIONAL FOOTPRINT Environmental sustainability assurance  As part of our efforts to drive continuous improvement  and provide transparency, Medtronic retained an accredited and competent independent organization, ERM CVS, to assess and verify the environmental sustainability data in our FY22 Integrated Report,  our FY22 CDP Water Security disclosure report,  and our FY22 CDP Climate Change disclosure report.
","('Business_Model_Resilience', 0.18116898834705353)","('Management_Of_Legal_And_Regulatory_Framework', 0.14936767518520355)","('Human_Rights_And_Community_Relations', 0.11803828924894333)","('NON-ESG', 0.18116898834705353)","('NON-ESG', 0.14936767518520355)","('NON-ESG', 0.11803828924894333)"
Line 359,"2022 Integrated Performance Report       35 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexREDUCING OUR OPERATIONAL FOOTPRINT Environmental sustainability assurance  As part of our efforts to drive continuous improvement  and provide transparency, Medtronic retained an accredited and competent independent organization, ERM CVS, to assess and verify the environmental sustainability data in our FY22 Integrated Report,  our FY22 CDP Water Security disclosure report,  and our FY22 CDP Climate Change disclosure report.
","('Physical_Impacts_Of_Climate_Change', 0.9433692097663879)","('Business_Model_Resilience', 0.012236042879521847)","('Systemic_Risk_Management', 0.00646158866584301)","(['Climate Change'], 0.9433692097663879)","('NON-ESG', 0.012236042879521847)","('NON-ESG', 0.00646158866584301)"
Line 360,"The assessment revealed previously undisclosed   GHG emissions sources and long-standing accounting errors pertaining to our calculation of GHG emissions.
","('GHG_Emissions', 0.9671899676322937)","('Air_Quality', 0.005023518111556768)","('Management_Of_Legal_And_Regulatory_Framework', 0.0028387263882905245)","(['Climate Change'], 0.9671899676322937)","('NON-ESG', 0.005023518111556768)","('NON-ESG', 0.0028387263882905245)"
Line 361,"Subsequently, Medtronic has upgraded our sourcing data and changed our calculation methodology to reassess our FY20 baseline and FY22 GHG emissions data.
","('GHG_Emissions', 0.9637647271156311)","('Air_Quality', 0.006425223313271999)","('Physical_Impacts_Of_Climate_Change', 0.002919002203270793)","(['Climate Change'], 0.9637647271156311)","('NON-ESG', 0.006425223313271999)","('NON-ESG', 0.002919002203270793)"
Line 362,"These changes are accurately reflected in this FY22 Medtronic Integrated Performance Report and have been amended in our FY22 CDP Climate Change disclosure.
","('Physical_Impacts_Of_Climate_Change', 0.939493715763092)","('Business_Model_Resilience', 0.011827106587588787)","('GHG_Emissions', 0.008238391019403934)","(['Climate Change'], 0.939493715763092)","('NON-ESG', 0.011827106587588787)","('NON-ESG', 0.008238391019403934)"
Line 363,"Despite these changes having a slightly negative impact on our GHG reduction progress, we remain on track to achieve our FY25 goal to reduce operational GHG emissions intensity by 50% from  our FY20 baseline.
","('GHG_Emissions', 0.9675922989845276)","('Air_Quality', 0.004788227379322052)","('Ecological_Impacts', 0.002642451087012887)","(['Climate Change'], 0.9675922989845276)","('NON-ESG', 0.004788227379322052)","('NON-ESG', 0.002642451087012887)"
Line 364,"Having successfully completed this assessment, we  proudly acknowledge the first-time receipt of Letters  of Assurance from ERM CVS for the following: •   FY22 Integr ated Performance Report – EHS •   FY22 CDP  Water Security report •   FY22 CDP Clima te Change amended report  Regulatory compliance Aligned to our commitment to environmental, health,  and safety compliance at our sites, we completed several milestones in FY22, beginning with earning ISO 14001 certification for 13 manufacturing sites and earning ISO 45001/OHSAS 18001 certification for two manufacturing sites.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6354230046272278)","('Product_Quality_And_Safety', 0.135889932513237)","('Business_Ethics', 0.06334178894758224)","(['Corporate Governance'], 0.6354230046272278)","('NON-ESG', 0.135889932513237)","('NON-ESG', 0.06334178894758224)"
Line 365,"Having successfully completed this assessment, we  proudly acknowledge the first-time receipt of Letters  of Assurance from ERM CVS for the following: •   FY22 Integr ated Performance Report – EHS •   FY22 CDP  Water Security report •   FY22 CDP Clima te Change amended report  Regulatory compliance Aligned to our commitment to environmental, health,  and safety compliance at our sites, we completed several milestones in FY22, beginning with earning ISO 14001 certification for 13 manufacturing sites and earning ISO 45001/OHSAS 18001 certification for two manufacturing sites.
","('Product_Design_And_Lifecycle_Management', 0.3688051700592041)","('Product_Quality_And_Safety', 0.29891058802604675)","('Management_Of_Legal_And_Regulatory_Framework', 0.042725931853055954)","('NON-ESG', 0.3688051700592041)","('NON-ESG', 0.29891058802604675)","('NON-ESG', 0.042725931853055954)"
Line 366,"We also enhanced our audit program to ISO standards to ensure that all our locations comply with the Medtronic environmental performance management system and local, regional, and national regulations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3891383409500122)","('Product_Quality_And_Safety', 0.24172912538051605)","('Human_Rights_And_Community_Relations', 0.06828925013542175)","('NON-ESG', 0.3891383409500122)","('NON-ESG', 0.24172912538051605)","('NON-ESG', 0.06828925013542175)"
Line 367,"Audits are conducted on-site and virtually every three or more years, depending on the site’s activities.
","('Business_Ethics', 0.4271007478237152)","('Management_Of_Legal_And_Regulatory_Framework', 0.31065618991851807)","('Systemic_Risk_Management', 0.060528915375471115)","('NON-ESG', 0.4271007478237152)","('NON-ESG', 0.31065618991851807)","('NON-ESG', 0.060528915375471115)"
Line 368,"In FY22, we launched a new self-assessment audit program designed to equip site leads with tools to identify and correct potential cases of noncompliance.
","('Business_Ethics', 0.8800090551376343)","('Management_Of_Legal_And_Regulatory_Framework', 0.04950350895524025)","('Product_Quality_And_Safety', 0.012373817153275013)","(['Business Ethics'], 0.8800090551376343)","('NON-ESG', 0.04950350895524025)","('NON-ESG', 0.012373817153275013)"
Line 369,"We also underwent 28 environmental compliance  inspections by relevant authorities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6411722898483276)","('Business_Ethics', 0.14465944468975067)","('Product_Quality_And_Safety', 0.038160666823387146)","(['Corporate Governance'], 0.6411722898483276)","('NON-ESG', 0.14465944468975067)","('NON-ESG', 0.038160666823387146)"
Line 370,"While there were no findings in 27 of the inspections, one agency review resulted in a notice of noncompliance for minor violations that were corrected on-site with no downtime.
","('Business_Ethics', 0.6264852285385132)","('Management_Of_Legal_And_Regulatory_Framework', 0.15510213375091553)","('Product_Quality_And_Safety', 0.033842213451862335)","(['Business Ethics'], 0.6264852285385132)","('NON-ESG', 0.15510213375091553)","('NON-ESG', 0.033842213451862335)"
Line 371,"We continue to manage 26 cleanup sites where  remediation is required due to historical discharges that were permissible during past operations.
","('Water_And_Wastewater_Management', 0.5211161375045776)","('Ecological_Impacts', 0.1512012779712677)","('Waste_And_Hazardous_Materials_Management', 0.1139180064201355)","(['Operational Eco-Efficiency'], 0.5211161375045776)","('NON-ESG', 0.1512012779712677)","('NON-ESG', 0.1139180064201355)"
Line 372,"Two of these sites are included in our ongoing operations, though many result from historical acquisitions.
","('Business_Model_Resilience', 0.4431336224079132)","('Systemic_Risk_Management', 0.10635603219270706)","('Competitive_Behavior', 0.08980434387922287)","('NON-ESG', 0.4431336224079132)","('NON-ESG', 0.10635603219270706)","('NON-ESG', 0.08980434387922287)"
Line 373,"Twenty-two are multiparty sites, meaning Medtronic entities are one of multiple potentially responsible parties addressing site remediation under the applicable state or federal program.
","('Critical_Incident_Risk_Management', 0.22635629773139954)","('Water_And_Wastewater_Management', 0.20087791979312897)","('Supply_Chain_Management', 0.06639990210533142)","('NON-ESG', 0.22635629773139954)","('NON-ESG', 0.20087791979312897)","('NON-ESG', 0.06639990210533142)"
Line 374,"Nine have been designated as Superfund sites.
","('Waste_And_Hazardous_Materials_Management', 0.29590970277786255)","('Air_Quality', 0.14095266163349152)","('Ecological_Impacts', 0.09615784138441086)","('NON-ESG', 0.29590970277786255)","('NON-ESG', 0.14095266163349152)","('NON-ESG', 0.09615784138441086)"
Line 375,"2022 Integrated Performance Report       36 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexE.U. Registration,  Evaluation,  Authorisation,   and Restriction   of Chemicals   (REACH)E.U. Medical   Device Regulation  (MDR)Waste   Framework   Directive   requirements for  substances of very   high concern,   via the SCIP  database EXTERNAL PRODUCT STANDARDS We align our product stewardship activities with the following standards and regulations: California   Proposition 65,   see Medtronic  disclosuresE.U. Directive   on Restriction   of Hazardous   Substances  (RoHS)Product  stewardshipAdding business value By achieving the highest standards of quality,  safety, and environmental performance in our products, we enhance our reputation and minimize the risk of events that may damage it.
","('Product_Design_And_Lifecycle_Management', 0.5720211863517761)","('Product_Quality_And_Safety', 0.2699810564517975)","('Selling_Practices_And_Product_Labeling', 0.035451848059892654)","(['Product Stewardship'], 0.5720211863517761)","('NON-ESG', 0.2699810564517975)","('NON-ESG', 0.035451848059892654)"
Line 376,"2022 Integrated Performance Report       36 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexE.U. Registration,  Evaluation,  Authorisation,   and Restriction   of Chemicals   (REACH)E.U. Medical   Device Regulation  (MDR)Waste   Framework   Directive   requirements for  substances of very   high concern,   via the SCIP  database EXTERNAL PRODUCT STANDARDS We align our product stewardship activities with the following standards and regulations: California   Proposition 65,   see Medtronic  disclosuresE.U. Directive   on Restriction   of Hazardous   Substances  (RoHS)Product  stewardshipAdding business value By achieving the highest standards of quality,  safety, and environmental performance in our products, we enhance our reputation and minimize the risk of events that may damage it.
","('Product_Quality_And_Safety', 0.7615402936935425)","('Product_Design_And_Lifecycle_Management', 0.10170447081327438)","('Selling_Practices_And_Product_Labeling', 0.036316365003585815)","(['Product Quality & Recall Management'], 0.7615402936935425)","('NON-ESG', 0.10170447081327438)","('NON-ESG', 0.036316365003585815)"
Line 377,"With customer focus on product sustainability increasing, we are committed to reducing the environmental footprint of our products and packaging.
","('Product_Design_And_Lifecycle_Management', 0.9610393643379211)","('Product_Quality_And_Safety', 0.005419659893959761)","('Selling_Practices_And_Product_Labeling', 0.003673774190247059)","(['Product Stewardship'], 0.9610393643379211)","('NON-ESG', 0.005419659893959761)","('NON-ESG', 0.003673774190247059)"
Line 378,"ENVIRONMENTAL SUSTAINABILITY Product development at Medtronic  prioritizes quality, safety, and full compliance with frequently changing regulations.
","('Product_Quality_And_Safety', 0.8326149582862854)","('Product_Design_And_Lifecycle_Management', 0.07109729945659637)","('Selling_Practices_And_Product_Labeling', 0.014642351306974888)","(['Product Quality & Recall Management'], 0.8326149582862854)","('NON-ESG', 0.07109729945659637)","('NON-ESG', 0.014642351306974888)"
Line 379,"We also seek to minimize the environmental impact and increase the circularity of our products and packaging to meet stakeholder expectations and our environmental protection goals.
","('Product_Design_And_Lifecycle_Management', 0.9634305238723755)","('Product_Quality_And_Safety', 0.0049264803528785706)","('Selling_Practices_And_Product_Labeling', 0.0030956738628447056)","(['Product Stewardship'], 0.9634305238723755)","('NON-ESG', 0.0049264803528785706)","('NON-ESG', 0.0030956738628447056)"
Line 380,"2022 Integrated Performance Report       37 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexAward-winning packaging reduction The packaging development team in our Cranial and Spinal  Technologies operating unit won the Medtronic 2021 EHS Sustainability Award for innovative reductions to waste on three  spinal care products.
","('Waste_And_Hazardous_Materials_Management', 0.4343729615211487)","('Product_Design_And_Lifecycle_Management', 0.4120158851146698)","('Product_Quality_And_Safety', 0.022463729605078697)","('NON-ESG', 0.4343729615211487)","('NON-ESG', 0.4120158851146698)","('NON-ESG', 0.022463729605078697)"
Line 381,"The improvements included shifting from  paper to electronic instructions, using fewer standardized components, and enabling product stackability for ease of shipping and storage.
","('Product_Design_And_Lifecycle_Management', 0.9474827647209167)","('Selling_Practices_And_Product_Labeling', 0.005540892947465181)","('Waste_And_Hazardous_Materials_Management', 0.0055350675247609615)","(['Product Stewardship'], 0.9474827647209167)","('NON-ESG', 0.005540892947465181)","('NON-ESG', 0.0055350675247609615)"
Line 382,"The combined environmental savings correspond to a reduction of 143 metric tons of GHG emissions every year.
","('GHG_Emissions', 0.9653178453445435)","('Ecological_Impacts', 0.004330960102379322)","('Air_Quality', 0.003977095242589712)","(['Climate Change'], 0.9653178453445435)","('NON-ESG', 0.004330960102379322)","('NON-ESG', 0.003977095242589712)"
Line 383,"†  FY20 and FY21 data has been recast due to an update in how we calculate product weights and track  the number of products collected.
","('Product_Design_And_Lifecycle_Management', 0.9301151633262634)","('Selling_Practices_And_Product_Labeling', 0.012378297746181488)","('Product_Quality_And_Safety', 0.010922945104539394)","(['Product Stewardship'], 0.9301151633262634)","('NON-ESG', 0.012378297746181488)","('NON-ESG', 0.010922945104539394)"
Line 384,"PRODUCT STEWARDSHIP Sustainability Development Center  In FY22, we launched the Sustainability Development  Center (SDC).
","('Product_Design_And_Lifecycle_Management', 0.9506726264953613)","('Product_Quality_And_Safety', 0.008821394294500351)","('Customer_Welfare', 0.004788044840097427)","(['Product Stewardship'], 0.9506726264953613)","('NON-ESG', 0.008821394294500351)","('NON-ESG', 0.004788044840097427)"
Line 385,"With an aim to reduce waste and eliminate targeted materials of concern, the center focuses on streamlining packaging for high-volume products.
","('Waste_And_Hazardous_Materials_Management', 0.9015436768531799)","('Product_Design_And_Lifecycle_Management', 0.04014698043465614)","('Product_Quality_And_Safety', 0.005031373351812363)","(['Operational Eco-Efficiency'], 0.9015436768531799)","('NON-ESG', 0.04014698043465614)","('NON-ESG', 0.005031373351812363)"
Line 386,"The center has already established a core team, set a project roadmap, and began identifying waste and packaging solutions — a firm foundation for its planned continued growth.
","('Waste_And_Hazardous_Materials_Management', 0.9758583307266235)","('Water_And_Wastewater_Management', 0.002497601555660367)","('Product_Design_And_Lifecycle_Management', 0.0024825113359838724)","(['Operational Eco-Efficiency'], 0.9758583307266235)","('NON-ESG', 0.002497601555660367)","('NON-ESG', 0.0024825113359838724)"
Line 387,"The SDC is pursuing two product stewardship targets   in FY22: •   By FY25,  Medtronic will complete packaging  improvements to reduce packaging waste by 25%  for targeted high-volume products (tied to weight, material selection, and sourcing) compared to a  FY21 baseline.
","('Product_Design_And_Lifecycle_Management', 0.8890000581741333)","('Waste_And_Hazardous_Materials_Management', 0.031195545569062233)","('Product_Quality_And_Safety', 0.014121076092123985)","(['Product Stewardship'], 0.8890000581741333)","('NON-ESG', 0.031195545569062233)","('NON-ESG', 0.014121076092123985)"
Line 388,"•   By FY27,  Medtronic will minimize the impact of  Instructions for Use (IFUs) through a 35% paper reduction compared to a FY21 baseline.
","('Customer_Welfare', 0.23454080522060394)","('Product_Quality_And_Safety', 0.12023425847291946)","('Access_And_Affordability', 0.11891929805278778)","('NON-ESG', 0.23454080522060394)","('NON-ESG', 0.12023425847291946)","('NON-ESG', 0.11891929805278778)"
Line 389,"By the end of FY22, the SDC had selected five  product families to target for packaging waste  reduction toward our FY25 goal.
","('Waste_And_Hazardous_Materials_Management', 0.9562588930130005)","('Product_Design_And_Lifecycle_Management', 0.0076507823541760445)","('Water_And_Wastewater_Management', 0.00359174981713295)","(['Operational Eco-Efficiency'], 0.9562588930130005)","('NON-ESG', 0.0076507823541760445)","('NON-ESG', 0.00359174981713295)"
Line 390,"1 Minimizing product impacts Our goal is to lessen the impact of our products throughout their lifetimes.
","('Product_Design_And_Lifecycle_Management', 0.9639201760292053)","('Product_Quality_And_Safety', 0.003575642127543688)","('Selling_Practices_And_Product_Labeling', 0.0030814437195658684)","(['Product Stewardship'], 0.9639201760292053)","('NON-ESG', 0.003575642127543688)","('NON-ESG', 0.0030814437195658684)"
Line 391,"Although the SDC is our center for packaging innovations, our operating units also devote their expertise to creatively reduce impacts from the products they design.
","('Product_Design_And_Lifecycle_Management', 0.9671139121055603)","('Product_Quality_And_Safety', 0.0028912625275552273)","('Selling_Practices_And_Product_Labeling', 0.0024618306197226048)","(['Product Stewardship'], 0.9671139121055603)","('NON-ESG', 0.0028912625275552273)","('NON-ESG', 0.0024618306197226048)"
Line 392,"Where feasible, we collect certain products at their  end-of-use so they can be safely recycled, refurbished, or reprocessed, as shown in the table right.
","('Product_Design_And_Lifecycle_Management', 0.9625691175460815)","('Product_Quality_And_Safety', 0.003795665455982089)","('Waste_And_Hazardous_Materials_Management', 0.003366192104294896)","(['Product Stewardship'], 0.9625691175460815)","('NON-ESG', 0.003795665455982089)","('NON-ESG', 0.003366192104294896)"
Line 393,"In FY22, we took back more than 6.2 million products, saving raw materials through remanufacture and diverting more than 280 metric tons of waste from landfill.PRODUCTS COLLECTED THROUGH TAKEBACK   FY20 FY21 FYNumber of  productsMetric   tonsNumber of  productsMetric   tonsNumber of  productsMetric  tons Nellcor sensors Remanufactured 1,782,368 40.0 2,458,752 49.6 4,791,039 130.Recycled 3,950,200 87.4 1,174,553 32.3 1,226,952 33.Cardiac Rhythm Management  patient monitors and accessories† Refurbished and redeployed 101,737 77.5 150,058 109.6 182,344 101.Advanced energy project  zero collections program for  surgical technology Energy from waste incineration 341,331 40.7 354,193 41.1 94,814 24.Annual totals 6,175,636 245.6 4,137,556 232.64 6,295,149 289.1  T he product families include: Tri-Staple; Polysorb; Absorbatack; Spinal Implants;  and Pulse Oximeter.
","('Waste_And_Hazardous_Materials_Management', 0.7724930644035339)","('Product_Design_And_Lifecycle_Management', 0.1269659698009491)","('Product_Quality_And_Safety', 0.015218784101307392)","(['Operational Eco-Efficiency'], 0.7724930644035339)","('NON-ESG', 0.1269659698009491)","('NON-ESG', 0.015218784101307392)"
Line 394,"In FY22, we took back more than 6.2 million products, saving raw materials through remanufacture and diverting more than 280 metric tons of waste from landfill.PRODUCTS COLLECTED THROUGH TAKEBACK   FY20 FY21 FYNumber of  productsMetric   tonsNumber of  productsMetric   tonsNumber of  productsMetric  tons Nellcor sensors Remanufactured 1,782,368 40.0 2,458,752 49.6 4,791,039 130.Recycled 3,950,200 87.4 1,174,553 32.3 1,226,952 33.Cardiac Rhythm Management  patient monitors and accessories† Refurbished and redeployed 101,737 77.5 150,058 109.6 182,344 101.Advanced energy project  zero collections program for  surgical technology Energy from waste incineration 341,331 40.7 354,193 41.1 94,814 24.Annual totals 6,175,636 245.6 4,137,556 232.64 6,295,149 289.1  T he product families include: Tri-Staple; Polysorb; Absorbatack; Spinal Implants;  and Pulse Oximeter.
","('Waste_And_Hazardous_Materials_Management', 0.9606841802597046)","('Water_And_Wastewater_Management', 0.005018786992877722)","('Air_Quality', 0.0046740928664803505)","(['Operational Eco-Efficiency'], 0.9606841802597046)","('NON-ESG', 0.005018786992877722)","('NON-ESG', 0.0046740928664803505)"
Line 395,"280+ metric tons collected  through takeback in FY22  and diverted from landfills 2022 Integrated Performance Report       38 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexLowering the impact of device sterilization We participated in the FDA’s Sterilization Master File Pilot Program to explore  new ways to sterilize medical devices that reduce the environmental impact of ethylene oxide (EtO).
","('Employee_Health_And_Safety', 0.22904910147190094)","('Product_Quality_And_Safety', 0.18967458605766296)","('Waste_And_Hazardous_Materials_Management', 0.1567544937133789)","('NON-ESG', 0.22904910147190094)","('NON-ESG', 0.18967458605766296)","('NON-ESG', 0.1567544937133789)"
Line 396,"Through innovations developed during the program, we established a process that requires lower levels of EtO.
","('Competitive_Behavior', 0.27963826060295105)","('Management_Of_Legal_And_Regulatory_Framework', 0.24289335310459137)","('GHG_Emissions', 0.07105331122875214)","('NON-ESG', 0.27963826060295105)","('NON-ESG', 0.24289335310459137)","('NON-ESG', 0.07105331122875214)"
Line 397,"We have received FDA approval to implement this new process at our sterilization site in Puerto Rico for devices used for diabetes and cardiac care.
","('Access_And_Affordability', 0.28498461842536926)","('Product_Quality_And_Safety', 0.18306086957454681)","('Customer_Welfare', 0.10740335285663605)","('NON-ESG', 0.28498461842536926)","('NON-ESG', 0.18306086957454681)","('NON-ESG', 0.10740335285663605)"
Line 398,"To read more about our approach to using EtO, visit our website.Reducing waste for diabetes products Products made for diabetes treatment can result in large quantities of waste for facilities and patients.
","('Waste_And_Hazardous_Materials_Management', 0.980888307094574)","('Product_Design_And_Lifecycle_Management', 0.0018391927005723119)","('Water_And_Wastewater_Management', 0.0013645143480971456)","(['Operational Eco-Efficiency'], 0.980888307094574)","('NON-ESG', 0.0018391927005723119)","('NON-ESG', 0.0013645143480971456)"
Line 399,"To reduce the waste generated, we streamlined the packaging of several of our diabetes products.
","('Waste_And_Hazardous_Materials_Management', 0.9803459048271179)","('Product_Design_And_Lifecycle_Management', 0.002113132970407605)","('Water_And_Wastewater_Management', 0.001607150654308498)","(['Operational Eco-Efficiency'], 0.9803459048271179)","('NON-ESG', 0.002113132970407605)","('NON-ESG', 0.001607150654308498)"
Line 400,"•   Our InP en™ reusable smart insulin pen lasts up to one year, replacing   1,000 or more disposable plastic syringes.
","('Product_Design_And_Lifecycle_Management', 0.6637252569198608)","('Energy_Management', 0.07854240387678146)","('Waste_And_Hazardous_Materials_Management', 0.03985801339149475)","(['Product Stewardship'], 0.6637252569198608)","('NON-ESG', 0.07854240387678146)","('NON-ESG', 0.03985801339149475)"
Line 401,"•   T he Medtronic Extended infusion insulin tubing set is now designed   to be worn for twice as long as a standard set, saving an average of around  three to four pounds of plastic per patient every year.
","('Access_And_Affordability', 0.195011168718338)","('Customer_Welfare', 0.17225174605846405)","('Water_And_Wastewater_Management', 0.10118430852890015)","('NON-ESG', 0.195011168718338)","('NON-ESG', 0.17225174605846405)","('NON-ESG', 0.10118430852890015)"
Line 402,"•   T he MiniMed™ 770G System insulin management software allows  for software upgrades that obviate the need for a physical pump change.
","('Data_Security', 0.14973364770412445)","('Systemic_Risk_Management', 0.12784934043884277)","('Management_Of_Legal_And_Regulatory_Framework', 0.12065962702035904)","('NON-ESG', 0.14973364770412445)","('NON-ESG', 0.12784934043884277)","('NON-ESG', 0.12065962702035904)"
Line 403,"PRODUCT STEWARDSHIP Materials of concern  We closely adhere to global regulations governing  the use of materials of concern, as defined under a variety of global regulatory requirements.
","('Product_Design_And_Lifecycle_Management', 0.8401156663894653)","('Product_Quality_And_Safety', 0.04994795843958855)","('Selling_Practices_And_Product_Labeling', 0.031201304867863655)","(['Product Stewardship'], 0.8401156663894653)","('NON-ESG', 0.04994795843958855)","('NON-ESG', 0.031201304867863655)"
Line 404,"Materials of concern include substances with the potential – if not managed correctly – to negatively impact people or the environment.
","('Waste_And_Hazardous_Materials_Management', 0.4440993070602417)","('Ecological_Impacts', 0.1458657830953598)","('Water_And_Wastewater_Management', 0.09361805766820908)","('NON-ESG', 0.4440993070602417)","('NON-ESG', 0.1458657830953598)","('NON-ESG', 0.09361805766820908)"
Line 405,"Our Materials of Concern policy guides our approach to evaluating and managing materials of concern.
","('Waste_And_Hazardous_Materials_Management', 0.4064510464668274)","('Supply_Chain_Management', 0.24768178164958954)","('Product_Design_And_Lifecycle_Management', 0.09438493102788925)","('NON-ESG', 0.4064510464668274)","('NON-ESG', 0.24768178164958954)","('NON-ESG', 0.09438493102788925)"
Line 406,"We also participate in collaborative programs to find alternatives to, and reduce our use of, materials of concern, such as our involvement in the FDA’s Sterilization Master File Pilot Program to reduce the impact of ethylene oxide.
","('Product_Quality_And_Safety', 0.20190951228141785)","('Waste_And_Hazardous_Materials_Management', 0.20145712792873383)","('Product_Design_And_Lifecycle_Management', 0.13943766057491302)","('NON-ESG', 0.20190951228141785)","('NON-ESG', 0.20145712792873383)","('NON-ESG', 0.13943766057491302)"
Line 407,"2022 Integrated Performance Report       39 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index MiniMed™ 770G System  is for type 1 ages 2 and over.
","('Business_Model_Resilience', 0.26268693804740906)","('Management_Of_Legal_And_Regulatory_Framework', 0.15161432325839996)","('Human_Rights_And_Community_Relations', 0.14580540359020233)","('NON-ESG', 0.26268693804740906)","('NON-ESG', 0.15161432325839996)","('NON-ESG', 0.14580540359020233)"
Line 408,"Prescription required.
","('Selling_Practices_And_Product_Labeling', 0.4444425106048584)","('Product_Quality_And_Safety', 0.08864478766918182)","('Customer_Privacy', 0.07565034925937653)","('NON-ESG', 0.4444425106048584)","('NON-ESG', 0.08864478766918182)","('NON-ESG', 0.07565034925937653)"
Line 409,"WARNING: Do not use SmartGuard™ Auto Mode for people who require less than 8 units or more than 250 units of insulin/day.
","('Product_Design_And_Lifecycle_Management', 0.365036278963089)","('Energy_Management', 0.20149271190166473)","('Product_Quality_And_Safety', 0.10310043394565582)","('NON-ESG', 0.365036278963089)","('NON-ESG', 0.20149271190166473)","('NON-ESG', 0.10310043394565582)"
Line 410,"For details, see http://bit.ly/770gRisks.
","('Data_Security', 0.2399975061416626)","('Systemic_Risk_Management', 0.11691310256719589)","('Management_Of_Legal_And_Regulatory_Framework', 0.109280064702034)","('NON-ESG', 0.2399975061416626)","('NON-ESG', 0.11691310256719589)","('NON-ESG', 0.109280064702034)"
Line 411,"InPen requires a prescription  and proper settings, or you could experience highs/lows.
","('Customer_Welfare', 0.13630637526512146)","('Product_Quality_And_Safety', 0.11587466299533844)","('Employee_Health_And_Safety', 0.10414562374353409)","('NON-ESG', 0.13630637526512146)","('NON-ESG', 0.11587466299533844)","('NON-ESG', 0.10414562374353409)"
Line 412,"See bit.ly/InPen-Risks.Social impact Medtronic engineers the extraordinary — life-transforming technology, insight-driven  care, and experiences that put people first.
","('Product_Design_And_Lifecycle_Management', 0.1722700297832489)","('Business_Model_Resilience', 0.1342397779226303)","('Employee_Health_And_Safety', 0.11519848555326462)","('NON-ESG', 0.1722700297832489)","('NON-ESG', 0.1342397779226303)","('NON-ESG', 0.11519848555326462)"
Line 413,"Our work makes us a global healthcare technology leader, with the ability and desire to boldly attack the most challenging health problems facing humanity and deliver better outcomes for our world.
","('Access_And_Affordability', 0.36559009552001953)","('Employee_Health_And_Safety', 0.2138587087392807)","('Critical_Incident_Risk_Management', 0.05863907188177109)","('NON-ESG', 0.36559009552001953)","('NON-ESG', 0.2138587087392807)","('NON-ESG', 0.05863907188177109)"
Line 414,"To do this, we accelerate access to innovative treatments for underserved  communities and invest in capacity building for healthcare professionals and patients.
","('Access_And_Affordability', 0.9486306309700012)","('Critical_Incident_Risk_Management', 0.005035295616835356)","('Human_Rights_And_Community_Relations', 0.004276659339666367)","(['Health Outcome Contribution'], 0.9486306309700012)","('NON-ESG', 0.005035295616835356)","('NON-ESG', 0.004276659339666367)"
Line 415,"Our philanthropic contributions address inequities in healthcare and education, and we work to promote greater diversity and inclusion among our employees and suppliers.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9749326109886169)","('Employee_Health_And_Safety', 0.0019082617945969105)","('Labor_Practices', 0.0016459731850773096)","(['Human Capital Development'], 0.9749326109886169)","('NON-ESG', 0.0019082617945969105)","('NON-ESG', 0.0016459731850773096)"
Line 416,"To deliver patient-first healthcare solutions to those who need them most, we work with a resilient and innovative pool of trusted partners.
","('Business_Model_Resilience', 0.8203367590904236)","('Physical_Impacts_Of_Climate_Change', 0.025384239852428436)","('Supply_Chain_Management', 0.021755289286375046)","(['Codes of Business Conduct'], 0.8203367590904236)","('NON-ESG', 0.025384239852428436)","('NON-ESG', 0.021755289286375046)"
Line 417,"FY22 social impact highlights  Global healthcare access  42Philanthropy  51Inclusion, diversity, and equity  57 Supporting a global workforce  64 Patient safety and product quality  72Data privacy and security  78 Supply chain responsibility  2022 Integrated Performance Report Introduction 40 ESG strategy Environmental sustainability Governance and accountability ESG disclosure index  Social impact $2.7B invested in research   and development  $97.1M combined philanthropic   investment by Medtronic and   the Medtronic Foundation$69M invested in healthcare   capacity building, reaching  350,000+ medical professionals 36 % of our U.S. supplier spend,   totaling nearly $2.7 billion,   went to small and diverse-owned  companies100 % ethnically diverse and gender   pay equity achieved in the   U.S. and 99% gender pay   equity globally $50M   spent on employee learning   and developmentFY22 highlightsSOCIAL IMPACT 2022 Integrated Performance Report       41 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexSOCIAL IMPACT Global  healthcare accessAdding business value Inspired by our Mission and  powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform lives.
","('Product_Quality_And_Safety', 0.7171761989593506)","('Product_Design_And_Lifecycle_Management', 0.08947688341140747)","('Access_And_Affordability', 0.024973327293992043)","(['Product Quality & Recall Management'], 0.7171761989593506)","('NON-ESG', 0.08947688341140747)","('NON-ESG', 0.024973327293992043)"
Line 418,"FY22 social impact highlights  Global healthcare access  42Philanthropy  51Inclusion, diversity, and equity  57 Supporting a global workforce  64 Patient safety and product quality  72Data privacy and security  78 Supply chain responsibility  2022 Integrated Performance Report Introduction 40 ESG strategy Environmental sustainability Governance and accountability ESG disclosure index  Social impact $2.7B invested in research   and development  $97.1M combined philanthropic   investment by Medtronic and   the Medtronic Foundation$69M invested in healthcare   capacity building, reaching  350,000+ medical professionals 36 % of our U.S. supplier spend,   totaling nearly $2.7 billion,   went to small and diverse-owned  companies100 % ethnically diverse and gender   pay equity achieved in the   U.S. and 99% gender pay   equity globally $50M   spent on employee learning   and developmentFY22 highlightsSOCIAL IMPACT 2022 Integrated Performance Report       41 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexSOCIAL IMPACT Global  healthcare accessAdding business value Inspired by our Mission and  powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform lives.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9657533764839172)","('Access_And_Affordability', 0.0028020881582051516)","('Labor_Practices', 0.002610904397442937)","(['Human Capital Development'], 0.9657533764839172)","('NON-ESG', 0.0028020881582051516)","('NON-ESG', 0.002610904397442937)"
Line 419,"FY22 social impact highlights  Global healthcare access  42Philanthropy  51Inclusion, diversity, and equity  57 Supporting a global workforce  64 Patient safety and product quality  72Data privacy and security  78 Supply chain responsibility  2022 Integrated Performance Report Introduction 40 ESG strategy Environmental sustainability Governance and accountability ESG disclosure index  Social impact $2.7B invested in research   and development  $97.1M combined philanthropic   investment by Medtronic and   the Medtronic Foundation$69M invested in healthcare   capacity building, reaching  350,000+ medical professionals 36 % of our U.S. supplier spend,   totaling nearly $2.7 billion,   went to small and diverse-owned  companies100 % ethnically diverse and gender   pay equity achieved in the   U.S. and 99% gender pay   equity globally $50M   spent on employee learning   and developmentFY22 highlightsSOCIAL IMPACT 2022 Integrated Performance Report       41 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexSOCIAL IMPACT Global  healthcare accessAdding business value Inspired by our Mission and  powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform lives.
","('Business_Model_Resilience', 0.4733390212059021)","('Systemic_Risk_Management', 0.09598935395479202)","('Access_And_Affordability', 0.05189146474003792)","('NON-ESG', 0.4733390212059021)","('NON-ESG', 0.09598935395479202)","('NON-ESG', 0.05189146474003792)"
Line 420,"This contributes to our global business growth while also improving clinical, economic, and community-level outcomes for patients worldwide, with a focus on underserved and underrepresented communities.
","('Access_And_Affordability', 0.9461658596992493)","('Human_Rights_And_Community_Relations', 0.0057607246562838554)","('Product_Quality_And_Safety', 0.004606408998370171)","(['Health Outcome Contribution'], 0.9461658596992493)","('NON-ESG', 0.0057607246562838554)","('NON-ESG', 0.004606408998370171)"
Line 421,"The global crisis of health inequity can  only be solved by accelerating access to healthcare technologies that put people first.
","('Systemic_Risk_Management', 0.32591232657432556)","('Access_And_Affordability', 0.19230490922927856)","('Critical_Incident_Risk_Management', 0.13084131479263306)","('NON-ESG', 0.32591232657432556)","('NON-ESG', 0.19230490922927856)","('NON-ESG', 0.13084131479263306)"
Line 422,"We have the pipeline, data, and technology to help solve many of the world’s biggest health issues.
","('Employee_Health_And_Safety', 0.6446216702461243)","('Critical_Incident_Risk_Management', 0.09682640433311462)","('Access_And_Affordability', 0.06491651386022568)","(['Operational Eco-Efficiency'], 0.6446216702461243)","('NON-ESG', 0.09682640433311462)","('NON-ESG', 0.06491651386022568)"
Line 423,"By leveraging the power of advanced computing, smallest-size solutions, and hyper-personalization, we can increase access to innovative treatments tailored to unique patient needs.
","('Access_And_Affordability', 0.5897860527038574)","('Customer_Welfare', 0.09867855161428452)","('Energy_Management', 0.030060790479183197)","(['Health Outcome Contribution'], 0.5897860527038574)","('NON-ESG', 0.09867855161428452)","('NON-ESG', 0.030060790479183197)"
Line 424,"1   Major geogr aphies include China, Europe, Japan, and the United States.
","('GHG_Emissions', 0.14540284872055054)","('Business_Model_Resilience', 0.14010009169578552)","('Systemic_Risk_Management', 0.13472284376621246)","('NON-ESG', 0.14540284872055054)","('NON-ESG', 0.14010009169578552)","('NON-ESG', 0.13472284376621246)"
Line 425,"2022 Integrated Performance Report       42 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index $2.7B invested in research and development (R&D) 200+ product regulatory approvals in   major geographies1  active clinical trials 350,000+ medical professionals reached through   our healthcare capacity building efforts 51,patients received better clinical and   social outcomes since Medtronic LABS   was established on April 14, 2016Technology innovation  Our total R&D expenditure in FY22 was $2.7 billion,  more than 8% of our annual revenue.
","('Access_And_Affordability', 0.20993803441524506)","('Management_Of_Legal_And_Regulatory_Framework', 0.173721045255661)","('Business_Model_Resilience', 0.09692667424678802)","('NON-ESG', 0.20993803441524506)","('NON-ESG', 0.173721045255661)","('NON-ESG', 0.09692667424678802)"
Line 426,"2022 Integrated Performance Report       42 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index $2.7B invested in research and development (R&D) 200+ product regulatory approvals in   major geographies1  active clinical trials 350,000+ medical professionals reached through   our healthcare capacity building efforts 51,patients received better clinical and   social outcomes since Medtronic LABS   was established on April 14, 2016Technology innovation  Our total R&D expenditure in FY22 was $2.7 billion,  more than 8% of our annual revenue.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4212697446346283)","('Business_Model_Resilience', 0.1028018370270729)","('GHG_Emissions', 0.06740164756774902)","('NON-ESG', 0.4212697446346283)","('NON-ESG', 0.1028018370270729)","('NON-ESG', 0.06740164756774902)"
Line 427,"We make this investment to understand and develop a vast range  of leading-edge technologies with potential to improve our products and treatments and create new ones.
","('Product_Design_And_Lifecycle_Management', 0.9643977284431458)","('Product_Quality_And_Safety', 0.0043830424547195435)","('Customer_Welfare', 0.0032727208454161882)","(['Product Stewardship'], 0.9643977284431458)","('NON-ESG', 0.0043830424547195435)","('NON-ESG', 0.0032727208454161882)"
Line 428,"These include: •   Emer ging technologies such as edge computing   and pressure sensing, and innovations in areas like  sensors and biomaterials.
","('Energy_Management', 0.6496243476867676)","('Supply_Chain_Management', 0.03846662864089012)","('Product_Design_And_Lifecycle_Management', 0.03370637074112892)","(['Operational Eco-Efficiency'], 0.6496243476867676)","('NON-ESG', 0.03846662864089012)","('NON-ESG', 0.03370637074112892)"
Line 429,"•   E volving trends in areas such as regenerative  medicine, 3D printing, and augmented reality.
","('Energy_Management', 0.27197355031967163)","('Product_Design_And_Lifecycle_Management', 0.2255553901195526)","('Customer_Welfare', 0.05885286256670952)","('NON-ESG', 0.27197355031967163)","('NON-ESG', 0.2255553901195526)","('NON-ESG', 0.05885286256670952)"
Line 430,"•   New applica tions for data analytics, artificial  intelligence (AI) and machine learning, robotics, simulation, and modeling.
","('Business_Model_Resilience', 0.27459508180618286)","('Competitive_Behavior', 0.13948658108711243)","('Systemic_Risk_Management', 0.08365597575902939)","('NON-ESG', 0.27459508180618286)","('NON-ESG', 0.13948658108711243)","('NON-ESG', 0.08365597575902939)"
Line 431,"Our knowledge of evolving and established technologies enables us to deliver life-transforming technology and insight-driven care to tackle the most challenging health problems facing humanity.
","('Access_And_Affordability', 0.3308528661727905)","('Employee_Health_And_Safety', 0.32082149386405945)","('Critical_Incident_Risk_Management', 0.061739105731248856)","('NON-ESG', 0.3308528661727905)","('NON-ESG', 0.32082149386405945)","('NON-ESG', 0.061739105731248856)"
Line 432,"We also use these technologies to aid research and training.
","('Access_And_Affordability', 0.351074755191803)","('Management_Of_Legal_And_Regulatory_Framework', 0.18632729351520538)","('Product_Quality_And_Safety', 0.06324067711830139)","('NON-ESG', 0.351074755191803)","('NON-ESG', 0.18632729351520538)","('NON-ESG', 0.06324067711830139)"
Line 433,"For example, in FY22: •   W e increased use of digital twin technology —   virtual representations of devices, physiology, or  systems that use real-time data, simulation, and machine learning to aid our decision-making on potential innovations.
","('Competitive_Behavior', 0.25250157713890076)","('Data_Security', 0.20539821684360504)","('Systemic_Risk_Management', 0.07204480469226837)","('NON-ESG', 0.25250157713890076)","('NON-ESG', 0.20539821684360504)","('NON-ESG', 0.07204480469226837)"
Line 434,"•   W e continued to use virtual reality to bring employees  and customers together, reduce the need for business travel, and simplify training through use of more than 900 Oculus headsets.
","('Employee_Engagement_Inclusion_And_Diversity', 0.19305728375911713)","('Product_Design_And_Lifecycle_Management', 0.12204719334840775)","('Competitive_Behavior', 0.09714692085981369)","('NON-ESG', 0.19305728375911713)","('NON-ESG', 0.12204719334840775)","('NON-ESG', 0.09714692085981369)"
Line 435,"One project enables clinicians to practice finding and accounting for all surgical sponges used during a procedure.
","('Employee_Health_And_Safety', 0.5203489065170288)","('Waste_And_Hazardous_Materials_Management', 0.12017396092414856)","('Product_Quality_And_Safety', 0.06427369266748428)","(['Operational Eco-Efficiency'], 0.5203489065170288)","('NON-ESG', 0.12017396092414856)","('NON-ESG', 0.06427369266748428)"
Line 436,"Other programs bring physicians together with sales representatives in a virtual operating room to learn to use our products and surgical techniques.
","('Product_Design_And_Lifecycle_Management', 0.9244263768196106)","('Customer_Welfare', 0.013427017256617546)","('Product_Quality_And_Safety', 0.011165107600390911)","(['Product Stewardship'], 0.9244263768196106)","('NON-ESG', 0.013427017256617546)","('NON-ESG', 0.011165107600390911)"
Line 437,"Our Healthcare Innovation team, located at our Innovation Lab, supports our global innovation efforts.
","('Business_Model_Resilience', 0.18819846212863922)","('Product_Design_And_Lifecycle_Management', 0.17894494533538818)","('Competitive_Behavior', 0.11615422368049622)","('NON-ESG', 0.18819846212863922)","('NON-ESG', 0.17894494533538818)","('NON-ESG', 0.11615422368049622)"
Line 438,"This group of technologists, strategists, and designers help Medtronic teams across every operating unit turn innovative ideas into practical solutions, with a focus on human-centered design, high-quality deliverables, and hands-on learning.
","('Product_Design_And_Lifecycle_Management', 0.706935465335846)","('Business_Model_Resilience', 0.07273738831281662)","('Customer_Welfare', 0.03454705327749252)","(['Product Stewardship'], 0.706935465335846)","('NON-ESG', 0.07273738831281662)","('NON-ESG', 0.03454705327749252)"
Line 439,"Each year, the team completes approximately 65 projects, carries out more than 200 user interviews, and trains more than 1,000 Medtronic employees in new skills and creative methodologies.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7559643983840942)","('Product_Design_And_Lifecycle_Management', 0.032892435789108276)","('Employee_Health_And_Safety', 0.02730022743344307)","(['Human Capital Development'], 0.7559643983840942)","('NON-ESG', 0.032892435789108276)","('NON-ESG', 0.02730022743344307)"
Line 440,"GOALS TO EXPAND GLOBAL HEALTHCARE ACCESS  FY21 FYBy FY25, 20% of Medtronic revenue will flow from products and  therapies released in the prior 36 months (vitality index).17% 19% By FY25, 85 million patients will be served annually through our increased access strategies.GLOBAL HEALTHCARE ACCESS OUR INNOVATION PIPELINE  FY20 FY21 FYTotal R&D investment ($ billions) 2.3 2.5 2.Clinical studies completed 54 49 Active clinical trials during the fiscal year†247 244 Product regulatory approvals in major geographies‡– – 200+ †  In FY22,  we updated this metric from ongoing clinical trials at the end of the fiscal year to active clinical trials during the fiscal year to provide a more  meaningful picture.
","('Customer_Welfare', 0.24492301046848297)","('Product_Quality_And_Safety', 0.09991876035928726)","('Access_And_Affordability', 0.09501264989376068)","('NON-ESG', 0.24492301046848297)","('NON-ESG', 0.09991876035928726)","('NON-ESG', 0.09501264989376068)"
Line 441,"GOALS TO EXPAND GLOBAL HEALTHCARE ACCESS  FY21 FYBy FY25, 20% of Medtronic revenue will flow from products and  therapies released in the prior 36 months (vitality index).17% 19% By FY25, 85 million patients will be served annually through our increased access strategies.GLOBAL HEALTHCARE ACCESS OUR INNOVATION PIPELINE  FY20 FY21 FYTotal R&D investment ($ billions) 2.3 2.5 2.Clinical studies completed 54 49 Active clinical trials during the fiscal year†247 244 Product regulatory approvals in major geographies‡– – 200+ †  In FY22,  we updated this metric from ongoing clinical trials at the end of the fiscal year to active clinical trials during the fiscal year to provide a more  meaningful picture.
","('Customer_Welfare', 0.12849681079387665)","('Access_And_Affordability', 0.11184272915124893)","('GHG_Emissions', 0.09992218017578125)","('NON-ESG', 0.12849681079387665)","('NON-ESG', 0.11184272915124893)","('NON-ESG', 0.09992218017578125)"
Line 442,"""Active"" refers to any study that is recruiting subjects or is in the follow-up phase (all subjects have been recruited, follow-up visits  are ongoing) during the fiscal year.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6131812334060669)","('Access_And_Affordability', 0.08357851952314377)","('Customer_Welfare', 0.03767038509249687)","(['Human Capital Development'], 0.6131812334060669)","('NON-ESG', 0.08357851952314377)","('NON-ESG', 0.03767038509249687)"
Line 443,"‡  FY22 is the first ye ar Medtronic is disclosing this metric.
","('Management_Of_Legal_And_Regulatory_Framework', 0.22363503277301788)","('Competitive_Behavior', 0.22010496258735657)","('Systemic_Risk_Management', 0.1112755611538887)","('NON-ESG', 0.22363503277301788)","('NON-ESG', 0.22010496258735657)","('NON-ESG', 0.1112755611538887)"
Line 444,"Major geographies include China, Europe, Japan, and the United States.
","('Competitive_Behavior', 0.18469375371932983)","('Business_Model_Resilience', 0.1808539181947708)","('Systemic_Risk_Management', 0.148869588971138)","('NON-ESG', 0.18469375371932983)","('NON-ESG', 0.1808539181947708)","('NON-ESG', 0.148869588971138)"
Line 445,"Medical design excellence At the 2021 Medical Design Excellence Awards, we received Best in Show for the   LINQ II™ Insertable Cardiac Monitoring (ICM) system and the Medical Device and Diagnostic Industry Readers’ Choice award for the CareLink SmartSync™ device manager.
","('Product_Design_And_Lifecycle_Management', 0.8402684330940247)","('Product_Quality_And_Safety', 0.025926847010850906)","('Customer_Welfare', 0.015805356204509735)","(['Product Stewardship'], 0.8402684330940247)","('NON-ESG', 0.025926847010850906)","('NON-ESG', 0.015805356204509735)"
Line 446,"72   million 76.3  million 2022 Integrated Performance Report       43 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index See the device manuals for  detailed information regarding the implant procedure, indications/intended use, contraindications, warnings, precautions, and potential complications/adverse events.
","('Product_Quality_And_Safety', 0.1873018592596054)","('Business_Ethics', 0.18508592247962952)","('Systemic_Risk_Management', 0.16137292981147766)","('NON-ESG', 0.1873018592596054)","('NON-ESG', 0.18508592247962952)","('NON-ESG', 0.16137292981147766)"
Line 447,"For further information, please call Medtronic at 800-328-2518 (Technical Services), 800-551-5544 (Patient Services), and/or consult the Medtronic website at medtronic.com.
","('Access_And_Affordability', 0.27630680799484253)","('Product_Quality_And_Safety', 0.09169656783342361)","('Customer_Welfare', 0.08030828088521957)","('NON-ESG', 0.27630680799484253)","('NON-ESG', 0.09169656783342361)","('NON-ESG', 0.08030828088521957)"
Line 448,"Caution: Federal law (USA)  restricts this device to sale by or on the order of a physician.GLOBAL HEALTHCARE ACCESS Research and clinical trials Our rigorous process of design and development  enables us to tailor products and services to unique patient needs.
","('Product_Design_And_Lifecycle_Management', 0.7880618572235107)","('Customer_Welfare', 0.06917153298854828)","('Selling_Practices_And_Product_Labeling', 0.03212842717766762)","(['Product Stewardship'], 0.7880618572235107)","('NON-ESG', 0.06917153298854828)","('NON-ESG', 0.03212842717766762)"
Line 449,"Predictive engineering supported by advanced statistical methodology helps us understand how a product will work in the field, while the use of digital twin systems allows us to model different use scenarios.
","('Product_Design_And_Lifecycle_Management', 0.9118250608444214)","('Customer_Welfare', 0.011911435052752495)","('Energy_Management', 0.009947935119271278)","(['Product Stewardship'], 0.9118250608444214)","('NON-ESG', 0.011911435052752495)","('NON-ESG', 0.009947935119271278)"
Line 450,"We take our most promising innovations through  systematic preclinical or clinical trials, always taking a human-centered approach.
","('Competitive_Behavior', 0.1699049323797226)","('Customer_Welfare', 0.14945809543132782)","('Access_And_Affordability', 0.07946460694074631)","('NON-ESG', 0.1699049323797226)","('NON-ESG', 0.14945809543132782)","('NON-ESG', 0.07946460694074631)"
Line 451,"Throughout the development process, we prioritize safety, effectiveness, patient experience and diversity, and clinical outcomes.
","('Product_Quality_And_Safety', 0.41665568947792053)","('Access_And_Affordability', 0.13999852538108826)","('Employee_Health_And_Safety', 0.08268487453460693)","('NON-ESG', 0.41665568947792053)","('NON-ESG', 0.13999852538108826)","('NON-ESG', 0.08268487453460693)"
Line 452,"FY22 R&D highlights include: •   Launch of  the Medtronic Discovery™ app, designed  to recruit participants, communicate with them, and  collect data throughout large-scale clinical studies conducted remotely.
","('Customer_Welfare', 0.1852094829082489)","('Access_And_Affordability', 0.12120380252599716)","('Competitive_Behavior', 0.09750454127788544)","('NON-ESG', 0.1852094829082489)","('NON-ESG', 0.12120380252599716)","('NON-ESG', 0.09750454127788544)"
Line 453,"•   C ompletion of participant enrollment for the  Global Pivotal trial of the PulseSelect™ Pulsed Field Ablation system (PULSED AF) — a global, pre-market, multicenter clinical study that will evaluate this novel breakthrough technology for treating atrial fibrillation.
","('Customer_Welfare', 0.17665351927280426)","('Competitive_Behavior', 0.1191803589463234)","('Access_And_Affordability', 0.11252535879611969)","('NON-ESG', 0.17665351927280426)","('NON-ESG', 0.1191803589463234)","('NON-ESG', 0.11252535879611969)"
Line 454,"Launched last year, our technology development centers (TDCs) have continued to grow, providing critical R&D innovation for our operating units.
","('Product_Design_And_Lifecycle_Management', 0.31549298763275146)","('Business_Model_Resilience', 0.2156326025724411)","('Supply_Chain_Management', 0.1370600163936615)","('NON-ESG', 0.31549298763275146)","('NON-ESG', 0.2156326025724411)","('NON-ESG', 0.1370600163936615)"
Line 455,"We now have seven TDCs established, advancing technology for the future  in the areas of microelectronics, batteries, cardiac  and neuromodulation implantables, textiles, robotics, and image-guided navigation.
","('Product_Design_And_Lifecycle_Management', 0.4457654058933258)","('Energy_Management', 0.06950367987155914)","('Customer_Welfare', 0.06532512605190277)","('NON-ESG', 0.4457654058933258)","('NON-ESG', 0.06950367987155914)","('NON-ESG', 0.06532512605190277)"
Line 456,"New regulatory approvals In FY22, we had more than 200 product regulatory approvals in major geographies.
","('Management_Of_Legal_And_Regulatory_Framework', 0.938701868057251)","('Competitive_Behavior', 0.011029846966266632)","('GHG_Emissions', 0.006700871977955103)","(['Corporate Governance'], 0.938701868057251)","('NON-ESG', 0.011029846966266632)","('NON-ESG', 0.006700871977955103)"
Line 457,"Highlights include: •   T he Hugo™ RAS (robotic-assisted surgery) system  received the CE mark in Europe for urologic and  gynecologic procedures, which make up the majority of robotic procedures in Europe, and we completed the first general surgery procedures in Latin America and India (below right).
","('Employee_Health_And_Safety', 0.17734010517597198)","('Access_And_Affordability', 0.15344597399234772)","('Employee_Engagement_Inclusion_And_Diversity', 0.10915856063365936)","('NON-ESG', 0.17734010517597198)","('NON-ESG', 0.15344597399234772)","('NON-ESG', 0.10915856063365936)"
Line 458,"•  T he Prevail™ drug-coated balloon (DCB) catheter  received the CE mark in Europe and is used during percutaneous coronary intervention procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease (below).
","('Access_And_Affordability', 0.38325443863868713)","('Employee_Health_And_Safety', 0.12455390393733978)","('Critical_Incident_Risk_Management', 0.06815626472234726)","('NON-ESG', 0.38325443863868713)","('NON-ESG', 0.12455390393733978)","('NON-ESG', 0.06815626472234726)"
Line 459,"•   T he NuVent™ Eustachian tube dilation balloon is  a manually controlled balloon catheter system that enables surgeons to deliver treatment of chronic, obstructive Eustachian tube dysfunction in an outpatient or office setting.
","('Employee_Health_And_Safety', 0.4758818447589874)","('Access_And_Affordability', 0.09802653640508652)","('Employee_Engagement_Inclusion_And_Diversity', 0.08125501126050949)","('NON-ESG', 0.4758818447589874)","('NON-ESG', 0.09802653640508652)","('NON-ESG', 0.08125501126050949)"
Line 460,"Read more about our new FY22 approvals in the Medtronic Newsroom.Innovative partnerships  To advance our Mission, we partner with peers, innovators, healthcare systems, and others to deliver solutions matched to local need and develop new approaches to increase access to our treatments.
","('Access_And_Affordability', 0.36195364594459534)","('Customer_Welfare', 0.16491572558879852)","('Competitive_Behavior', 0.059953588992357254)","('NON-ESG', 0.36195364594459534)","('NON-ESG', 0.16491572558879852)","('NON-ESG', 0.059953588992357254)"
Line 461,"New FY22 partnerships included: •   P ublic-private partnership (PPP) with Pioneers  Technical Systems and Vision 3030 in Saudi Arabia to  produce up to 6,000 Puritan Bennett™ 560 (PB560) ventilators annually in Saudi Arabia.
","('Critical_Incident_Risk_Management', 0.5680034160614014)","('Energy_Management', 0.10759355872869492)","('Air_Quality', 0.09082690626382828)","(['Risk & Crisis Management'], 0.5680034160614014)","('NON-ESG', 0.10759355872869492)","('NON-ESG', 0.09082690626382828)"
Line 462,"These will be the first ventilators and first pieces of capital medical equipment made in the Kingdom.
","('Critical_Incident_Risk_Management', 0.6885957717895508)","('Employee_Health_And_Safety', 0.07119009643793106)","('Air_Quality', 0.062312908470630646)","(['Risk & Crisis Management'], 0.6885957717895508)","('NON-ESG', 0.07119009643793106)","('NON-ESG', 0.062312908470630646)"
Line 463,"•   C ollaboration with Rockley Photonics to develop the  next generation of wearable healthcare monitoring devices.
","('Product_Design_And_Lifecycle_Management', 0.5266019701957703)","('Energy_Management', 0.1951523721218109)","('Data_Security', 0.0344306081533432)","(['Product Stewardship'], 0.5266019701957703)","('NON-ESG', 0.1951523721218109)","('NON-ESG', 0.0344306081533432)"
Line 464,"This was achieved by adding Rockley’s Bioptx™ biomarker-sensing platform to Medtronic offerings for use across a range of healthcare settings.In FY22, we launched our first Open Innovation Platform (OIP) with support from the Government of Singapore and the Singapore Economic Development Board, enabling multistakeholder strategic collaboration in healthcare technologies.
","('Customer_Welfare', 0.15039397776126862)","('Business_Model_Resilience', 0.12065915018320084)","('Access_And_Affordability', 0.10850111395120621)","('NON-ESG', 0.15039397776126862)","('NON-ESG', 0.12065915018320084)","('NON-ESG', 0.10850111395120621)"
Line 465,"The first OIP initiative was the Medtronic APAC Innovation Challenge (MAIC), which invited innovative startups and businesses across the Asia-Pacific region to submit proposals for medtech and digital health solutions.
","('Business_Model_Resilience', 0.17512807250022888)","('Product_Design_And_Lifecycle_Management', 0.16394971311092377)","('Supply_Chain_Management', 0.10738328844308853)","('NON-ESG', 0.17512807250022888)","('NON-ESG', 0.16394971311092377)","('NON-ESG', 0.10738328844308853)"
Line 466,"There were more than 320 ideas submitted across 46 countries.
","('Competitive_Behavior', 0.3333621919155121)","('Management_Of_Legal_And_Regulatory_Framework', 0.10807350277900696)","('Business_Model_Resilience', 0.05029444769024849)","('NON-ESG', 0.3333621919155121)","('NON-ESG', 0.10807350277900696)","('NON-ESG', 0.05029444769024849)"
Line 467,"The top five winners are now partnering with Medtronic for a commercial pilot.
","('Product_Design_And_Lifecycle_Management', 0.15419922769069672)","('Competitive_Behavior', 0.12766040861606598)","('Customer_Welfare', 0.11262395977973938)","('NON-ESG', 0.15419922769069672)","('NON-ESG', 0.12766040861606598)","('NON-ESG', 0.11262395977973938)"
Line 468,"Investment in innovative companies is another route  to increasing access to treatments and therapies.
","('Access_And_Affordability', 0.7425185441970825)","('Product_Quality_And_Safety', 0.041271746158599854)","('Customer_Welfare', 0.026682846248149872)","(['Health Outcome Contribution'], 0.7425185441970825)","('NON-ESG', 0.041271746158599854)","('NON-ESG', 0.026682846248149872)"
Line 469,"Read about our approach to acquisitions.
","('Competitive_Behavior', 0.29017576575279236)","('Business_Model_Resilience', 0.2534741759300232)","('Systemic_Risk_Management', 0.18017396330833435)","('NON-ESG', 0.29017576575279236)","('NON-ESG', 0.2534741759300232)","('NON-ESG', 0.18017396330833435)"
Line 470,"2022 Integrated Performance Report       44 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index Risks may include  mild bleeding, pain and/or tissue trauma.
","('Employee_Health_And_Safety', 0.9616349339485168)","('Critical_Incident_Risk_Management', 0.007293551694601774)","('Employee_Engagement_Inclusion_And_Diversity', 0.002847988624125719)","(['Operational Eco-Efficiency'], 0.9616349339485168)","('NON-ESG', 0.007293551694601774)","('NON-ESG', 0.002847988624125719)"
Line 471,"1  T he Medtronic Hugo™ RAS system is commercially available in certain  geographies.
","('Customer_Welfare', 0.16667912900447845)","('Product_Design_And_Lifecycle_Management', 0.14474236965179443)","('Competitive_Behavior', 0.1034267470240593)","('NON-ESG', 0.16667912900447845)","('NON-ESG', 0.14474236965179443)","('NON-ESG', 0.1034267470240593)"
Line 472,"Regulatory requirements of individual countries and regions will determine approval, clearance, or market availability.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9620411396026611)","('Competitive_Behavior', 0.006370150484144688)","('Business_Ethics', 0.002893816912546754)","(['Corporate Governance'], 0.9620411396026611)","('NON-ESG', 0.006370150484144688)","('NON-ESG', 0.002893816912546754)"
Line 473,"In the EU, the Hugo™ RAS system is CE marked.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7564945816993713)","('Competitive_Behavior', 0.02673596329987049)","('Director_Removal', 0.02530544064939022)","(['Corporate Governance'], 0.7564945816993713)","('NON-ESG', 0.02673596329987049)","('NON-ESG', 0.02530544064939022)"
Line 474,"In the U.S., the Hugo™ system is an investigational device not for sale.GLOBAL HEALTHCARE ACCESS Affordable healthcare Our pricing approach The Medtronic Mission calls us to engineer the  extraordinary — products and solutions that can alleviate pain, restore health, and extend life, but engineering alone cannot make them accessible; they must also  be affordable.
","('Product_Design_And_Lifecycle_Management', 0.32034406065940857)","('Access_And_Affordability', 0.17329606413841248)","('Product_Quality_And_Safety', 0.10644856840372086)","('NON-ESG', 0.32034406065940857)","('NON-ESG', 0.17329606413841248)","('NON-ESG', 0.10644856840372086)"
Line 475,"Our Mission-driven pricing programs  and policies account for local circumstances and  market dynamics, as well as the product’s value to the healthcare system.
","('Product_Design_And_Lifecycle_Management', 0.5031115412712097)","('Customer_Welfare', 0.12619352340698242)","('Selling_Practices_And_Product_Labeling', 0.0806879922747612)","(['Product Stewardship'], 0.5031115412712097)","('NON-ESG', 0.12619352340698242)","('NON-ESG', 0.0806879922747612)"
Line 476,"The principles of fairness and sustainability underpin  all our pricing models, which are aligned with local market environments.
","('Competitive_Behavior', 0.8720875978469849)","('Management_Of_Legal_And_Regulatory_Framework', 0.03540392220020294)","('Business_Ethics', 0.031800173223018646)","(['Business Ethics'], 0.8720875978469849)","('NON-ESG', 0.03540392220020294)","('NON-ESG', 0.031800173223018646)"
Line 477,"Our Healthcare Economics Policy and Reimbursement (HEPR) function oversees our reimbursement strategy and systems across all our portfolios.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4163834750652313)","('Business_Ethics', 0.30239081382751465)","('Systemic_Risk_Management', 0.0872533842921257)","('NON-ESG', 0.4163834750652313)","('NON-ESG', 0.30239081382751465)","('NON-ESG', 0.0872533842921257)"
Line 478,"HEPR allows us to adapt to local needs by ensuring close coordination and cooperation across operating units and markets.Value-based healthcare We focus on delivering value-based healthcare  (VBHC) models that improve patient outcomes while reducing the overall cost of care.
","('Access_And_Affordability', 0.4319685995578766)","('Energy_Management', 0.10741984844207764)","('Customer_Welfare', 0.06697899103164673)","('NON-ESG', 0.4319685995578766)","('NON-ESG', 0.10741984844207764)","('NON-ESG', 0.06697899103164673)"
Line 479,"Rather than receiving  payment for a volume of product or therapy, we collaborate with partners to integrate products and services into long-term solutions that elevate clinical  and economic outcomes.
","('Product_Design_And_Lifecycle_Management', 0.5578237175941467)","('Customer_Welfare', 0.19417734444141388)","('Selling_Practices_And_Product_Labeling', 0.061564601957798004)","(['Product Stewardship'], 0.5578237175941467)","('NON-ESG', 0.19417734444141388)","('NON-ESG', 0.061564601957798004)"
Line 480,"Our VBHC collaborations enable practitioners at  healthcare systems globally to apply the right therapy at the right time to patients who will benefit most.
","('Access_And_Affordability', 0.801410436630249)","('Customer_Welfare', 0.018770504742860794)","('Energy_Management', 0.018652115017175674)","(['Health Outcome Contribution'], 0.801410436630249)","('NON-ESG', 0.018770504742860794)","('NON-ESG', 0.018652115017175674)"
Line 481,"For example, last year the Medtronic Diabetes operating  unit and two longtime health plan partners, Blue Cross and Blue Shield of Minnesota, achieved an industry first by moving the supply of insulin pumps to the same process used for prescription medications.
","('Customer_Welfare', 0.328850656747818)","('Access_And_Affordability', 0.14310291409492493)","('Energy_Management', 0.08856063336133957)","('NON-ESG', 0.328850656747818)","('NON-ESG', 0.14310291409492493)","('NON-ESG', 0.08856063336133957)"
Line 482,"In the United States, patients pay an average of $800 out of pocket for an insulin pump while waiting a month or more for approval of an insurance claim.
","('Management_Of_Legal_And_Regulatory_Framework', 0.26510095596313477)","('Access_And_Affordability', 0.23799863457679749)","('Labor_Practices', 0.11404283344745636)","('NON-ESG', 0.26510095596313477)","('NON-ESG', 0.23799863457679749)","('NON-ESG', 0.11404283344745636)"
Line 483,"Now, Blue Cross and Blue Shield of Minnesota members with Prime Therapeutics as their pharmacy benefits manager get a prescription from their doctor and pay an average of just $50 for a MiniMed™ 670G or MiniMed™ 770G system.
","('Access_And_Affordability', 0.14161242544651031)","('Customer_Welfare', 0.12960264086723328)","('Management_Of_Legal_And_Regulatory_Framework', 0.08589402586221695)","('NON-ESG', 0.14161242544651031)","('NON-ESG', 0.12960264086723328)","('NON-ESG', 0.08589402586221695)"
Line 484,"This has the potential to significantly lower costs for people living with diabetes, reduce paperwork, and make life easier for physicians.
","('Access_And_Affordability', 0.26342061161994934)","('Employee_Health_And_Safety', 0.2099076509475708)","('Product_Quality_And_Safety', 0.12249495089054108)","('NON-ESG', 0.26342061161994934)","('NON-ESG', 0.2099076509475708)","('NON-ESG', 0.12249495089054108)"
Line 485,"In FY22, we launched a two-year strategic collaboration  with GE Healthcare, working with ambulatory surgery centers and office-based labs to help them meet evolving patient needs cost effectively and efficiently.
","('Access_And_Affordability', 0.3996337056159973)","('Customer_Welfare', 0.10389579087495804)","('Energy_Management', 0.10222799330949783)","('NON-ESG', 0.3996337056159973)","('NON-ESG', 0.10389579087495804)","('NON-ESG', 0.10222799330949783)"
Line 486,"The collaboration features a flexible custom rebate program that enables direct rebates to be earned on Medtronic products and associated capital.Demonstrating the value of monitoring   opioid treatment Last year, we shared the results of our PRODIGY trial, which was designed to assist  clinicians in the identification of high-risk patients receiving opioids and reduce the likelihood of complications from respiratory depression.
","('Access_And_Affordability', 0.2491586059331894)","('Product_Quality_And_Safety', 0.14832691848278046)","('Employee_Health_And_Safety', 0.10434015840291977)","('NON-ESG', 0.2491586059331894)","('NON-ESG', 0.14832691848278046)","('NON-ESG', 0.10434015840291977)"
Line 487,"In FY22, we shared new data from the trial that added an indication of potential  economic benefit of continuous capnography and pulse oximetry monitoring of high-risk patients.
","('Access_And_Affordability', 0.5849065184593201)","('Employee_Health_And_Safety', 0.086741141974926)","('Product_Quality_And_Safety', 0.04524041712284088)","(['Health Outcome Contribution'], 0.5849065184593201)","('NON-ESG', 0.086741141974926)","('NON-ESG', 0.04524041712284088)"
Line 488,"The model suggested a potential $535,531 annual savings for a median-sized U.S. hospital and a cumulative patient length of stay decrease of 103 days per year, assuming respiratory depression is decreased by 20%.
","('Employee_Health_And_Safety', 0.7463892102241516)","('Access_And_Affordability', 0.0529484748840332)","('Employee_Engagement_Inclusion_And_Diversity', 0.02371412329375744)","(['Operational Eco-Efficiency'], 0.7463892102241516)","('NON-ESG', 0.0529484748840332)","('NON-ESG', 0.02371412329375744)"
Line 489,"Our model suggests that a reduction of just 1.5% in the incidence of respiratory  depression would allow hospital systems to recover costs associated with the investment in monitoring.
","('Employee_Health_And_Safety', 0.7068029642105103)","('Access_And_Affordability', 0.09384021908044815)","('Critical_Incident_Risk_Management', 0.03970567137002945)","(['Operational Eco-Efficiency'], 0.7068029642105103)","('NON-ESG', 0.09384021908044815)","('NON-ESG', 0.03970567137002945)"
Line 490,"2022 Integrated Performance Report       45 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexGLOBAL HEALTHCARE ACCESS Addressing healthcare disparities To reduce disparities across global healthcare  systems, we work to increase access to life-changing technologies.
","('Access_And_Affordability', 0.8531357049942017)","('Product_Quality_And_Safety', 0.012158649042248726)","('Employee_Engagement_Inclusion_And_Diversity', 0.011775556951761246)","(['Health Outcome Contribution'], 0.8531357049942017)","('NON-ESG', 0.012158649042248726)","('NON-ESG', 0.011775556951761246)"
Line 491,"We develop programs and foster relationships to scale access to our products and services — focusing on prevention, detection, and treatment of noncommunicable diseases in underserved communities.
","('Access_And_Affordability', 0.945591926574707)","('Product_Quality_And_Safety', 0.005203893408179283)","('Human_Rights_And_Community_Relations', 0.004672433715313673)","(['Health Outcome Contribution'], 0.945591926574707)","('NON-ESG', 0.005203893408179283)","('NON-ESG', 0.004672433715313673)"
Line 492,"In FY22, we established the Medtronic Health Equity  Advisory Committee (HEAC) in the United States, comprising representatives from across our operating units, Employee Resource Groups (ERGs), and U.S. functions.
","('Access_And_Affordability', 0.22874167561531067)","('Employee_Health_And_Safety', 0.14254239201545715)","('Employee_Engagement_Inclusion_And_Diversity', 0.11136745661497116)","('NON-ESG', 0.22874167561531067)","('NON-ESG', 0.14254239201545715)","('NON-ESG', 0.11136745661497116)"
Line 493,"The HEAC’s purpose is to: •   Shar e best practices and ensure consistency of  customer engagement on health equity.
","('Business_Model_Resilience', 0.619694173336029)","('Systemic_Risk_Management', 0.06605467200279236)","('Employee_Engagement_Inclusion_And_Diversity', 0.06081550195813179)","(['Codes of Business Conduct'], 0.619694173336029)","('NON-ESG', 0.06605467200279236)","('NON-ESG', 0.06081550195813179)"
Line 494,"•   W ork collaboratively to help shape strategy and  solutions that will be scalable and sustainable and  have a measurable impact.
","('Business_Model_Resilience', 0.4100055992603302)","('Product_Design_And_Lifecycle_Management', 0.18306434154510498)","('Supply_Chain_Management', 0.055534202605485916)","('NON-ESG', 0.4100055992603302)","('NON-ESG', 0.18306434154510498)","('NON-ESG', 0.055534202605485916)"
Line 495,"•   Align on he alth equity definitions and consistent  language, craft a common framework, and maximize data analysis models to promote health equity opportunities.
","('Systemic_Risk_Management', 0.2171955406665802)","('Business_Model_Resilience', 0.1710914969444275)","('Employee_Engagement_Inclusion_And_Diversity', 0.15658064186573029)","('NON-ESG', 0.2171955406665802)","('NON-ESG', 0.1710914969444275)","('NON-ESG', 0.15658064186573029)"
Line 496,"To date, the HEAC has focused on developing ways to engage and support healthcare customers.
","('Product_Design_And_Lifecycle_Management', 0.1743379384279251)","('Access_And_Affordability', 0.15667788684368134)","('Customer_Welfare', 0.12205223739147186)","('NON-ESG', 0.1743379384279251)","('NON-ESG', 0.15667788684368134)","('NON-ESG', 0.12205223739147186)"
Line 497,"This includes agreeing on a common framework to help customers take a community-focused approach designed to address health equity, accelerate access, and remove structural and social barriers to quality care.
","('Access_And_Affordability', 0.903653085231781)","('Human_Rights_And_Community_Relations', 0.012087734416127205)","('Product_Quality_And_Safety', 0.008089323528110981)","(['Health Outcome Contribution'], 0.903653085231781)","('NON-ESG', 0.012087734416127205)","('NON-ESG', 0.008089323528110981)"
Line 498,"Some of our current activities to improve equitable  identification, engagement, interventions, and measurement include: •   Educa tion and awareness campaigns on inequities in  diabetes care through our Aquire some knowledge   (ASK) program.•  Dona tions through the Medtronic Health Equity  Assistance Program for colon cancer screening —  see case study right.
","('Access_And_Affordability', 0.6606815457344055)","('Employee_Engagement_Inclusion_And_Diversity', 0.05492885410785675)","('Customer_Welfare', 0.036124419420957565)","(['Health Outcome Contribution'], 0.6606815457344055)","('NON-ESG', 0.05492885410785675)","('NON-ESG', 0.036124419420957565)"
Line 499,"•   C ollaborations with Virtua Health, the Cherry Hill Free  Clinic, and Medtronic LABS that work to improve healthcare access and health outcomes.
","('Access_And_Affordability', 0.8476100564002991)","('Employee_Health_And_Safety', 0.022550875321030617)","('Customer_Welfare', 0.0130397854372859)","(['Health Outcome Contribution'], 0.8476100564002991)","('NON-ESG', 0.022550875321030617)","('NON-ESG', 0.0130397854372859)"
Line 500,"This is achieved by disrupting and reimagining traditional healthcare models with technology for underserved patient communities with chronic conditions in southern New Jersey.
","('Access_And_Affordability', 0.9482685327529907)","('Critical_Incident_Risk_Management', 0.004942978732287884)","('Human_Rights_And_Community_Relations', 0.004142457153648138)","(['Health Outcome Contribution'], 0.9482685327529907)","('NON-ESG', 0.004942978732287884)","('NON-ESG', 0.004142457153648138)"
Line 501,"•   P artnerships with four local health systems in the  U.S. to explore root causes of disparities in access to transcatheter aortic valve replacement (TAVR) among people of color — based on the lessons learned from these local programs, we have defined a roadmap and resources to support a broader base of customers who want to address similar disparities in their local markets.
","('Access_And_Affordability', 0.3274713158607483)","('Employee_Health_And_Safety', 0.30327823758125305)","('Employee_Engagement_Inclusion_And_Diversity', 0.07784709334373474)","('NON-ESG', 0.3274713158607483)","('NON-ESG', 0.30327823758125305)","('NON-ESG', 0.07784709334373474)"
Line 502,"•   C ollaboration between Medtronic, Mpirik, and Vizient  to pilot electronic health record screening for the identification of sudden cardiac arrest risks, regardless of race or gender.
","('Employee_Health_And_Safety', 0.7674807906150818)","('Employee_Engagement_Inclusion_And_Diversity', 0.14533378183841705)","('Product_Quality_And_Safety', 0.010455559939146042)","(['Operational Eco-Efficiency'], 0.7674807906150818)","('NON-ESG', 0.14533378183841705)","('NON-ESG', 0.010455559939146042)"
Line 503,"•   Affilia tion with MedTech Color, along with internal  efforts, to foster racial and ethnic diversity in Medtronic clinical trials.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9752968549728394)","('Employee_Health_And_Safety', 0.0018828834872692823)","('Human_Rights_And_Community_Relations', 0.0016548946732655168)","(['Human Capital Development'], 0.9752968549728394)","('NON-ESG', 0.0018828834872692823)","('NON-ESG', 0.0016548946732655168)"
Line 504,"•   R eaffirmation of our commitment to quality   outcomes through our memberships with the National Quality Forum and the National Committee for Quality Assurance.
","('Business_Ethics', 0.23392526805400848)","('Product_Quality_And_Safety', 0.21184463798999786)","('Management_Of_Legal_And_Regulatory_Framework', 0.11491101235151291)","('NON-ESG', 0.23392526805400848)","('NON-ESG', 0.21184463798999786)","('NON-ESG', 0.11491101235151291)"
Line 505,"Our philanthropic activities also help reduce inequities across healthcare systems and in STEM education.Reducing inequities in cancer detection Colorectal cancer is the third most common cancer, excluding  skin cancers, and third deadliest cancer among adults in the United States.
","('Employee_Health_And_Safety', 0.42613720893859863)","('Employee_Engagement_Inclusion_And_Diversity', 0.0820666030049324)","('Access_And_Affordability', 0.04945767670869827)","('NON-ESG', 0.42613720893859863)","('NON-ESG', 0.0820666030049324)","('NON-ESG', 0.04945767670869827)"
Line 506,"1 Black adults are more likely to be diagnosed and  subsequently die from the disease.
","('Employee_Health_And_Safety', 0.6063439249992371)","('Access_And_Affordability', 0.1049078032374382)","('Employee_Engagement_Inclusion_And_Diversity', 0.053992461413145065)","(['Operational Eco-Efficiency'], 0.6063439249992371)","('NON-ESG', 0.1049078032374382)","('NON-ESG', 0.053992461413145065)"
Line 507,"There are also disparities in screenings among different groups, including adults in rural communities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3279794752597809)","('Access_And_Affordability', 0.20111191272735596)","('Human_Rights_And_Community_Relations', 0.1552899330854416)","('NON-ESG', 0.3279794752597809)","('NON-ESG', 0.20111191272735596)","('NON-ESG', 0.1552899330854416)"
Line 508,"When caught early the survival rate for colorectal cancer is around 90%.
","('Employee_Health_And_Safety', 0.2547130882740021)","('Access_And_Affordability', 0.21869778633117676)","('Product_Quality_And_Safety', 0.08263698220252991)","('NON-ESG', 0.2547130882740021)","('NON-ESG', 0.21869778633117676)","('NON-ESG', 0.08263698220252991)"
Line 509,"In FY22, Medtronic began a partnership with the American  Society for Gastrointestinal Endoscopy (ASGE), with support from Amazon Web Services, to provide colorectal cancer screening technologies in low-income and underserved communities across the United States.
","('Access_And_Affordability', 0.941306471824646)","('Product_Quality_And_Safety', 0.0054361289367079735)","('Ecological_Impacts', 0.004387999419122934)","(['Health Outcome Contribution'], 0.941306471824646)","('NON-ESG', 0.0054361289367079735)","('NON-ESG', 0.004387999419122934)"
Line 510,"The Medtronic Health Equity Assistance Program for colon cancer screening includes a donation of  130 Medtronic GI Genius TM intelligent endoscopy modules   (left) to endoscopy centers across the country.
","('Access_And_Affordability', 0.46083611249923706)","('Employee_Health_And_Safety', 0.0843883603811264)","('Product_Quality_And_Safety', 0.08080433309078217)","('NON-ESG', 0.46083611249923706)","('NON-ESG', 0.0843883603811264)","('NON-ESG', 0.08080433309078217)"
Line 511,"These devices  aid endoscopists in the detection of polyps that can lead to colorectal cancer.
","('Employee_Health_And_Safety', 0.14859329164028168)","('Product_Quality_And_Safety', 0.12792477011680603)","('Access_And_Affordability', 0.10905666649341583)","('NON-ESG', 0.14859329164028168)","('NON-ESG', 0.12792477011680603)","('NON-ESG', 0.10905666649341583)"
Line 512,"Deployment of the devices could impact more than 500,000  patients over three years by increasing early detection and diagnosis in underserved communities.
","('Access_And_Affordability', 0.9473134279251099)","('Critical_Incident_Risk_Management', 0.004712967202067375)","('Product_Quality_And_Safety', 0.004513146821409464)","(['Health Outcome Contribution'], 0.9473134279251099)","('NON-ESG', 0.004712967202067375)","('NON-ESG', 0.004513146821409464)"
Line 513,"2022 Integrated Performance Report       46 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index The device shall not be used as a  stand-alone diagnostic device and is not intended to replace clinical decision making.1  J anuary 12, 2022, American Cancer Society, Key Statistics for Colorectal CancerGLOBAL HEALTHCARE ACCESS Medtronic Care Management Services Medtronic Care Management Services (MCMS) offers  at-home remote patient monitoring to help healthcare providers manage patients for chronic conditions, post-surgery or post-hospitalization.
","('Access_And_Affordability', 0.8158069849014282)","('Customer_Welfare', 0.020969456061720848)","('Product_Quality_And_Safety', 0.013548534363508224)","(['Health Outcome Contribution'], 0.8158069849014282)","('NON-ESG', 0.020969456061720848)","('NON-ESG', 0.013548534363508224)"
Line 514,"2022 Integrated Performance Report       46 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index The device shall not be used as a  stand-alone diagnostic device and is not intended to replace clinical decision making.1  J anuary 12, 2022, American Cancer Society, Key Statistics for Colorectal CancerGLOBAL HEALTHCARE ACCESS Medtronic Care Management Services Medtronic Care Management Services (MCMS) offers  at-home remote patient monitoring to help healthcare providers manage patients for chronic conditions, post-surgery or post-hospitalization.
","('Employee_Health_And_Safety', 0.4106488525867462)","('Access_And_Affordability', 0.3111724555492401)","('Critical_Incident_Risk_Management', 0.039729028940200806)","('NON-ESG', 0.4106488525867462)","('NON-ESG', 0.3111724555492401)","('NON-ESG', 0.039729028940200806)"
Line 515,"The monitoring combines patient engagement technology, clinical monitoring software, care management services, data analytics, and reporting.
","('Access_And_Affordability', 0.4081547260284424)","('Customer_Welfare', 0.06407056003808975)","('Energy_Management', 0.0592464953660965)","('NON-ESG', 0.4081547260284424)","('NON-ESG', 0.06407056003808975)","('NON-ESG', 0.0592464953660965)"
Line 516,"In FY22, MCMS increased accessibility and flexibility  in its programs by adding bring-your-own-device capabilities 1 to its remote monitoring product portfolio  and expanding options for use of peripheral devices.
","('Product_Design_And_Lifecycle_Management', 0.9429939985275269)","('Energy_Management', 0.005594062618911266)","('Customer_Welfare', 0.005517764948308468)","(['Product Stewardship'], 0.9429939985275269)","('NON-ESG', 0.005594062618911266)","('NON-ESG', 0.005517764948308468)"
Line 517,"MCMS also began testing digital program enrollment approaches designed to allow patients to get started quickly on their own.
","('Access_And_Affordability', 0.34342721104621887)","('Employee_Engagement_Inclusion_And_Diversity', 0.2074020802974701)","('Customer_Welfare', 0.0667300820350647)","('NON-ESG', 0.34342721104621887)","('NON-ESG', 0.2074020802974701)","('NON-ESG', 0.0667300820350647)"
Line 518,"In addition, MCMS is piloting a new comorbid disease  management program that allows clinicians to more closely monitor people with diabetes who also have continuous glucose monitoring devices.
","('Access_And_Affordability', 0.3143250644207001)","('Employee_Health_And_Safety', 0.17735551297664642)","('Product_Quality_And_Safety', 0.07964932173490524)","('NON-ESG', 0.3143250644207001)","('NON-ESG', 0.17735551297664642)","('NON-ESG', 0.07964932173490524)"
Line 519,"The aim is to empower patients with self-management education and help clinicians identify hypoglycemic episodes and potentially intervene.
","('Access_And_Affordability', 0.42477765679359436)","('Employee_Health_And_Safety', 0.2625088095664978)","('Product_Quality_And_Safety', 0.049172405153512955)","('NON-ESG', 0.42477765679359436)","('NON-ESG', 0.2625088095664978)","('NON-ESG', 0.049172405153512955)"
Line 520,"MCMS plans to continue developing a suite of modular,  personalized digital health solutions that are integrated into patients’ everyday lives and providers’ workflows.Care access  In developed and emerging markets, we identify barriers to access and quantify treatment needs using our Patient Access Acceleration (PAA) methodology.
","('Access_And_Affordability', 0.8795962929725647)","('Employee_Health_And_Safety', 0.01104450412094593)","('Critical_Incident_Risk_Management', 0.010049707256257534)","(['Health Outcome Contribution'], 0.8795962929725647)","('NON-ESG', 0.01104450412094593)","('NON-ESG', 0.010049707256257534)"
Line 521,"This data-driven approach guides our market  development strategy and helps identify investment opportunities to remove barriers to access.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3638765513896942)","('Access_And_Affordability', 0.12806613743305206)","('Systemic_Risk_Management', 0.11362696439027786)","('NON-ESG', 0.3638765513896942)","('NON-ESG', 0.12806613743305206)","('NON-ESG', 0.11362696439027786)"
Line 522,"For example, access may be improved by generating more evidence or expanding economic coverage; capacity building, training, and education; or disease and therapy awareness.
","('Access_And_Affordability', 0.8736655116081238)","('Product_Quality_And_Safety', 0.014878036454319954)","('Employee_Health_And_Safety', 0.011747281067073345)","(['Health Outcome Contribution'], 0.8736655116081238)","('NON-ESG', 0.014878036454319954)","('NON-ESG', 0.011747281067073345)"
Line 523,"Each year, we combine data from thousands of PAA assessments across countries and therapies.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3018547296524048)","('Competitive_Behavior', 0.13609452545642853)","('Business_Ethics', 0.0952116996049881)","('NON-ESG', 0.3018547296524048)","('NON-ESG', 0.13609452545642853)","('NON-ESG', 0.0952116996049881)"
Line 524,"We use our learning to improve planning and reduce risks associated with future market development investments.
","('Systemic_Risk_Management', 0.8834561705589294)","('Business_Model_Resilience', 0.0388350635766983)","('Competitive_Behavior', 0.009182442910969257)","(['Risk & Crisis Management'], 0.8834561705589294)","('NON-ESG', 0.0388350635766983)","('NON-ESG', 0.009182442910969257)"
Line 525,"Specifically, we are integrating machine learning models to help predict how many patients could be treated by our therapies and technologies.
","('Access_And_Affordability', 0.561087429523468)","('Customer_Welfare', 0.0584605447947979)","('Product_Quality_And_Safety', 0.03567274287343025)","(['Health Outcome Contribution'], 0.561087429523468)","('NON-ESG', 0.0584605447947979)","('NON-ESG', 0.03567274287343025)"
Line 526,"Our Patient Access Insights (PAI) consulting service  identifies local needs and barriers to access.
","('Access_And_Affordability', 0.8698901534080505)","('Human_Rights_And_Community_Relations', 0.018798045814037323)","('Critical_Incident_Risk_Management', 0.009398138150572777)","(['Health Outcome Contribution'], 0.8698901534080505)","('NON-ESG', 0.018798045814037323)","('NON-ESG', 0.009398138150572777)"
Line 527,"Around the world, we partner with hospitals to apply PAI to specific services and pathways of care, helping them develop appropriate solutions based on our findings.
","('Access_And_Affordability', 0.6566874384880066)","('Management_Of_Legal_And_Regulatory_Framework', 0.032895490527153015)","('Customer_Welfare', 0.030168933793902397)","(['Health Outcome Contribution'], 0.6566874384880066)","('NON-ESG', 0.032895490527153015)","('NON-ESG', 0.030168933793902397)"
Line 528,"Helping surgeons flourish Following discussions with surgeons about the challenges they face in their surgery  businesses, a member of our Obesity and Metabolic Health team launched an innovative business model to help address the issues of top-line growth, profitability, and operational efficiency.
","('Customer_Welfare', 0.3160281479358673)","('Systemic_Risk_Management', 0.15135212242603302)","('Business_Model_Resilience', 0.12052804976701736)","('NON-ESG', 0.3160281479358673)","('NON-ESG', 0.15135212242603302)","('NON-ESG', 0.12052804976701736)"
Line 529,"As part of the Bariatric Business Consulting service, Medtronic diagnoses the surgeon’s  business challenges.
","('Systemic_Risk_Management', 0.18989332020282745)","('Customer_Welfare', 0.09567151218652725)","('Access_And_Affordability', 0.09326280653476715)","('NON-ESG', 0.18989332020282745)","('NON-ESG', 0.09567151218652725)","('NON-ESG', 0.09326280653476715)"
Line 530,"We then develop and help implement customized solutions, which may include solutions like new digital marketing techniques, improved patient pathways, and various kinds of staff training.
","('Customer_Welfare', 0.14984367787837982)","('Access_And_Affordability', 0.14594365656375885)","('Management_Of_Legal_And_Regulatory_Framework', 0.11756297945976257)","('NON-ESG', 0.14984367787837982)","('NON-ESG', 0.14594365656375885)","('NON-ESG', 0.11756297945976257)"
Line 531,"As the surgeons’ businesses grow and treat more patients, we grow with them.
","('Access_And_Affordability', 0.1834888756275177)","('Competitive_Behavior', 0.13780757784843445)","('Customer_Welfare', 0.12876030802726746)","('NON-ESG', 0.1834888756275177)","('NON-ESG', 0.13780757784843445)","('NON-ESG', 0.12876030802726746)"
Line 532,"Already in 18 countries, the model has helped double our market share in key European, Middle East, and African markets, and we continue to scale it globally.
","('Business_Model_Resilience', 0.3576267659664154)","('Competitive_Behavior', 0.2636973559856415)","('Systemic_Risk_Management', 0.18308986723423004)","('NON-ESG', 0.3576267659664154)","('NON-ESG', 0.2636973559856415)","('NON-ESG', 0.18308986723423004)"
Line 533,"1  P atients can use their own iOS and Android devices.
","('Data_Security', 0.3133400082588196)","('Customer_Privacy', 0.1421906054019928)","('Product_Design_And_Lifecycle_Management', 0.13346080482006073)","('NON-ESG', 0.3133400082588196)","('NON-ESG', 0.1421906054019928)","('NON-ESG', 0.13346080482006073)"
Line 534,"2022 Integrated Performance Report       47 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexGLOBAL HEALTHCARE ACCESS CAPACITY BUILDING FY20 FY21 FYEducation for medical professionals ($ million) $145.4 $69.9†$69.Education for patients ($ million) $18.9 $7.8‡$6.Medical professionals reached 62,889 974,914§354,Capital investment ($ million) – $3.7Ω$33.†  Spend on educa tion for medical professionals decreased in FY21, largely due to the shift to online training.
","('Access_And_Affordability', 0.7142325639724731)","('Employee_Engagement_Inclusion_And_Diversity', 0.047246303409338)","('Human_Rights_And_Community_Relations', 0.023671334609389305)","(['Health Outcome Contribution'], 0.7142325639724731)","('NON-ESG', 0.047246303409338)","('NON-ESG', 0.023671334609389305)"
Line 535,"2022 Integrated Performance Report       47 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexGLOBAL HEALTHCARE ACCESS CAPACITY BUILDING FY20 FY21 FYEducation for medical professionals ($ million) $145.4 $69.9†$69.Education for patients ($ million) $18.9 $7.8‡$6.Medical professionals reached 62,889 974,914§354,Capital investment ($ million) – $3.7Ω$33.†  Spend on educa tion for medical professionals decreased in FY21, largely due to the shift to online training.
","('Access_And_Affordability', 0.5662391185760498)","('Employee_Engagement_Inclusion_And_Diversity', 0.06775608658790588)","('Product_Quality_And_Safety', 0.04448564350605011)","(['Health Outcome Contribution'], 0.5662391185760498)","('NON-ESG', 0.06775608658790588)","('NON-ESG', 0.04448564350605011)"
Line 536,"‡  Spend on educa tion for patients decreased in FY21, partly because of the impacts of the COVID-19 pandemic, including the shift to using more  internal training resources.
","('Access_And_Affordability', 0.7645688056945801)","('Product_Quality_And_Safety', 0.029712703078985214)","('Critical_Incident_Risk_Management', 0.02183288149535656)","(['Health Outcome Contribution'], 0.7645688056945801)","('NON-ESG', 0.029712703078985214)","('NON-ESG', 0.02183288149535656)"
Line 537,"§  T he number of medical professionals reached increased in FY21, partly due to the shift to online training and partly due to additional time available  when many medical professionals were not allowed to operate during the COVID-19 pandemic.
","('Access_And_Affordability', 0.28336068987846375)","('Employee_Health_And_Safety', 0.24966657161712646)","('Product_Quality_And_Safety', 0.08227815479040146)","('NON-ESG', 0.28336068987846375)","('NON-ESG', 0.24966657161712646)","('NON-ESG', 0.08227815479040146)"
Line 538,"Ω  In FY21,  we began reporting capital investments, such as funding toward internal systems like the Medtronic Academy.Capacity building We help patients and healthcare professionals stay up  to date with current treatments and technology to help them achieve better outcomes and increase access to our products and services.
","('Product_Design_And_Lifecycle_Management', 0.2718234062194824)","('Access_And_Affordability', 0.24766290187835693)","('Customer_Welfare', 0.1413934826850891)","('NON-ESG', 0.2718234062194824)","('NON-ESG', 0.24766290187835693)","('NON-ESG', 0.1413934826850891)"
Line 539,"Increasing the number of practitioners employing our therapies, particularly, but not only, in emerging markets, radically expands healthcare access and allows patients to receive treatment in their home countries.
","('Access_And_Affordability', 0.8313226699829102)","('Customer_Welfare', 0.017838498577475548)","('Product_Quality_And_Safety', 0.017115594819188118)","(['Health Outcome Contribution'], 0.8313226699829102)","('NON-ESG', 0.017838498577475548)","('NON-ESG', 0.017115594819188118)"
Line 540,"Our global Innovation Centers, with locations in South  Korea, Turkey, and beyond, provide specialist training to healthcare professionals wanting to expand and update their skills and knowledge.
","('Employee_Engagement_Inclusion_And_Diversity', 0.48917633295059204)","('Access_And_Affordability', 0.1530122458934784)","('Customer_Welfare', 0.044875044375658035)","('NON-ESG', 0.48917633295059204)","('NON-ESG', 0.1530122458934784)","('NON-ESG', 0.044875044375658035)"
Line 541,"This year, we opened our newest innovation center in Sichuan Province, China.
","('Business_Model_Resilience', 0.2707737386226654)","('Product_Design_And_Lifecycle_Management', 0.17303058505058289)","('Supply_Chain_Management', 0.14368250966072083)","('NON-ESG', 0.2707737386226654)","('NON-ESG', 0.17303058505058289)","('NON-ESG', 0.14368250966072083)"
Line 542,"Within five years of operation, we expect to train approximately 7,000 healthcare professionals annually  at this new center.
","('Employee_Engagement_Inclusion_And_Diversity', 0.38347089290618896)","('Access_And_Affordability', 0.24349388480186462)","('Customer_Welfare', 0.04758711904287338)","('NON-ESG', 0.38347089290618896)","('NON-ESG', 0.24349388480186462)","('NON-ESG', 0.04758711904287338)"
Line 543,"Other FY22 highlights: •   Medtr onic mobile lab trucks continued to host training  events for U.S. healthcare professionals in rural regions  throughout the COVID-19 pandemic.
","('Critical_Incident_Risk_Management', 0.32536575198173523)","('Access_And_Affordability', 0.20818398892879486)","('Employee_Health_And_Safety', 0.0853896364569664)","('NON-ESG', 0.32536575198173523)","('NON-ESG', 0.20818398892879486)","('NON-ESG', 0.0853896364569664)"
Line 544,"•   Medtr onic patients with diabetes in Europe, the  Middle East, and Africa can now access Sara — a virtual assistant with an online chat service available at any time of day to answer questions about our products  or services.
","('Customer_Welfare', 0.26176413893699646)","('Product_Quality_And_Safety', 0.1707027703523636)","('Selling_Practices_And_Product_Labeling', 0.14896953105926514)","('NON-ESG', 0.26176413893699646)","('NON-ESG', 0.1707027703523636)","('NON-ESG', 0.14896953105926514)"
Line 545,"•   Our new sur gical skills lab in India, the result of a  partnership between Medtronic India and the Sher-I-Kashmir Institute of Medical Sciences, is training and developing young surgeons in the Union Territory of Jammu and Kashmir.
","('Access_And_Affordability', 0.5295425057411194)","('Employee_Health_And_Safety', 0.11061576008796692)","('Employee_Engagement_Inclusion_And_Diversity', 0.09198161214590073)","(['Health Outcome Contribution'], 0.5295425057411194)","('NON-ESG', 0.11061576008796692)","('NON-ESG', 0.09198161214590073)"
Line 546,"•   T he Medtronic Surgical Robotics Experience Center,  our first in the Asia-Pacific region, has started to enable clinicians in Gurugram, India, to experience and train on robotic-assisted surgery (RAS) technology from Medtronic, with a focus on the Hugo RAS system —  a modular, multiquadrant platform designed for a broad range of soft-tissue procedures (right).
","('Employee_Health_And_Safety', 0.3127685785293579)","('Access_And_Affordability', 0.15542711317539215)","('Product_Design_And_Lifecycle_Management', 0.08459704369306564)","('NON-ESG', 0.3127685785293579)","('NON-ESG', 0.15542711317539215)","('NON-ESG', 0.08459704369306564)"
Line 547,"Expanding remote monitoring  In FY22, Medtronic formed new partnerships to expand the benefits and capabilities of remote monitoring for patients and healthcare professionals, including:  •   C areLine Solutions in France — integrating data  transmitted by Medtronic cardiac-implanted electrical  devices (pacemakers and defibrillators) into the CareLine monitoring platform.
","('Critical_Incident_Risk_Management', 0.2399718016386032)","('Access_And_Affordability', 0.16737638413906097)","('Energy_Management', 0.11483549326658249)","('NON-ESG', 0.2399718016386032)","('NON-ESG', 0.16737638413906097)","('NON-ESG', 0.11483549326658249)"
Line 548,"•   Cloud D X in Canada — providing world-class virtual  healthcare to patients across Canada through exclusive access to Cloud DX’s remote patient monitoring technology and services.
","('Access_And_Affordability', 0.3123311400413513)","('Energy_Management', 0.30579882860183716)","('Critical_Incident_Risk_Management', 0.04483697935938835)","('NON-ESG', 0.3123311400413513)","('NON-ESG', 0.30579882860183716)","('NON-ESG', 0.04483697935938835)"
Line 549,"•   S tasis in India — expanding access to the state-of-the- art Stasis Monitor, a bedside monitoring system that automates and digitizes monitoring, documentation, and communication of critical patient information in hospital settings.
","('Customer_Privacy', 0.24167834222316742)","('Critical_Incident_Risk_Management', 0.1748017817735672)","('Employee_Health_And_Safety', 0.13977615535259247)","('NON-ESG', 0.24167834222316742)","('NON-ESG', 0.1748017817735672)","('NON-ESG', 0.13977615535259247)"
Line 550,"$69.1M education for medical professionals   in FY2022 Integrated Performance Report       48 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index The Medtronic Hugo™ RAS  system is commercially available in certain geographies.
","('Human_Rights_And_Community_Relations', 0.2868615686893463)","('Management_Of_Legal_And_Regulatory_Framework', 0.1380758434534073)","('Business_Model_Resilience', 0.1369055211544037)","('NON-ESG', 0.2868615686893463)","('NON-ESG', 0.1380758434534073)","('NON-ESG', 0.1369055211544037)"
Line 551,"Regulatory requirements of individual countries and regions will determine approval, clearance, or market availability.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9620411396026611)","('Competitive_Behavior', 0.006370150484144688)","('Business_Ethics', 0.002893816912546754)","(['Corporate Governance'], 0.9620411396026611)","('NON-ESG', 0.006370150484144688)","('NON-ESG', 0.002893816912546754)"
Line 552,"In the EU, the Hugo™ RAS system is CE marked.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7564945816993713)","('Competitive_Behavior', 0.02673596329987049)","('Director_Removal', 0.02530544064939022)","(['Corporate Governance'], 0.7564945816993713)","('NON-ESG', 0.02673596329987049)","('NON-ESG', 0.02530544064939022)"
Line 553,"In the U.S., the Hugo™ system is an investigational device not for sale.GLOBAL HEALTHCARE ACCESS MEDTRONIC LABS IMPACT Cumulative since April 14, FY20 FY21 FYPatients screened (cumulative) 850,000+ 960,000+ 1,214,000+ Health workers trained (cumulative) 1,500+ 2,400+ 3,200+ Patients with better clinical and social outcomes (cumulative) 23,000+ 38,000+ 51,000+ Medtronic LABS operational sites 90 120+ 250+Medtronic LABS Medtronic LABS is a health systems innovator that  develops community-based, tech-enabled solutions for underserved patients, families, and communities around the world.
","('Access_And_Affordability', 0.5489383339881897)","('Customer_Welfare', 0.08313176035881042)","('Product_Design_And_Lifecycle_Management', 0.035741157829761505)","(['Health Outcome Contribution'], 0.5489383339881897)","('NON-ESG', 0.08313176035881042)","('NON-ESG', 0.035741157829761505)"
Line 554,"In the U.S., the Hugo™ system is an investigational device not for sale.GLOBAL HEALTHCARE ACCESS MEDTRONIC LABS IMPACT Cumulative since April 14, FY20 FY21 FYPatients screened (cumulative) 850,000+ 960,000+ 1,214,000+ Health workers trained (cumulative) 1,500+ 2,400+ 3,200+ Patients with better clinical and social outcomes (cumulative) 23,000+ 38,000+ 51,000+ Medtronic LABS operational sites 90 120+ 250+Medtronic LABS Medtronic LABS is a health systems innovator that  develops community-based, tech-enabled solutions for underserved patients, families, and communities around the world.
","('Access_And_Affordability', 0.94480299949646)","('Critical_Incident_Risk_Management', 0.005648556165397167)","('Human_Rights_And_Community_Relations', 0.00499066011980176)","(['Health Outcome Contribution'], 0.94480299949646)","('NON-ESG', 0.005648556165397167)","('NON-ESG', 0.00499066011980176)"
Line 555,"An independent, public benefit corporation funded  by Medtronic, Medtronic LABS combines hyper-local services with cutting-edge technology, providing sustainable and localized healthcare solutions that produce measurable patient outcomes.
","('Access_And_Affordability', 0.522351086139679)","('Customer_Welfare', 0.0813819020986557)","('Energy_Management', 0.07711920887231827)","(['Health Outcome Contribution'], 0.522351086139679)","('NON-ESG', 0.0813819020986557)","('NON-ESG', 0.07711920887231827)"
Line 556,"The Medtronic LABS approach integrates three   core elements: •   Digital technology  — software solutions designed for  patients, community health workers, and healthcare  providers operating in low-resource settings.
","('Access_And_Affordability', 0.6123185753822327)","('Employee_Health_And_Safety', 0.09942345321178436)","('Critical_Incident_Risk_Management', 0.06810098886489868)","(['Health Outcome Contribution'], 0.6123185753822327)","('NON-ESG', 0.09942345321178436)","('NON-ESG', 0.06810098886489868)"
Line 557,"•   F ield operations — community-based teams integrated  with health systems to expand screening, diagnosis, treatment, and patient engagement.
","('Access_And_Affordability', 0.6875476241111755)","('Employee_Health_And_Safety', 0.09509728103876114)","('Critical_Incident_Risk_Management', 0.024887727573513985)","(['Health Outcome Contribution'], 0.6875476241111755)","('NON-ESG', 0.09509728103876114)","('NON-ESG', 0.024887727573513985)"
Line 558,"•   P artnerships — collaboration with health systems,  governments, local innovators, multinationals, and funders to drive sustainable system-level transformation.Since its inception, Medtronic LABS has reached more than 1 million patients.
","('Access_And_Affordability', 0.570137083530426)","('Customer_Welfare', 0.054229896515607834)","('Systemic_Risk_Management', 0.029114698991179466)","(['Health Outcome Contribution'], 0.570137083530426)","('NON-ESG', 0.054229896515607834)","('NON-ESG', 0.029114698991179466)"
Line 559,"Key activities in FY22 included: •   R elease of a new cutting-edge technology platform  and expansion of its impact in seven new countries.
","('Product_Design_And_Lifecycle_Management', 0.3202143907546997)","('Business_Model_Resilience', 0.17764143645763397)","('Data_Security', 0.07054673135280609)","('NON-ESG', 0.3202143907546997)","('NON-ESG', 0.17764143645763397)","('NON-ESG', 0.07054673135280609)"
Line 560,"The innovative Medtronic LABS SPICE software platform is designed to support community-based population health at scale by offering end-to-end patient services.
","('Access_And_Affordability', 0.7215710282325745)","('Human_Rights_And_Community_Relations', 0.07872355729341507)","('Critical_Incident_Risk_Management', 0.02679889090359211)","(['Health Outcome Contribution'], 0.7215710282325745)","('NON-ESG', 0.07872355729341507)","('NON-ESG', 0.02679889090359211)"
Line 561,"The platform was launched with new features that enhance customizability, interoperability, and flexibility.
","('Data_Security', 0.37357187271118164)","('Business_Model_Resilience', 0.12999190390110016)","('Product_Design_And_Lifecycle_Management', 0.10604981333017349)","('NON-ESG', 0.37357187271118164)","('NON-ESG', 0.12999190390110016)","('NON-ESG', 0.10604981333017349)"
Line 562,"•   Establishment of  landmark partnerships for  technology-enabled, community-based chronic disease management.
","('Access_And_Affordability', 0.29228290915489197)","('Human_Rights_And_Community_Relations', 0.18754024803638458)","('Critical_Incident_Risk_Management', 0.108929343521595)","('NON-ESG', 0.29228290915489197)","('NON-ESG', 0.18754024803638458)","('NON-ESG', 0.108929343521595)"
Line 563,"Programs launched in Tanzania, Sierra Leone, Rwanda, Bhutan, the Philippines, Cambodia, and the United States.
","('Human_Rights_And_Community_Relations', 0.35412129759788513)","('Management_Of_Legal_And_Regulatory_Framework', 0.1980370581150055)","('Ecological_Impacts', 0.09073981642723083)","('NON-ESG', 0.35412129759788513)","('NON-ESG', 0.1980370581150055)","('NON-ESG', 0.09073981642723083)"
Line 564,"In Kenya and Ghana, LABS programs are poised for national scale, and in India, Medtronic LABS grew in both the private and public sectors.
","('Access_And_Affordability', 0.3903895914554596)","('Systemic_Risk_Management', 0.09123978763818741)","('Management_Of_Legal_And_Regulatory_Framework', 0.06439266353845596)","('NON-ESG', 0.3903895914554596)","('NON-ESG', 0.09123978763818741)","('NON-ESG', 0.06439266353845596)"
Line 565,"Public-private partnerships (PPPs) with governments to strengthen public health systems is key to sustainable population health impact.
","('Employee_Health_And_Safety', 0.37171924114227295)","('Access_And_Affordability', 0.26727885007858276)","('Critical_Incident_Risk_Management', 0.08080384880304337)","('NON-ESG', 0.37171924114227295)","('NON-ESG', 0.26727885007858276)","('NON-ESG', 0.08080384880304337)"
Line 566,"Medtronic LABS is building a track record of partnering with national, state, and local governments to deliver impacts aligned with government priorities and patient needs.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7777072787284851)","('Human_Rights_And_Community_Relations', 0.07558577507734299)","('Access_And_Affordability', 0.03489938750863075)","(['Corporate Governance'], 0.7777072787284851)","('NON-ESG', 0.07558577507734299)","('NON-ESG', 0.03489938750863075)"
Line 567,"For example:  •   Medtr onic LABS and the Kenyan Ministry of Health are  partnering to expand the Empower Health program,  powered by the Medtronic LABS SPICE platform, across Kenya.
","('Access_And_Affordability', 0.6718297004699707)","('Management_Of_Legal_And_Regulatory_Framework', 0.047890555113554)","('Human_Rights_And_Community_Relations', 0.031914789229631424)","(['Health Outcome Contribution'], 0.6718297004699707)","('NON-ESG', 0.047890555113554)","('NON-ESG', 0.031914789229631424)"
Line 568,"The program is expected to roll out over the next four years and will fully integrate into the country’s digital health ecosystem.
","('Access_And_Affordability', 0.5324791669845581)","('Human_Rights_And_Community_Relations', 0.07486636191606522)","('Product_Quality_And_Safety', 0.046663086861371994)","(['Health Outcome Contribution'], 0.5324791669845581)","('NON-ESG', 0.07486636191606522)","('NON-ESG', 0.046663086861371994)"
Line 569,"The nationally scaled program will manage hypertension and diabetes for over 300,000 people across Kenya’s  47 counties, tripling current patient impact and becoming the largest scale chronic disease  program in Africa.•  In Ghana,  Medtronic LABS is partnering with the  German Development Agency and the Christian Hospital Association of Ghana, the second largest health system in the country.
","('Employee_Health_And_Safety', 0.2877335250377655)","('Access_And_Affordability', 0.2703234553337097)","('Product_Quality_And_Safety', 0.053387049585580826)","('NON-ESG', 0.2877335250377655)","('NON-ESG', 0.2703234553337097)","('NON-ESG', 0.053387049585580826)"
Line 570,"The Akoma Pa program will manage over 60,000 patients with hypertension and diabetes and is already one of the largest NCD programs in West Africa.
","('Access_And_Affordability', 0.42823758721351624)","('Employee_Health_And_Safety', 0.1562156081199646)","('Employee_Engagement_Inclusion_And_Diversity', 0.04802407696843147)","('NON-ESG', 0.42823758721351624)","('NON-ESG', 0.1562156081199646)","('NON-ESG', 0.04802407696843147)"
Line 571,"Expansion to the public sector is expected next year.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4870118200778961)","('Access_And_Affordability', 0.10022511333227158)","('Systemic_Risk_Management', 0.06216827407479286)","('NON-ESG', 0.4870118200778961)","('NON-ESG', 0.10022511333227158)","('NON-ESG', 0.06216827407479286)"
Line 572,"•   In Bhutan,  Medtronic LABS is collaborating with   United Nations Technology Bank, the Ministry of Health, UNICEF, and MedEl to deploy the Shruti program model to reach every child in Bhutan over the next three years.
","('Access_And_Affordability', 0.9301695227622986)","('Product_Quality_And_Safety', 0.006598984822630882)","('Human_Rights_And_Community_Relations', 0.006474710069596767)","(['Health Outcome Contribution'], 0.9301695227622986)","('NON-ESG', 0.006598984822630882)","('NON-ESG', 0.006474710069596767)"
Line 573,"Looking ahead, Medtronic LABS is focused on expanding into new clinical areas to strengthen patient outcomes at the primary care level, and deepening impact through health system partnerships.
","('Access_And_Affordability', 0.7849991917610168)","('Customer_Welfare', 0.032166507095098495)","('Product_Quality_And_Safety', 0.01546657457947731)","(['Health Outcome Contribution'], 0.7849991917610168)","('NON-ESG', 0.032166507095098495)","('NON-ESG', 0.01546657457947731)"
Line 574,"1 .2M+ patients screened through   Medtronic LABS since 2022 Integrated Performance Report       49 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexGLOBAL HEALTHCARE ACCESS Partnering for impact Advocacy Improving access to treatment in underserved  populations requires appropriate policy frameworks that support and enable equitable healthcare systems and pathways.
","('Access_And_Affordability', 0.9471477270126343)","('Product_Quality_And_Safety', 0.004797842353582382)","('Critical_Incident_Risk_Management', 0.004544581286609173)","(['Health Outcome Contribution'], 0.9471477270126343)","('NON-ESG', 0.004797842353582382)","('NON-ESG', 0.004544581286609173)"
Line 575,"We work with peers and partners to advocate for public policy that enables increased access to vital treatment.
","('Access_And_Affordability', 0.9166885614395142)","('Product_Quality_And_Safety', 0.009778518229722977)","('Human_Rights_And_Community_Relations', 0.007360536139458418)","(['Health Outcome Contribution'], 0.9166885614395142)","('NON-ESG', 0.009778518229722977)","('NON-ESG', 0.007360536139458418)"
Line 576,"Amid the COVID-19 pandemic, we continue to advocate for access to biomedical technologies based on equity and fairness — and where individuals can access technologies for the highest level of care.
","('Access_And_Affordability', 0.8482391834259033)","('Product_Quality_And_Safety', 0.017108790576457977)","('Employee_Engagement_Inclusion_And_Diversity', 0.014406855218112469)","(['Health Outcome Contribution'], 0.8482391834259033)","('NON-ESG', 0.017108790576457977)","('NON-ESG', 0.014406855218112469)"
Line 577,"In FY22, we participated in a meeting about the Cancer  Moonshot initiative launched by U.S. President Biden.
","('Access_And_Affordability', 0.21581579744815826)","('Management_Of_Legal_And_Regulatory_Framework', 0.15148767828941345)","('Human_Rights_And_Community_Relations', 0.07111304253339767)","('NON-ESG', 0.21581579744815826)","('NON-ESG', 0.15148767828941345)","('NON-ESG', 0.07111304253339767)"
Line 578,"The discussion focused on the role that medical technology plays at every stage of the cancer diagnosis and care continuum, as well as the importance of fully utilizing innovative technologies that can prevent and detect cancer.
","('Employee_Health_And_Safety', 0.34403443336486816)","('Access_And_Affordability', 0.12740978598594666)","('Product_Quality_And_Safety', 0.10432053357362747)","('NON-ESG', 0.34403443336486816)","('NON-ESG', 0.12740978598594666)","('NON-ESG', 0.10432053357362747)"
Line 579,"Our CEO also joined with other business leaders,  the U.S. President, and key representatives of the administration to call on Congress to take swift action and deliver competition legislation, like the Bipartisan Innovation Act, to the President’s desk.
","('Competitive_Behavior', 0.8788953423500061)","('Management_Of_Legal_And_Regulatory_Framework', 0.04868868365883827)","('Systemic_Risk_Management', 0.008930829353630543)","(['Business Ethics'], 0.8788953423500061)","('NON-ESG', 0.04868868365883827)","('NON-ESG', 0.008930829353630543)"
Line 580,"Of particular concern were current shortages in semiconductor supplies affecting the medical technology sector.
","('Supply_Chain_Management', 0.5412737131118774)","('Critical_Incident_Risk_Management', 0.13306379318237305)","('Water_And_Wastewater_Management', 0.03890230506658554)","(['Supply Chain Management'], 0.5412737131118774)","('NON-ESG', 0.13306379318237305)","('NON-ESG', 0.03890230506658554)"
Line 581,"To enable procurement of medical equipment to  address country-level needs, we continue to talk and cooperate with the United States, other governments, and international organizations, such as multilateral development banks and UN agencies.Public-private partnerships We develop long-term partnerships with national, regional, and municipal governments and health systems in underserved communities to understand and address local needs and challenges.
","('Access_And_Affordability', 0.9406291842460632)","('Human_Rights_And_Community_Relations', 0.006039957515895367)","('Critical_Incident_Risk_Management', 0.005539810284972191)","(['Health Outcome Contribution'], 0.9406291842460632)","('NON-ESG', 0.006039957515895367)","('NON-ESG', 0.005539810284972191)"
Line 582,"We work through these partnerships to expand access to healthcare knowledge and technology.
","('Access_And_Affordability', 0.8280083537101746)","('Employee_Engagement_Inclusion_And_Diversity', 0.024042323231697083)","('Human_Rights_And_Community_Relations', 0.014954266138374805)","(['Health Outcome Contribution'], 0.8280083537101746)","('NON-ESG', 0.024042323231697083)","('NON-ESG', 0.014954266138374805)"
Line 583,"Our aim is to create sustainable, scalable projects in   four areas: •  R&D •  Manufacturing for mark et access •  Clinical tr aining and education •  He alth system strengthening Our Public-Private Partnership Council guides our  efforts.
","('Access_And_Affordability', 0.5994267463684082)","('Customer_Welfare', 0.05814748629927635)","('Employee_Engagement_Inclusion_And_Diversity', 0.03122672252357006)","(['Health Outcome Contribution'], 0.5994267463684082)","('NON-ESG', 0.05814748629927635)","('NON-ESG', 0.03122672252357006)"
Line 584,"The council uses a United Nations Economic Commission for Europe (UNECE) self-assessment tool  for “people first” public-private partnerships to evaluate our partnerships against key issues, such as access.
","('Access_And_Affordability', 0.5114105939865112)","('Human_Rights_And_Community_Relations', 0.2693899869918823)","('Employee_Engagement_Inclusion_And_Diversity', 0.032818637788295746)","(['Health Outcome Contribution'], 0.5114105939865112)","('NON-ESG', 0.2693899869918823)","('NON-ESG', 0.032818637788295746)"
Line 585,"For example, in FY22, Medtronic Vietnam signed a  memorandum of understanding with the Vietnam Ministry of Health to elevate healthcare professionals’ clinical skill sets in ICU departments and centers.
","('Access_And_Affordability', 0.5728009939193726)","('Customer_Welfare', 0.05380115285515785)","('Employee_Engagement_Inclusion_And_Diversity', 0.04198576882481575)","(['Health Outcome Contribution'], 0.5728009939193726)","('NON-ESG', 0.05380115285515785)","('NON-ESG', 0.04198576882481575)"
Line 586,"The aim is to train more than 4,000 healthcare professionals in  12 months, including a train-the-trainer program to create a board of trainers with 30 doctors and in-depth training for key hospitals.
","('Access_And_Affordability', 0.4947656989097595)","('Employee_Engagement_Inclusion_And_Diversity', 0.11445477604866028)","('Employee_Health_And_Safety', 0.05970799922943115)","('NON-ESG', 0.4947656989097595)","('NON-ESG', 0.11445477604866028)","('NON-ESG', 0.05970799922943115)"
Line 587,"Progress toward this goal is underway, and several key milestones have already  been achieved.
","('Human_Rights_And_Community_Relations', 0.34364697337150574)","('Business_Model_Resilience', 0.17435260117053986)","('Management_Of_Legal_And_Regulatory_Framework', 0.09457137435674667)","('NON-ESG', 0.34364697337150574)","('NON-ESG', 0.17435260117053986)","('NON-ESG', 0.09457137435674667)"
Line 588,"2022 Integrated Performance Report       50 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexPhilanthropySOCIAL IMPACT Adding business value Medtronic and the Medtronic Foundation engage in  philanthropic activities to further the Medtronic Mission.
","('Business_Model_Resilience', 0.29175713658332825)","('Management_Of_Legal_And_Regulatory_Framework', 0.15798798203468323)","('Human_Rights_And_Community_Relations', 0.11632776260375977)","('NON-ESG', 0.29175713658332825)","('NON-ESG', 0.15798798203468323)","('NON-ESG', 0.11632776260375977)"
Line 589,"By giving our time, resources, and skills, we address inequities and improve lives in underserved communities around the world.
","('Access_And_Affordability', 0.9462019205093384)","('Human_Rights_And_Community_Relations', 0.0054504601284861565)","('Critical_Incident_Risk_Management', 0.004526806995272636)","(['Health Outcome Contribution'], 0.9462019205093384)","('NON-ESG', 0.0054504601284861565)","('NON-ESG', 0.004526806995272636)"
Line 590,"Partnerships with local, national, and international organizations amplify the impact of our activities and benefit our business by building trust and long-term social capital.Global challenges, including the COVID-19  pandemic, climate change, and conflict, continue to exacerbate inequities in communities and in healthcare access.
","('Physical_Impacts_Of_Climate_Change', 0.9348028898239136)","('Business_Model_Resilience', 0.014930636622011662)","('Supply_Chain_Management', 0.005807149689644575)","(['Climate Change'], 0.9348028898239136)","('NON-ESG', 0.014930636622011662)","('NON-ESG', 0.005807149689644575)"
Line 591,"Medtronic and the Medtronic Foundation work together to improve the lives of underserved and underrepresented populations around the world.
","('Access_And_Affordability', 0.9454081058502197)","('Product_Quality_And_Safety', 0.004973085131496191)","('Human_Rights_And_Community_Relations', 0.004655396565794945)","(['Health Outcome Contribution'], 0.9454081058502197)","('NON-ESG', 0.004973085131496191)","('NON-ESG', 0.004655396565794945)"
Line 592,"Our philanthropic actions combine financial investments, skills-based volunteerism, and strategic advice to deliver long-term, sustainable change.
","('Human_Rights_And_Community_Relations', 0.25698524713516235)","('Management_Of_Legal_And_Regulatory_Framework', 0.2517585754394531)","('Access_And_Affordability', 0.16206608712673187)","('NON-ESG', 0.25698524713516235)","('NON-ESG', 0.2517585754394531)","('NON-ESG', 0.16206608712673187)"
Line 593,"$97.1M combined philanthropic  contributions by Medtronic   and the Medtronic Foundation 144K+  Medtronic employee hours  volunteered in communities 2022 Integrated Performance Report       51 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexOur contributions In FY22, Medtronic and the Medtronic Foundation  contributed more than $97.1 million globally in combined philanthropic investments through four key mechanisms: •   C ash contributions — funding medical professionals  and fellowship positions, clinical research grants,   third-party-sponsored health education programs,  and other health-related activities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7323441505432129)","('Human_Rights_And_Community_Relations', 0.05296752229332924)","('Business_Ethics', 0.040201541036367416)","(['Corporate Governance'], 0.7323441505432129)","('NON-ESG', 0.05296752229332924)","('NON-ESG', 0.040201541036367416)"
Line 594,"$97.1M combined philanthropic  contributions by Medtronic   and the Medtronic Foundation 144K+  Medtronic employee hours  volunteered in communities 2022 Integrated Performance Report       51 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexOur contributions In FY22, Medtronic and the Medtronic Foundation  contributed more than $97.1 million globally in combined philanthropic investments through four key mechanisms: •   C ash contributions — funding medical professionals  and fellowship positions, clinical research grants,   third-party-sponsored health education programs,  and other health-related activities.
","('Access_And_Affordability', 0.44833654165267944)","('Management_Of_Legal_And_Regulatory_Framework', 0.12257187068462372)","('Employee_Engagement_Inclusion_And_Diversity', 0.06722387671470642)","('NON-ESG', 0.44833654165267944)","('NON-ESG', 0.12257187068462372)","('NON-ESG', 0.06722387671470642)"
Line 595,"•   Medtr onic Foundation grants — improving the lives   of underserved populations worldwide and supporting communities in which Medtronic employees live and give.
","('Access_And_Affordability', 0.9452918767929077)","('Product_Quality_And_Safety', 0.005031793378293514)","('Critical_Incident_Risk_Management', 0.004531899932771921)","(['Health Outcome Contribution'], 0.9452918767929077)","('NON-ESG', 0.005031793378293514)","('NON-ESG', 0.004531899932771921)"
Line 596,"•   P roduct donations — supporting disaster recovery  and access to care through monetary and product donations distributed to nonprofit organizations  and in-country clinics.
","('Critical_Incident_Risk_Management', 0.7070654630661011)","('Access_And_Affordability', 0.08453882485628128)","('Human_Rights_And_Community_Relations', 0.026724711060523987)","(['Risk & Crisis Management'], 0.7070654630661011)","('NON-ESG', 0.08453882485628128)","('NON-ESG', 0.026724711060523987)"
Line 597,"•   Y ear-round employee volunteering and giving  opportunities — giving time, skills, and resources to  the communities in which Medtronic employees  live and work.TYPE OF PHILANTHROPIC CONTRIBUTIONS  ($ million) FY20 FY21 FYCorporate cash donations†$56.4 $48.9 $50.Medtronic Foundation giving total $34.2 $36.4 $30.3‡ Product donations $10.2 $13.2 $12.Value of volunteering $4.3 $4.6 $4.0§ Total givingΩ$ 105.1 $ 103.0 $97.† The changes in cash contributions year over year reflects our strategy to focus on impacts and outcomes rather than dollar amount.
","('Human_Rights_And_Community_Relations', 0.26823440194129944)","('Access_And_Affordability', 0.12304873019456863)","('Employee_Health_And_Safety', 0.10254008322954178)","('NON-ESG', 0.26823440194129944)","('NON-ESG', 0.12304873019456863)","('NON-ESG', 0.10254008322954178)"
Line 598,"•   Y ear-round employee volunteering and giving  opportunities — giving time, skills, and resources to  the communities in which Medtronic employees  live and work.TYPE OF PHILANTHROPIC CONTRIBUTIONS  ($ million) FY20 FY21 FYCorporate cash donations†$56.4 $48.9 $50.Medtronic Foundation giving total $34.2 $36.4 $30.3‡ Product donations $10.2 $13.2 $12.Value of volunteering $4.3 $4.6 $4.0§ Total givingΩ$ 105.1 $ 103.0 $97.† The changes in cash contributions year over year reflects our strategy to focus on impacts and outcomes rather than dollar amount.
","('Competitive_Behavior', 0.41361019015312195)","('Business_Ethics', 0.237387552857399)","('Management_Of_Legal_And_Regulatory_Framework', 0.18271078169345856)","('NON-ESG', 0.41361019015312195)","('NON-ESG', 0.237387552857399)","('NON-ESG', 0.18271078169345856)"
Line 599,"‡  Medtronic Foundation matches are usually made on a 1:1 basis up to $5,000.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5953618884086609)","('Access_And_Affordability', 0.05628962069749832)","('Energy_Management', 0.04773478955030441)","(['Corporate Governance'], 0.5953618884086609)","('NON-ESG', 0.05628962069749832)","('NON-ESG', 0.04773478955030441)"
Line 600,"In response to COVID-19, Medtronic Foundation matches were increased to 2:1 from April 1  through October 30, 2020.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2809503674507141)","('Access_And_Affordability', 0.14708641171455383)","('Customer_Welfare', 0.07887938618659973)","('NON-ESG', 0.2809503674507141)","('NON-ESG', 0.14708641171455383)","('NON-ESG', 0.07887938618659973)"
Line 601,"The reduction in Medtronic Foundation giving in FY22 reflects the return to 1:1 giving, as well as the separation of Medtronic Global Health from the Medtronic Foundation this year.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3941577076911926)","('Access_And_Affordability', 0.23748715221881866)","('Business_Ethics', 0.04424664005637169)","('NON-ESG', 0.3941577076911926)","('NON-ESG', 0.23748715221881866)","('NON-ESG', 0.04424664005637169)"
Line 602,"Medtronic Global Health is now part of Medtronic LABS (see page 48).
","('Customer_Welfare', 0.2424784004688263)","('Supply_Chain_Management', 0.11738025397062302)","('Product_Design_And_Lifecycle_Management', 0.11675447970628738)","('NON-ESG', 0.2424784004688263)","('NON-ESG', 0.11738025397062302)","('NON-ESG', 0.11675447970628738)"
Line 603,"Medtronic LABS data are not included in the Medtronic Foundation giving total.
","('Customer_Welfare', 0.13217461109161377)","('Supply_Chain_Management', 0.10896686464548111)","('Systemic_Risk_Management', 0.09821344166994095)","('NON-ESG', 0.13217461109161377)","('NON-ESG', 0.10896686464548111)","('NON-ESG', 0.09821344166994095)"
Line 604,"§  Calculated with an hourly rate of $29.95, provided by Independent Sector.
","('Labor_Practices', 0.7517606019973755)","('Management_Of_Legal_And_Regulatory_Framework', 0.038697049021720886)","('Energy_Management', 0.032964177429676056)","(['Labor Practice Indicators'], 0.7517606019973755)","('NON-ESG', 0.038697049021720886)","('NON-ESG', 0.032964177429676056)"
Line 605,"Volunteer hours reflect hours that are self-reported by Medtronic employees and represent hours of volunteerism during normal business hours.
","('Labor_Practices', 0.3476487994194031)","('Employee_Health_And_Safety', 0.18167585134506226)","('Employee_Engagement_Inclusion_And_Diversity', 0.141346275806427)","('NON-ESG', 0.3476487994194031)","('NON-ESG', 0.18167585134506226)","('NON-ESG', 0.141346275806427)"
Line 606,"Ω Row totals may not add up due to rounding.$97.1M combined philanthropic   contributions by Medtronic   and the Medtronic FoundationPHILANTHROPY †  Total does not add up to 100% due to rounding.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6463354229927063)","('Business_Ethics', 0.04851524531841278)","('Director_Removal', 0.028365934267640114)","(['Corporate Governance'], 0.6463354229927063)","('NON-ESG', 0.04851524531841278)","('NON-ESG', 0.028365934267640114)"
Line 607,"2022 Integrated Performance Report       52 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index 31.2 % Medtronic Foundation grants68.7 % Medtronic plcSPLIT OF PHILANTHROPIC CONTRIBUTIONS† Continued support during COVID-In FY22, Medtronic and the Medtronic Foundation  continued to support communities and healthcare systems impacted by COVID-19, partnering with organizations that have diverse leadership representative of local communities.
","('Human_Rights_And_Community_Relations', 0.8899053335189819)","('Access_And_Affordability', 0.025354765355587006)","('Employee_Engagement_Inclusion_And_Diversity', 0.010670173913240433)","(['Community Relations'], 0.8899053335189819)","('NON-ESG', 0.025354765355587006)","('NON-ESG', 0.010670173913240433)"
Line 608,"Together, Medtronic and the Medtronic Foundation committed an additional $3 million for COVID-19 relief efforts in FY22 focused on underserved areas of India, Brazil, the United States, and other global regions.
","('Access_And_Affordability', 0.9422419667243958)","('Critical_Incident_Risk_Management', 0.005072304513305426)","('Product_Quality_And_Safety', 0.0050513711757957935)","(['Health Outcome Contribution'], 0.9422419667243958)","('NON-ESG', 0.005072304513305426)","('NON-ESG', 0.0050513711757957935)"
Line 609,"The Medtronic Foundation partnered with key  organizations distributing COVID-19 relief funds and resources — including, but not limited to, Americares Foundation Inc., Direct Relief, Healthcare Ready, International Medical Corps, and Project HOPE.
","('Critical_Incident_Risk_Management', 0.4046452045440674)","('Access_And_Affordability', 0.24545302987098694)","('Human_Rights_And_Community_Relations', 0.06840133666992188)","('NON-ESG', 0.4046452045440674)","('NON-ESG', 0.24545302987098694)","('NON-ESG', 0.06840133666992188)"
Line 610,"Together, these efforts: •   Served approximately 564,000 patients   in 1,074 communities.
","('Access_And_Affordability', 0.6738317608833313)","('Customer_Welfare', 0.03831392899155617)","('Product_Quality_And_Safety', 0.02836923860013485)","(['Health Outcome Contribution'], 0.6738317608833313)","('NON-ESG', 0.03831392899155617)","('NON-ESG', 0.02836923860013485)"
Line 611,"•   T rained more than 45,500 community health   workers and reached more than 1.6 million   community members with messages to address vaccine hesitancy.
","('Human_Rights_And_Community_Relations', 0.31447362899780273)","('Access_And_Affordability', 0.3116084337234497)","('Employee_Health_And_Safety', 0.15076544880867004)","('NON-ESG', 0.31447362899780273)","('NON-ESG', 0.3116084337234497)","('NON-ESG', 0.15076544880867004)"
Line 612,"•   Suppor ted health facilities in underserved areas   and supplied vital medical supplies, equipment,  and PPE.
","('Access_And_Affordability', 0.9407862424850464)","('Critical_Incident_Risk_Management', 0.006832251790910959)","('Product_Quality_And_Safety', 0.004608883056789637)","(['Health Outcome Contribution'], 0.9407862424850464)","('NON-ESG', 0.006832251790910959)","('NON-ESG', 0.004608883056789637)"
Line 613,"Together, Medtronic Foundation and Medtronic provided more than 34 million items, protecting more than 16,000 health workers and supporting 955 health facilities.
","('Employee_Health_And_Safety', 0.9737474322319031)","('Critical_Incident_Risk_Management', 0.004899580962955952)","('Employee_Engagement_Inclusion_And_Diversity', 0.0020336622837930918)","(['Operational Eco-Efficiency'], 0.9737474322319031)","('NON-ESG', 0.004899580962955952)","('NON-ESG', 0.0020336622837930918)"
Line 614,"MEDTRONIC FOUNDATION FY22  COVID-19 CONTRIBUTIONS  ($ million) Health grants $2.Community grants $0.Employee-matched giving/assistance†$9.Total contribution $12.† Amount represents estimated matched donations supporting COVID-19 relief efforts.PHILANTHROPY Supporting India’s COVID-19 response India has been hit hard by COVID-19, recording  more than half a million deaths since the start of the pandemic and seeing the unemployment rate climb to a 45-year high.
","('Critical_Incident_Risk_Management', 0.27114880084991455)","('Access_And_Affordability', 0.18295332789421082)","('Employee_Health_And_Safety', 0.15872228145599365)","('NON-ESG', 0.27114880084991455)","('NON-ESG', 0.18295332789421082)","('NON-ESG', 0.15872228145599365)"
Line 615,"Research suggests existing gender inequities in education, health, and employment have also worsened.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8937091827392578)","('Labor_Practices', 0.018110256642103195)","('Employee_Health_And_Safety', 0.01676657795906067)","(['Human Capital Development'], 0.8937091827392578)","('NON-ESG', 0.018110256642103195)","('NON-ESG', 0.01676657795906067)"
Line 616,"In FY22, Medtronic and the Medtronic  Foundation continued to contribute to the COVID-19 response in India to help alleviate  the impact and address healthcare inequities: •   Medtr onic completed delivery of 25,000  oxygen concentrators and committed to  coordinating the shipping and distribution  of more than 1,000 Medtronic ventilators.•    Medtr onic led vaccine procurement, import,  and distribution efforts for employees and household family members in India.
","('Access_And_Affordability', 0.6007078289985657)","('Employee_Health_And_Safety', 0.05439894273877144)","('Customer_Welfare', 0.05133387818932533)","(['Health Outcome Contribution'], 0.6007078289985657)","('NON-ESG', 0.05439894273877144)","('NON-ESG', 0.05133387818932533)"
Line 617,"•   Medtr onic CEO Geoff Martha was a member  of the Global Task Force on Pandemic Response as part of the Business Roundtable to address COVID-19 response in India.
","('Critical_Incident_Risk_Management', 0.4278593063354492)","('Physical_Impacts_Of_Climate_Change', 0.23243103921413422)","('Systemic_Risk_Management', 0.05049616098403931)","('NON-ESG', 0.4278593063354492)","('NON-ESG', 0.23243103921413422)","('NON-ESG', 0.05049616098403931)"
Line 618,"•   T he Medtronic Foundation committed   $2.1 million via key partner organizations  to distribute medical supplies, set up temporary treatment and quarantine facilities, train frontline health workers, and support vaccine rollout.
","('Employee_Health_And_Safety', 0.7815801501274109)","('Critical_Incident_Risk_Management', 0.06020596995949745)","('Access_And_Affordability', 0.02526649460196495)","(['Operational Eco-Efficiency'], 0.7815801501274109)","('NON-ESG', 0.06020596995949745)","('NON-ESG', 0.02526649460196495)"
Line 619,"2022 Integrated Performance Report       53 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index COVID-19 RELIEF FROM MEDTRONIC   FOUNDATION PARTNERS  2.2M+ patients, community members, and   health workers positively impacted 34M+ items of medical supplies, equipment,   and PPE donatedMedtronic Foundation programs Medtronic plc is the sole funder of Medtronic  Foundation, whose focus is on improving lives for underserved and underrepresented populations worldwide and supporting communities in which Medtronic employees live and give.
","('Access_And_Affordability', 0.9428882598876953)","('Human_Rights_And_Community_Relations', 0.00524149090051651)","('Product_Quality_And_Safety', 0.005090911872684956)","(['Health Outcome Contribution'], 0.9428882598876953)","('NON-ESG', 0.00524149090051651)","('NON-ESG', 0.005090911872684956)"
Line 620,"2022 Integrated Performance Report       53 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index COVID-19 RELIEF FROM MEDTRONIC   FOUNDATION PARTNERS  2.2M+ patients, community members, and   health workers positively impacted 34M+ items of medical supplies, equipment,   and PPE donatedMedtronic Foundation programs Medtronic plc is the sole funder of Medtronic  Foundation, whose focus is on improving lives for underserved and underrepresented populations worldwide and supporting communities in which Medtronic employees live and give.
","('Human_Rights_And_Community_Relations', 0.543392539024353)","('Access_And_Affordability', 0.18556050956249237)","('Employee_Engagement_Inclusion_And_Diversity', 0.04990164563059807)","(['Community Relations'], 0.543392539024353)","('NON-ESG', 0.18556050956249237)","('NON-ESG', 0.04990164563059807)"
Line 621,"The work of the Medtronic Foundation complements the global work of Medtronic LABS to address healthcare disparities.
","('Systemic_Risk_Management', 0.18039989471435547)","('Access_And_Affordability', 0.17067556083202362)","('Supply_Chain_Management', 0.12051578611135483)","('NON-ESG', 0.18039989471435547)","('NON-ESG', 0.17067556083202362)","('NON-ESG', 0.12051578611135483)"
Line 622,"In FY22, the Medtronic Foundation updated its focus, targeting philanthropic work in three strategic areas: •   Equity-based youth pr ograms — removing barriers  to quality education and supporting health and  well-being for underserved and underrepresented students, including growing the representation of underserved and underrepresented populations in science, technology, engineering, and math (STEM) studies and jobs.
","('Access_And_Affordability', 0.9308196306228638)","('Product_Quality_And_Safety', 0.007443258073180914)","('Employee_Engagement_Inclusion_And_Diversity', 0.0057787662371993065)","(['Health Outcome Contribution'], 0.9308196306228638)","('NON-ESG', 0.007443258073180914)","('NON-ESG', 0.0057787662371993065)"
Line 623,"•   Employee  engagement — supporting communities  in which more than 95,000 Medtronic employees live and give through sustainable year-round, hands-on, and skills-based volunteerism, alongside matching grants and volunteer grants.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2290063202381134)","('Employee_Health_And_Safety', 0.20854265987873077)","('Human_Rights_And_Community_Relations', 0.1789163202047348)","('NON-ESG', 0.2290063202381134)","('NON-ESG', 0.20854265987873077)","('NON-ESG', 0.1789163202047348)"
Line 624,"Read more about Medtronic and the Medtronic Foundation’s work to engage with employees through volunteering.
","('Employee_Health_And_Safety', 0.2841867208480835)","('Employee_Engagement_Inclusion_And_Diversity', 0.18500584363937378)","('Access_And_Affordability', 0.1294456571340561)","('NON-ESG', 0.2841867208480835)","('NON-ESG', 0.18500584363937378)","('NON-ESG', 0.1294456571340561)"
Line 625,"•   Global disaster r elief — strengthening the capacity  and resiliency of communities to prepare for, and recover from, global disasters and humanitarian crises, including COVID-19.
","('Critical_Incident_Risk_Management', 0.9566611051559448)","('Physical_Impacts_Of_Climate_Change', 0.009907703846693039)","('Air_Quality', 0.0034054829739034176)","(['Risk & Crisis Management'], 0.9566611051559448)","('NON-ESG', 0.009907703846693039)","('NON-ESG', 0.0034054829739034176)"
Line 626,"Read more about Medtronic and the Medtronic Foundation’s work to support the pandemic response.Advancing STEM equity  Investment in STEM education to advance diversity across career pathways contributes to vital research and innovation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9539259076118469)","('Access_And_Affordability', 0.005152132827788591)","('Employee_Health_And_Safety', 0.00432478915899992)","(['Human Capital Development'], 0.9539259076118469)","('NON-ESG', 0.005152132827788591)","('NON-ESG', 0.00432478915899992)"
Line 627,"By addressing these inequities early, the Medtronic Foundation is contributing to a more diverse pipeline of talent for medical technology and other sectors, while also advancing more equitable economic opportunities for underrepresented populations.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9412238001823425)","('Competitive_Behavior', 0.0051294597797095776)","('Customer_Welfare', 0.004736513365060091)","(['Human Capital Development'], 0.9412238001823425)","('NON-ESG', 0.0051294597797095776)","('NON-ESG', 0.004736513365060091)"
Line 628,"The work of the Medtronic Foundation complements the Medtronic effort to facilitate a more diverse talent pipeline.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9434834718704224)","('Employee_Health_And_Safety', 0.005508840549737215)","('Access_And_Affordability', 0.004288890399038792)","(['Human Capital Development'], 0.9434834718704224)","('NON-ESG', 0.005508840549737215)","('NON-ESG', 0.004288890399038792)"
Line 629,"Read more about Medtronic’s approach to inclusion, diversity, and equity in the workplace.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9747435450553894)","('Employee_Health_And_Safety', 0.0022539773490279913)","('Human_Rights_And_Community_Relations', 0.0018826436717063189)","(['Human Capital Development'], 0.9747435450553894)","('NON-ESG', 0.0022539773490279913)","('NON-ESG', 0.0018826436717063189)"
Line 630,"In FY22, the Medtronic Foundation continued to develop  health and education partnerships to address racial disparities and advance social justice in the United States, as part of the $16 million investment announced in FY21.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7069680094718933)","('Human_Rights_And_Community_Relations', 0.17467744648456573)","('Access_And_Affordability', 0.018519727513194084)","(['Human Capital Development'], 0.7069680094718933)","('NON-ESG', 0.17467744648456573)","('NON-ESG', 0.018519727513194084)"
Line 631,"For example, in FY22, the Medtronic Foundation  launched a new STEM partnership program with the aim of serving more than 60,000 underserved and underrepresented students.
","('Access_And_Affordability', 0.940750241279602)","('Human_Rights_And_Community_Relations', 0.005730871576815844)","('Product_Quality_And_Safety', 0.005502085201442242)","(['Health Outcome Contribution'], 0.940750241279602)","('NON-ESG', 0.005730871576815844)","('NON-ESG', 0.005502085201442242)"
Line 632,"The two-year program will invest nearly $4 million in 13 partnerships with leading organizations in Minnesota, Northern California, and Puerto Rico.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7584934830665588)","('Access_And_Affordability', 0.035977140069007874)","('Systemic_Risk_Management', 0.02051626890897751)","(['Corporate Governance'], 0.7584934830665588)","('NON-ESG', 0.035977140069007874)","('NON-ESG', 0.02051626890897751)"
Line 633,"These locations have been prioritized based on evidence of racial and economic disparities in communities where Medtronic employees have the greatest footprint and capability to drive social change.
","('Employee_Engagement_Inclusion_And_Diversity', 0.775507926940918)","('Human_Rights_And_Community_Relations', 0.13380464911460876)","('Access_And_Affordability', 0.008534655906260014)","(['Human Capital Development'], 0.775507926940918)","('NON-ESG', 0.13380464911460876)","('NON-ESG', 0.008534655906260014)"
Line 634,"A second round of partnerships will be announced  mid-FY23.
","('Business_Model_Resilience', 0.5470029711723328)","('Systemic_Risk_Management', 0.13592429459095)","('Supply_Chain_Management', 0.03196170553565025)","(['Codes of Business Conduct'], 0.5470029711723328)","('NON-ESG', 0.13592429459095)","('NON-ESG', 0.03196170553565025)"
Line 635,"In addition, Medtronic employee volunteers will   partner with each organization to mentor students and facilitate other skilled volunteerism focused on strengthening systems of care and helping deliver  more sustainable outcomes.
","('Employee_Health_And_Safety', 0.2960795760154724)","('Employee_Engagement_Inclusion_And_Diversity', 0.1964118629693985)","('Access_And_Affordability', 0.1783013641834259)","('NON-ESG', 0.2960795760154724)","('NON-ESG', 0.1964118629693985)","('NON-ESG', 0.1783013641834259)"
Line 636,"PHILANTHROPY Children’s heart care Every child with congenital heart disease deserves access to quality  pediatric heart care.
","('Access_And_Affordability', 0.6563944816589355)","('Employee_Health_And_Safety', 0.06918784230947495)","('Product_Quality_And_Safety', 0.035686518996953964)","(['Health Outcome Contribution'], 0.6563944816589355)","('NON-ESG', 0.06918784230947495)","('NON-ESG', 0.035686518996953964)"
Line 637,"In late FY21, the Medtronic Foundation launched a $2.5 million, three-year partnership with Children’s HeartLink® to increase access to care in Brazil, China, and India.
","('Access_And_Affordability', 0.8672707676887512)","('Product_Quality_And_Safety', 0.01536185946315527)","('Employee_Health_And_Safety', 0.012887958437204361)","(['Health Outcome Contribution'], 0.8672707676887512)","('NON-ESG', 0.01536185946315527)","('NON-ESG', 0.012887958437204361)"
Line 638,"In FY22, the partnership provided training for more than 2,300 clinicians and enabled more than 45,000 outpatient visits and 2,295 essential surgeries.Encouraging STEM careers As part of the Medtronic Foundation’s partnership with the Northside Achievement Zone in Minneapolis, Minnesota, members of the Minnesota Vikings football team joined Medtronic employees for a unique STEM event at the Bakken Museum.
","('Employee_Engagement_Inclusion_And_Diversity', 0.32546618580818176)","('Access_And_Affordability', 0.29931119084358215)","('Employee_Health_And_Safety', 0.1176173985004425)","('NON-ESG', 0.32546618580818176)","('NON-ESG', 0.29931119084358215)","('NON-ESG', 0.1176173985004425)"
Line 639,"Inspired by a lesson on simple machines  from the inventor of the Super Soaker, teammates and scientists worked with 50 students to find creative ways to turn simple household items into extraordinary contraptions.
","('Product_Design_And_Lifecycle_Management', 0.8787029385566711)","('Customer_Welfare', 0.016297031193971634)","('Energy_Management', 0.015490802936255932)","(['Product Stewardship'], 0.8787029385566711)","('NON-ESG', 0.016297031193971634)","('NON-ESG', 0.015490802936255932)"
Line 640,"The goal was to motivate students toward careers in STEM and introduce them to professionals in the field who share similar backgrounds.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9422716498374939)","('Access_And_Affordability', 0.0048385849222540855)","('Employee_Health_And_Safety', 0.004216557368636131)","(['Human Capital Development'], 0.9422716498374939)","('NON-ESG', 0.0048385849222540855)","('NON-ESG', 0.004216557368636131)"
Line 641,"2022 Integrated Performance Report       54 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexEmployee volunteering The Medtronic Foundation offers Medtronic employees  a range of options to donate their time, talent, and resources to support causes close to their hearts.
","('Human_Rights_And_Community_Relations', 0.35738152265548706)","('Employee_Engagement_Inclusion_And_Diversity', 0.10242985934019089)","('Access_And_Affordability', 0.09130606800317764)","('NON-ESG', 0.35738152265548706)","('NON-ESG', 0.10242985934019089)","('NON-ESG', 0.09130606800317764)"
Line 642,"Project 6 is the Medtronic Foundation’s annual global  kickoff campaign for hands-on volunteerism.
","('Employee_Health_And_Safety', 0.3675908148288727)","('Human_Rights_And_Community_Relations', 0.14598143100738525)","('Access_And_Affordability', 0.08703456073999405)","('NON-ESG', 0.3675908148288727)","('NON-ESG', 0.14598143100738525)","('NON-ESG', 0.08703456073999405)"
Line 643,"Employees are encouraged to engage in year-round volunteering, with the Medtronic Foundation offering a variety of opportunities through an online portal that matches  skills to available opportunities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.551898181438446)","('Employee_Health_And_Safety', 0.17179664969444275)","('Access_And_Affordability', 0.05332133546471596)","(['Human Capital Development'], 0.551898181438446)","('NON-ESG', 0.17179664969444275)","('NON-ESG', 0.05332133546471596)"
Line 644,"These include skilled service opportunities through programs like the  Global Innovation Fellows and consulting sprints.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5167958736419678)","('Business_Model_Resilience', 0.05690612643957138)","('Competitive_Behavior', 0.04529358446598053)","(['Human Capital Development'], 0.5167958736419678)","('NON-ESG', 0.05690612643957138)","('NON-ESG', 0.04529358446598053)"
Line 645,"In FY22, the Medtronic Foundation engaged employees to implement 20 skills-based volunteer projects with  32 international organizations across 10 countries.
","('Access_And_Affordability', 0.4021064043045044)","('Employee_Health_And_Safety', 0.1416196972131729)","('Employee_Engagement_Inclusion_And_Diversity', 0.10264461487531662)","('NON-ESG', 0.4021064043045044)","('NON-ESG', 0.1416196972131729)","('NON-ESG', 0.10264461487531662)"
Line 646,"To amplify employees’ efforts, the Medtronic   Foundation offers: •   Ma tched giving — the Medtronic Foundation matches  employee and retiree donations made to any eligible  nonprofit, up to $5,000 per calendar year.
","('Management_Of_Legal_And_Regulatory_Framework', 0.17846569418907166)","('Labor_Practices', 0.15595509111881256)","('Employee_Engagement_Inclusion_And_Diversity', 0.13390007615089417)","('NON-ESG', 0.17846569418907166)","('NON-ESG', 0.15595509111881256)","('NON-ESG', 0.13390007615089417)"
Line 647,"•   V olunteer grants — employees can volunteer with  eligible nonprofits to earn money for causes important to them.
","('Access_And_Affordability', 0.48344099521636963)","('Human_Rights_And_Community_Relations', 0.15683890879154205)","('Management_Of_Legal_And_Regulatory_Framework', 0.10020577907562256)","('NON-ESG', 0.48344099521636963)","('NON-ESG', 0.15683890879154205)","('NON-ESG', 0.10020577907562256)"
Line 648,"For every 10 volunteer hours an employee works with a qualified nonprofit, Medtronic will donate $200 ($20 per volunteer hour).
","('Employee_Health_And_Safety', 0.21227699518203735)","('Labor_Practices', 0.17011964321136475)","('Access_And_Affordability', 0.16711653769016266)","('NON-ESG', 0.21227699518203735)","('NON-ESG', 0.17011964321136475)","('NON-ESG', 0.16711653769016266)"
Line 649,"Employees can generate a maximum donation of $1,000 by volunteering 50 hours per calendar year.PHILANTHROPY Other FY22 initiatives include: •   Medtr onic and the Medtronic Foundation partnered  with the Society of Hispanic Professional Engineers  (SHPE) to launch a new college program designed to remove barriers for Hispanic and Latino students studying STEM.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9643955826759338)","('Access_And_Affordability', 0.0035432125441730022)","('Human_Rights_And_Community_Relations', 0.0028617018833756447)","(['Human Capital Development'], 0.9643955826759338)","('NON-ESG', 0.0035432125441730022)","('NON-ESG', 0.0028617018833756447)"
Line 650,"A combined commitment of more than $3 million over the next four years will help fund scholarships, internships, and mentorship opportunities for SHPE students.
","('Employee_Engagement_Inclusion_And_Diversity', 0.40369129180908203)","('Access_And_Affordability', 0.3137035667896271)","('Human_Rights_And_Community_Relations', 0.03481162339448929)","('NON-ESG', 0.40369129180908203)","('NON-ESG', 0.3137035667896271)","('NON-ESG', 0.03481162339448929)"
Line 651,"•   Medtr onic and the Medtronic Foundation partnered  with the Thurgood Marshall College Fund (TMCF) to foster stronger relationships with Historically Black Colleges and Universities and diversify the pipeline of STEM talent through both internships and scholarships.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9228628277778625)","('Access_And_Affordability', 0.007258022669702768)","('Customer_Welfare', 0.006229819729924202)","(['Human Capital Development'], 0.9228628277778625)","('NON-ESG', 0.007258022669702768)","('NON-ESG', 0.006229819729924202)"
Line 652,"Through the partnership, Medtronic hired 41 summer interns of African descent in FY22 — an increase from 8% in 2020 to 20% in 2021.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9643715620040894)","('Business_Model_Resilience', 0.0027428013272583485)","('Human_Rights_And_Community_Relations', 0.0024083652533590794)","(['Human Capital Development'], 0.9643715620040894)","('NON-ESG', 0.0027428013272583485)","('NON-ESG', 0.0024083652533590794)"
Line 653,"•   Medtr onic held its first STEM consulting sprints —  two days of skilled volunteering with more than 100 employees largely from across the United States, in partnership with Taproot Foundation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3530372381210327)","('Access_And_Affordability', 0.20771671831607819)","('Employee_Health_And_Safety', 0.10429622232913971)","('NON-ESG', 0.3530372381210327)","('NON-ESG', 0.20771671831607819)","('NON-ESG', 0.10429622232913971)"
Line 654,"Teams of four to six employees supported one of 22 STEM-focused organizations to solve current challenges or problems by matching employee skills with nonprofit needs.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5345905423164368)","('Access_And_Affordability', 0.1896400898694992)","('Employee_Health_And_Safety', 0.05439014360308647)","(['Human Capital Development'], 0.5345905423164368)","('NON-ESG', 0.1896400898694992)","('NON-ESG', 0.05439014360308647)"
Line 655,"GRANTS AND EMPLOYEE VOLUNTEERISM  FY20 FY21 FY22† Year-round volunteerism Volunteers 14,000 12,200 11,Countries 49 61 Total volunteer events‡– – 4,Total volunteer hours 170,000 174,000 144,Volunteer grantsVolunteer grants 1,271 689 1,Volunteer grants ($ raised) $635,500 $450,000 $1,700,Global matching grantsMedtronic Foundation match of employee contributions ($ million) §$8.1 $13.6 $9.† Year-round volunteerism and volunteer hours data are based on reported FY22 data, correct as of July 12, 2022.
","('Employee_Health_And_Safety', 0.2917609214782715)","('Access_And_Affordability', 0.17485803365707397)","('Employee_Engagement_Inclusion_And_Diversity', 0.12898918986320496)","('NON-ESG', 0.2917609214782715)","('NON-ESG', 0.17485803365707397)","('NON-ESG', 0.12898918986320496)"
Line 656,"‡ In FY22, we began reporting total volunteer events in place of employee-led projects.
","('Employee_Health_And_Safety', 0.3104296326637268)","('Labor_Practices', 0.15150518715381622)","('Employee_Engagement_Inclusion_And_Diversity', 0.1226842999458313)","('NON-ESG', 0.3104296326637268)","('NON-ESG', 0.15150518715381622)","('NON-ESG', 0.1226842999458313)"
Line 657,"§  Medtronic Foundation matches are usually made on a 1:1 basis up to $5,000.
","('Management_Of_Legal_And_Regulatory_Framework', 0.620932400226593)","('Access_And_Affordability', 0.05543537810444832)","('Business_Ethics', 0.0474860854446888)","(['Corporate Governance'], 0.620932400226593)","('NON-ESG', 0.05543537810444832)","('NON-ESG', 0.0474860854446888)"
Line 658,"In response to COVID-19, Medtronic Foundation matches were increased to 2:1 from   April 1 through October 30, 2020.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2809503674507141)","('Access_And_Affordability', 0.14708641171455383)","('Customer_Welfare', 0.07887938618659973)","('NON-ESG', 0.2809503674507141)","('NON-ESG', 0.14708641171455383)","('NON-ESG', 0.07887938618659973)"
Line 659,"2022 Integrated Performance Report       55 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexDisaster response Together with ongoing efforts to contribute to COVID-19  response, Medtronic and the Medtronic Foundation continue to respond to global challenges that impact the health of communities — including conflicts, natural disasters, and extreme weather.
","('Human_Rights_And_Community_Relations', 0.7272729873657227)","('Business_Model_Resilience', 0.05918526649475098)","('Physical_Impacts_Of_Climate_Change', 0.040855418890714645)","(['Community Relations'], 0.7272729873657227)","('NON-ESG', 0.05918526649475098)","('NON-ESG', 0.040855418890714645)"
Line 660,"We focus on establishing long-term partnerships with local and global organizations that can aid recovery.
","('Human_Rights_And_Community_Relations', 0.45795780420303345)","('Critical_Incident_Risk_Management', 0.17128506302833557)","('Access_And_Affordability', 0.11372561007738113)","('NON-ESG', 0.45795780420303345)","('NON-ESG', 0.17128506302833557)","('NON-ESG', 0.11372561007738113)"
Line 661,"Medtronic employees also can take five days of paid  time off each year to support relief and recovery efforts by volunteering with nonprofits and nongovernmental organizations.
","('Labor_Practices', 0.636860191822052)","('Employee_Health_And_Safety', 0.0837327316403389)","('Management_Of_Legal_And_Regulatory_Framework', 0.052264776080846786)","(['Labor Practice Indicators'], 0.636860191822052)","('NON-ESG', 0.0837327316403389)","('NON-ESG', 0.052264776080846786)"
Line 662,"The Medtronic Employee Emergency Assistance Fund (MEEAF) also offers financial support when employees’ own communities are impacted.
","('Critical_Incident_Risk_Management', 0.9741488099098206)","('Employee_Health_And_Safety', 0.003157001920044422)","('Air_Quality', 0.002867793897166848)","(['Risk & Crisis Management'], 0.9741488099098206)","('NON-ESG', 0.003157001920044422)","('NON-ESG', 0.002867793897166848)"
Line 663,"In FY22, the Medtronic Foundation was awarded  the Project HOPE Global Health Partner Award in recognition of its support for over three decades, including becoming the first corporate partner to support Project HOPE’s Emergency Response and Preparedness Fund.
","('Critical_Incident_Risk_Management', 0.9744377136230469)","('Air_Quality', 0.0027304927352815866)","('Physical_Impacts_Of_Climate_Change', 0.002636697143316269)","(['Risk & Crisis Management'], 0.9744377136230469)","('NON-ESG', 0.0027304927352815866)","('NON-ESG', 0.002636697143316269)"
Line 664,"Response to the Ukraine conflict Upon outbreak of the conflict in Ukraine, Medtronic and the Medtronic Foundation began monitoring and assessing support and response needs.
","('Critical_Incident_Risk_Management', 0.7962720394134521)","('Physical_Impacts_Of_Climate_Change', 0.0402967743575573)","('Human_Rights_And_Community_Relations', 0.028478948399424553)","(['Risk & Crisis Management'], 0.7962720394134521)","('NON-ESG', 0.0402967743575573)","('NON-ESG', 0.028478948399424553)"
Line 665,"We have experienced strong attendance at employee  sessions covering topics such as support for employees and managers directly impacted, those with family in Ukraine, and employees across Europe.
","('Employee_Health_And_Safety', 0.4000094532966614)","('Employee_Engagement_Inclusion_And_Diversity', 0.26548242568969727)","('Access_And_Affordability', 0.07807546854019165)","('NON-ESG', 0.4000094532966614)","('NON-ESG', 0.26548242568969727)","('NON-ESG', 0.07807546854019165)"
Line 666,"To date, more than 600 employees have attended 27 sessions hosted in nine languages.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5181719660758972)","('Access_And_Affordability', 0.08510670065879822)","('Labor_Practices', 0.05788232758641243)","(['Human Capital Development'], 0.5181719660758972)","('NON-ESG', 0.08510670065879822)","('NON-ESG', 0.05788232758641243)"
Line 667,"Two types of MEEAF grants are available for Ukrainian employees; in FY22, 30 employees applied for these.
","('Labor_Practices', 0.5220279097557068)","('Employee_Engagement_Inclusion_And_Diversity', 0.2502100169658661)","('Management_Of_Legal_And_Regulatory_Framework', 0.04172900691628456)","(['Labor Practice Indicators'], 0.5220279097557068)","('NON-ESG', 0.2502100169658661)","('NON-ESG', 0.04172900691628456)"
Line 668,"As of May 26, 2022, Medtronic and the Medtronic Foundation donated a total of $6.7 million to support Ukraine via direct relief grants, employee donations,  and product donations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5770481824874878)","('Access_And_Affordability', 0.048548366874456406)","('Customer_Welfare', 0.048035211861133575)","(['Corporate Governance'], 0.5770481824874878)","('NON-ESG', 0.048548366874456406)","('NON-ESG', 0.048035211861133575)"
Line 669,"This includes: •  $4.9 million in pr oduct donations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7960852980613708)","('GHG_Emissions', 0.023472145199775696)","('Ecological_Impacts', 0.01919942907989025)","(['Corporate Governance'], 0.7960852980613708)","('NON-ESG', 0.023472145199775696)","('NON-ESG', 0.01919942907989025)"
Line 670,"•   $607,000 in Medtr onic local giving and Medtronic  Foundation Direct Relief Grants to global partners  Project Hope, International Medical Corps,  and Americares.
","('Management_Of_Legal_And_Regulatory_Framework', 0.665220320224762)","('Access_And_Affordability', 0.12069078534841537)","('Human_Rights_And_Community_Relations', 0.02836388535797596)","(['Corporate Governance'], 0.665220320224762)","('NON-ESG', 0.12069078534841537)","('NON-ESG', 0.02836388535797596)"
Line 671,"•   $1.14 million total in employee dona tions, including  matched giving.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5399665236473083)","('Labor_Practices', 0.05956301838159561)","('Access_And_Affordability', 0.05185718089342117)","(['Corporate Governance'], 0.5399665236473083)","('NON-ESG', 0.05956301838159561)","('NON-ESG', 0.05185718089342117)"
Line 672,"To date, 2,133 employees have contributed, and donations continue to roll in.
","('Management_Of_Legal_And_Regulatory_Framework', 0.18773788213729858)","('Labor_Practices', 0.12046259641647339)","('Human_Rights_And_Community_Relations', 0.10775049775838852)","('NON-ESG', 0.18773788213729858)","('NON-ESG', 0.12046259641647339)","('NON-ESG', 0.10775049775838852)"
Line 673,"Read more about employee volunteering efforts relating  to Ukraine.
","('Employee_Health_And_Safety', 0.33997461199760437)","('Human_Rights_And_Community_Relations', 0.26873624324798584)","('Employee_Engagement_Inclusion_And_Diversity', 0.10725382715463638)","('NON-ESG', 0.33997461199760437)","('NON-ESG', 0.26873624324798584)","('NON-ESG', 0.10725382715463638)"
Line 674,"Natural disasters To address healthcare provision for children and families following hurricane Maria in Puerto Rico, the Medtronic Foundation continued to develop its partnership with the island’s public health trust.
","('Critical_Incident_Risk_Management', 0.6968662738800049)","('Physical_Impacts_Of_Climate_Change', 0.18820251524448395)","('Air_Quality', 0.01391097903251648)","(['Risk & Crisis Management'], 0.6968662738800049)","('NON-ESG', 0.18820251524448395)","('NON-ESG', 0.01391097903251648)"
Line 675,"The partnership focuses on increasing access to care and future resiliency for underserved populations, improving health outcomes for chronic conditions, and involving Medtronic employees in executing these programs.
","('Access_And_Affordability', 0.9477820992469788)","('Critical_Incident_Risk_Management', 0.005078617949038744)","('Product_Quality_And_Safety', 0.0047007473185658455)","(['Health Outcome Contribution'], 0.9477820992469788)","('NON-ESG', 0.005078617949038744)","('NON-ESG', 0.0047007473185658455)"
Line 676,"In response to the FY22 wildfires in Louisville, Colorado,  Medtronic and the Medtronic Foundation provided employee and community support and resources, including assisting 10 employees whose homes were lost or suffered heavy fire damage.PHILANTHROPY DISASTER RELIEF† ($ million) FY20 FY21 FYContributions $2.2 $2.1 $3.†  C ontributions vary year over year depending on the number and nature of disasters requiring response.
","('Critical_Incident_Risk_Management', 0.9700363874435425)","('Physical_Impacts_Of_Climate_Change', 0.004330256022512913)","('Employee_Health_And_Safety', 0.0033782669343054295)","(['Risk & Crisis Management'], 0.9700363874435425)","('NON-ESG', 0.004330256022512913)","('NON-ESG', 0.0033782669343054295)"
Line 677,"Figures do not include contributions relating to the COVID-19 pandemic or the war in Ukraine.
","('Physical_Impacts_Of_Climate_Change', 0.36835092306137085)","('Systemic_Risk_Management', 0.25450924038887024)","('Critical_Incident_Risk_Management', 0.053114719688892365)","('NON-ESG', 0.36835092306137085)","('NON-ESG', 0.25450924038887024)","('NON-ESG', 0.053114719688892365)"
Line 678,"$6.7M to support Ukraine via direct relief  grants, employee donations,   and product donations  Employee support for Ukraine The conflict in Ukraine has triggered a humanitarian crisis, devastating communities across  the country and beyond.
","('Critical_Incident_Risk_Management', 0.8836576342582703)","('Human_Rights_And_Community_Relations', 0.020223043859004974)","('Physical_Impacts_Of_Climate_Change', 0.016553591936826706)","(['Risk & Crisis Management'], 0.8836576342582703)","('NON-ESG', 0.020223043859004974)","('NON-ESG', 0.016553591936826706)"
Line 679,"Medtronic employees have stepped up to help colleagues and their families in this time of need.
","('Access_And_Affordability', 0.422570139169693)","('Human_Rights_And_Community_Relations', 0.1763916015625)","('Employee_Health_And_Safety', 0.16865062713623047)","('NON-ESG', 0.422570139169693)","('NON-ESG', 0.1763916015625)","('NON-ESG', 0.16865062713623047)"
Line 680,"Dozens of employees in Poland and Central Eastern Europe have provided free  accommodation, food, clothes, and transport from the Ukrainian border.
","('Labor_Practices', 0.4773140847682953)","('Employee_Health_And_Safety', 0.2588269114494324)","('Supply_Chain_Management', 0.02553868293762207)","('NON-ESG', 0.4773140847682953)","('NON-ESG', 0.2588269114494324)","('NON-ESG', 0.02553868293762207)"
Line 681,"Further west, one Medtronic employee in Switzerland, supported by more than 200 volunteers, set up an operation to distribute clothes and food to refugees fleeing Ukraine.
","('Critical_Incident_Risk_Management', 0.3301626741886139)","('Human_Rights_And_Community_Relations', 0.10388372093439102)","('Employee_Health_And_Safety', 0.07777275145053864)","('NON-ESG', 0.3301626741886139)","('NON-ESG', 0.10388372093439102)","('NON-ESG', 0.07777275145053864)"
Line 682,"2022 Integrated Performance Report       56 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index50 %  42 % 39 % 27 % Inclusion,  diversity, and equitySOCIAL IMPACT Adding business value We prioritize creating an environment  where everyone feels included, all contributions are valued, and the playing field is level.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9494242072105408)","('Business_Model_Resilience', 0.005605081561952829)","('Human_Rights_And_Community_Relations', 0.005400683730840683)","(['Human Capital Development'], 0.9494242072105408)","('NON-ESG', 0.005605081561952829)","('NON-ESG', 0.005400683730840683)"
Line 683,"These attributes help us recruit and retain the best talent and develop products and therapies that serve more people worldwide.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7611334919929504)","('Product_Design_And_Lifecycle_Management', 0.04194818437099457)","('Customer_Welfare', 0.031103340908885002)","(['Human Capital Development'], 0.7611334919929504)","('NON-ESG', 0.04194818437099457)","('NON-ESG', 0.031103340908885002)"
Line 684,"Our approach to inclusion, diversity, and equity  (ID&E) is holistic.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9738630652427673)","('Human_Rights_And_Community_Relations', 0.002520847599953413)","('Employee_Health_And_Safety', 0.002090067369863391)","(['Human Capital Development'], 0.9738630652427673)","('NON-ESG', 0.002520847599953413)","('NON-ESG', 0.002090067369863391)"
Line 685,"We integrate ID&E principles throughout our company to ensure every operating unit, team, and leader recognizes and celebrates the value of diverse experiences and backgrounds.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9713677763938904)","('Human_Rights_And_Community_Relations', 0.002652774564921856)","('Employee_Health_And_Safety', 0.0022336929105222225)","(['Human Capital Development'], 0.9713677763938904)","('NON-ESG', 0.002652774564921856)","('NON-ESG', 0.0022336929105222225)"
Line 686,"Developing an inclusive, diverse, and equitable workforce empowers us to reach our highest potential in our business and in our communities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.969183087348938)","('Human_Rights_And_Community_Relations', 0.0036481565330177546)","('Business_Model_Resilience', 0.0020270938985049725)","(['Human Capital Development'], 0.969183087348938)","('NON-ESG', 0.0036481565330177546)","('NON-ESG', 0.0020270938985049725)"
Line 687,"of our global  workforce are women of our global  managers are women of our U.S. workforce  are ethnically diverse of our U.S. managers  are ethnically diverse 2022 Integrated Performance Report       57 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexID&E at Medtronic  Our ID&E strategy is organized under three pillars: •   Individual  – being accountable role models of ID&E   in our daily work  •   C ompany – ingraining ID&E into our DNA through  training, policies, and practices •   C ommunity – amplifying our ID&E impact beyond   our walls This strategy makes promoting ID&E a collective  responsibility — as an organization and as individual employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9730623364448547)","('Human_Rights_And_Community_Relations', 0.0019710524939000607)","('Business_Model_Resilience', 0.0018750738818198442)","(['Human Capital Development'], 0.9730623364448547)","('NON-ESG', 0.0019710524939000607)","('NON-ESG', 0.0018750738818198442)"
Line 688,"of our global  workforce are women of our global  managers are women of our U.S. workforce  are ethnically diverse of our U.S. managers  are ethnically diverse 2022 Integrated Performance Report       57 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexID&E at Medtronic  Our ID&E strategy is organized under three pillars: •   Individual  – being accountable role models of ID&E   in our daily work  •   C ompany – ingraining ID&E into our DNA through  training, policies, and practices •   C ommunity – amplifying our ID&E impact beyond   our walls This strategy makes promoting ID&E a collective  responsibility — as an organization and as individual employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4593426287174225)","('Labor_Practices', 0.19483931362628937)","('Employee_Health_And_Safety', 0.07921142131090164)","('NON-ESG', 0.4593426287174225)","('NON-ESG', 0.19483931362628937)","('NON-ESG', 0.07921142131090164)"
Line 689,"In so doing, we can extend our positive impact from the company to the communities in which we operate, hire from, and live.Our progress  Accelerating the pace of change to advance inclusion, diversity, and equity requires new approaches and ways of thinking.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9732146263122559)","('Human_Rights_And_Community_Relations', 0.0028569824062287807)","('Employee_Health_And_Safety', 0.0020642236340790987)","(['Human Capital Development'], 0.9732146263122559)","('NON-ESG', 0.0028569824062287807)","('NON-ESG', 0.0020642236340790987)"
Line 690,"We have taken several strategic actions to help us move faster toward zero barriers to equity.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4515560269355774)","('Systemic_Risk_Management', 0.16250714659690857)","('Competitive_Behavior', 0.11681193858385086)","('NON-ESG', 0.4515560269355774)","('NON-ESG', 0.16250714659690857)","('NON-ESG', 0.11681193858385086)"
Line 691,"This includes shifting to a leader-led model for ID&E, building stronger accountability across our organization, setting new five-year organizational diversity representation goals, measuring beyond representation, and being even more transparent publicly about our progress.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9717733263969421)","('Employee_Health_And_Safety', 0.0023778697941452265)","('Competitive_Behavior', 0.0022181831300258636)","(['Human Capital Development'], 0.9717733263969421)","('NON-ESG', 0.0023778697941452265)","('NON-ESG', 0.0022181831300258636)"
Line 692,"Our approach helped us surpass the corporate benchmark for inclusion, where our FY22 inclusion  rating achieved world-class levels, 1 it also earned us   a top-ten spot on DiversityInc’s 2022 Top 50 Companies for Diversity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9725179076194763)","('Human_Rights_And_Community_Relations', 0.002434495370835066)","('Employee_Health_And_Safety', 0.002419049385935068)","(['Human Capital Development'], 0.9725179076194763)","('NON-ESG', 0.002434495370835066)","('NON-ESG', 0.002419049385935068)"
Line 693,"In FY22, we made progress on our goals to have more  women and people from ethnically diverse groups in management positions, and we increased hiring rates for women and ethnically diverse talent.
","('Employee_Engagement_Inclusion_And_Diversity', 0.977165937423706)","('Employee_Health_And_Safety', 0.0016931276768445969)","('Human_Rights_And_Community_Relations', 0.0015048085479065776)","(['Human Capital Development'], 0.977165937423706)","('NON-ESG', 0.0016931276768445969)","('NON-ESG', 0.0015048085479065776)"
Line 694,"Our total population of woman employees remained stable  while our total population of ethnically diverse employees slightly increased.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9737701416015625)","('Labor_Practices', 0.002663016552105546)","('Employee_Health_And_Safety', 0.00209687533788383)","(['Human Capital Development'], 0.9737701416015625)","('NON-ESG', 0.002663016552105546)","('NON-ESG', 0.00209687533788383)"
Line 695,"FY26 LEADERSHIP DIVERSITY GOALS FY15 baseline FY22 progress FY26 goal Manager-and-above positions globally held   by women32% 42% 45% Manager-and-above positions in the United States held by people from ethnically diverse groups17% 27% 30%INCLUSION, DIVERSITY, AND EQUITY Our ID&E commitment Our unwavering commitment to  ID&E means we are working toward zero barriers to opportunity within Medtronic and toward a culture where all employees belong, are respected, and feel valued for who they are and the life experiences they contribute.ID&E STRATEGIC PILLARS 1  T his benchmark was derived via internal historical OHS data and externally published  reports from highly reputable survey vendors and through professional judgment.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9759058952331543)","('Employee_Health_And_Safety', 0.0019286428578197956)","('Human_Rights_And_Community_Relations', 0.0017533617792651057)","(['Human Capital Development'], 0.9759058952331543)","('NON-ESG', 0.0019286428578197956)","('NON-ESG', 0.0017533617792651057)"
Line 696,"FY26 LEADERSHIP DIVERSITY GOALS FY15 baseline FY22 progress FY26 goal Manager-and-above positions globally held   by women32% 42% 45% Manager-and-above positions in the United States held by people from ethnically diverse groups17% 27% 30%INCLUSION, DIVERSITY, AND EQUITY Our ID&E commitment Our unwavering commitment to  ID&E means we are working toward zero barriers to opportunity within Medtronic and toward a culture where all employees belong, are respected, and feel valued for who they are and the life experiences they contribute.ID&E STRATEGIC PILLARS 1  T his benchmark was derived via internal historical OHS data and externally published  reports from highly reputable survey vendors and through professional judgment.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3298790156841278)","('Competitive_Behavior', 0.31046193838119507)","('Systemic_Risk_Management', 0.07113843411207199)","('NON-ESG', 0.3298790156841278)","('NON-ESG', 0.31046193838119507)","('NON-ESG', 0.07113843411207199)"
Line 697,"We have also compared survey results against a global normative database and leveraged data collected through a panel vendor to inform the benchmarks.Strategic Pillars Individual Be accounta ble role  models for inclusion  and diversityCompany Ingrain inclusion and  equity into our DNACommunity Amplify our impact  beyond Medtronic Desired Outcomes Culture of  belongingEquity in  opportunity   and payMeasurable  social impactWorld-class  diverse talent  destinat ionour global  communities 2022 Integrated Performance Report       58 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexLeadership’s role in ID&E  ID&E is a business priority, and we believe that driving  progress begins with our leadership.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9725522994995117)","('Human_Rights_And_Community_Relations', 0.0029988745227456093)","('Business_Model_Resilience', 0.002080360194668174)","(['Human Capital Development'], 0.9725522994995117)","('NON-ESG', 0.0029988745227456093)","('NON-ESG', 0.002080360194668174)"
Line 698,"We have also compared survey results against a global normative database and leveraged data collected through a panel vendor to inform the benchmarks.Strategic Pillars Individual Be accounta ble role  models for inclusion  and diversityCompany Ingrain inclusion and  equity into our DNACommunity Amplify our impact  beyond Medtronic Desired Outcomes Culture of  belongingEquity in  opportunity   and payMeasurable  social impactWorld-class  diverse talent  destinat ionour global  communities 2022 Integrated Performance Report       58 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexLeadership’s role in ID&E  ID&E is a business priority, and we believe that driving  progress begins with our leadership.
","('Business_Model_Resilience', 0.5602604150772095)","('Human_Rights_And_Community_Relations', 0.06071028113365173)","('Systemic_Risk_Management', 0.05476108938455582)","(['Codes of Business Conduct'], 0.5602604150772095)","('NON-ESG', 0.06071028113365173)","('NON-ESG', 0.05476108938455582)"
Line 699,"In FY22, we focused on ensuring accountability for meeting ID&E goals by tying executive compensation to ID&E results.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5450184941291809)","('Business_Ethics', 0.15651623904705048)","('Competitive_Behavior', 0.058245427906513214)","(['Corporate Governance'], 0.5450184941291809)","('NON-ESG', 0.15651623904705048)","('NON-ESG', 0.058245427906513214)"
Line 700,"Up to  15% of annual incentive compensation for senior Medtronic executives 1 now depends on their  performance against ID&E objectives.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3118203282356262)","('Business_Ethics', 0.2785140872001648)","('Labor_Practices', 0.14955000579357147)","('NON-ESG', 0.3118203282356262)","('NON-ESG', 0.2785140872001648)","('NON-ESG', 0.14955000579357147)"
Line 701,"In FY22, we also rolled out a new Board Diversity Policy providing guidelines for diversity criteria when considering the composition of our board.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9533470273017883)","('Director_Removal', 0.004427450243383646)","('Business_Model_Resilience', 0.003170240670442581)","(['Human Capital Development'], 0.9533470273017883)","('NON-ESG', 0.004427450243383646)","('NON-ESG', 0.003170240670442581)"
Line 702,"We also set new FY26 goals for diverse representation  in management positions after meeting our FY20 goals.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9672076106071472)","('Competitive_Behavior', 0.0026605792809277773)","('Business_Model_Resilience', 0.0025110780261456966)","(['Human Capital Development'], 0.9672076106071472)","('NON-ESG', 0.0026605792809277773)","('NON-ESG', 0.0025110780261456966)"
Line 703,"We aim for 45% of manager-and-above roles globally to be held by women and for 30% of those roles in the United States to be held by people from ethnically diverse groups.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9761149883270264)","('Human_Rights_And_Community_Relations', 0.0018443616572767496)","('Employee_Health_And_Safety', 0.001497557619586587)","(['Human Capital Development'], 0.9761149883270264)","('NON-ESG', 0.0018443616572767496)","('NON-ESG', 0.001497557619586587)"
Line 704,"By the end of FY22, women held 42% of manager-and-above roles globally and people from ethnically diverse groups held 27% of those in the United States.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9748572707176208)","('Human_Rights_And_Community_Relations', 0.0021204303484410048)","('Customer_Privacy', 0.0015823086723685265)","(['Human Capital Development'], 0.9748572707176208)","('NON-ESG', 0.0021204303484410048)","('NON-ESG', 0.0015823086723685265)"
Line 705,"To progress toward our goals, vice presidents (VPs) and  other senior executives develop individualized plans to drive ID&E in their operating unit, region, or function.
","('Business_Model_Resilience', 0.36185282468795776)","('Director_Removal', 0.23045209050178528)","('Employee_Engagement_Inclusion_And_Diversity', 0.07053371518850327)","('NON-ESG', 0.36185282468795776)","('NON-ESG', 0.23045209050178528)","('NON-ESG', 0.07053371518850327)"
Line 706,"Doing so acknowledges the unique context and needs of each team and equips leaders to drive progress in a locally relevant way.
","('Human_Rights_And_Community_Relations', 0.4058419167995453)","('Business_Model_Resilience', 0.16165253520011902)","('Management_Of_Legal_And_Regulatory_Framework', 0.05933535844087601)","('NON-ESG', 0.4058419167995453)","('NON-ESG', 0.16165253520011902)","('NON-ESG', 0.05933535844087601)"
Line 707,"Additionally, the CEO and members of the executive team conduct a Quarterly Diversity Review to evaluate ID&E progress, integrating best practices from external partners, internal leaders, and diversity networks.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9693495035171509)","('Employee_Health_And_Safety', 0.002438565716147423)","('Human_Rights_And_Community_Relations', 0.002082335762679577)","(['Human Capital Development'], 0.9693495035171509)","('NON-ESG', 0.002438565716147423)","('NON-ESG', 0.002082335762679577)"
Line 708,"These reviews serve as a mechanism to hold our top leaders accountable and help them learn and grow.
","('Systemic_Risk_Management', 0.24802809953689575)","('Business_Model_Resilience', 0.16844835877418518)","('Business_Ethics', 0.08797197043895721)","('NON-ESG', 0.24802809953689575)","('NON-ESG', 0.16844835877418518)","('NON-ESG', 0.08797197043895721)"
Line 709,"Read more about our work on ID&E in our Global ID&E  2021 Annual Report.WOMAN TALENT GLOBALLY FY20 FY21 FYWoman employees 49% 50% 50% Manager-and-above positions held by women 39% 40% 42% Management positions in revenue-generating functions (i.e., sales)  held by women 32% 32% 34% U.S. ETHNICALLY DIVERSE TALENT†  FY20 FY21 FYEthnically diverse employees 37%  38%  39% Manager -and-above positions held by people from ethnically   diverse groups23%  25%‡27% † United States, excluding Puerto Rico (excludes blank, no data, or did not disclose).
","('Employee_Engagement_Inclusion_And_Diversity', 0.9751284718513489)","('Employee_Health_And_Safety', 0.0017532478086650372)","('Customer_Privacy', 0.0016265172744169831)","(['Human Capital Development'], 0.9751284718513489)","('NON-ESG', 0.0017532478086650372)","('NON-ESG', 0.0016265172744169831)"
Line 710,"Read more about our work on ID&E in our Global ID&E  2021 Annual Report.WOMAN TALENT GLOBALLY FY20 FY21 FYWoman employees 49% 50% 50% Manager-and-above positions held by women 39% 40% 42% Management positions in revenue-generating functions (i.e., sales)  held by women 32% 32% 34% U.S. ETHNICALLY DIVERSE TALENT†  FY20 FY21 FYEthnically diverse employees 37%  38%  39% Manager -and-above positions held by people from ethnically   diverse groups23%  25%‡27% † United States, excluding Puerto Rico (excludes blank, no data, or did not disclose).
","('Customer_Privacy', 0.7325043678283691)","('Data_Security', 0.05346335470676422)","('Waste_And_Hazardous_Materials_Management', 0.02399032562971115)","(['Privacy Protection'], 0.7325043678283691)","('NON-ESG', 0.05346335470676422)","('NON-ESG', 0.02399032562971115)"
Line 711,"‡  T his number is based on fiscal year 2021 and therefore is different than the number reported for our calendar year 2020 target, where we achieved 24% ethnically diverse  talent in manager-and-above positions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9730706810951233)","('Customer_Privacy', 0.0022335227113217115)","('Human_Rights_And_Community_Relations', 0.0016790766967460513)","(['Human Capital Development'], 0.9730706810951233)","('NON-ESG', 0.0022335227113217115)","('NON-ESG', 0.0016790766967460513)"
Line 712,"NEW HIRES†  FY20 FY21 FYWoman (global) 51%‡ 50%§52%Ω Ethnically diverse (U.S.) 52%  46%  47% † Employee popula tion data expressed here may vary from our 10-K form depending on the time of year in which the data was gathered.
","('Employee_Engagement_Inclusion_And_Diversity', 0.971907913684845)","('Customer_Privacy', 0.002385977655649185)","('Business_Model_Resilience', 0.001900401315651834)","(['Human Capital Development'], 0.971907913684845)","('NON-ESG', 0.002385977655649185)","('NON-ESG', 0.001900401315651834)"
Line 713,"‡ Z ero records have values out-of-bounds (e.g., age=0).
","('Systemic_Risk_Management', 0.13063398003578186)","('Competitive_Behavior', 0.12615498900413513)","('Employee_Engagement_Inclusion_And_Diversity', 0.09996578097343445)","('NON-ESG', 0.13063398003578186)","('NON-ESG', 0.12615498900413513)","('NON-ESG', 0.09996578097343445)"
Line 714,"49 records do not specify gender.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8634296655654907)","('Labor_Practices', 0.031015420332551003)","('Customer_Privacy', 0.018095573410391808)","(['Human Capital Development'], 0.8634296655654907)","('NON-ESG', 0.031015420332551003)","('NON-ESG', 0.018095573410391808)"
Line 715,"§ Z ero records have values out-of-bounds (e.g., age=0).
","('Competitive_Behavior', 0.11693470925092697)","('Data_Security', 0.11442741006612778)","('Systemic_Risk_Management', 0.11310724169015884)","('NON-ESG', 0.11693470925092697)","('NON-ESG', 0.11442741006612778)","('NON-ESG', 0.11310724169015884)"
Line 716,"34 records do not specify gender.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8783742785453796)","('Labor_Practices', 0.028060968965291977)","('Customer_Privacy', 0.014705048874020576)","(['Human Capital Development'], 0.8783742785453796)","('NON-ESG', 0.028060968965291977)","('NON-ESG', 0.014705048874020576)"
Line 717,"Ω Z ero records have values out-of-bounds (e.g., age=0).
","('Systemic_Risk_Management', 0.20182564854621887)","('Competitive_Behavior', 0.18912622332572937)","('Data_Security', 0.07932798564434052)","('NON-ESG', 0.20182564854621887)","('NON-ESG', 0.18912622332572937)","('NON-ESG', 0.07932798564434052)"
Line 718,"24 records do not specify gender.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8606357574462891)","('Labor_Practices', 0.03211025148630142)","('Customer_Privacy', 0.018224384635686874)","(['Human Capital Development'], 0.8606357574462891)","('NON-ESG', 0.03211025148630142)","('NON-ESG', 0.018224384635686874)"
Line 719,"BOARD DIVERSITY  FY20 FY21 FYWoman 25%  25% 30% Ethnically diverse 17%  17%  20%INCLUSION, DIVERSITY, AND EQUITY 1   T his includes our C-suite and their direct reports, including 160 leaders at the vice  president-level and above.50 % of Medtronic employees   were women in FY2022 Integrated Performance Report       59 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexINCLUSION, DIVERSITY, AND EQUITY DIVERSITY NETWORKS AND   EMPLOYEE RESOURCE GROUPS In FY22, we had eight  ERGs   and five  Diversity NetworksEquity week In its second year, our Action for Equity program expanded  to include a week of activities designed to empower and enable employees to make their greatest contributions to equity within and beyond Medtronic.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9753798246383667)","('Employee_Health_And_Safety', 0.001977653708308935)","('Business_Model_Resilience', 0.0016888881800696254)","(['Human Capital Development'], 0.9753798246383667)","('NON-ESG', 0.001977653708308935)","('NON-ESG', 0.0016888881800696254)"
Line 720,"BOARD DIVERSITY  FY20 FY21 FYWoman 25%  25% 30% Ethnically diverse 17%  17%  20%INCLUSION, DIVERSITY, AND EQUITY 1   T his includes our C-suite and their direct reports, including 160 leaders at the vice  president-level and above.50 % of Medtronic employees   were women in FY2022 Integrated Performance Report       59 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexINCLUSION, DIVERSITY, AND EQUITY DIVERSITY NETWORKS AND   EMPLOYEE RESOURCE GROUPS In FY22, we had eight  ERGs   and five  Diversity NetworksEquity week In its second year, our Action for Equity program expanded  to include a week of activities designed to empower and enable employees to make their greatest contributions to equity within and beyond Medtronic.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9654850363731384)","('Human_Rights_And_Community_Relations', 0.003228013403713703)","('Employee_Health_And_Safety', 0.0027398185338824987)","(['Human Capital Development'], 0.9654850363731384)","('NON-ESG', 0.003228013403713703)","('NON-ESG', 0.0027398185338824987)"
Line 721,"Over 6,000 employees participated in our FY22 Week of Action for Equity, which included activities like interactive group learning sessions, fireside chats on allyship, and exploration of our resource toolkit containing helpful articles, podcasts, and more.
","('Access_And_Affordability', 0.1682962030172348)","('Human_Rights_And_Community_Relations', 0.13995301723480225)","('Employee_Engagement_Inclusion_And_Diversity', 0.1352843940258026)","('NON-ESG', 0.1682962030172348)","('NON-ESG', 0.13995301723480225)","('NON-ESG', 0.1352843940258026)"
Line 722,"Afterwards, employees reported feeling inspired to do more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.23422293365001678)","('Employee_Health_And_Safety', 0.12065908312797546)","('Human_Rights_And_Community_Relations', 0.06216476857662201)","('NON-ESG', 0.23422293365001678)","('NON-ESG', 0.12065908312797546)","('NON-ESG', 0.06216476857662201)"
Line 723,"“We decided as a team to  hold each other accountable  quarterly.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5196427702903748)","('Business_Ethics', 0.21452918648719788)","('Director_Removal', 0.054533012211322784)","(['Corporate Governance'], 0.5196427702903748)","('NON-ESG', 0.21452918648719788)","('NON-ESG', 0.054533012211322784)"
Line 724,"We are turning   allyship into action!”  Equity Week attendeeIndividual’s role in ID&E  Creating an environment where everyone feels safe  and valued for who they are requires all Medtronic employees to be accountable role models for ID&E.
","('Employee_Health_And_Safety', 0.3274085819721222)","('Human_Rights_And_Community_Relations', 0.19160081446170807)","('Access_And_Affordability', 0.1396457999944687)","('NON-ESG', 0.3274085819721222)","('NON-ESG', 0.19160081446170807)","('NON-ESG', 0.1396457999944687)"
Line 725,"Our Diversity Networks and Employee Resource Groups  (ERGs) help strengthen a sense of belonging across our company.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9743562340736389)","('Employee_Health_And_Safety', 0.002246570773422718)","('Human_Rights_And_Community_Relations', 0.0017998038092628121)","(['Human Capital Development'], 0.9743562340736389)","('NON-ESG', 0.002246570773422718)","('NON-ESG', 0.0017998038092628121)"
Line 726,"These groups ensure everyone has a platform to share their voice and the voice of the community, collaborate across functions and levels, and advance programs and initiatives in the areas of talent, education and community, and partnerships.
","('Human_Rights_And_Community_Relations', 0.8562309741973877)","('Employee_Engagement_Inclusion_And_Diversity', 0.032122060656547546)","('Access_And_Affordability', 0.028928609564900398)","(['Community Relations'], 0.8562309741973877)","('NON-ESG', 0.032122060656547546)","('NON-ESG', 0.028928609564900398)"
Line 727,"In FY22, more than 34,000 employees in 75 countries were members of a Diversity Network or ERG.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9698677062988281)","('Employee_Health_And_Safety', 0.002380605787038803)","('Labor_Practices', 0.0022699192631989717)","(['Human Capital Development'], 0.9698677062988281)","('NON-ESG', 0.002380605787038803)","('NON-ESG', 0.0022699192631989717)"
Line 728,"Diversity Networks Diversity Networks provide a platform for employees from underrepresented populations to connect and provide feedback to our leadership.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9747704267501831)","('Employee_Health_And_Safety', 0.0020943661220371723)","('Human_Rights_And_Community_Relations', 0.0015832596691325307)","(['Human Capital Development'], 0.9747704267501831)","('NON-ESG', 0.0020943661220371723)","('NON-ESG', 0.0015832596691325307)"
Line 729,"Each of our five Diversity Networks has two co-chairs and an executive sponsor who reports directly to the CEO.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9682086110115051)","('Human_Rights_And_Community_Relations', 0.002791705308482051)","('Employee_Health_And_Safety', 0.0025387005880475044)","(['Human Capital Development'], 0.9682086110115051)","('NON-ESG', 0.002791705308482051)","('NON-ESG', 0.0025387005880475044)"
Line 730,"Employee Resource Groups  Our ERGs are grassroots affinity groups for employees with shared identities, backgrounds, and interests, as well as for allies.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9636470079421997)","('Human_Rights_And_Community_Relations', 0.003418568056076765)","('Customer_Privacy', 0.0031551101710647345)","(['Human Capital Development'], 0.9636470079421997)","('NON-ESG', 0.003418568056076765)","('NON-ESG', 0.0031551101710647345)"
Line 731,"They provide a safe community to share, learn, and support one another.
","('Access_And_Affordability', 0.2909587323665619)","('Human_Rights_And_Community_Relations', 0.21079236268997192)","('Employee_Health_And_Safety', 0.11532308161258698)","('NON-ESG', 0.2909587323665619)","('NON-ESG', 0.21079236268997192)","('NON-ESG', 0.11532308161258698)"
Line 732,"In FY22, we added a new ERG, Medtronic Seasoned Professionals (MSP), bringing our total number of ERGs to eight.
","('Employee_Engagement_Inclusion_And_Diversity', 0.32153794169425964)","('Access_And_Affordability', 0.16546490788459778)","('Product_Quality_And_Safety', 0.06586156040430069)","('NON-ESG', 0.32153794169425964)","('NON-ESG', 0.16546490788459778)","('NON-ESG', 0.06586156040430069)"
Line 733,"MSP aims to develop a culture of inclusion and recognition for mature workers and leverage their experience to benefit all of Medtronic.
","('Employee_Engagement_Inclusion_And_Diversity', 0.961304783821106)","('Labor_Practices', 0.005198776721954346)","('Employee_Health_And_Safety', 0.0039504291489720345)","(['Human Capital Development'], 0.961304783821106)","('NON-ESG', 0.005198776721954346)","('NON-ESG', 0.0039504291489720345)"
Line 734,"1inMedtronic employees were part  of a Diversity Network or ERG  in FY22 across 300+ hubs in  75 countries.Awareness  Benefiting  Leadership and  Employees about  Disabilities  (ABLED) American   Indian   Employee   Resource   GroupAsian Impact   at Medtronic  Network   (AIM) Medtronic   Young   ProfessionalsPRIDE   NetworkAfrican   Descent   Network   (ADN)  Medtronic   Jewish   CommunityMedtronic  Women’s   Network   (MWN) Christian   Employee   Resource   GroupHispanic   Latino   Network   (HLN) Medtronic  Seasoned  Professionals   (MSP)Muslims   and   Friends Veterans   Employee   Resource   Group 2022 Integrated Performance Report       60 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexEmployee engagement  Our Diversity Networks are just one avenue for diverse  employees to share their feedback with us.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9673656821250916)","('Employee_Health_And_Safety', 0.0045519983395934105)","('Access_And_Affordability', 0.0021947945933789015)","(['Human Capital Development'], 0.9673656821250916)","('NON-ESG', 0.0045519983395934105)","('NON-ESG', 0.0021947945933789015)"
Line 735,"1inMedtronic employees were part  of a Diversity Network or ERG  in FY22 across 300+ hubs in  75 countries.Awareness  Benefiting  Leadership and  Employees about  Disabilities  (ABLED) American   Indian   Employee   Resource   GroupAsian Impact   at Medtronic  Network   (AIM) Medtronic   Young   ProfessionalsPRIDE   NetworkAfrican   Descent   Network   (ADN)  Medtronic   Jewish   CommunityMedtronic  Women’s   Network   (MWN) Christian   Employee   Resource   GroupHispanic   Latino   Network   (HLN) Medtronic  Seasoned  Professionals   (MSP)Muslims   and   Friends Veterans   Employee   Resource   Group 2022 Integrated Performance Report       60 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexEmployee engagement  Our Diversity Networks are just one avenue for diverse  employees to share their feedback with us.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9756937623023987)","('Business_Model_Resilience', 0.0018047649646177888)","('Employee_Health_And_Safety', 0.0017168981721624732)","(['Human Capital Development'], 0.9756937623023987)","('NON-ESG', 0.0018047649646177888)","('NON-ESG', 0.0017168981721624732)"
Line 736,"In our annual Organizational Health Survey (OHS), we ask employees to rate their sense of belonging and engagement so that we can better understand their experiences and needs.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6690418124198914)","('Human_Rights_And_Community_Relations', 0.09185180068016052)","('Employee_Health_And_Safety', 0.04853587597608566)","(['Human Capital Development'], 0.6690418124198914)","('NON-ESG', 0.09185180068016052)","('NON-ESG', 0.04853587597608566)"
Line 737,"We use this feedback to adjust our communications and programs to provide employees with better support.
","('Employee_Engagement_Inclusion_And_Diversity', 0.30666691064834595)","('Access_And_Affordability', 0.1698150336742401)","('Employee_Health_And_Safety', 0.09111001342535019)","('NON-ESG', 0.30666691064834595)","('NON-ESG', 0.1698150336742401)","('NON-ESG', 0.09111001342535019)"
Line 738,"Our overall rates of survey completion remain high.
","('Management_Of_Legal_And_Regulatory_Framework', 0.1942855268716812)","('Competitive_Behavior', 0.09438290446996689)","('Business_Model_Resilience', 0.08586734533309937)","('NON-ESG', 0.1942855268716812)","('NON-ESG', 0.09438290446996689)","('NON-ESG', 0.08586734533309937)"
Line 739,"In  FY22, our survey was completed by 83% of employees, with employees who regularly participate in a Diversity Network or ERG twice as likely to be engaged compared with those who do not.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9707847237586975)","('Employee_Health_And_Safety', 0.0025220070965588093)","('Labor_Practices', 0.002223034156486392)","(['Human Capital Development'], 0.9707847237586975)","('NON-ESG', 0.0025220070965588093)","('NON-ESG', 0.002223034156486392)"
Line 740,"We also saw strong engagement scores across gender, achieving 81% for women and 80% for men.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8190160989761353)","('Human_Rights_And_Community_Relations', 0.0395355150103569)","('Labor_Practices', 0.031651392579078674)","(['Human Capital Development'], 0.8190160989761353)","('NON-ESG', 0.0395355150103569)","('NON-ESG', 0.031651392579078674)"
Line 741,"Of the employees who completed the survey, 84% reported feeling they belong at Medtronic and 92% felt that Medtronic embraces cultural differences.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8447908759117126)","('Human_Rights_And_Community_Relations', 0.03738226369023323)","('Competitive_Behavior', 0.014040679670870304)","(['Human Capital Development'], 0.8447908759117126)","('NON-ESG', 0.03738226369023323)","('NON-ESG', 0.014040679670870304)"
Line 742,"In addition, 85% reported feeling that Medtronic fosters a workplace that allows them to  be themselves.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5300990343093872)","('Employee_Health_And_Safety', 0.15237437188625336)","('Product_Design_And_Lifecycle_Management', 0.03947172313928604)","(['Human Capital Development'], 0.5300990343093872)","('NON-ESG', 0.15237437188625336)","('NON-ESG', 0.03947172313928604)"
Line 743,"We underscore the importance of individual  accountability by celebrating our ID&E champions through recognition of their actions with honors like our annual Global Inclusion, Diversity, and Equity (GIDE) Awards.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9495772123336792)","('Human_Rights_And_Community_Relations', 0.009197703562676907)","('Employee_Health_And_Safety', 0.0035365826915949583)","(['Human Capital Development'], 0.9495772123336792)","('NON-ESG', 0.009197703562676907)","('NON-ESG', 0.0035365826915949583)"
Line 744,"Read more about several of our 2021 award winners in our Global ID&E 2021 Annual Report.Company’s role in ID&E  ID&E considerations are integrated into our corporate business strategies and are incorporated companywide through training and the adoption of research-informed practices to ensure we meet our ID&E goals.
","('Business_Model_Resilience', 0.6173449158668518)","('Employee_Engagement_Inclusion_And_Diversity', 0.05031221732497215)","('Supply_Chain_Management', 0.041947171092033386)","(['Codes of Business Conduct'], 0.6173449158668518)","('NON-ESG', 0.05031221732497215)","('NON-ESG', 0.041947171092033386)"
Line 745,"This includes building inclusive environments globally and developing workforce diversity through hiring, training, and mentorship.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9754210114479065)","('Employee_Health_And_Safety', 0.001791146001778543)","('Human_Rights_And_Community_Relations', 0.0017129654297605157)","(['Human Capital Development'], 0.9754210114479065)","('NON-ESG', 0.001791146001778543)","('NON-ESG', 0.0017129654297605157)"
Line 746,"Policies Our robust human rights policies provide a framework  to protect the dignity of, and ensure equal opportunities for, each Medtronic employee.
","('Human_Rights_And_Community_Relations', 0.9046648740768433)","('Labor_Practices', 0.017067354172468185)","('Employee_Engagement_Inclusion_And_Diversity', 0.012743877246975899)","(['Community Relations'], 0.9046648740768433)","('NON-ESG', 0.017067354172468185)","('NON-ESG', 0.012743877246975899)"
Line 747,"Our Code of Conduct, Global Human Rights and Labor Standards Policy,  Global Inclusion and Equal Employment Opportunity Policy, and others safeguard employees from discrimination, harassment, retaliation, and more while protecting their right to fair compensation.
","('Labor_Practices', 0.867851734161377)","('Employee_Engagement_Inclusion_And_Diversity', 0.06593956798315048)","('Employee_Health_And_Safety', 0.009035458788275719)","(['Labor Practice Indicators'], 0.867851734161377)","('NON-ESG', 0.06593956798315048)","('NON-ESG', 0.009035458788275719)"
Line 748,"We continuously monitor changes in the local, national, and international regulatory environment to ensure our policies remain up to date.
","('Management_Of_Legal_And_Regulatory_Framework', 0.971051037311554)","('Human_Rights_And_Community_Relations', 0.002019233303144574)","('Ecological_Impacts', 0.001984515693038702)","(['Corporate Governance'], 0.971051037311554)","('NON-ESG', 0.002019233303144574)","('NON-ESG', 0.001984515693038702)"
Line 749,"Read more about these and our other human rights policies.
","('Human_Rights_And_Community_Relations', 0.9277129769325256)","('Labor_Practices', 0.010820399969816208)","('Management_Of_Legal_And_Regulatory_Framework', 0.0069531407207250595)","(['Community Relations'], 0.9277129769325256)","('NON-ESG', 0.010820399969816208)","('NON-ESG', 0.0069531407207250595)"
Line 750,"Pay equity At Medtronic, we address pay equity through equitable employment policies and practices.
","('Labor_Practices', 0.9448590278625488)","('Employee_Engagement_Inclusion_And_Diversity', 0.01894456520676613)","('Employee_Health_And_Safety', 0.002807734301313758)","(['Labor Practice Indicators'], 0.9448590278625488)","('NON-ESG', 0.01894456520676613)","('NON-ESG', 0.002807734301313758)"
Line 751,"In addition, we conduct an annual pay equity audit in the United States and several other countries to continue to improve equity.
","('Management_Of_Legal_And_Regulatory_Framework', 0.43738600611686707)","('Systemic_Risk_Management', 0.22500020265579224)","('Competitive_Behavior', 0.09561459720134735)","('NON-ESG', 0.43738600611686707)","('NON-ESG', 0.22500020265579224)","('NON-ESG', 0.09561459720134735)"
Line 752,"In FY22, we achieved 100% gender pay equity and  ethnically diverse pay equity in the United States.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9742851853370667)","('Labor_Practices', 0.0022776031401008368)","('Human_Rights_And_Community_Relations', 0.0018941167509183288)","(['Human Capital Development'], 0.9742851853370667)","('NON-ESG', 0.0022776031401008368)","('NON-ESG', 0.0018941167509183288)"
Line 753,"Our current analysis shows that globally, gender pay equity is at 99%.
","('Labor_Practices', 0.9475528597831726)","('Employee_Engagement_Inclusion_And_Diversity', 0.011530831456184387)","('Director_Removal', 0.004727157764136791)","(['Labor Practice Indicators'], 0.9475528597831726)","('NON-ESG', 0.011530831456184387)","('NON-ESG', 0.004727157764136791)"
Line 754,"We continue to work toward reaching 100%.Practices We drive diverse representation at all levels through outreach to diverse candidates, training to support diverse promotions, and mentorship to help diverse leaders overcome barriers to continued growth.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9728109240531921)","('Human_Rights_And_Community_Relations', 0.002268026117235422)","('Competitive_Behavior', 0.00222633290104568)","(['Human Capital Development'], 0.9728109240531921)","('NON-ESG', 0.002268026117235422)","('NON-ESG', 0.00222633290104568)"
Line 755,"We partner with leading external organizations to learn and adopt best practices for creating work environments where employees from diverse backgrounds and identities can thrive.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9764431118965149)","('Human_Rights_And_Community_Relations', 0.0019853911362588406)","('Employee_Health_And_Safety', 0.0018560043536126614)","(['Human Capital Development'], 0.9764431118965149)","('NON-ESG', 0.0019853911362588406)","('NON-ESG', 0.0018560043536126614)"
Line 756,"Diverse recruitment We aspire for our teams to better reflect the communities they serve.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9585821628570557)","('Human_Rights_And_Community_Relations', 0.00742115406319499)","('Access_And_Affordability', 0.002666476182639599)","(['Human Capital Development'], 0.9585821628570557)","('NON-ESG', 0.00742115406319499)","('NON-ESG', 0.002666476182639599)"
Line 757,"We partner with our Diversity Networks and ERGs to help us create relationships with organizations aligned with our ID&E hiring goals, such as OneTen, and others, including:  •   Multiple P athways Initiative – Led by the Business  Roundtable, this initiative is a multiyear effort to  eliminate internal and external barriers to advancing diversity in STEM.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9750130772590637)","('Employee_Health_And_Safety', 0.0018602230120450258)","('Business_Model_Resilience', 0.0015300398226827383)","(['Human Capital Development'], 0.9750130772590637)","('NON-ESG', 0.0018602230120450258)","('NON-ESG', 0.0015300398226827383)"
Line 758,"As part of our pilot year, we replaced degree requirements with skills requirements for five IT job families, representing 25% of our  IT roles.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7944492101669312)","('Labor_Practices', 0.04425203055143356)","('Employee_Health_And_Safety', 0.01693347468972206)","(['Human Capital Development'], 0.7944492101669312)","('NON-ESG', 0.04425203055143356)","('NON-ESG', 0.01693347468972206)"
Line 759,"•   Medtr onic Advancement Pathways and Skill Building  (MAPS) - Research shows that underrepresented groups historically have limited access to a four-year college degree, so we set out to remove financial barriers to college education.
","('Access_And_Affordability', 0.8055384159088135)","('Employee_Engagement_Inclusion_And_Diversity', 0.04190020635724068)","('Product_Quality_And_Safety', 0.014729460701346397)","(['Health Outcome Contribution'], 0.8055384159088135)","('NON-ESG', 0.04190020635724068)","('NON-ESG', 0.014729460701346397)"
Line 760,"We implemented a pilot at seven U.S.-based locations where we provided tuition for employees pursuing online undergraduate degrees.
","('Access_And_Affordability', 0.3539890944957733)","('Employee_Engagement_Inclusion_And_Diversity', 0.13905124366283417)","('Management_Of_Legal_And_Regulatory_Framework', 0.10783202946186066)","('NON-ESG', 0.3539890944957733)","('NON-ESG', 0.13905124366283417)","('NON-ESG', 0.10783202946186066)"
Line 761,"Following the success of the pilot, in FY23 we will launch the program across the United States and Puerto Rico.INCLUSION, DIVERSITY, AND EQUITY ID&E award Federico Gavioli, our VP , Diabetes for Europe,  Middle East, and Africa, received the 2021 GIDE Award for his ID&E contributions to our Diabetes operating unit.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9538967609405518)","('Access_And_Affordability', 0.0054037803784012794)","('Employee_Health_And_Safety', 0.005102827679365873)","(['Human Capital Development'], 0.9538967609405518)","('NON-ESG', 0.0054037803784012794)","('NON-ESG', 0.005102827679365873)"
Line 762,"His team established the Mindset Awards to recognize actions that foster adoption of the Medtronic Mindset and give visibility to diversity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9718447327613831)","('Human_Rights_And_Community_Relations', 0.002167794154956937)","('Employee_Health_And_Safety', 0.0019609094597399235)","(['Human Capital Development'], 0.9718447327613831)","('NON-ESG', 0.002167794154956937)","('NON-ESG', 0.0019609094597399235)"
Line 763,"Federico and his team also launched a campaign to raise awareness, mitigate bias, and increase inclusion in diabetes care.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8548141717910767)","('Access_And_Affordability', 0.02810804545879364)","('Employee_Health_And_Safety', 0.01149799395352602)","(['Human Capital Development'], 0.8548141717910767)","('NON-ESG', 0.02810804545879364)","('NON-ESG', 0.01149799395352602)"
Line 764,"$4.8M contributed to ID&E non-profit partners   including SHPE, TMCF, OneTen, and more.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6042840480804443)","('Access_And_Affordability', 0.0812348872423172)","('Business_Ethics', 0.03597106412053108)","(['Corporate Governance'], 0.6042840480804443)","('NON-ESG', 0.0812348872423172)","('NON-ESG', 0.03597106412053108)"
Line 765,"2022 Integrated Performance Report       61 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index Federico Gavioli  VP , Diabetes for EMEA •  T hurgood Marshall College Fund (TMCF) –   We partnered with TMCF to cultivate a pipeline of  talent from Historically Black Colleges and Universities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6168855428695679)","('Business_Model_Resilience', 0.05134398490190506)","('Business_Ethics', 0.04025586321949959)","(['Human Capital Development'], 0.6168855428695679)","('NON-ESG', 0.05134398490190506)","('NON-ESG', 0.04025586321949959)"
Line 766,"Through the partnership, we hired 41 summer interns of African descent in FY22 – an increase from 8% in 2020 to 20% in 2021.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9663143754005432)","('Business_Model_Resilience', 0.0025203765835613012)","('Human_Rights_And_Community_Relations', 0.0022861992474645376)","(['Human Capital Development'], 0.9663143754005432)","('NON-ESG', 0.0025203765835613012)","('NON-ESG', 0.0022861992474645376)"
Line 767,"•   Society of  Hispanic Professional Engineers (SHPE) –  Medtronic and the Medtronic Foundation partnered with SHPE to help remove barriers to Hispanic and Latino students studying STEM subjects.
","('Employee_Engagement_Inclusion_And_Diversity', 0.969057559967041)","('Access_And_Affordability', 0.002612108364701271)","('Human_Rights_And_Community_Relations', 0.0024562908802181482)","(['Human Capital Development'], 0.969057559967041)","('NON-ESG', 0.002612108364701271)","('NON-ESG', 0.0024562908802181482)"
Line 768,"The Medtronic Foundation has committed more than  $3 million over the next four years for scholarships and Medtronic now offers internships and mentorship opportunities to SHPE students.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5378066897392273)","('Access_And_Affordability', 0.1787531077861786)","('Employee_Health_And_Safety', 0.03731997683644295)","(['Human Capital Development'], 0.5378066897392273)","('NON-ESG', 0.1787531077861786)","('NON-ESG', 0.03731997683644295)"
Line 769,"We also hold Diversity Career Events to connect with diverse candidates through professional societies, like SHPE.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9741458892822266)","('Employee_Health_And_Safety', 0.0019110565772280097)","('Human_Rights_And_Community_Relations', 0.0017052637413144112)","(['Human Capital Development'], 0.9741458892822266)","('NON-ESG', 0.0019110565772280097)","('NON-ESG', 0.0017052637413144112)"
Line 770,"In FY22, we held 14 virtual Diversity Career Events for different demographic groups to hire for roles in sales, engineering, software, and more.Empowering diverse leaders To increase representation of diverse employees in leadership roles, we offer several training and mentorship programs to promising talent.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9769538044929504)","('Employee_Health_And_Safety', 0.0015696254558861256)","('Business_Model_Resilience', 0.0014561329735442996)","(['Human Capital Development'], 0.9769538044929504)","('NON-ESG', 0.0015696254558861256)","('NON-ESG', 0.0014561329735442996)"
Line 771,"Our programs are tailored to address the specific barriers employees from underrepresented groups face, such as a lack of access to professional networks.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9270239472389221)","('Labor_Practices', 0.010280456393957138)","('Access_And_Affordability', 0.008432095870375633)","(['Human Capital Development'], 0.9270239472389221)","('NON-ESG', 0.010280456393957138)","('NON-ESG', 0.008432095870375633)"
Line 772,"Our programs include: •   LIFT  – a nine-month development program for high- potential managers with sponsorship and mentorship  from senior executives.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8870591521263123)","('Access_And_Affordability', 0.013457097113132477)","('Human_Rights_And_Community_Relations', 0.010882237926125526)","(['Human Capital Development'], 0.8870591521263123)","('NON-ESG', 0.013457097113132477)","('NON-ESG', 0.010882237926125526)"
Line 773,"In FY22, the number of LIFT participants increased by over 60% and the program achieved a 93% retention rate among participants.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6748300790786743)","('Business_Model_Resilience', 0.048745714128017426)","('Systemic_Risk_Management', 0.03214747831225395)","(['Human Capital Development'], 0.6748300790786743)","('NON-ESG', 0.048745714128017426)","('NON-ESG', 0.03214747831225395)"
Line 774,"•   Efficacy  – a cohort-based leadership development  program designed for Diversity Network and ERG members.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9704625010490417)","('Human_Rights_And_Community_Relations', 0.0021519141737371683)","('Business_Model_Resilience', 0.0019281919812783599)","(['Human Capital Development'], 0.9704625010490417)","('NON-ESG', 0.0021519141737371683)","('NON-ESG', 0.0019281919812783599)"
Line 775,"In FY22, Efficacy trained 389 participants and received an average score of 97% on participant satisfaction.
","('Access_And_Affordability', 0.1348731964826584)","('Product_Quality_And_Safety', 0.10867183655500412)","('Competitive_Behavior', 0.09938739240169525)","('NON-ESG', 0.1348731964826584)","('NON-ESG', 0.10867183655500412)","('NON-ESG', 0.09938739240169525)"
Line 776,"•   Impact  – a year-long mentorship program for high- potential individual contributors from historically INCLUSION, DIVERSITY, AND EQUITY underrepresented populations.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9745813012123108)","('Human_Rights_And_Community_Relations', 0.0018992613768205047)","('Employee_Health_And_Safety', 0.0017316685989499092)","(['Human Capital Development'], 0.9745813012123108)","('NON-ESG', 0.0018992613768205047)","('NON-ESG', 0.0017316685989499092)"
Line 777,"Thirty-two percent of the FY22 participants received a promotion, of which nearly 100% were ethnically diverse.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9707150459289551)","('Customer_Privacy', 0.002317247446626425)","('Human_Rights_And_Community_Relations', 0.001988461008295417)","(['Human Capital Development'], 0.9707150459289551)","('NON-ESG', 0.002317247446626425)","('NON-ESG', 0.001988461008295417)"
Line 778,"•   Acceler ate – a new program that pairs directors and  emerging talent of African descent with a VP-level sponsor.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9508432149887085)","('Business_Model_Resilience', 0.005269394721835852)","('Human_Rights_And_Community_Relations', 0.0032169967889785767)","(['Human Capital Development'], 0.9508432149887085)","('NON-ESG', 0.005269394721835852)","('NON-ESG', 0.0032169967889785767)"
Line 779,"We look forward to sharing the results of this program upon the completion of its first year.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3794361650943756)","('Access_And_Affordability', 0.21426089107990265)","('Ecological_Impacts', 0.044568318873643875)","('NON-ESG', 0.3794361650943756)","('NON-ESG', 0.21426089107990265)","('NON-ESG', 0.044568318873643875)"
Line 780,"•   VP W omen’s Sponsorship – a year-long program  in which 15 female VPs are paired with a high-level Medtronic executive as their sponsor.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5777693390846252)","('Competitive_Behavior', 0.054634325206279755)","('Access_And_Affordability', 0.03824079781770706)","(['Human Capital Development'], 0.5777693390846252)","('NON-ESG', 0.054634325206279755)","('NON-ESG', 0.03824079781770706)"
Line 781,"Our third  cohort will launch in FY23.
","('Employee_Engagement_Inclusion_And_Diversity', 0.21761192381381989)","('Business_Model_Resilience', 0.1667458862066269)","('GHG_Emissions', 0.11111930757761002)","('NON-ESG', 0.21761192381381989)","('NON-ESG', 0.1667458862066269)","('NON-ESG', 0.11111930757761002)"
Line 782,"ID&E beyond Medtronic To facilitate lasting change, we believe in amplifying our impact beyond our walls by investing in our local communities.
","('Human_Rights_And_Community_Relations', 0.8149658441543579)","('Business_Model_Resilience', 0.041343074291944504)","('Employee_Engagement_Inclusion_And_Diversity', 0.019210800528526306)","(['Community Relations'], 0.8149658441543579)","('NON-ESG', 0.041343074291944504)","('NON-ESG', 0.019210800528526306)"
Line 783,"Medtronic and the Medtronic Foundation partner with nonprofit organizations and business alliances to advance equity broadly across society.
","('Access_And_Affordability', 0.22367176413536072)","('Management_Of_Legal_And_Regulatory_Framework', 0.1461850255727768)","('Competitive_Behavior', 0.10685247927904129)","('NON-ESG', 0.22367176413536072)","('NON-ESG', 0.1461850255727768)","('NON-ESG', 0.10685247927904129)"
Line 784,"For example, as a founding member of OneTen, Medtronic is spearheading efforts in Minnesota to hire Black Americans for skilled jobs, with opportunities for advancement at Medtronic and across our home state.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9607540965080261)","('Labor_Practices', 0.005447118543088436)","('Employee_Health_And_Safety', 0.0037484762724488974)","(['Human Capital Development'], 0.9607540965080261)","('NON-ESG', 0.005447118543088436)","('NON-ESG', 0.0037484762724488974)"
Line 785,"We also leverage the scale of our company by working with women- and minority-owned suppliers.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7032938599586487)","('Labor_Practices', 0.15879501402378082)","('Human_Rights_And_Community_Relations', 0.022513505071401596)","(['Human Capital Development'], 0.7032938599586487)","('NON-ESG', 0.15879501402378082)","('NON-ESG', 0.022513505071401596)"
Line 786,"To read more about our approach to supplier diversity, see Supply chain responsibility.
","('Supply_Chain_Management', 0.9354730844497681)","('Labor_Practices', 0.006847115699201822)","('Product_Design_And_Lifecycle_Management', 0.00534479646012187)","(['Supply Chain Management'], 0.9354730844497681)","('NON-ESG', 0.006847115699201822)","('NON-ESG', 0.00534479646012187)"
Line 787,"STEM careers Black and Hispanic workers continue to be underrepresented in STEM fields.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9579452872276306)","('Labor_Practices', 0.009084241464734077)","('Employee_Health_And_Safety', 0.002743929624557495)","(['Human Capital Development'], 0.9579452872276306)","('NON-ESG', 0.009084241464734077)","('NON-ESG', 0.002743929624557495)"
Line 788,"With the rate of STEM job growth set to outpace non-STEM job growth by 2030, encouraging diverse students to enter STEM careers will be a key opportunity to meet hiring needs.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9621447324752808)","('Customer_Welfare', 0.0032682435121387243)","('Access_And_Affordability', 0.0026690454687923193)","(['Human Capital Development'], 0.9621447324752808)","('NON-ESG', 0.0032682435121387243)","('NON-ESG', 0.0026690454687923193)"
Line 789,"Medtronic and the Medtronic Foundation are investing in opportunities to support students from underserved and underrepresented communities to pursue STEM education.
","('Access_And_Affordability', 0.9432195425033569)","('Product_Quality_And_Safety', 0.005157734267413616)","('Critical_Incident_Risk_Management', 0.00458527309820056)","(['Health Outcome Contribution'], 0.9432195425033569)","('NON-ESG', 0.005157734267413616)","('NON-ESG', 0.00458527309820056)"
Line 790,"The initiative has committed to support students from kindergarten through graduate programs across North America by covering tuition fees, providing internship and mentorship opportunities, and offering practical skill-building experiences.
","('Access_And_Affordability', 0.42719700932502747)","('Employee_Engagement_Inclusion_And_Diversity', 0.27993935346603394)","('Labor_Practices', 0.03671758249402046)","('NON-ESG', 0.42719700932502747)","('NON-ESG', 0.27993935346603394)","('NON-ESG', 0.03671758249402046)"
Line 791,"In FY21, we also partnered with TMCF to provide $10 million in scholarship funding over the next 5 years to support  250 students.
","('Access_And_Affordability', 0.748379647731781)","('Management_Of_Legal_And_Regulatory_Framework', 0.04558485746383667)","('Employee_Engagement_Inclusion_And_Diversity', 0.03934118524193764)","(['Health Outcome Contribution'], 0.748379647731781)","('NON-ESG', 0.04558485746383667)","('NON-ESG', 0.03934118524193764)"
Line 792,"Advancing diversity in STEM OneTen's mission is to hire, promote, and advance 1 million Black individuals who do not have a  four-year degree into family-sustaining careers over the next 10 years.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9725989699363708)","('Employee_Health_And_Safety', 0.001997814979404211)","('Business_Model_Resilience', 0.0018214035080745816)","(['Human Capital Development'], 0.9725989699363708)","('NON-ESG', 0.001997814979404211)","('NON-ESG', 0.0018214035080745816)"
Line 793,"As a founding member of OneTen, along with nearly 30 other companies, Medtronic has committed  to advance OneTen's mission by working to close the “opportunity gap” faced by Black Americans without a four-year college degree.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9484367370605469)","('Access_And_Affordability', 0.005637344438582659)","('Human_Rights_And_Community_Relations', 0.004579956643283367)","(['Human Capital Development'], 0.9484367370605469)","('NON-ESG', 0.005637344438582659)","('NON-ESG', 0.004579956643283367)"
Line 794,"We are approaching this challenge with a skills-first model, creating new career pathways at Medtronic.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7307645082473755)","('Employee_Health_And_Safety', 0.04302481189370155)","('Product_Design_And_Lifecycle_Management', 0.030668606981635094)","(['Human Capital Development'], 0.7307645082473755)","('NON-ESG', 0.04302481189370155)","('NON-ESG', 0.030668606981635094)"
Line 795,"2022 Integrated Performance Report       62 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexINCLUSION, DIVERSITY, AND EQUITY ID&E recognition We are proud to be recognized for our commitment  to making our workplaces and communities more equitable.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9568079710006714)","('Human_Rights_And_Community_Relations', 0.006862584501504898)","('Business_Model_Resilience', 0.0033133176621049643)","(['Human Capital Development'], 0.9568079710006714)","('NON-ESG', 0.006862584501504898)","('NON-ESG', 0.0033133176621049643)"
Line 796,"In May 2022, we were named as one of the top 10 Companies for Diversity by DiversityInc.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9649388194084167)","('Employee_Health_And_Safety', 0.0029570944607257843)","('Human_Rights_And_Community_Relations', 0.0027071537915617228)","(['Human Capital Development'], 0.9649388194084167)","('NON-ESG', 0.0029570944607257843)","('NON-ESG', 0.0027071537915617228)"
Line 797,"Some of our other awards for ID&E are shown in the table.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4673275947570801)","('Competitive_Behavior', 0.10332165658473969)","('Business_Ethics', 0.07373589277267456)","('NON-ESG', 0.4673275947570801)","('NON-ESG', 0.10332165658473969)","('NON-ESG', 0.07373589277267456)"
Line 798,"Top In May 2022, we were named   as one of the top 10 Companies   for Diversity by DiversityInc Date Award 2022 Ranked as #4 for mentoring; #5 for supplier diversity;   #11 for environmental, social, and governance; and #13 for sponsorship by DiversityInc Best Places to Work for LGBTQ+ Equality and top score of   100 on the Human Rights Campaign’s Corporate Equality Index Campus Forward Award Brandon Hall Human Capital Management Award Gold Medal  in the category Best Learning Program that Supports and Promotes ID&E for our Inclusive Leader Training 2021 Secretary of Defense Employer Support Freedom Award  Society of  Women Engineers Diversity & Inclusion Award  Best Places to Work for Disability Inclusion and top score of 100 on the Disability Equality Index, a joint initiative of the American Association of People with Disabilities and Disability:IN America’s Best Employers for Diversity by Forbes 2022 Integrated Performance Report       63 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index5,new tools and resources for   learning and training added $49M+ spent on learning and   development — roughly   $500 per employeeWorld-classWorld-class levels of employee engagement,   as gauged by our Organizational  Health Survey 9% decrease in near misses reported  compared to the previous year,  despite an increase in overall incident  reporting due to our new automated  hazard reporting systemAdding business value Safeguarding the well-being of our employees gives  them the peace of mind to fully engage with their work.
","('Employee_Engagement_Inclusion_And_Diversity', 0.969087541103363)","('Human_Rights_And_Community_Relations', 0.0034648103173822165)","('Employee_Health_And_Safety', 0.0031799981370568275)","(['Human Capital Development'], 0.969087541103363)","('NON-ESG', 0.0034648103173822165)","('NON-ESG', 0.0031799981370568275)"
Line 799,"Top In May 2022, we were named   as one of the top 10 Companies   for Diversity by DiversityInc Date Award 2022 Ranked as #4 for mentoring; #5 for supplier diversity;   #11 for environmental, social, and governance; and #13 for sponsorship by DiversityInc Best Places to Work for LGBTQ+ Equality and top score of   100 on the Human Rights Campaign’s Corporate Equality Index Campus Forward Award Brandon Hall Human Capital Management Award Gold Medal  in the category Best Learning Program that Supports and Promotes ID&E for our Inclusive Leader Training 2021 Secretary of Defense Employer Support Freedom Award  Society of  Women Engineers Diversity & Inclusion Award  Best Places to Work for Disability Inclusion and top score of 100 on the Disability Equality Index, a joint initiative of the American Association of People with Disabilities and Disability:IN America’s Best Employers for Diversity by Forbes 2022 Integrated Performance Report       63 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index5,new tools and resources for   learning and training added $49M+ spent on learning and   development — roughly   $500 per employeeWorld-classWorld-class levels of employee engagement,   as gauged by our Organizational  Health Survey 9% decrease in near misses reported  compared to the previous year,  despite an increase in overall incident  reporting due to our new automated  hazard reporting systemAdding business value Safeguarding the well-being of our employees gives  them the peace of mind to fully engage with their work.
","('Employee_Engagement_Inclusion_And_Diversity', 0.975796103477478)","('Employee_Health_And_Safety', 0.002732881112024188)","('Human_Rights_And_Community_Relations', 0.0017120675183832645)","(['Human Capital Development'], 0.975796103477478)","('NON-ESG', 0.002732881112024188)","('NON-ESG', 0.0017120675183832645)"
Line 800,"Top In May 2022, we were named   as one of the top 10 Companies   for Diversity by DiversityInc Date Award 2022 Ranked as #4 for mentoring; #5 for supplier diversity;   #11 for environmental, social, and governance; and #13 for sponsorship by DiversityInc Best Places to Work for LGBTQ+ Equality and top score of   100 on the Human Rights Campaign’s Corporate Equality Index Campus Forward Award Brandon Hall Human Capital Management Award Gold Medal  in the category Best Learning Program that Supports and Promotes ID&E for our Inclusive Leader Training 2021 Secretary of Defense Employer Support Freedom Award  Society of  Women Engineers Diversity & Inclusion Award  Best Places to Work for Disability Inclusion and top score of 100 on the Disability Equality Index, a joint initiative of the American Association of People with Disabilities and Disability:IN America’s Best Employers for Diversity by Forbes 2022 Integrated Performance Report       63 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index5,new tools and resources for   learning and training added $49M+ spent on learning and   development — roughly   $500 per employeeWorld-classWorld-class levels of employee engagement,   as gauged by our Organizational  Health Survey 9% decrease in near misses reported  compared to the previous year,  despite an increase in overall incident  reporting due to our new automated  hazard reporting systemAdding business value Safeguarding the well-being of our employees gives  them the peace of mind to fully engage with their work.
","('Employee_Engagement_Inclusion_And_Diversity', 0.20385712385177612)","('Human_Rights_And_Community_Relations', 0.1663942039012909)","('Employee_Health_And_Safety', 0.11071466654539108)","('NON-ESG', 0.20385712385177612)","('NON-ESG', 0.1663942039012909)","('NON-ESG', 0.11071466654539108)"
Line 801,"Top In May 2022, we were named   as one of the top 10 Companies   for Diversity by DiversityInc Date Award 2022 Ranked as #4 for mentoring; #5 for supplier diversity;   #11 for environmental, social, and governance; and #13 for sponsorship by DiversityInc Best Places to Work for LGBTQ+ Equality and top score of   100 on the Human Rights Campaign’s Corporate Equality Index Campus Forward Award Brandon Hall Human Capital Management Award Gold Medal  in the category Best Learning Program that Supports and Promotes ID&E for our Inclusive Leader Training 2021 Secretary of Defense Employer Support Freedom Award  Society of  Women Engineers Diversity & Inclusion Award  Best Places to Work for Disability Inclusion and top score of 100 on the Disability Equality Index, a joint initiative of the American Association of People with Disabilities and Disability:IN America’s Best Employers for Diversity by Forbes 2022 Integrated Performance Report       63 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index5,new tools and resources for   learning and training added $49M+ spent on learning and   development — roughly   $500 per employeeWorld-classWorld-class levels of employee engagement,   as gauged by our Organizational  Health Survey 9% decrease in near misses reported  compared to the previous year,  despite an increase in overall incident  reporting due to our new automated  hazard reporting systemAdding business value Safeguarding the well-being of our employees gives  them the peace of mind to fully engage with their work.
","('Employee_Health_And_Safety', 0.405136376619339)","('Labor_Practices', 0.1678551435470581)","('Human_Rights_And_Community_Relations', 0.12321774661540985)","('NON-ESG', 0.405136376619339)","('NON-ESG', 0.1678551435470581)","('NON-ESG', 0.12321774661540985)"
Line 802,"Our well-rounded employee support — at work and at home — results in higher productivity, engagement, and retention and lower rates of absenteeism.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9526703357696533)","('Labor_Practices', 0.0066055781207978725)","('Employee_Health_And_Safety', 0.006337551865726709)","(['Human Capital Development'], 0.9526703357696533)","('NON-ESG', 0.0066055781207978725)","('NON-ESG', 0.006337551865726709)"
Line 803,"We further expanded our robust  benefit offerings, including enhanced  fertility and family planning coverageSupporting  a global workforceSOCIAL IMPACT 2022 Integrated Performance Report       64 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index Our global and diverse employees make  innovation possible.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8303875923156738)","('Human_Rights_And_Community_Relations', 0.030302442610263824)","('Business_Model_Resilience', 0.02188388630747795)","(['Human Capital Development'], 0.8303875923156738)","('NON-ESG', 0.030302442610263824)","('NON-ESG', 0.02188388630747795)"
Line 804,"We strive to take the same care with their health, safety, and well-being as we do for our patients – both on-site and at home.
","('Employee_Health_And_Safety', 0.64396071434021)","('Access_And_Affordability', 0.17602317035198212)","('Product_Quality_And_Safety', 0.026655878871679306)","(['Operational Eco-Efficiency'], 0.64396071434021)","('NON-ESG', 0.17602317035198212)","('NON-ESG', 0.026655878871679306)"
Line 805,"Our EHS system, a robust suite of health and wellness benefits, and fair and equitable pay foster employee health, safety, and well-being and inspire employees to engineer the extraordinary.
","('Employee_Health_And_Safety', 0.9732114672660828)","('Employee_Engagement_Inclusion_And_Diversity', 0.004347025882452726)","('Product_Quality_And_Safety', 0.002264434704557061)","(['Operational Eco-Efficiency'], 0.9732114672660828)","('NON-ESG', 0.004347025882452726)","('NON-ESG', 0.002264434704557061)"
Line 806,"We empower employees in their careers at Medtronic with regular performance reviews and training programs to build skills and celebrate their contributions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8183462619781494)","('Employee_Health_And_Safety', 0.03948250785470009)","('Human_Rights_And_Community_Relations', 0.02163850888609886)","(['Human Capital Development'], 0.8183462619781494)","('NON-ESG', 0.03948250785470009)","('NON-ESG', 0.02163850888609886)"
Line 807,"Development and engagement We design our learning and development programs  to attract and retain world-class talent from global and diverse populations, sparking innovation and driving opportunity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9613417983055115)","('Human_Rights_And_Community_Relations', 0.0029004947282373905)","('Employee_Health_And_Safety', 0.0028410826344043016)","(['Human Capital Development'], 0.9613417983055115)","('NON-ESG', 0.0029004947282373905)","('NON-ESG', 0.0028410826344043016)"
Line 808,"Our investments in development help our talent embody the Medtronic Mindset, giving them the tools to act boldly, compete to win, move with speed and decisiveness, foster belonging, and deliver results.
","('Employee_Engagement_Inclusion_And_Diversity', 0.40552717447280884)","('Competitive_Behavior', 0.1478254348039627)","('Business_Model_Resilience', 0.1384521722793579)","('NON-ESG', 0.40552717447280884)","('NON-ESG', 0.1478254348039627)","('NON-ESG', 0.1384521722793579)"
Line 809,"Employees at every level have access to training opportunities in multiple formats, meeting individual learning needs and enabling employees to grow in their career.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4674532115459442)","('Access_And_Affordability', 0.25290176272392273)","('Product_Quality_And_Safety', 0.03419642522931099)","('NON-ESG', 0.4674532115459442)","('NON-ESG', 0.25290176272392273)","('NON-ESG', 0.03419642522931099)"
Line 810,"As a global healthcare technology leader, we ensure programs are available at every Medtronic location and in languages relevant to our employees.
","('Access_And_Affordability', 0.2630809247493744)","('Customer_Welfare', 0.14865250885486603)","('Employee_Engagement_Inclusion_And_Diversity', 0.08399869501590729)","('NON-ESG', 0.2630809247493744)","('NON-ESG', 0.14865250885486603)","('NON-ESG', 0.08399869501590729)"
Line 811,"In addition to our formal programs, we offer on-demand digital courses and resources for employees who want to direct their own learning or focus on a particular skill.
","('Access_And_Affordability', 0.3554449677467346)","('Employee_Engagement_Inclusion_And_Diversity', 0.2717346251010895)","('Product_Quality_And_Safety', 0.04644802212715149)","('NON-ESG', 0.3554449677467346)","('NON-ESG', 0.2717346251010895)","('NON-ESG', 0.04644802212715149)"
Line 812,"We partner with several platforms to deliver digital learning to employees, including Degreed, Harvard ManageMentor, getAbstract, Cornerstone OnDemand, Adeption, and others.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3512996733188629)","('Access_And_Affordability', 0.22224494814872742)","('Customer_Welfare', 0.058034997433423996)","('NON-ESG', 0.3512996733188629)","('NON-ESG', 0.22224494814872742)","('NON-ESG', 0.058034997433423996)"
Line 813,"In FY22, we delivered most of our professional  development courses virtually due to the ongoing pandemic.
","('Access_And_Affordability', 0.4319441616535187)","('Employee_Health_And_Safety', 0.07300306856632233)","('Employee_Engagement_Inclusion_And_Diversity', 0.06431226432323456)","('NON-ESG', 0.4319441616535187)","('NON-ESG', 0.07300306856632233)","('NON-ESG', 0.06431226432323456)"
Line 814,"We continued to grow our offerings in  FY22, providing more than 32,000 learning resources,  an increase of more than 5,000 tools and courses  over the previous year.
","('Access_And_Affordability', 0.37537074089050293)","('Employee_Engagement_Inclusion_And_Diversity', 0.17297148704528809)","('Product_Design_And_Lifecycle_Management', 0.06332218647003174)","('NON-ESG', 0.37537074089050293)","('NON-ESG', 0.17297148704528809)","('NON-ESG', 0.06332218647003174)"
Line 815,"Some of the new learning  tools we launched in FY22 include: •   Skills Lab  – a new technology platform, powered  by our partner Degreed, that enables employees to  target and develop specific skills.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8111943602561951)","('Employee_Health_And_Safety', 0.027875535190105438)","('Access_And_Affordability', 0.02383834682404995)","(['Human Capital Development'], 0.8111943602561951)","('NON-ESG', 0.027875535190105438)","('NON-ESG', 0.02383834682404995)"
Line 816,"•   Mind G ym – a set of tools based on behavioral  science principles to help leaders solve problems more effectively.In FY22, we spent more than $49 million on learning and development — an average of nearly $500 per employee.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2784065008163452)","('Access_And_Affordability', 0.18802115321159363)","('Product_Design_And_Lifecycle_Management', 0.06530362367630005)","('NON-ESG', 0.2784065008163452)","('NON-ESG', 0.18802115321159363)","('NON-ESG', 0.06530362367630005)"
Line 817,"Our employees completed an average of 33 hours of training per person, enabled by these additional virtual resources.
","('Employee_Engagement_Inclusion_And_Diversity', 0.30086976289749146)","('Labor_Practices', 0.257599800825119)","('Employee_Health_And_Safety', 0.1909732073545456)","('NON-ESG', 0.30086976289749146)","('NON-ESG', 0.257599800825119)","('NON-ESG', 0.1909732073545456)"
Line 818,"As employees return to the office, we plan to shift to a hybrid learning model, retaining many of these virtual tools while also returning to in-person training.
","('Employee_Engagement_Inclusion_And_Diversity', 0.31711748242378235)","('Access_And_Affordability', 0.2800343930721283)","('Customer_Welfare', 0.047159042209386826)","('NON-ESG', 0.31711748242378235)","('NON-ESG', 0.2800343930721283)","('NON-ESG', 0.047159042209386826)"
Line 819,"$49M+ spent on learning and development in FY22,  an average of nearly $500 per employeeSUPPORTING A GLOBAL WORKFORCE Another successful Grow Your Career Week! In FY22, we hosted our third annual Grow Your Career Week (GYCW), a series of events  held globally to inform employees about the wide variety of leadership, learning, and career development opportunities offered at Medtronic.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8876017928123474)","('Employee_Health_And_Safety', 0.01748993620276451)","('Business_Model_Resilience', 0.010591579601168633)","(['Human Capital Development'], 0.8876017928123474)","('NON-ESG', 0.01748993620276451)","('NON-ESG', 0.010591579601168633)"
Line 820,"Features of GYCW include interactive workshops, panel discussions, podcasts, and a dedicated Yammer channel for networking.
","('Management_Of_Legal_And_Regulatory_Framework', 0.16602954268455505)","('Competitive_Behavior', 0.11008676141500473)","('Employee_Engagement_Inclusion_And_Diversity', 0.10191980749368668)","('NON-ESG', 0.16602954268455505)","('NON-ESG', 0.11008676141500473)","('NON-ESG', 0.10191980749368668)"
Line 821,"During our FY22 GYCW, over 97,000 learning activities occurred companywide — 40% more than the previous year — and included 60+ live sessions  and 7,000+ digital interactions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.15844763815402985)","('Access_And_Affordability', 0.13489118218421936)","('Business_Model_Resilience', 0.07012607157230377)","('NON-ESG', 0.15844763815402985)","('NON-ESG', 0.13489118218421936)","('NON-ESG', 0.07012607157230377)"
Line 822,"2022 Integrated Performance Report       65 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexLeadership development A good relationship between employee and manager  is central to job satisfaction, retention, and promotion.
","('Employee_Engagement_Inclusion_And_Diversity', 0.949942409992218)","('Employee_Health_And_Safety', 0.00628512492403388)","('Labor_Practices', 0.0036714794114232063)","(['Human Capital Development'], 0.949942409992218)","('NON-ESG', 0.00628512492403388)","('NON-ESG', 0.0036714794114232063)"
Line 823,"We focus on identifying and promoting high-potential employees into managerial roles and equipping managers with the right leadership skills to engage and develop their team members.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8745220899581909)","('Human_Rights_And_Community_Relations', 0.016338255256414413)","('Employee_Health_And_Safety', 0.015046789310872555)","(['Human Capital Development'], 0.8745220899581909)","('NON-ESG', 0.016338255256414413)","('NON-ESG', 0.015046789310872555)"
Line 824,"We offer targeted leadership development programs for  employees at different levels, including: •   Edge  – teaches leadership skills for all managers  focused on the Medtronic Mindset •   Eleva te – prepares manager-level leaders for the   next career step •   Emer ge – accelerates professional development   for emerging leaders •   Ignite  – prepares director-level leaders to   become executives •   Internal C oaching Certification – trains leaders to  become certified coaches •   VP  Welcome – supports new vice presidents as   they make their career transition We also offer dedicated programs to support employees  from underrepresented groups to overcome barriers to career growth.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8108025789260864)","('Business_Model_Resilience', 0.02963515743613243)","('Human_Rights_And_Community_Relations', 0.017575271427631378)","(['Human Capital Development'], 0.8108025789260864)","('NON-ESG', 0.02963515743613243)","('NON-ESG', 0.017575271427631378)"
Line 825,"We offer targeted leadership development programs for  employees at different levels, including: •   Edge  – teaches leadership skills for all managers  focused on the Medtronic Mindset •   Eleva te – prepares manager-level leaders for the   next career step •   Emer ge – accelerates professional development   for emerging leaders •   Ignite  – prepares director-level leaders to   become executives •   Internal C oaching Certification – trains leaders to  become certified coaches •   VP  Welcome – supports new vice presidents as   they make their career transition We also offer dedicated programs to support employees  from underrepresented groups to overcome barriers to career growth.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9443378448486328)","('Employee_Health_And_Safety', 0.004921708256006241)","('Business_Model_Resilience', 0.004014354199171066)","(['Human Capital Development'], 0.9443378448486328)","('NON-ESG', 0.004921708256006241)","('NON-ESG', 0.004014354199171066)"
Line 826,"An inclusive, diverse, and equitable workforce empowers everyone to reach their potential, enabling our success.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9707255959510803)","('Human_Rights_And_Community_Relations', 0.0025609685108065605)","('Business_Model_Resilience', 0.001956260995939374)","(['Human Capital Development'], 0.9707255959510803)","('NON-ESG', 0.0025609685108065605)","('NON-ESG', 0.001956260995939374)"
Line 827,"Read more about these  programs in Inclusion, diversity, and equity.Career growth Sharing feedback and providing guidance and support to employees is a key component of promoting our performance-driven culture in which everyone is motivated to perform and achieve organizational success.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9755558967590332)","('Employee_Health_And_Safety', 0.0019913213327527046)","('Human_Rights_And_Community_Relations', 0.0016478298930451274)","(['Human Capital Development'], 0.9755558967590332)","('NON-ESG', 0.0019913213327527046)","('NON-ESG', 0.0016478298930451274)"
Line 828,"Employees meet with their managers three to six times per year to review goals and discuss performance, and managers hold themselves and their team accountable to goals by measuring results and impact.
","('Human_Rights_And_Community_Relations', 0.19375964999198914)","('Employee_Engagement_Inclusion_And_Diversity', 0.15293534100055695)","('Business_Model_Resilience', 0.11355438828468323)","('NON-ESG', 0.19375964999198914)","('NON-ESG', 0.15293534100055695)","('NON-ESG', 0.11355438828468323)"
Line 829,"In FY22, 98% of employees participated in an annual performance review.
","('Labor_Practices', 0.3095262050628662)","('Employee_Engagement_Inclusion_And_Diversity', 0.27509018778800964)","('Business_Ethics', 0.05248521268367767)","('NON-ESG', 0.3095262050628662)","('NON-ESG', 0.27509018778800964)","('NON-ESG', 0.05248521268367767)"
Line 830,"In FY22, in response to employee and manager  feedback, we made two notable adjustments to our formal evaluation and check-in process.
","('Management_Of_Legal_And_Regulatory_Framework', 0.25504255294799805)","('Employee_Engagement_Inclusion_And_Diversity', 0.1782352328300476)","('Business_Ethics', 0.08850684762001038)","('NON-ESG', 0.25504255294799805)","('NON-ESG', 0.1782352328300476)","('NON-ESG', 0.08850684762001038)"
Line 831,"We changed the timeline for goal setting and mid-year career development conversations, holding both conversations earlier in the year.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7369968891143799)","('Business_Model_Resilience', 0.05202942341566086)","('Director_Removal', 0.023097438737750053)","(['Human Capital Development'], 0.7369968891143799)","('NON-ESG', 0.05202942341566086)","('NON-ESG', 0.023097438737750053)"
Line 832,"Based on feedback, we also  separated conversations on performance from those  on development and inclusion to clarify achievements and improvement areas.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8925141096115112)","('Human_Rights_And_Community_Relations', 0.028675636276602745)","('Access_And_Affordability', 0.010469433851540089)","(['Human Capital Development'], 0.8925141096115112)","('NON-ESG', 0.028675636276602745)","('NON-ESG', 0.010469433851540089)"
Line 833,"We employ a forward-looking approach to career  development through our Organization and Talent Planning (OTP) process, a critical program that enables us to achieve Tenet 5 of our Mission through the identification and development of our future leaders.
","('Employee_Engagement_Inclusion_And_Diversity', 0.936962366104126)","('Business_Model_Resilience', 0.005778543651103973)","('Employee_Health_And_Safety', 0.004854623693972826)","(['Human Capital Development'], 0.936962366104126)","('NON-ESG', 0.005778543651103973)","('NON-ESG', 0.004854623693972826)"
Line 834,"This proactive process helps us plan for future talent needs and deliver on business outcomes.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5120907425880432)","('Business_Model_Resilience', 0.08352891355752945)","('Access_And_Affordability', 0.07685060054063797)","(['Human Capital Development'], 0.5120907425880432)","('NON-ESG', 0.08352891355752945)","('NON-ESG', 0.07685060054063797)"
Line 835,"OTP has three key components that all people leaders are expected to follow: •   Assess the potential,  retention risk, and career  development actions for all direct reports.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9436536431312561)","('Employee_Health_And_Safety', 0.006963388994336128)","('Business_Model_Resilience', 0.005083027295768261)","(['Human Capital Development'], 0.9436536431312561)","('NON-ESG', 0.006963388994336128)","('NON-ESG', 0.005083027295768261)"
Line 836,"•   Mitiga te business risk through the identification of  successors for intentional talent movement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9220472574234009)","('Business_Model_Resilience', 0.007935861125588417)","('Employee_Health_And_Safety', 0.005865829065442085)","(['Human Capital Development'], 0.9220472574234009)","('NON-ESG', 0.007935861125588417)","('NON-ESG', 0.005865829065442085)"
Line 837,"•   Ensur e that focused development actions aligned  to our talents’ potential are executed for career and  development growth.
","('Employee_Engagement_Inclusion_And_Diversity', 0.842674970626831)","('Access_And_Affordability', 0.021821094676852226)","('Business_Model_Resilience', 0.01582636870443821)","(['Human Capital Development'], 0.842674970626831)","('NON-ESG', 0.021821094676852226)","('NON-ESG', 0.01582636870443821)"
Line 838,"In addition to our OTP process, we formally integrated Strategic Workforce Planning with our annual business strategic planning process in FY22.
","('Business_Model_Resilience', 0.36790725588798523)","('Employee_Engagement_Inclusion_And_Diversity', 0.3651290535926819)","('Product_Design_And_Lifecycle_Management', 0.03541025519371033)","('NON-ESG', 0.36790725588798523)","('NON-ESG', 0.3651290535926819)","('NON-ESG', 0.03541025519371033)"
Line 839,"This framework ensures that we are proactively identifying the capabilities needed to deliver companywide strategies in partnership with the business and finance teams.
","('Business_Model_Resilience', 0.7552118897438049)","('Systemic_Risk_Management', 0.0532243438065052)","('Supply_Chain_Management', 0.022132333368062973)","(['Codes of Business Conduct'], 0.7552118897438049)","('NON-ESG', 0.0532243438065052)","('NON-ESG', 0.022132333368062973)"
Line 840,"Through this application and our OTP process, we will continue to advance leadership skills to more proactively assess and plan for organizational talent needs.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9476960301399231)","('Employee_Health_And_Safety', 0.006473544519394636)","('Business_Model_Resilience', 0.004515354987233877)","(['Human Capital Development'], 0.9476960301399231)","('NON-ESG', 0.006473544519394636)","('NON-ESG', 0.004515354987233877)"
Line 841,"We also support employees’ career ambitions by  tracking our rates of internal hiring.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9024485945701599)","('Labor_Practices', 0.024891378358006477)","('Employee_Health_And_Safety', 0.011027933098375797)","(['Human Capital Development'], 0.9024485945701599)","('NON-ESG', 0.024891378358006477)","('NON-ESG', 0.011027933098375797)"
Line 842,"Hiring from within not only encourages retention by providing internal pathways for career growth, but also helps us retain institutional knowledge.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9651385545730591)","('Employee_Health_And_Safety', 0.0037173295859247446)","('Business_Model_Resilience', 0.0022693390492349863)","(['Human Capital Development'], 0.9651385545730591)","('NON-ESG', 0.0037173295859247446)","('NON-ESG', 0.0022693390492349863)"
Line 843,"We maintain this emphasis on internal hiring in conjunction with our hiring initiatives that bring in external talent to fuel innovation and add more perspectives to our company culture.SUPPORTING A GLOBAL WORKFORCE INTERNAL HIRING FY20 FY21 FYTotal roles filled with internal candidates 34% 31% 29% VP roles filled with internal candidates 91% 91% 79% 2022 Integrated Performance Report       66 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexRecognition Recognizing a job well done is essential.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9235094785690308)","('Business_Model_Resilience', 0.012364535592496395)","('Systemic_Risk_Management', 0.004958447068929672)","(['Human Capital Development'], 0.9235094785690308)","('NON-ESG', 0.012364535592496395)","('NON-ESG', 0.004958447068929672)"
Line 844,"We maintain this emphasis on internal hiring in conjunction with our hiring initiatives that bring in external talent to fuel innovation and add more perspectives to our company culture.SUPPORTING A GLOBAL WORKFORCE INTERNAL HIRING FY20 FY21 FYTotal roles filled with internal candidates 34% 31% 29% VP roles filled with internal candidates 91% 91% 79% 2022 Integrated Performance Report       66 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexRecognition Recognizing a job well done is essential.
","('Business_Model_Resilience', 0.1635795533657074)","('Director_Removal', 0.11093071103096008)","('Business_Ethics', 0.07503749430179596)","('NON-ESG', 0.1635795533657074)","('NON-ESG', 0.11093071103096008)","('NON-ESG', 0.07503749430179596)"
Line 845,"Managers are  encouraged to acknowledge employee achievements during formal evaluations and general check-ins.
","('Employee_Engagement_Inclusion_And_Diversity', 0.36789220571517944)","('Business_Ethics', 0.14190499484539032)","('Employee_Health_And_Safety', 0.07116395980119705)","('NON-ESG', 0.36789220571517944)","('NON-ESG', 0.14190499484539032)","('NON-ESG', 0.07116395980119705)"
Line 846,"They may also reward notable contributions through our Recognize! Platform, which enables managers and employees to celebrate the achievements, accomplishments, and milestones of team members.
","('Employee_Engagement_Inclusion_And_Diversity', 0.26618629693984985)","('Employee_Health_And_Safety', 0.13260352611541748)","('Human_Rights_And_Community_Relations', 0.11108777672052383)","('NON-ESG', 0.26618629693984985)","('NON-ESG', 0.13260352611541748)","('NON-ESG', 0.11108777672052383)"
Line 847,"We also have a formal awards program to recognize  exceptional achievements in technology, quality, leadership, and ethics, including: •   Bakk en Fellowship – honors employees who have  made multiple technical contributions to the company  and to the biomedical device industry.
","('Employee_Engagement_Inclusion_And_Diversity', 0.26617908477783203)","('Business_Ethics', 0.1499083787202835)","('Employee_Health_And_Safety', 0.09896037727594376)","('NON-ESG', 0.26617908477783203)","('NON-ESG', 0.1499083787202835)","('NON-ESG', 0.09896037727594376)"
Line 848,"•   C ompass Award – recognizes employees who   live out the Medtronic Mission by demonstrating  high-integrity behavior that champions our Code  of Conduct.
","('Business_Ethics', 0.9138926863670349)","('Director_Removal', 0.007267002947628498)","('Human_Rights_And_Community_Relations', 0.007046709768474102)","(['Business Ethics'], 0.9138926863670349)","('NON-ESG', 0.007267002947628498)","('NON-ESG', 0.007046709768474102)"
Line 849,"•   Global Inclusion,  Diversity, and Equity Leadership  Award – recognizes VPs who champion an inclusive work environment.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9750202298164368)","('Employee_Health_And_Safety', 0.002113993978127837)","('Human_Rights_And_Community_Relations', 0.0020629516802728176)","(['Human Capital Development'], 0.9750202298164368)","('NON-ESG', 0.002113993978127837)","('NON-ESG', 0.0020629516802728176)"
Line 850,"•   S tar of Excellence – acknowledges quality and  innovation of the highest level.
","('Product_Design_And_Lifecycle_Management', 0.5727679133415222)","('Business_Model_Resilience', 0.0644424557685852)","('Competitive_Behavior', 0.05451742559671402)","(['Product Stewardship'], 0.5727679133415222)","('NON-ESG', 0.0644424557685852)","('NON-ESG', 0.05451742559671402)"
Line 851,"•   EHS  Sustainability Award – celebrates projects that  exemplify the many ways Medtronic contributes to a sustainable business, workforce, and environment.
","('Ecological_Impacts', 0.23859861493110657)","('Product_Design_And_Lifecycle_Management', 0.14548847079277039)","('Business_Model_Resilience', 0.13715535402297974)","('NON-ESG', 0.23859861493110657)","('NON-ESG', 0.14548847079277039)","('NON-ESG', 0.13715535402297974)"
Line 852,"•   W allin Leadership Award – recognizes leaders  who actively foster an inclusive and diverse work environment and successfully develop leadership talent to enable superior business outcomes.Employee engagement Effective feedback must include a two-way dialogue.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9664589166641235)","('Human_Rights_And_Community_Relations', 0.003601999254897237)","('Employee_Health_And_Safety', 0.0028029829263687134)","(['Human Capital Development'], 0.9664589166641235)","('NON-ESG', 0.003601999254897237)","('NON-ESG', 0.0028029829263687134)"
Line 853,"We solicit input from employees through our internal social media channels and our Organizational Health Survey (OHS), which we conduct annually.
","('Employee_Engagement_Inclusion_And_Diversity', 0.447668194770813)","('Labor_Practices', 0.11211761087179184)","('Employee_Health_And_Safety', 0.092899389564991)","('NON-ESG', 0.447668194770813)","('NON-ESG', 0.11211761087179184)","('NON-ESG', 0.092899389564991)"
Line 854,"1 In FY22,   a record 83% of full- and part-time employees responded to the OHS.
","('Labor_Practices', 0.8730401396751404)","('Employee_Engagement_Inclusion_And_Diversity', 0.0349845364689827)","('Employee_Health_And_Safety', 0.012217880226671696)","(['Labor Practice Indicators'], 0.8730401396751404)","('NON-ESG', 0.0349845364689827)","('NON-ESG', 0.012217880226671696)"
Line 855,"The survey indicated that 90% of employees who  completed the survey feel proud to work at  Medtronic and 93% feel Medtronic has a positive  impact on the world.
","('Employee_Engagement_Inclusion_And_Diversity', 0.22261980175971985)","('Employee_Health_And_Safety', 0.1509251743555069)","('Product_Design_And_Lifecycle_Management', 0.13791875541210175)","('NON-ESG', 0.22261980175971985)","('NON-ESG', 0.1509251743555069)","('NON-ESG', 0.13791875541210175)"
Line 856,"To continuously improve the employee experience,  we use OHS results and other employee feedback to adjust how we operate and interact with one another.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5505794286727905)","('Employee_Health_And_Safety', 0.09340381622314453)","('Human_Rights_And_Community_Relations', 0.06843679398298264)","(['Human Capital Development'], 0.5505794286727905)","('NON-ESG', 0.09340381622314453)","('NON-ESG', 0.06843679398298264)"
Line 857,"For example, only 60% of respondents rated their stress levels as being reasonable.
","('Systemic_Risk_Management', 0.6329414248466492)","('Supply_Chain_Management', 0.09406545013189316)","('Physical_Impacts_Of_Climate_Change', 0.049855321645736694)","(['Risk & Crisis Management'], 0.6329414248466492)","('NON-ESG', 0.09406545013189316)","('NON-ESG', 0.049855321645736694)"
Line 858,"With this information, we  are taking steps to support employees and lessen  work-related stress, including: •   Intr oducing the Four Weeks from Anywhere program.
","('Employee_Health_And_Safety', 0.4790542721748352)","('Labor_Practices', 0.37431392073631287)","('Employee_Engagement_Inclusion_And_Diversity', 0.01738993264734745)","('NON-ESG', 0.4790542721748352)","('NON-ESG', 0.37431392073631287)","('NON-ESG', 0.01738993264734745)"
Line 859,"•  F acilitating uninterrupted, protected work time.
","('Supply_Chain_Management', 0.17606495320796967)","('Energy_Management', 0.13303609192371368)","('Competitive_Behavior', 0.09488171339035034)","('NON-ESG', 0.17606495320796967)","('NON-ESG', 0.13303609192371368)","('NON-ESG', 0.09488171339035034)"
Line 860,"•   F ocusing on task prioritization and meeting  management.
","('Management_Of_Legal_And_Regulatory_Framework', 0.25068357586860657)","('Business_Model_Resilience', 0.22772996127605438)","('Human_Rights_And_Community_Relations', 0.07704440504312515)","('NON-ESG', 0.25068357586860657)","('NON-ESG', 0.22772996127605438)","('NON-ESG', 0.07704440504312515)"
Line 861,"90 % of employees report that they  feel proud to work at Medtronic  and 93% said they feel Medtronic  has a positive impact on the  world, according to our FY22  Organizational Health SurveySUPPORTING A GLOBAL WORKFORCE ORGANIZATIONAL HEALTH SURVEY RESULTS  (excerpt) FY20 FY21†FYEmployee engagement score 77% – 80% Percent of employees who reported feeling proud   to work at Medtronic 89% – 90% Percent of employees who reported actively looking  for ways to improve their work91% – 94% Percent of employees who reported feeling Medtronic  has a positive impact on the world ‡NA NA 93% †  Our all-employee OHS was postponed in FY21 due to the pandemic.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5676788687705994)","('Employee_Health_And_Safety', 0.1599629670381546)","('Human_Rights_And_Community_Relations', 0.04302036762237549)","(['Human Capital Development'], 0.5676788687705994)","('NON-ESG', 0.1599629670381546)","('NON-ESG', 0.04302036762237549)"
Line 862,"90 % of employees report that they  feel proud to work at Medtronic  and 93% said they feel Medtronic  has a positive impact on the  world, according to our FY22  Organizational Health SurveySUPPORTING A GLOBAL WORKFORCE ORGANIZATIONAL HEALTH SURVEY RESULTS  (excerpt) FY20 FY21†FYEmployee engagement score 77% – 80% Percent of employees who reported feeling proud   to work at Medtronic 89% – 90% Percent of employees who reported actively looking  for ways to improve their work91% – 94% Percent of employees who reported feeling Medtronic  has a positive impact on the world ‡NA NA 93% †  Our all-employee OHS was postponed in FY21 due to the pandemic.
","('Employee_Health_And_Safety', 0.22887101769447327)","('Critical_Incident_Risk_Management', 0.16997912526130676)","('Access_And_Affordability', 0.10403002053499222)","('NON-ESG', 0.22887101769447327)","('NON-ESG', 0.16997912526130676)","('NON-ESG', 0.10403002053499222)"
Line 863,"Instead, we distributed an online pulse survey to employees with access to a Medtronic email address.
","('Customer_Privacy', 0.5714043378829956)","('Data_Security', 0.06771744042634964)","('Labor_Practices', 0.05611834302544594)","(['Privacy Protection'], 0.5714043378829956)","('NON-ESG', 0.06771744042634964)","('NON-ESG', 0.05611834302544594)"
Line 864,"‡ This question first appeared in our FY22 survey; data is not available for FY20 or FY21.
","('Business_Model_Resilience', 0.28476426005363464)","('Physical_Impacts_Of_Climate_Change', 0.13021431863307953)","('Management_Of_Legal_And_Regulatory_Framework', 0.06559782475233078)","('NON-ESG', 0.28476426005363464)","('NON-ESG', 0.13021431863307953)","('NON-ESG', 0.06559782475233078)"
Line 865,"1  Our all-employee OHS was postponed in FY21 due to the pandemic.
","('Employee_Health_And_Safety', 0.4159984886646271)","('Critical_Incident_Risk_Management', 0.11817238479852676)","('Labor_Practices', 0.09695958346128464)","('NON-ESG', 0.4159984886646271)","('NON-ESG', 0.11817238479852676)","('NON-ESG', 0.09695958346128464)"
Line 866,"Instead,   we distributed an online pulse survey to employees with access to a Medtr onic   email address.
","('Customer_Privacy', 0.2055017203092575)","('Labor_Practices', 0.11537575721740723)","('Employee_Engagement_Inclusion_And_Diversity', 0.11332280188798904)","('NON-ESG', 0.2055017203092575)","('NON-ESG', 0.11537575721740723)","('NON-ESG', 0.11332280188798904)"
Line 867,"2022 Integrated Performance Report       67 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexHealth and safety Our industry-leading healthcare technologies are  developed and produced through harnessing the expertise of each employee.
","('Management_Of_Legal_And_Regulatory_Framework', 0.18229331076145172)","('Business_Model_Resilience', 0.17396540939807892)","('Human_Rights_And_Community_Relations', 0.10489009320735931)","('NON-ESG', 0.18229331076145172)","('NON-ESG', 0.17396540939807892)","('NON-ESG', 0.10489009320735931)"
Line 868,"A safe and healthy work environment enables our workforce to innovate insight-driven care and experiences that put people first, driving better outcomes for our world.
","('Employee_Health_And_Safety', 0.7305761575698853)","('Access_And_Affordability', 0.07760655879974365)","('Employee_Engagement_Inclusion_And_Diversity', 0.050228022038936615)","(['Operational Eco-Efficiency'], 0.7305761575698853)","('NON-ESG', 0.07760655879974365)","('NON-ESG', 0.050228022038936615)"
Line 869,"Our approach Medtronic is committed to a safe, healthy work environment that is in compliance with applicable laws and regulations.
","('Employee_Health_And_Safety', 0.4699760377407074)","('Access_And_Affordability', 0.11410669982433319)","('Human_Rights_And_Community_Relations', 0.0931922122836113)","('NON-ESG', 0.4699760377407074)","('NON-ESG', 0.11410669982433319)","('NON-ESG', 0.0931922122836113)"
Line 870,"Through our Environmental Health and Safety (EHS) Policy and our EHS Management System (EHS MS), we establish enterprise-wide standards, objectives, and processes for health and safety risk evaluation, compliance, continual improvement, verification, communication, and education.
","('Employee_Health_And_Safety', 0.9181501269340515)","('Product_Quality_And_Safety', 0.032582275569438934)","('Product_Design_And_Lifecycle_Management', 0.0048251464031636715)","(['Operational Eco-Efficiency'], 0.9181501269340515)","('NON-ESG', 0.032582275569438934)","('NON-ESG', 0.0048251464031636715)"
Line 871,"EHS management and performance systems Our EHS MS is aligned with industry best practices including ISO 14001 (environmental management) and ISO 45001 (occupational health and safety management).
","('Employee_Health_And_Safety', 0.9842942953109741)","('Employee_Engagement_Inclusion_And_Diversity', 0.0016183664556592703)","('Critical_Incident_Risk_Management', 0.0016156299971044064)","(['Operational Eco-Efficiency'], 0.9842942953109741)","('NON-ESG', 0.0016183664556592703)","('NON-ESG', 0.0016156299971044064)"
Line 872,"The management system helps us assess EHS impacts and risks in our organization by providing a:  •   S ystematic method for managing EHS and   improving performance.
","('Systemic_Risk_Management', 0.8705306053161621)","('Business_Model_Resilience', 0.02735769748687744)","('Supply_Chain_Management', 0.019451385363936424)","(['Risk & Crisis Management'], 0.8705306053161621)","('NON-ESG', 0.02735769748687744)","('NON-ESG', 0.019451385363936424)"
Line 873,"•   S tructure to address the impacts of the   company’s products, services, and processes on   the environment.
","('Product_Design_And_Lifecycle_Management', 0.9564242959022522)","('Selling_Practices_And_Product_Labeling', 0.006391247268766165)","('Product_Quality_And_Safety', 0.004929454065859318)","(['Product Stewardship'], 0.9564242959022522)","('NON-ESG', 0.006391247268766165)","('NON-ESG', 0.004929454065859318)"
Line 874,"•   S tandard for allocating resources, establishing  responsibilities, and evaluating practices, procedures, and processes.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7642397284507751)","('Human_Rights_And_Community_Relations', 0.058006081730127335)","('Business_Ethics', 0.026527592912316322)","(['Corporate Governance'], 0.7642397284507751)","('NON-ESG', 0.058006081730127335)","('NON-ESG', 0.026527592912316322)"
Line 875,"All employees are expected to develop a proactive, cooperative attitude toward health and safety.
","('Employee_Health_And_Safety', 0.9824907183647156)","('Critical_Incident_Risk_Management', 0.0023047886788845062)","('Employee_Engagement_Inclusion_And_Diversity', 0.0019660245161503553)","(['Operational Eco-Efficiency'], 0.9824907183647156)","('NON-ESG', 0.0023047886788845062)","('NON-ESG', 0.0019660245161503553)"
Line 876,"Our Environmental, Health, and Safety Performance System (EHS PS) helps us drive a culture of safety through the careful monitoring of our recordable incident rate, safety standards, employee training, and auditing.
","('Employee_Health_And_Safety', 0.9720721244812012)","('Critical_Incident_Risk_Management', 0.008282437920570374)","('Product_Quality_And_Safety', 0.00207098969258368)","(['Operational Eco-Efficiency'], 0.9720721244812012)","('NON-ESG', 0.008282437920570374)","('NON-ESG', 0.00207098969258368)"
Line 877,"The EHS PS provides each employee with the practices and tools to reduce risks and employ the competencies and safe behaviors necessary to succeed.
","('Systemic_Risk_Management', 0.8757680058479309)","('Business_Ethics', 0.030925896018743515)","('Competitive_Behavior', 0.012269825674593449)","(['Risk & Crisis Management'], 0.8757680058479309)","('NON-ESG', 0.030925896018743515)","('NON-ESG', 0.012269825674593449)"
Line 878,"It also exemplifies the actions and behavior expectations to be displayed by leadership and employees alike and provides a heightened awareness and sense of ownership in EHS.
","('Employee_Engagement_Inclusion_And_Diversity', 0.41865187883377075)","('Business_Ethics', 0.12946611642837524)","('Human_Rights_And_Community_Relations', 0.09556684643030167)","('NON-ESG', 0.41865187883377075)","('NON-ESG', 0.12946611642837524)","('NON-ESG', 0.09556684643030167)"
Line 879,"Our progress In FY22, we maintained our best-in-class level of safety across our global operations and supply chain.
","('Supply_Chain_Management', 0.9481944441795349)","('Labor_Practices', 0.00598758552223444)","('Product_Design_And_Lifecycle_Management', 0.004060273990035057)","(['Supply Chain Management'], 0.9481944441795349)","('NON-ESG', 0.00598758552223444)","('NON-ESG', 0.004060273990035057)"
Line 880,"Our overall safety record improved with rates of high-consequence work-related injuries and lost workdays declining compared to the previous two years.
","('Employee_Health_And_Safety', 0.9820386171340942)","('Employee_Engagement_Inclusion_And_Diversity', 0.0018960190936923027)","('Labor_Practices', 0.0017068168381229043)","(['Operational Eco-Efficiency'], 0.9820386171340942)","('NON-ESG', 0.0018960190936923027)","('NON-ESG', 0.0017068168381229043)"
Line 881,"Our overall injury incident rate increased slightly in FY22, to 0.21 compared to 0.20 in FY21, primarily due to an increase in slips, trips, and falls.
","('Employee_Health_And_Safety', 0.9749607443809509)","('Critical_Incident_Risk_Management', 0.008161677047610283)","('Employee_Engagement_Inclusion_And_Diversity', 0.0011847297428175807)","(['Operational Eco-Efficiency'], 0.9749607443809509)","('NON-ESG', 0.008161677047610283)","('NON-ESG', 0.0011847297428175807)"
Line 882,"In response, we published and communicated slip, trip, and fall campaigns across all sites, improved outdoor walking surfaces and lighting where deficiencies were identified, emphasized use of stair rails while ascending or descending stairways, and promoted heightened awareness while walking on our premises.
","('Employee_Health_And_Safety', 0.7615921497344971)","('Access_And_Affordability', 0.02120504528284073)","('Employee_Engagement_Inclusion_And_Diversity', 0.020295873284339905)","(['Operational Eco-Efficiency'], 0.7615921497344971)","('NON-ESG', 0.02120504528284073)","('NON-ESG', 0.020295873284339905)"
Line 883,"To bring rapid companywide attention to hazards, we  launched a Global Alert program.
","('Critical_Incident_Risk_Management', 0.6665778160095215)","('Employee_Health_And_Safety', 0.1535835713148117)","('Air_Quality', 0.03333145007491112)","(['Risk & Crisis Management'], 0.6665778160095215)","('NON-ESG', 0.1535835713148117)","('NON-ESG', 0.03333145007491112)"
Line 884,"The program provides summary communications to relevant businesses of a high-risk or significant EHS incident that has the potential to result in, or has resulted in, major injury, illness, environmental release, or property damage.
","('Employee_Health_And_Safety', 0.9761077761650085)","('Critical_Incident_Risk_Management', 0.006682535167783499)","('Access_And_Affordability', 0.001272316207177937)","(['Operational Eco-Efficiency'], 0.9761077761650085)","('NON-ESG', 0.006682535167783499)","('NON-ESG', 0.001272316207177937)"
Line 885,"We also  introduced our own EHS PS, including reducing  high-consequence injury rates and increasing rates of hazard reporting.SUPPORTING A GLOBAL WORKFORCE SAFETY RECORD†‡§  FY20 FY21 FYEmployee injury incident rateΩ0.26 0.20 0.Employee lost/restricted workday case rate††0.15 0.13 0.Fatalities 1§§1§§High-consequence work-related injuries (excluding fatalities) 5 5 † Our safety records include all employees as well as contingent workers working at Medtronic facilities.
","('Employee_Health_And_Safety', 0.9849973917007446)","('Employee_Engagement_Inclusion_And_Diversity', 0.0015047595370560884)","('Critical_Incident_Risk_Management', 0.0014942387351766229)","(['Operational Eco-Efficiency'], 0.9849973917007446)","('NON-ESG', 0.0015047595370560884)","('NON-ESG', 0.0014942387351766229)"
Line 886,"‡ Safety data has been verified by an external third party.
","('Product_Quality_And_Safety', 0.8115628957748413)","('Employee_Health_And_Safety', 0.07805845886468887)","('Product_Design_And_Lifecycle_Management', 0.009210413321852684)","(['Product Quality & Recall Management'], 0.8115628957748413)","('NON-ESG', 0.07805845886468887)","('NON-ESG', 0.009210413321852684)"
Line 887,"§ FY22 injury incident, lost/restricted workday case rate, and fatalities have been verified by ERM CVS.
","('Employee_Health_And_Safety', 0.9833682179450989)","('Critical_Incident_Risk_Management', 0.002499587833881378)","('Employee_Engagement_Inclusion_And_Diversity', 0.0013513094745576382)","(['Operational Eco-Efficiency'], 0.9833682179450989)","('NON-ESG', 0.002499587833881378)","('NON-ESG', 0.0013513094745576382)"
Line 888,"Ω The number of work-related injuries or illnesses serious enough to require treatment beyond first aid, per 100 employees working a full year.
","('Employee_Health_And_Safety', 0.9842376112937927)","('Critical_Incident_Risk_Management', 0.0018955506384372711)","('Employee_Engagement_Inclusion_And_Diversity', 0.0014141736319288611)","(['Operational Eco-Efficiency'], 0.9842376112937927)","('NON-ESG', 0.0018955506384372711)","('NON-ESG', 0.0014141736319288611)"
Line 889,"††  The number of work-related injuries or illnesses serious enough to cause an employee to miss one or more workdays or to have one or more workdays of restricted duty,   per 100 employees working a full year.
","('Employee_Health_And_Safety', 0.9805236458778381)","('Labor_Practices', 0.002382446313276887)","('Employee_Engagement_Inclusion_And_Diversity', 0.0022063127253204584)","(['Operational Eco-Efficiency'], 0.9805236458778381)","('NON-ESG', 0.002382446313276887)","('NON-ESG', 0.0022063127253204584)"
Line 890,"§ § Motor vehicle collision.
","('Critical_Incident_Risk_Management', 0.7492753267288208)","('Employee_Health_And_Safety', 0.14747518301010132)","('Air_Quality', 0.012273562140762806)","(['Risk & Crisis Management'], 0.7492753267288208)","('NON-ESG', 0.14747518301010132)","('NON-ESG', 0.012273562140762806)"
Line 891,"FY22 Health and Safety Recognition All four of our Puerto Rico manufacturing sites received environmental and safety  performance awards from the Puerto Rico Manufacturers Association (above).
","('Product_Quality_And_Safety', 0.5284344553947449)","('Employee_Health_And_Safety', 0.34038498997688293)","('Product_Design_And_Lifecycle_Management', 0.020080113783478737)","(['Product Quality & Recall Management'], 0.5284344553947449)","('NON-ESG', 0.34038498997688293)","('NON-ESG', 0.020080113783478737)"
Line 892,"Nine Medtronic sites in the state of Minnesota received the Governor’s Safety Award —   recognizing these sites for their exceptional safety performance and program compared to national industry averages.
","('Employee_Health_And_Safety', 0.5903834104537964)","('Product_Quality_And_Safety', 0.27807706594467163)","('Product_Design_And_Lifecycle_Management', 0.01569877192378044)","(['Operational Eco-Efficiency'], 0.5903834104537964)","('NON-ESG', 0.27807706594467163)","('NON-ESG', 0.01569877192378044)"
Line 893,"2022 Integrated Performance Report       68 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexContinuous improvement Employee involvement and feedback improves safety  programs and performance.
","('Employee_Health_And_Safety', 0.7707927227020264)","('Product_Quality_And_Safety', 0.06478039920330048)","('Access_And_Affordability', 0.02548028528690338)","(['Operational Eco-Efficiency'], 0.7707927227020264)","('NON-ESG', 0.06478039920330048)","('NON-ESG', 0.02548028528690338)"
Line 894,"We provide several opportunities for employees to be involved in their personal, team, and company safety, as well as methods to provide feedback.
","('Employee_Health_And_Safety', 0.9684031009674072)","('Employee_Engagement_Inclusion_And_Diversity', 0.004329322837293148)","('Product_Quality_And_Safety', 0.0027758257929235697)","(['Operational Eco-Efficiency'], 0.9684031009674072)","('NON-ESG', 0.004329322837293148)","('NON-ESG', 0.0027758257929235697)"
Line 895,"For example, our online hazard reporting system allows  employees to identify and report hazards and support action to mitigate or eliminate the associated risks.
","('Employee_Health_And_Safety', 0.6925718784332275)","('Critical_Incident_Risk_Management', 0.06873785704374313)","('Waste_And_Hazardous_Materials_Management', 0.046561550348997116)","(['Operational Eco-Efficiency'], 0.6925718784332275)","('NON-ESG', 0.06873785704374313)","('NON-ESG', 0.046561550348997116)"
Line 896,"We also encourage employees to report potential hazards, such as water leaks or fire risks, along with near-miss incidents.
","('Critical_Incident_Risk_Management', 0.5070804357528687)","('Employee_Health_And_Safety', 0.14512409269809723)","('Water_And_Wastewater_Management', 0.12351032346487045)","(['Risk & Crisis Management'], 0.5070804357528687)","('NON-ESG', 0.14512409269809723)","('NON-ESG', 0.12351032346487045)"
Line 897,"In FY22, our employees reported more than 57,000 potential hazards and 486 near misses, an increase of 66% and decrease of 9%, respectively, compared to FY21.
","('Employee_Health_And_Safety', 0.9254085421562195)","('Critical_Incident_Risk_Management', 0.028864474967122078)","('Air_Quality', 0.004557716194540262)","(['Operational Eco-Efficiency'], 0.9254085421562195)","('NON-ESG', 0.028864474967122078)","('NON-ESG', 0.004557716194540262)"
Line 898,"Hazard reporting increased year  over year due to wider companywide adoption of  our new reporting tools.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5670119524002075)","('Systemic_Risk_Management', 0.13080912828445435)","('Physical_Impacts_Of_Climate_Change', 0.04090157151222229)","(['Corporate Governance'], 0.5670119524002075)","('NON-ESG', 0.13080912828445435)","('NON-ESG', 0.04090157151222229)"
Line 899,"As part of our annual corporate-wide Organizational  Health Survey (OHS), we solicit feedback on workplace safety.
","('Employee_Health_And_Safety', 0.9748630523681641)","('Product_Quality_And_Safety', 0.004172010812908411)","('Employee_Engagement_Inclusion_And_Diversity', 0.002467733807861805)","(['Operational Eco-Efficiency'], 0.9748630523681641)","('NON-ESG', 0.004172010812908411)","('NON-ESG', 0.002467733807861805)"
Line 900,"Of the 83% of full- and part-time employees who responded to the FY22 survey, more than 90% reported feeling that: •   Medtr onic provides a safe and healthy work  environment and encourages safe working behaviors.
","('Employee_Health_And_Safety', 0.8556651473045349)","('Labor_Practices', 0.04953237995505333)","('Employee_Engagement_Inclusion_And_Diversity', 0.02055186592042446)","(['Operational Eco-Efficiency'], 0.8556651473045349)","('NON-ESG', 0.04953237995505333)","('NON-ESG', 0.02055186592042446)"
Line 901,"•   T hey felt comfortable reporting safety concerns and  injuries at work.
","('Employee_Health_And_Safety', 0.9828240871429443)","('Critical_Incident_Risk_Management', 0.002086054300889373)","('Employee_Engagement_Inclusion_And_Diversity', 0.001648925943300128)","(['Operational Eco-Efficiency'], 0.9828240871429443)","('NON-ESG', 0.002086054300889373)","('NON-ESG', 0.001648925943300128)"
Line 902,"Continued safety amid COVID-As an essential business during COVID-19, keeping  our employees and customers safe while fulfilling our Mission was and continues to be a top priority.
","('Employee_Health_And_Safety', 0.9779710173606873)","('Critical_Incident_Risk_Management', 0.0038141380064189434)","('Employee_Engagement_Inclusion_And_Diversity', 0.002163882600143552)","(['Operational Eco-Efficiency'], 0.9779710173606873)","('NON-ESG', 0.0038141380064189434)","('NON-ESG', 0.002163882600143552)"
Line 903,"The protective measures we implemented, combined with the new ways of conducting business during this SUPPORTING A GLOBAL WORKFORCE COVID-19 controls Include: •  Cr oss-functional COVID-19 Safety team  •   C entralized COVID-19 Assessment Team and  intake process •  R evised global pandemic standard •   Risk -based assessment tool to determine  adequacy of site-level controls•   Utiliza tion database tool to quickly  communicate site cases •  Hybrid R eturn to Office Policy and program •  V entilation efficiency and filtration upgrades •  Employee V accination Programunprecedented event, reduced COVID-19 related risks  and impacts to our organization.
","('Employee_Health_And_Safety', 0.9244557023048401)","('Product_Quality_And_Safety', 0.023489927873015404)","('Critical_Incident_Risk_Management', 0.00750104570761323)","(['Operational Eco-Efficiency'], 0.9244557023048401)","('NON-ESG', 0.023489927873015404)","('NON-ESG', 0.00750104570761323)"
Line 904,"The protective measures we implemented, combined with the new ways of conducting business during this SUPPORTING A GLOBAL WORKFORCE COVID-19 controls Include: •  Cr oss-functional COVID-19 Safety team  •   C entralized COVID-19 Assessment Team and  intake process •  R evised global pandemic standard •   Risk -based assessment tool to determine  adequacy of site-level controls•   Utiliza tion database tool to quickly  communicate site cases •  Hybrid R eturn to Office Policy and program •  V entilation efficiency and filtration upgrades •  Employee V accination Programunprecedented event, reduced COVID-19 related risks  and impacts to our organization.
","('Energy_Management', 0.47534677386283875)","('Water_And_Wastewater_Management', 0.12071941047906876)","('GHG_Emissions', 0.07109454274177551)","('NON-ESG', 0.47534677386283875)","('NON-ESG', 0.12071941047906876)","('NON-ESG', 0.07109454274177551)"
Line 905,"Our multifaceted approach to navigating the COVID-19  pandemic involves cross-functional efforts across the organization.
","('Physical_Impacts_Of_Climate_Change', 0.2757353186607361)","('Critical_Incident_Risk_Management', 0.15989235043525696)","('Systemic_Risk_Management', 0.09392257034778595)","('NON-ESG', 0.2757353186607361)","('NON-ESG', 0.15989235043525696)","('NON-ESG', 0.09392257034778595)"
Line 906,"Our Medical Affairs staff provides factual, science-based information to guide our decisions and actions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8802420496940613)","('Business_Ethics', 0.01537956390529871)","('Director_Removal', 0.011021403595805168)","(['Corporate Governance'], 0.8802420496940613)","('NON-ESG', 0.01537956390529871)","('NON-ESG', 0.011021403595805168)"
Line 907,"This internal guidance, paired with governmental requirements, enhances our governance approach, helping us create the necessary framework to direct  our practices.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9656928777694702)","('Business_Ethics', 0.004559146240353584)","('Director_Removal', 0.0032041382510215044)","(['Corporate Governance'], 0.9656928777694702)","('NON-ESG', 0.004559146240353584)","('NON-ESG', 0.0032041382510215044)"
Line 908,"To maintain safe and healthy work environments amid  the pandemic, we established cleaning protocols,  paired with stringent facility-entry requirements.
","('Employee_Health_And_Safety', 0.6791437864303589)","('Waste_And_Hazardous_Materials_Management', 0.09998945891857147)","('Product_Design_And_Lifecycle_Management', 0.028497448191046715)","(['Operational Eco-Efficiency'], 0.6791437864303589)","('NON-ESG', 0.09998945891857147)","('NON-ESG', 0.028497448191046715)"
Line 909,"We also implemented a global system to manage  and track employee COVID-19 cases and assist with  case investigations.
","('Business_Ethics', 0.3569914400577545)","('Critical_Incident_Risk_Management', 0.21741734445095062)","('Management_Of_Legal_And_Regulatory_Framework', 0.0830145925283432)","('NON-ESG', 0.3569914400577545)","('NON-ESG', 0.21741734445095062)","('NON-ESG', 0.0830145925283432)"
Line 910,"To keep employees informed  and vigilant throughout the pandemic, we used communication campaigns, facility signage,  employee trainings, and educational sessions, as well as strongly encouraging vaccinations and holding on-site vaccination clinics.
","('Employee_Health_And_Safety', 0.4380307197570801)","('Access_And_Affordability', 0.138766348361969)","('Product_Quality_And_Safety', 0.06576532125473022)","('NON-ESG', 0.4380307197570801)","('NON-ESG', 0.138766348361969)","('NON-ESG', 0.06576532125473022)"
Line 911,"Health and safety assurance  As part of our efforts to drive continuous improvement and provide transparency, Medtronic retained an accredited and competent independent organization, ERM CVS, to assess, verify, and certify our FY22 health, safety, and environmental sustainability data.
","('Employee_Health_And_Safety', 0.8185125589370728)","('Product_Quality_And_Safety', 0.09989996254444122)","('Employee_Engagement_Inclusion_And_Diversity', 0.0074948533438146114)","(['Operational Eco-Efficiency'], 0.8185125589370728)","('NON-ESG', 0.09989996254444122)","('NON-ESG', 0.0074948533438146114)"
Line 912,"We proudly acknowledge the receipt of the following Letters of Assurance for Health and Safety data from ERM CVS:  •   L etter of Accreditation for Medtronic’s FY22 Health &  Safety program   •   L etter of Assurance for Medtronic’s FY22 Integrated  Performance Report 2022 Integrated Performance Report       69 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexCompensation, benefits, and wellness We support our 95,000+ passionate employees from  onboarding through retirement with compensation, benefits, and wellness programs.
","('Employee_Health_And_Safety', 0.7446861267089844)","('Product_Quality_And_Safety', 0.15953272581100464)","('Employee_Engagement_Inclusion_And_Diversity', 0.009716836735606194)","(['Operational Eco-Efficiency'], 0.7446861267089844)","('NON-ESG', 0.15953272581100464)","('NON-ESG', 0.009716836735606194)"
Line 913,"We proudly acknowledge the receipt of the following Letters of Assurance for Health and Safety data from ERM CVS:  •   L etter of Accreditation for Medtronic’s FY22 Health &  Safety program   •   L etter of Assurance for Medtronic’s FY22 Integrated  Performance Report 2022 Integrated Performance Report       69 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexCompensation, benefits, and wellness We support our 95,000+ passionate employees from  onboarding through retirement with compensation, benefits, and wellness programs.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5178929567337036)","('Employee_Health_And_Safety', 0.18681789934635162)","('Access_And_Affordability', 0.04639962315559387)","(['Human Capital Development'], 0.5178929567337036)","('NON-ESG', 0.18681789934635162)","('NON-ESG', 0.04639962315559387)"
Line 914,"Providing robust benefits and equitable compensation packages helps us attract and retain the industry-leading talent necessary to engineer the extraordinary.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7732185125350952)","('Labor_Practices', 0.06363165378570557)","('Employee_Health_And_Safety', 0.021246572956442833)","(['Human Capital Development'], 0.7732185125350952)","('NON-ESG', 0.06363165378570557)","('NON-ESG', 0.021246572956442833)"
Line 915,"We continuously seek ways to improve our compensation and benefits offerings to be more inclusive and support a greater diversity of needs.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9723666310310364)","('Employee_Health_And_Safety', 0.0024963747709989548)","('Labor_Practices', 0.0021329536102712154)","(['Human Capital Development'], 0.9723666310310364)","('NON-ESG', 0.0024963747709989548)","('NON-ESG', 0.0021329536102712154)"
Line 916,"Compensation We design our compensation framework to support  a culture of performance and to recognize and reward our employees in more than 80 countries for their ongoing commitment.
","('Labor_Practices', 0.8058170080184937)","('Employee_Engagement_Inclusion_And_Diversity', 0.07167568057775497)","('Employee_Health_And_Safety', 0.022185739129781723)","(['Labor Practice Indicators'], 0.8058170080184937)","('NON-ESG', 0.07167568057775497)","('NON-ESG', 0.022185739129781723)"
Line 917,"Our competitive compensation plans include base salary, cash incentives based on a variety of performance measures, retirement contributions, a stock purchase plan, and, for nominated employees, equity in the company.
","('Labor_Practices', 0.8818738460540771)","('Employee_Engagement_Inclusion_And_Diversity', 0.034377243369817734)","('Management_Of_Legal_And_Regulatory_Framework', 0.013501441106200218)","(['Labor Practice Indicators'], 0.8818738460540771)","('NON-ESG', 0.034377243369817734)","('NON-ESG', 0.013501441106200218)"
Line 918,"Our compensation  is comparable with industry benchmarks and local market standards.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3747720420360565)","('Business_Ethics', 0.189699187874794)","('Competitive_Behavior', 0.12146174907684326)","('NON-ESG', 0.3747720420360565)","('NON-ESG', 0.189699187874794)","('NON-ESG', 0.12146174907684326)"
Line 919,"We apply the same methodology  to determining executive compensation, overseen by  the board of directors’ Compensation Committee.
","('Labor_Practices', 0.5313543677330017)","('Director_Removal', 0.20351311564445496)","('Employee_Engagement_Inclusion_And_Diversity', 0.06546787172555923)","(['Labor Practice Indicators'], 0.5313543677330017)","('NON-ESG', 0.20351311564445496)","('NON-ESG', 0.06546787172555923)"
Line 920,"To learn more about executive compensation, see  our Proxy Statement.
","('Labor_Practices', 0.31110525131225586)","('Management_Of_Legal_And_Regulatory_Framework', 0.18340647220611572)","('Business_Ethics', 0.09784746915102005)","('NON-ESG', 0.31110525131225586)","('NON-ESG', 0.18340647220611572)","('NON-ESG', 0.09784746915102005)"
Line 921,"We conduct pay gap analyses in the United States and  10 other countries and adjust to close any gaps not based on job-related factors.
","('Labor_Practices', 0.9562017917633057)","('Employee_Engagement_Inclusion_And_Diversity', 0.0048125917091965675)","('Director_Removal', 0.0037216569762676954)","(['Labor Practice Indicators'], 0.9562017917633057)","('NON-ESG', 0.0048125917091965675)","('NON-ESG', 0.0037216569762676954)"
Line 922,"In FY22, we achieved 100% gender and ethnically diverse pay equity in the United States.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9740299582481384)","('Labor_Practices', 0.001990224001929164)","('Human_Rights_And_Community_Relations', 0.0018368413439020514)","(['Human Capital Development'], 0.9740299582481384)","('NON-ESG', 0.001990224001929164)","('NON-ESG', 0.0018368413439020514)"
Line 923,"Globally, gender pay equity is at 99%.
","('Labor_Practices', 0.9549563527107239)","('Employee_Engagement_Inclusion_And_Diversity', 0.00860252883285284)","('Director_Removal', 0.004060429986566305)","(['Labor Practice Indicators'], 0.9549563527107239)","('NON-ESG', 0.00860252883285284)","('NON-ESG', 0.004060429986566305)"
Line 924,"Read more about pay equity in Inclusion, diversity, and equity.Benefits We round out our compensation plans with robust health and lifestyle benefits.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9722103476524353)","('Employee_Health_And_Safety', 0.0035183061845600605)","('Labor_Practices', 0.002549725817516446)","(['Human Capital Development'], 0.9722103476524353)","('NON-ESG', 0.0035183061845600605)","('NON-ESG', 0.002549725817516446)"
Line 925,"Our benefits package provides care for employees and their families and, in many locations, includes: •  He alth, dental, disability, and life insurance.
","('Employee_Health_And_Safety', 0.6375840306282043)","('Employee_Engagement_Inclusion_And_Diversity', 0.09996342658996582)","('Access_And_Affordability', 0.09914036840200424)","(['Operational Eco-Efficiency'], 0.6375840306282043)","('NON-ESG', 0.09996342658996582)","('NON-ESG', 0.09914036840200424)"
Line 926,"•  P aid time off.
","('Critical_Incident_Risk_Management', 0.6284369826316833)","('Employee_Health_And_Safety', 0.11198355257511139)","('Physical_Impacts_Of_Climate_Change', 0.02503555454313755)","(['Risk & Crisis Management'], 0.6284369826316833)","('NON-ESG', 0.11198355257511139)","('NON-ESG', 0.02503555454313755)"
Line 927,"•  P aid volunteer time.
","('Critical_Incident_Risk_Management', 0.4992750585079193)","('Human_Rights_And_Community_Relations', 0.12342895567417145)","('Access_And_Affordability', 0.11867669224739075)","('NON-ESG', 0.4992750585079193)","('NON-ESG', 0.12342895567417145)","('NON-ESG', 0.11867669224739075)"
Line 928,"•  Medtr onic Employee Assistance program.
","('Employee_Health_And_Safety', 0.3588049113750458)","('Labor_Practices', 0.2400607019662857)","('Employee_Engagement_Inclusion_And_Diversity', 0.20879146456718445)","('NON-ESG', 0.3588049113750458)","('NON-ESG', 0.2400607019662857)","('NON-ESG', 0.20879146456718445)"
Line 929,"•  Sick and family car e leave.
","('Employee_Health_And_Safety', 0.7286645174026489)","('Critical_Incident_Risk_Management', 0.09416262805461884)","('Labor_Practices', 0.03202022984623909)","(['Operational Eco-Efficiency'], 0.7286645174026489)","('NON-ESG', 0.09416262805461884)","('NON-ESG', 0.03202022984623909)"
Line 930,"•  R etirement plans.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6202377676963806)","('Systemic_Risk_Management', 0.03797435015439987)","('Energy_Management', 0.034363869577646255)","(['Corporate Governance'], 0.6202377676963806)","('NON-ESG', 0.03797435015439987)","('NON-ESG', 0.034363869577646255)"
Line 931,"•  Access to our employee stock pur chase plan.
","('Systemic_Risk_Management', 0.17679034173488617)","('Business_Model_Resilience', 0.161333367228508)","('Competitive_Behavior', 0.14539296925067902)","('NON-ESG', 0.17679034173488617)","('NON-ESG', 0.161333367228508)","('NON-ESG', 0.14539296925067902)"
Line 932,"We update our benefit package regularly by enhancing  existing offerings and providing additional or improved benefits to meet the diverse needs of our employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.936665415763855)","('Access_And_Affordability', 0.007953712716698647)","('Customer_Welfare', 0.006062631960958242)","(['Human Capital Development'], 0.936665415763855)","('NON-ESG', 0.007953712716698647)","('NON-ESG', 0.006062631960958242)"
Line 933,"In the United States, we expanded our value-based health plan offering to provide lower-cost options.
","('Access_And_Affordability', 0.6874051094055176)","('Energy_Management', 0.054151199758052826)","('Customer_Welfare', 0.039246559143066406)","(['Health Outcome Contribution'], 0.6874051094055176)","('NON-ESG', 0.054151199758052826)","('NON-ESG', 0.039246559143066406)"
Line 934,"We also enhanced our fertility and family planning benefits to cover additional treatments and increased coverage for adoption, donor, and surrogacy reimbursement.
","('Access_And_Affordability', 0.5879999399185181)","('Employee_Engagement_Inclusion_And_Diversity', 0.10093529522418976)","('Employee_Health_And_Safety', 0.059045709669589996)","(['Health Outcome Contribution'], 0.5879999399185181)","('NON-ESG', 0.10093529522418976)","('NON-ESG', 0.059045709669589996)"
Line 935,"We continue to focus on embedding inclusion and  diversity considerations into our global benefits portfolio.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9761290550231934)","('Employee_Health_And_Safety', 0.0019401066238060594)","('Human_Rights_And_Community_Relations', 0.0016605597920715809)","(['Human Capital Development'], 0.9761290550231934)","('NON-ESG', 0.0019401066238060594)","('NON-ESG', 0.0016605597920715809)"
Line 936,"We are currently defining an essential health standard for all employees that considers topics such  as access to vaccines, maternity care, mental health,  and more.
","('Access_And_Affordability', 0.4531891942024231)","('Employee_Health_And_Safety', 0.327563613653183)","('Product_Quality_And_Safety', 0.038826100528240204)","('NON-ESG', 0.4531891942024231)","('NON-ESG', 0.327563613653183)","('NON-ESG', 0.038826100528240204)"
Line 937,"Employees in select countries can review  their rewards package at any time through our online portal, MyRewards.SUPPORTING A GLOBAL WORKFORCE Supporting growing families We provide our employees with a suite of health services to support family planning.
","('Access_And_Affordability', 0.7444944381713867)","('Employee_Health_And_Safety', 0.05598558112978935)","('Employee_Engagement_Inclusion_And_Diversity', 0.05394566059112549)","(['Health Outcome Contribution'], 0.7444944381713867)","('NON-ESG', 0.05598558112978935)","('NON-ESG', 0.05394566059112549)"
Line 938,"In FY22,  we added several new and expanded services for U.S. employees, including personalized health coaching for new parents and fertility and parenthood articles through the LGBTQ+-inclusive Ovia Health app.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9082367420196533)","('Employee_Health_And_Safety', 0.017020726576447487)","('Access_And_Affordability', 0.015800679102540016)","(['Human Capital Development'], 0.9082367420196533)","('NON-ESG', 0.017020726576447487)","('NON-ESG', 0.015800679102540016)"
Line 939,"We also increased our Adoption, Donor, and Surrogacy Reimbursement Program benefit to include donor egg and sperm expenses, including legal and adoption fees.Work flexibility As our teams return to the office, we want to retain the lessons learned from our extended work-from-home period.
","('Employee_Engagement_Inclusion_And_Diversity', 0.19687038660049438)","('Employee_Health_And_Safety', 0.1930689662694931)","('Access_And_Affordability', 0.132390096783638)","('NON-ESG', 0.19687038660049438)","('NON-ESG', 0.1930689662694931)","('NON-ESG', 0.132390096783638)"
Line 940,"To support work-life balance and continue the flexibility offered by remote work, we instituted a new hybrid work model — a combination of working on- and off-site by flexing between a Medtronic facility and an approved remote location.
","('Employee_Health_And_Safety', 0.49307915568351746)","('Labor_Practices', 0.10609430819749832)","('Product_Design_And_Lifecycle_Management', 0.05952782556414604)","('NON-ESG', 0.49307915568351746)","('NON-ESG', 0.10609430819749832)","('NON-ESG', 0.05952782556414604)"
Line 941,"The program is dependent on the nature of the role and, to be eligible, employees must ensure business and customer needs are met.
","('Business_Model_Resilience', 0.13265788555145264)","('Customer_Privacy', 0.12818549573421478)","('Employee_Engagement_Inclusion_And_Diversity', 0.12156788259744644)","('NON-ESG', 0.13265788555145264)","('NON-ESG', 0.12818549573421478)","('NON-ESG', 0.12156788259744644)"
Line 942,"Due to the pandemic, in FY22, most employees continued working from home.
","('Labor_Practices', 0.3791328966617584)","('Employee_Health_And_Safety', 0.35792431235313416)","('Supply_Chain_Management', 0.03434525430202484)","('NON-ESG', 0.3791328966617584)","('NON-ESG', 0.35792431235313416)","('NON-ESG', 0.03434525430202484)"
Line 943,"The program will likely go into full effect in FY23.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6692503690719604)","('Access_And_Affordability', 0.04983561858534813)","('Systemic_Risk_Management', 0.043860990554094315)","(['Corporate Governance'], 0.6692503690719604)","('NON-ESG', 0.04983561858534813)","('NON-ESG', 0.043860990554094315)"
Line 944,"Employees can also take advantage of our 4 Weeks from Anywhere program which allows  them to work from anywhere in the world for one month out of the year, as long as business and customer needs can be met.
","('Labor_Practices', 0.4924514591693878)","('Employee_Engagement_Inclusion_And_Diversity', 0.1021747812628746)","('Employee_Health_And_Safety', 0.0748523399233818)","('NON-ESG', 0.4924514591693878)","('NON-ESG', 0.1021747812628746)","('NON-ESG', 0.0748523399233818)"
Line 945,"2022 Integrated Performance Report       70 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexWellness Our wellness benefits promote a holistic approach to  good health.
","('Management_Of_Legal_And_Regulatory_Framework', 0.42967766523361206)","('Business_Model_Resilience', 0.11910705268383026)","('Human_Rights_And_Community_Relations', 0.08575364947319031)","('NON-ESG', 0.42967766523361206)","('NON-ESG', 0.11910705268383026)","('NON-ESG', 0.08575364947319031)"
Line 946,"Our Healthier Together program, available to nearly 100% of employees globally, supports the physical, emotional, social, and financial well-being of our employees.
","('Employee_Health_And_Safety', 0.5614043474197388)","('Human_Rights_And_Community_Relations', 0.1153801754117012)","('Employee_Engagement_Inclusion_And_Diversity', 0.08678383380174637)","(['Operational Eco-Efficiency'], 0.5614043474197388)","('NON-ESG', 0.1153801754117012)","('NON-ESG', 0.08678383380174637)"
Line 947,"Amid the COVID-19 pandemic, we expanded the program’s virtual offerings to provide wellness support to employees working from home.
","('Employee_Health_And_Safety', 0.814906120300293)","('Employee_Engagement_Inclusion_And_Diversity', 0.035672321915626526)","('Access_And_Affordability', 0.03484101966023445)","(['Operational Eco-Efficiency'], 0.814906120300293)","('NON-ESG', 0.035672321915626526)","('NON-ESG', 0.03484101966023445)"
Line 948,"Virtual resources included activities such as guided meditation, yoga, and workout sessions.
","('Access_And_Affordability', 0.2987361252307892)","('Employee_Health_And_Safety', 0.12603075802326202)","('Employee_Engagement_Inclusion_And_Diversity', 0.11242261528968811)","('NON-ESG', 0.2987361252307892)","('NON-ESG', 0.12603075802326202)","('NON-ESG', 0.11242261528968811)"
Line 949,"Access to additional offerings is available to employees  through our YouTube channel.
","('Access_And_Affordability', 0.4246162474155426)","('Customer_Welfare', 0.08569454401731491)","('Management_Of_Legal_And_Regulatory_Framework', 0.07815495133399963)","('NON-ESG', 0.4246162474155426)","('NON-ESG', 0.08569454401731491)","('NON-ESG', 0.07815495133399963)"
Line 950,"The program offers a wide range of services for  employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.29943400621414185)","('Access_And_Affordability', 0.25021564960479736)","('Employee_Health_And_Safety', 0.07673966139554977)","('NON-ESG', 0.29943400621414185)","('NON-ESG', 0.25021564960479736)","('NON-ESG', 0.07673966139554977)"
Line 951,"For example, in the United States, we  offer a blood pressure management program through Hello Heart that helps members monitor their blood pressure and track medications.
","('Employee_Health_And_Safety', 0.20323282480239868)","('Energy_Management', 0.10502959787845612)","('Critical_Incident_Risk_Management', 0.0996711254119873)","('NON-ESG', 0.20323282480239868)","('NON-ESG', 0.10502959787845612)","('NON-ESG', 0.0996711254119873)"
Line 952,"At office locations, we also provide on-site gyms with live classes to help employees stay fit.
","('Access_And_Affordability', 0.3555479943752289)","('Employee_Engagement_Inclusion_And_Diversity', 0.09381411224603653)","('Customer_Welfare', 0.07758913189172745)","('NON-ESG', 0.3555479943752289)","('NON-ESG', 0.09381411224603653)","('NON-ESG', 0.07758913189172745)"
Line 953,"In FY22, through our Healthier Together initiative, we  held Rhythms That Move You, a wellness challenge to help employees build community and healthy habits together.
","('Employee_Health_And_Safety', 0.4969502091407776)","('Access_And_Affordability', 0.09153518080711365)","('Employee_Engagement_Inclusion_And_Diversity', 0.08430477231740952)","('NON-ESG', 0.4969502091407776)","('NON-ESG', 0.09153518080711365)","('NON-ESG', 0.08430477231740952)"
Line 954,"Nearly 3,500 participants joined the challenge and nearly 54% of those engaged developed social connections as a result.
","('Human_Rights_And_Community_Relations', 0.49018266797065735)","('Employee_Engagement_Inclusion_And_Diversity', 0.18874189257621765)","('Employee_Health_And_Safety', 0.05249251797795296)","('NON-ESG', 0.49018266797065735)","('NON-ESG', 0.18874189257621765)","('NON-ESG', 0.05249251797795296)"
Line 955,"Additionally, over 18,000 digital coaching sessions were completed.
","('Access_And_Affordability', 0.6014567613601685)","('Employee_Engagement_Inclusion_And_Diversity', 0.12335054576396942)","('Product_Quality_And_Safety', 0.025466976687312126)","(['Health Outcome Contribution'], 0.6014567613601685)","('NON-ESG', 0.12335054576396942)","('NON-ESG', 0.025466976687312126)"
Line 956,"Healthier Together members report high rates of success  using the program.
","('Access_And_Affordability', 0.4182276129722595)","('Product_Quality_And_Safety', 0.07867523282766342)","('Customer_Welfare', 0.0727277547121048)","('NON-ESG', 0.4182276129722595)","('NON-ESG', 0.07867523282766342)","('NON-ESG', 0.0727277547121048)"
Line 957,"Of participants with high-risk health issues, 62% reported being more active.
","('Employee_Health_And_Safety', 0.89121413230896)","('Access_And_Affordability', 0.01914077065885067)","('Product_Quality_And_Safety', 0.01237437967211008)","(['Operational Eco-Efficiency'], 0.89121413230896)","('NON-ESG', 0.01914077065885067)","('NON-ESG', 0.01237437967211008)"
Line 958,"In addition to Healthier Together, we offer  employees access to two additional health and  well-being programs: •   Medtr onic Employee Assistance program –  supplements our existing health and wellness benefits  with services such as financial and legal advice and mental health counseling.
","('Employee_Health_And_Safety', 0.6738041639328003)","('Access_And_Affordability', 0.14892958104610443)","('Employee_Engagement_Inclusion_And_Diversity', 0.02879185974597931)","(['Operational Eco-Efficiency'], 0.6738041639328003)","('NON-ESG', 0.14892958104610443)","('NON-ESG', 0.02879185974597931)"
Line 959,"•   Medtr onic Employee Emergency Assistance Fund –  supports employees in times of personal crisis, such as a serious illness or natural disaster.
","('Critical_Incident_Risk_Management', 0.9752897024154663)","('Employee_Health_And_Safety', 0.004697069060057402)","('Air_Quality', 0.0021853826474398375)","(['Risk & Crisis Management'], 0.9752897024154663)","('NON-ESG', 0.004697069060057402)","('NON-ESG', 0.0021853826474398375)"
Line 960,"Donations to the fund are made by employees and matched dollar-for-dollar by the Medtronic Foundation.SUPPORTING A GLOBAL WORKFORCE Welcoming Ginger In FY22, we added a new global benefit to our Medtronic Employee Assistance Program:  Ginger, on-demand emotional health support.
","('Employee_Health_And_Safety', 0.40316903591156006)","('Employee_Engagement_Inclusion_And_Diversity', 0.2805195152759552)","('Access_And_Affordability', 0.12049663066864014)","('NON-ESG', 0.40316903591156006)","('NON-ESG', 0.2805195152759552)","('NON-ESG', 0.12049663066864014)"
Line 961,"Ginger provides users with access to trained behavioral health coaches, licensed therapists and psychiatrists, and clinically validated resources.
","('Access_And_Affordability', 0.6767938733100891)","('Product_Quality_And_Safety', 0.03370160609483719)","('Employee_Engagement_Inclusion_And_Diversity', 0.03354544937610626)","(['Health Outcome Contribution'], 0.6767938733100891)","('NON-ESG', 0.03370160609483719)","('NON-ESG', 0.03354544937610626)"
Line 962,"For U.S.-based employees, the first six counseling sessions are included with standard coverage and additional sessions are available based on medical benefits.Stepping into better health The COVID-19 pandemic was a wake-up call for Medtronic employee Riddhi Gandhi.
","('Employee_Health_And_Safety', 0.7971835732460022)","('Critical_Incident_Risk_Management', 0.037984348833560944)","('Access_And_Affordability', 0.035468243062496185)","(['Operational Eco-Efficiency'], 0.7971835732460022)","('NON-ESG', 0.037984348833560944)","('NON-ESG', 0.035468243062496185)"
Line 963,"“It helped me realize that my health is as much a priority as my family and my work,” she said.
","('Employee_Health_And_Safety', 0.7960156798362732)","('Employee_Engagement_Inclusion_And_Diversity', 0.023739086464047432)","('Access_And_Affordability', 0.020075086504220963)","(['Operational Eco-Efficiency'], 0.7960156798362732)","('NON-ESG', 0.023739086464047432)","('NON-ESG', 0.020075086504220963)"
Line 964,"That’s when she decided to join the Wondr program through Healthier Together.
","('Access_And_Affordability', 0.5959653258323669)","('Employee_Health_And_Safety', 0.07890360802412033)","('Customer_Welfare', 0.04788455367088318)","(['Health Outcome Contribution'], 0.5959653258323669)","('NON-ESG', 0.07890360802412033)","('NON-ESG', 0.04788455367088318)"
Line 965,"Wondr helps participants achieve a healthier weight through behavioral changes.
","('Access_And_Affordability', 0.16142234206199646)","('Product_Quality_And_Safety', 0.13466237485408783)","('Customer_Welfare', 0.13172878324985504)","('NON-ESG', 0.16142234206199646)","('NON-ESG', 0.13466237485408783)","('NON-ESG', 0.13172878324985504)"
Line 966,"The program encouraged her to adopt healthy habits, like taking daily  walks and staying hydrated.
","('Employee_Health_And_Safety', 0.6164915561676025)","('Access_And_Affordability', 0.0639682412147522)","('Employee_Engagement_Inclusion_And_Diversity', 0.03628141060471535)","(['Operational Eco-Efficiency'], 0.6164915561676025)","('NON-ESG', 0.0639682412147522)","('NON-ESG', 0.03628141060471535)"
Line 967,"Riddhi lost 30 pounds, her weight loss goal, after one year in the program.“The resources we have at  Medtronic through Healthier  Together are truly there for our  benefit.
","('Employee_Health_And_Safety', 0.27570173144340515)","('Employee_Engagement_Inclusion_And_Diversity', 0.2096613198518753)","('Access_And_Affordability', 0.09240256994962692)","('NON-ESG', 0.27570173144340515)","('NON-ESG', 0.2096613198518753)","('NON-ESG', 0.09240256994962692)"
Line 968,"We are lucky to have  such resources at hand.”  Riddhi Gandhi  Medtronic employee 2022 Integrated Performance Report       71 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexPatient safety and  product qualitySOCIAL IMPACT 2022 Integrated Performance Report       72 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index Adding business value Delivering safe and effective products is our  responsibility as a global healthcare technology  leader and is essential to our business success.
","('Product_Design_And_Lifecycle_Management', 0.353816956281662)","('Product_Quality_And_Safety', 0.2982501983642578)","('Business_Model_Resilience', 0.0707329735159874)","('NON-ESG', 0.353816956281662)","('NON-ESG', 0.2982501983642578)","('NON-ESG', 0.0707329735159874)"
Line 969,"We are lucky to have  such resources at hand.”  Riddhi Gandhi  Medtronic employee 2022 Integrated Performance Report       71 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexPatient safety and  product qualitySOCIAL IMPACT 2022 Integrated Performance Report       72 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index Adding business value Delivering safe and effective products is our  responsibility as a global healthcare technology  leader and is essential to our business success.
","('Business_Model_Resilience', 0.8386862874031067)","('Supply_Chain_Management', 0.02548282966017723)","('Systemic_Risk_Management', 0.025058230385184288)","(['Codes of Business Conduct'], 0.8386862874031067)","('NON-ESG', 0.02548282966017723)","('NON-ESG', 0.025058230385184288)"
Line 970,"We devote meticulous attention to product quality  to keep patients safe, and, in turn, we maintain the  trust of our stakeholders and uphold our reputation among patients and healthcare professionals.Our innovative technologies transform  the lives of two people every second.
","('Product_Design_And_Lifecycle_Management', 0.7730107307434082)","('Product_Quality_And_Safety', 0.08089226484298706)","('Customer_Welfare', 0.029559312388300896)","(['Product Stewardship'], 0.7730107307434082)","('NON-ESG', 0.08089226484298706)","('NON-ESG', 0.029559312388300896)"
Line 971,"Ensuring the quality, safety, and reliability of our products and therapies is essential to the well-being of those who depend on them.
","('Product_Quality_And_Safety', 0.6484425663948059)","('Product_Design_And_Lifecycle_Management', 0.2120085060596466)","('Employee_Health_And_Safety', 0.021977359429001808)","(['Product Quality & Recall Management'], 0.6484425663948059)","('NON-ESG', 0.2120085060596466)","('NON-ESG', 0.021977359429001808)"
Line 972,"We extend our high standards for quality across our value chain to every employee, partner, and distributor.
","('Supply_Chain_Management', 0.17884863913059235)","('Product_Quality_And_Safety', 0.14707015454769135)","('Business_Ethics', 0.1063975989818573)","('NON-ESG', 0.17884863913059235)","('NON-ESG', 0.14707015454769135)","('NON-ESG', 0.1063975989818573)"
Line 973,"2,employees dedicated to   ensuring our clinical trials   are robustly designed and  efficiently conducted 78 % of new products in our pipeline  are achieving high-maturity  implementation of design,  reliability, manufacturability methodologyOur approach to patient safety and  product quality  We prioritize the needs and well-being of patients in  all facets of our product quality initiatives.
","('Product_Design_And_Lifecycle_Management', 0.5775988698005676)","('Product_Quality_And_Safety', 0.2910529375076294)","('Customer_Welfare', 0.020365476608276367)","(['Product Stewardship'], 0.5775988698005676)","('NON-ESG', 0.2910529375076294)","('NON-ESG', 0.020365476608276367)"
Line 974,"The safety of our patients is inextricably linked to the quality of our technology, and we consider the weight of this responsibility through every stage of development.
","('Product_Quality_And_Safety', 0.5543423295021057)","('Employee_Health_And_Safety', 0.23831123113632202)","('Selling_Practices_And_Product_Labeling', 0.025408204644918442)","(['Product Quality & Recall Management'], 0.5543423295021057)","('NON-ESG', 0.23831123113632202)","('NON-ESG', 0.025408204644918442)"
Line 975,"Patient safety We take our safety commitment to patients, their families, and their clinicians seriously.
","('Employee_Health_And_Safety', 0.9193702340126038)","('Product_Quality_And_Safety', 0.024995774030685425)","('Access_And_Affordability', 0.006111623719334602)","(['Operational Eco-Efficiency'], 0.9193702340126038)","('NON-ESG', 0.024995774030685425)","('NON-ESG', 0.006111623719334602)"
Line 976,"We are committed to producing safe and effective healthcare technologies and advancing a culture of patient-centricity and quality.
","('Access_And_Affordability', 0.4725401699542999)","('Critical_Incident_Risk_Management', 0.06802105903625488)","('Employee_Health_And_Safety', 0.06068381667137146)","('NON-ESG', 0.4725401699542999)","('NON-ESG', 0.06802105903625488)","('NON-ESG', 0.06068381667137146)"
Line 977,"Our operating units collaborate with the new Patient  Safety and Risk Board — composed of senior medical, quality, and regulatory corporate leaders — to evaluate and advise appropriate action on safety and quality issues that pose risks to patients or users.
","('Product_Quality_And_Safety', 0.7538956999778748)","('Employee_Health_And_Safety', 0.13228514790534973)","('Product_Design_And_Lifecycle_Management', 0.011560207232832909)","(['Product Quality & Recall Management'], 0.7538956999778748)","('NON-ESG', 0.13228514790534973)","('NON-ESG', 0.011560207232832909)"
Line 978,"In FY22, we reorganized our Medical Safety group under  the supervision of a new chief medical safety officer.
","('Product_Quality_And_Safety', 0.765812873840332)","('Employee_Health_And_Safety', 0.10837073624134064)","('Product_Design_And_Lifecycle_Management', 0.012105859816074371)","(['Product Quality & Recall Management'], 0.765812873840332)","('NON-ESG', 0.10837073624134064)","('NON-ESG', 0.012105859816074371)"
Line 979,"The group matches teams of dedicated medical safety experts with various operating units and therapy areas.
","('Product_Quality_And_Safety', 0.7674962282180786)","('Employee_Health_And_Safety', 0.11322826147079468)","('Access_And_Affordability', 0.011666218750178814)","(['Product Quality & Recall Management'], 0.7674962282180786)","('NON-ESG', 0.11322826147079468)","('NON-ESG', 0.011666218750178814)"
Line 980,"These internal experts use their clinical experience to assess the risk, benefit, and safety concerns throughout the product life cycle.
","('Product_Quality_And_Safety', 0.9045144319534302)","('Selling_Practices_And_Product_Labeling', 0.014527570456266403)","('Product_Design_And_Lifecycle_Management', 0.011208780109882355)","(['Product Quality & Recall Management'], 0.9045144319534302)","('NON-ESG', 0.014527570456266403)","('NON-ESG', 0.011208780109882355)"
Line 981,"They also engage with external practitioners in formalized panels to incorporate up-to-date, real-world data and expertise into how we evaluate safety issues.
","('Product_Quality_And_Safety', 0.6945558786392212)","('Employee_Health_And_Safety', 0.1860693395137787)","('Product_Design_And_Lifecycle_Management', 0.012471270747482777)","(['Product Quality & Recall Management'], 0.6945558786392212)","('NON-ESG', 0.1860693395137787)","('NON-ESG', 0.012471270747482777)"
Line 982,"We will continue to enhance our commitment to safety  through Put Patients First, an imperative launching in FY23 that will further ensure quality and patient safety are embedded in our culture.
","('Product_Quality_And_Safety', 0.8455198407173157)","('Employee_Health_And_Safety', 0.03898152709007263)","('Access_And_Affordability', 0.012848787009716034)","(['Product Quality & Recall Management'], 0.8455198407173157)","('NON-ESG', 0.03898152709007263)","('NON-ESG', 0.012848787009716034)"
Line 983,"Put Patients First will inspire and require employees to work with a sense  of purpose and ownership, knowing there is a human  life on the other side of every decision.
","('Human_Rights_And_Community_Relations', 0.2841711640357971)","('Employee_Engagement_Inclusion_And_Diversity', 0.12099678069353104)","('Employee_Health_And_Safety', 0.12061350047588348)","('NON-ESG', 0.2841711640357971)","('NON-ESG', 0.12099678069353104)","('NON-ESG', 0.12061350047588348)"
Line 984,"Product quality  In FY22, we launched a cross-functional, enterprise-wide product quality plan to drive consistency and accountability across the company, ensuring we deliver on our Mission to alleviate pain, restore health, and extend life.
","('Product_Design_And_Lifecycle_Management', 0.6647270321846008)","('Product_Quality_And_Safety', 0.19994845986366272)","('Customer_Welfare', 0.019920863211154938)","(['Product Stewardship'], 0.6647270321846008)","('NON-ESG', 0.19994845986366272)","('NON-ESG', 0.019920863211154938)"
Line 985,"The plan focuses on increasing consistency and rigor across the quality systems, including the areas of risk management and product design.
","('Product_Design_And_Lifecycle_Management', 0.936466634273529)","('Product_Quality_And_Safety', 0.011451603844761848)","('Supply_Chain_Management', 0.00627875654026866)","(['Product Stewardship'], 0.936466634273529)","('NON-ESG', 0.011451603844761848)","('NON-ESG', 0.00627875654026866)"
Line 986,"We monitor compliance with our quality standards at  every point in a product’s life cycle, from design and manufacturing through product testing and post-market surveillance.
","('Product_Quality_And_Safety', 0.7955641150474548)","('Product_Design_And_Lifecycle_Management', 0.05421549454331398)","('Business_Ethics', 0.02492091991007328)","(['Product Quality & Recall Management'], 0.7955641150474548)","('NON-ESG', 0.05421549454331398)","('NON-ESG', 0.02492091991007328)"
Line 987,"Our risk management process is aligned  to the ISO 14971 standard for medical devices and enables us to rapidly identify and escalate potential issues.
","('Systemic_Risk_Management', 0.867680549621582)","('Physical_Impacts_Of_Climate_Change', 0.026758184656500816)","('Supply_Chain_Management', 0.01868349313735962)","(['Risk & Crisis Management'], 0.867680549621582)","('NON-ESG', 0.026758184656500816)","('NON-ESG', 0.01868349313735962)"
Line 988,"We also align our quality management systems with relevant regulations and international standards, including 21 CFR Part 820 and ISO 13485, and we regularly communicate with and train employees to reinforce our Put Patients First imperative.
","('Product_Quality_And_Safety', 0.5109783411026001)","('Management_Of_Legal_And_Regulatory_Framework', 0.1612955927848816)","('Business_Ethics', 0.07602962851524353)","(['Product Quality & Recall Management'], 0.5109783411026001)","('NON-ESG', 0.1612955927848816)","('NON-ESG', 0.07602962851524353)"
Line 989,"Oversight Our board and executive leadership ultimately oversee quality matters.
","('Director_Removal', 0.5350748300552368)","('Management_Of_Legal_And_Regulatory_Framework', 0.1283472180366516)","('Business_Ethics', 0.06359896808862686)","(['Anti-Crime Policy & Measures'], 0.5350748300552368)","('NON-ESG', 0.1283472180366516)","('NON-ESG', 0.06359896808862686)"
Line 990,"The board’s Quality Committee supervises risks relating to product quality and safety, cybersecurity, and research.
","('Product_Quality_And_Safety', 0.9051839113235474)","('Product_Design_And_Lifecycle_Management', 0.018322361633181572)","('Employee_Health_And_Safety', 0.0076124342158436775)","(['Product Quality & Recall Management'], 0.9051839113235474)","('NON-ESG', 0.018322361633181572)","('NON-ESG', 0.0076124342158436775)"
Line 991,"Our chief quality officer  sits on the executive committee and reports directly  to the CEO.
","('Director_Removal', 0.597556471824646)","('Management_Of_Legal_And_Regulatory_Framework', 0.09344074875116348)","('Business_Model_Resilience', 0.050988804548978806)","(['Anti-Crime Policy & Measures'], 0.597556471824646)","('NON-ESG', 0.09344074875116348)","('NON-ESG', 0.050988804548978806)"
Line 992,"Product development Design, reliability, manufacturability Our design, reliability, manufacturability (DRM) framework is a set of best practices that drive product quality, safety, and reliability for all types of Medtronic medical devices, including standalone software products and those that include software.
","('Product_Design_And_Lifecycle_Management', 0.4665609896183014)","('Product_Quality_And_Safety', 0.38773313164711)","('Employee_Health_And_Safety', 0.02510553039610386)","('NON-ESG', 0.4665609896183014)","('NON-ESG', 0.38773313164711)","('NON-ESG', 0.02510553039610386)"
Line 993,"We work to embed  DRM in every stage of the product design and development process through:  •   Applica tion of predictive engineering in the  development of devices.
","('Product_Design_And_Lifecycle_Management', 0.9637976884841919)","('Product_Quality_And_Safety', 0.004318279679864645)","('Customer_Welfare', 0.0034880831371992826)","(['Product Stewardship'], 0.9637976884841919)","('NON-ESG', 0.004318279679864645)","('NON-ESG', 0.0034880831371992826)"
Line 994,"•   A  mandate from our company leadership for   DRM accountability.
","('Management_Of_Legal_And_Regulatory_Framework', 0.24290217459201813)","('Business_Ethics', 0.24119003117084503)","('Systemic_Risk_Management', 0.10180491954088211)","('NON-ESG', 0.24290217459201813)","('NON-ESG', 0.24119003117084503)","('NON-ESG', 0.10180491954088211)"
Line 995,"•   Customized DRM tr aining and certification for   project development teams as well as progressive  training and certification companywide.
","('Employee_Engagement_Inclusion_And_Diversity', 0.29974818229675293)","('Access_And_Affordability', 0.18524597585201263)","('Product_Quality_And_Safety', 0.1350705623626709)","('NON-ESG', 0.29974818229675293)","('NON-ESG', 0.18524597585201263)","('NON-ESG', 0.1350705623626709)"
Line 996,"•   P roject assessments to ensure consistent use across  our project portfolio.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3683965802192688)","('Energy_Management', 0.2074243724346161)","('Access_And_Affordability', 0.11235896497964859)","('NON-ESG', 0.3683965802192688)","('NON-ESG', 0.2074243724346161)","('NON-ESG', 0.11235896497964859)"
Line 997,"•   K ey performance indicators to help evaluate   DRM progress.
","('Systemic_Risk_Management', 0.24530068039894104)","('Human_Rights_And_Community_Relations', 0.1318613588809967)","('Management_Of_Legal_And_Regulatory_Framework', 0.12212608754634857)","('NON-ESG', 0.24530068039894104)","('NON-ESG', 0.1318613588809967)","('NON-ESG', 0.12212608754634857)"
Line 998,"•   Annual assessments and impr ovement plans at  product development locations.
","('Product_Design_And_Lifecycle_Management', 0.9264376759529114)","('Product_Quality_And_Safety', 0.014412952587008476)","('Customer_Welfare', 0.009254428558051586)","(['Product Stewardship'], 0.9264376759529114)","('NON-ESG', 0.014412952587008476)","('NON-ESG', 0.009254428558051586)"
Line 999,"•   Skills and capability development for k ey functions  such as Research and Development, Operations, Quality, Medical Safety, Regulatory, and Marketing.
","('Access_And_Affordability', 0.2806605398654938)","('Product_Quality_And_Safety', 0.26743948459625244)","('Employee_Engagement_Inclusion_And_Diversity', 0.08762526512145996)","('NON-ESG', 0.2806605398654938)","('NON-ESG', 0.26743948459625244)","('NON-ESG', 0.08762526512145996)"
Line 1000,"DRM sits at the heart of our predictive engineering process, which our engineers use to simulate  product use, forecast performance, and pinpoint potential improvements.
","('Product_Design_And_Lifecycle_Management', 0.961904764175415)","('Product_Quality_And_Safety', 0.00460339430719614)","('Business_Model_Resilience', 0.003447978524491191)","(['Product Stewardship'], 0.961904764175415)","('NON-ESG', 0.00460339430719614)","('NON-ESG', 0.003447978524491191)"
Line 1001,"At the end of FY22, 78% of  new products in our pipeline are achieving high- maturity implementation of design, reliability, manufacturability methodology.Manufacturing and supplier quality Our standardized manufacturing quality programs promote a consistent approach across product manufacturing processes.
","('Product_Design_And_Lifecycle_Management', 0.9542887806892395)","('Product_Quality_And_Safety', 0.009233164601027966)","('Supply_Chain_Management', 0.003823160659521818)","(['Product Stewardship'], 0.9542887806892395)","('NON-ESG', 0.009233164601027966)","('NON-ESG', 0.003823160659521818)"
Line 1002,"These programs include our First Time Quality (FTQ) methodology and our Supplier Optimization and Risk Reduction (SOAR) process.
","('Supply_Chain_Management', 0.9488136172294617)","('Product_Design_And_Lifecycle_Management', 0.005622679367661476)","('Physical_Impacts_Of_Climate_Change', 0.004270314704626799)","(['Supply Chain Management'], 0.9488136172294617)","('NON-ESG', 0.005622679367661476)","('NON-ESG', 0.004270314704626799)"
Line 1003,"FTQ instills quality awareness across the workforce,  strengthens risk identification skills, and embeds a  “Do Not Make Defects” mentality across the product  life cycle.
","('Employee_Engagement_Inclusion_And_Diversity', 0.34700581431388855)","('Product_Quality_And_Safety', 0.21262100338935852)","('Product_Design_And_Lifecycle_Management', 0.12530791759490967)","('NON-ESG', 0.34700581431388855)","('NON-ESG', 0.21262100338935852)","('NON-ESG', 0.12530791759490967)"
Line 1004,"FTQ delivers a 90% reduction of high- business-impact risks and quality instabilities on  targeted workflows.
","('Systemic_Risk_Management', 0.9327594637870789)","('Business_Model_Resilience', 0.013847661204636097)","('Physical_Impacts_Of_Climate_Change', 0.010860729962587357)","(['Risk & Crisis Management'], 0.9327594637870789)","('NON-ESG', 0.013847661204636097)","('NON-ESG', 0.010860729962587357)"
Line 1005,"In FY22, we expanded FTQ into the workflows of our new  product development and other transactional processes across our business to further reduce the potential for errors.
","('Product_Design_And_Lifecycle_Management', 0.9596337676048279)","('Product_Quality_And_Safety', 0.004921812564134598)","('Customer_Welfare', 0.004297764506191015)","(['Product Stewardship'], 0.9596337676048279)","('NON-ESG', 0.004921812564134598)","('NON-ESG', 0.004297764506191015)"
Line 1006,"We also: •   Acceler ated FTQ coach training to make the program  self-sustainable at key manufacturing sites.
","('Product_Design_And_Lifecycle_Management', 0.783525288105011)","('Product_Quality_And_Safety', 0.036161698400974274)","('Supply_Chain_Management', 0.02590336836874485)","(['Product Stewardship'], 0.783525288105011)","('NON-ESG', 0.036161698400974274)","('NON-ESG', 0.02590336836874485)"
Line 1007,"•   Developed a new FT Q portal to track event execution  and risk mitigation, as well as coach development.
","('Systemic_Risk_Management', 0.4695555567741394)","('Business_Model_Resilience', 0.32504287362098694)","('Physical_Impacts_Of_Climate_Change', 0.0698399618268013)","('NON-ESG', 0.4695555567741394)","('NON-ESG', 0.32504287362098694)","('NON-ESG', 0.0698399618268013)"
Line 1008,"•   Established FT Q Communities of Practice to share  knowledge, recognize top performance, and  strengthen quality culture.
","('Employee_Engagement_Inclusion_And_Diversity', 0.36099785566329956)","('Human_Rights_And_Community_Relations', 0.07974287867546082)","('Business_Model_Resilience', 0.07559321820735931)","('NON-ESG', 0.36099785566329956)","('NON-ESG', 0.07974287867546082)","('NON-ESG', 0.07559321820735931)"
Line 1009,"SOAR is a continuous improvement strategy that uses predictive and preventive risk assessments to reduce risk and optimize our supply base to avoid product supply disruptions.
","('Supply_Chain_Management', 0.9485437870025635)","('Systemic_Risk_Management', 0.005551530048251152)","('Product_Design_And_Lifecycle_Management', 0.004120716359466314)","(['Supply Chain Management'], 0.9485437870025635)","('NON-ESG', 0.005551530048251152)","('NON-ESG', 0.004120716359466314)"
Line 1010,"Through the program, we partner with our suppliers to identify potential hazardous situations and implement best-in-class processes and tools to prevent these hazards from becoming issues.PATIENT SAFETY AND PRODUCT QUALITY 2022 Integrated Performance Report       73 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexFacility compliance We assess quality management systems at our  manufacturing, design, and distribution centers through global internal audits and corporate excellence assessments.
","('Product_Quality_And_Safety', 0.8092347979545593)","('Employee_Health_And_Safety', 0.049420494586229324)","('Product_Design_And_Lifecycle_Management', 0.04827343672513962)","(['Product Quality & Recall Management'], 0.8092347979545593)","('NON-ESG', 0.049420494586229324)","('NON-ESG', 0.04827343672513962)"
Line 1011,"Through the program, we partner with our suppliers to identify potential hazardous situations and implement best-in-class processes and tools to prevent these hazards from becoming issues.PATIENT SAFETY AND PRODUCT QUALITY 2022 Integrated Performance Report       73 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexFacility compliance We assess quality management systems at our  manufacturing, design, and distribution centers through global internal audits and corporate excellence assessments.
","('Business_Ethics', 0.8154669404029846)","('Management_Of_Legal_And_Regulatory_Framework', 0.07000024616718292)","('Systemic_Risk_Management', 0.013412024825811386)","(['Business Ethics'], 0.8154669404029846)","('NON-ESG', 0.07000024616718292)","('NON-ESG', 0.013412024825811386)"
Line 1012,"These focus on maintaining consistently high-quality management levels and complying with evolving regulatory requirements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9548236727714539)","('Ecological_Impacts', 0.00451978575438261)","('Product_Quality_And_Safety', 0.003820523852482438)","(['Corporate Governance'], 0.9548236727714539)","('NON-ESG', 0.00451978575438261)","('NON-ESG', 0.003820523852482438)"
Line 1013,"External regulatory audits help to keep us accountable,  aware of regulatory priorities, and focused on making necessary changes to policies and practices.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9713358879089355)","('Business_Ethics', 0.0030870416667312384)","('Director_Removal', 0.002417720388621092)","(['Corporate Governance'], 0.9713358879089355)","('NON-ESG', 0.0030870416667312384)","('NON-ESG', 0.002417720388621092)"
Line 1014,"We share the findings and actions from these activities across the enterprise via our knowledge management process.
","('Human_Rights_And_Community_Relations', 0.14915789663791656)","('Management_Of_Legal_And_Regulatory_Framework', 0.13622574508190155)","('Business_Model_Resilience', 0.13515760004520416)","('NON-ESG', 0.14915789663791656)","('NON-ESG', 0.13622574508190155)","('NON-ESG', 0.13515760004520416)"
Line 1015,"In FY22, 95% of external regulatory inspections at Medtronic facilities globally resulted in no findings.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6085517406463623)","('Business_Ethics', 0.2692348062992096)","('Product_Quality_And_Safety', 0.01602083258330822)","(['Corporate Governance'], 0.6085517406463623)","('NON-ESG', 0.2692348062992096)","('NON-ESG', 0.01602083258330822)"
Line 1016,"We received an average of 0.38 findings per regulatory  inspection overall and 2.6 findings per U.S. FDA inspection in FY22.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8446968197822571)","('Business_Ethics', 0.04154835641384125)","('Product_Quality_And_Safety', 0.02193242311477661)","(['Corporate Governance'], 0.8446968197822571)","('NON-ESG', 0.04154835641384125)","('NON-ESG', 0.02193242311477661)"
Line 1017,"These figures were partially affected by an increase in FDA inspections after the lifting of COVID-19 restrictions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9078847169876099)","('Business_Ethics', 0.011621112003922462)","('Product_Quality_And_Safety', 0.011180279776453972)","(['Corporate Governance'], 0.9078847169876099)","('NON-ESG', 0.011621112003922462)","('NON-ESG', 0.011180279776453972)"
Line 1018,"We expect the number of external inspections to remain high in FY23 and are working to ensure all of our sites are operating in a manner that will produce positive regulatory inspection outcomes.Product security We work proactively to identify, address, and minimize vulnerabilities in our products that could expose them to cyberattacks or other potential risks.
","('Data_Security', 0.7507703900337219)","('Business_Ethics', 0.06929711252450943)","('Systemic_Risk_Management', 0.039057426154613495)","(['Information Security/Cybersecurity & System Availability'], 0.7507703900337219)","('NON-ESG', 0.06929711252450943)","('NON-ESG', 0.039057426154613495)"
Line 1019,"Our Product Security Office manages our rigorous  approach to security — including vulnerability testing, updates, and remediation — as well as impact assessment for device functionality and patient safety.
","('Data_Security', 0.664283037185669)","('Product_Quality_And_Safety', 0.09881255030632019)","('Product_Design_And_Lifecycle_Management', 0.03476616367697716)","(['Information Security/Cybersecurity & System Availability'], 0.664283037185669)","('NON-ESG', 0.09881255030632019)","('NON-ESG', 0.03476616367697716)"
Line 1020,"We monitor current practices and emerging risks by engaging with employees, regulators, peers, healthcare delivery organizations, clinicians, and security researchers.
","('Systemic_Risk_Management', 0.775047779083252)","('Business_Ethics', 0.03013322316110134)","('Management_Of_Legal_And_Regulatory_Framework', 0.02913682907819748)","(['Risk & Crisis Management'], 0.775047779083252)","('NON-ESG', 0.03013322316110134)","('NON-ESG', 0.02913682907819748)"
Line 1021,"As part of our global quality management system,  subject matter experts within each operating unit are responsible for integrating security considerations throughout the product life cycle.
","('Product_Design_And_Lifecycle_Management', 0.8727139830589294)","('Product_Quality_And_Safety', 0.0401613712310791)","('Supply_Chain_Management', 0.010549190454185009)","(['Product Stewardship'], 0.8727139830589294)","('NON-ESG', 0.0401613712310791)","('NON-ESG', 0.010549190454185009)"
Line 1022,"In FY22, we established new leadership groups to advise the Product Security Office on the execution of our Enterprise Product Security Strategy, which comprises three pillars: A mindset of excellence, industry participation, and pre- and post-market maturity.
","('Business_Model_Resilience', 0.2741265594959259)","('Product_Design_And_Lifecycle_Management', 0.16775180399417877)","('Systemic_Risk_Management', 0.10684511810541153)","('NON-ESG', 0.2741265594959259)","('NON-ESG', 0.16775180399417877)","('NON-ESG', 0.10684511810541153)"
Line 1023,"We also trained 450 employees on product security best practices in FY22.
","('Data_Security', 0.2958395481109619)","('Business_Ethics', 0.2468768209218979)","('Systemic_Risk_Management', 0.15108756721019745)","('NON-ESG', 0.2958395481109619)","('NON-ESG', 0.2468768209218979)","('NON-ESG', 0.15108756721019745)"
Line 1024,"In FY22, we publicly disclosed six security vulnerabilities,  which included security bulletins, updates to previous bulletins, and security notices responding to third-party risks that may not be applicable to Medtronic but helped address customer inquiries.
","('Data_Security', 0.9574613571166992)","('Systemic_Risk_Management', 0.005811008159071207)","('Customer_Privacy', 0.003236503805965185)","(['Information Security/Cybersecurity & System Availability'], 0.9574613571166992)","('NON-ESG', 0.005811008159071207)","('NON-ESG', 0.003236503805965185)"
Line 1025,"Also, we became a CVE Numbering Authority, which allows us to move more rapidly and decisively in the coordinated disclosure process.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7880067825317383)","('Business_Ethics', 0.044633831828832626)","('Competitive_Behavior', 0.03003912791609764)","(['Corporate Governance'], 0.7880067825317383)","('NON-ESG', 0.044633831828832626)","('NON-ESG', 0.03003912791609764)"
Line 1026,"We publicly recognize the work of independent   security researchers who have demonstrated ethical  behavior and followed coordinated disclosure  processes to advance our product security.
","('Business_Ethics', 0.9451471567153931)","('Data_Security', 0.006360406521707773)","('Competitive_Behavior', 0.0058270650915801525)","(['Business Ethics'], 0.9451471567153931)","('NON-ESG', 0.006360406521707773)","('NON-ESG', 0.0058270650915801525)"
Line 1027,"If anyone believes they have identified a potential security REGULATORY INSPECTIONS AND INTERNAL ASSESSMENTS AT OUR FACILITIES FY20 FY21 FYExternal regulatory inspections at Medtronic sites globally 237 242 284  External regulatory inspections globally that resulted in no findings 95% 99% 95%  Average findings per external regulatory inspection 0.09 0.02 0.Average findings per FDA inspection 0.17 0.02 2.Internal assessments and supported improvements 46 21 28 PATIENT SAFETY AND PRODUCT QUALITY 95 % of external regulatory  inspections at our   facilities globally   resulted in   no findings 2022 Integrated Performance Report       74 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexvulnerability in any of our products or services or has  questions or concerns, we encourage them to contact  us via Medtronic.com/security.
","('Product_Quality_And_Safety', 0.880079984664917)","('Business_Ethics', 0.02733345329761505)","('Employee_Health_And_Safety', 0.011235442943871021)","(['Product Quality & Recall Management'], 0.880079984664917)","('NON-ESG', 0.02733345329761505)","('NON-ESG', 0.011235442943871021)"
Line 1028,"If anyone believes they have identified a potential security REGULATORY INSPECTIONS AND INTERNAL ASSESSMENTS AT OUR FACILITIES FY20 FY21 FYExternal regulatory inspections at Medtronic sites globally 237 242 284  External regulatory inspections globally that resulted in no findings 95% 99% 95%  Average findings per external regulatory inspection 0.09 0.02 0.Average findings per FDA inspection 0.17 0.02 2.Internal assessments and supported improvements 46 21 28 PATIENT SAFETY AND PRODUCT QUALITY 95 % of external regulatory  inspections at our   facilities globally   resulted in   no findings 2022 Integrated Performance Report       74 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexvulnerability in any of our products or services or has  questions or concerns, we encourage them to contact  us via Medtronic.com/security.
","('Management_Of_Legal_And_Regulatory_Framework', 0.28055721521377563)","('Product_Design_And_Lifecycle_Management', 0.19996526837348938)","('Product_Quality_And_Safety', 0.14351706206798553)","('NON-ESG', 0.28055721521377563)","('NON-ESG', 0.19996526837348938)","('NON-ESG', 0.14351706206798553)"
Line 1029,"Our product security strategy includes a focus on pre-  and post-market product security rigor and engagement in industry activities to help shape regulations, standards, technology, and practices.
","('Data_Security', 0.3858029544353485)","('Product_Quality_And_Safety', 0.150223508477211)","('Business_Ethics', 0.08860433846712112)","('NON-ESG', 0.3858029544353485)","('NON-ESG', 0.150223508477211)","('NON-ESG', 0.08860433846712112)"
Line 1030,"In FY22, we joined Optum, Boston Scientific, Abbott Laboratories, and others to help launch the new Center for Medical Device Cybersecurity (CMDC) at the University of Minnesota.
","('Data_Security', 0.8877530694007874)","('Systemic_Risk_Management', 0.01685800403356552)","('Business_Model_Resilience', 0.011362950317561626)","(['Information Security/Cybersecurity & System Availability'], 0.8877530694007874)","('NON-ESG', 0.01685800403356552)","('NON-ESG', 0.011362950317561626)"
Line 1031,"We also serve on the steering committee for the center, which is a hub for discovery, outreach, and workforce training in the device security field.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8184605836868286)","('Employee_Health_And_Safety', 0.042875491082668304)","('Access_And_Affordability', 0.027781041339039803)","(['Human Capital Development'], 0.8184605836868286)","('NON-ESG', 0.042875491082668304)","('NON-ESG', 0.027781041339039803)"
Line 1032,"Additionally, we participate in several industry bodies,  including the Health Information Sharing and Analysis Center (H-ISAC), the National Capital Region Threat Intelligence Consortium, and the Medical Device Innovation Consortium.
","('Data_Security', 0.3412984609603882)","('Product_Quality_And_Safety', 0.05768558382987976)","('Systemic_Risk_Management', 0.05504221096634865)","('NON-ESG', 0.3412984609603882)","('NON-ESG', 0.05768558382987976)","('NON-ESG', 0.05504221096634865)"
Line 1033,"Many of our team members lead initiatives in these groups to help advance product security for the entire industry.Preclinical research Preclinical research lets us examine how potential new treatments will function in practice, prior to evaluating them in clinical trials.
","('Customer_Welfare', 0.2998066544532776)","('Competitive_Behavior', 0.18674755096435547)","('Selling_Practices_And_Product_Labeling', 0.08543942868709564)","('NON-ESG', 0.2998066544532776)","('NON-ESG', 0.18674755096435547)","('NON-ESG', 0.08543942868709564)"
Line 1034,"Our biomedical research sometimes involves human cadaver and modeling work, animal-related research, and the use of animal-derived stem cells, but does not involve use of human embryonic stem cell lines.
","('Access_And_Affordability', 0.28148889541625977)","('Ecological_Impacts', 0.09649001806974411)","('Customer_Welfare', 0.08685030043125153)","('NON-ESG', 0.28148889541625977)","('NON-ESG', 0.09649001806974411)","('NON-ESG', 0.08685030043125153)"
Line 1035,"Animal-related research Animal research and testing is sometimes a regulatory requirement for the development of new medical products.
","('Selling_Practices_And_Product_Labeling', 0.3866100609302521)","('Customer_Welfare', 0.2020282745361328)","('Product_Quality_And_Safety', 0.10245247930288315)","('NON-ESG', 0.3866100609302521)","('NON-ESG', 0.2020282745361328)","('NON-ESG', 0.10245247930288315)"
Line 1036,"We use animals in research activities only  when no acceptable alternatives exist, as described in our Policy Regarding the Use of Animals.
","('Customer_Welfare', 0.16905097663402557)","('Selling_Practices_And_Product_Labeling', 0.15371975302696228)","('Ecological_Impacts', 0.13763871788978577)","('NON-ESG', 0.16905097663402557)","('NON-ESG', 0.15371975302696228)","('NON-ESG', 0.13763871788978577)"
Line 1037,"The policy applies to: •   R esearch that contributes significantly to patient  welfare.
","('Access_And_Affordability', 0.7229395508766174)","('Management_Of_Legal_And_Regulatory_Framework', 0.07432357966899872)","('Human_Rights_And_Community_Relations', 0.03389144316315651)","(['Health Outcome Contribution'], 0.7229395508766174)","('NON-ESG', 0.07432357966899872)","('NON-ESG', 0.03389144316315651)"
Line 1038,"•   W ork specifically mandated by regulatory agencies to  ensure patient safety or effectiveness.
","('Product_Quality_And_Safety', 0.7709426879882812)","('Employee_Health_And_Safety', 0.0937604084610939)","('Access_And_Affordability', 0.020464302971959114)","(['Product Quality & Recall Management'], 0.7709426879882812)","('NON-ESG', 0.0937604084610939)","('NON-ESG', 0.020464302971959114)"
Line 1039,"Any animal-related research or testing is first externally  approved by the Institutional Animal Care and Use Committee.
","('Selling_Practices_And_Product_Labeling', 0.14675575494766235)","('Management_Of_Legal_And_Regulatory_Framework', 0.1344468891620636)","('GHG_Emissions', 0.09895863384008408)","('NON-ESG', 0.14675575494766235)","('NON-ESG', 0.1344468891620636)","('NON-ESG', 0.09895863384008408)"
Line 1040,"We comply with the U.S. Animal Welfare Act and other relevant standards and requirements set by the National Academy of Sciences' Guide for the Care and Use of Laboratory Animals.
","('Ecological_Impacts', 0.12992781400680542)","('Product_Quality_And_Safety', 0.09505033493041992)","('Waste_And_Hazardous_Materials_Management', 0.0861981064081192)","('NON-ESG', 0.12992781400680542)","('NON-ESG', 0.09505033493041992)","('NON-ESG', 0.0861981064081192)"
Line 1041,"We are committed to a respectful, humane approach and  take the welfare of animals used in research seriously.
","('Ecological_Impacts', 0.30694064497947693)","('Waste_And_Hazardous_Materials_Management', 0.08537402004003525)","('Human_Rights_And_Community_Relations', 0.06981223821640015)","('NON-ESG', 0.30694064497947693)","('NON-ESG', 0.08537402004003525)","('NON-ESG', 0.06981223821640015)"
Line 1042,"Our work with scientists, veterinary surgeons, and other experts helps refine our methods, always aiming to alleviate or minimize harm and distress.PATIENT SAFETY AND PRODUCT QUALITY 2022 Integrated Performance Report       75 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexAlternatives to animal-related research Where possible, we reduce the use of animals and  replace animal-related research with other methods, including: •   Submit ting research findings to inform the work of the  International Organization for Standardization (ISO)  on a standard for the testing of human skin cell-based irritation without the use of animals.
","('Product_Quality_And_Safety', 0.8053446412086487)","('Product_Design_And_Lifecycle_Management', 0.07168368995189667)","('Selling_Practices_And_Product_Labeling', 0.02496419847011566)","(['Product Quality & Recall Management'], 0.8053446412086487)","('NON-ESG', 0.07168368995189667)","('NON-ESG', 0.02496419847011566)"
Line 1043,"Our work with scientists, veterinary surgeons, and other experts helps refine our methods, always aiming to alleviate or minimize harm and distress.PATIENT SAFETY AND PRODUCT QUALITY 2022 Integrated Performance Report       75 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexAlternatives to animal-related research Where possible, we reduce the use of animals and  replace animal-related research with other methods, including: •   Submit ting research findings to inform the work of the  International Organization for Standardization (ISO)  on a standard for the testing of human skin cell-based irritation without the use of animals.
","('Employee_Health_And_Safety', 0.49030306935310364)","('Product_Quality_And_Safety', 0.19052676856517792)","('Product_Design_And_Lifecycle_Management', 0.05783011019229889)","('NON-ESG', 0.49030306935310364)","('NON-ESG', 0.19052676856517792)","('NON-ESG', 0.05783011019229889)"
Line 1044,"•   Investing in our C orporate Research Group’s  fundamental modeling work to potentially reduce the number of animals used in future research.
","('Access_And_Affordability', 0.19160155951976776)","('GHG_Emissions', 0.15350323915481567)","('Management_Of_Legal_And_Regulatory_Framework', 0.11200033128261566)","('NON-ESG', 0.19160155951976776)","('NON-ESG', 0.15350323915481567)","('NON-ESG', 0.11200033128261566)"
Line 1045,"Clinical trials As a key part of the product development process,  we conduct clinical trials to provide the necessary evidence on product and therapy safety and effectiveness.
","('Product_Quality_And_Safety', 0.6884170174598694)","('Product_Design_And_Lifecycle_Management', 0.10908977687358856)","('Selling_Practices_And_Product_Labeling', 0.05094433203339577)","(['Product Quality & Recall Management'], 0.6884170174598694)","('NON-ESG', 0.10908977687358856)","('NON-ESG', 0.05094433203339577)"
Line 1046,"We also conduct clinical trials to support market access activities after products are launched.
","('Customer_Welfare', 0.26093852519989014)","('Selling_Practices_And_Product_Labeling', 0.11904642730951309)","('Competitive_Behavior', 0.07989282160997391)","('NON-ESG', 0.26093852519989014)","('NON-ESG', 0.11904642730951309)","('NON-ESG', 0.07989282160997391)"
Line 1047,"More than 2,000 employees in our Clinical Research  and Medical Science functions collaborate to ensure  the trials are robustly designed and efficiently  conducted in accordance with appropriate regulations and ethical practices.
","('Business_Ethics', 0.9444858431816101)","('Competitive_Behavior', 0.010213763453066349)","('Management_Of_Legal_And_Regulatory_Framework', 0.008087853901088238)","(['Business Ethics'], 0.9444858431816101)","('NON-ESG', 0.010213763453066349)","('NON-ESG', 0.008087853901088238)"
Line 1048,"Increasing diversity in clinical trials is a critical element  of working within the current regulatory and social landscape to reduce health inequities and improve outcomes for a broader, more inclusive patient population.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9173571467399597)","('Access_And_Affordability', 0.011468407697975636)","('Customer_Welfare', 0.007399601396173239)","(['Human Capital Development'], 0.9173571467399597)","('NON-ESG', 0.011468407697975636)","('NON-ESG', 0.007399601396173239)"
Line 1049,"We are committed to developing sustainable solutions that overcome barriers to achieving diverse representation across our clinical trials.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6605795621871948)","('Competitive_Behavior', 0.07952339202165604)","('Customer_Welfare', 0.04197109118103981)","(['Human Capital Development'], 0.6605795621871948)","('NON-ESG', 0.07952339202165604)","('NON-ESG', 0.04197109118103981)"
Line 1050,"This effort includes:  •   Assessing r ace and gender representation   across indications.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9625935554504395)","('Human_Rights_And_Community_Relations', 0.003765600034967065)","('Labor_Practices', 0.0033306593541055918)","(['Human Capital Development'], 0.9625935554504395)","('NON-ESG', 0.003765600034967065)","('NON-ESG', 0.0033306593541055918)"
Line 1051,"•   S tandardizing collection of demographics   across Medtronic.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6124452352523804)","('Competitive_Behavior', 0.07077209651470184)","('Business_Model_Resilience', 0.04328399524092674)","(['Human Capital Development'], 0.6124452352523804)","('NON-ESG', 0.07077209651470184)","('NON-ESG', 0.04328399524092674)"
Line 1052,"•   Establishing an enr ollment target methodology   for targeted indications.
","('Customer_Welfare', 0.33715569972991943)","('Selling_Practices_And_Product_Labeling', 0.19885870814323425)","('Competitive_Behavior', 0.04997312277555466)","('NON-ESG', 0.33715569972991943)","('NON-ESG', 0.19885870814323425)","('NON-ESG', 0.04997312277555466)"
Line 1053,"•   Identifying oppor tunities to increase access to  underrepresented patient populations.
","('Access_And_Affordability', 0.7271458506584167)","('Employee_Engagement_Inclusion_And_Diversity', 0.05526681989431381)","('Product_Quality_And_Safety', 0.028737418353557587)","(['Health Outcome Contribution'], 0.7271458506584167)","('NON-ESG', 0.05526681989431381)","('NON-ESG', 0.028737418353557587)"
Line 1054,"•   Developing pr ocesses and tools to reduce specific  health equity gaps.
","('Access_And_Affordability', 0.4465791881084442)","('Employee_Health_And_Safety', 0.07628418505191803)","('Systemic_Risk_Management', 0.06987977772951126)","('NON-ESG', 0.4465791881084442)","('NON-ESG', 0.07628418505191803)","('NON-ESG', 0.06987977772951126)"
Line 1055,"Amid the ongoing COVID-19 pandemic, we continue  to implement new approaches to increase both patient engagement and efficiency in clinical trials.
","('Access_And_Affordability', 0.34403494000434875)","('Customer_Welfare', 0.09542586654424667)","('Systemic_Risk_Management', 0.0527944453060627)","('NON-ESG', 0.34403494000434875)","('NON-ESG', 0.09542586654424667)","('NON-ESG', 0.0527944453060627)"
Line 1056,"This includes continued deployment of remote technologies, as well as the use of apps and wearable devices for direct-to-patient data collection.
","('Customer_Privacy', 0.3891710042953491)","('Data_Security', 0.13208216428756714)","('Energy_Management', 0.09469211846590042)","('NON-ESG', 0.3891710042953491)","('NON-ESG', 0.13208216428756714)","('NON-ESG', 0.09469211846590042)"
Line 1057,"Our Code of Conduct, Global Business Conduct  Standards Policy, and strict data privacy standards  guide our approach to clinical trials.
","('Data_Security', 0.8472342491149902)","('Customer_Privacy', 0.06942129135131836)","('Business_Ethics', 0.013959309086203575)","(['Information Security/Cybersecurity & System Availability'], 0.8472342491149902)","('NON-ESG', 0.06942129135131836)","('NON-ESG', 0.013959309086203575)"
Line 1058,"We adhere to all relevant laws and regulations, including the E.U. Medical Device Regulation and ISO 14155:2020 standard for clinical research.Collaboration, engagement, and data sharing The advancement of medical research depends upon transparent data sharing and collaboration.
","('Management_Of_Legal_And_Regulatory_Framework', 0.25487902760505676)","('Customer_Privacy', 0.2039424031972885)","('Data_Security', 0.12164120376110077)","('NON-ESG', 0.25487902760505676)","('NON-ESG', 0.2039424031972885)","('NON-ESG', 0.12164120376110077)"
Line 1059,"We continue to share knowledge by: •   Disclosing informa tion on applicable trials to the  U.S. Clinical Trials Registry — a database of more than  422,000 research studies.
","('Competitive_Behavior', 0.17171204090118408)","('Access_And_Affordability', 0.11260686069726944)","('Customer_Welfare', 0.10533049702644348)","('NON-ESG', 0.17171204090118408)","('NON-ESG', 0.11260686069726944)","('NON-ESG', 0.10533049702644348)"
Line 1060,"•  P ublishing trial findings in peer-reviewed journals.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3722821772098541)","('Competitive_Behavior', 0.11361824721097946)","('Access_And_Affordability', 0.07194513082504272)","('NON-ESG', 0.3722821772098541)","('NON-ESG', 0.11361824721097946)","('NON-ESG', 0.07194513082504272)"
Line 1061,"•   C ollaborating with research scientists, institutions, and  physicians to advance our clinical trials practice.
","('Competitive_Behavior', 0.14499148726463318)","('Access_And_Affordability', 0.11615996807813644)","('Customer_Welfare', 0.10813239216804504)","('NON-ESG', 0.14499148726463318)","('NON-ESG', 0.11615996807813644)","('NON-ESG', 0.10813239216804504)"
Line 1062,"•   C ontributing to the advancement of clinical  standards by working with the Association for the Advancement of Medical Instrumentation, the Clinical Trials Transformation Initiative, the Medical Device Innovation Consortium, the National Evaluation System for Health Technology Coordinating  Center, and the Digital Health Measurement Collaborative Community.
","('Customer_Welfare', 0.1514626145362854)","('Competitive_Behavior', 0.12634854018688202)","('Access_And_Affordability', 0.11840594559907913)","('NON-ESG', 0.1514626145362854)","('NON-ESG', 0.12634854018688202)","('NON-ESG', 0.11840594559907913)"
Line 1063,"•   P articipating in the MedTech Color Collaborative as we  advance patient diversity in clinical trials at Medtronic.PATIENT SAFETY AND PRODUCT QUALITY 2022 Integrated Performance Report       76 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexProduct use and performance Once we launch a product, we monitor its use and  performance to measure and improve safety and inform future designs.
","('Product_Quality_And_Safety', 0.884992241859436)","('Product_Design_And_Lifecycle_Management', 0.025257622823119164)","('Selling_Practices_And_Product_Labeling', 0.011612297967076302)","(['Product Quality & Recall Management'], 0.884992241859436)","('NON-ESG', 0.025257622823119164)","('NON-ESG', 0.011612297967076302)"
Line 1064,"Post-market surveillance Through our post-market surveillance process, we  collect patient outcome data in partnership with hospitals, physicians, clinics, governments, and third parties.
","('Customer_Privacy', 0.20651274919509888)","('Competitive_Behavior', 0.16622908413410187)","('Systemic_Risk_Management', 0.06927116215229034)","('NON-ESG', 0.20651274919509888)","('NON-ESG', 0.16622908413410187)","('NON-ESG', 0.06927116215229034)"
Line 1065,"We also gather data from: •   P ost-market clinical studies on specific products   and therapies.
","('Selling_Practices_And_Product_Labeling', 0.3741658329963684)","('Customer_Welfare', 0.29571592807769775)","('Product_Quality_And_Safety', 0.07082118093967438)","('NON-ESG', 0.3741658329963684)","('NON-ESG', 0.29571592807769775)","('NON-ESG', 0.07082118093967438)"
Line 1066,"•   Customer feedback analyzed via our global complaint  handling system — now consolida ted into a single  companywide organization to improve our ability to quickly detect and resolve product performance issues.
","('Product_Quality_And_Safety', 0.48638471961021423)","('Competitive_Behavior', 0.10005295276641846)","('Selling_Practices_And_Product_Labeling', 0.056934621185064316)","('NON-ESG', 0.48638471961021423)","('NON-ESG', 0.10005295276641846)","('NON-ESG', 0.056934621185064316)"
Line 1067,"We also collect post-market surveillance data via an extensive internal Product Surveillance Registry that captures patients’ real-world experiences and outcomes with many of our products.
","('Product_Design_And_Lifecycle_Management', 0.5282827019691467)","('Selling_Practices_And_Product_Labeling', 0.149379163980484)","('Product_Quality_And_Safety', 0.08717463165521622)","(['Product Stewardship'], 0.5282827019691467)","('NON-ESG', 0.149379163980484)","('NON-ESG', 0.08717463165521622)"
Line 1068,"Data from the registry is increasingly used to generate evidence to ensure continued market access through routine reporting shared with global regulators.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8639903664588928)","('Competitive_Behavior', 0.023269936442375183)","('Systemic_Risk_Management', 0.015416450798511505)","(['Corporate Governance'], 0.8639903664588928)","('NON-ESG', 0.023269936442375183)","('NON-ESG', 0.015416450798511505)"
Line 1069,"We also use this valuable data to engage with payers and other stakeholders on maintaining access to critical products and therapies for the patients we serve.
","('Product_Design_And_Lifecycle_Management', 0.23278209567070007)","('Customer_Welfare', 0.218291237950325)","('Access_And_Affordability', 0.17107857763767242)","('NON-ESG', 0.23278209567070007)","('NON-ESG', 0.218291237950325)","('NON-ESG', 0.17107857763767242)"
Line 1070,"We develop standardized models to measure and  improve patient safety and clinical outcomes.
","('Product_Quality_And_Safety', 0.782250165939331)","('Employee_Health_And_Safety', 0.055879682302474976)","('Product_Design_And_Lifecycle_Management', 0.018139446154236794)","(['Product Quality & Recall Management'], 0.782250165939331)","('NON-ESG', 0.055879682302474976)","('NON-ESG', 0.018139446154236794)"
Line 1071,"In  addition, we regularly engage the U.S. FDA and other regulators to make sure we meet their post-market surveillance expectations.Caring for patients We work to improve the patient experience through many avenues, including how patients interact with our products and the outcomes they experience.
","('Customer_Welfare', 0.2363193929195404)","('Product_Design_And_Lifecycle_Management', 0.22826053202152252)","('Selling_Practices_And_Product_Labeling', 0.11466982215642929)","('NON-ESG', 0.2363193929195404)","('NON-ESG', 0.22826053202152252)","('NON-ESG', 0.11466982215642929)"
Line 1072,"Complaint rates are an important indicator of patient  experience and product quality and we continuously strive to reduce this rate.
","('Product_Quality_And_Safety', 0.67518150806427)","('Product_Design_And_Lifecycle_Management', 0.11693167686462402)","('Customer_Welfare', 0.024201499298214912)","(['Product Quality & Recall Management'], 0.67518150806427)","('NON-ESG', 0.11693167686462402)","('NON-ESG', 0.024201499298214912)"
Line 1073,"Previously, our efforts resulted in a more than 40% decline in customer-reported complaints for our pacemaker/defibrillator devices  and lead systems.
","('Employee_Health_And_Safety', 0.2360897809267044)","('Product_Quality_And_Safety', 0.19744329154491425)","('Business_Ethics', 0.1719672828912735)","('NON-ESG', 0.2360897809267044)","('NON-ESG', 0.19744329154491425)","('NON-ESG', 0.1719672828912735)"
Line 1074,"To further enhance product quality and patient  experience, we are targeting a 10% reduction in aggregate product complaint rate by FY25, compared with a FY20 baseline, for key product families.
","('Product_Design_And_Lifecycle_Management', 0.8833601474761963)","('Product_Quality_And_Safety', 0.0422106608748436)","('Selling_Practices_And_Product_Labeling', 0.01498063188046217)","(['Product Stewardship'], 0.8833601474761963)","('NON-ESG', 0.0422106608748436)","('NON-ESG', 0.01498063188046217)"
Line 1075,"1 As of  FY22, we are on track to achieve a 10% aggregate reduction by FY25.
","('Systemic_Risk_Management', 0.22001618146896362)","('Management_Of_Legal_And_Regulatory_Framework', 0.1477435678243637)","('Business_Model_Resilience', 0.1062341183423996)","('NON-ESG', 0.22001618146896362)","('NON-ESG', 0.1477435678243637)","('NON-ESG', 0.1062341183423996)"
Line 1076,"Product-related actions The safety and well-being of patients is our paramount concern.
","('Product_Quality_And_Safety', 0.6688834428787231)","('Product_Design_And_Lifecycle_Management', 0.10944506525993347)","('Selling_Practices_And_Product_Labeling', 0.07553477585315704)","(['Product Quality & Recall Management'], 0.6688834428787231)","('NON-ESG', 0.10944506525993347)","('NON-ESG', 0.07553477585315704)"
Line 1077,"Any time product performance is called into question, we act swiftly to engage in transparent communications, reduce risk, and ensure optimal patient management.
","('Systemic_Risk_Management', 0.25609713792800903)","('Business_Ethics', 0.2158677726984024)","('Business_Model_Resilience', 0.08485861122608185)","('NON-ESG', 0.25609713792800903)","('NON-ESG', 0.2158677726984024)","('NON-ESG', 0.08485861122608185)"
Line 1078,"We take prompt action whenever we are alerted to  regulatory or field-safety issues with a Medtronic product.
","('Product_Quality_And_Safety', 0.9235617518424988)","('Employee_Health_And_Safety', 0.011033407412469387)","('Selling_Practices_And_Product_Labeling', 0.009824130684137344)","(['Product Quality & Recall Management'], 0.9235617518424988)","('NON-ESG', 0.011033407412469387)","('NON-ESG', 0.009824130684137344)"
Line 1079,"Our corrective actions include voluntary product recalls when needed.
","('Product_Quality_And_Safety', 0.4661411941051483)","('Selling_Practices_And_Product_Labeling', 0.27848562598228455)","('Product_Design_And_Lifecycle_Management', 0.037537019699811935)","('NON-ESG', 0.4661411941051483)","('NON-ESG', 0.27848562598228455)","('NON-ESG', 0.037537019699811935)"
Line 1080,"We examine underlying issues and root causes and work to resolve them to avoid recurrence.
","('Systemic_Risk_Management', 0.4034683406352997)","('Human_Rights_And_Community_Relations', 0.09862186759710312)","('Business_Ethics', 0.08153633773326874)","('NON-ESG', 0.4034683406352997)","('NON-ESG', 0.09862186759710312)","('NON-ESG', 0.08153633773326874)"
Line 1081,"Our Design Quality Center of Expertise supports our  operating units in implementing quality and reliability improvements via our product-development process, including incorporating lessons learned from post-PATIENT SAFETY AND PRODUCT QUALITY U.S. FDA RECALLS FY20 FY21 FYFDA Class I recalls 6 10 FDA Class II recalls 25†46†Annual recall ratio normalized by revenue (FDA Class I and II recalls  per $1 billion in revenue)1.07†1.86†1.†  The data has been recast from our 2021 Integrated Performance Report due to recalls that occurred in a select fiscal year but were not confirmed until after the report   was published.
","('Product_Quality_And_Safety', 0.8993468284606934)","('Product_Design_And_Lifecycle_Management', 0.020382391288876534)","('Customer_Welfare', 0.00927557609975338)","(['Product Quality & Recall Management'], 0.8993468284606934)","('NON-ESG', 0.020382391288876534)","('NON-ESG', 0.00927557609975338)"
Line 1082,"Our Design Quality Center of Expertise supports our  operating units in implementing quality and reliability improvements via our product-development process, including incorporating lessons learned from post-PATIENT SAFETY AND PRODUCT QUALITY U.S. FDA RECALLS FY20 FY21 FYFDA Class I recalls 6 10 FDA Class II recalls 25†46†Annual recall ratio normalized by revenue (FDA Class I and II recalls  per $1 billion in revenue)1.07†1.86†1.†  The data has been recast from our 2021 Integrated Performance Report due to recalls that occurred in a select fiscal year but were not confirmed until after the report   was published.
","('Critical_Incident_Risk_Management', 0.5829498767852783)","('Air_Quality', 0.06537323445081711)","('Systemic_Risk_Management', 0.05161649361252785)","(['Risk & Crisis Management'], 0.5829498767852783)","('NON-ESG', 0.06537323445081711)","('NON-ESG', 0.05161649361252785)"
Line 1083,"U.S. FDA WARNING LETTERS FY20 FY21 FYOpen FDA warning letters 4 1 2  Open FDA warning letters resolved during the year 3 0 0  market surveillance.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7025503516197205)","('Product_Quality_And_Safety', 0.054710760712623596)","('Competitive_Behavior', 0.04830815643072128)","(['Corporate Governance'], 0.7025503516197205)","('NON-ESG', 0.054710760712623596)","('NON-ESG', 0.04830815643072128)"
Line 1084,"Our Risk Management Center of  Expertise provides oversight of the post-market safety process, ensuring consistency of decision-making across Medtronic.
","('Systemic_Risk_Management', 0.4522441029548645)","('Product_Quality_And_Safety', 0.17783480882644653)","('Business_Ethics', 0.08255241811275482)","('NON-ESG', 0.4522441029548645)","('NON-ESG', 0.17783480882644653)","('NON-ESG', 0.08255241811275482)"
Line 1085,"In FY22, nine Medtronic products were subject to  voluntary Class I recalls.
","('Product_Quality_And_Safety', 0.46929144859313965)","('Product_Design_And_Lifecycle_Management', 0.2668043076992035)","('Selling_Practices_And_Product_Labeling', 0.061400655657052994)","('NON-ESG', 0.46929144859313965)","('NON-ESG', 0.2668043076992035)","('NON-ESG', 0.061400655657052994)"
Line 1086,"This represents 0.005% of product models offered by Medtronic in FY22.
","('Product_Design_And_Lifecycle_Management', 0.9321315884590149)","('Product_Quality_And_Safety', 0.009360644966363907)","('Energy_Management', 0.008266257122159004)","(['Product Stewardship'], 0.9321315884590149)","('NON-ESG', 0.009360644966363907)","('NON-ESG', 0.008266257122159004)"
Line 1087,"Our ratio of recalls classified by FDA as either Class I or II per  $1 billion in revenue declined to 1.74 in FY22 compared with 1.86 in FY21.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5963311195373535)","('Competitive_Behavior', 0.14646029472351074)","('Systemic_Risk_Management', 0.06338594108819962)","(['Corporate Governance'], 0.5963311195373535)","('NON-ESG', 0.14646029472351074)","('NON-ESG', 0.06338594108819962)"
Line 1088,"With each recall, we focus on correcting safety issues but  also conduct rigorous root-cause investigations focused on the product and our processes.
","('Product_Quality_And_Safety', 0.9087499380111694)","('Selling_Practices_And_Product_Labeling', 0.015551756136119366)","('Employee_Health_And_Safety', 0.011640449054539204)","(['Product Quality & Recall Management'], 0.9087499380111694)","('NON-ESG', 0.015551756136119366)","('NON-ESG', 0.011640449054539204)"
Line 1089,"More detail on recalls is available on the FDA List of Device Recalls.
","('Product_Quality_And_Safety', 0.2888670861721039)","('Critical_Incident_Risk_Management', 0.10724999010562897)","('Systemic_Risk_Management', 0.09306381642818451)","('NON-ESG', 0.2888670861721039)","('NON-ESG', 0.10724999010562897)","('NON-ESG', 0.09306381642818451)"
Line 1090,"Further detail on calendar-year recalls are provided in  our ESG disclosure index.
","('Systemic_Risk_Management', 0.28618285059928894)","('Business_Ethics', 0.18683649599552155)","('Product_Quality_And_Safety', 0.13866211473941803)","('NON-ESG', 0.28618285059928894)","('NON-ESG', 0.18683649599552155)","('NON-ESG', 0.13866211473941803)"
Line 1091,"1  The goal covers the following products: Transcatheter Aortic valves and delivery  systems, Venous Closure Systems, Spinal Cord Stimulation systems, Mazor Robot, Signia TM handles, Puritan BennettTM 980 ventilator and Diabetes NGP pumps,  and sensors.
","('Employee_Health_And_Safety', 0.7102694511413574)","('Access_And_Affordability', 0.052827611565589905)","('Product_Quality_And_Safety', 0.025501390919089317)","(['Operational Eco-Efficiency'], 0.7102694511413574)","('NON-ESG', 0.052827611565589905)","('NON-ESG', 0.025501390919089317)"
Line 1092,"We are focusing on these product families because they represent strategic opportunities to positively influence complaint rate and patient experience through new product introductions and post-release changes.
","('Product_Design_And_Lifecycle_Management', 0.38628122210502625)","('Customer_Welfare', 0.20968173444271088)","('Selling_Practices_And_Product_Labeling', 0.1307787299156189)","('NON-ESG', 0.38628122210502625)","('NON-ESG', 0.20968173444271088)","('NON-ESG', 0.1307787299156189)"
Line 1093,"We continuously evaluate opportunities to reduce complaints and improve the patient experience.
","('Access_And_Affordability', 0.1678372025489807)","('Business_Ethics', 0.16755245625972748)","('Employee_Health_And_Safety', 0.09577442705631256)","('NON-ESG', 0.1678372025489807)","('NON-ESG', 0.16755245625972748)","('NON-ESG', 0.09577442705631256)"
Line 1094,"As opportunities are identified we may expand the scope of this commitment in future years.
","('Business_Model_Resilience', 0.3575637638568878)","('Systemic_Risk_Management', 0.1950204074382782)","('Management_Of_Legal_And_Regulatory_Framework', 0.0624077171087265)","('NON-ESG', 0.3575637638568878)","('NON-ESG', 0.1950204074382782)","('NON-ESG', 0.0624077171087265)"
Line 1095,"This target is an aggregate percent reduction from FY20 to FY25.
","('GHG_Emissions', 0.1394914835691452)","('Business_Model_Resilience', 0.13789775967597961)","('Management_Of_Legal_And_Regulatory_Framework', 0.11311997473239899)","('NON-ESG', 0.1394914835691452)","('NON-ESG', 0.13789775967597961)","('NON-ESG', 0.11311997473239899)"
Line 1096,"Therefore, annual progress toward this target prior to FY25 does not represent achieving or missing the target.
","('GHG_Emissions', 0.18107245862483978)","('Business_Model_Resilience', 0.1560756117105484)","('Management_Of_Legal_And_Regulatory_Framework', 0.12582385540008545)","('NON-ESG', 0.18107245862483978)","('NON-ESG', 0.1560756117105484)","('NON-ESG', 0.12582385540008545)"
Line 1097,"2022 Integrated Performance Report       77 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexData privacy  and securitySOCIAL IMPACT 2022 Integrated Performance Report       78 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index Adding business value By investing in information security, product security, and data privacy,   we comply with regulations, build investor confidence, retain customer  trust, and respect patients.Today, more patients and providers are turning to connected  devices than ever before.
","('Data_Security', 0.6099071502685547)","('Management_Of_Legal_And_Regulatory_Framework', 0.08865103125572205)","('Business_Ethics', 0.06428313255310059)","(['Information Security/Cybersecurity & System Availability'], 0.6099071502685547)","('NON-ESG', 0.08865103125572205)","('NON-ESG', 0.06428313255310059)"
Line 1098,"2022 Integrated Performance Report       77 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexData privacy  and securitySOCIAL IMPACT 2022 Integrated Performance Report       78 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index Adding business value By investing in information security, product security, and data privacy,   we comply with regulations, build investor confidence, retain customer  trust, and respect patients.Today, more patients and providers are turning to connected  devices than ever before.
","('Competitive_Behavior', 0.16515250504016876)","('Customer_Privacy', 0.11255970597267151)","('Business_Ethics', 0.11155984550714493)","('NON-ESG', 0.16515250504016876)","('NON-ESG', 0.11255970597267151)","('NON-ESG', 0.11155984550714493)"
Line 1099,"And we’ve seen an unprecedented volume and scale of ransomware attacks and vulnerability disclosures across many sectors over the past year.
","('Data_Security', 0.9521116018295288)","('Systemic_Risk_Management', 0.007285615894943476)","('Physical_Impacts_Of_Climate_Change', 0.003951384220272303)","(['Information Security/Cybersecurity & System Availability'], 0.9521116018295288)","('NON-ESG', 0.007285615894943476)","('NON-ESG', 0.003951384220272303)"
Line 1100,"It’s critically important that we safeguard information, assets, and systems  in the ever-evolving data and cybersecurity landscape.
","('Data_Security', 0.9570268988609314)","('Systemic_Risk_Management', 0.00468042679131031)","('Customer_Privacy', 0.004444437567144632)","(['Information Security/Cybersecurity & System Availability'], 0.9570268988609314)","('NON-ESG', 0.00468042679131031)","('NON-ESG', 0.004444437567144632)"
Line 1101,"Our programs are designed to protect data and systems,  comply with global regulations, and maintain the safety and privacy of the patients who use our products.Privacy and security approach Our Global Cybersecurity program operates under  strong governance, risk, and compliance processes that are aligned with the National Institute of Standards and Technology Cybersecurity Framework (NIST), the ISO/IEC 27001 standard, and other relevant international security standards.
","('Data_Security', 0.9586194157600403)","('Customer_Privacy', 0.008077944628894329)","('Business_Ethics', 0.0037127758841961622)","(['Information Security/Cybersecurity & System Availability'], 0.9586194157600403)","('NON-ESG', 0.008077944628894329)","('NON-ESG', 0.0037127758841961622)"
Line 1102,"The Audit Committee of the Medtronic board of directors has oversight of cybersecurity risk within our organization and our companywide security policies, standards, and procedures ensure consistency across our organization.
","('Data_Security', 0.922463059425354)","('Business_Ethics', 0.016780773177742958)","('Systemic_Risk_Management', 0.011205703020095825)","(['Information Security/Cybersecurity & System Availability'], 0.922463059425354)","('NON-ESG', 0.016780773177742958)","('NON-ESG', 0.011205703020095825)"
Line 1103,"We continuously scan our operational environment for cyber risks and vulnerabilities, and we also assess the risks of third-party partners, projects, and initiatives.
","('Data_Security', 0.5296652317047119)","('Systemic_Risk_Management', 0.34048306941986084)","('Physical_Impacts_Of_Climate_Change', 0.014675743877887726)","(['Information Security/Cybersecurity & System Availability'], 0.5296652317047119)","('NON-ESG', 0.34048306941986084)","('NON-ESG', 0.014675743877887726)"
Line 1104,"We secure information, including intellectual property and personal data, with a suite of physical, technical, and administrative controls.
","('Customer_Privacy', 0.9179055094718933)","('Data_Security', 0.03685185685753822)","('Waste_And_Hazardous_Materials_Management', 0.004103755112737417)","(['Privacy Protection'], 0.9179055094718933)","('NON-ESG', 0.03685185685753822)","('NON-ESG', 0.004103755112737417)"
Line 1105,"To advance data security practices, we collaborate with  third-party organizations such as the Health Information Sharing and Analysis Center (H-ISAC), AdvaMed, and the European Union Agency for Cybersecurity.
","('Data_Security', 0.9641065001487732)","('Customer_Privacy', 0.003392911981791258)","('Systemic_Risk_Management', 0.003299610922113061)","(['Information Security/Cybersecurity & System Availability'], 0.9641065001487732)","('NON-ESG', 0.003392911981791258)","('NON-ESG', 0.003299610922113061)"
Line 1106,"We also contribute to global product security and cybersecurity standards in collaboration with the U.S. FDA and other regulatory advocacy groups.
","('Data_Security', 0.7967370748519897)","('Management_Of_Legal_And_Regulatory_Framework', 0.04069548100233078)","('Business_Ethics', 0.03252572566270828)","(['Information Security/Cybersecurity & System Availability'], 0.7967370748519897)","('NON-ESG', 0.04069548100233078)","('NON-ESG', 0.03252572566270828)"
Line 1107,"We have processes in place for coordinated disclosure of potential security vulnerabilities when they are identified by third parties, and for notification or other remediation regarding vulnerabilities when necessary.
","('Data_Security', 0.9166907072067261)","('Systemic_Risk_Management', 0.0186553243547678)","('Business_Ethics', 0.006731180939823389)","(['Information Security/Cybersecurity & System Availability'], 0.9166907072067261)","('NON-ESG', 0.0186553243547678)","('NON-ESG', 0.006731180939823389)"
Line 1108,"Our data privacy policies, standards, and procedures  define our principles and approach for stewardship of personal data.
","('Customer_Privacy', 0.9124745726585388)","('Data_Security', 0.0396462008357048)","('Waste_And_Hazardous_Materials_Management', 0.003779273247346282)","(['Privacy Protection'], 0.9124745726585388)","('NON-ESG', 0.0396462008357048)","('NON-ESG', 0.003779273247346282)"
Line 1109,"They are aligned to common and evolving privacy principles derived from privacy laws such as HIPAA and the E.U. General Data Protection Regulation (GDPR).
","('Data_Security', 0.8853319883346558)","('Customer_Privacy', 0.04250796139240265)","('Systemic_Risk_Management', 0.0058199577033519745)","(['Information Security/Cybersecurity & System Availability'], 0.8853319883346558)","('NON-ESG', 0.04250796139240265)","('NON-ESG', 0.0058199577033519745)"
Line 1110,"This approach provides a high level of data protection for our patients, participants in clinical trials, customers, employees, vendors, and partners.
","('Competitive_Behavior', 0.2415630966424942)","('Customer_Privacy', 0.15162163972854614)","('Data_Security', 0.09541720896959305)","('NON-ESG', 0.2415630966424942)","('NON-ESG', 0.15162163972854614)","('NON-ESG', 0.09541720896959305)"
Line 1111,"We also meet local data privacy requirements where those are stricter than our Medtronic-wide standards.
","('Data_Security', 0.5604879260063171)","('Customer_Privacy', 0.33138418197631836)","('Business_Ethics', 0.009810379706323147)","(['Information Security/Cybersecurity & System Availability'], 0.5604879260063171)","('NON-ESG', 0.33138418197631836)","('NON-ESG', 0.009810379706323147)"
Line 1112,"As with any company, Medtronic employees and  contingent workers play a crucial role in safeguarding data.
","('Data_Security', 0.2887727916240692)","('Customer_Privacy', 0.20218321681022644)","('Employee_Health_And_Safety', 0.11740610003471375)","('NON-ESG', 0.2887727916240692)","('NON-ESG', 0.20218321681022644)","('NON-ESG', 0.11740610003471375)"
Line 1113,"We train all employees and contingent workers on security and privacy so they understand how to identify, protect, and preserve sensitive data and prevent cyber intrusions.
","('Data_Security', 0.9630786776542664)","('Customer_Privacy', 0.0039013444911688566)","('Director_Removal', 0.0028954835142940283)","(['Information Security/Cybersecurity & System Availability'], 0.9630786776542664)","('NON-ESG', 0.0039013444911688566)","('NON-ESG', 0.0028954835142940283)"
Line 1114,"We continue to expand and improve our global training programs to raise employee awareness of privacy and security obligations.
","('Data_Security', 0.945451021194458)","('Customer_Privacy', 0.013971107080578804)","('Business_Ethics', 0.0037394363898783922)","(['Information Security/Cybersecurity & System Availability'], 0.945451021194458)","('NON-ESG', 0.013971107080578804)","('NON-ESG', 0.0037394363898783922)"
Line 1115,"Our annual training includes: •  A wareness around International Privacy Day.
","('Data_Security', 0.8495028614997864)","('Customer_Privacy', 0.05704803392291069)","('Business_Ethics', 0.016208190470933914)","(['Information Security/Cybersecurity & System Availability'], 0.8495028614997864)","('NON-ESG', 0.05704803392291069)","('NON-ESG', 0.016208190470933914)"
Line 1116,"•   P rivacy and security training for global employees and  contingent workers.
","('Labor_Practices', 0.5029796957969666)","('Employee_Health_And_Safety', 0.3392241597175598)","('Employee_Engagement_Inclusion_And_Diversity', 0.030916819348931313)","(['Labor Practice Indicators'], 0.5029796957969666)","('NON-ESG', 0.3392241597175598)","('NON-ESG', 0.030916819348931313)"
Line 1117,"•   U .S.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2931046485900879)","('GHG_Emissions', 0.1579560786485672)","('Competitive_Behavior', 0.0635477602481842)","('NON-ESG', 0.2931046485900879)","('NON-ESG', 0.1579560786485672)","('NON-ESG', 0.0635477602481842)"
Line 1118,"privacy law training for U.S. employees,   including supplemental California Consumer Privacy  Act training.
","('Data_Security', 0.2343749850988388)","('Customer_Privacy', 0.1976732462644577)","('Management_Of_Legal_And_Regulatory_Framework', 0.12662819027900696)","('NON-ESG', 0.2343749850988388)","('NON-ESG', 0.1976732462644577)","('NON-ESG', 0.12662819027900696)"
Line 1119,"•   Gener al Data Protection Regulation training for select  global corporate employees, as well as noncorporate E.U. employees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.22365446388721466)","('Management_Of_Legal_And_Regulatory_Framework', 0.2062772512435913)","('Business_Ethics', 0.1208229511976242)","('NON-ESG', 0.22365446388721466)","('NON-ESG', 0.2062772512435913)","('NON-ESG', 0.1208229511976242)"
Line 1120,"•   China privacy law tr aining for Medtronic employees in  China.
","('Data_Security', 0.7507490515708923)","('Business_Ethics', 0.06580522656440735)","('Customer_Privacy', 0.04141295701265335)","(['Information Security/Cybersecurity & System Availability'], 0.7507490515708923)","('NON-ESG', 0.06580522656440735)","('NON-ESG', 0.04141295701265335)"
Line 1121,"•   R egion-specific privacy training for Medtronic  employees in Latin America.
","('Data_Security', 0.917059063911438)","('Customer_Privacy', 0.016920754685997963)","('Business_Ethics', 0.010385056957602501)","(['Information Security/Cybersecurity & System Availability'], 0.917059063911438)","('NON-ESG', 0.016920754685997963)","('NON-ESG', 0.010385056957602501)"
Line 1122,"•   P rivacy by Design training for employees in key global  functions, such as Legal and IT, as well as the vast majority of E.U. employees.Additionally, we expect our vendors to adhere to our data privacy and security standards, and we evaluate these risks as part of our vendor assessment process.
","('Data_Security', 0.9591166973114014)","('Customer_Privacy', 0.005465215537697077)","('Business_Ethics', 0.003384422045201063)","(['Information Security/Cybersecurity & System Availability'], 0.9591166973114014)","('NON-ESG', 0.005465215537697077)","('NON-ESG', 0.003384422045201063)"
Line 1123,"When we acquire a company, we conduct privacy and security due diligence and implement an integration plan that includes training as well as policy and procedure standardization.
","('Data_Security', 0.947491466999054)","('Customer_Privacy', 0.012118322774767876)","('Director_Removal', 0.003591538406908512)","(['Information Security/Cybersecurity & System Availability'], 0.947491466999054)","('NON-ESG', 0.012118322774767876)","('NON-ESG', 0.003591538406908512)"
Line 1124,"With regard to data breach reporting, Medtronic   adheres to state, federal, and, where applicable, international data breach notification requirements.
","('Data_Security', 0.9432535767555237)","('Systemic_Risk_Management', 0.007250424474477768)","('Business_Ethics', 0.006755686830729246)","(['Information Security/Cybersecurity & System Availability'], 0.9432535767555237)","('NON-ESG', 0.007250424474477768)","('NON-ESG', 0.006755686830729246)"
Line 1125,"As an example, in accordance with HIPAA-related data breach requirements, Medtronic self-reports incidents involving loss of, or inappropriate access to, patient information to the Office for Civil Rights of the U.S. Department of Health and Human Services.
","('Data_Security', 0.8463003635406494)","('Customer_Privacy', 0.07124044001102448)","('Business_Ethics', 0.012372394092381)","(['Information Security/Cybersecurity & System Availability'], 0.8463003635406494)","('NON-ESG', 0.07124044001102448)","('NON-ESG', 0.012372394092381)"
Line 1126,"Looking ahead, we are focused on reducing risks related  to data security, product security, and privacy by raising the ’data and security intelligence’ of employees and continuously improving: •   P rocesses and technology for threat detection and  response.
","('Data_Security', 0.9641715884208679)","('Customer_Privacy', 0.003927836660295725)","('Systemic_Risk_Management', 0.0026449193246662617)","(['Information Security/Cybersecurity & System Availability'], 0.9641715884208679)","('NON-ESG', 0.003927836660295725)","('NON-ESG', 0.0026449193246662617)"
Line 1127,"•   P rocesses and technology for privacy risk assessments  and data subject request execution.
","('Data_Security', 0.9325436949729919)","('Customer_Privacy', 0.02153758518397808)","('Systemic_Risk_Management', 0.0037977085448801517)","(['Information Security/Cybersecurity & System Availability'], 0.9325436949729919)","('NON-ESG', 0.02153758518397808)","('NON-ESG', 0.0037977085448801517)"
Line 1128,"•   Guidelines and tr aining on data security, product  security, and privacy.
","('Data_Security', 0.9325534105300903)","('Customer_Privacy', 0.01929621212184429)","('Business_Ethics', 0.004203274846076965)","(['Information Security/Cybersecurity & System Availability'], 0.9325534105300903)","('NON-ESG', 0.01929621212184429)","('NON-ESG', 0.004203274846076965)"
Line 1129,"For more information on product security, see   Patient safety and product quality.DATA PRIVACY AND SECURITY 2022 Integrated Performance Report       79 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index$13.5B spent with more than  63,800   partners across  130  countriesSupply chain  responsibilitySOCIAL IMPACT Adding business value In the past year, Medtronic  therapies improved the lives of  76 million people.
","('Product_Quality_And_Safety', 0.8303730487823486)","('Product_Design_And_Lifecycle_Management', 0.05573868006467819)","('Selling_Practices_And_Product_Labeling', 0.022747039794921875)","(['Product Quality & Recall Management'], 0.8303730487823486)","('NON-ESG', 0.05573868006467819)","('NON-ESG', 0.022747039794921875)"
Line 1130,"Responsibly managing our global supply  chain makes that possible.
","('Supply_Chain_Management', 0.9446030855178833)","('Product_Design_And_Lifecycle_Management', 0.0050484901294112206)","('Physical_Impacts_Of_Climate_Change', 0.004272601567208767)","(['Supply Chain Management'], 0.9446030855178833)","('NON-ESG', 0.0050484901294112206)","('NON-ESG', 0.004272601567208767)"
Line 1131,"By continuously improving our supply chain resiliency and engaging with a diverse pool  of innovative partners, we are better able to create and deliver high-quality, life-improving products and services while  also minimizing disruptions  and quality issues.Our ability to boldly tackle the most  challenging health problems facing humanity depends on a responsible, resilient supply chain.
","('Supply_Chain_Management', 0.8725391626358032)","('Product_Design_And_Lifecycle_Management', 0.041400570422410965)","('Business_Model_Resilience', 0.01715671643614769)","(['Supply Chain Management'], 0.8725391626358032)","('NON-ESG', 0.041400570422410965)","('NON-ESG', 0.01715671643614769)"
Line 1132,"By enforcing  strong policies, monitoring and mitigating risk, performing supplier due diligence, and disclosing and reporting appropriate matters, we ensure that our innovative technologies are manufactured and delivered responsibly and disruptions are managed effectively.
","('Supply_Chain_Management', 0.9473216533660889)","('Systemic_Risk_Management', 0.007495245896279812)","('Physical_Impacts_Of_Climate_Change', 0.0049763815477490425)","(['Supply Chain Management'], 0.9473216533660889)","('NON-ESG', 0.007495245896279812)","('NON-ESG', 0.0049763815477490425)"
Line 1133,"In addition to streamlining our supply chain operationally, we also reinforce human rights, environmental stewardship,  and ethical behavior.
","('Supply_Chain_Management', 0.9189506769180298)","('Labor_Practices', 0.010639390908181667)","('Human_Rights_And_Community_Relations', 0.00738930469378829)","(['Supply Chain Management'], 0.9189506769180298)","('NON-ESG', 0.010639390908181667)","('NON-ESG', 0.00738930469378829)"
Line 1134,"2022 Integrated Performance Report       80 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexSustainability and responsibility  As a global healthcare technology leader, we attract and  cultivate relationships with responsible, reliable suppliers who enable our delivery of high-quality products to customers and patients.
","('Product_Design_And_Lifecycle_Management', 0.9527240991592407)","('Supply_Chain_Management', 0.00647004833444953)","('Product_Quality_And_Safety', 0.005868907552212477)","(['Product Stewardship'], 0.9527240991592407)","('NON-ESG', 0.00647004833444953)","('NON-ESG', 0.005868907552212477)"
Line 1135,"We procure materials and services from more than 63,800 partners across 130 countries, spending more than $13.5 billion with suppliers globally in FY22.
","('Supply_Chain_Management', 0.6443677544593811)","('Product_Design_And_Lifecycle_Management', 0.17855267226696014)","('Energy_Management', 0.024038923904299736)","(['Supply Chain Management'], 0.6443677544593811)","('NON-ESG', 0.17855267226696014)","('NON-ESG', 0.024038923904299736)"
Line 1136,"Our long-standing commitment to sustainable and socially responsible supply management practices came to the forefront in the face of this year’s global challenges.
","('Supply_Chain_Management', 0.9406074285507202)","('Product_Design_And_Lifecycle_Management', 0.00956676620990038)","('Physical_Impacts_Of_Climate_Change', 0.005076802801340818)","(['Supply Chain Management'], 0.9406074285507202)","('NON-ESG', 0.00956676620990038)","('NON-ESG', 0.005076802801340818)"
Line 1137,"Our commitment to excellence and persistent work with suppliers allowed us to remain strong and manage disruption amid the ongoing pandemic; global raw material constraints in key commodities, including semiconductors, resins, and metals; labor and energy shortages; rising inflation; and the war in Ukraine.
","('Supply_Chain_Management', 0.9258292317390442)","('Systemic_Risk_Management', 0.011398150585591793)","('Labor_Practices', 0.008331870660185814)","(['Supply Chain Management'], 0.9258292317390442)","('NON-ESG', 0.011398150585591793)","('NON-ESG', 0.008331870660185814)"
Line 1138,"For years, our Global Supply Management team has  developed relationships with suppliers, instilling our high standards for excellence and good citizenship.
","('Supply_Chain_Management', 0.9158210754394531)","('Product_Design_And_Lifecycle_Management', 0.01741156168282032)","('Employee_Health_And_Safety', 0.006235064473003149)","(['Supply Chain Management'], 0.9158210754394531)","('NON-ESG', 0.01741156168282032)","('NON-ESG', 0.006235064473003149)"
Line 1139,"This team oversees our Responsible Supply Management program, which integrates responsible business practices into processes such as supplier selection and supplier performance management.
","('Supply_Chain_Management', 0.944053590297699)","('Product_Design_And_Lifecycle_Management', 0.0059007564559578896)","('Labor_Practices', 0.005727806594222784)","(['Supply Chain Management'], 0.944053590297699)","('NON-ESG', 0.0059007564559578896)","('NON-ESG', 0.005727806594222784)"
Line 1140,"Our suppliers understand that Medtronic expects them  to respect human rights, labor standards, business ethics, and the environment.
","('Labor_Practices', 0.8400706052780151)","('Human_Rights_And_Community_Relations', 0.036539170891046524)","('Business_Ethics', 0.034635990858078)","(['Labor Practice Indicators'], 0.8400706052780151)","('NON-ESG', 0.036539170891046524)","('NON-ESG', 0.034635990858078)"
Line 1141,"Formal company policies are foundational to their understanding; they include: •   Global Supplier S tandards — describes the minimum  social, ethical, and environmental requirements and  expectations for our suppliers.
","('Supply_Chain_Management', 0.901175856590271)","('Labor_Practices', 0.018707389011979103)","('Human_Rights_And_Community_Relations', 0.007480677682906389)","(['Supply Chain Management'], 0.901175856590271)","('NON-ESG', 0.018707389011979103)","('NON-ESG', 0.007480677682906389)"
Line 1142,"•   Global Human Rights and Labor S tandards Policy  — guides how we should conduct business to demonstrate respect for internationally recognized human rights and the dignity of all people.•  Global Anti-Human Trafficking and Forced  Labor Policy — outlines our commitment to a work environment free from human trafficking, slavery, unlawful child labor, and forced labor of any kind.
","('Labor_Practices', 0.9162604212760925)","('Human_Rights_And_Community_Relations', 0.023056941106915474)","('Employee_Health_And_Safety', 0.008696225471794605)","(['Labor Practice Indicators'], 0.9162604212760925)","('NON-ESG', 0.023056941106915474)","('NON-ESG', 0.008696225471794605)"
Line 1143,"•   C ode of Conduct — states our companywide standard  for behavior and applies to employees, officers, directors, and anyone conducting business on our behalf, including contractors, consultants,  and distributors.
","('Business_Ethics', 0.32613927125930786)","('Director_Removal', 0.27441027760505676)","('Labor_Practices', 0.1176348552107811)","('NON-ESG', 0.32613927125930786)","('NON-ESG', 0.27441027760505676)","('NON-ESG', 0.1176348552107811)"
Line 1144,"Our Responsible Supply Management program aligns with international standards and guidelines, including those from the Organization for Economic Co-operation and Development and the United Nations Guiding Principles on Business and Human Rights.
","('Supply_Chain_Management', 0.8496007919311523)","('Human_Rights_And_Community_Relations', 0.028203440830111504)","('Access_And_Affordability', 0.01007904950529337)","(['Supply Chain Management'], 0.8496007919311523)","('NON-ESG', 0.028203440830111504)","('NON-ESG', 0.01007904950529337)"
Line 1145,"Training and collaboration To ensure a responsible supply chain, we provide comprehensive Responsible Supply Management training for employees in our procurement, sourcing, and supplier quality groups.
","('Supply_Chain_Management', 0.9457213282585144)","('Product_Design_And_Lifecycle_Management', 0.004967837128788233)","('Labor_Practices', 0.004814857617020607)","(['Supply Chain Management'], 0.9457213282585144)","('NON-ESG', 0.004967837128788233)","('NON-ESG', 0.004814857617020607)"
Line 1146,"Trainings focus on environmental and social topics such as greenhouse  gas (GHG) emissions, labor conditions, human rights, human trafficking, and modern slavery.
","('Human_Rights_And_Community_Relations', 0.4804544150829315)","('Labor_Practices', 0.18450385332107544)","('GHG_Emissions', 0.06747318059206009)","('NON-ESG', 0.4804544150829315)","('NON-ESG', 0.18450385332107544)","('NON-ESG', 0.06747318059206009)"
Line 1147,"In FY22, more than 300 employees participated in our Responsible Supply Management training program, bringing the  total number of employees trained since FY21 to  more than 1,300.
","('Supply_Chain_Management', 0.4990260601043701)","('Labor_Practices', 0.2570803165435791)","('Employee_Health_And_Safety', 0.050902873277664185)","('NON-ESG', 0.4990260601043701)","('NON-ESG', 0.2570803165435791)","('NON-ESG', 0.050902873277664185)"
Line 1148,"We expect suppliers to implement their own human  rights and labor standards and also comply with our Global Supplier Standards, which are included in supplier agreements and purchase order terms and conditions.
","('Labor_Practices', 0.9440624117851257)","('Supply_Chain_Management', 0.010136084631085396)","('Human_Rights_And_Community_Relations', 0.00575628038495779)","(['Labor Practice Indicators'], 0.9440624117851257)","('NON-ESG', 0.010136084631085396)","('NON-ESG', 0.00575628038495779)"
Line 1149,"All new suppliers must agree to these standards before working with us.SUPPLY CHAIN RESPONSIBILITY SUPPLY CHAIN SPEND†  ($ million) FY20 FY21 FYAustralia $67.3 $54.1 $63.Canada $126.8 $118.9 $121.0  China $465.7 $596.5 $556.France $188.0 $204.7 $171.Germany $285.5 $270.7 $290.Ireland $272.9 $408.2 $328.Israel $65.9 $133.9 $185.4  Japan $176.7 $178.8 $231.Mexico $156.2 $191.1 $187.3  Netherlands $252.8 $266.2 $279.9  Singapore $122.2 $176.0 $161.5  Switzerland $251.5 $114.3 $113.2  United States $8,754.8 $8,040.4 $8,863.0  Total for locations listed $11,186.3 $10,753.8 $11,552.3  Total spend $12,835.6 $12,536.9 $13,527.6  † Totals may not add up due to rounding.
","('Supply_Chain_Management', 0.9441192150115967)","('Labor_Practices', 0.0054795630276203156)","('Physical_Impacts_Of_Climate_Change', 0.004240778274834156)","(['Supply Chain Management'], 0.9441192150115967)","('NON-ESG', 0.0054795630276203156)","('NON-ESG', 0.004240778274834156)"
Line 1150,"All new suppliers must agree to these standards before working with us.SUPPLY CHAIN RESPONSIBILITY SUPPLY CHAIN SPEND†  ($ million) FY20 FY21 FYAustralia $67.3 $54.1 $63.Canada $126.8 $118.9 $121.0  China $465.7 $596.5 $556.France $188.0 $204.7 $171.Germany $285.5 $270.7 $290.Ireland $272.9 $408.2 $328.Israel $65.9 $133.9 $185.4  Japan $176.7 $178.8 $231.Mexico $156.2 $191.1 $187.3  Netherlands $252.8 $266.2 $279.9  Singapore $122.2 $176.0 $161.5  Switzerland $251.5 $114.3 $113.2  United States $8,754.8 $8,040.4 $8,863.0  Total for locations listed $11,186.3 $10,753.8 $11,552.3  Total spend $12,835.6 $12,536.9 $13,527.6  † Totals may not add up due to rounding.
","('Systemic_Risk_Management', 0.2216745913028717)","('Management_Of_Legal_And_Regulatory_Framework', 0.21680906414985657)","('Competitive_Behavior', 0.08083644509315491)","('NON-ESG', 0.2216745913028717)","('NON-ESG', 0.21680906414985657)","('NON-ESG', 0.08083644509315491)"
Line 1151,"2022 Integrated Performance Report       81 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexSuppliers that do not fully comply with our Global  Supplier Standards must undergo additional training.
","('Supply_Chain_Management', 0.8655216097831726)","('Product_Design_And_Lifecycle_Management', 0.023109296336770058)","('Product_Quality_And_Safety', 0.014946850948035717)","(['Supply Chain Management'], 0.8655216097831726)","('NON-ESG', 0.023109296336770058)","('NON-ESG', 0.014946850948035717)"
Line 1152,"During FY22, we held 26 one-on-one training  sessions on our standards and expectations.
","('Product_Quality_And_Safety', 0.33623260259628296)","('Management_Of_Legal_And_Regulatory_Framework', 0.19065149128437042)","('Business_Ethics', 0.0985431894659996)","('NON-ESG', 0.33623260259628296)","('NON-ESG', 0.19065149128437042)","('NON-ESG', 0.0985431894659996)"
Line 1153,"These suppliers also received sample policies to integrate  into their operations.
","('Supply_Chain_Management', 0.9092883467674255)","('Product_Design_And_Lifecycle_Management', 0.010818587616086006)","('Labor_Practices', 0.008219907060265541)","(['Supply Chain Management'], 0.9092883467674255)","('NON-ESG', 0.010818587616086006)","('NON-ESG', 0.008219907060265541)"
Line 1154,"To enhance supplier environmental sustainability, in  FY22, we joined CDP Supply Chain, a consortium of global companies working to help 40,000 suppliers quantify their GHG emissions and other components of their environmental footprint.
","('Supply_Chain_Management', 0.6774311065673828)","('GHG_Emissions', 0.16946102678775787)","('Physical_Impacts_Of_Climate_Change', 0.022335706278681755)","(['Supply Chain Management'], 0.6774311065673828)","('NON-ESG', 0.16946102678775787)","('NON-ESG', 0.022335706278681755)"
Line 1155,"Our Responsible Supply Management and Environmental, Health, and Safety functions collaborate in the CDP Supply Chain membership, which will help us better understand our Scope 3 emissions and inform the development of science-based targets.
","('Supply_Chain_Management', 0.9436901211738586)","('Product_Design_And_Lifecycle_Management', 0.004884975031018257)","('Waste_And_Hazardous_Materials_Management', 0.004528941120952368)","(['Supply Chain Management'], 0.9436901211738586)","('NON-ESG', 0.004884975031018257)","('NON-ESG', 0.004528941120952368)"
Line 1156,"This membership will also  help our suppliers identify climate risks and reduce  their environmental impact.
","('Physical_Impacts_Of_Climate_Change', 0.8348273038864136)","('Supply_Chain_Management', 0.06316285580396652)","('Business_Model_Resilience', 0.020391684025526047)","(['Climate Change'], 0.8348273038864136)","('NON-ESG', 0.06316285580396652)","('NON-ESG', 0.020391684025526047)"
Line 1157,"We launched our CDP Supply Chain training program in FY22 and invited  101 suppliers to participate in the first year.
","('Supply_Chain_Management', 0.9522637128829956)","('Physical_Impacts_Of_Climate_Change', 0.003991228528320789)","('Labor_Practices', 0.0039405860006809235)","(['Supply Chain Management'], 0.9522637128829956)","('NON-ESG', 0.003991228528320789)","('NON-ESG', 0.0039405860006809235)"
Line 1158,"As part of  the launch, we provided training to 46 suppliers and  21 category managers.
","('Supply_Chain_Management', 0.8415628671646118)","('Product_Design_And_Lifecycle_Management', 0.026301762089133263)","('Labor_Practices', 0.016038669273257256)","(['Supply Chain Management'], 0.8415628671646118)","('NON-ESG', 0.026301762089133263)","('NON-ESG', 0.016038669273257256)"
Line 1159,"Learn more about our work  with CDP in Reducing our environmental footprint.
","('Ecological_Impacts', 0.30318573117256165)","('Physical_Impacts_Of_Climate_Change', 0.12553702294826508)","('Business_Model_Resilience', 0.11899587512016296)","('NON-ESG', 0.30318573117256165)","('NON-ESG', 0.12553702294826508)","('NON-ESG', 0.11899587512016296)"
Line 1160,"We collaborate with peers on issues that affect our  industry, which in turn help us learn and benchmark our progress.
","('Systemic_Risk_Management', 0.28024327754974365)","('Competitive_Behavior', 0.15499460697174072)","('Business_Model_Resilience', 0.11622492223978043)","('NON-ESG', 0.28024327754974365)","('NON-ESG', 0.15499460697174072)","('NON-ESG', 0.11622492223978043)"
Line 1161,"Our collaboration in FY22 included engagements with the Sustainable Purchasing Leadership Council and the Conference Board’s Responsible Sourcing Council.
","('Product_Design_And_Lifecycle_Management', 0.6943455338478088)","('Supply_Chain_Management', 0.1331094205379486)","('Customer_Welfare', 0.03730366379022598)","(['Product Stewardship'], 0.6943455338478088)","('NON-ESG', 0.1331094205379486)","('NON-ESG', 0.03730366379022598)"
Line 1162,"We also participated in MedTech Europe working groups to discuss emerging human rights and environmental due-diligence laws.Monitoring compliance and  performance Setting strong standards is a good start, but   meaningful monitoring and enforcement is necessary  for our approach to be effective.
","('Human_Rights_And_Community_Relations', 0.7971653938293457)","('Management_Of_Legal_And_Regulatory_Framework', 0.08105171471834183)","('Labor_Practices', 0.0151057755574584)","(['Community Relations'], 0.7971653938293457)","('NON-ESG', 0.08105171471834183)","('NON-ESG', 0.0151057755574584)"
Line 1163,"Our Supplier Sustainability Assessment program monitors suppliers’ compliance and performance against our standards, prioritizing suppliers where we have the highest spend and those deemed to be highest risk.
","('Supply_Chain_Management', 0.931505560874939)","('Labor_Practices', 0.006745393853634596)","('Product_Design_And_Lifecycle_Management', 0.00556138763204217)","(['Supply Chain Management'], 0.931505560874939)","('NON-ESG', 0.006745393853634596)","('NON-ESG', 0.00556138763204217)"
Line 1164,"To ensure suppliers’ participation, we expanded this program in FY22 to involve our category managers in the assessment process.
","('Supply_Chain_Management', 0.9129060506820679)","('Product_Design_And_Lifecycle_Management', 0.00828259252011776)","('GHG_Emissions', 0.00657400768250227)","(['Supply Chain Management'], 0.9129060506820679)","('NON-ESG', 0.00828259252011776)","('NON-ESG', 0.00657400768250227)"
Line 1165,"In FY21, we set a FY1 target to assess the sustainability  performance of suppliers representing at least 80%  of our annual managed spend.
","('Supply_Chain_Management', 0.9181504249572754)","('Product_Design_And_Lifecycle_Management', 0.01637507602572441)","('Business_Model_Resilience', 0.005853345151990652)","(['Supply Chain Management'], 0.9181504249572754)","('NON-ESG', 0.01637507602572441)","('NON-ESG', 0.005853345151990652)"
Line 1166,"In FY22, we exceeded previous years by completing sustainability assessments of 186 suppliers.
","('Supply_Chain_Management', 0.8488048315048218)","('Product_Design_And_Lifecycle_Management', 0.03262580558657646)","('Business_Model_Resilience', 0.012780215591192245)","(['Supply Chain Management'], 0.8488048315048218)","('NON-ESG', 0.03262580558657646)","('NON-ESG', 0.012780215591192245)"
Line 1167,"This brings our total assessments of suppliers to 66% of our annual managed spend, keeping us on track to achieve our FY26 goal.
","('Supply_Chain_Management', 0.9171659350395203)","('Product_Design_And_Lifecycle_Management', 0.007601382210850716)","('Energy_Management', 0.00718504935503006)","(['Supply Chain Management'], 0.9171659350395203)","('NON-ESG', 0.007601382210850716)","('NON-ESG', 0.00718504935503006)"
Line 1168,"Using self-assessment surveys and on-site audits,  we determine supplier risk in four areas: labor and human rights; environment; ethics; and sustainable procurement.
","('Labor_Practices', 0.6743394136428833)","('Supply_Chain_Management', 0.13630229234695435)","('Human_Rights_And_Community_Relations', 0.03429717198014259)","(['Labor Practice Indicators'], 0.6743394136428833)","('NON-ESG', 0.13630229234695435)","('NON-ESG', 0.03429717198014259)"
Line 1169,"Our risk determination dictates the frequency of a supplier’s self-assessment.
","('Supply_Chain_Management', 0.9387959241867065)","('Systemic_Risk_Management', 0.00821277778595686)","('Labor_Practices', 0.005267513450235128)","(['Supply Chain Management'], 0.9387959241867065)","('NON-ESG', 0.00821277778595686)","('NON-ESG', 0.005267513450235128)"
Line 1170,"Low-risk suppliers complete assessments every three years,  while medium- and high-risk suppliers complete assessments every two years and annually, respectively.
","('Supply_Chain_Management', 0.9348836541175842)","('Product_Design_And_Lifecycle_Management', 0.0063929143361747265)","('Systemic_Risk_Management', 0.005796424113214016)","(['Supply Chain Management'], 0.9348836541175842)","('NON-ESG', 0.0063929143361747265)","('NON-ESG', 0.005796424113214016)"
Line 1171,"We issue corrective action requests to all suppliers identified as a medium- or high-risk, and we expect them to promptly address high-priority incidents of noncompliance.
","('Supply_Chain_Management', 0.9323487877845764)","('Systemic_Risk_Management', 0.006589647848159075)","('Physical_Impacts_Of_Climate_Change', 0.0061157080344855785)","(['Supply Chain Management'], 0.9323487877845764)","('NON-ESG', 0.006589647848159075)","('NON-ESG', 0.0061157080344855785)"
Line 1172,"We also conduct on-site workplace conditions inspections and audit the business practices of the majority of high-risk suppliers.SUPPLY CHAIN RESPONSIBILITY 1  Managed spend, also known as addressable spend, is the spend that Medtronic  actively manages through a category management process.2  The risk score yielded by the algorithm is used to identify suppliers that require escalation to other sustainability programs.RESPONSIBLE SUPPLY MANAGEMENT FROM THE BOTTOM UPNUMBER OF SUPPLIERS COMPLETING SELF-ASSESSMENTS FY20 FY21 FY170 128 2022 Integrated Performance Report       82 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index Audits Highest-risk  suppliers are subject   to on-site workplace   conditions audits Sustainability   performance score Third-party assessment of Medtronic’s  highest-risk and highest-spend suppliers Supplier risk mapping An algorithm produces inherent risk score  across all of Medtronic’s Tier 1 suppliers2In FY22, we piloted a new Supplier Risk Mapping tool  to analyze suppliers for risks related to their geographic location and industry, taking into consideration the amount we spend with them annually.
","('Supply_Chain_Management', 0.9502382278442383)","('Labor_Practices', 0.005889279302209616)","('Waste_And_Hazardous_Materials_Management', 0.003694344311952591)","(['Supply Chain Management'], 0.9502382278442383)","('NON-ESG', 0.005889279302209616)","('NON-ESG', 0.003694344311952591)"
Line 1173,"We also conduct on-site workplace conditions inspections and audit the business practices of the majority of high-risk suppliers.SUPPLY CHAIN RESPONSIBILITY 1  Managed spend, also known as addressable spend, is the spend that Medtronic  actively manages through a category management process.2  The risk score yielded by the algorithm is used to identify suppliers that require escalation to other sustainability programs.RESPONSIBLE SUPPLY MANAGEMENT FROM THE BOTTOM UPNUMBER OF SUPPLIERS COMPLETING SELF-ASSESSMENTS FY20 FY21 FY170 128 2022 Integrated Performance Report       82 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index Audits Highest-risk  suppliers are subject   to on-site workplace   conditions audits Sustainability   performance score Third-party assessment of Medtronic’s  highest-risk and highest-spend suppliers Supplier risk mapping An algorithm produces inherent risk score  across all of Medtronic’s Tier 1 suppliers2In FY22, we piloted a new Supplier Risk Mapping tool  to analyze suppliers for risks related to their geographic location and industry, taking into consideration the amount we spend with them annually.
","('Supply_Chain_Management', 0.948538601398468)","('Systemic_Risk_Management', 0.005452284123748541)","('Labor_Practices', 0.004957080353051424)","(['Supply Chain Management'], 0.948538601398468)","('NON-ESG', 0.005452284123748541)","('NON-ESG', 0.004957080353051424)"
Line 1174,"We also conduct on-site workplace conditions inspections and audit the business practices of the majority of high-risk suppliers.SUPPLY CHAIN RESPONSIBILITY 1  Managed spend, also known as addressable spend, is the spend that Medtronic  actively manages through a category management process.2  The risk score yielded by the algorithm is used to identify suppliers that require escalation to other sustainability programs.RESPONSIBLE SUPPLY MANAGEMENT FROM THE BOTTOM UPNUMBER OF SUPPLIERS COMPLETING SELF-ASSESSMENTS FY20 FY21 FY170 128 2022 Integrated Performance Report       82 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index Audits Highest-risk  suppliers are subject   to on-site workplace   conditions audits Sustainability   performance score Third-party assessment of Medtronic’s  highest-risk and highest-spend suppliers Supplier risk mapping An algorithm produces inherent risk score  across all of Medtronic’s Tier 1 suppliers2In FY22, we piloted a new Supplier Risk Mapping tool  to analyze suppliers for risks related to their geographic location and industry, taking into consideration the amount we spend with them annually.
","('Supply_Chain_Management', 0.9512635469436646)","('Labor_Practices', 0.004888162482529879)","('Physical_Impacts_Of_Climate_Change', 0.00377546064555645)","(['Supply Chain Management'], 0.9512635469436646)","('NON-ESG', 0.004888162482529879)","('NON-ESG', 0.00377546064555645)"
Line 1175,"This new tool incorporates a methodology for systematic analysis of all our Tier 1 suppliers and helps prioritize which suppliers should undergo third-party assessments and audits.
","('Supply_Chain_Management', 0.9405834078788757)","('Systemic_Risk_Management', 0.0050256522372365)","('Labor_Practices', 0.004967589862644672)","(['Supply Chain Management'], 0.9405834078788757)","('NON-ESG', 0.0050256522372365)","('NON-ESG', 0.004967589862644672)"
Line 1176,"During the pilot phase, we evaluated and assigned inherent risk scores to 6,000 of our Tier 1 suppliers.
","('Supply_Chain_Management', 0.9111790657043457)","('Water_And_Wastewater_Management', 0.011382066644728184)","('Waste_And_Hazardous_Materials_Management', 0.00900835357606411)","(['Supply Chain Management'], 0.9111790657043457)","('NON-ESG', 0.011382066644728184)","('NON-ESG', 0.00900835357606411)"
Line 1177,"Supplier audits In FY22, we worked with a third party to conduct on-site audits of six suppliers and three follow-up audits.
","('Supply_Chain_Management', 0.920328676700592)","('Labor_Practices', 0.01011645421385765)","('Systemic_Risk_Management', 0.0074286446906626225)","(['Supply Chain Management'], 0.920328676700592)","('NON-ESG', 0.01011645421385765)","('NON-ESG', 0.0074286446906626225)"
Line 1178,"Because COVID-19 limited the number of audits we could perform, we prioritized audits of suppliers that had received high-risk scores on their online assessment surveys.
","('Supply_Chain_Management', 0.8252175450325012)","('Systemic_Risk_Management', 0.056145764887332916)","('Business_Model_Resilience', 0.011681737378239632)","(['Supply Chain Management'], 0.8252175450325012)","('NON-ESG', 0.056145764887332916)","('NON-ESG', 0.011681737378239632)"
Line 1179,"The scope of these audits included labor, wages, and hours; health and safety; management systems; environment; and business practices.
","('Labor_Practices', 0.9519156217575073)","('Employee_Health_And_Safety', 0.015304366126656532)","('Director_Removal', 0.0025074768345803022)","(['Labor Practice Indicators'], 0.9519156217575073)","('NON-ESG', 0.015304366126656532)","('NON-ESG', 0.0025074768345803022)"
Line 1180,"For certain suppliers that received a high-risk score from  their online assessment, we accepted another third-party provider’s audit report as an alternative to our own to help reduce supplier auditing fatigue.
","('Supply_Chain_Management', 0.9302130341529846)","('Systemic_Risk_Management', 0.011995574459433556)","('Labor_Practices', 0.006432314869016409)","(['Supply Chain Management'], 0.9302130341529846)","('NON-ESG', 0.011995574459433556)","('NON-ESG', 0.006432314869016409)"
Line 1181,"We also encourage our suppliers to report publicly  on their environmental and social performance.
","('Supply_Chain_Management', 0.818714439868927)","('Human_Rights_And_Community_Relations', 0.02532472275197506)","('Product_Design_And_Lifecycle_Management', 0.01952574960887432)","(['Supply Chain Management'], 0.818714439868927)","('NON-ESG', 0.02532472275197506)","('NON-ESG', 0.01952574960887432)"
Line 1182,"Every two years, we assess the sustainability reporting of our top suppliers by spend.
","('Supply_Chain_Management', 0.9087950587272644)","('Product_Design_And_Lifecycle_Management', 0.020425278693437576)","('Physical_Impacts_Of_Climate_Change', 0.0063270702958106995)","(['Supply Chain Management'], 0.9087950587272644)","('NON-ESG', 0.020425278693437576)","('NON-ESG', 0.0063270702958106995)"
Line 1183,"In FY21, we assessed the top 200 suppliers and confirmed that 37% published sustainability reports, 8% had sustainability goals published online, and 26% had information relating to sustainability on their website.
","('Supply_Chain_Management', 0.40005233883857727)","('Product_Design_And_Lifecycle_Management', 0.29022279381752014)","('Product_Quality_And_Safety', 0.04660890996456146)","('NON-ESG', 0.40005233883857727)","('NON-ESG', 0.29022279381752014)","('NON-ESG', 0.04660890996456146)"
Line 1184,"In total, seven suppliers published inaugural sustainability reports, two suppliers shared new goals, and five suppliers shared new information on sustainability in the past year.Conflict minerals Some of our products contain tin, tungsten, tantalum, or gold.
","('Product_Design_And_Lifecycle_Management', 0.7664539217948914)","('Supply_Chain_Management', 0.10316906869411469)","('Customer_Welfare', 0.01640128716826439)","(['Product Stewardship'], 0.7664539217948914)","('NON-ESG', 0.10316906869411469)","('NON-ESG', 0.01640128716826439)"
Line 1185,"In the Democratic Republic of Congo and neighboring countries, mining and processing of these metals have been linked to funding armed conflict.
","('Supply_Chain_Management', 0.1881387084722519)","('Critical_Incident_Risk_Management', 0.17990265786647797)","('Human_Rights_And_Community_Relations', 0.1644282042980194)","('NON-ESG', 0.1881387084722519)","('NON-ESG', 0.17990265786647797)","('NON-ESG', 0.1644282042980194)"
Line 1186,"To promote the use of responsibly sourced minerals,  we continue to: •   Suppor t the U.S. Dodd-Frank Act, which   requires companies to disclose the use of any   such conflict minerals.
","('Supply_Chain_Management', 0.30318930745124817)","('Product_Design_And_Lifecycle_Management', 0.07478749006986618)","('Selling_Practices_And_Product_Labeling', 0.06797558814287186)","('NON-ESG', 0.30318930745124817)","('NON-ESG', 0.07478749006986618)","('NON-ESG', 0.06797558814287186)"
Line 1187,"•   R equire suppliers to comply with the law and   uphold responsible sourcing practices.
","('Supply_Chain_Management', 0.8392842411994934)","('Product_Design_And_Lifecycle_Management', 0.030484909191727638)","('Customer_Welfare', 0.014702802523970604)","(['Supply Chain Management'], 0.8392842411994934)","('NON-ESG', 0.030484909191727638)","('NON-ESG', 0.014702802523970604)"
Line 1188,"•   R eference conflict minerals in supplier agreements  and purchase orders.
","('Supply_Chain_Management', 0.8910329341888428)","('Labor_Practices', 0.016406625509262085)","('GHG_Emissions', 0.010047439485788345)","(['Supply Chain Management'], 0.8910329341888428)","('NON-ESG', 0.016406625509262085)","('NON-ESG', 0.010047439485788345)"
Line 1189,"•   P articipate as a member of the Responsible   Minerals Initiative.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5463440418243408)","('Human_Rights_And_Community_Relations', 0.04722726717591286)","('Supply_Chain_Management', 0.04485606774687767)","(['Corporate Governance'], 0.5463440418243408)","('NON-ESG', 0.04722726717591286)","('NON-ESG', 0.04485606774687767)"
Line 1190,"•   F ollow the Organization for Economic Cooperation  and Development (OECD) guidance on conflict minerals — including surveying suppliers to collect data on smelters in their supply chains.
","('Supply_Chain_Management', 0.9416802525520325)","('Labor_Practices', 0.006531175225973129)","('Water_And_Wastewater_Management', 0.004091782961040735)","(['Supply Chain Management'], 0.9416802525520325)","('NON-ESG', 0.006531175225973129)","('NON-ESG', 0.004091782961040735)"
Line 1191,"We report our supplier survey results to the U.S. Securities and Exchange Commission annually in a dedicated Conflict Minerals Report.
","('Supply_Chain_Management', 0.897808849811554)","('GHG_Emissions', 0.012361877597868443)","('Labor_Practices', 0.00852117408066988)","(['Supply Chain Management'], 0.897808849811554)","('NON-ESG', 0.012361877597868443)","('NON-ESG', 0.00852117408066988)"
Line 1192,"For calendar year (CY) 2021, 56 of our suppliers reported red-flag smelters or refineries in their supply chain, an increase of 125% compared with CY20.
","('Supply_Chain_Management', 0.9343043565750122)","('Labor_Practices', 0.007048309780657291)","('Energy_Management', 0.006268197204917669)","(['Supply Chain Management'], 0.9343043565750122)","('NON-ESG', 0.007048309780657291)","('NON-ESG', 0.006268197204917669)"
Line 1193,"This increase occurred because a single, large gold refiner was added to the red-flag category in CY21.
","('Competitive_Behavior', 0.2760604918003082)","('Energy_Management', 0.10854419320821762)","('Systemic_Risk_Management', 0.09739838540554047)","('NON-ESG', 0.2760604918003082)","('NON-ESG', 0.10854419320821762)","('NON-ESG', 0.09739838540554047)"
Line 1194,"In such instances, we request that the supplier work to eliminate red-flag smelters from their supply chain.
","('Supply_Chain_Management', 0.9345690608024597)","('Labor_Practices', 0.007310688961297274)","('Energy_Management', 0.005528458394110203)","(['Supply Chain Management'], 0.9345690608024597)","('NON-ESG', 0.007310688961297274)","('NON-ESG', 0.005528458394110203)"
Line 1195,"More information on our approach is available in our  Conflict Minerals Policy.SUPPLY CHAIN RESPONSIBILITY 2022 Integrated Performance Report       83 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexSupplier quality management Because suppliers are our essential partners, we clearly  communicate our quality expectations and specifications and provide support through our Supplier Quality Excellence Manual.
","('Supply_Chain_Management', 0.9319437146186829)","('Product_Design_And_Lifecycle_Management', 0.011465918272733688)","('Labor_Practices', 0.004864118993282318)","(['Supply Chain Management'], 0.9319437146186829)","('NON-ESG', 0.011465918272733688)","('NON-ESG', 0.004864118993282318)"
Line 1196,"In addition, we help suppliers meet our stringent  standards through: •   C ontinuous improvement programs, facilitated on-site  at supplier manufacturing locations.
","('Supply_Chain_Management', 0.7857401967048645)","('Product_Quality_And_Safety', 0.03205365687608719)","('Labor_Practices', 0.027413489297032356)","(['Supply Chain Management'], 0.7857401967048645)","('NON-ESG', 0.03205365687608719)","('NON-ESG', 0.027413489297032356)"
Line 1197,"•   C ollaboration with suppliers to improve the design,  reliability, and manufacturability of components  and products.
","('Product_Design_And_Lifecycle_Management', 0.9640465974807739)","('Product_Quality_And_Safety', 0.0034352377988398075)","('Supply_Chain_Management', 0.003262473735958338)","(['Product Stewardship'], 0.9640465974807739)","('NON-ESG', 0.0034352377988398075)","('NON-ESG', 0.003262473735958338)"
Line 1198,"Supplier diversity Our growing base of high-quality, diverse-owned suppliers strengthens our ability to deliver on our Mission to alleviate pain, restore health, and extend life.
","('Supply_Chain_Management', 0.8744823336601257)","('Labor_Practices', 0.015525023452937603)","('Employee_Health_And_Safety', 0.015114584006369114)","(['Supply Chain Management'], 0.8744823336601257)","('NON-ESG', 0.015525023452937603)","('NON-ESG', 0.015114584006369114)"
Line 1199,"We gain a competitive advantage through the different perspectives and innovations that diverse-owned suppliers provide.
","('Competitive_Behavior', 0.5474727749824524)","('Supply_Chain_Management', 0.23086175322532654)","('Customer_Welfare', 0.028652779757976532)","(['Business Ethics'], 0.5474727749824524)","('NON-ESG', 0.23086175322532654)","('NON-ESG', 0.028652779757976532)"
Line 1200,"Improving our supplier diversity performance also stimulates long-term economic benefits; creates jobs and opportunities for communities; and builds more innovative, resilient, and agile supply chains.
","('Supply_Chain_Management', 0.9405856132507324)","('Product_Design_And_Lifecycle_Management', 0.00789839681237936)","('Business_Model_Resilience', 0.006888667121529579)","(['Supply Chain Management'], 0.9405856132507324)","('NON-ESG', 0.00789839681237936)","('NON-ESG', 0.006888667121529579)"
Line 1201,"To further our commitment, in FY22 we stated our ambition to join the Billion Dollar Roundtable and have established a roadmap to achieve this goal.
","('Management_Of_Legal_And_Regulatory_Framework', 0.47038114070892334)","('Business_Model_Resilience', 0.17111551761627197)","('GHG_Emissions', 0.052431438118219376)","('NON-ESG', 0.47038114070892334)","('NON-ESG', 0.17111551761627197)","('NON-ESG', 0.052431438118219376)"
Line 1202,"Our Supplier Diversity program aligns with the  companywide approach to inclusion, diversity, and equity (ID&E) and Global Supply Management.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9247698783874512)","('Labor_Practices', 0.011359242722392082)","('Supply_Chain_Management', 0.007626041769981384)","(['Human Capital Development'], 0.9247698783874512)","('NON-ESG', 0.011359242722392082)","('NON-ESG', 0.007626041769981384)"
Line 1203,"Our VP , chief inclusion and diversity officer (CIDO) serves on the Supplier Diversity Steering Committee, which, together with our Supplier Diversity and Global Supply Management leaders, governs our Supplier Diversity program, strategy, and goals.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9575479030609131)","('Employee_Health_And_Safety', 0.004678122699260712)","('Labor_Practices', 0.003600998083129525)","(['Human Capital Development'], 0.9575479030609131)","('NON-ESG', 0.004678122699260712)","('NON-ESG', 0.003600998083129525)"
Line 1204,"The CIDO highlights our supplier diversity performance as part of the Quarterly Diversity Report to our CEO and executive leadership.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9701328873634338)","('Employee_Health_And_Safety', 0.00256369449198246)","('Human_Rights_And_Community_Relations', 0.002114047994837165)","(['Human Capital Development'], 0.9701328873634338)","('NON-ESG', 0.00256369449198246)","('NON-ESG', 0.002114047994837165)"
Line 1205,"In addition, our chief procurement officer leads visibility of the initiative within the Global Operations and  Supply Chain organization.
","('Supply_Chain_Management', 0.9483979940414429)","('Product_Design_And_Lifecycle_Management', 0.005859586410224438)","('Physical_Impacts_Of_Climate_Change', 0.003678813111037016)","(['Supply Chain Management'], 0.9483979940414429)","('NON-ESG', 0.005859586410224438)","('NON-ESG', 0.003678813111037016)"
Line 1206,"The Supplier Advisory Board (SAB), composed of our  strategic suppliers, is instrumental to the success of the Supplier Diversity program.
","('Supply_Chain_Management', 0.9174363017082214)","('Labor_Practices', 0.009867438115179539)","('Product_Design_And_Lifecycle_Management', 0.006111985072493553)","(['Supply Chain Management'], 0.9174363017082214)","('NON-ESG', 0.009867438115179539)","('NON-ESG', 0.006111985072493553)"
Line 1207,"The 12-member SAB includes two diverse-owned suppliers who, along with fellow members, inform our global sourcing strategy  and our approach to supplier partnerships.
","('Supply_Chain_Management', 0.9423325657844543)","('Product_Design_And_Lifecycle_Management', 0.006294885650277138)","('Labor_Practices', 0.004831535741686821)","(['Supply Chain Management'], 0.9423325657844543)","('NON-ESG', 0.006294885650277138)","('NON-ESG', 0.004831535741686821)"
Line 1208,"In FY22, we directed $830 million to companies owned  by people from diverse backgrounds.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9699386954307556)","('Human_Rights_And_Community_Relations', 0.0028938050381839275)","('Business_Model_Resilience', 0.0020969293545931578)","(['Human Capital Development'], 0.9699386954307556)","('NON-ESG', 0.0028938050381839275)","('NON-ESG', 0.0020969293545931578)"
Line 1209,"When combined with nondiverse small businesses, this figure reaches $2.7 billion, approximately 36% of our total U.S.  supplier spend.
","('Supply_Chain_Management', 0.9143287539482117)","('Product_Design_And_Lifecycle_Management', 0.011287787929177284)","('Energy_Management', 0.008115383796393871)","(['Supply Chain Management'], 0.9143287539482117)","('NON-ESG', 0.011287787929177284)","('NON-ESG', 0.008115383796393871)"
Line 1210,"Medtronic operating units drive our  performance and are expected to support diverse-owned businesses, which include those owned by women, people from ethnically diverse groups, people with disabilities, LGBTQ+ individuals, veterans, and those located in historically underutilized or disadvantaged business zones.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9744760990142822)","('Human_Rights_And_Community_Relations', 0.0021465588361024857)","('Employee_Health_And_Safety', 0.0017899117665365338)","(['Human Capital Development'], 0.9744760990142822)","('NON-ESG', 0.0021465588361024857)","('NON-ESG', 0.0017899117665365338)"
Line 1211,"In FY22, we surpassed our annual goals to increase  spending with diverse-owned suppliers by a minimum of 5% year over year, and to increase, year over year, the percentage of Medtronic requests for proposal that include a diverse-owned supplier, which ensures inclusion across the majority of sourcing events.
","('Supply_Chain_Management', 0.9279292821884155)","('Product_Design_And_Lifecycle_Management', 0.010386522859334946)","('Customer_Welfare', 0.005689860787242651)","(['Supply Chain Management'], 0.9279292821884155)","('NON-ESG', 0.010386522859334946)","('NON-ESG', 0.005689860787242651)"
Line 1212,"Through these strategies, in FY22, we increased spend with diverse-owned firms by 29% compared with  the previous year.
","('Competitive_Behavior', 0.3727300763130188)","('Employee_Engagement_Inclusion_And_Diversity', 0.11919620633125305)","('Systemic_Risk_Management', 0.10289417207241058)","('NON-ESG', 0.3727300763130188)","('NON-ESG', 0.11919620633125305)","('NON-ESG', 0.10289417207241058)"
Line 1213,"SUPPLY CHAIN RESPONSIBILITY $830M directed to companies owned by   people from diverse backgrounds in  FY22.
","('Supply_Chain_Management', 0.9007066488265991)","('Product_Design_And_Lifecycle_Management', 0.010763691738247871)","('Labor_Practices', 0.008375396020710468)","(['Supply Chain Management'], 0.9007066488265991)","('NON-ESG', 0.010763691738247871)","('NON-ESG', 0.008375396020710468)"
Line 1214,"When combined with nondiverse  small businesses, this figure reaches   $2.7 billion, approximately 36% of   our total U.S. supplier spend.
","('Supply_Chain_Management', 0.9143287539482117)","('Product_Design_And_Lifecycle_Management', 0.011287787929177284)","('Energy_Management', 0.008115383796393871)","(['Supply Chain Management'], 0.9143287539482117)","('NON-ESG', 0.011287787929177284)","('NON-ESG', 0.008115383796393871)"
Line 1215,"5th DiversityInc.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9434709548950195)","('Human_Rights_And_Community_Relations', 0.0052725886926054955)","('Business_Model_Resilience', 0.0041430434212088585)","(['Human Capital Development'], 0.9434709548950195)","('NON-ESG', 0.0052725886926054955)","('NON-ESG', 0.0041430434212088585)"
Line 1216,"ranked  Medtronic 5th on its list  of 2022 Top Companies  for Supplier Diversity  and 11th among the  overall 2022 Top  Companies for ESG.
","('Supply_Chain_Management', 0.8999935984611511)","('Product_Design_And_Lifecycle_Management', 0.0160369910299778)","('Labor_Practices', 0.009405586868524551)","(['Supply Chain Management'], 0.8999935984611511)","('NON-ESG', 0.0160369910299778)","('NON-ESG', 0.009405586868524551)"
Line 1217,"2022 Integrated Performance Report       84 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexBecause ID&E is essential to our ongoing innovation,  we work hard to increase supplier diversity globally.
","('Supply_Chain_Management', 0.7503014206886292)","('Employee_Engagement_Inclusion_And_Diversity', 0.05746182054281235)","('Business_Model_Resilience', 0.020869778469204903)","(['Supply Chain Management'], 0.7503014206886292)","('NON-ESG', 0.05746182054281235)","('NON-ESG', 0.020869778469204903)"
Line 1218,"We expanded our International Supplier Diversity program in FY21, with a focus on engaging women-owned businesses in Europe, the Middle East, Africa, and Latin America.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9486852288246155)","('Labor_Practices', 0.006705103907734156)","('Employee_Health_And_Safety', 0.003811378963291645)","(['Human Capital Development'], 0.9486852288246155)","('NON-ESG', 0.006705103907734156)","('NON-ESG', 0.003811378963291645)"
Line 1219,"In FY22, supplier diversity leadership from the Europe, Middle East, and Africa region drove the adoption of goals to grow diverse spend within the region and ensure the inclusion of diverse-owned suppliers in new bid opportunities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9170565605163574)","('Supply_Chain_Management', 0.009922820143401623)","('Employee_Health_And_Safety', 0.006991854403167963)","(['Human Capital Development'], 0.9170565605163574)","('NON-ESG', 0.009922820143401623)","('NON-ESG', 0.006991854403167963)"
Line 1220,"These efforts led to new partners being added to our supply chain, including: •   Adwise Iletisim  — a marketing communications agency  in Turkey and a certified Women Business Enterprise  that provides digital marketing services to Medtronic.
","('Supply_Chain_Management', 0.856312096118927)","('Product_Design_And_Lifecycle_Management', 0.02061500959098339)","('Customer_Welfare', 0.017910119146108627)","(['Supply Chain Management'], 0.856312096118927)","('NON-ESG', 0.02061500959098339)","('NON-ESG', 0.017910119146108627)"
Line 1221,"•   Masoom  Training Solutions — a human resources  training company and a certified Black Economic Empowerment and Women Business Enterprise that provides training for Medtronic in South Africa.
","('Human_Rights_And_Community_Relations', 0.5447931885719299)","('Employee_Engagement_Inclusion_And_Diversity', 0.19409264624118805)","('Access_And_Affordability', 0.06868603825569153)","(['Community Relations'], 0.5447931885719299)","('NON-ESG', 0.19409264624118805)","('NON-ESG', 0.06868603825569153)"
Line 1222,"During our inaugural Medtronic Supplier Diversity Conference, held virtually in November 2021, more  than 200 attendees joined for two days of knowledge sharing, training, and business networking.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9530979990959167)","('Employee_Health_And_Safety', 0.00409980583935976)","('Business_Model_Resilience', 0.0038129060994833708)","(['Human Capital Development'], 0.9530979990959167)","('NON-ESG', 0.00409980583935976)","('NON-ESG', 0.0038129060994833708)"
Line 1223,"The event culminated in approximately 150 one-on-one sessions between diverse-owned suppliers and Medtronic sourcing managers.
","('Supply_Chain_Management', 0.9038098454475403)","('Product_Design_And_Lifecycle_Management', 0.027651971206068993)","('Customer_Welfare', 0.006392295006662607)","(['Supply Chain Management'], 0.9038098454475403)","('NON-ESG', 0.027651971206068993)","('NON-ESG', 0.006392295006662607)"
Line 1224,"In FY22, we also launched an Early Payment Program   for Diverse Suppliers in partnership with a global provider of working capital solutions.
","('Supply_Chain_Management', 0.7597321271896362)","('Systemic_Risk_Management', 0.027457788586616516)","('Competitive_Behavior', 0.02720852941274643)","(['Supply Chain Management'], 0.7597321271896362)","('NON-ESG', 0.027457788586616516)","('NON-ESG', 0.02720852941274643)"
Line 1225,"This offering helped ease cash-flow pressures by accelerating more than $19 million in payments to over 540 participating diverse-owned suppliers within the first six months of  the program.
","('Supply_Chain_Management', 0.801816463470459)","('Management_Of_Legal_And_Regulatory_Framework', 0.0315256267786026)","('Energy_Management', 0.01874963752925396)","(['Supply Chain Management'], 0.801816463470459)","('NON-ESG', 0.0315256267786026)","('NON-ESG', 0.01874963752925396)"
Line 1226,"SUPPLY CHAIN RESPONSIBILITY U.S. DIVERSE SUPPLY CHAIN SPEND  ($ million by category) FY20 FY21 FY$ U.S.   spend% U.S.   spend$ U.S.   spend% U.S.   spend$ U.S.   spend% U.S.   spend Small business  enterprise$1,896 26.2% $1,776 27.2% $1,706 23.0% Veteran-owned business enterprise$113 1.6% $133 2.0% $136 1.8%  Minority-owned business enterprise $273 3.8% $265 4.1% $320 4.6% Women-owned business enterprise$172 2.4% $172 2.6% $498 7.2% Impact of diverse-owned firms LGBTQ+-owned  Reason Research provides the ""voice of the customer” to help us better  understand the needs of  patients and physicians so we can more quickly make our technologies  accessible.
","('Supply_Chain_Management', 0.41459980607032776)","('Employee_Engagement_Inclusion_And_Diversity', 0.31565427780151367)","('Business_Model_Resilience', 0.03321970999240875)","('NON-ESG', 0.41459980607032776)","('NON-ESG', 0.31565427780151367)","('NON-ESG', 0.03321970999240875)"
Line 1227,"SUPPLY CHAIN RESPONSIBILITY U.S. DIVERSE SUPPLY CHAIN SPEND  ($ million by category) FY20 FY21 FY$ U.S.   spend% U.S.   spend$ U.S.   spend% U.S.   spend$ U.S.   spend% U.S.   spend Small business  enterprise$1,896 26.2% $1,776 27.2% $1,706 23.0% Veteran-owned business enterprise$113 1.6% $133 2.0% $136 1.8%  Minority-owned business enterprise $273 3.8% $265 4.1% $320 4.6% Women-owned business enterprise$172 2.4% $172 2.6% $498 7.2% Impact of diverse-owned firms LGBTQ+-owned  Reason Research provides the ""voice of the customer” to help us better  understand the needs of  patients and physicians so we can more quickly make our technologies  accessible.
","('Access_And_Affordability', 0.2345852255821228)","('Customer_Welfare', 0.18867860734462738)","('Energy_Management', 0.0838974267244339)","('NON-ESG', 0.2345852255821228)","('NON-ESG', 0.18867860734462738)","('NON-ESG', 0.0838974267244339)"
Line 1228,"Reason Research also amplifies diverse voices in its own operations by participating  in the Diversity Alliance for Science, an organization that helps small and/or diverse businesses drive inclusive procurement practices in the life science and healthcare industries.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9758996367454529)","('Employee_Health_And_Safety', 0.0017829474527388811)","('Competitive_Behavior', 0.0016651420155540109)","(['Human Capital Development'], 0.9758996367454529)","('NON-ESG', 0.0017829474527388811)","('NON-ESG', 0.0016651420155540109)"
Line 1229,"“Supplier diversity signals that companies  aren’t just talking about inclusion, they’re  doing it beyond their own walls.” Gary White  CEO, Reason Research $2.7B purchased from small and   diverse-owned businesses $4.9B in economic production activity $1.8B in wages and benefits through   supported jobs 29 ,small and diverse supplier jobs   supported in the United StatesSUPPLIER DIVERSITY   ECONOMIC IMPACT 2022 Integrated Performance Report       85 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexGovernance and  accountability We uphold robust corporate governance practices and instill principles  of ethical behavior across our business as essential drivers of Medtronic’s financial success and responsible growth.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9737550020217896)","('Employee_Health_And_Safety', 0.0025685932487249374)","('Human_Rights_And_Community_Relations', 0.001711841905489564)","(['Human Capital Development'], 0.9737550020217896)","('NON-ESG', 0.0025685932487249374)","('NON-ESG', 0.001711841905489564)"
Line 1230,"“Supplier diversity signals that companies  aren’t just talking about inclusion, they’re  doing it beyond their own walls.” Gary White  CEO, Reason Research $2.7B purchased from small and   diverse-owned businesses $4.9B in economic production activity $1.8B in wages and benefits through   supported jobs 29 ,small and diverse supplier jobs   supported in the United StatesSUPPLIER DIVERSITY   ECONOMIC IMPACT 2022 Integrated Performance Report       85 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexGovernance and  accountability We uphold robust corporate governance practices and instill principles  of ethical behavior across our business as essential drivers of Medtronic’s financial success and responsible growth.
","('Business_Ethics', 0.9502228498458862)","('Management_Of_Legal_And_Regulatory_Framework', 0.011357027105987072)","('Competitive_Behavior', 0.006567911710590124)","(['Business Ethics'], 0.9502228498458862)","('NON-ESG', 0.011357027105987072)","('NON-ESG', 0.006567911710590124)"
Line 1231,"Our uncompromising standard of accountability sets the foundation for investors’ confidence and underpins our stakeholder engagements.
","('Business_Ethics', 0.806378960609436)","('Competitive_Behavior', 0.041713617742061615)","('Management_Of_Legal_And_Regulatory_Framework', 0.031049951910972595)","(['Business Ethics'], 0.806378960609436)","('NON-ESG', 0.041713617742061615)","('NON-ESG', 0.031049951910972595)"
Line 1232,"FY22 governance and accountability highlights  Corporate governance  88    Ethical business conduct   91    Ethics in sales and mark eting  95    Our economic impact   2022 Integrated Performance Report Introduction 86 ESG strategy Environmental sustainability Social impact ESG disclosure index  Governance and accountability FY22 highlightsGOVERNANCE AND ACCOUNTABILITY 30 % of board members were women,   and following the June 27, 2022  appointment of Lidia Fonseca as  a new director, 36% of board  members are women 20 % of board members were from  ethnically diverse backgrounds,   and following the June 27, 2022 appointment of Lidia Fonseca as  a new director, 27% of board members  are from ethnically diverse backgrounds ~100 % nearly all U.S. employees   certified as having read and   understood our Code of Conduct $31.7B  revenue generated and 92% of free   cash flow returned to shareholders $1.7Btotal strategic investment and   acquisition spend 1      Includes acquisitions,  additions to property, plant and equipment,  and net purchases of investments.
","('Business_Ethics', 0.9450897574424744)","('Director_Removal', 0.007042462471872568)","('Management_Of_Legal_And_Regulatory_Framework', 0.006281040143221617)","(['Business Ethics'], 0.9450897574424744)","('NON-ESG', 0.007042462471872568)","('NON-ESG', 0.006281040143221617)"
Line 1233,"FY22 governance and accountability highlights  Corporate governance  88    Ethical business conduct   91    Ethics in sales and mark eting  95    Our economic impact   2022 Integrated Performance Report Introduction 86 ESG strategy Environmental sustainability Social impact ESG disclosure index  Governance and accountability FY22 highlightsGOVERNANCE AND ACCOUNTABILITY 30 % of board members were women,   and following the June 27, 2022  appointment of Lidia Fonseca as  a new director, 36% of board  members are women 20 % of board members were from  ethnically diverse backgrounds,   and following the June 27, 2022 appointment of Lidia Fonseca as  a new director, 27% of board members  are from ethnically diverse backgrounds ~100 % nearly all U.S. employees   certified as having read and   understood our Code of Conduct $31.7B  revenue generated and 92% of free   cash flow returned to shareholders $1.7Btotal strategic investment and   acquisition spend 1      Includes acquisitions,  additions to property, plant and equipment,  and net purchases of investments.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9706165790557861)","('Business_Model_Resilience', 0.0023394646123051643)","('Customer_Privacy', 0.00185307243373245)","(['Human Capital Development'], 0.9706165790557861)","('NON-ESG', 0.0023394646123051643)","('NON-ESG', 0.00185307243373245)"
Line 1234,"FY22 governance and accountability highlights  Corporate governance  88    Ethical business conduct   91    Ethics in sales and mark eting  95    Our economic impact   2022 Integrated Performance Report Introduction 86 ESG strategy Environmental sustainability Social impact ESG disclosure index  Governance and accountability FY22 highlightsGOVERNANCE AND ACCOUNTABILITY 30 % of board members were women,   and following the June 27, 2022  appointment of Lidia Fonseca as  a new director, 36% of board  members are women 20 % of board members were from  ethnically diverse backgrounds,   and following the June 27, 2022 appointment of Lidia Fonseca as  a new director, 27% of board members  are from ethnically diverse backgrounds ~100 % nearly all U.S. employees   certified as having read and   understood our Code of Conduct $31.7B  revenue generated and 92% of free   cash flow returned to shareholders $1.7Btotal strategic investment and   acquisition spend 1      Includes acquisitions,  additions to property, plant and equipment,  and net purchases of investments.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4370824694633484)","('Energy_Management', 0.10079486668109894)","('Systemic_Risk_Management', 0.08368900418281555)","('NON-ESG', 0.4370824694633484)","('NON-ESG', 0.10079486668109894)","('NON-ESG', 0.08368900418281555)"
Line 1235,"2022 Integrated Performance Report       87 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexOUR BOARD’S SIX STANDING COMMITTEES each composed of independent directorsAudit Nominating  and Corporate  GovernanceCompensation QualityFinance and  Financial Risk Science and  TechnologyCorporate governance Our principled approach to  corporate governance is defined through clear policies and procedures.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7163184285163879)","('Business_Ethics', 0.08823298662900925)","('Systemic_Risk_Management', 0.0317993238568306)","(['Corporate Governance'], 0.7163184285163879)","('NON-ESG', 0.08823298662900925)","('NON-ESG', 0.0317993238568306)"
Line 1236,"Independent oversight of the company strengthens our financial health and ethical accountability and enables us to fulfill our Mission.
","('Business_Ethics', 0.9396092891693115)","('Management_Of_Legal_And_Regulatory_Framework', 0.015008099377155304)","('Competitive_Behavior', 0.006183807272464037)","(['Business Ethics'], 0.9396092891693115)","('NON-ESG', 0.015008099377155304)","('NON-ESG', 0.006183807272464037)"
Line 1237,"Adding business value Strong corporate governance upholds our  company values, safeguards us against risks, and maintains our stakeholders’ trust — which is essential to the continuing success of our business.
","('Business_Ethics', 0.26106029748916626)","('Business_Model_Resilience', 0.20623458921909332)","('Systemic_Risk_Management', 0.18452860414981842)","('NON-ESG', 0.26106029748916626)","('NON-ESG', 0.20623458921909332)","('NON-ESG', 0.18452860414981842)"
Line 1238,"GOVERNANCE AND ACCOUNTABILITY 2022 Integrated Performance Report       88 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexCORPORATE GOVERNANCE Board of directors  We are governed by a board that comprises nine  independent directors and our CEO, Geoff Martha,  during FY22.
","('Director_Removal', 0.2714797854423523)","('Management_Of_Legal_And_Regulatory_Framework', 0.23267698287963867)","('Business_Ethics', 0.11170954257249832)","('NON-ESG', 0.2714797854423523)","('NON-ESG', 0.23267698287963867)","('NON-ESG', 0.11170954257249832)"
Line 1239,"Martha serves as Chairman of the Board,  and Craig Arnold serves as lead independent director.
","('Director_Removal', 0.7219191193580627)","('Business_Model_Resilience', 0.03190315142273903)","('Management_Of_Legal_And_Regulatory_Framework', 0.029965948313474655)","(['Anti-Crime Policy & Measures'], 0.7219191193580627)","('NON-ESG', 0.03190315142273903)","('NON-ESG', 0.029965948313474655)"
Line 1240,"Our board has six standing committees, each composed   of independent directors.
","('Director_Removal', 0.7214690446853638)","('Management_Of_Legal_And_Regulatory_Framework', 0.053375907242298126)","('Business_Ethics', 0.020918359979987144)","(['Anti-Crime Policy & Measures'], 0.7214690446853638)","('NON-ESG', 0.053375907242298126)","('NON-ESG', 0.020918359979987144)"
Line 1241,"The committees are: •  Audit •  C ompensation •  F inance and Financial Risk •  Nomina ting and Corporate Governance •  Quality •  Science  and Technology Our board members have diverse experience, skills,   and backgrounds essential to understanding and responding to stakeholder needs and enhancing the  quality of discussions and decisions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.20051325857639313)","('Director_Removal', 0.18901345133781433)","('Business_Model_Resilience', 0.1665860265493393)","('NON-ESG', 0.20051325857639313)","('NON-ESG', 0.18901345133781433)","('NON-ESG', 0.1665860265493393)"
Line 1242,"At the end of FY22, 30% of our board members were women, and 20% of members were from ethnically diverse backgrounds.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9708679914474487)","('Human_Rights_And_Community_Relations', 0.0024055843241512775)","('Business_Model_Resilience', 0.0018559873569756746)","(['Human Capital Development'], 0.9708679914474487)","('NON-ESG', 0.0024055843241512775)","('NON-ESG', 0.0018559873569756746)"
Line 1243,"With the addition of new director Lidia Fonseca in early FY23, 36% of board members are women and 27% are  from ethnically diverse backgrounds.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9682528972625732)","('Human_Rights_And_Community_Relations', 0.002481983043253422)","('Business_Model_Resilience', 0.0022353874519467354)","(['Human Capital Development'], 0.9682528972625732)","('NON-ESG', 0.002481983043253422)","('NON-ESG', 0.0022353874519467354)"
Line 1244,"When evaluating director candidates, we consider a   variety of factors, including diversity of skills, experience, and community involvement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9725462198257446)","('Human_Rights_And_Community_Relations', 0.0025180296506732702)","('Business_Model_Resilience', 0.001877285772934556)","(['Human Capital Development'], 0.9725462198257446)","('NON-ESG', 0.0025180296506732702)","('NON-ESG', 0.001877285772934556)"
Line 1245,"Our Board Diversity Policy  and Principles of Corporate Governance outline the principles and processes through which the Nominating  and Corporate Governance Committee assesses the appropriate mix of board diversity and evaluates  candidates for directorship.The Nominating and Corporate Governance Committee also oversees our environmental, social, and governance (ESG) performance.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5720515847206116)","('Director_Removal', 0.1980845034122467)","('Business_Model_Resilience', 0.026440531015396118)","(['Human Capital Development'], 0.5720515847206116)","('NON-ESG', 0.1980845034122467)","('NON-ESG', 0.026440531015396118)"
Line 1246,"More detailed information on our  ESG governance is shared in ESG strategy.
","('Business_Model_Resilience', 0.44594621658325195)","('Systemic_Risk_Management', 0.12664741277694702)","('Management_Of_Legal_And_Regulatory_Framework', 0.11485492438077927)","('NON-ESG', 0.44594621658325195)","('NON-ESG', 0.12664741277694702)","('NON-ESG', 0.11485492438077927)"
Line 1247,"Enterprise risk and continuity management Unexpected events, such as COVID-19, political turmoil, extreme weather, and civil unrest can disrupt our business and prevent us from serving those who need our products and therapies.
","('Physical_Impacts_Of_Climate_Change', 0.6530959010124207)","('Systemic_Risk_Management', 0.09215687215328217)","('Business_Model_Resilience', 0.0662727877497673)","(['Climate Change'], 0.6530959010124207)","('NON-ESG', 0.09215687215328217)","('NON-ESG', 0.0662727877497673)"
Line 1248,"Our Enterprise Risk & Continuity team helps us remain resilient in the face of uncertainty.
","('Business_Model_Resilience', 0.9026169776916504)","('Physical_Impacts_Of_Climate_Change', 0.015629412606358528)","('Systemic_Risk_Management', 0.01304757222533226)","(['Codes of Business Conduct'], 0.9026169776916504)","('NON-ESG', 0.015629412606358528)","('NON-ESG', 0.01304757222533226)"
Line 1249,"We stay nimble and prepared through three key programs: •   Enterprise risk management (ERM)  — Our overarching  approach helps ensure risk management activities are  consistent across Medtronic.
","('Systemic_Risk_Management', 0.9106575846672058)","('Business_Model_Resilience', 0.015834251418709755)","('Business_Ethics', 0.013431981205940247)","(['Risk & Crisis Management'], 0.9106575846672058)","('NON-ESG', 0.015834251418709755)","('NON-ESG', 0.013431981205940247)"
Line 1250,"In FY22, we continued to embed our ERM framework within our strategic planning and other core business processes and functions to continue to sharpen our focus on risk mitigation.
","('Business_Model_Resilience', 0.6420146822929382)","('Systemic_Risk_Management', 0.21334704756736755)","('Physical_Impacts_Of_Climate_Change', 0.036707207560539246)","(['Codes of Business Conduct'], 0.6420146822929382)","('NON-ESG', 0.21334704756736755)","('NON-ESG', 0.036707207560539246)"
Line 1251,"•   Business continuity management  — We prioritize critical  products and services based on patient impact and our strategic priorities.
","('Product_Design_And_Lifecycle_Management', 0.9032753705978394)","('Business_Model_Resilience', 0.018383875489234924)","('Supply_Chain_Management', 0.010756638832390308)","(['Product Stewardship'], 0.9032753705978394)","('NON-ESG', 0.018383875489234924)","('NON-ESG', 0.010756638832390308)"
Line 1252,"End-to-end mapping of our value stream enables us to quickly identify and effectively manage key operational risks, with a strong focus on resiliency.
","('Business_Model_Resilience', 0.9111694693565369)","('Physical_Impacts_Of_Climate_Change', 0.011984631419181824)","('Supply_Chain_Management', 0.011179729364812374)","(['Codes of Business Conduct'], 0.9111694693565369)","('NON-ESG', 0.011984631419181824)","('NON-ESG', 0.011179729364812374)"
Line 1253,"•   Crisis management (CM)  — The CM team prioritizes and  coordinates our response, including resource allocation, to crises that affect our people, operations, and/or reputation.
","('Critical_Incident_Risk_Management', 0.7059555649757385)","('Physical_Impacts_Of_Climate_Change', 0.14484231173992157)","('Systemic_Risk_Management', 0.035260993987321854)","(['Risk & Crisis Management'], 0.7059555649757385)","('NON-ESG', 0.14484231173992157)","('NON-ESG', 0.035260993987321854)"
Line 1254,"The executive committee sponsors the CM program, with more support provided from the Medtronic Global Command Center and leadership.
","('Management_Of_Legal_And_Regulatory_Framework', 0.19567517936229706)","('Director_Removal', 0.15196935832500458)","('Employee_Engagement_Inclusion_And_Diversity', 0.1355707049369812)","('NON-ESG', 0.19567517936229706)","('NON-ESG', 0.15196935832500458)","('NON-ESG', 0.1355707049369812)"
Line 1255,"Read more about the philanthropic support provided by Medtronic and the Medtronic Foundation during global crises and natural disasters.CRISIS MANAGEMENT PROCESS Corporate Corporate functions and business groups   provide strategic guidance and coordinated  support to countries and sites.
","('Critical_Incident_Risk_Management', 0.7762673497200012)","('Physical_Impacts_Of_Climate_Change', 0.12390011548995972)","('Systemic_Risk_Management', 0.013117562979459763)","(['Risk & Crisis Management'], 0.7762673497200012)","('NON-ESG', 0.12390011548995972)","('NON-ESG', 0.013117562979459763)"
Line 1256,"Regional Regional crisis action teams provide   consistent and timely corporate support   during crisis events.
","('Critical_Incident_Risk_Management', 0.9191545844078064)","('Physical_Impacts_Of_Climate_Change', 0.022910695523023605)","('Systemic_Risk_Management', 0.006511379033327103)","(['Risk & Crisis Management'], 0.9191545844078064)","('NON-ESG', 0.022910695523023605)","('NON-ESG', 0.006511379033327103)"
Line 1257,"Local/site Teams provide coordinated response   for events impacting an area of   significance to Medtronic.Monitor Notify Lessons learnedManage eventActivate Deactivate and hand offCrisis management teams Crisis management structure 2022 Integrated Performance Report       89 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexCORPORATE GOVERNANCE Public policy We believe that through our public policy efforts, we can  help produce long-term societal benefits by improving healthcare access, quality, efficiency, and outcomes for all patients.
","('Systemic_Risk_Management', 0.3290858566761017)","('Management_Of_Legal_And_Regulatory_Framework', 0.18219217658042908)","('Business_Model_Resilience', 0.1350114345550537)","('NON-ESG', 0.3290858566761017)","('NON-ESG', 0.18219217658042908)","('NON-ESG', 0.1350114345550537)"
Line 1258,"Local/site Teams provide coordinated response   for events impacting an area of   significance to Medtronic.Monitor Notify Lessons learnedManage eventActivate Deactivate and hand offCrisis management teams Crisis management structure 2022 Integrated Performance Report       89 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexCORPORATE GOVERNANCE Public policy We believe that through our public policy efforts, we can  help produce long-term societal benefits by improving healthcare access, quality, efficiency, and outcomes for all patients.
","('Access_And_Affordability', 0.8673425912857056)","('Critical_Incident_Risk_Management', 0.012953918427228928)","('Energy_Management', 0.011697969399392605)","(['Health Outcome Contribution'], 0.8673425912857056)","('NON-ESG', 0.012953918427228928)","('NON-ESG', 0.011697969399392605)"
Line 1259,"Our Government Affairs, Health Economics, Policy and  Reimbursement, and Regulatory Affairs teams work with governments, industry peers, and other stakeholders to: •  R ealize the potential of digital health technology.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9709787964820862)","('GHG_Emissions', 0.0024439028929919004)","('Business_Ethics', 0.002310370095074177)","(['Corporate Governance'], 0.9709787964820862)","('NON-ESG', 0.0024439028929919004)","('NON-ESG', 0.002310370095074177)"
Line 1260,"•  Enable technology innova tions.
","('Business_Model_Resilience', 0.4672681987285614)","('Product_Design_And_Lifecycle_Management', 0.09233705699443817)","('Supply_Chain_Management', 0.09183543175458908)","('NON-ESG', 0.4672681987285614)","('NON-ESG', 0.09233705699443817)","('NON-ESG', 0.09183543175458908)"
Line 1261,"•  F acilitate access to lifesaving therapies and devices.
","('Access_And_Affordability', 0.7515589594841003)","('Product_Design_And_Lifecycle_Management', 0.03417706862092018)","('Customer_Welfare', 0.028424516320228577)","(['Health Outcome Contribution'], 0.7515589594841003)","('NON-ESG', 0.03417706862092018)","('NON-ESG', 0.028424516320228577)"
Line 1262,"•   Gener ate economic value for healthcare system  stakeholders.
","('Access_And_Affordability', 0.2082299441099167)","('Management_Of_Legal_And_Regulatory_Framework', 0.1809544712305069)","('Systemic_Risk_Management', 0.09232322126626968)","('NON-ESG', 0.2082299441099167)","('NON-ESG', 0.1809544712305069)","('NON-ESG', 0.09232322126626968)"
Line 1263,"•  P romote outcome-driven and value-based healthcare.
","('Access_And_Affordability', 0.5432673692703247)","('Customer_Welfare', 0.05079488828778267)","('Human_Rights_And_Community_Relations', 0.04779205098748207)","(['Health Outcome Contribution'], 0.5432673692703247)","('NON-ESG', 0.05079488828778267)","('NON-ESG', 0.04779205098748207)"
Line 1264,"•   Harmonize and coor dinate international regulatory  requirements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9612986445426941)","('Competitive_Behavior', 0.004176793619990349)","('Business_Ethics', 0.0035250792279839516)","(['Corporate Governance'], 0.9612986445426941)","('NON-ESG', 0.004176793619990349)","('NON-ESG', 0.0035250792279839516)"
Line 1265,"Digital health remains among our top public-policy  priorities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3290732800960541)","('Physical_Impacts_Of_Climate_Change', 0.15386688709259033)","('Business_Model_Resilience', 0.07410220056772232)","('NON-ESG', 0.3290732800960541)","('NON-ESG', 0.15386688709259033)","('NON-ESG', 0.07410220056772232)"
Line 1266,"We are helping to shape the digital health policy landscape on issues that include device security, data privacy and security, access to data for research  and development, product regulatory issues, and coverage and reimbursement.
","('Data_Security', 0.9434847831726074)","('Customer_Privacy', 0.013215783052146435)","('Business_Ethics', 0.004541140981018543)","(['Information Security/Cybersecurity & System Availability'], 0.9434847831726074)","('NON-ESG', 0.013215783052146435)","('NON-ESG', 0.004541140981018543)"
Line 1267,"We also seek to inform public policies aimed at  narrowing disparities in healthcare access and promoting equitable patient care.
","('Access_And_Affordability', 0.916284441947937)","('Human_Rights_And_Community_Relations', 0.008878159336745739)","('Product_Quality_And_Safety', 0.007087438367307186)","(['Health Outcome Contribution'], 0.916284441947937)","('NON-ESG', 0.008878159336745739)","('NON-ESG', 0.007087438367307186)"
Line 1268,"For example, we provide resources and tools that help emergency medical service personnel more quickly and effectively assess and treat patients suffering an acute stroke.
","('Critical_Incident_Risk_Management', 0.9485948085784912)","('Employee_Health_And_Safety', 0.019321074709296227)","('Access_And_Affordability', 0.004140080418437719)","(['Risk & Crisis Management'], 0.9485948085784912)","('NON-ESG', 0.019321074709296227)","('NON-ESG', 0.004140080418437719)"
Line 1269,"Medtronic makes contributions to candidates for  federal office that align with our company values,  and we comply with all relevant laws regarding  political contribution disclosures.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7372598052024841)","('Competitive_Behavior', 0.027321917936205864)","('Director_Removal', 0.026301123201847076)","(['Corporate Governance'], 0.7372598052024841)","('NON-ESG', 0.027321917936205864)","('NON-ESG', 0.026301123201847076)"
Line 1270,"Read more about  our Political Contribution Policy.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6577104926109314)","('Human_Rights_And_Community_Relations', 0.07715065032243729)","('Director_Removal', 0.03383764997124672)","(['Corporate Governance'], 0.6577104926109314)","('NON-ESG', 0.07715065032243729)","('NON-ESG', 0.03383764997124672)"
Line 1271,"Collaborations Our Mission inspires Medtronic to partner with others to expand equitable access to quality, affordable healthcare.
","('Access_And_Affordability', 0.9014545679092407)","('Product_Quality_And_Safety', 0.009203643538057804)","('Human_Rights_And_Community_Relations', 0.008646761067211628)","(['Health Outcome Contribution'], 0.9014545679092407)","('NON-ESG', 0.009203643538057804)","('NON-ESG', 0.008646761067211628)"
Line 1272,"Our partners in these efforts span patients, physicians,  treatment facilities, health system administrators, government officials, public policymakers, nonprofits, nongovernmental organizations, and advocacy groups.
","('Access_And_Affordability', 0.511520504951477)","('Management_Of_Legal_And_Regulatory_Framework', 0.18698681890964508)","('Human_Rights_And_Community_Relations', 0.03735991567373276)","(['Health Outcome Contribution'], 0.511520504951477)","('NON-ESG', 0.18698681890964508)","('NON-ESG', 0.03735991567373276)"
Line 1273,"Like us, they have a direct interest in improving healthcare and overcoming industry challenges.
","('Supply_Chain_Management', 0.24956774711608887)","('Systemic_Risk_Management', 0.17564350366592407)","('Business_Model_Resilience', 0.1281023919582367)","('NON-ESG', 0.24956774711608887)","('NON-ESG', 0.17564350366592407)","('NON-ESG', 0.1281023919582367)"
Line 1274,"A growing number of nations are implementing universal  health coverage (UHC) to provide everyone access to health services without risk of financial ruin.
","('Access_And_Affordability', 0.8602524995803833)","('Critical_Incident_Risk_Management', 0.01766645722091198)","('Human_Rights_And_Community_Relations', 0.012807746417820454)","(['Health Outcome Contribution'], 0.8602524995803833)","('NON-ESG', 0.01766645722091198)","('NON-ESG', 0.012807746417820454)"
Line 1275,"According to the World Health Organization, countries with UHC have less poverty and stronger economic development, as well as improved health indicators.
","('Access_And_Affordability', 0.3739469051361084)","('Human_Rights_And_Community_Relations', 0.21841131150722504)","('Management_Of_Legal_And_Regulatory_Framework', 0.08405184000730515)","('NON-ESG', 0.3739469051361084)","('NON-ESG', 0.21841131150722504)","('NON-ESG', 0.08405184000730515)"
Line 1276,"Medtronic is well-positioned to support governments as they work toward UHC, and we seek broader ways to contribute to this progress.
","('Management_Of_Legal_And_Regulatory_Framework', 0.778143048286438)","('Human_Rights_And_Community_Relations', 0.0716344341635704)","('Access_And_Affordability', 0.03074420616030693)","(['Corporate Governance'], 0.778143048286438)","('NON-ESG', 0.0716344341635704)","('NON-ESG', 0.03074420616030693)"
Line 1277,"For example, Medtronic LABS is part of the UHC2030 Private Sector Constituency and served on the UHC2030 Steering Committee in FY22.
","('Supply_Chain_Management', 0.19011209905147552)","('Business_Model_Resilience', 0.17365926504135132)","('Systemic_Risk_Management', 0.10867935419082642)","('NON-ESG', 0.19011209905147552)","('NON-ESG', 0.17365926504135132)","('NON-ESG', 0.10867935419082642)"
Line 1278,"Also, our CEO, Geoff Martha, is a co-chair of the B20 Health & Life Sciences Task Force within the G20 forum for international economic cooperation.We continue to promote value-based healthcare conversations in policy discussions, including meetings of G20 health officials.
","('Human_Rights_And_Community_Relations', 0.2762867510318756)","('Management_Of_Legal_And_Regulatory_Framework', 0.19568896293640137)","('Business_Model_Resilience', 0.0857144147157669)","('NON-ESG', 0.2762867510318756)","('NON-ESG', 0.19568896293640137)","('NON-ESG', 0.0857144147157669)"
Line 1279,"We also promote policies to increase access to care and innovation, including the application of digital technology to improve diagnosis, therapy, and care management.
","('Access_And_Affordability', 0.8312404751777649)","('Employee_Health_And_Safety', 0.021340386942029)","('Product_Quality_And_Safety', 0.018136581405997276)","(['Health Outcome Contribution'], 0.8312404751777649)","('NON-ESG', 0.021340386942029)","('NON-ESG', 0.018136581405997276)"
Line 1280,"We also participate in business and MedTech industry  trade organizations working to advance global health.
","('Competitive_Behavior', 0.3601757287979126)","('Management_Of_Legal_And_Regulatory_Framework', 0.2346908301115036)","('Systemic_Risk_Management', 0.12051975727081299)","('NON-ESG', 0.3601757287979126)","('NON-ESG', 0.2346908301115036)","('NON-ESG', 0.12051975727081299)"
Line 1281,"We share expertise and advocate for a more sustainable healthcare model through forums in the United States and elsewhere.
","('Product_Design_And_Lifecycle_Management', 0.3025676906108856)","('Access_And_Affordability', 0.22534912824630737)","('Energy_Management', 0.08291460573673248)","('NON-ESG', 0.3025676906108856)","('NON-ESG', 0.22534912824630737)","('NON-ESG', 0.08291460573673248)"
Line 1282,"This includes serving on the boards of industry organizations such as AdvaMed, APACMed,  and MedTech Europe.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3741064667701721)","('Access_And_Affordability', 0.07795891910791397)","('Customer_Welfare', 0.06470005959272385)","('NON-ESG', 0.3741064667701721)","('NON-ESG', 0.07795891910791397)","('NON-ESG', 0.06470005959272385)"
Line 1283,"1        Arguing for Universal Health Coverage Report, The World Health Organization,   page 10.
","('Access_And_Affordability', 0.43742966651916504)","('Employee_Health_And_Safety', 0.07831701636314392)","('Product_Quality_And_Safety', 0.06288984417915344)","('NON-ESG', 0.43742966651916504)","('NON-ESG', 0.07831701636314392)","('NON-ESG', 0.06288984417915344)"
Line 1284,"2022 Integrated Performance Report       90 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexEthical business  conduct Our commitment to “Delivering  Results The Right Way” includes empowering our employees to think critically and equipping them with the insights and support they need  to make ethical decisions.
","('Business_Ethics', 0.787327229976654)","('Human_Rights_And_Community_Relations', 0.04511808976531029)","('Management_Of_Legal_And_Regulatory_Framework', 0.03025951236486435)","(['Business Ethics'], 0.787327229976654)","('NON-ESG', 0.04511808976531029)","('NON-ESG', 0.03025951236486435)"
Line 1285,"Adding business value Our lasting success relies on maintaining strong  trust among those with whom we work and the patients benefitting from our products and therapies.
","('Product_Design_And_Lifecycle_Management', 0.8899238109588623)","('Customer_Welfare', 0.01895863190293312)","('Product_Quality_And_Safety', 0.014207088388502598)","(['Product Stewardship'], 0.8899238109588623)","('NON-ESG', 0.01895863190293312)","('NON-ESG', 0.014207088388502598)"
Line 1286,"By ensuring our people act with integrity, we safeguard our reputation, protect the best interests of patients, and minimize our exposure to risks.GOVERNANCE AND ACCOUNTABILITY 99%  of employees received  Code of Conduct  training in FY~100%  nearly all U.S. employees  certified as having read and  understood the Code of  Conduct in FY2022 Integrated Performance Report       91 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexETHICAL BUSINESS CONDUCT Building an ethical culture Our Office of Ethics & Compliance (OEC) is responsible  for ethics policies and programs.
","('Business_Ethics', 0.9078587889671326)","('Management_Of_Legal_And_Regulatory_Framework', 0.01827233098447323)","('Systemic_Risk_Management', 0.010190935805439949)","(['Business Ethics'], 0.9078587889671326)","('NON-ESG', 0.01827233098447323)","('NON-ESG', 0.010190935805439949)"
Line 1287,"By ensuring our people act with integrity, we safeguard our reputation, protect the best interests of patients, and minimize our exposure to risks.GOVERNANCE AND ACCOUNTABILITY 99%  of employees received  Code of Conduct  training in FY~100%  nearly all U.S. employees  certified as having read and  understood the Code of  Conduct in FY2022 Integrated Performance Report       91 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexETHICAL BUSINESS CONDUCT Building an ethical culture Our Office of Ethics & Compliance (OEC) is responsible  for ethics policies and programs.
","('Business_Ethics', 0.9694445133209229)","('Management_Of_Legal_And_Regulatory_Framework', 0.0032789581455290318)","('Product_Quality_And_Safety', 0.002536548301577568)","(['Business Ethics'], 0.9694445133209229)","('NON-ESG', 0.0032789581455290318)","('NON-ESG', 0.002536548301577568)"
Line 1288,"The OEC provides an annual ethics report for the board of directors, supplemented by quarterly briefings for the board’s Audit Committee.
","('Business_Ethics', 0.5529337525367737)","('Director_Removal', 0.18642444908618927)","('Management_Of_Legal_And_Regulatory_Framework', 0.07271333038806915)","(['Business Ethics'], 0.5529337525367737)","('NON-ESG', 0.18642444908618927)","('NON-ESG', 0.07271333038806915)"
Line 1289,"Our chief ethics and compliance officer also has an independent reporting line directly  to the Audit Committee.
","('Business_Ethics', 0.7476372718811035)","('Management_Of_Legal_And_Regulatory_Framework', 0.13994508981704712)","('Director_Removal', 0.022833799943327904)","(['Business Ethics'], 0.7476372718811035)","('NON-ESG', 0.13994508981704712)","('NON-ESG', 0.022833799943327904)"
Line 1290,"In addition, the OEC processes and thoroughly  investigates reported concerns of alleged misconduct.
","('Business_Ethics', 0.9631597399711609)","('Management_Of_Legal_And_Regulatory_Framework', 0.004175625275820494)","('Employee_Health_And_Safety', 0.002547545125707984)","(['Business Ethics'], 0.9631597399711609)","('NON-ESG', 0.004175625275820494)","('NON-ESG', 0.002547545125707984)"
Line 1291,"As part of the process, a disciplinary action committee reviews the details to help ensure fair and equitable treatment of employees.
","('Labor_Practices', 0.42912590503692627)","('Business_Ethics', 0.23743760585784912)","('Employee_Engagement_Inclusion_And_Diversity', 0.10211686044931412)","('NON-ESG', 0.42912590503692627)","('NON-ESG', 0.23743760585784912)","('NON-ESG', 0.10211686044931412)"
Line 1292,"The committee includes representatives from the OEC, HR, employee relations, and business leaders.
","('Employee_Engagement_Inclusion_And_Diversity', 0.798957884311676)","('Human_Rights_And_Community_Relations', 0.02561982348561287)","('Director_Removal', 0.019110731780529022)","(['Human Capital Development'], 0.798957884311676)","('NON-ESG', 0.02561982348561287)","('NON-ESG', 0.019110731780529022)"
Line 1293,"Code of Conduct and Business  Standards We articulate our expectations for ethical behavior  through policies and principles that are accessible, explicit, and relevant to employees’ day-to-day work.
","('Business_Ethics', 0.9563069343566895)","('Product_Quality_And_Safety', 0.004814548417925835)","('Labor_Practices', 0.0035815879236906767)","(['Business Ethics'], 0.9563069343566895)","('NON-ESG', 0.004814548417925835)","('NON-ESG', 0.0035815879236906767)"
Line 1294,"Our Code of Conduct anchors this approach.
","('Business_Ethics', 0.7340458631515503)","('Management_Of_Legal_And_Regulatory_Framework', 0.1161646842956543)","('Customer_Privacy', 0.015557321719825268)","(['Business Ethics'], 0.7340458631515503)","('NON-ESG', 0.1161646842956543)","('NON-ESG', 0.015557321719825268)"
Line 1295,"To ensure every employee understands and is accountable for upholding our Code, we: •   P rovide the Code in 22 languages so that 99% of  employees can read it in their first language.
","('Management_Of_Legal_And_Regulatory_Framework', 0.23583047091960907)","('Access_And_Affordability', 0.1394042819738388)","('Human_Rights_And_Community_Relations', 0.13782978057861328)","('NON-ESG', 0.23583047091960907)","('NON-ESG', 0.1394042819738388)","('NON-ESG', 0.13782978057861328)"
Line 1296,"•   Deliver multilingual C ode training for new employees  and those joining Medtronic through acquisitions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8294394612312317)","('Access_And_Affordability', 0.021912753582000732)","('Employee_Health_And_Safety', 0.020472856238484383)","(['Human Capital Development'], 0.8294394612312317)","('NON-ESG', 0.021912753582000732)","('NON-ESG', 0.020472856238484383)"
Line 1297,"•   R etrain employees in multiple languages on the  Code annually and require everyone at Medtronic —  including our board — to certify their understanding  of its contents.We regularly refresh the training on our Code to stay current with emerging issues.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5084977746009827)","('Product_Quality_And_Safety', 0.08989951014518738)","('Human_Rights_And_Community_Relations', 0.07321690022945404)","(['Corporate Governance'], 0.5084977746009827)","('NON-ESG', 0.08989951014518738)","('NON-ESG', 0.07321690022945404)"
Line 1298,"In FY22, our updates included making the training more interactive and incorporating new ethical conduct scenarios.
","('Business_Ethics', 0.9278287291526794)","('Product_Quality_And_Safety', 0.012008116580545902)","('Management_Of_Legal_And_Regulatory_Framework', 0.00795286800712347)","(['Business Ethics'], 0.9278287291526794)","('NON-ESG', 0.012008116580545902)","('NON-ESG', 0.00795286800712347)"
Line 1299,"FY22 trainings also reinforced our expectation and support for employees to freely speak up about ethical concerns without fear of retaliation.
","('Business_Ethics', 0.9448183178901672)","('Competitive_Behavior', 0.007026745937764645)","('Management_Of_Legal_And_Regulatory_Framework', 0.006196948699653149)","(['Business Ethics'], 0.9448183178901672)","('NON-ESG', 0.007026745937764645)","('NON-ESG', 0.006196948699653149)"
Line 1300,"Additional core training modules include conflicts of interest, anti-harassment, fair competition, and insider trading.
","('Competitive_Behavior', 0.9184311032295227)","('Business_Ethics', 0.027030711993575096)","('Management_Of_Legal_And_Regulatory_Framework', 0.005596655420958996)","(['Business Ethics'], 0.9184311032295227)","('NON-ESG', 0.027030711993575096)","('NON-ESG', 0.005596655420958996)"
Line 1301,"Our Global Business Conduct Standards Policy governs  how employees interact with healthcare professionals and other stakeholders who are able to influence purchasing decisions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4174618721008301)","('Business_Ethics', 0.30073511600494385)","('Product_Quality_And_Safety', 0.06189357861876488)","('NON-ESG', 0.4174618721008301)","('NON-ESG', 0.30073511600494385)","('NON-ESG', 0.06189357861876488)"
Line 1302,"The policy aligns with industry best practices and the high ethical standards established by AdvaMed, including its recently updated Code of Ethics; MedTech Europe; and APACMed, the leading global medical device trade associations.
","('Business_Ethics', 0.9603310823440552)","('Product_Quality_And_Safety', 0.0041567981243133545)","('Competitive_Behavior', 0.0040783328004181385)","(['Business Ethics'], 0.9603310823440552)","('NON-ESG', 0.0041567981243133545)","('NON-ESG', 0.0040783328004181385)"
Line 1303,"We also embed an ethics and compliance review into our due diligence and integration processes for all mergers and acquisitions.
","('Business_Ethics', 0.9680083990097046)","('Management_Of_Legal_And_Regulatory_Framework', 0.006297812331467867)","('Product_Quality_And_Safety', 0.00277245556935668)","(['Business Ethics'], 0.9680083990097046)","('NON-ESG', 0.006297812331467867)","('NON-ESG', 0.00277245556935668)"
Line 1304,"99 % of employees received  Code of Conduct  training in FY22ENSURING COMPLIANCE WITH OUR CODE OF CONDUCT FY20 FY21 FYEmployees receiving Code of Conduct training and certification 90% 69%†99% Employees terminated for ethical and compliance-related infractions‡194 270 †  In-person trainings at manufacturing facilities were suspended in FY20 and FY21 due to COVID-19 restrictions, leading to a decrease in the number of employees who  completed training.
","('Business_Ethics', 0.9275506138801575)","('Product_Quality_And_Safety', 0.011091369204223156)","('Management_Of_Legal_And_Regulatory_Framework', 0.009480727836489677)","(['Business Ethics'], 0.9275506138801575)","('NON-ESG', 0.011091369204223156)","('NON-ESG', 0.009480727836489677)"
Line 1305,"‡ Based on calendar years 2019, 2020, and 2021.
","('Management_Of_Legal_And_Regulatory_Framework', 0.200413778424263)","('Physical_Impacts_Of_Climate_Change', 0.1464509814977646)","('Business_Model_Resilience', 0.09203559905290604)","('NON-ESG', 0.200413778424263)","('NON-ESG', 0.1464509814977646)","('NON-ESG', 0.09203559905290604)"
Line 1306,"2022 Integrated Performance Report       92 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexExcellence in ethical practices Each year, our Compass Awards honor a select group of employees who exemplify the Medtronic  Mission through actions that demonstrate high integrity and who champion our Code of Conduct.
","('Business_Ethics', 0.9539819955825806)","('Human_Rights_And_Community_Relations', 0.004376065451651812)","('Competitive_Behavior', 0.004281393252313137)","(['Business Ethics'], 0.9539819955825806)","('NON-ESG', 0.004376065451651812)","('NON-ESG', 0.004281393252313137)"
Line 1307,"In FY22, a panel of leaders and peers from across Medtronic evaluated numerous nominations, from which they selected three individuals and two teams to receive our Compass Award.
","('Employee_Engagement_Inclusion_And_Diversity', 0.49761077761650085)","('Business_Ethics', 0.05315517261624336)","('Director_Removal', 0.05142311006784439)","('NON-ESG', 0.49761077761650085)","('NON-ESG', 0.05315517261624336)","('NON-ESG', 0.05142311006784439)"
Line 1308,"The recipients included eight members of our Diabetes Operating Unit, who were recognized   for their efforts to safeguard patient privacy and consent as the team rolled out marketing information for a new project.
","('Customer_Privacy', 0.9119004607200623)","('Data_Security', 0.030786914750933647)","('Waste_And_Hazardous_Materials_Management', 0.004945084452629089)","(['Privacy Protection'], 0.9119004607200623)","('NON-ESG', 0.030786914750933647)","('NON-ESG', 0.004945084452629089)"
Line 1309,"Team members balanced the need to move quickly and  decisively with a staunch commitment to putting the interests of our patients first.ETHICAL BUSINESS CONDUCT Employee ethics Our Medtronic Mindset of “Delivering Results the  Right Way” is a fundamental element of our ethics communications.
","('Business_Ethics', 0.9355044960975647)","('Competitive_Behavior', 0.006682322360575199)","('Human_Rights_And_Community_Relations', 0.005525090266019106)","(['Business Ethics'], 0.9355044960975647)","('NON-ESG', 0.006682322360575199)","('NON-ESG', 0.005525090266019106)"
Line 1310,"We continuously expand and improve our ethics touch points and learning opportunities to strengthen employees’ understanding and adherence.
","('Business_Ethics', 0.9128116965293884)","('Management_Of_Legal_And_Regulatory_Framework', 0.01260344497859478)","('Product_Quality_And_Safety', 0.009032255969941616)","(['Business Ethics'], 0.9128116965293884)","('NON-ESG', 0.01260344497859478)","('NON-ESG', 0.009032255969941616)"
Line 1311,"In FY22, we introduced a new approach that ingrains  ethics conversations into regular team meetings at our global manufacturing facilities.
","('Business_Ethics', 0.9577539563179016)","('Management_Of_Legal_And_Regulatory_Framework', 0.004121206700801849)","('Systemic_Risk_Management', 0.003673710161820054)","(['Business Ethics'], 0.9577539563179016)","('NON-ESG', 0.004121206700801849)","('NON-ESG', 0.003673710161820054)"
Line 1312,"At least monthly, supervisors lead a discussion on a select aspect of ethical behavior.
","('Business_Ethics', 0.8972695469856262)","('Human_Rights_And_Community_Relations', 0.01287846639752388)","('Competitive_Behavior', 0.010723757557570934)","(['Business Ethics'], 0.8972695469856262)","('NON-ESG', 0.01287846639752388)","('NON-ESG', 0.010723757557570934)"
Line 1313,"Supervisors can use one of our prepared discussion guides or tailor their conversations to address team-specific issues and interests.
","('Human_Rights_And_Community_Relations', 0.39781394600868225)","('Management_Of_Legal_And_Regulatory_Framework', 0.20924222469329834)","('Director_Removal', 0.05870449170470238)","('NON-ESG', 0.39781394600868225)","('NON-ESG', 0.20924222469329834)","('NON-ESG', 0.05870449170470238)"
Line 1314,"We are averaging more than 1,000 ethics conversations a month since this practice began in February 2022.We also build awareness and engagement on ethics through initiatives such as: •   Ethics and Integrity  Week — our annual event featuring  educational activities and resources for employees  companywide.
","('Business_Ethics', 0.9609915614128113)","('Product_Quality_And_Safety', 0.003973253071308136)","('Management_Of_Legal_And_Regulatory_Framework', 0.0029815728776156902)","(['Business Ethics'], 0.9609915614128113)","('NON-ESG', 0.003973253071308136)","('NON-ESG', 0.0029815728776156902)"
Line 1315,"A key theme for FY22 was enhancing trust across our interactions with patients, customers, employees, and healthcare professionals.
","('Business_Ethics', 0.15937717258930206)","('Customer_Privacy', 0.13419221341609955)","('Human_Rights_And_Community_Relations', 0.13350346684455872)","('NON-ESG', 0.15937717258930206)","('NON-ESG', 0.13419221341609955)","('NON-ESG', 0.13350346684455872)"
Line 1316,"•   Ethics Cir cles — a year-round series that brings small  groups of employees together to discuss hypothetical scenarios, as well as their personal experiences.
","('Employee_Health_And_Safety', 0.3954241871833801)","('Employee_Engagement_Inclusion_And_Diversity', 0.24179059267044067)","('Customer_Privacy', 0.066696397960186)","('NON-ESG', 0.3954241871833801)","('NON-ESG', 0.24179059267044067)","('NON-ESG', 0.066696397960186)"
Line 1317,"FY22 topics included ethical requirements in foreign business practices, sexual harassment, and pressure to perform.To better understand employees’ perspectives on ethics, we include targeted questions in our annual Organizational Health Survey.
","('Business_Ethics', 0.9449764490127563)","('Employee_Health_And_Safety', 0.00647595664486289)","('Product_Quality_And_Safety', 0.005056249443441629)","(['Business Ethics'], 0.9449764490127563)","('NON-ESG', 0.00647595664486289)","('NON-ESG', 0.005056249443441629)"
Line 1318,"In FY22, 86% of survey respondents gave a positive rating for Medtronic’s ethical culture — our highest-ever score in this category.
","('Business_Ethics', 0.44243326783180237)","('Employee_Health_And_Safety', 0.06209918111562729)","('Business_Model_Resilience', 0.05077626183629036)","('NON-ESG', 0.44243326783180237)","('NON-ESG', 0.06209918111562729)","('NON-ESG', 0.05077626183629036)"
Line 1319,"In addition, we periodically conduct a dedicated all- employee ethics survey to gauge our progress toward setting an unsurpassed standard for integrity.
","('Business_Ethics', 0.9642339944839478)","('Product_Quality_And_Safety', 0.0030137253925204277)","('Director_Removal', 0.0029410768765956163)","(['Business Ethics'], 0.9642339944839478)","('NON-ESG', 0.0030137253925204277)","('NON-ESG', 0.0029410768765956163)"
Line 1320,"Our last ethics survey, conducted in FY20, identified four opportunity areas in which we can enhance our ethical culture: tone at the top; comfort speaking up; openness of communication; and trust and team cohesion.
","('Business_Ethics', 0.8617496490478516)","('Human_Rights_And_Community_Relations', 0.014410424046218395)","('Competitive_Behavior', 0.01189990434795618)","(['Business Ethics'], 0.8617496490478516)","('NON-ESG', 0.014410424046218395)","('NON-ESG', 0.01189990434795618)"
Line 1321,"Our CEO appointed two members of the executive committee to address this feedback, resulting in new tools, resources, and approaches.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4537760317325592)","('Director_Removal', 0.13794425129890442)","('Human_Rights_And_Community_Relations', 0.06794218719005585)","('NON-ESG', 0.4537760317325592)","('NON-ESG', 0.13794425129890442)","('NON-ESG', 0.06794218719005585)"
Line 1322,"We will reevaluate our performance in FY23.
","('Business_Model_Resilience', 0.5592250823974609)","('Systemic_Risk_Management', 0.16670294106006622)","('Competitive_Behavior', 0.03926374390721321)","(['Codes of Business Conduct'], 0.5592250823974609)","('NON-ESG', 0.16670294106006622)","('NON-ESG', 0.03926374390721321)"
Line 1323,"2022 Integrated Performance Report       93 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexETHICAL BUSINESS CONDUCT Risk assessment and monitoring While we design our communication and training to  prevent unethical situations from occurring, even a comprehensive program cannot eliminate all risk of unethical behavior.
","('Business_Ethics', 0.9539867639541626)","('Systemic_Risk_Management', 0.00567347276955843)","('Data_Security', 0.00473861675709486)","(['Business Ethics'], 0.9539867639541626)","('NON-ESG', 0.00567347276955843)","('NON-ESG', 0.00473861675709486)"
Line 1324,"Therefore, we proactively assess our risks and monitor our activities and processes.
","('Systemic_Risk_Management', 0.8958880305290222)","('Physical_Impacts_Of_Climate_Change', 0.019355328753590584)","('Business_Model_Resilience', 0.014297557063400745)","(['Risk & Crisis Management'], 0.8958880305290222)","('NON-ESG', 0.019355328753590584)","('NON-ESG', 0.014297557063400745)"
Line 1325,"When we uncover an issue, we investigate and remediate through a formal, consistent, and fair review process.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7139251232147217)","('Business_Ethics', 0.13169194757938385)","('Human_Rights_And_Community_Relations', 0.0181149709969759)","(['Corporate Governance'], 0.7139251232147217)","('NON-ESG', 0.13169194757938385)","('NON-ESG', 0.0181149709969759)"
Line 1326,"Our annual risk-assessment process includes a rigorous review of internal and external data and trends.
","('Systemic_Risk_Management', 0.7939161658287048)","('Business_Model_Resilience', 0.04825849458575249)","('Physical_Impacts_Of_Climate_Change', 0.021923957392573357)","(['Risk & Crisis Management'], 0.7939161658287048)","('NON-ESG', 0.04825849458575249)","('NON-ESG', 0.021923957392573357)"
Line 1327,"Components of this review include regulatory enforcement actions, hotline reporting, investigations, internal auditing, and data analyses to identify high-risk areas for investigation and remediation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9154253005981445)","('Business_Ethics', 0.031960226595401764)","('Director_Removal', 0.004069623537361622)","(['Corporate Governance'], 0.9154253005981445)","('NON-ESG', 0.031960226595401764)","('NON-ESG', 0.004069623537361622)"
Line 1328,"We conduct root-cause analyses on confirmed issues and take appropriate corrective action to prevent recurrences.
","('Management_Of_Legal_And_Regulatory_Framework', 0.505612850189209)","('Business_Ethics', 0.12657055258750916)","('Systemic_Risk_Management', 0.11820292472839355)","(['Corporate Governance'], 0.505612850189209)","('NON-ESG', 0.12657055258750916)","('NON-ESG', 0.11820292472839355)"
Line 1329,"Encouraging a speak up culture When employees need ethical guidance or have concerns about potential violations, we strongly encourage them to speak up, even anonymously  if they choose, through one of the following channels: •  T heir manager •  Human R esources •  L egal or Compliance representatives •   T he board of directors’ email inbox, which is  monitored by staff who bring pertinent matters to   the board’s attention •  V oice Your Concern Line •   Exit interviews,  in which departing employees are  invited to share ethical concernsOur chief counsel of global compliance investigations is responsible for supporting these processes across Medtronic.
","('Business_Ethics', 0.915118932723999)","('Management_Of_Legal_And_Regulatory_Framework', 0.009248015470802784)","('Human_Rights_And_Community_Relations', 0.008996592834591866)","(['Business Ethics'], 0.915118932723999)","('NON-ESG', 0.009248015470802784)","('NON-ESG', 0.008996592834591866)"
Line 1330,"Encouraging a speak up culture When employees need ethical guidance or have concerns about potential violations, we strongly encourage them to speak up, even anonymously  if they choose, through one of the following channels: •  T heir manager •  Human R esources •  L egal or Compliance representatives •   T he board of directors’ email inbox, which is  monitored by staff who bring pertinent matters to   the board’s attention •  V oice Your Concern Line •   Exit interviews,  in which departing employees are  invited to share ethical concernsOur chief counsel of global compliance investigations is responsible for supporting these processes across Medtronic.
","('Business_Ethics', 0.9686412811279297)","('Management_Of_Legal_And_Regulatory_Framework', 0.006028229370713234)","('Product_Quality_And_Safety', 0.0030289962887763977)","(['Business Ethics'], 0.9686412811279297)","('NON-ESG', 0.006028229370713234)","('NON-ESG', 0.0030289962887763977)"
Line 1331,"Partnering with our colleagues in Employee Relations, we also maintain an Organizational Justice program to enhance consistency in our internal processes around alleged misconduct, including how we remediate misconduct globally.
","('Business_Ethics', 0.9546276330947876)","('Employee_Health_And_Safety', 0.005479377694427967)","('Product_Quality_And_Safety', 0.0035932150203734636)","(['Business Ethics'], 0.9546276330947876)","('NON-ESG', 0.005479377694427967)","('NON-ESG', 0.0035932150203734636)"
Line 1332,"Our anonymity rate is below external benchmarks and is trending down over time, evidencing a positive “speak up” culture.
","('Customer_Privacy', 0.5908547639846802)","('Data_Security', 0.11686114966869354)","('Business_Ethics', 0.07556638866662979)","(['Privacy Protection'], 0.5908547639846802)","('NON-ESG', 0.11686114966869354)","('NON-ESG', 0.07556638866662979)"
Line 1333,"Employees globally can access our Voice Your Concern  Line at any time to report potential ethics issues or seek guidance, and we updated our reporting portal to simplify access in local languages.
","('Business_Ethics', 0.9503090381622314)","('Management_Of_Legal_And_Regulatory_Framework', 0.010866882279515266)","('Product_Quality_And_Safety', 0.004760566167533398)","(['Business Ethics'], 0.9503090381622314)","('NON-ESG', 0.010866882279515266)","('NON-ESG', 0.004760566167533398)"
Line 1334,"Of the concerns received in FY22, 87% were deemed mild risk, 12% were moderate risk, and 1% were elevated risk.
","('Systemic_Risk_Management', 0.8423675894737244)","('Physical_Impacts_Of_Climate_Change', 0.018746746703982353)","('Business_Ethics', 0.017878344282507896)","(['Risk & Crisis Management'], 0.8423675894737244)","('NON-ESG', 0.018746746703982353)","('NON-ESG', 0.017878344282507896)"
Line 1335,"The most common inquiries pertained to workplace misconduct (63%), followed by general questions or concerns (14%).
","('Business_Ethics', 0.876643717288971)","('Employee_Health_And_Safety', 0.0311268363147974)","('Employee_Engagement_Inclusion_And_Diversity', 0.013221727684140205)","(['Business Ethics'], 0.876643717288971)","('NON-ESG', 0.0311268363147974)","('NON-ESG', 0.013221727684140205)"
Line 1336,"We closely monitor the number of days between reporting and closure to help ensure timely review of  all concerns.
","('Critical_Incident_Risk_Management', 0.4055905044078827)","('Management_Of_Legal_And_Regulatory_Framework', 0.08647003769874573)","('Air_Quality', 0.06434432417154312)","('NON-ESG', 0.4055905044078827)","('NON-ESG', 0.08647003769874573)","('NON-ESG', 0.06434432417154312)"
Line 1337,"Corrective actions If an investigation confirms employee misconduct, we take corrective action, which may include coaching, discussion during performance reviews, changes in job responsibilities (such as a demotion), or, in serious cases, dismissal.
","('Business_Ethics', 0.7295948266983032)","('Employee_Health_And_Safety', 0.08897119015455246)","('Labor_Practices', 0.03152500465512276)","(['Business Ethics'], 0.7295948266983032)","('NON-ESG', 0.08897119015455246)","('NON-ESG', 0.03152500465512276)"
Line 1338,"We also review root causes to assess for broader improvement actions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5669388771057129)","('Human_Rights_And_Community_Relations', 0.14494234323501587)","('Access_And_Affordability', 0.03850677236914635)","(['Corporate Governance'], 0.5669388771057129)","('NON-ESG', 0.14494234323501587)","('NON-ESG', 0.03850677236914635)"
Line 1339,"During calendar year 2022, 201 employees were terminated for ethical and compliance-related infractions, down from 270 in calendar year 2021.VOICE YOUR CONCERN LINE  FY20 FY21 FYNumber of inquires 972 789  Mild risk 84% 84% 87%  Moderate risk 14% 14% 12% Elevated risk 2% 2% 1% INQUIRIES BY ISSUE†  FY20 FY21 FYWorkplace conduct 63% 56% 63% Concerns or questions 15% 21% 14% EHS concerns 7% 8% 8% Quality/regulatory 4% 4% 3% Fraud and accounting 4% 3% 4% HCP interactions 4% 3% 3% Patient relations 1% 3% 2% Privacy/security 2% 1% 2% Antitrust/fair dealing 1% 1% 0% Theft 0% 0% 0% Import/export‡0% 0% N/A Security concerns‡N/A N/A N/A † Some columns may not add up to 100% due to rounding.
","('Business_Ethics', 0.9680742025375366)","('Management_Of_Legal_And_Regulatory_Framework', 0.003988099750131369)","('Product_Quality_And_Safety', 0.0027491117361932993)","(['Business Ethics'], 0.9680742025375366)","('NON-ESG', 0.003988099750131369)","('NON-ESG', 0.0027491117361932993)"
Line 1340,"During calendar year 2022, 201 employees were terminated for ethical and compliance-related infractions, down from 270 in calendar year 2021.VOICE YOUR CONCERN LINE  FY20 FY21 FYNumber of inquires 972 789  Mild risk 84% 84% 87%  Moderate risk 14% 14% 12% Elevated risk 2% 2% 1% INQUIRIES BY ISSUE†  FY20 FY21 FYWorkplace conduct 63% 56% 63% Concerns or questions 15% 21% 14% EHS concerns 7% 8% 8% Quality/regulatory 4% 4% 3% Fraud and accounting 4% 3% 4% HCP interactions 4% 3% 3% Patient relations 1% 3% 2% Privacy/security 2% 1% 2% Antitrust/fair dealing 1% 1% 0% Theft 0% 0% 0% Import/export‡0% 0% N/A Security concerns‡N/A N/A N/A † Some columns may not add up to 100% due to rounding.
","('Business_Ethics', 0.905441164970398)","('Competitive_Behavior', 0.023910988122224808)","('Systemic_Risk_Management', 0.012538292445242405)","(['Business Ethics'], 0.905441164970398)","('NON-ESG', 0.023910988122224808)","('NON-ESG', 0.012538292445242405)"
Line 1341,"‡ N/A denotes 0 inquiries whereas 0% represents a near zero percent of inquiries.
","('Competitive_Behavior', 0.3432702124118805)","('Management_Of_Legal_And_Regulatory_Framework', 0.189649760723114)","('Business_Ethics', 0.05338238179683685)","('NON-ESG', 0.3432702124118805)","('NON-ESG', 0.189649760723114)","('NON-ESG', 0.05338238179683685)"
Line 1342,"2022 Integrated Performance Report       94 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexemployees (full-time equivalent)  supporting anti-corruption efforts in FY99 % third-party distributors received   anti-corruption training in FY99.5 %  marketing and sales employees trained  on ethical product promotionEthics in  sales and marketing We advance patient safety as our top priority  by upholding the highest standards of integrity in our sales and marketing practices.
","('Business_Ethics', 0.8572962880134583)","('Product_Quality_And_Safety', 0.05882866308093071)","('Employee_Health_And_Safety', 0.00976939219981432)","(['Business Ethics'], 0.8572962880134583)","('NON-ESG', 0.05882866308093071)","('NON-ESG', 0.00976939219981432)"
Line 1343,"2022 Integrated Performance Report       94 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexemployees (full-time equivalent)  supporting anti-corruption efforts in FY99 % third-party distributors received   anti-corruption training in FY99.5 %  marketing and sales employees trained  on ethical product promotionEthics in  sales and marketing We advance patient safety as our top priority  by upholding the highest standards of integrity in our sales and marketing practices.
","('Competitive_Behavior', 0.19852286577224731)","('Customer_Privacy', 0.14843986928462982)","('Selling_Practices_And_Product_Labeling', 0.12450674921274185)","('NON-ESG', 0.19852286577224731)","('NON-ESG', 0.14843986928462982)","('NON-ESG', 0.12450674921274185)"
Line 1344,"Our uncompromising approach to ethical responsibility extends from how we label and promote Medtronic products to the ways our sales and marketing teams interact with healthcare professionals.Adding business value Ethical sales and marketing practices are  paramount in building and maintaining trust with our stakeholders, safeguarding our reputation, and reducing legal and regulatory risk.GOVERNANCE AND ACCOUNTABILITY 2022 Integrated Performance Report       95 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexETHICS IN SALES AND MARKETING Responsible marketing All Medtronic employees are required to adhere to   the sales and marketing practices outlined in our  Code of Conduct and our Global Business Conduct Standards Policy.
","('Business_Ethics', 0.5066359639167786)","('Product_Quality_And_Safety', 0.11248354613780975)","('Selling_Practices_And_Product_Labeling', 0.09659337252378464)","(['Business Ethics'], 0.5066359639167786)","('NON-ESG', 0.11248354613780975)","('NON-ESG', 0.09659337252378464)"
Line 1345,"Our uncompromising approach to ethical responsibility extends from how we label and promote Medtronic products to the ways our sales and marketing teams interact with healthcare professionals.Adding business value Ethical sales and marketing practices are  paramount in building and maintaining trust with our stakeholders, safeguarding our reputation, and reducing legal and regulatory risk.GOVERNANCE AND ACCOUNTABILITY 2022 Integrated Performance Report       95 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexETHICS IN SALES AND MARKETING Responsible marketing All Medtronic employees are required to adhere to   the sales and marketing practices outlined in our  Code of Conduct and our Global Business Conduct Standards Policy.
","('Business_Ethics', 0.42831510305404663)","('Competitive_Behavior', 0.13538917899131775)","('Management_Of_Legal_And_Regulatory_Framework', 0.10017839819192886)","('NON-ESG', 0.42831510305404663)","('NON-ESG', 0.13538917899131775)","('NON-ESG', 0.10017839819192886)"
Line 1346,"We also expect employees to comply with industry codes of ethics and to follow all local  laws and regulations.
","('Business_Ethics', 0.9312151670455933)","('Management_Of_Legal_And_Regulatory_Framework', 0.01565583609044552)","('Product_Quality_And_Safety', 0.006115252152085304)","(['Business Ethics'], 0.9312151670455933)","('NON-ESG', 0.01565583609044552)","('NON-ESG', 0.006115252152085304)"
Line 1347,"We continually evolve our responsible marketing  practices in line with current and emerging market trends.
","('Competitive_Behavior', 0.46015992760658264)","('Customer_Welfare', 0.1650102734565735)","('Selling_Practices_And_Product_Labeling', 0.08676473796367645)","('NON-ESG', 0.46015992760658264)","('NON-ESG', 0.1650102734565735)","('NON-ESG', 0.08676473796367645)"
Line 1348,"This commitment helps shape our approach to ethics in marketing-related areas, such as social media communications, virtual interactions with customers, and off-label use of Medtronic products.
","('Product_Design_And_Lifecycle_Management', 0.3760937750339508)","('Selling_Practices_And_Product_Labeling', 0.31523048877716064)","('Customer_Welfare', 0.0815998911857605)","('NON-ESG', 0.3760937750339508)","('NON-ESG', 0.31523048877716064)","('NON-ESG', 0.0815998911857605)"
Line 1349,"Ethical interactions We work with healthcare professionals to expand patient access to our products and therapies.
","('Product_Design_And_Lifecycle_Management', 0.5493443608283997)","('Customer_Welfare', 0.1206636056303978)","('Selling_Practices_And_Product_Labeling', 0.06718913465738297)","(['Product Stewardship'], 0.5493443608283997)","('NON-ESG', 0.1206636056303978)","('NON-ESG', 0.06718913465738297)"
Line 1350,"Our Code of Conduct incorporates companywide principles and standards governing employee interactions with healthcare professionals.
","('Business_Ethics', 0.6913824081420898)","('Customer_Privacy', 0.05122493579983711)","('Product_Quality_And_Safety', 0.04593496397137642)","(['Business Ethics'], 0.6913824081420898)","('NON-ESG', 0.05122493579983711)","('NON-ESG', 0.04593496397137642)"
Line 1351,"Our policies include a strong focus on appropriate  interactions and transparency around those interactions, including payments to physicians, physician-owned entities, and healthcare organizations.
","('Business_Ethics', 0.9646255970001221)","('Customer_Privacy', 0.0035006192047148943)","('Data_Security', 0.003309220541268587)","(['Business Ethics'], 0.9646255970001221)","('NON-ESG', 0.0035006192047148943)","('NON-ESG', 0.003309220541268587)"
Line 1352,"Through diligent adherence to ethical requirements, we preserve the integrity of physician-patient relationships and avoid conflicts of interest.Our physician interactions include: •  C ollaborating to develop new devices and therapies.
","('Business_Ethics', 0.7941674590110779)","('Competitive_Behavior', 0.03571971505880356)","('Management_Of_Legal_And_Regulatory_Framework', 0.029459094628691673)","(['Business Ethics'], 0.7941674590110779)","('NON-ESG', 0.03571971505880356)","('NON-ESG', 0.029459094628691673)"
Line 1353,"•  Developing educa tional materials and campaigns.
","('Access_And_Affordability', 0.17822790145874023)","('Management_Of_Legal_And_Regulatory_Framework', 0.1742667406797409)","('Product_Design_And_Lifecycle_Management', 0.11489509046077728)","('NON-ESG', 0.17822790145874023)","('NON-ESG', 0.1742667406797409)","('NON-ESG', 0.11489509046077728)"
Line 1354,"•  P artnering on clinical research.
","('Access_And_Affordability', 0.19801893830299377)","('Customer_Welfare', 0.11281273514032364)","('Competitive_Behavior', 0.09326083213090897)","('NON-ESG', 0.19801893830299377)","('NON-ESG', 0.11281273514032364)","('NON-ESG', 0.09326083213090897)"
Line 1355,"•   P roviding training on how to use our devices and  therapies.
","('Product_Design_And_Lifecycle_Management', 0.5583623647689819)","('Customer_Welfare', 0.0824037566781044)","('Access_And_Affordability', 0.07476592808961868)","(['Product Stewardship'], 0.5583623647689819)","('NON-ESG', 0.0824037566781044)","('NON-ESG', 0.07476592808961868)"
Line 1356,"All physician collaboration requires a verified legitimate  business purpose.
","('Competitive_Behavior', 0.15663324296474457)","('Business_Ethics', 0.14060309529304504)","('Access_And_Affordability', 0.08750840276479721)","('NON-ESG', 0.15663324296474457)","('NON-ESG', 0.14060309529304504)","('NON-ESG', 0.08750840276479721)"
Line 1357,"We follow a rigorous process to assess physician collaboration opportunities and ensure that any consulting payments reflect fair market value for services performed.
","('Competitive_Behavior', 0.43418633937835693)","('Management_Of_Legal_And_Regulatory_Framework', 0.26564809679985046)","('Business_Ethics', 0.10810082405805588)","('NON-ESG', 0.43418633937835693)","('NON-ESG', 0.26564809679985046)","('NON-ESG', 0.10810082405805588)"
Line 1358,"Our actions in FY22 included providing an updated  mobile app to help our employees comply with spending limits on business meals with healthcare professionals.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5696868300437927)","('Labor_Practices', 0.16539008915424347)","('Access_And_Affordability', 0.04716784134507179)","(['Corporate Governance'], 0.5696868300437927)","('NON-ESG', 0.16539008915424347)","('NON-ESG', 0.04716784134507179)"
Line 1359,"We also launched the Capital Equipment Optimization Project, which delivers consistent training and other guidance on appropriate practices governing capital equipment arrangements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7032074928283691)","('Competitive_Behavior', 0.06428394466638565)","('Business_Model_Resilience', 0.04136580601334572)","(['Corporate Governance'], 0.7032074928283691)","('NON-ESG', 0.06428394466638565)","('NON-ESG', 0.04136580601334572)"
Line 1360,"We transparently disclose transfers of value to healthcare  professionals in each country where required by law.
","('Management_Of_Legal_And_Regulatory_Framework', 0.32679712772369385)","('Business_Ethics', 0.20254546403884888)","('Systemic_Risk_Management', 0.07506325840950012)","('NON-ESG', 0.32679712772369385)","('NON-ESG', 0.20254546403884888)","('NON-ESG', 0.07506325840950012)"
Line 1361,"In the U.S., we publish our payment disclosures on the Centers for Medicare and Medicaid Services open payments site.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7107438445091248)","('Systemic_Risk_Management', 0.07116567343473434)","('Business_Ethics', 0.038103412836790085)","(['Corporate Governance'], 0.7107438445091248)","('NON-ESG', 0.07116567343473434)","('NON-ESG', 0.038103412836790085)"
Line 1362,"Beginning with our calendar year 2021 disclosure, we expanded our U.S. reporting to include Physician Assistants and Advance Practice Registered Nurses and consolidated reporting under one entity to help reinforce our commitment to transparency.
","('Business_Ethics', 0.9253886342048645)","('Systemic_Risk_Management', 0.01035352237522602)","('Management_Of_Legal_And_Regulatory_Framework', 0.008693660609424114)","(['Business Ethics'], 0.9253886342048645)","('NON-ESG', 0.01035352237522602)","('NON-ESG', 0.008693660609424114)"
Line 1363,"Finally, we also ensure adherence to appropriate  marketing practices through routine audits, monitoring, and our investigative processes.
","('Business_Ethics', 0.7118278741836548)","('Management_Of_Legal_And_Regulatory_Framework', 0.06583765894174576)","('Competitive_Behavior', 0.04939650744199753)","(['Business Ethics'], 0.7118278741836548)","('NON-ESG', 0.06583765894174576)","('NON-ESG', 0.04939650744199753)"
Line 1364,"2022 Integrated Performance Report       96 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexETHICS IN SALES AND MARKETING Countering corruption The Medtronic board of directors oversees our anti- bribery and anti-corruption (ABAC) program.
","('Business_Ethics', 0.9757004380226135)","('Management_Of_Legal_And_Regulatory_Framework', 0.002494571963325143)","('Competitive_Behavior', 0.0021355494391173124)","(['Business Ethics'], 0.9757004380226135)","('NON-ESG', 0.002494571963325143)","('NON-ESG', 0.0021355494391173124)"
Line 1365,"We strengthen this program by periodically incorporating information from regulators, third-party audits, benchmarking, and best practices.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8667559623718262)","('Business_Ethics', 0.05317000299692154)","('Competitive_Behavior', 0.01342950202524662)","(['Corporate Governance'], 0.8667559623718262)","('NON-ESG', 0.05317000299692154)","('NON-ESG', 0.01342950202524662)"
Line 1366,"We have 179 full-time equivalent employees supporting ABAC efforts.
","('Labor_Practices', 0.9011355638504028)","('Employee_Engagement_Inclusion_And_Diversity', 0.03321390599012375)","('Employee_Health_And_Safety', 0.006535618100315332)","(['Labor Practice Indicators'], 0.9011355638504028)","('NON-ESG', 0.03321390599012375)","('NON-ESG', 0.006535618100315332)"
Line 1367,"Our Code of Conduct and ABAC policy prohibit bribery  or facilitation payments and, in most countries, prohibits gift exchange.
","('Business_Ethics', 0.9755716323852539)","('Management_Of_Legal_And_Regulatory_Framework', 0.0025812394451349974)","('Competitive_Behavior', 0.0021126624196767807)","(['Business Ethics'], 0.9755716323852539)","('NON-ESG', 0.0025812394451349974)","('NON-ESG', 0.0021126624196767807)"
Line 1368,"We clearly communicate these and other ethical standards to our full-time and part-time employees, as well as to contractors, through Medtronic policies, guidelines, and training programs.
","('Business_Ethics', 0.7221115827560425)","('Labor_Practices', 0.11136756837368011)","('Product_Quality_And_Safety', 0.021642319858074188)","(['Business Ethics'], 0.7221115827560425)","('NON-ESG', 0.11136756837368011)","('NON-ESG', 0.021642319858074188)"
Line 1369,"We train internal and external stakeholders on ABAC  to make them aware of applicable regulations and to help them address ethically challenging scenarios.
","('Business_Ethics', 0.7805972099304199)","('Management_Of_Legal_And_Regulatory_Framework', 0.12743209302425385)","('Competitive_Behavior', 0.016903595998883247)","(['Business Ethics'], 0.7805972099304199)","('NON-ESG', 0.12743209302425385)","('NON-ESG', 0.016903595998883247)"
Line 1370,"All newly hired sales employees receive in-depth training on our ethical sales practices within their first 60 days, with multiple, focused touch points throughout their first year.
","('Product_Quality_And_Safety', 0.2545565366744995)","('Employee_Engagement_Inclusion_And_Diversity', 0.15555410087108612)","('Business_Ethics', 0.09912212193012238)","('NON-ESG', 0.2545565366744995)","('NON-ESG', 0.15555410087108612)","('NON-ESG', 0.09912212193012238)"
Line 1371,"Additionally, in FY22, we rolled out expanded global  training on fair competition practices for all Medtronic personnel who interact with customers and for employees in supporting roles.
","('Competitive_Behavior', 0.9593035578727722)","('Business_Ethics', 0.005614779889583588)","('Product_Quality_And_Safety', 0.0029690400697290897)","(['Business Ethics'], 0.9593035578727722)","('NON-ESG', 0.005614779889583588)","('NON-ESG', 0.0029690400697290897)"
Line 1372,"Distributors and partners When partnering with third-party entities to distribute our products to customers, we hold these partners to our high standards and require them to implement their own anti-corruption programs.
","('Business_Ethics', 0.6613988280296326)","('Product_Quality_And_Safety', 0.14224573969841003)","('Competitive_Behavior', 0.04719815403223038)","(['Business Ethics'], 0.6613988280296326)","('NON-ESG', 0.14224573969841003)","('NON-ESG', 0.04719815403223038)"
Line 1373,"We also share resources such as a best-practices toolkit, which we co-developed with AdvaMed and has been translated into nine languages to enable consistent industry standards.As a condition of working with Medtronic, all distributors must formally adopt a code of conduct that aligns with our ethical standards.
","('Business_Ethics', 0.9380525350570679)","('Product_Quality_And_Safety', 0.011276517994701862)","('Management_Of_Legal_And_Regulatory_Framework', 0.007759644649922848)","(['Business Ethics'], 0.9380525350570679)","('NON-ESG', 0.011276517994701862)","('NON-ESG', 0.007759644649922848)"
Line 1374,"We provide a sample code of conduct that distributors may use as a template, as well as other online resources in 13 languages to help distributors implement their own compliance program.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6743128895759583)","('Business_Ethics', 0.23428043723106384)","('Product_Quality_And_Safety', 0.011317574419081211)","(['Corporate Governance'], 0.6743128895759583)","('NON-ESG', 0.23428043723106384)","('NON-ESG', 0.011317574419081211)"
Line 1375,"To further ensure that distributors adhere to our ethical  standards, we: •   R equire an annual commitment to abide by their  adopted code of conduct.
","('Business_Ethics', 0.9297237396240234)","('Product_Quality_And_Safety', 0.015322603285312653)","('Management_Of_Legal_And_Regulatory_Framework', 0.0063383933156728745)","(['Business Ethics'], 0.9297237396240234)","('NON-ESG', 0.015322603285312653)","('NON-ESG', 0.0063383933156728745)"
Line 1376,"•   R equire that they complete anti-corruption training   at least every two years and implement their own   anti-corruption programs.
","('Business_Ethics', 0.9659966826438904)","('Management_Of_Legal_And_Regulatory_Framework', 0.004428867716342211)","('Competitive_Behavior', 0.0031569150742143393)","(['Business Ethics'], 0.9659966826438904)","('NON-ESG', 0.004428867716342211)","('NON-ESG', 0.0031569150742143393)"
Line 1377,"•   Suppor t and monitor compliance, including  conducting on-site monitoring of distributors.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5841491222381592)","('Business_Ethics', 0.25440630316734314)","('Product_Quality_And_Safety', 0.022769367322325706)","(['Corporate Governance'], 0.5841491222381592)","('NON-ESG', 0.25440630316734314)","('NON-ESG', 0.022769367322325706)"
Line 1378,"•   Assess corruption potential prior to r enewing or  entering contracts.
","('Business_Ethics', 0.9725894331932068)","('Management_Of_Legal_And_Regulatory_Framework', 0.003437136532738805)","('Competitive_Behavior', 0.002979160286486149)","(['Business Ethics'], 0.9725894331932068)","('NON-ESG', 0.003437136532738805)","('NON-ESG', 0.002979160286486149)"
Line 1379,"Our internal commercial Distributor Relationship Owners (DROs) are responsible for holding distributors accountable to ABAC requirements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3918471932411194)","('Competitive_Behavior', 0.24718907475471497)","('Systemic_Risk_Management', 0.10459138453006744)","('NON-ESG', 0.3918471932411194)","('NON-ESG', 0.24718907475471497)","('NON-ESG', 0.10459138453006744)"
Line 1380,"Distributors must assign a senior leader from their management team to oversee their organization’s ethical practices, conduct employee training, ensure compliance with their code of conduct, and address Medtronic-specific reporting requirements.
","('Business_Ethics', 0.9514548182487488)","('Product_Quality_And_Safety', 0.004963110666722059)","('Labor_Practices', 0.003731842851266265)","(['Business Ethics'], 0.9514548182487488)","('NON-ESG', 0.004963110666722059)","('NON-ESG', 0.003731842851266265)"
Line 1381,"DROs also meet regularly with distributors to discuss  and certify their understanding of ethical requirements.
","('Business_Ethics', 0.8312720060348511)","('Product_Quality_And_Safety', 0.03436555340886116)","('Competitive_Behavior', 0.017760848626494408)","(['Business Ethics'], 0.8312720060348511)","('NON-ESG', 0.03436555340886116)","('NON-ESG', 0.017760848626494408)"
Line 1382,"In FY22, we held numerous training and communication activities involving distributors and their respective DROs on various topics, such as accounting transparency.
","('Business_Ethics', 0.9419050216674805)","('Management_Of_Legal_And_Regulatory_Framework', 0.009804855100810528)","('Systemic_Risk_Management', 0.008805525489151478)","(['Business Ethics'], 0.9419050216674805)","('NON-ESG', 0.009804855100810528)","('NON-ESG', 0.008805525489151478)"
Line 1383,"We continue to expand our direct sales infrastructure  in specific markets to reduce our reliance on third-party distributors, decrease risk, and improve customer service.COUNTERING CORRUPTION   FY20 FY21 FYEmployees (full-time equivalent) supporting   anti-corruption efforts214 215 179† Third-party distributors receiving anti-corruption training 98% 99% 99% Third-party distributors receiving on-site monitoring  (life of program)12% 13% 15% †  Beginning in FY22,  we removed nonlegal/compliance employees from this count, leading to a decrease from prior years.
","('Business_Ethics', 0.9709638357162476)","('Product_Quality_And_Safety', 0.0026836448814719915)","('Data_Security', 0.002470222767442465)","(['Business Ethics'], 0.9709638357162476)","('NON-ESG', 0.0026836448814719915)","('NON-ESG', 0.002470222767442465)"
Line 1384,"We continue to expand our direct sales infrastructure  in specific markets to reduce our reliance on third-party distributors, decrease risk, and improve customer service.COUNTERING CORRUPTION   FY20 FY21 FYEmployees (full-time equivalent) supporting   anti-corruption efforts214 215 179† Third-party distributors receiving anti-corruption training 98% 99% 99% Third-party distributors receiving on-site monitoring  (life of program)12% 13% 15% †  Beginning in FY22,  we removed nonlegal/compliance employees from this count, leading to a decrease from prior years.
","('Systemic_Risk_Management', 0.19002065062522888)","('Employee_Engagement_Inclusion_And_Diversity', 0.10876645892858505)","('Management_Of_Legal_And_Regulatory_Framework', 0.0802408829331398)","('NON-ESG', 0.19002065062522888)","('NON-ESG', 0.10876645892858505)","('NON-ESG', 0.0802408829331398)"
Line 1385,"RESPONSIBLE MARKETING TO CUSTOMERS AND PATIENTS  FY20 FY21 FYFines or settlements related to improper marketing  or sales of products †0 1‡Fines or settlements paid by Medtronic related to noncompliance with anti-corruption laws (#) §– – Marketing and sales employees trained on  product promotion18,753 18,416 18,† Fines noted represent the year the fine was paid.
","('Business_Ethics', 0.6607322096824646)","('Selling_Practices_And_Product_Labeling', 0.0664527416229248)","('Competitive_Behavior', 0.05724899470806122)","(['Business Ethics'], 0.6607322096824646)","('NON-ESG', 0.0664527416229248)","('NON-ESG', 0.05724899470806122)"
Line 1386,"‡ $9.2 million settlement related to the interaction between sales employees and a neurosurgeon in South Dakota.
","('Employee_Health_And_Safety', 0.5623257160186768)","('Employee_Engagement_Inclusion_And_Diversity', 0.11683157086372375)","('Access_And_Affordability', 0.05365815758705139)","(['Operational Eco-Efficiency'], 0.5623257160186768)","('NON-ESG', 0.11683157086372375)","('NON-ESG', 0.05365815758705139)"
Line 1387,"§ FY22 is the first year for which Medtronic is reporting on this category.
","('Systemic_Risk_Management', 0.24164244532585144)","('Management_Of_Legal_And_Regulatory_Framework', 0.22674547135829926)","('Product_Quality_And_Safety', 0.06715632975101471)","('NON-ESG', 0.24164244532585144)","('NON-ESG', 0.22674547135829926)","('NON-ESG', 0.06715632975101471)"
Line 1388,"2022 Integrated Performance Report       97 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure index95,000+ full-time employees in more than   150 countries $31.7B in revenue in FY22 Our economic  impact Medtronic creates rewarding jobs and  expands economic opportunity in local communities through our global operations.
","('Human_Rights_And_Community_Relations', 0.8827416896820068)","('Access_And_Affordability', 0.020313691347837448)","('Employee_Engagement_Inclusion_And_Diversity', 0.014811929315328598)","(['Community Relations'], 0.8827416896820068)","('NON-ESG', 0.020313691347837448)","('NON-ESG', 0.014811929315328598)"
Line 1389,"We deliver direct economic benefit to individuals and communities through the wages and taxes we pay, and indirect benefit through our business with suppliers.
","('Labor_Practices', 0.9255833029747009)","('Management_Of_Legal_And_Regulatory_Framework', 0.019459960982203484)","('Human_Rights_And_Community_Relations', 0.008215570822358131)","(['Labor Practice Indicators'], 0.9255833029747009)","('NON-ESG', 0.019459960982203484)","('NON-ESG', 0.008215570822358131)"
Line 1390,"Our strong business track record and continued growth enables us to increase the dividends we return to shareholders.
","('Systemic_Risk_Management', 0.42422327399253845)","('Competitive_Behavior', 0.17318062484264374)","('Business_Model_Resilience', 0.15984392166137695)","('NON-ESG', 0.42422327399253845)","('NON-ESG', 0.17318062484264374)","('NON-ESG', 0.15984392166137695)"
Line 1391,"Adding business value Growing businesses need healthy economies to thrive.
","('Business_Model_Resilience', 0.7311716079711914)","('Systemic_Risk_Management', 0.049515388906002045)","('Supply_Chain_Management', 0.03620050475001335)","(['Codes of Business Conduct'], 0.7311716079711914)","('NON-ESG', 0.049515388906002045)","('NON-ESG', 0.03620050475001335)"
Line 1392,"Our continued financial success fuels broader long-term prosperity for our employees, suppliers, communities, and shareholders, which collectively contribute to the wider economic health of society.GOVERNANCE AND ACCOUNTABILITY 2022 Integrated Performance Report       98 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexOUR ECONOMIC IMPACT Financial performance In FY22, we continued to increase our revenue and  market share while contending with global supply chain issues and other ongoing impacts of COVID-19, including a revenue decline in our China operations due to recent lockdowns.
","('Human_Rights_And_Community_Relations', 0.5752195715904236)","('Management_Of_Legal_And_Regulatory_Framework', 0.10460592061281204)","('Business_Model_Resilience', 0.08300181478261948)","(['Community Relations'], 0.5752195715904236)","('NON-ESG', 0.10460592061281204)","('NON-ESG', 0.08300181478261948)"
Line 1393,"Our continued financial success fuels broader long-term prosperity for our employees, suppliers, communities, and shareholders, which collectively contribute to the wider economic health of society.GOVERNANCE AND ACCOUNTABILITY 2022 Integrated Performance Report       98 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexOUR ECONOMIC IMPACT Financial performance In FY22, we continued to increase our revenue and  market share while contending with global supply chain issues and other ongoing impacts of COVID-19, including a revenue decline in our China operations due to recent lockdowns.
","('Supply_Chain_Management', 0.9549707174301147)","('Physical_Impacts_Of_Climate_Change', 0.004342164844274521)","('Systemic_Risk_Management', 0.0034886146895587444)","(['Supply Chain Management'], 0.9549707174301147)","('NON-ESG', 0.004342164844274521)","('NON-ESG', 0.0034886146895587444)"
Line 1394,"Although these challenges had an impact on our financial performance, we maintained strong support for customers, employees, and communities in more than 150 countries.
","('Human_Rights_And_Community_Relations', 0.8521292209625244)","('Employee_Health_And_Safety', 0.015135366469621658)","('Business_Model_Resilience', 0.014126420952379704)","(['Community Relations'], 0.8521292209625244)","('NON-ESG', 0.015135366469621658)","('NON-ESG', 0.014126420952379704)"
Line 1395,"Our FY22 revenue totaled nearly $31.7 billion — an  increase of approximately 5.5% on an organic basis, compared to FY21 — which excludes the $75 million negative impact of foreign currency translation.
","('Systemic_Risk_Management', 0.4458025097846985)","('Management_Of_Legal_And_Regulatory_Framework', 0.19967857003211975)","('Business_Model_Resilience', 0.08078285306692123)","('NON-ESG', 0.4458025097846985)","('NON-ESG', 0.19967857003211975)","('NON-ESG', 0.08078285306692123)"
Line 1396,"Revenue from emerging markets comprised 17% of our total revenue and increased 13% on an organic basis compared to FY21.
","('Business_Model_Resilience', 0.2991121709346771)","('Systemic_Risk_Management', 0.2717254161834717)","('Supply_Chain_Management', 0.08207341283559799)","('NON-ESG', 0.2991121709346771)","('NON-ESG', 0.2717254161834717)","('NON-ESG', 0.08207341283559799)"
Line 1397,"Our non-GAAP , currency-adjusted operating profit of  $8.7 billion increased by nearly 22% compared to FY21, and we grew adjusted earnings per share by 26% in FY22.
","('Systemic_Risk_Management', 0.6930015683174133)","('Business_Model_Resilience', 0.09265007823705673)","('Competitive_Behavior', 0.038360193371772766)","(['Risk & Crisis Management'], 0.6930015683174133)","('NON-ESG', 0.09265007823705673)","('NON-ESG', 0.038360193371772766)"
Line 1398,"Our research and development (R&D) investments grew to an all-time high of $2.7 billion in FY22 — a 10% increase compared to the previous fiscal year — which reflects our continued focus on innovation as the engine of our long-term revenue growth.
","('Business_Model_Resilience', 0.6970834136009216)","('Systemic_Risk_Management', 0.059940438717603683)","('Supply_Chain_Management', 0.04789638891816139)","(['Codes of Business Conduct'], 0.6970834136009216)","('NON-ESG', 0.059940438717603683)","('NON-ESG', 0.04789638891816139)"
Line 1399,"For example, we are investing in capabilities such as renal denervation, surgical robotics, and additional breakthroughs in data and artificial intelligence.
","('Business_Model_Resilience', 0.14299876987934113)","('Product_Design_And_Lifecycle_Management', 0.11516732722520828)","('Competitive_Behavior', 0.09425836056470871)","('NON-ESG', 0.14299876987934113)","('NON-ESG', 0.11516732722520828)","('NON-ESG', 0.09425836056470871)"
Line 1400,"We have set long-term goals to continue growing our  annual organic revenue by 5% or more, return at least 80% of our free cash flow to shareholders, and increase our adjusted earnings per share by 8% annually.
","('Business_Model_Resilience', 0.49388387799263)","('Systemic_Risk_Management', 0.1523410528898239)","('Competitive_Behavior', 0.05729874223470688)","('NON-ESG', 0.49388387799263)","('NON-ESG', 0.1523410528898239)","('NON-ESG', 0.05729874223470688)"
Line 1401,"See our 2022 Form 10-K for more detail on our financial  performance.Return to shareholders Our non-GAAP diluted earnings per share of $5.55 in FY22 represents a 26% increase compared to FY21.
","('Systemic_Risk_Management', 0.566581666469574)","('Business_Model_Resilience', 0.18825992941856384)","('Management_Of_Legal_And_Regulatory_Framework', 0.035709090530872345)","(['Risk & Crisis Management'], 0.566581666469574)","('NON-ESG', 0.18825992941856384)","('NON-ESG', 0.035709090530872345)"
Line 1402,"We paid dividends of $2.52 per share in FY22, marking our 44th consecutive year of dividend increases.
","('Systemic_Risk_Management', 0.7258023023605347)","('Business_Model_Resilience', 0.033438246697187424)","('Labor_Practices', 0.03195769339799881)","(['Risk & Crisis Management'], 0.7258023023605347)","('NON-ESG', 0.033438246697187424)","('NON-ESG', 0.03195769339799881)"
Line 1403,"Out of our more than $6.0 billion total free cash flow in FY22, we returned $5.5 billion — or 92% — through dividends and net share repurchases.92 % of free cash flow  returned to   shareholders in FYyears of consecutive  dividend increases in  the S&P 500 Dividend  Aristocrats Index13 % increase in emerging  market revenue on an  organic basis compared  with the previous yearDIVIDENDS PER SHARE   ($ dollars)   FY20 FY21 FY2.16 2.32 2.2022 Integrated Performance Report       99 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexOUR ECONOMIC IMPACT Employment and compensation We design our compensation framework to   reward our 95,000+ full-time employees in more than 150 countries for their ongoing commitment and to drive a high-performance culture.
","('Systemic_Risk_Management', 0.7083743810653687)","('Business_Model_Resilience', 0.13334910571575165)","('Supply_Chain_Management', 0.022470831871032715)","(['Risk & Crisis Management'], 0.7083743810653687)","('NON-ESG', 0.13334910571575165)","('NON-ESG', 0.022470831871032715)"
Line 1404,"Out of our more than $6.0 billion total free cash flow in FY22, we returned $5.5 billion — or 92% — through dividends and net share repurchases.92 % of free cash flow  returned to   shareholders in FYyears of consecutive  dividend increases in  the S&P 500 Dividend  Aristocrats Index13 % increase in emerging  market revenue on an  organic basis compared  with the previous yearDIVIDENDS PER SHARE   ($ dollars)   FY20 FY21 FY2.16 2.32 2.2022 Integrated Performance Report       99 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexOUR ECONOMIC IMPACT Employment and compensation We design our compensation framework to   reward our 95,000+ full-time employees in more than 150 countries for their ongoing commitment and to drive a high-performance culture.
","('Labor_Practices', 0.7096067070960999)","('Employee_Engagement_Inclusion_And_Diversity', 0.18501459062099457)","('Employee_Health_And_Safety', 0.017796026542782784)","(['Labor Practice Indicators'], 0.7096067070960999)","('NON-ESG', 0.18501459062099457)","('NON-ESG', 0.017796026542782784)"
Line 1405,"We align our employment and compensation support with the values expressed in Tenet 5 of the Medtronic Mission — to recognize the worth of all employees.
","('Labor_Practices', 0.7915910482406616)","('Employee_Engagement_Inclusion_And_Diversity', 0.11542963236570358)","('Employee_Health_And_Safety', 0.018313786014914513)","(['Labor Practice Indicators'], 0.7915910482406616)","('NON-ESG', 0.11542963236570358)","('NON-ESG', 0.018313786014914513)"
Line 1406,"Read more about our approach to pay equity   and compensation and benefits.Investment, expenditures, and taxes  We deliver direct economic benefit to individuals and communities through the wages and taxes we pay, and indirect benefit through our business with suppliers.
","('Labor_Practices', 0.9192249774932861)","('Management_Of_Legal_And_Regulatory_Framework', 0.02863769605755806)","('Human_Rights_And_Community_Relations', 0.005494145676493645)","(['Labor Practice Indicators'], 0.9192249774932861)","('NON-ESG', 0.02863769605755806)","('NON-ESG', 0.005494145676493645)"
Line 1407,"We sustain this positive impact through ongoing capital investments and operating outlays.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3424595296382904)","('Business_Model_Resilience', 0.2030201256275177)","('Systemic_Risk_Management', 0.13398213684558868)","('NON-ESG', 0.3424595296382904)","('NON-ESG', 0.2030201256275177)","('NON-ESG', 0.13398213684558868)"
Line 1408,"Our commitment to maintaining good corporate citizenship includes paying taxes in every country in which we operate, as detailed in our Tax Policy statement.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9598105549812317)","('Energy_Management', 0.00492794718593359)","('Competitive_Behavior', 0.0031174765899777412)","(['Corporate Governance'], 0.9598105549812317)","('NON-ESG', 0.00492794718593359)","('NON-ESG', 0.0031174765899777412)"
Line 1409,"In FY22, Medtronic paid more than $2.2 billion in taxes.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8090370297431946)","('Business_Ethics', 0.029786746948957443)","('Labor_Practices', 0.02928866632282734)","(['Corporate Governance'], 0.8090370297431946)","('NON-ESG', 0.029786746948957443)","('NON-ESG', 0.02928866632282734)"
Line 1410,"Our total tax contribution to governments on a global basis, including taxes collected from customers and employees related to the products we sell and the employment we provide, was $6.0 billion in FY22.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8125540614128113)","('Product_Design_And_Lifecycle_Management', 0.046147339046001434)","('Selling_Practices_And_Product_Labeling', 0.022898439317941666)","(['Corporate Governance'], 0.8125540614128113)","('NON-ESG', 0.046147339046001434)","('NON-ESG', 0.022898439317941666)"
Line 1411,"Acquisitions and divestitures We invest in or acquire other healthcare technology companies to access innovative solutions, strategic skills, and expertise aligned with our Mission.
","('Business_Model_Resilience', 0.5130717754364014)","('Systemic_Risk_Management', 0.2226935774087906)","('Competitive_Behavior', 0.035962384194135666)","(['Codes of Business Conduct'], 0.5130717754364014)","('NON-ESG', 0.2226935774087906)","('NON-ESG', 0.035962384194135666)"
Line 1412,"When appropriate, we use divestitures to ensure our portfolio remains focused on our strategic priorities.
","('Business_Model_Resilience', 0.6267504692077637)","('Systemic_Risk_Management', 0.10764305293560028)","('Competitive_Behavior', 0.037785615772008896)","(['Codes of Business Conduct'], 0.6267504692077637)","('NON-ESG', 0.10764305293560028)","('NON-ESG', 0.037785615772008896)"
Line 1413,"In FY22, we did not divest any significant business operations or finalize any significant acquisitions.
","('Business_Model_Resilience', 0.5777720808982849)","('Systemic_Risk_Management', 0.15296655893325806)","('Director_Removal', 0.03932812064886093)","(['Codes of Business Conduct'], 0.5777720808982849)","('NON-ESG', 0.15296655893325806)","('NON-ESG', 0.03932812064886093)"
Line 1414,"We expect to finalize a number of acquisitions in FY23, and we continue to evaluate additional venture investing opportunities.
","('Business_Model_Resilience', 0.5256271362304688)","('Systemic_Risk_Management', 0.17596878111362457)","('Competitive_Behavior', 0.06194484978914261)","(['Codes of Business Conduct'], 0.5256271362304688)","('NON-ESG', 0.17596878111362457)","('NON-ESG', 0.06194484978914261)"
Line 1415,"Our total strategic investment and acquisition spend  in FY22 was $1.7 billion.
","('Business_Model_Resilience', 0.6635515689849854)","('Systemic_Risk_Management', 0.11319369822740555)","('Physical_Impacts_Of_Climate_Change', 0.02116830088198185)","(['Codes of Business Conduct'], 0.6635515689849854)","('NON-ESG', 0.11319369822740555)","('NON-ESG', 0.02116830088198185)"
Line 1416,"1 Our investments included  funding a new innovation campus in Colorado, United States, which will bring together 1,100 employees to further expand our R&D capabilities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5654433965682983)","('Business_Model_Resilience', 0.07413969933986664)","('Product_Design_And_Lifecycle_Management', 0.057818930596113205)","(['Human Capital Development'], 0.5654433965682983)","('NON-ESG', 0.07413969933986664)","('NON-ESG', 0.057818930596113205)"
Line 1417,"In addition, we started work on our first core manufacturing facility in China to develop new cardiovascular device production lines in the Shanghai free trade zone.EMPLOYEES†  (thousands)  FY20 FY21 FY92.7 94.9 101.2‡ †   Number includes full-time and part-time employees.
","('Labor_Practices', 0.6367376446723938)","('Employee_Engagement_Inclusion_And_Diversity', 0.0844985768198967)","('Employee_Health_And_Safety', 0.060089319944381714)","(['Labor Practice Indicators'], 0.6367376446723938)","('NON-ESG', 0.0844985768198967)","('NON-ESG', 0.060089319944381714)"
Line 1418,"All counts are based on average  calculations for the fiscal year; therefore, instances of rounding can cause the total count to vary by a small amount.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2671268880367279)","('Systemic_Risk_Management', 0.1380649358034134)","('Competitive_Behavior', 0.07474031299352646)","('NON-ESG', 0.2671268880367279)","('NON-ESG', 0.1380649358034134)","('NON-ESG', 0.07474031299352646)"
Line 1419,"Employee population data expressed here may vary from our form10-K depending on the time of year we gathered data.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8941200375556946)","('Customer_Privacy', 0.01874821074306965)","('Labor_Practices', 0.012842658907175064)","(['Human Capital Development'], 0.8941200375556946)","('NON-ESG', 0.01874821074306965)","('NON-ESG', 0.012842658907175064)"
Line 1420,"‡  W e communicate “more than 95,000 full-time employees” publicly, including in this  report, as a general statement of the employee population, which is always evolving.
","('Labor_Practices', 0.5539577603340149)","('Employee_Engagement_Inclusion_And_Diversity', 0.20762933790683746)","('Director_Removal', 0.03599867224693298)","(['Labor Practice Indicators'], 0.5539577603340149)","('NON-ESG', 0.20762933790683746)","('NON-ESG', 0.03599867224693298)"
Line 1421,"EMPLOYEE SALARY AND WAGES†  ($ million)   FY20 FY21 FY5,628 6,003 6,†  FY20 and FY21 da ta has been recast due to a change in how we report employee salary  and wages.
","('Labor_Practices', 0.9674654006958008)","('Director_Removal', 0.003557548625394702)","('Employee_Engagement_Inclusion_And_Diversity', 0.00336020952090621)","(['Labor Practice Indicators'], 0.9674654006958008)","('NON-ESG', 0.003557548625394702)","('NON-ESG', 0.00336020952090621)"
Line 1422,"EMPLOYEE RETIREMENT BENEFIT PLANS†  ($ million)  FY20 FY21 FY467 668 †  Employee R etirement Benefits spend fluctuates based on several factors, including a  variable 401(k) match component that is incremental to the standard 401(k) match.TOTAL EMPLOYEE COSTS   ($ million)  FY20 FY21 FY9,366 10,105 10,1   Includes acquisitions,  additions to property, plant and equipment, and net purchases  of investments.TAX PAYMENTS IN FY22†  ($ billion)  Type of tax Taxes paid by  MedtronicAdditional taxes  collected by Medtronic Corporate income, franchise, excise1.1 N/A Payroll, social insurance0.8 2.Other ‡0.3 1.Total tax payments 2.2 3.Total tax contribution   $6.†  The tax information contained in this section is intended to provide the reader with an  overview of all taxes paid by Medtronic plc.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8588703274726868)","('Labor_Practices', 0.04099288955330849)","('Director_Removal', 0.010078069753944874)","(['Corporate Governance'], 0.8588703274726868)","('NON-ESG', 0.04099288955330849)","('NON-ESG', 0.010078069753944874)"
Line 1423,"EMPLOYEE RETIREMENT BENEFIT PLANS†  ($ million)  FY20 FY21 FY467 668 †  Employee R etirement Benefits spend fluctuates based on several factors, including a  variable 401(k) match component that is incremental to the standard 401(k) match.TOTAL EMPLOYEE COSTS   ($ million)  FY20 FY21 FY9,366 10,105 10,1   Includes acquisitions,  additions to property, plant and equipment, and net purchases  of investments.TAX PAYMENTS IN FY22†  ($ billion)  Type of tax Taxes paid by  MedtronicAdditional taxes  collected by Medtronic Corporate income, franchise, excise1.1 N/A Payroll, social insurance0.8 2.Other ‡0.3 1.Total tax payments 2.2 3.Total tax contribution   $6.†  The tax information contained in this section is intended to provide the reader with an  overview of all taxes paid by Medtronic plc.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9403406977653503)","('Energy_Management', 0.008983924053609371)","('Labor_Practices', 0.0065029822289943695)","(['Corporate Governance'], 0.9403406977653503)","('NON-ESG', 0.008983924053609371)","('NON-ESG', 0.0065029822289943695)"
Line 1424,"It should be read in conjunction with the Company’s tax information filed with the U.S. Securities and Exchange Commission (SEC), including in the most recently filed Quarterly Reports on Form 10-Q and Annual Report on Form 10-K.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9004772305488586)","('Customer_Privacy', 0.011515839956700802)","('Director_Removal', 0.008631284348666668)","(['Corporate Governance'], 0.9004772305488586)","('NON-ESG', 0.011515839956700802)","('NON-ESG', 0.008631284348666668)"
Line 1425,"This tax information is supplemental to, and not a substitute for, the information reported in the Company’s SEC filings.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9140326976776123)","('Waste_And_Hazardous_Materials_Management', 0.007581713609397411)","('Energy_Management', 0.006103013176470995)","(['Corporate Governance'], 0.9140326976776123)","('NON-ESG', 0.007581713609397411)","('NON-ESG', 0.006103013176470995)"
Line 1426,"Taxes paid in a year can represent amounts accrued or owed related to prior tax years and paid in the current year, or prepayment of taxes that relate to a subsequent year.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9422102570533752)","('Energy_Management', 0.00976476538926363)","('Access_And_Affordability', 0.006324035115540028)","(['Corporate Governance'], 0.9422102570533752)","('NON-ESG', 0.00976476538926363)","('NON-ESG', 0.006324035115540028)"
Line 1427,"‡  Includes VAT, Sales & Use, Property, Customs/Duties, dividend withholding, Municipal/Local, and Stamp taxes.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9289656281471252)","('Labor_Practices', 0.008588512428104877)","('Competitive_Behavior', 0.007674615830183029)","(['Corporate Governance'], 0.9289656281471252)","('NON-ESG', 0.008588512428104877)","('NON-ESG', 0.007674615830183029)"
Line 1428,"95K+ full-time employees   at Medtronic in FY2022 Integrated Performance Report       100 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexESG disclosure   index Global Reporting Initiative index   Sustainability  Accounting Standards Board index  Task Force on Climate-Related Financial Disclosures  World Economic Forum Stakeholder Capitalism Metrics  133Employee data summary  138Our FY22 environmental, social, and governance (ESG) disclosure index  references disclosures for our material issues that align with reporting frameworks and standards from the Global Reporting Initiative; Sustainability Accounting Standards Board; Task Force on Climate-related Financial Disclosures; and the World Economic Forum Stakeholder Capitalism Metrics.
","('Human_Rights_And_Community_Relations', 0.2662505805492401)","('Business_Model_Resilience', 0.1533832848072052)","('Management_Of_Legal_And_Regulatory_Framework', 0.12879519164562225)","('NON-ESG', 0.2662505805492401)","('NON-ESG', 0.1533832848072052)","('NON-ESG', 0.12879519164562225)"
Line 1429,"95K+ full-time employees   at Medtronic in FY2022 Integrated Performance Report       100 Introduction ESG strategy Environmental sustainability Social impact Governance and accountability ESG disclosure indexESG disclosure   index Global Reporting Initiative index   Sustainability  Accounting Standards Board index  Task Force on Climate-Related Financial Disclosures  World Economic Forum Stakeholder Capitalism Metrics  133Employee data summary  138Our FY22 environmental, social, and governance (ESG) disclosure index  references disclosures for our material issues that align with reporting frameworks and standards from the Global Reporting Initiative; Sustainability Accounting Standards Board; Task Force on Climate-related Financial Disclosures; and the World Economic Forum Stakeholder Capitalism Metrics.
","('Physical_Impacts_Of_Climate_Change', 0.5048156976699829)","('Management_Of_Legal_And_Regulatory_Framework', 0.11738494038581848)","('Business_Model_Resilience', 0.09541856497526169)","(['Climate Change'], 0.5048156976699829)","('NON-ESG', 0.11738494038581848)","('NON-ESG', 0.09541856497526169)"
Line 1430,"2022 Integrated Performance Report Introduction 101 ESG strategy Environmental sustainability Social impact Governance and accountability  ESG disclosure index GRI 3-3: EVALUATION OF THE MANAGEMENT APPROACH Access A.
","('Business_Model_Resilience', 0.2633964419364929)","('Management_Of_Legal_And_Regulatory_Framework', 0.18299995362758636)","('Human_Rights_And_Community_Relations', 0.1435498148202896)","('NON-ESG', 0.2633964419364929)","('NON-ESG', 0.18299995362758636)","('NON-ESG', 0.1435498148202896)"
Line 1431,"Describe actual and potential nega tive and positive impacts on economy, environment,  and people, including impacts on their human rightsGlobally, too many people do not have access to the life-saving products, treatments, and services that are readily available for others1  — particularly with respect to the prevention, detection, and treatment of noncommunicable diseases.
","('Access_And_Affordability', 0.6079180836677551)","('Product_Quality_And_Safety', 0.06549356877803802)","('Human_Rights_And_Community_Relations', 0.058335453271865845)","(['Health Outcome Contribution'], 0.6079180836677551)","('NON-ESG', 0.06549356877803802)","('NON-ESG', 0.058335453271865845)"
Line 1432,"The global health inequity  crisis can only be solved by accelerating access to healthcare technologies that put people first.
","('Access_And_Affordability', 0.3092798888683319)","('Systemic_Risk_Management', 0.20456695556640625)","('Critical_Incident_Risk_Management', 0.13841114938259125)","('NON-ESG', 0.3092798888683319)","('NON-ESG', 0.20456695556640625)","('NON-ESG', 0.13841114938259125)"
Line 1433,"The accessibility of our products and solutions is critical to our Mission and our business success.
","('Product_Design_And_Lifecycle_Management', 0.9573162198066711)","('Product_Quality_And_Safety', 0.005488079972565174)","('Selling_Practices_And_Product_Labeling', 0.004408376757055521)","(['Product Stewardship'], 0.9573162198066711)","('NON-ESG', 0.005488079972565174)","('NON-ESG', 0.004408376757055521)"
Line 1434,"B.
","('Competitive_Behavior', 0.13404199481010437)","('Management_Of_Legal_And_Regulatory_Framework', 0.12049221247434616)","('Access_And_Affordability', 0.1028861552476883)","('NON-ESG', 0.13404199481010437)","('NON-ESG', 0.12049221247434616)","('NON-ESG', 0.1028861552476883)"
Line 1435,"R eport whether negative impacts are created through its activities or as a result of its  business relationships, and describe the activities or business relationshipsA negative impact is created when those who need our products and therapies cannot access them or cannot use them.
","('Product_Design_And_Lifecycle_Management', 0.8959047794342041)","('Product_Quality_And_Safety', 0.02003268525004387)","('Selling_Practices_And_Product_Labeling', 0.011561407707631588)","(['Product Stewardship'], 0.8959047794342041)","('NON-ESG', 0.02003268525004387)","('NON-ESG', 0.011561407707631588)"
Line 1436,"One of the many ways in which we are addressing this is by increasing the diversity in clinical trials and in the mix of healthcare professionals and others with whom we collaborate.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9095699787139893)","('Business_Model_Resilience', 0.009385376237332821)","('Customer_Welfare', 0.008616473525762558)","(['Human Capital Development'], 0.9095699787139893)","('NON-ESG', 0.009385376237332821)","('NON-ESG', 0.008616473525762558)"
Line 1437,"Doing so informs our product development and innovation so we can create solutions that work for patients around the world.
","('Product_Design_And_Lifecycle_Management', 0.9436630606651306)","('Customer_Welfare', 0.007317493204027414)","('Product_Quality_And_Safety', 0.006791912019252777)","(['Product Stewardship'], 0.9436630606651306)","('NON-ESG', 0.007317493204027414)","('NON-ESG', 0.006791912019252777)"
Line 1438,"C.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35686638951301575)","('Business_Ethics', 0.09611602127552032)","('Competitive_Behavior', 0.05494384095072746)","('NON-ESG', 0.35686638951301575)","('NON-ESG', 0.09611602127552032)","('NON-ESG', 0.05494384095072746)"
Line 1439,"Describe policies or commitments r egarding the material topic See policies and commitments in Global healthcare access.
","('Management_Of_Legal_And_Regulatory_Framework', 0.357308566570282)","('Access_And_Affordability', 0.31766289472579956)","('Human_Rights_And_Community_Relations', 0.1186455562710762)","('NON-ESG', 0.357308566570282)","('NON-ESG', 0.31766289472579956)","('NON-ESG', 0.1186455562710762)"
Line 1440,"D.
","('Employee_Engagement_Inclusion_And_Diversity', 0.11258140206336975)","('Management_Of_Legal_And_Regulatory_Framework', 0.08865229040384293)","('Access_And_Affordability', 0.06962209194898605)","('NON-ESG', 0.11258140206336975)","('NON-ESG', 0.08865229040384293)","('NON-ESG', 0.06962209194898605)"
Line 1441,"Describe actions tak en to manage topics and related impacts, including a.
","('Business_Model_Resilience', 0.29075926542282104)","('Physical_Impacts_Of_Climate_Change', 0.11013726145029068)","('Human_Rights_And_Community_Relations', 0.08778087794780731)","('NON-ESG', 0.29075926542282104)","('NON-ESG', 0.11013726145029068)","('NON-ESG', 0.08778087794780731)"
Line 1442,"Actions to pr event or mitigate potential negative impacts b.
","('Physical_Impacts_Of_Climate_Change', 0.29464656114578247)","('Systemic_Risk_Management', 0.23987378180027008)","('Business_Model_Resilience', 0.09173007309436798)","('NON-ESG', 0.29464656114578247)","('NON-ESG', 0.23987378180027008)","('NON-ESG', 0.09173007309436798)"
Line 1443,"Actions to addr ess actual negative impacts, including actions to provide for or  cooperate in their remediation c.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4002867639064789)","('Physical_Impacts_Of_Climate_Change', 0.11589834839105606)","('Ecological_Impacts', 0.07703129947185516)","('NON-ESG', 0.4002867639064789)","('NON-ESG', 0.11589834839105606)","('NON-ESG', 0.07703129947185516)"
Line 1444,"Actions to manage actual and potential positive impactsOur actions to manage the potential positive impacts toward access are shared in Global healthcare access.
","('Access_And_Affordability', 0.9151937961578369)","('Product_Quality_And_Safety', 0.009101650677621365)","('Human_Rights_And_Community_Relations', 0.008043465204536915)","(['Health Outcome Contribution'], 0.9151937961578369)","('NON-ESG', 0.009101650677621365)","('NON-ESG', 0.008043465204536915)"
Line 1445,"E.
","('Management_Of_Legal_And_Regulatory_Framework', 0.10841184854507446)","('Product_Design_And_Lifecycle_Management', 0.09176333993673325)","('Competitive_Behavior', 0.08798782527446747)","('NON-ESG', 0.10841184854507446)","('NON-ESG', 0.09176333993673325)","('NON-ESG', 0.08798782527446747)"
Line 1446,"R eport on tracking the effectiveness of actions taken  a.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5443630814552307)","('Human_Rights_And_Community_Relations', 0.11589175462722778)","('Business_Ethics', 0.05138600990176201)","(['Corporate Governance'], 0.5443630814552307)","('NON-ESG', 0.11589175462722778)","('NON-ESG', 0.05138600990176201)"
Line 1447,"P rocesses used to track the effectiveness of the actions b.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5499942302703857)","('Business_Ethics', 0.12774807214736938)","('Competitive_Behavior', 0.0598081573843956)","(['Corporate Governance'], 0.5499942302703857)","('NON-ESG', 0.12774807214736938)","('NON-ESG', 0.0598081573843956)"
Line 1448,"Goals,  targets, and indicators used to evaluate progress c.
","('Human_Rights_And_Community_Relations', 0.3535557985305786)","('Management_Of_Legal_And_Regulatory_Framework', 0.11948598921298981)","('Business_Model_Resilience', 0.11248379200696945)","('NON-ESG', 0.3535557985305786)","('NON-ESG', 0.11948598921298981)","('NON-ESG', 0.11248379200696945)"
Line 1449,"T he effectiveness of the actions, including progress toward the goals and targets d.
","('Human_Rights_And_Community_Relations', 0.4061984717845917)","('Business_Model_Resilience', 0.14526352286338806)","('Management_Of_Legal_And_Regulatory_Framework', 0.10114128142595291)","('NON-ESG', 0.4061984717845917)","('NON-ESG', 0.14526352286338806)","('NON-ESG', 0.10114128142595291)"
Line 1450,"L essons learned and how these have been incorporated into the organization’s  operational policies and proceduresThe ultimate measures of our success are the number of patients globally who benefit from our products and therapies as well as our ability to continue to reach underserved communities with new products and healthcare models.
","('Access_And_Affordability', 0.9355289340019226)","('Product_Quality_And_Safety', 0.006388866808265448)","('Energy_Management', 0.0050103673711419106)","(['Health Outcome Contribution'], 0.9355289340019226)","('NON-ESG', 0.006388866808265448)","('NON-ESG', 0.0050103673711419106)"
Line 1451,"Medtronic has a goal that 85 million patients will be served annually through our increased access strategies by FY25.
","('Access_And_Affordability', 0.8446537852287292)","('Customer_Welfare', 0.01896919310092926)","('Employee_Engagement_Inclusion_And_Diversity', 0.011699694208800793)","(['Health Outcome Contribution'], 0.8446537852287292)","('NON-ESG', 0.01896919310092926)","('NON-ESG', 0.011699694208800793)"
Line 1452,"In FY22, we served more than 76 million patients.
","('Access_And_Affordability', 0.4369052052497864)","('Customer_Welfare', 0.0729035958647728)","('Product_Quality_And_Safety', 0.0470656082034111)","('NON-ESG', 0.4369052052497864)","('NON-ESG', 0.0729035958647728)","('NON-ESG', 0.0470656082034111)"
Line 1453,"F.
","('GHG_Emissions', 0.15389062464237213)","('Management_Of_Legal_And_Regulatory_Framework', 0.11919295787811279)","('Competitive_Behavior', 0.11879564821720123)","('NON-ESG', 0.15389062464237213)","('NON-ESG', 0.11919295787811279)","('NON-ESG', 0.11879564821720123)"
Line 1454,"Describe how engagement with stak eholders has informed the actions taken and how  it has informed whether the actions have been effectiveWe partner with peers, innovators, healthcare systems, governments, and others to deliver solutions matched to local needs and develop new approaches to increase access to our treatments.
","('Access_And_Affordability', 0.8157101273536682)","('Customer_Welfare', 0.02269265614449978)","('Human_Rights_And_Community_Relations', 0.014489181339740753)","(['Health Outcome Contribution'], 0.8157101273536682)","('NON-ESG', 0.02269265614449978)","('NON-ESG', 0.014489181339740753)"
Line 1455,"Read more in Global healthcare access.
","('Access_And_Affordability', 0.8571601510047913)","('Product_Quality_And_Safety', 0.014620286412537098)","('Human_Rights_And_Community_Relations', 0.012144137173891068)","(['Health Outcome Contribution'], 0.8571601510047913)","('NON-ESG', 0.014620286412537098)","('NON-ESG', 0.012144137173891068)"
Line 1456,"1 World Health Organization, 2017.Global Reporting Initiative (GRI) index 2022 Integrated Performance Report      GRI 102 SASB TCFD WEF Employee dataAffordability A.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3723115026950836)","('Access_And_Affordability', 0.12228908389806747)","('Systemic_Risk_Management', 0.10038197040557861)","('NON-ESG', 0.3723115026950836)","('NON-ESG', 0.12228908389806747)","('NON-ESG', 0.10038197040557861)"
Line 1457,"Describe actual and potential nega tive and positive impacts on economy, environment,  and people, including impacts on their human rightsWe view access to healthcare as a human rights issue.
","('Human_Rights_And_Community_Relations', 0.9631049036979675)","('Access_And_Affordability', 0.005222102161496878)","('Labor_Practices', 0.0020448339637368917)","(['Community Relations'], 0.9631049036979675)","('NON-ESG', 0.005222102161496878)","('NON-ESG', 0.0020448339637368917)"
Line 1458,"One of the central levers for increasing access to life-saving products and  solutions is affordability.
","('Product_Design_And_Lifecycle_Management', 0.9600610136985779)","('Energy_Management', 0.005259870085865259)","('Customer_Welfare', 0.0034760211128741503)","(['Product Stewardship'], 0.9600610136985779)","('NON-ESG', 0.005259870085865259)","('NON-ESG', 0.0034760211128741503)"
Line 1459,"B.
","('Competitive_Behavior', 0.13404199481010437)","('Management_Of_Legal_And_Regulatory_Framework', 0.12049221247434616)","('Access_And_Affordability', 0.1028861552476883)","('NON-ESG', 0.13404199481010437)","('NON-ESG', 0.12049221247434616)","('NON-ESG', 0.1028861552476883)"
Line 1460,"R eport whether negative impacts are created through its activities or as a result of its  business relationships, and describe the activities or business relationshipsAffordability of healthcare products and solutions is an industry-wide challenge.
","('Product_Design_And_Lifecycle_Management', 0.9251939654350281)","('Supply_Chain_Management', 0.009928750805556774)","('Product_Quality_And_Safety', 0.00966987106949091)","(['Product Stewardship'], 0.9251939654350281)","('NON-ESG', 0.009928750805556774)","('NON-ESG', 0.00966987106949091)"
Line 1461,"Too often, the traditional systems of payment for a volume of product or therapy do not incentivize value and tend to be based on short-term transactions rather than long-term results.
","('Competitive_Behavior', 0.3742368817329407)","('Management_Of_Legal_And_Regulatory_Framework', 0.1337682455778122)","('Product_Design_And_Lifecycle_Management', 0.09181757271289825)","('NON-ESG', 0.3742368817329407)","('NON-ESG', 0.1337682455778122)","('NON-ESG', 0.09181757271289825)"
Line 1462,"Additionally, affordability can be impacted by whether or not a product or therapy is approved to be covered by an insurance provider, and therefore reimbursed to the patient.
","('Access_And_Affordability', 0.18395966291427612)","('Customer_Welfare', 0.1574247181415558)","('Product_Quality_And_Safety', 0.11845384538173676)","('NON-ESG', 0.18395966291427612)","('NON-ESG', 0.1574247181415558)","('NON-ESG', 0.11845384538173676)"
Line 1463,"C.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35686638951301575)","('Business_Ethics', 0.09611602127552032)","('Competitive_Behavior', 0.05494384095072746)","('NON-ESG', 0.35686638951301575)","('NON-ESG', 0.09611602127552032)","('NON-ESG', 0.05494384095072746)"
Line 1464,"Describe policies or commitments r egarding the material topic Read about our policies and commitments in Global healthcare access.
","('Access_And_Affordability', 0.5366048812866211)","('Management_Of_Legal_And_Regulatory_Framework', 0.173836350440979)","('Human_Rights_And_Community_Relations', 0.0971379354596138)","(['Health Outcome Contribution'], 0.5366048812866211)","('NON-ESG', 0.173836350440979)","('NON-ESG', 0.0971379354596138)"
Line 1465,"D.
","('Employee_Engagement_Inclusion_And_Diversity', 0.11258140206336975)","('Management_Of_Legal_And_Regulatory_Framework', 0.08865229040384293)","('Access_And_Affordability', 0.06962209194898605)","('NON-ESG', 0.11258140206336975)","('NON-ESG', 0.08865229040384293)","('NON-ESG', 0.06962209194898605)"
Line 1466,"Describe actions tak en to manage topics and related impacts, including a.
","('Business_Model_Resilience', 0.29075926542282104)","('Physical_Impacts_Of_Climate_Change', 0.11013726145029068)","('Human_Rights_And_Community_Relations', 0.08778087794780731)","('NON-ESG', 0.29075926542282104)","('NON-ESG', 0.11013726145029068)","('NON-ESG', 0.08778087794780731)"
Line 1467,"Actions to pr event or mitigate potential negative impacts b.
","('Physical_Impacts_Of_Climate_Change', 0.29464656114578247)","('Systemic_Risk_Management', 0.23987378180027008)","('Business_Model_Resilience', 0.09173007309436798)","('NON-ESG', 0.29464656114578247)","('NON-ESG', 0.23987378180027008)","('NON-ESG', 0.09173007309436798)"
Line 1468,"Actions to addr ess actual negative impacts, including actions to provide for  or cooperate in their remediation c.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4002867639064789)","('Physical_Impacts_Of_Climate_Change', 0.11589834839105606)","('Ecological_Impacts', 0.07703129947185516)","('NON-ESG', 0.4002867639064789)","('NON-ESG', 0.11589834839105606)","('NON-ESG', 0.07703129947185516)"
Line 1469,"Actions to manage actual and potential positive impactsW e take a VBHC approach — integrating products and services into solutions that improve patient outcomes while reducing the cost  of care.
","('Product_Design_And_Lifecycle_Management', 0.8143125176429749)","('Customer_Welfare', 0.033579565584659576)","('Product_Quality_And_Safety', 0.025430859997868538)","(['Product Stewardship'], 0.8143125176429749)","('NON-ESG', 0.033579565584659576)","('NON-ESG', 0.025430859997868538)"
Line 1470,"Value is measured by long-term patient outcomes rather than short-term transactions.
","('Access_And_Affordability', 0.3786877393722534)","('Human_Rights_And_Community_Relations', 0.1095779612660408)","('Business_Model_Resilience', 0.0855502113699913)","('NON-ESG', 0.3786877393722534)","('NON-ESG', 0.1095779612660408)","('NON-ESG', 0.0855502113699913)"
Line 1471,"To accelerate the transformation of healthcare systems toward VBHC, we collaborate with others and advocate the advantages of this model.
","('Systemic_Risk_Management', 0.14995433390140533)","('Access_And_Affordability', 0.10502065718173981)","('Supply_Chain_Management', 0.10335460305213928)","('NON-ESG', 0.14995433390140533)","('NON-ESG', 0.10502065718173981)","('NON-ESG', 0.10335460305213928)"
Line 1472,"We also leverage all relevant communication channels and technologies with customers and business partners to provide detailed,  accurate price information across the world.
","('Customer_Privacy', 0.2429523468017578)","('Competitive_Behavior', 0.2146945744752884)","('Product_Design_And_Lifecycle_Management', 0.0766167938709259)","('NON-ESG', 0.2429523468017578)","('NON-ESG', 0.2146945744752884)","('NON-ESG', 0.0766167938709259)"
Line 1473,"Medtronic offers a variety of pricing models based on the principles of fairness, sustainability, and value aligned with the local market  environment; these include volume pricing or rebate options for hospitals, adaptive pricing for treating long-term conditions, and programs to assist new and existing patients and customers.
","('Competitive_Behavior', 0.888227105140686)","('Management_Of_Legal_And_Regulatory_Framework', 0.03651251271367073)","('Customer_Welfare', 0.01012568548321724)","(['Business Ethics'], 0.888227105140686)","('NON-ESG', 0.03651251271367073)","('NON-ESG', 0.01012568548321724)"
Line 1474,"E.
","('Management_Of_Legal_And_Regulatory_Framework', 0.10841184854507446)","('Product_Design_And_Lifecycle_Management', 0.09176333993673325)","('Competitive_Behavior', 0.08798782527446747)","('NON-ESG', 0.10841184854507446)","('NON-ESG', 0.09176333993673325)","('NON-ESG', 0.08798782527446747)"
Line 1475,"R eport on tracking the effectiveness of actions taken a.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5443630814552307)","('Human_Rights_And_Community_Relations', 0.11589175462722778)","('Business_Ethics', 0.05138600990176201)","(['Corporate Governance'], 0.5443630814552307)","('NON-ESG', 0.11589175462722778)","('NON-ESG', 0.05138600990176201)"
Line 1476,"P rocesses used to track the effectiveness of the actions b.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5499942302703857)","('Business_Ethics', 0.12774807214736938)","('Competitive_Behavior', 0.0598081573843956)","(['Corporate Governance'], 0.5499942302703857)","('NON-ESG', 0.12774807214736938)","('NON-ESG', 0.0598081573843956)"
Line 1477,"Goals,  targets, and indicators used to evaluate progress c.
","('Human_Rights_And_Community_Relations', 0.3535557985305786)","('Management_Of_Legal_And_Regulatory_Framework', 0.11948598921298981)","('Business_Model_Resilience', 0.11248379200696945)","('NON-ESG', 0.3535557985305786)","('NON-ESG', 0.11948598921298981)","('NON-ESG', 0.11248379200696945)"
Line 1478,"T he effectiveness of the actions, including progress toward the goals and targets d.
","('Human_Rights_And_Community_Relations', 0.4061984717845917)","('Business_Model_Resilience', 0.14526352286338806)","('Management_Of_Legal_And_Regulatory_Framework', 0.10114128142595291)","('NON-ESG', 0.4061984717845917)","('NON-ESG', 0.14526352286338806)","('NON-ESG', 0.10114128142595291)"
Line 1479,"L essons learned and how these have been incorporated into the organization’s  operational policies and proceduresWe monitor our VBHC partnerships on a case-by-case basis — tracking patient outcomes and efficiencies.
","('Access_And_Affordability', 0.47504791617393494)","('Employee_Health_And_Safety', 0.08659220486879349)","('Human_Rights_And_Community_Relations', 0.047967761754989624)","('NON-ESG', 0.47504791617393494)","('NON-ESG', 0.08659220486879349)","('NON-ESG', 0.047967761754989624)"
Line 1480,"Read more about VBHC in Global healthcare access.
","('Access_And_Affordability', 0.5909412503242493)","('Energy_Management', 0.0464254654943943)","('Product_Quality_And_Safety', 0.04249674454331398)","(['Health Outcome Contribution'], 0.5909412503242493)","('NON-ESG', 0.0464254654943943)","('NON-ESG', 0.04249674454331398)"
Line 1481,"F.
","('GHG_Emissions', 0.15389062464237213)","('Management_Of_Legal_And_Regulatory_Framework', 0.11919295787811279)","('Competitive_Behavior', 0.11879564821720123)","('NON-ESG', 0.15389062464237213)","('NON-ESG', 0.11919295787811279)","('NON-ESG', 0.11879564821720123)"
Line 1482,"Describe how engagement with stak eholders has informed the actions taken and how it  has informed whether the actions have been effectiveOur VBHC collaborations enable practitioners at healthcare systems globally to apply the right therapy at the right time to patients who  will benefit most.
","('Access_And_Affordability', 0.7891334891319275)","('Product_Quality_And_Safety', 0.021259726956486702)","('Customer_Welfare', 0.021221280097961426)","(['Health Outcome Contribution'], 0.7891334891319275)","('NON-ESG', 0.021259726956486702)","('NON-ESG', 0.021221280097961426)"
Line 1483,"Rather than receiving payment for a volume of product or therapy, we work with healthcare providers to integrate products and services into long-term solutions that elevate clinical and economic outcomes.
","('Product_Design_And_Lifecycle_Management', 0.7337502241134644)","('Customer_Welfare', 0.10995746403932571)","('Selling_Practices_And_Product_Labeling', 0.03000110387802124)","(['Product Stewardship'], 0.7337502241134644)","('NON-ESG', 0.10995746403932571)","('NON-ESG', 0.03000110387802124)"
Line 1484,"Read more in Global healthcare access.
","('Access_And_Affordability', 0.8571601510047913)","('Product_Quality_And_Safety', 0.014620286412537098)","('Human_Rights_And_Community_Relations', 0.012144137173891068)","(['Health Outcome Contribution'], 0.8571601510047913)","('NON-ESG', 0.014620286412537098)","('NON-ESG', 0.012144137173891068)"
Line 1485,"2022 Integrated Performance Report      GRI 103 SASB TCFD WEF Employee dataClimate risk and resilience A.
","('Business_Model_Resilience', 0.9117486476898193)","('Physical_Impacts_Of_Climate_Change', 0.011809778399765491)","('Supply_Chain_Management', 0.008755486458539963)","(['Codes of Business Conduct'], 0.9117486476898193)","('NON-ESG', 0.011809778399765491)","('NON-ESG', 0.008755486458539963)"
Line 1486,"Describe actual and potential nega tive and positive impacts on economy, environment,  and people, including impacts on their human rightsSocieties globally are threatened by the accelerating impacts of climate change, such as severe weather events, droughts, flooding,  wildfires, disease, migration, and food scarcity.
","('Physical_Impacts_Of_Climate_Change', 0.9372497200965881)","('Business_Model_Resilience', 0.012903472408652306)","('GHG_Emissions', 0.006762657780200243)","(['Climate Change'], 0.9372497200965881)","('NON-ESG', 0.012903472408652306)","('NON-ESG', 0.006762657780200243)"
Line 1487,"Globally, the healthcare industry is responsible for 4.5% of carbon emissions, and that percentage jumps to 8.5% in the United States.
","('GHG_Emissions', 0.8525110483169556)","('Air_Quality', 0.02562721259891987)","('Energy_Management', 0.019989876076579094)","(['Climate Change'], 0.8525110483169556)","('NON-ESG', 0.02562721259891987)","('NON-ESG', 0.019989876076579094)"
Line 1488,"B.
","('Competitive_Behavior', 0.13404199481010437)","('Management_Of_Legal_And_Regulatory_Framework', 0.12049221247434616)","('Access_And_Affordability', 0.1028861552476883)","('NON-ESG', 0.13404199481010437)","('NON-ESG', 0.12049221247434616)","('NON-ESG', 0.1028861552476883)"
Line 1489,"R eport whether negative impacts are created through its activities or as a result of its  business relationships, and describe the activities or business relationshipsThe business activities that enable us to develop leading medical technologies also carry environmental impacts.
","('Business_Model_Resilience', 0.6173698902130127)","('Supply_Chain_Management', 0.06783268600702286)","('Physical_Impacts_Of_Climate_Change', 0.0550399050116539)","(['Codes of Business Conduct'], 0.6173698902130127)","('NON-ESG', 0.06783268600702286)","('NON-ESG', 0.0550399050116539)"
Line 1490,"These impacts include energy demand and emissions across our value chain, from supplier impacts during product manufacture, to our operations, to product end of life.
","('Product_Design_And_Lifecycle_Management', 0.9600481390953064)","('Supply_Chain_Management', 0.005603105295449495)","('Product_Quality_And_Safety', 0.003538324497640133)","(['Product Stewardship'], 0.9600481390953064)","('NON-ESG', 0.005603105295449495)","('NON-ESG', 0.003538324497640133)"
Line 1491,"C.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35686638951301575)","('Business_Ethics', 0.09611602127552032)","('Competitive_Behavior', 0.05494384095072746)","('NON-ESG', 0.35686638951301575)","('NON-ESG', 0.09611602127552032)","('NON-ESG', 0.05494384095072746)"
Line 1492,"Describe policies or commitments r egarding the material topic Read about our policies and commitments in Reducing our operational footprint and Climate risk and resiliency.
","('Business_Model_Resilience', 0.8691949248313904)","('Physical_Impacts_Of_Climate_Change', 0.039398323744535446)","('Supply_Chain_Management', 0.009450203739106655)","(['Codes of Business Conduct'], 0.8691949248313904)","('NON-ESG', 0.039398323744535446)","('NON-ESG', 0.009450203739106655)"
Line 1493,"D.
","('Employee_Engagement_Inclusion_And_Diversity', 0.11258140206336975)","('Management_Of_Legal_And_Regulatory_Framework', 0.08865229040384293)","('Access_And_Affordability', 0.06962209194898605)","('NON-ESG', 0.11258140206336975)","('NON-ESG', 0.08865229040384293)","('NON-ESG', 0.06962209194898605)"
Line 1494,"Describe actions tak en to manage topics and related impacts, including a.
","('Business_Model_Resilience', 0.29075926542282104)","('Physical_Impacts_Of_Climate_Change', 0.11013726145029068)","('Human_Rights_And_Community_Relations', 0.08778087794780731)","('NON-ESG', 0.29075926542282104)","('NON-ESG', 0.11013726145029068)","('NON-ESG', 0.08778087794780731)"
Line 1495,"Actions to pr event or mitigate potential negative impacts b.
","('Physical_Impacts_Of_Climate_Change', 0.29464656114578247)","('Systemic_Risk_Management', 0.23987378180027008)","('Business_Model_Resilience', 0.09173007309436798)","('NON-ESG', 0.29464656114578247)","('NON-ESG', 0.23987378180027008)","('NON-ESG', 0.09173007309436798)"
Line 1496,"Actions to addr ess actual negative impacts, including actions to provide for or  cooperate in their remediation c.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4002867639064789)","('Physical_Impacts_Of_Climate_Change', 0.11589834839105606)","('Ecological_Impacts', 0.07703129947185516)","('NON-ESG', 0.4002867639064789)","('NON-ESG', 0.11589834839105606)","('NON-ESG', 0.07703129947185516)"
Line 1497,"Actions to manage actual and potential positive impactsOne way we manage our climate risk and resilience is through our Decarbonization Roadmap, which includes pursuing science-based targets for the following:  •  Achieving carbon neutr ality in our operations by FY30.
","('Business_Model_Resilience', 0.8509525656700134)","('Physical_Impacts_Of_Climate_Change', 0.05872444435954094)","('Supply_Chain_Management', 0.01139908004552126)","(['Codes of Business Conduct'], 0.8509525656700134)","('NON-ESG', 0.05872444435954094)","('NON-ESG', 0.01139908004552126)"
Line 1498,"•  Engaging suppliers to r educe their emissions.
","('GHG_Emissions', 0.8213244676589966)","('Management_Of_Legal_And_Regulatory_Framework', 0.0275468360632658)","('Air_Quality', 0.024731552228331566)","(['Climate Change'], 0.8213244676589966)","('NON-ESG', 0.0275468360632658)","('NON-ESG', 0.024731552228331566)"
Line 1499,"•  Ex ecuting ongoing logistics improvements.
","('Product_Design_And_Lifecycle_Management', 0.2913554906845093)","('Supply_Chain_Management', 0.14349395036697388)","('Energy_Management', 0.0844445526599884)","('NON-ESG', 0.2913554906845093)","('NON-ESG', 0.14349395036697388)","('NON-ESG', 0.0844445526599884)"
Line 1500,"E.
","('Management_Of_Legal_And_Regulatory_Framework', 0.10841184854507446)","('Product_Design_And_Lifecycle_Management', 0.09176333993673325)","('Competitive_Behavior', 0.08798782527446747)","('NON-ESG', 0.10841184854507446)","('NON-ESG', 0.09176333993673325)","('NON-ESG', 0.08798782527446747)"
Line 1501,"R eport on tracking the effectiveness of actions taken a.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5443630814552307)","('Human_Rights_And_Community_Relations', 0.11589175462722778)","('Business_Ethics', 0.05138600990176201)","(['Corporate Governance'], 0.5443630814552307)","('NON-ESG', 0.11589175462722778)","('NON-ESG', 0.05138600990176201)"
Line 1502,"P rocesses used to track the effectiveness of the actions b.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5499942302703857)","('Business_Ethics', 0.12774807214736938)","('Competitive_Behavior', 0.0598081573843956)","(['Corporate Governance'], 0.5499942302703857)","('NON-ESG', 0.12774807214736938)","('NON-ESG', 0.0598081573843956)"
Line 1503,"Goals,  targets, and indicators used to evaluate progress c.
","('Human_Rights_And_Community_Relations', 0.3535557985305786)","('Management_Of_Legal_And_Regulatory_Framework', 0.11948598921298981)","('Business_Model_Resilience', 0.11248379200696945)","('NON-ESG', 0.3535557985305786)","('NON-ESG', 0.11948598921298981)","('NON-ESG', 0.11248379200696945)"
Line 1504,"T he effectiveness of the actions, including progress toward the goals and targets d.
","('Human_Rights_And_Community_Relations', 0.4061984717845917)","('Business_Model_Resilience', 0.14526352286338806)","('Management_Of_Legal_And_Regulatory_Framework', 0.10114128142595291)","('NON-ESG', 0.4061984717845917)","('NON-ESG', 0.14526352286338806)","('NON-ESG', 0.10114128142595291)"
Line 1505,"L essons learned and how these have been incorporated into the organization’s  operational policies and proceduresWe have the following goals to guide our climate progress:•   R educe operational greenhouse gas emissions intensity 50% by FY25 compared to a FY20 baseline.
","('GHG_Emissions', 0.9649149775505066)","('Air_Quality', 0.005740007851272821)","('Physical_Impacts_Of_Climate_Change', 0.0029010651633143425)","(['Climate Change'], 0.9649149775505066)","('NON-ESG', 0.005740007851272821)","('NON-ESG', 0.0029010651633143425)"
Line 1506,"In FY22, we achieved   a 35% reduction compared to FY20.
","('Business_Model_Resilience', 0.22995011508464813)","('Systemic_Risk_Management', 0.12576448917388916)","('Physical_Impacts_Of_Climate_Change', 0.10798853635787964)","('NON-ESG', 0.22995011508464813)","('NON-ESG', 0.12576448917388916)","('NON-ESG', 0.10798853635787964)"
Line 1507,"•  R educe energy intensity by 20% by FY25 compared to a FY20 baseline.
","('Energy_Management', 0.9753468632698059)","('Management_Of_Legal_And_Regulatory_Framework', 0.0027297348715364933)","('Water_And_Wastewater_Management', 0.0024672625586390495)","(['Operational Eco-Efficiency'], 0.9753468632698059)","('NON-ESG', 0.0027297348715364933)","('NON-ESG', 0.0024672625586390495)"
Line 1508,"In FY22, we achieved 9% reduction compared to FY20.
","('Business_Model_Resilience', 0.2178274393081665)","('Systemic_Risk_Management', 0.12968817353248596)","('Physical_Impacts_Of_Climate_Change', 0.12247288227081299)","('NON-ESG', 0.2178274393081665)","('NON-ESG', 0.12968817353248596)","('NON-ESG', 0.12247288227081299)"
Line 1509,"•  Achieve carbon neutr ality in our operations by FY30 and achieve net zero across our value chain by FY45.
","('Business_Model_Resilience', 0.3695307672023773)","('Systemic_Risk_Management', 0.28374725580215454)","('Supply_Chain_Management', 0.10712157189846039)","('NON-ESG', 0.3695307672023773)","('NON-ESG', 0.28374725580215454)","('NON-ESG', 0.10712157189846039)"
Line 1510,"F.
","('GHG_Emissions', 0.15389062464237213)","('Management_Of_Legal_And_Regulatory_Framework', 0.11919295787811279)","('Competitive_Behavior', 0.11879564821720123)","('NON-ESG', 0.15389062464237213)","('NON-ESG', 0.11919295787811279)","('NON-ESG', 0.11879564821720123)"
Line 1511,"Describe how engagement with stak eholders has informed the actions taken and how it  has informed whether the actions have been effectiveMedtronic communicates to all stakeholders on its approach to climate risk and resilience through our annual Integrated Performance  Report and Task Force on Climate-Related Financial Disclosure (TCFD) report.
","('Physical_Impacts_Of_Climate_Change', 0.5954191088676453)","('Business_Model_Resilience', 0.29012805223464966)","('Supply_Chain_Management', 0.015397013165056705)","(['Climate Change'], 0.5954191088676453)","('NON-ESG', 0.29012805223464966)","('NON-ESG', 0.015397013165056705)"
Line 1512,"In FY22, we partnered with England’s National Health Service and the U.S. National Academy of Medicine to find ways to reduce the healthcare industry’s carbon emissions.
","('GHG_Emissions', 0.8722835779190063)","('Air_Quality', 0.026769021525979042)","('Physical_Impacts_Of_Climate_Change', 0.02050725743174553)","(['Climate Change'], 0.8722835779190063)","('NON-ESG', 0.026769021525979042)","('NON-ESG', 0.02050725743174553)"
Line 1513,"Additionally,  our ongoing engagement with investors and customers informed our climate goals and ambitions.
","('Physical_Impacts_Of_Climate_Change', 0.8969785571098328)","('Business_Model_Resilience', 0.030819637700915337)","('GHG_Emissions', 0.010236033238470554)","(['Climate Change'], 0.8969785571098328)","('NON-ESG', 0.030819637700915337)","('NON-ESG', 0.010236033238470554)"
Line 1514,"Read more on our stakeholder engagement in Reducing our operational footprint, Climate risk and resilience, and  Stakeholder engagement.
","('Business_Model_Resilience', 0.8008763790130615)","('Physical_Impacts_Of_Climate_Change', 0.08922024071216583)","('Supply_Chain_Management', 0.019483307376503944)","(['Codes of Business Conduct'], 0.8008763790130615)","('NON-ESG', 0.08922024071216583)","('NON-ESG', 0.019483307376503944)"
Line 1515,"2 P ichler PP , Jaccard IS, Weisz U, Weisz H.
","('Competitive_Behavior', 0.3235415816307068)","('Management_Of_Legal_And_Regulatory_Framework', 0.15152385830879211)","('Business_Ethics', 0.07339801639318466)","('NON-ESG', 0.3235415816307068)","('NON-ESG', 0.15152385830879211)","('NON-ESG', 0.07339801639318466)"
Line 1516,"International comparison of healthcare carbon footprints.
","('Supply_Chain_Management', 0.27180081605911255)","('Physical_Impacts_Of_Climate_Change', 0.18444226682186127)","('Systemic_Risk_Management', 0.11482575535774231)","('NON-ESG', 0.27180081605911255)","('NON-ESG', 0.18444226682186127)","('NON-ESG', 0.11482575535774231)"
Line 1517,"Environ Res Lett.
","('Management_Of_Legal_And_Regulatory_Framework', 0.17614884674549103)","('Product_Design_And_Lifecycle_Management', 0.09432346373796463)","('Business_Model_Resilience', 0.08792085200548172)","('NON-ESG', 0.17614884674549103)","('NON-ESG', 0.09432346373796463)","('NON-ESG', 0.08792085200548172)"
Line 1518,"2019;14(6):064004.
","('Management_Of_Legal_And_Regulatory_Framework', 0.31317833065986633)","('Data_Security', 0.0759570449590683)","('Systemic_Risk_Management', 0.0759270116686821)","('NON-ESG', 0.31317833065986633)","('NON-ESG', 0.0759570449590683)","('NON-ESG', 0.0759270116686821)"
Line 1519,"2022 Integrated Performance Report      GRI 104 SASB TCFD WEF Employee dataCorruption and bribery A.
","('Business_Ethics', 0.9716866612434387)","('Competitive_Behavior', 0.003134344704449177)","('Management_Of_Legal_And_Regulatory_Framework', 0.0028877758886665106)","(['Business Ethics'], 0.9716866612434387)","('NON-ESG', 0.003134344704449177)","('NON-ESG', 0.0028877758886665106)"
Line 1520,"Describe actual and potential nega tive and positive impacts on economy, environment,  and people, including impacts on their human rightsUnethical business practices that violate state, federal, or international laws pertaining to healthcare fraud and abuse, including anti- kickback laws, anticompetitive practices, and the U.S. Foreign Corrupt Practices Act can result in economic, environmental, and societal disservices, among other impacts.
","('Business_Ethics', 0.9747466444969177)","('Management_Of_Legal_And_Regulatory_Framework', 0.0031606419943273067)","('Competitive_Behavior', 0.0024901756551116705)","(['Business Ethics'], 0.9747466444969177)","('NON-ESG', 0.0031606419943273067)","('NON-ESG', 0.0024901756551116705)"
Line 1521,"B.
","('Competitive_Behavior', 0.13404199481010437)","('Management_Of_Legal_And_Regulatory_Framework', 0.12049221247434616)","('Access_And_Affordability', 0.1028861552476883)","('NON-ESG', 0.13404199481010437)","('NON-ESG', 0.12049221247434616)","('NON-ESG', 0.1028861552476883)"
Line 1522,"R eport whether negative impacts are created through its activities or as a result of  its business relationships, and describe the activities or business relationshipsPotential negative impacts could result from the actions of employees or our third-party distributors as it relates to the sale of our products and therapies, including interactions with healthcare professionals.
","('Product_Design_And_Lifecycle_Management', 0.7830485701560974)","('Selling_Practices_And_Product_Labeling', 0.04847143217921257)","('Product_Quality_And_Safety', 0.037318769842386246)","(['Product Stewardship'], 0.7830485701560974)","('NON-ESG', 0.04847143217921257)","('NON-ESG', 0.037318769842386246)"
Line 1523,"C.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35686638951301575)","('Business_Ethics', 0.09611602127552032)","('Competitive_Behavior', 0.05494384095072746)","('NON-ESG', 0.35686638951301575)","('NON-ESG', 0.09611602127552032)","('NON-ESG', 0.05494384095072746)"
Line 1524,"Describe policies or commitments r egarding the material topic To reduce the risk of corruption, we articulate our expectations through policies and principles, provide communication and training to employees at all levels of the organization, and proactively monitor our business transactions for unethical behavior.
","('Business_Ethics', 0.9729675650596619)","('Competitive_Behavior', 0.002291813725605607)","('Product_Quality_And_Safety', 0.0019191261380910873)","(['Business Ethics'], 0.9729675650596619)","('NON-ESG', 0.002291813725605607)","('NON-ESG', 0.0019191261380910873)"
Line 1525,"See our policies and commitments in Ethical business conduct and Ethics in sales and marketing.
","('Business_Ethics', 0.9667997360229492)","('Competitive_Behavior', 0.003219131613150239)","('Product_Quality_And_Safety', 0.002944167936220765)","(['Business Ethics'], 0.9667997360229492)","('NON-ESG', 0.003219131613150239)","('NON-ESG', 0.002944167936220765)"
Line 1526,"D.
","('Employee_Engagement_Inclusion_And_Diversity', 0.11258140206336975)","('Management_Of_Legal_And_Regulatory_Framework', 0.08865229040384293)","('Access_And_Affordability', 0.06962209194898605)","('NON-ESG', 0.11258140206336975)","('NON-ESG', 0.08865229040384293)","('NON-ESG', 0.06962209194898605)"
Line 1527,"Describe actions tak en to manage topics and related impacts, including a.
","('Business_Model_Resilience', 0.29075926542282104)","('Physical_Impacts_Of_Climate_Change', 0.11013726145029068)","('Human_Rights_And_Community_Relations', 0.08778087794780731)","('NON-ESG', 0.29075926542282104)","('NON-ESG', 0.11013726145029068)","('NON-ESG', 0.08778087794780731)"
Line 1528,"Actions to pr event or mitigate potential negative impacts b.
","('Physical_Impacts_Of_Climate_Change', 0.29464656114578247)","('Systemic_Risk_Management', 0.23987378180027008)","('Business_Model_Resilience', 0.09173007309436798)","('NON-ESG', 0.29464656114578247)","('NON-ESG', 0.23987378180027008)","('NON-ESG', 0.09173007309436798)"
Line 1529,"Actions to addr ess actual negative impacts, including actions to provide  for or cooperate in their remediation c.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4002867639064789)","('Physical_Impacts_Of_Climate_Change', 0.11589834839105606)","('Ecological_Impacts', 0.07703129947185516)","('NON-ESG', 0.4002867639064789)","('NON-ESG', 0.11589834839105606)","('NON-ESG', 0.07703129947185516)"
Line 1530,"Actions to manage actual and potential positive impactsT o reduce the risk of corruption, we: •  Ar ticulate our expectations through policies and principles.
","('Business_Ethics', 0.9595296382904053)","('Management_Of_Legal_And_Regulatory_Framework', 0.008733587339520454)","('Systemic_Risk_Management', 0.003436725353822112)","(['Business Ethics'], 0.9595296382904053)","('NON-ESG', 0.008733587339520454)","('NON-ESG', 0.003436725353822112)"
Line 1531,"•  P rovide communication and training to employees at all levels of the organization.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4672817289829254)","('Employee_Health_And_Safety', 0.16525474190711975)","('Product_Quality_And_Safety', 0.062492165714502335)","('NON-ESG', 0.4672817289829254)","('NON-ESG', 0.16525474190711975)","('NON-ESG', 0.062492165714502335)"
Line 1532,"•  P roactively monitor our business transactions for unethical behavior.
","('Business_Ethics', 0.9491370320320129)","('Competitive_Behavior', 0.011126253753900528)","('Product_Quality_And_Safety', 0.003482634201645851)","(['Business Ethics'], 0.9491370320320129)","('NON-ESG', 0.011126253753900528)","('NON-ESG', 0.003482634201645851)"
Line 1533,"•  P rohibit bribery or facilitation payments and, in most countries, prohibit gift exchange.
","('Business_Ethics', 0.974796712398529)","('Competitive_Behavior', 0.0025860744062811136)","('Management_Of_Legal_And_Regulatory_Framework', 0.00229862192645669)","(['Business Ethics'], 0.974796712398529)","('NON-ESG', 0.0025860744062811136)","('NON-ESG', 0.00229862192645669)"
Line 1534,"•  Incorpor ate information from regulators, third-party audits, and best practices into our Anti-Bribery and Anti-Corruption programs.
","('Business_Ethics', 0.9727333188056946)","('Management_Of_Legal_And_Regulatory_Framework', 0.0037048470694571733)","('Competitive_Behavior', 0.003063770243898034)","(['Business Ethics'], 0.9727333188056946)","('NON-ESG', 0.0037048470694571733)","('NON-ESG', 0.003063770243898034)"
Line 1535,"•  P rovide annual ethics report for the board of directors and quarterly briefings for the board's Audit Committee.
","('Business_Ethics', 0.7741974592208862)","('Director_Removal', 0.07839401811361313)","('Management_Of_Legal_And_Regulatory_Framework', 0.029515525326132774)","(['Business Ethics'], 0.7741974592208862)","('NON-ESG', 0.07839401811361313)","('NON-ESG', 0.029515525326132774)"
Line 1536,"•   T ake corrective actions for any employee misconduct, including coaching, discussion during performance reviews, changes in job  responsibilities (such as a demotion), or in serious cases, dismissal.
","('Business_Ethics', 0.7514265775680542)","('Employee_Health_And_Safety', 0.06944277882575989)","('Labor_Practices', 0.0385088250041008)","(['Business Ethics'], 0.7514265775680542)","('NON-ESG', 0.06944277882575989)","('NON-ESG', 0.0385088250041008)"
Line 1537,"•  R equire distributors to formally adopt a code of conduct that aligns with our ethical standards.
","('Business_Ethics', 0.9400805830955505)","('Product_Quality_And_Safety', 0.011269530281424522)","('Management_Of_Legal_And_Regulatory_Framework', 0.006129323039203882)","(['Business Ethics'], 0.9400805830955505)","('NON-ESG', 0.011269530281424522)","('NON-ESG', 0.006129323039203882)"
Line 1538,"•   Shar e resources, such as a best-practices toolkit, co-developed with AdvaMed and translated into nine languages, that all industry  companies can provide to their distributors.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4820972681045532)","('Product_Quality_And_Safety', 0.06413108855485916)","('Systemic_Risk_Management', 0.05438907817006111)","('NON-ESG', 0.4820972681045532)","('NON-ESG', 0.06413108855485916)","('NON-ESG', 0.05438907817006111)"
Line 1539,"•  Encour age employees to speak up through our Voice Your Concern Line.
","('Human_Rights_And_Community_Relations', 0.37021854519844055)","('Employee_Engagement_Inclusion_And_Diversity', 0.08936495333909988)","('Employee_Health_And_Safety', 0.07330313324928284)","('NON-ESG', 0.37021854519844055)","('NON-ESG', 0.08936495333909988)","('NON-ESG', 0.07330313324928284)"
Line 1540,"E.
","('Management_Of_Legal_And_Regulatory_Framework', 0.10841184854507446)","('Product_Design_And_Lifecycle_Management', 0.09176333993673325)","('Competitive_Behavior', 0.08798782527446747)","('NON-ESG', 0.10841184854507446)","('NON-ESG', 0.09176333993673325)","('NON-ESG', 0.08798782527446747)"
Line 1541,"R eport on tracking the effectiveness of actions taken a.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5443630814552307)","('Human_Rights_And_Community_Relations', 0.11589175462722778)","('Business_Ethics', 0.05138600990176201)","(['Corporate Governance'], 0.5443630814552307)","('NON-ESG', 0.11589175462722778)","('NON-ESG', 0.05138600990176201)"
Line 1542,"P rocesses used to track the effectiveness of the actions b.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5499942302703857)","('Business_Ethics', 0.12774807214736938)","('Competitive_Behavior', 0.0598081573843956)","(['Corporate Governance'], 0.5499942302703857)","('NON-ESG', 0.12774807214736938)","('NON-ESG', 0.0598081573843956)"
Line 1543,"Goals,  targets, and indicators used to evaluate progress c.
","('Human_Rights_And_Community_Relations', 0.3535557985305786)","('Management_Of_Legal_And_Regulatory_Framework', 0.11948598921298981)","('Business_Model_Resilience', 0.11248379200696945)","('NON-ESG', 0.3535557985305786)","('NON-ESG', 0.11948598921298981)","('NON-ESG', 0.11248379200696945)"
Line 1544,"T he effectiveness of the actions, including progress toward the goals and targets d.
","('Human_Rights_And_Community_Relations', 0.4061984717845917)","('Business_Model_Resilience', 0.14526352286338806)","('Management_Of_Legal_And_Regulatory_Framework', 0.10114128142595291)","('NON-ESG', 0.4061984717845917)","('NON-ESG', 0.14526352286338806)","('NON-ESG', 0.10114128142595291)"
Line 1545,"L essons learned and how these have been incorporated into the organization’s  operational policies and proceduresThe following metrics illustrate the effectiveness of our actions and highlight our progress toward our goals and targets:•  179 employees (full-time equivalent) suppor ting anti-corruption efforts in FY22.
","('Business_Ethics', 0.9565961956977844)","('Management_Of_Legal_And_Regulatory_Framework', 0.004050674382597208)","('Data_Security', 0.003509612288326025)","(['Business Ethics'], 0.9565961956977844)","('NON-ESG', 0.004050674382597208)","('NON-ESG', 0.003509612288326025)"
Line 1546,"•  99% thir d-party distributors receiving anti-corruption training in FY22.
","('Business_Ethics', 0.9639745950698853)","('Management_Of_Legal_And_Regulatory_Framework', 0.006141253747045994)","('Product_Quality_And_Safety', 0.003014812944456935)","(['Business Ethics'], 0.9639745950698853)","('NON-ESG', 0.006141253747045994)","('NON-ESG', 0.003014812944456935)"
Line 1547,"•  99.5% mark eting and sales employees trained on ethical product promotion.
","('Business_Ethics', 0.22351160645484924)","('Product_Quality_And_Safety', 0.2123856246471405)","('Selling_Practices_And_Product_Labeling', 0.13176773488521576)","('NON-ESG', 0.22351160645484924)","('NON-ESG', 0.2123856246471405)","('NON-ESG', 0.13176773488521576)"
Line 1548,"Through our annual risk assessment process, we also: •  R eview internal and external inputs, such as regulatory or enforcement actions, hotline reporting, audit findings, and investigations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8039485216140747)","('Business_Ethics', 0.08118090033531189)","('Systemic_Risk_Management', 0.030719928443431854)","(['Corporate Governance'], 0.8039485216140747)","('NON-ESG', 0.08118090033531189)","('NON-ESG', 0.030719928443431854)"
Line 1549,"•  P erform internal auditing and data analysis to identify high-risk areas for investigation and remediation.
","('Business_Ethics', 0.5119925737380981)","('Systemic_Risk_Management', 0.17218050360679626)","('Management_Of_Legal_And_Regulatory_Framework', 0.07517588883638382)","(['Business Ethics'], 0.5119925737380981)","('NON-ESG', 0.17218050360679626)","('NON-ESG', 0.07517588883638382)"
Line 1550,"Read more about our goals and tracking in Ethical business conduct.
","('Business_Ethics', 0.9565756320953369)","('Competitive_Behavior', 0.004495731554925442)","('Product_Quality_And_Safety', 0.0036067008040845394)","(['Business Ethics'], 0.9565756320953369)","('NON-ESG', 0.004495731554925442)","('NON-ESG', 0.0036067008040845394)"
Line 1551,"F.
","('GHG_Emissions', 0.15389062464237213)","('Management_Of_Legal_And_Regulatory_Framework', 0.11919295787811279)","('Competitive_Behavior', 0.11879564821720123)","('NON-ESG', 0.15389062464237213)","('NON-ESG', 0.11919295787811279)","('NON-ESG', 0.11879564821720123)"
Line 1552,"Describe how engagement with stak eholders has informed the actions taken and how  it has informed whether the actions have been effectiveWe invite all Medtronic employees to provide feedback on our Ethics program through annual surveys.
","('Business_Ethics', 0.9611712694168091)","('Management_Of_Legal_And_Regulatory_Framework', 0.0068053812719881535)","('Product_Quality_And_Safety', 0.003571536624804139)","(['Business Ethics'], 0.9611712694168091)","('NON-ESG', 0.0068053812719881535)","('NON-ESG', 0.003571536624804139)"
Line 1553,"Employees globally can also  access our Voice Your Concern Line at any time to report potential ethics issues or seek guidance, and we updated our reporting portal to simplify access in local languages.
","('Business_Ethics', 0.9529057145118713)","('Management_Of_Legal_And_Regulatory_Framework', 0.009693925268948078)","('Product_Quality_And_Safety', 0.00452035665512085)","(['Business Ethics'], 0.9529057145118713)","('NON-ESG', 0.009693925268948078)","('NON-ESG', 0.00452035665512085)"
Line 1554,"Read more about our stakeholder engagement on ethical issues in Ethical business conduct.
","('Business_Ethics', 0.9226462244987488)","('Human_Rights_And_Community_Relations', 0.009995830245316029)","('Competitive_Behavior', 0.009610462933778763)","(['Business Ethics'], 0.9226462244987488)","('NON-ESG', 0.009995830245316029)","('NON-ESG', 0.009610462933778763)"
Line 1555,"2022 Integrated Performance Report      GRI 105 SASB TCFD WEF Employee dataData privacy and security A.
","('Data_Security', 0.9527772068977356)","('Customer_Privacy', 0.010179256089031696)","('Business_Ethics', 0.0033532604575157166)","(['Information Security/Cybersecurity & System Availability'], 0.9527772068977356)","('NON-ESG', 0.010179256089031696)","('NON-ESG', 0.0033532604575157166)"
Line 1556,"Describe actual and potential nega tive and positive impacts on economy, environment,  and people, including impacts on their human rightsWe are in a time of rapid adoption of connected data devices and powerful data analysis that is contributing to innovative products,  therapies, and delivery modalities, as well as faster research.
","('Human_Rights_And_Community_Relations', 0.9525659084320068)","('Access_And_Affordability', 0.005693085491657257)","('Ecological_Impacts', 0.0038983356207609177)","(['Community Relations'], 0.9525659084320068)","('NON-ESG', 0.005693085491657257)","('NON-ESG', 0.0038983356207609177)"
Line 1557,"In parallel, there has been an unprecedented increase in ransomware attacks and vulnerability announcements across sectors.
","('Data_Security', 0.9525746703147888)","('Systemic_Risk_Management', 0.006654185242950916)","('Physical_Impacts_Of_Climate_Change', 0.0038175403606146574)","(['Information Security/Cybersecurity & System Availability'], 0.9525746703147888)","('NON-ESG', 0.006654185242950916)","('NON-ESG', 0.0038175403606146574)"
Line 1558,"It is essential that we safeguard information, assets, and systems in the  ever-evolving data and cybersecurity landscape.
","('Data_Security', 0.9571462869644165)","('Customer_Privacy', 0.005836458411067724)","('Systemic_Risk_Management', 0.0038795655127614737)","(['Information Security/Cybersecurity & System Availability'], 0.9571462869644165)","('NON-ESG', 0.005836458411067724)","('NON-ESG', 0.0038795655127614737)"
Line 1559,"B.
","('Competitive_Behavior', 0.13404199481010437)","('Management_Of_Legal_And_Regulatory_Framework', 0.12049221247434616)","('Access_And_Affordability', 0.1028861552476883)","('NON-ESG', 0.13404199481010437)","('NON-ESG', 0.12049221247434616)","('NON-ESG', 0.1028861552476883)"
Line 1560,"R eport whether negative impacts are created through its activities or as a result of its  business relationships, and describe the activities or business relationshipsNegative impacts related to data privacy and security could result from business activities and business relationships, but are continuously monitored and risk mitigations are applied.
","('Data_Security', 0.9547893404960632)","('Customer_Privacy', 0.007869702763855457)","('Systemic_Risk_Management', 0.0034418911673128605)","(['Information Security/Cybersecurity & System Availability'], 0.9547893404960632)","('NON-ESG', 0.007869702763855457)","('NON-ESG', 0.0034418911673128605)"
Line 1561,"C.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35686638951301575)","('Business_Ethics', 0.09611602127552032)","('Competitive_Behavior', 0.05494384095072746)","('NON-ESG', 0.35686638951301575)","('NON-ESG', 0.09611602127552032)","('NON-ESG', 0.05494384095072746)"
Line 1562,"Describe policies or commitments r egarding the material topic Read about our policies and commitments in Data privacy and security.
","('Data_Security', 0.9266988039016724)","('Customer_Privacy', 0.025524476543068886)","('Business_Ethics', 0.0036311422009021044)","(['Information Security/Cybersecurity & System Availability'], 0.9266988039016724)","('NON-ESG', 0.025524476543068886)","('NON-ESG', 0.0036311422009021044)"
Line 1563,"D.
","('Employee_Engagement_Inclusion_And_Diversity', 0.11258140206336975)","('Management_Of_Legal_And_Regulatory_Framework', 0.08865229040384293)","('Access_And_Affordability', 0.06962209194898605)","('NON-ESG', 0.11258140206336975)","('NON-ESG', 0.08865229040384293)","('NON-ESG', 0.06962209194898605)"
Line 1564,"Describe actions tak en to manage topics and related impacts, including a.
","('Business_Model_Resilience', 0.29075926542282104)","('Physical_Impacts_Of_Climate_Change', 0.11013726145029068)","('Human_Rights_And_Community_Relations', 0.08778087794780731)","('NON-ESG', 0.29075926542282104)","('NON-ESG', 0.11013726145029068)","('NON-ESG', 0.08778087794780731)"
Line 1565,"Actions to pr event or mitigate potential negative impacts b.
","('Physical_Impacts_Of_Climate_Change', 0.29464656114578247)","('Systemic_Risk_Management', 0.23987378180027008)","('Business_Model_Resilience', 0.09173007309436798)","('NON-ESG', 0.29464656114578247)","('NON-ESG', 0.23987378180027008)","('NON-ESG', 0.09173007309436798)"
Line 1566,"Actions to addr ess actual negative impacts, including actions to provide for or  cooperate in their remediation c.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4002867639064789)","('Physical_Impacts_Of_Climate_Change', 0.11589834839105606)","('Ecological_Impacts', 0.07703129947185516)","('NON-ESG', 0.4002867639064789)","('NON-ESG', 0.11589834839105606)","('NON-ESG', 0.07703129947185516)"
Line 1567,"Actions to manage actual and potential positive impactsOur Global C ybersecurity and privacy programs are designed to protect data in the ever-evolving technology and cybersecurity  landscape.
","('Data_Security', 0.9650422930717468)","('Customer_Privacy', 0.003723103553056717)","('Systemic_Risk_Management', 0.0032378549221903086)","(['Information Security/Cybersecurity & System Availability'], 0.9650422930717468)","('NON-ESG', 0.003723103553056717)","('NON-ESG', 0.0032378549221903086)"
Line 1568,"We take the following actions to address and mitigate impacts related to data privacy and security: •  Use technology to scan our oper ational environment for risks.
","('Data_Security', 0.9580312967300415)","('Customer_Privacy', 0.00757445627823472)","('Systemic_Risk_Management', 0.002910294570028782)","(['Information Security/Cybersecurity & System Availability'], 0.9580312967300415)","('NON-ESG', 0.00757445627823472)","('NON-ESG', 0.002910294570028782)"
Line 1569,"•  Assess the risk s of third-party projects and initiatives.
","('Management_Of_Legal_And_Regulatory_Framework', 0.29136452078819275)","('Systemic_Risk_Management', 0.2717772126197815)","('Business_Model_Resilience', 0.09307155013084412)","('NON-ESG', 0.29136452078819275)","('NON-ESG', 0.2717772126197815)","('NON-ESG', 0.09307155013084412)"
Line 1570,"•   T rain all employees and contingent workers on security and privacy so they understand how to identify, protect, and preserve  sensitive data and prevent cyber intrusions.
","('Data_Security', 0.9637589454650879)","('Customer_Privacy', 0.003910171799361706)","('Director_Removal', 0.0028156703338027)","(['Information Security/Cybersecurity & System Availability'], 0.9637589454650879)","('NON-ESG', 0.003910171799361706)","('NON-ESG', 0.0028156703338027)"
Line 1571,"•   R equire our vendors to adhere to our data privacy and security standards, and evaluate these risks as part of our vendor  assessment process.
","('Data_Security', 0.9572070240974426)","('Customer_Privacy', 0.006921959109604359)","('Systemic_Risk_Management', 0.0035789913963526487)","(['Information Security/Cybersecurity & System Availability'], 0.9572070240974426)","('NON-ESG', 0.006921959109604359)","('NON-ESG', 0.0035789913963526487)"
Line 1572,"•  Supervise risk s relating to cybersecurity with our board’s Audit Committee.
","('Data_Security', 0.8396684527397156)","('Systemic_Risk_Management', 0.05118299275636673)","('Business_Ethics', 0.027902770787477493)","(['Information Security/Cybersecurity & System Availability'], 0.8396684527397156)","('NON-ESG', 0.05118299275636673)","('NON-ESG', 0.027902770787477493)"
Line 1573,"•  C ollaborate with third-party organizations, such as the Health Information Sharing and Analysis Center and AdvaMed.
","('Data_Security', 0.2864372134208679)","('Customer_Privacy', 0.16662245988845825)","('Access_And_Affordability', 0.09674912691116333)","('NON-ESG', 0.2864372134208679)","('NON-ESG', 0.16662245988845825)","('NON-ESG', 0.09674912691116333)"
Line 1574,"•  C onduct ongoing privacy and security due diligence of IT systems and apply appropriate risk mitigations.
","('Data_Security', 0.9597715735435486)","('Customer_Privacy', 0.0045786104165017605)","('Systemic_Risk_Management', 0.0036236357409507036)","(['Information Security/Cybersecurity & System Availability'], 0.9597715735435486)","('NON-ESG', 0.0045786104165017605)","('NON-ESG', 0.0036236357409507036)"
Line 1575,"E.
","('Management_Of_Legal_And_Regulatory_Framework', 0.10841184854507446)","('Product_Design_And_Lifecycle_Management', 0.09176333993673325)","('Competitive_Behavior', 0.08798782527446747)","('NON-ESG', 0.10841184854507446)","('NON-ESG', 0.09176333993673325)","('NON-ESG', 0.08798782527446747)"
Line 1576,"R eport on tracking the effectiveness of actions taken a.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5443630814552307)","('Human_Rights_And_Community_Relations', 0.11589175462722778)","('Business_Ethics', 0.05138600990176201)","(['Corporate Governance'], 0.5443630814552307)","('NON-ESG', 0.11589175462722778)","('NON-ESG', 0.05138600990176201)"
Line 1577,"P rocesses used to track the effectiveness of the actions b.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5499942302703857)","('Business_Ethics', 0.12774807214736938)","('Competitive_Behavior', 0.0598081573843956)","(['Corporate Governance'], 0.5499942302703857)","('NON-ESG', 0.12774807214736938)","('NON-ESG', 0.0598081573843956)"
Line 1578,"Goals,  targets, and indicators used to evaluate progress c.
","('Human_Rights_And_Community_Relations', 0.3535557985305786)","('Management_Of_Legal_And_Regulatory_Framework', 0.11948598921298981)","('Business_Model_Resilience', 0.11248379200696945)","('NON-ESG', 0.3535557985305786)","('NON-ESG', 0.11948598921298981)","('NON-ESG', 0.11248379200696945)"
Line 1579,"T he effectiveness of the actions, including progress toward the goals and targets d.
","('Human_Rights_And_Community_Relations', 0.4061984717845917)","('Business_Model_Resilience', 0.14526352286338806)","('Management_Of_Legal_And_Regulatory_Framework', 0.10114128142595291)","('NON-ESG', 0.4061984717845917)","('NON-ESG', 0.14526352286338806)","('NON-ESG', 0.10114128142595291)"
Line 1580,"L essons learned and how these have been incorporated into the organization’s  operational policies and proceduresWe continuously scan our operational environment for cyber risks and vulnerabilities, and we also assess the risks of third-party  partners, projects, and initiatives.
","('Systemic_Risk_Management', 0.6750304698944092)","('Data_Security', 0.1925756186246872)","('Business_Model_Resilience', 0.018396608531475067)","(['Risk & Crisis Management'], 0.6750304698944092)","('NON-ESG', 0.1925756186246872)","('NON-ESG', 0.018396608531475067)"
Line 1581,"We closely track our performance across data privacy and security to identify where programs are succeeding and areas of  opportunity.
","('Data_Security', 0.9507473111152649)","('Customer_Privacy', 0.010635309852659702)","('Systemic_Risk_Management', 0.0031987596303224564)","(['Information Security/Cybersecurity & System Availability'], 0.9507473111152649)","('NON-ESG', 0.010635309852659702)","('NON-ESG', 0.0031987596303224564)"
Line 1582,"We also collaborate externally to understand how others are addressing similar challenges and to find new solutions to implement.
","('Systemic_Risk_Management', 0.2022223174571991)","('Human_Rights_And_Community_Relations', 0.1415366232395172)","('Management_Of_Legal_And_Regulatory_Framework', 0.12942098081111908)","('NON-ESG', 0.2022223174571991)","('NON-ESG', 0.1415366232395172)","('NON-ESG', 0.12942098081111908)"
Line 1583,"F.
","('GHG_Emissions', 0.15389062464237213)","('Management_Of_Legal_And_Regulatory_Framework', 0.11919295787811279)","('Competitive_Behavior', 0.11879564821720123)","('NON-ESG', 0.15389062464237213)","('NON-ESG', 0.11919295787811279)","('NON-ESG', 0.11879564821720123)"
Line 1584,"Describe how engagement with stak eholders has informed the actions taken and how it  has informed whether the actions have been effectiveTo advance data security practices, we collaborate with third-party organizations, such as the Health Information Sharing and Analysis Center (H-ISAC), AdvaMed, and the European Union Agency for Cybersecurity.
","('Data_Security', 0.9635607004165649)","('Customer_Privacy', 0.0039374749176204205)","('Systemic_Risk_Management', 0.003229112597182393)","(['Information Security/Cybersecurity & System Availability'], 0.9635607004165649)","('NON-ESG', 0.0039374749176204205)","('NON-ESG', 0.003229112597182393)"
Line 1585,"We also contribute to global product security and cybersecurity standards in collaboration with the U.S. FDA and other regulatory advocacy groups.
","('Data_Security', 0.7967370748519897)","('Management_Of_Legal_And_Regulatory_Framework', 0.04069548100233078)","('Business_Ethics', 0.03252572566270828)","(['Information Security/Cybersecurity & System Availability'], 0.7967370748519897)","('NON-ESG', 0.04069548100233078)","('NON-ESG', 0.03252572566270828)"
Line 1586,"W e also monitor current practices and emerging risks by engaging with employees, regulators, peers, healthcare delivery  organizations, clinicians, and security researchers.
","('Systemic_Risk_Management', 0.7743129134178162)","('Supply_Chain_Management', 0.030078940093517303)","('Physical_Impacts_Of_Climate_Change', 0.027610883116722107)","(['Risk & Crisis Management'], 0.7743129134178162)","('NON-ESG', 0.030078940093517303)","('NON-ESG', 0.027610883116722107)"
Line 1587,"Read more about how we engage with stakeholders in Data privacy and security.
","('Data_Security', 0.946990966796875)","('Customer_Privacy', 0.011829531751573086)","('Director_Removal', 0.003520520403981209)","(['Information Security/Cybersecurity & System Availability'], 0.946990966796875)","('NON-ESG', 0.011829531751573086)","('NON-ESG', 0.003520520403981209)"
Line 1588,"2022 Integrated Performance Report      GRI 106 SASB TCFD WEF Employee dataEthics in sales and marketing A.
","('Employee_Engagement_Inclusion_And_Diversity', 0.46532198786735535)","('Competitive_Behavior', 0.06912346184253693)","('Labor_Practices', 0.05812903493642807)","('NON-ESG', 0.46532198786735535)","('NON-ESG', 0.06912346184253693)","('NON-ESG', 0.05812903493642807)"
Line 1589,"Describe actual and potential nega tive and positive impacts on economy, environment,  and people, including impacts on their human rightsMaintaining the trust of customers, patients, industry partners, healthcare providers, investors, regulators, governments, and employees  is critical to our ability to provide life-transforming care.
","('Human_Rights_And_Community_Relations', 0.8116722702980042)","('Access_And_Affordability', 0.06555037200450897)","('Employee_Health_And_Safety', 0.03101634979248047)","(['Community Relations'], 0.8116722702980042)","('NON-ESG', 0.06555037200450897)","('NON-ESG', 0.03101634979248047)"
Line 1590,"Our customers depend on our medical products, services, and therapies, and promoting them factually and lawfully supports their delivery to patients with intended outcomes.
","('Product_Design_And_Lifecycle_Management', 0.560411810874939)","('Customer_Welfare', 0.13702450692653656)","('Selling_Practices_And_Product_Labeling', 0.12804807722568512)","(['Product Stewardship'], 0.560411810874939)","('NON-ESG', 0.13702450692653656)","('NON-ESG', 0.12804807722568512)"
Line 1591,"Promoting our products ethically protects patient safety.
","('Product_Quality_And_Safety', 0.8498330116271973)","('Product_Design_And_Lifecycle_Management', 0.035590700805187225)","('Selling_Practices_And_Product_Labeling', 0.015330642461776733)","(['Product Quality & Recall Management'], 0.8498330116271973)","('NON-ESG', 0.035590700805187225)","('NON-ESG', 0.015330642461776733)"
Line 1592,"Unethical behavior could have a negative impact on patient safety and equitable health outcomes.
","('Business_Ethics', 0.9446448683738708)","('Product_Quality_And_Safety', 0.006527024786919355)","('Employee_Health_And_Safety', 0.005328762345016003)","(['Business Ethics'], 0.9446448683738708)","('NON-ESG', 0.006527024786919355)","('NON-ESG', 0.005328762345016003)"
Line 1593,"B.
","('Competitive_Behavior', 0.13404199481010437)","('Management_Of_Legal_And_Regulatory_Framework', 0.12049221247434616)","('Access_And_Affordability', 0.1028861552476883)","('NON-ESG', 0.13404199481010437)","('NON-ESG', 0.12049221247434616)","('NON-ESG', 0.1028861552476883)"
Line 1594,"R eport whether negative impacts are created through its activities or as a result of its  business relationships, and describe the activities or business relationshipsPotential negative impacts resulting from sales and marketing include misleading promotion of products to customers, medical professionals, and the broader scientific community and noncompliance with anti-corruption or anti-bribery laws.
","('Business_Ethics', 0.9711976647377014)","('Competitive_Behavior', 0.0034835590049624443)","('Management_Of_Legal_And_Regulatory_Framework', 0.0025614441838115454)","(['Business Ethics'], 0.9711976647377014)","('NON-ESG', 0.0034835590049624443)","('NON-ESG', 0.0025614441838115454)"
Line 1595,"C.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35686638951301575)","('Business_Ethics', 0.09611602127552032)","('Competitive_Behavior', 0.05494384095072746)","('NON-ESG', 0.35686638951301575)","('NON-ESG', 0.09611602127552032)","('NON-ESG', 0.05494384095072746)"
Line 1596,"Describe policies or commitments r egarding the material topic We promote our products based on their approved labeling and promote and sell our products through accurate and truthful communication of their efficacy, safety, and price.
","('Selling_Practices_And_Product_Labeling', 0.7562194466590881)","('Product_Quality_And_Safety', 0.10829770565032959)","('Product_Design_And_Lifecycle_Management', 0.02221113070845604)","(['Marketing Practices'], 0.7562194466590881)","('NON-ESG', 0.10829770565032959)","('NON-ESG', 0.02221113070845604)"
Line 1597,"Read about our policies and commitments in Ethics in sales and marketing.
","('Business_Ethics', 0.9617586731910706)","('Competitive_Behavior', 0.004483959637582302)","('Management_Of_Legal_And_Regulatory_Framework', 0.0044145118445158005)","(['Business Ethics'], 0.9617586731910706)","('NON-ESG', 0.004483959637582302)","('NON-ESG', 0.0044145118445158005)"
Line 1598,"D.
","('Employee_Engagement_Inclusion_And_Diversity', 0.11258140206336975)","('Management_Of_Legal_And_Regulatory_Framework', 0.08865229040384293)","('Access_And_Affordability', 0.06962209194898605)","('NON-ESG', 0.11258140206336975)","('NON-ESG', 0.08865229040384293)","('NON-ESG', 0.06962209194898605)"
Line 1599,"Describe actions tak en to manage topics and related impacts, including a.
","('Business_Model_Resilience', 0.29075926542282104)","('Physical_Impacts_Of_Climate_Change', 0.11013726145029068)","('Human_Rights_And_Community_Relations', 0.08778087794780731)","('NON-ESG', 0.29075926542282104)","('NON-ESG', 0.11013726145029068)","('NON-ESG', 0.08778087794780731)"
Line 1600,"Actions to pr event or mitigate potential negative impacts b.
","('Physical_Impacts_Of_Climate_Change', 0.29464656114578247)","('Systemic_Risk_Management', 0.23987378180027008)","('Business_Model_Resilience', 0.09173007309436798)","('NON-ESG', 0.29464656114578247)","('NON-ESG', 0.23987378180027008)","('NON-ESG', 0.09173007309436798)"
Line 1601,"Actions to addr ess actual negative impacts, including actions to provide for or  cooperate in their remediation c.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4002867639064789)","('Physical_Impacts_Of_Climate_Change', 0.11589834839105606)","('Ecological_Impacts', 0.07703129947185516)","('NON-ESG', 0.4002867639064789)","('NON-ESG', 0.11589834839105606)","('NON-ESG', 0.07703129947185516)"
Line 1602,"Actions to manage actual and potential positive impactsT o maintain our high level of ethics in our sales and marketing practices, we: •  Investiga te all reported concerns of alleged misconduct through our Office of Ethics and Compliance (OEC).
","('Business_Ethics', 0.9705297350883484)","('Product_Quality_And_Safety', 0.0024892291985452175)","('Competitive_Behavior', 0.00209704483859241)","(['Business Ethics'], 0.9705297350883484)","('NON-ESG', 0.0024892291985452175)","('NON-ESG', 0.00209704483859241)"
Line 1603,"•  R emediate ethical issues swiftly through our streamlined review process.
","('Business_Ethics', 0.9452022910118103)","('Competitive_Behavior', 0.007756069768220186)","('Product_Quality_And_Safety', 0.005746604409068823)","(['Business Ethics'], 0.9452022910118103)","('NON-ESG', 0.007756069768220186)","('NON-ESG', 0.005746604409068823)"
Line 1604,"•  Upda te our mobile app to help our sales teams ensure they comply with spending limits on meals with healthcare providers.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7213873267173767)","('Energy_Management', 0.1013743057847023)","('Labor_Practices', 0.029607504606246948)","(['Corporate Governance'], 0.7213873267173767)","('NON-ESG', 0.1013743057847023)","('NON-ESG', 0.029607504606246948)"
Line 1605,"•   Deliver tr aining and guidance on ethics policies governing sales of capital equipment through the Capital Program   Optimization Project.
","('Business_Ethics', 0.9624835252761841)","('Management_Of_Legal_And_Regulatory_Framework', 0.0050322310999035835)","('Competitive_Behavior', 0.004363661631941795)","(['Business Ethics'], 0.9624835252761841)","('NON-ESG', 0.0050322310999035835)","('NON-ESG', 0.004363661631941795)"
Line 1606,"•  P rovide training and guidance on promoting our products based on their approved labeling.
","('Selling_Practices_And_Product_Labeling', 0.8940322399139404)","('Customer_Welfare', 0.019782651215791702)","('Product_Quality_And_Safety', 0.017552372068166733)","(['Marketing Practices'], 0.8940322399139404)","('NON-ESG', 0.019782651215791702)","('NON-ESG', 0.017552372068166733)"
Line 1607,"•  Hold distributors accountable to anti-corruption r equirements through our Distributor Relationship Owners.
","('Business_Ethics', 0.9686045050621033)","('Management_Of_Legal_And_Regulatory_Framework', 0.005744020454585552)","('Competitive_Behavior', 0.0038139428943395615)","(['Business Ethics'], 0.9686045050621033)","('NON-ESG', 0.005744020454585552)","('NON-ESG', 0.0038139428943395615)"
Line 1608,"•  R equire distributors to certify their understanding of ethical requirements.
","('Business_Ethics', 0.8880699872970581)","('Competitive_Behavior', 0.023421067744493484)","('Product_Quality_And_Safety', 0.017629163339734077)","(['Business Ethics'], 0.8880699872970581)","('NON-ESG', 0.023421067744493484)","('NON-ESG', 0.017629163339734077)"
Line 1609,"E.
","('Management_Of_Legal_And_Regulatory_Framework', 0.10841184854507446)","('Product_Design_And_Lifecycle_Management', 0.09176333993673325)","('Competitive_Behavior', 0.08798782527446747)","('NON-ESG', 0.10841184854507446)","('NON-ESG', 0.09176333993673325)","('NON-ESG', 0.08798782527446747)"
Line 1610,"R eport on tracking the effectiveness of actions taken a.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5443630814552307)","('Human_Rights_And_Community_Relations', 0.11589175462722778)","('Business_Ethics', 0.05138600990176201)","(['Corporate Governance'], 0.5443630814552307)","('NON-ESG', 0.11589175462722778)","('NON-ESG', 0.05138600990176201)"
Line 1611,"P rocesses used to track the effectiveness of the actions b.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5499942302703857)","('Business_Ethics', 0.12774807214736938)","('Competitive_Behavior', 0.0598081573843956)","(['Corporate Governance'], 0.5499942302703857)","('NON-ESG', 0.12774807214736938)","('NON-ESG', 0.0598081573843956)"
Line 1612,"Goals,  targets, and indicators used to evaluate progress c.
","('Human_Rights_And_Community_Relations', 0.3535557985305786)","('Management_Of_Legal_And_Regulatory_Framework', 0.11948598921298981)","('Business_Model_Resilience', 0.11248379200696945)","('NON-ESG', 0.3535557985305786)","('NON-ESG', 0.11948598921298981)","('NON-ESG', 0.11248379200696945)"
Line 1613,"T he effectiveness of the actions, including progress toward the goals and targets d.
","('Human_Rights_And_Community_Relations', 0.4061984717845917)","('Business_Model_Resilience', 0.14526352286338806)","('Management_Of_Legal_And_Regulatory_Framework', 0.10114128142595291)","('NON-ESG', 0.4061984717845917)","('NON-ESG', 0.14526352286338806)","('NON-ESG', 0.10114128142595291)"
Line 1614,"L essons learned and how these have been incorporated into the organization’s  operational policies and proceduresOur annual risk assessment process includes the OEC’s rigorous review of internal and external inputs, such as regulatory or  enforcement actions, hotline reporting, audit findings, and investigations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8960179686546326)","('Business_Ethics', 0.03242512419819832)","('Systemic_Risk_Management', 0.011108326725661755)","(['Corporate Governance'], 0.8960179686546326)","('NON-ESG', 0.03242512419819832)","('NON-ESG', 0.011108326725661755)"
Line 1615,"The following metrics illustrate the effectiveness of our actions and highlight our progress toward our goals and targets:•  179 employees (full-time equivalent) suppor ting anti-corruption efforts in FY22.
","('Business_Ethics', 0.9432626962661743)","('Employee_Health_And_Safety', 0.005539023783057928)","('Labor_Practices', 0.0050365617498755455)","(['Business Ethics'], 0.9432626962661743)","('NON-ESG', 0.005539023783057928)","('NON-ESG', 0.0050365617498755455)"
Line 1616,"•  99% thir d-party distributors receiving anti-corruption training in FY22.
","('Business_Ethics', 0.9639745950698853)","('Management_Of_Legal_And_Regulatory_Framework', 0.006141253747045994)","('Product_Quality_And_Safety', 0.003014812944456935)","(['Business Ethics'], 0.9639745950698853)","('NON-ESG', 0.006141253747045994)","('NON-ESG', 0.003014812944456935)"
Line 1617,"•  99.5% mark eting and sales employees trained on ethical product promotion.
","('Business_Ethics', 0.22351160645484924)","('Product_Quality_And_Safety', 0.2123856246471405)","('Selling_Practices_And_Product_Labeling', 0.13176773488521576)","('NON-ESG', 0.22351160645484924)","('NON-ESG', 0.2123856246471405)","('NON-ESG', 0.13176773488521576)"
Line 1618,"F.
","('GHG_Emissions', 0.15389062464237213)","('Management_Of_Legal_And_Regulatory_Framework', 0.11919295787811279)","('Competitive_Behavior', 0.11879564821720123)","('NON-ESG', 0.15389062464237213)","('NON-ESG', 0.11919295787811279)","('NON-ESG', 0.11879564821720123)"
Line 1619,"Describe how engagement with stak eholders has informed the actions taken and how it  has informed whether the actions have been effectiveWe invite all Medtronic employees to provide feedback on our Ethics program through annual surveys and to express any concerns to  our Voice Your Concern Line.
","('Business_Ethics', 0.9602647423744202)","('Management_Of_Legal_And_Regulatory_Framework', 0.006658083293586969)","('Product_Quality_And_Safety', 0.003922624047845602)","(['Business Ethics'], 0.9602647423744202)","('NON-ESG', 0.006658083293586969)","('NON-ESG', 0.003922624047845602)"
Line 1620,"Learn more about our engagement on ethics in Ethics in sales and marketing.
","('Business_Ethics', 0.9648032188415527)","('Competitive_Behavior', 0.0041101109236478806)","('Product_Quality_And_Safety', 0.002850497839972377)","(['Business Ethics'], 0.9648032188415527)","('NON-ESG', 0.0041101109236478806)","('NON-ESG', 0.002850497839972377)"
Line 1621,"2022 Integrated Performance Report      GRI 107 SASB TCFD WEF Employee dataInclusion, diversity, and equity  A.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9759330153465271)","('Employee_Health_And_Safety', 0.0020354713778942823)","('Human_Rights_And_Community_Relations', 0.0016203889390453696)","(['Human Capital Development'], 0.9759330153465271)","('NON-ESG', 0.0020354713778942823)","('NON-ESG', 0.0016203889390453696)"
Line 1622,"Describe actual and potential nega tive and positive impacts on economy, environment,  and people, including impacts on their human rightsWomen and minority groups have historically been underrepresented in the science, technology, engineering, and math (STEM)  workforce and in positions of influence across sectors.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8816849589347839)","('Human_Rights_And_Community_Relations', 0.04945121333003044)","('Access_And_Affordability', 0.007346001453697681)","(['Human Capital Development'], 0.8816849589347839)","('NON-ESG', 0.04945121333003044)","('NON-ESG', 0.007346001453697681)"
Line 1623,"At Medtronic, we believe that diversity makes us stronger, so we work hard to treat employees and prospective employees equitably.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9698739051818848)","('Employee_Health_And_Safety', 0.002797693945467472)","('Labor_Practices', 0.002761173527687788)","(['Human Capital Development'], 0.9698739051818848)","('NON-ESG', 0.002797693945467472)","('NON-ESG', 0.002761173527687788)"
Line 1624,"Beyond our workforce, we recognize that there are historical and ongoing inequities in healthcare.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5187920928001404)","('Systemic_Risk_Management', 0.09037638455629349)","('Labor_Practices', 0.05581105500459671)","(['Human Capital Development'], 0.5187920928001404)","('NON-ESG', 0.09037638455629349)","('NON-ESG', 0.05581105500459671)"
Line 1625,"These inequities continue to be  exacerbated by global challenges, including the COVID-19 pandemic, climate change, and conflict.
","('Physical_Impacts_Of_Climate_Change', 0.9088383316993713)","('Business_Model_Resilience', 0.02140279859304428)","('Systemic_Risk_Management', 0.013925834558904171)","(['Climate Change'], 0.9088383316993713)","('NON-ESG', 0.02140279859304428)","('NON-ESG', 0.013925834558904171)"
Line 1626,"Medtronic and the Medtronic Foundation are working to expand economic opportunities, improve access to vital treatment, and build fairer healthcare systems and communities.
","('Access_And_Affordability', 0.902482271194458)","('Critical_Incident_Risk_Management', 0.009257321245968342)","('Product_Quality_And_Safety', 0.008509432896971703)","(['Health Outcome Contribution'], 0.902482271194458)","('NON-ESG', 0.009257321245968342)","('NON-ESG', 0.008509432896971703)"
Line 1627,"We also actively invest in our communities – advancing diversity in STEM education and careers and promoting local economies and jobs through our supplier diversity program.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9753516912460327)","('Employee_Health_And_Safety', 0.0021381389815360308)","('Human_Rights_And_Community_Relations', 0.0017654995899647474)","(['Human Capital Development'], 0.9753516912460327)","('NON-ESG', 0.0021381389815360308)","('NON-ESG', 0.0017654995899647474)"
Line 1628,"Internally, our ERGs and Diversity Networks encourage employee engagement, an outcome of our concerted ID&E efforts.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9745922684669495)","('Employee_Health_And_Safety', 0.0022641359828412533)","('Human_Rights_And_Community_Relations', 0.0018086289055645466)","(['Human Capital Development'], 0.9745922684669495)","('NON-ESG', 0.0022641359828412533)","('NON-ESG', 0.0018086289055645466)"
Line 1629,"B.
","('Competitive_Behavior', 0.13404199481010437)","('Management_Of_Legal_And_Regulatory_Framework', 0.12049221247434616)","('Access_And_Affordability', 0.1028861552476883)","('NON-ESG', 0.13404199481010437)","('NON-ESG', 0.12049221247434616)","('NON-ESG', 0.1028861552476883)"
Line 1630,"R eport whether negative impacts are created through its activities or as a result of its  business relationships, and describe the activities or business relationshipsWe are not aware of specific negative impacts related to our ID&E strategies.
","('Systemic_Risk_Management', 0.49076369404792786)","('Business_Model_Resilience', 0.2591647505760193)","('Physical_Impacts_Of_Climate_Change', 0.045578207820653915)","('NON-ESG', 0.49076369404792786)","('NON-ESG', 0.2591647505760193)","('NON-ESG', 0.045578207820653915)"
Line 1631,"C.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35686638951301575)","('Business_Ethics', 0.09611602127552032)","('Competitive_Behavior', 0.05494384095072746)","('NON-ESG', 0.35686638951301575)","('NON-ESG', 0.09611602127552032)","('NON-ESG', 0.05494384095072746)"
Line 1632,"Describe policies or commitments r egarding the material topic Read about our policies and commitments in Inclusion, diversity, and equity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9743518233299255)","('Human_Rights_And_Community_Relations', 0.0022393916733562946)","('Employee_Health_And_Safety', 0.0020821632351726294)","(['Human Capital Development'], 0.9743518233299255)","('NON-ESG', 0.0022393916733562946)","('NON-ESG', 0.0020821632351726294)"
Line 1633,"D.
","('Employee_Engagement_Inclusion_And_Diversity', 0.11258140206336975)","('Management_Of_Legal_And_Regulatory_Framework', 0.08865229040384293)","('Access_And_Affordability', 0.06962209194898605)","('NON-ESG', 0.11258140206336975)","('NON-ESG', 0.08865229040384293)","('NON-ESG', 0.06962209194898605)"
Line 1634,"Describe actions tak en to manage topics and related impacts, including a.
","('Business_Model_Resilience', 0.29075926542282104)","('Physical_Impacts_Of_Climate_Change', 0.11013726145029068)","('Human_Rights_And_Community_Relations', 0.08778087794780731)","('NON-ESG', 0.29075926542282104)","('NON-ESG', 0.11013726145029068)","('NON-ESG', 0.08778087794780731)"
Line 1635,"Actions to pr event or mitigate potential negative impacts b.
","('Physical_Impacts_Of_Climate_Change', 0.29464656114578247)","('Systemic_Risk_Management', 0.23987378180027008)","('Business_Model_Resilience', 0.09173007309436798)","('NON-ESG', 0.29464656114578247)","('NON-ESG', 0.23987378180027008)","('NON-ESG', 0.09173007309436798)"
Line 1636,"Actions to addr ess actual negative impacts, including actions to provide for or  cooperate in their remediation c.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4002867639064789)","('Physical_Impacts_Of_Climate_Change', 0.11589834839105606)","('Ecological_Impacts', 0.07703129947185516)","('NON-ESG', 0.4002867639064789)","('NON-ESG', 0.11589834839105606)","('NON-ESG', 0.07703129947185516)"
Line 1637,"Actions to manage actual and potential positive impactsOur ID&E strategy takes into consideration Medtronic’s responsibility, as a collective organization and as individual employees, to promote ID&E in all of our spheres of influence.
","('Human_Rights_And_Community_Relations', 0.31875601410865784)","('Management_Of_Legal_And_Regulatory_Framework', 0.12025590986013412)","('Competitive_Behavior', 0.07213421911001205)","('NON-ESG', 0.31875601410865784)","('NON-ESG', 0.12025590986013412)","('NON-ESG', 0.07213421911001205)"
Line 1638,"Hence, we account for our ability to positively impact the communities we operate in, hire from, and live in as well as the impact we can have internally within our company.
","('Human_Rights_And_Community_Relations', 0.8943670988082886)","('Employee_Engagement_Inclusion_And_Diversity', 0.016635620966553688)","('Access_And_Affordability', 0.016101103276014328)","(['Community Relations'], 0.8943670988082886)","('NON-ESG', 0.016635620966553688)","('NON-ESG', 0.016101103276014328)"
Line 1639,"In FY22:•   T he Medtronic Foundation donated over $9 million to nonprofits, many of which address racial and social justice issues, through  employee matches, volunteer grants, and program grants.
","('Human_Rights_And_Community_Relations', 0.6826983690261841)","('Employee_Engagement_Inclusion_And_Diversity', 0.17211540043354034)","('Employee_Health_And_Safety', 0.02288244105875492)","(['Community Relations'], 0.6826983690261841)","('NON-ESG', 0.17211540043354034)","('NON-ESG', 0.02288244105875492)"
Line 1640,"•  W e tied 15% of executive compensation to ID&E results.
","('Labor_Practices', 0.3394441306591034)","('Employee_Engagement_Inclusion_And_Diversity', 0.17423902451992035)","('Director_Removal', 0.11344628036022186)","('NON-ESG', 0.3394441306591034)","('NON-ESG', 0.17423902451992035)","('NON-ESG', 0.11344628036022186)"
Line 1641,"•  W e offered Being an Inclusive Leader training to all U.S.-based managers.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8307839035987854)","('Access_And_Affordability', 0.01759934239089489)","('Employee_Health_And_Safety', 0.015443562529981136)","(['Human Capital Development'], 0.8307839035987854)","('NON-ESG', 0.01759934239089489)","('NON-ESG', 0.015443562529981136)"
Line 1642,"•   W e built out a new, best-in-class operating mechanism to address social justice and societal issues management, called the  Reputation Issues Management team.
","('Human_Rights_And_Community_Relations', 0.9393172860145569)","('Business_Model_Resilience', 0.005325803533196449)","('Management_Of_Legal_And_Regulatory_Framework', 0.005118588451296091)","(['Community Relations'], 0.9393172860145569)","('NON-ESG', 0.005325803533196449)","('NON-ESG', 0.005118588451296091)"
Line 1643,"•   W e directed $2.7 billion of U.S. supplier spend to small and diverse-owned companies, approximately 36% of our total   U.S. supplier spend.
","('Supply_Chain_Management', 0.9211522340774536)","('Labor_Practices', 0.010829176753759384)","('Product_Design_And_Lifecycle_Management', 0.007768968120217323)","(['Supply Chain Management'], 0.9211522340774536)","('NON-ESG', 0.010829176753759384)","('NON-ESG', 0.007768968120217323)"
Line 1644,"You can read more about the actions we’ve taken in Inclusion, diversity, and equity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9711042046546936)","('Human_Rights_And_Community_Relations', 0.0028425517957657576)","('Employee_Health_And_Safety', 0.0022721856366842985)","(['Human Capital Development'], 0.9711042046546936)","('NON-ESG', 0.0028425517957657576)","('NON-ESG', 0.0022721856366842985)"
Line 1645,"E.
","('Management_Of_Legal_And_Regulatory_Framework', 0.10841184854507446)","('Product_Design_And_Lifecycle_Management', 0.09176333993673325)","('Competitive_Behavior', 0.08798782527446747)","('NON-ESG', 0.10841184854507446)","('NON-ESG', 0.09176333993673325)","('NON-ESG', 0.08798782527446747)"
Line 1646,"R eport on tracking the effectiveness of actions taken a.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5443630814552307)","('Human_Rights_And_Community_Relations', 0.11589175462722778)","('Business_Ethics', 0.05138600990176201)","(['Corporate Governance'], 0.5443630814552307)","('NON-ESG', 0.11589175462722778)","('NON-ESG', 0.05138600990176201)"
Line 1647,"P rocesses used to track the effectiveness of the actions b.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5499942302703857)","('Business_Ethics', 0.12774807214736938)","('Competitive_Behavior', 0.0598081573843956)","(['Corporate Governance'], 0.5499942302703857)","('NON-ESG', 0.12774807214736938)","('NON-ESG', 0.0598081573843956)"
Line 1648,"Goals,  targets, and indicators used to evaluate progress c.
","('Human_Rights_And_Community_Relations', 0.3535557985305786)","('Management_Of_Legal_And_Regulatory_Framework', 0.11948598921298981)","('Business_Model_Resilience', 0.11248379200696945)","('NON-ESG', 0.3535557985305786)","('NON-ESG', 0.11948598921298981)","('NON-ESG', 0.11248379200696945)"
Line 1649,"T he effectiveness of the actions, including progress toward the goals and targets d.
","('Human_Rights_And_Community_Relations', 0.4061984717845917)","('Business_Model_Resilience', 0.14526352286338806)","('Management_Of_Legal_And_Regulatory_Framework', 0.10114128142595291)","('NON-ESG', 0.4061984717845917)","('NON-ESG', 0.14526352286338806)","('NON-ESG', 0.10114128142595291)"
Line 1650,"L essons learned and how these have been incorporated into the organization’s  operational policies and proceduresWe have set goals to monitor our progress on ID&E:•  45% of  global manager-and-above roles held by women by FY26.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5058740973472595)","('Director_Removal', 0.13665629923343658)","('Human_Rights_And_Community_Relations', 0.04837590083479881)","(['Human Capital Development'], 0.5058740973472595)","('NON-ESG', 0.13665629923343658)","('NON-ESG', 0.04837590083479881)"
Line 1651,"–   FY22 pr ogress: 42% of global manager-and-above roles were held by women.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5431075692176819)","('Labor_Practices', 0.1507055014371872)","('Director_Removal', 0.10292631387710571)","(['Human Capital Development'], 0.5431075692176819)","('NON-ESG', 0.1507055014371872)","('NON-ESG', 0.10292631387710571)"
Line 1652,"•  30% of  U.S.-based manager-and-above roles held by ethnically diverse talent by FY26.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9732649922370911)","('Customer_Privacy', 0.0017755210865288973)","('Employee_Health_And_Safety', 0.0016277356771752238)","(['Human Capital Development'], 0.9732649922370911)","('NON-ESG', 0.0017755210865288973)","('NON-ESG', 0.0016277356771752238)"
Line 1653,"–   FY22 pr ogress: 27% of U.S.-based manager-and-above roles held by people from diverse groups.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9648457169532776)","('Human_Rights_And_Community_Relations', 0.0030508472118526697)","('Employee_Health_And_Safety', 0.0023598221596330404)","(['Human Capital Development'], 0.9648457169532776)","('NON-ESG', 0.0030508472118526697)","('NON-ESG', 0.0023598221596330404)"
Line 1654,"2022 Integrated Performance Report      GRI 108 SASB TCFD WEF Employee dataInclusion, diversity, and equity (continued) F.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9754407405853271)","('Employee_Health_And_Safety', 0.0020176596008241177)","('Human_Rights_And_Community_Relations', 0.0016852994449436665)","(['Human Capital Development'], 0.9754407405853271)","('NON-ESG', 0.0020176596008241177)","('NON-ESG', 0.0016852994449436665)"
Line 1655,"Describe how engagement with stak eholders has informed the actions taken and how it  has informed whether the actions have been effectiveTo further our ID&E goals, we engage with: •   V ice presidents and other senior executives by requiring them to develop individualized plans to drive ID&E in their business,  region, or function.
","('Business_Model_Resilience', 0.5843152403831482)","('Director_Removal', 0.05577590689063072)","('Systemic_Risk_Management', 0.04474661499261856)","(['Codes of Business Conduct'], 0.5843152403831482)","('NON-ESG', 0.05577590689063072)","('NON-ESG', 0.04474661499261856)"
Line 1656,"•  Employees thr ough our Diversity Networks, Resource Groups, and our annual all-employee survey.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9713609218597412)","('Employee_Health_And_Safety', 0.002692496171221137)","('Labor_Practices', 0.0024426099844276905)","(['Human Capital Development'], 0.9713609218597412)","('NON-ESG', 0.002692496171221137)","('NON-ESG', 0.0024426099844276905)"
Line 1657,"•   New talent thr ough our annual Diversity Career Events, where we engage with diverse candidates to hire for roles in sales,  engineering, software, and more.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9726066589355469)","('Employee_Health_And_Safety', 0.001955955056473613)","('Business_Model_Resilience', 0.0018827777821570635)","(['Human Capital Development'], 0.9726066589355469)","('NON-ESG', 0.001955955056473613)","('NON-ESG', 0.0018827777821570635)"
Line 1658,"•  External diversity le aders, such as DiversityInc, by participating in surveys and integrating shared knowledge into our approach.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9733177423477173)","('Employee_Health_And_Safety', 0.0018887402256950736)","('Business_Model_Resilience', 0.0018195572774857283)","(['Human Capital Development'], 0.9733177423477173)","('NON-ESG', 0.0018887402256950736)","('NON-ESG', 0.0018195572774857283)"
Line 1659,"Read more about how we engage stakeholders in ID&E in Inclusion, diversity and equity and Stakeholder engagement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.972564697265625)","('Human_Rights_And_Community_Relations', 0.0027974355034530163)","('Employee_Health_And_Safety', 0.002270299708470702)","(['Human Capital Development'], 0.972564697265625)","('NON-ESG', 0.0027974355034530163)","('NON-ESG', 0.002270299708470702)"
Line 1660,"Innovation A.
","('Competitive_Behavior', 0.24218003451824188)","('Product_Design_And_Lifecycle_Management', 0.12164217233657837)","('Business_Model_Resilience', 0.10972554236650467)","('NON-ESG', 0.24218003451824188)","('NON-ESG', 0.12164217233657837)","('NON-ESG', 0.10972554236650467)"
Line 1661,"Describe actual and potential nega tive and positive impacts on economy, environment,  and people, including impacts on their human rightsMaintaining a strong pipeline of innovative treatments and services is central to our Mission and supports the universal human right  to healthcare.
","('Human_Rights_And_Community_Relations', 0.9629688858985901)","('Access_And_Affordability', 0.004932504612952471)","('Labor_Practices', 0.002919600112363696)","(['Community Relations'], 0.9629688858985901)","('NON-ESG', 0.004932504612952471)","('NON-ESG', 0.002919600112363696)"
Line 1662,"Our products and therapies help patients achieve positive health outcomes.
","('Product_Design_And_Lifecycle_Management', 0.19369789958000183)","('Product_Quality_And_Safety', 0.17438124120235443)","('Access_And_Affordability', 0.13084347546100616)","('NON-ESG', 0.19369789958000183)","('NON-ESG', 0.17438124120235443)","('NON-ESG', 0.13084347546100616)"
Line 1663,"B.
","('Competitive_Behavior', 0.13404199481010437)","('Management_Of_Legal_And_Regulatory_Framework', 0.12049221247434616)","('Access_And_Affordability', 0.1028861552476883)","('NON-ESG', 0.13404199481010437)","('NON-ESG', 0.12049221247434616)","('NON-ESG', 0.1028861552476883)"
Line 1664,"R eport whether negative impacts are created through its activities or as a result of its  business relationships, and describe the activities or business relationshipsWe are not aware of specific negative impacts related to our innovation strategies.
","('Business_Model_Resilience', 0.4580608606338501)","('Systemic_Risk_Management', 0.2691915035247803)","('Supply_Chain_Management', 0.0613497756421566)","('NON-ESG', 0.4580608606338501)","('NON-ESG', 0.2691915035247803)","('NON-ESG', 0.0613497756421566)"
Line 1665,"Innovation focused on just the consumer without looking at human rights and the environment can have negative impacts.
","('Human_Rights_And_Community_Relations', 0.9285621047019958)","('Management_Of_Legal_And_Regulatory_Framework', 0.00850711576640606)","('Labor_Practices', 0.007110623177140951)","(['Community Relations'], 0.9285621047019958)","('NON-ESG', 0.00850711576640606)","('NON-ESG', 0.007110623177140951)"
Line 1666,"At Medtronic, we are driven by our mission to be patient-centric while focusing on sustainability and economic equity.
","('Business_Model_Resilience', 0.43547534942626953)","('Systemic_Risk_Management', 0.1550416499376297)","('Human_Rights_And_Community_Relations', 0.06907383352518082)","('NON-ESG', 0.43547534942626953)","('NON-ESG', 0.1550416499376297)","('NON-ESG', 0.06907383352518082)"
Line 1667,"C.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35686638951301575)","('Business_Ethics', 0.09611602127552032)","('Competitive_Behavior', 0.05494384095072746)","('NON-ESG', 0.35686638951301575)","('NON-ESG', 0.09611602127552032)","('NON-ESG', 0.05494384095072746)"
Line 1668,"Describe policies or commitments r egarding the material topic Read about our policies and commitments in Global healthcare access.
","('Access_And_Affordability', 0.5366048812866211)","('Management_Of_Legal_And_Regulatory_Framework', 0.173836350440979)","('Human_Rights_And_Community_Relations', 0.0971379354596138)","(['Health Outcome Contribution'], 0.5366048812866211)","('NON-ESG', 0.173836350440979)","('NON-ESG', 0.0971379354596138)"
Line 1669,"D.
","('Employee_Engagement_Inclusion_And_Diversity', 0.11258140206336975)","('Management_Of_Legal_And_Regulatory_Framework', 0.08865229040384293)","('Access_And_Affordability', 0.06962209194898605)","('NON-ESG', 0.11258140206336975)","('NON-ESG', 0.08865229040384293)","('NON-ESG', 0.06962209194898605)"
Line 1670,"Describe actions tak en to manage topics and related impacts, including a.
","('Business_Model_Resilience', 0.29075926542282104)","('Physical_Impacts_Of_Climate_Change', 0.11013726145029068)","('Human_Rights_And_Community_Relations', 0.08778087794780731)","('NON-ESG', 0.29075926542282104)","('NON-ESG', 0.11013726145029068)","('NON-ESG', 0.08778087794780731)"
Line 1671,"Actions to pr event or mitigate potential negative impacts b.
","('Physical_Impacts_Of_Climate_Change', 0.29464656114578247)","('Systemic_Risk_Management', 0.23987378180027008)","('Business_Model_Resilience', 0.09173007309436798)","('NON-ESG', 0.29464656114578247)","('NON-ESG', 0.23987378180027008)","('NON-ESG', 0.09173007309436798)"
Line 1672,"Actions to addr ess actual negative impacts, including actions to provide for or  cooperate in their remediation c.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4002867639064789)","('Physical_Impacts_Of_Climate_Change', 0.11589834839105606)","('Ecological_Impacts', 0.07703129947185516)","('NON-ESG', 0.4002867639064789)","('NON-ESG', 0.11589834839105606)","('NON-ESG', 0.07703129947185516)"
Line 1673,"Actions to manage actual and potential positive impactsW e foster innovation through our actions, including: •  Maintaining a str ong product pipeline, focusing on new and emerging solutions alongside novel applications of existing technology.
","('Product_Design_And_Lifecycle_Management', 0.9559739232063293)","('Customer_Welfare', 0.005554123315960169)","('Product_Quality_And_Safety', 0.004568201024085283)","(['Product Stewardship'], 0.9559739232063293)","('NON-ESG', 0.005554123315960169)","('NON-ESG', 0.004568201024085283)"
Line 1674,"•  T ailoring products and services to the unique needs of each patient.
","('Product_Design_And_Lifecycle_Management', 0.930168867111206)","('Customer_Welfare', 0.012019550427794456)","('Product_Quality_And_Safety', 0.009067369624972343)","(['Product Stewardship'], 0.930168867111206)","('NON-ESG', 0.012019550427794456)","('NON-ESG', 0.009067369624972343)"
Line 1675,"•  T aking our most promising innovations through systematic preclinical or clinical trials, always taking a human-centered approach.
","('Competitive_Behavior', 0.16217409074306488)","('Customer_Welfare', 0.129709854722023)","('Business_Model_Resilience', 0.11503470689058304)","('NON-ESG', 0.16217409074306488)","('NON-ESG', 0.129709854722023)","('NON-ESG', 0.11503470689058304)"
Line 1676,"•  L everaging the power of advanced computing and hyper-personalization to increase access to treatments.
","('Competitive_Behavior', 0.127834752202034)","('Customer_Welfare', 0.12708793580532074)","('Data_Security', 0.12685541808605194)","('NON-ESG', 0.127834752202034)","('NON-ESG', 0.12708793580532074)","('NON-ESG', 0.12685541808605194)"
Line 1677,"•  P rioritizing hiring diverse talent to spur innovation by broadening our perspective, backgrounds, and experiences.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9716543555259705)","('Business_Model_Resilience', 0.0020932930056005716)","('Employee_Health_And_Safety', 0.0018581061158329248)","(['Human Capital Development'], 0.9716543555259705)","('NON-ESG', 0.0020932930056005716)","('NON-ESG', 0.0018581061158329248)"
Line 1678,"•  P artnering with, investing in, or acquiring other healthcare technology companies to provide broader access to innovative technology.
","('Energy_Management', 0.13276781141757965)","('Product_Design_And_Lifecycle_Management', 0.11446932703256607)","('Data_Security', 0.11280442029237747)","('NON-ESG', 0.13276781141757965)","('NON-ESG', 0.11446932703256607)","('NON-ESG', 0.11280442029237747)"
Line 1679,"Today, Medtronic LABS is an independent Medtronic-funded nonprofit organization that accelerates healthcare access for underserved communities around the world through technology.
","('Access_And_Affordability', 0.9473878741264343)","('Critical_Incident_Risk_Management', 0.005320175085216761)","('Energy_Management', 0.004143216647207737)","(['Health Outcome Contribution'], 0.9473878741264343)","('NON-ESG', 0.005320175085216761)","('NON-ESG', 0.004143216647207737)"
Line 1680,"E.
","('Management_Of_Legal_And_Regulatory_Framework', 0.10841184854507446)","('Product_Design_And_Lifecycle_Management', 0.09176333993673325)","('Competitive_Behavior', 0.08798782527446747)","('NON-ESG', 0.10841184854507446)","('NON-ESG', 0.09176333993673325)","('NON-ESG', 0.08798782527446747)"
Line 1681,"R eport on tracking the effectiveness of actions taken a.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5443630814552307)","('Human_Rights_And_Community_Relations', 0.11589175462722778)","('Business_Ethics', 0.05138600990176201)","(['Corporate Governance'], 0.5443630814552307)","('NON-ESG', 0.11589175462722778)","('NON-ESG', 0.05138600990176201)"
Line 1682,"P rocesses used to track the effectiveness of the actions b.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5499942302703857)","('Business_Ethics', 0.12774807214736938)","('Competitive_Behavior', 0.0598081573843956)","(['Corporate Governance'], 0.5499942302703857)","('NON-ESG', 0.12774807214736938)","('NON-ESG', 0.0598081573843956)"
Line 1683,"Goals,  targets, and indicators used to evaluate progress c.
","('Human_Rights_And_Community_Relations', 0.3535557985305786)","('Management_Of_Legal_And_Regulatory_Framework', 0.11948598921298981)","('Business_Model_Resilience', 0.11248379200696945)","('NON-ESG', 0.3535557985305786)","('NON-ESG', 0.11948598921298981)","('NON-ESG', 0.11248379200696945)"
Line 1684,"T he effectiveness of the actions, including progress toward the goals and targets d.
","('Human_Rights_And_Community_Relations', 0.4061984717845917)","('Business_Model_Resilience', 0.14526352286338806)","('Management_Of_Legal_And_Regulatory_Framework', 0.10114128142595291)","('NON-ESG', 0.4061984717845917)","('NON-ESG', 0.14526352286338806)","('NON-ESG', 0.10114128142595291)"
Line 1685,"L essons learned and how these have been incorporated into the organization’s  operational policies and proceduresWe have the following target in place: •   By FY25,  20% of Medtronic revenue will flow from products and therapies released in the prior 36 months as a measure of the  vitality of our innovation efforts.
","('Product_Design_And_Lifecycle_Management', 0.9382886290550232)","('Customer_Welfare', 0.008862732909619808)","('Product_Quality_And_Safety', 0.00734916003420949)","(['Product Stewardship'], 0.9382886290550232)","('NON-ESG', 0.008862732909619808)","('NON-ESG', 0.00734916003420949)"
Line 1686,"–   FY22 pr ogress: 19% of Medtronic revenue flowed from products and therapies released in the prior 36 months.
","('Product_Design_And_Lifecycle_Management', 0.44015464186668396)","('Customer_Welfare', 0.2135705202817917)","('Selling_Practices_And_Product_Labeling', 0.07193638384342194)","('NON-ESG', 0.44015464186668396)","('NON-ESG', 0.2135705202817917)","('NON-ESG', 0.07193638384342194)"
Line 1687,"Through our tracking of product impacts and waste management, we identified that we could make improvements to our packaging.
","('Waste_And_Hazardous_Materials_Management', 0.7008306384086609)","('Product_Design_And_Lifecycle_Management', 0.1870405226945877)","('Product_Quality_And_Safety', 0.010537155903875828)","(['Operational Eco-Efficiency'], 0.7008306384086609)","('NON-ESG', 0.1870405226945877)","('NON-ESG', 0.010537155903875828)"
Line 1688,"So, we have committed dedicated resources to innovations in packaging through our Sustainability Development Center.
","('Product_Design_And_Lifecycle_Management', 0.9527972340583801)","('Product_Quality_And_Safety', 0.005228438880294561)","('Energy_Management', 0.004270156845450401)","(['Product Stewardship'], 0.9527972340583801)","('NON-ESG', 0.005228438880294561)","('NON-ESG', 0.004270156845450401)"
Line 1689,"2022 Integrated Performance Report      GRI 109 SASB TCFD WEF Employee dataInnovation (continued) F.
","('Business_Model_Resilience', 0.3253275156021118)","('Systemic_Risk_Management', 0.20195138454437256)","('Management_Of_Legal_And_Regulatory_Framework', 0.05869503691792488)","('NON-ESG', 0.3253275156021118)","('NON-ESG', 0.20195138454437256)","('NON-ESG', 0.05869503691792488)"
Line 1690,"Describe how engagement with stak eholders has informed the actions taken and how it  has informed whether the actions have been effectiveOur healthcare innovation team, a group of technologists, strategists, and designers, engages with Medtronic teams across every  operating unit to turn innovative ideas into practical solutions, with a focus on human-centered design, high-quality deliverables, and hands-on learning.
","('Product_Design_And_Lifecycle_Management', 0.5828485488891602)","('Business_Model_Resilience', 0.1411973387002945)","('Customer_Welfare', 0.04519234597682953)","(['Product Stewardship'], 0.5828485488891602)","('NON-ESG', 0.1411973387002945)","('NON-ESG', 0.04519234597682953)"
Line 1691,"W e partner with peers, innovators, healthcare systems and others stakeholders to deliver solutions matched to local needs and  develop new approaches that increase access to our treatments.
","('Access_And_Affordability', 0.8138115406036377)","('Customer_Welfare', 0.024738982319831848)","('Energy_Management', 0.015460953116416931)","(['Health Outcome Contribution'], 0.8138115406036377)","('NON-ESG', 0.024738982319831848)","('NON-ESG', 0.015460953116416931)"
Line 1692,"Read more about our stakeholder engagement in Global healthcare access and Stakeholder engagement.
","('Human_Rights_And_Community_Relations', 0.5364106297492981)","('Business_Model_Resilience', 0.06821614503860474)","('Access_And_Affordability', 0.05540449172258377)","(['Community Relations'], 0.5364106297492981)","('NON-ESG', 0.06821614503860474)","('NON-ESG', 0.05540449172258377)"
Line 1693,"Integrated care A.
","('Access_And_Affordability', 0.5312593579292297)","('Product_Design_And_Lifecycle_Management', 0.06767868250608444)","('Customer_Welfare', 0.04781494662165642)","(['Health Outcome Contribution'], 0.5312593579292297)","('NON-ESG', 0.06767868250608444)","('NON-ESG', 0.04781494662165642)"
Line 1694,"Describe actual and potential nega tive and positive impacts on economy, environment,  and people, including impacts on their human rightsHealthcare systems are complex, and siloed approaches to care can result in higher costs and unsatisfactory outcomes for patients.
","('Human_Rights_And_Community_Relations', 0.8875267505645752)","('Access_And_Affordability', 0.03477116674184799)","('Employee_Health_And_Safety', 0.011449446901679039)","(['Community Relations'], 0.8875267505645752)","('NON-ESG', 0.03477116674184799)","('NON-ESG', 0.011449446901679039)"
Line 1695,"B.
","('Competitive_Behavior', 0.13404199481010437)","('Management_Of_Legal_And_Regulatory_Framework', 0.12049221247434616)","('Access_And_Affordability', 0.1028861552476883)","('NON-ESG', 0.13404199481010437)","('NON-ESG', 0.12049221247434616)","('NON-ESG', 0.1028861552476883)"
Line 1696,"R eport whether negative impacts are created through its activities or as a result of its  business relationships, and describe the activities or business relationshipsOur activities to develop integrated care focus on partnerships with others to create healthcare technologies and new business models  that improve patients' lives.
","('Business_Model_Resilience', 0.49351128935813904)","('Access_And_Affordability', 0.07618754357099533)","('Systemic_Risk_Management', 0.06712216138839722)","('NON-ESG', 0.49351128935813904)","('NON-ESG', 0.07618754357099533)","('NON-ESG', 0.06712216138839722)"
Line 1697,"Through these partnerships, we bring together inputs, delivery, management, and organization of services related to diagnosis, treatment, care, rehabilitation, and health promotion.
","('Access_And_Affordability', 0.4332997500896454)","('Employee_Health_And_Safety', 0.3241386413574219)","('Product_Quality_And_Safety', 0.030240902677178383)","('NON-ESG', 0.4332997500896454)","('NON-ESG', 0.3241386413574219)","('NON-ESG', 0.030240902677178383)"
Line 1698,"C.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35686638951301575)","('Business_Ethics', 0.09611602127552032)","('Competitive_Behavior', 0.05494384095072746)","('NON-ESG', 0.35686638951301575)","('NON-ESG', 0.09611602127552032)","('NON-ESG', 0.05494384095072746)"
Line 1699,"Describe policies or commitments r egarding the material topic Read about our policies and commitments in Global healthcare access.
","('Access_And_Affordability', 0.5366048812866211)","('Management_Of_Legal_And_Regulatory_Framework', 0.173836350440979)","('Human_Rights_And_Community_Relations', 0.0971379354596138)","(['Health Outcome Contribution'], 0.5366048812866211)","('NON-ESG', 0.173836350440979)","('NON-ESG', 0.0971379354596138)"
Line 1700,"D.
","('Employee_Engagement_Inclusion_And_Diversity', 0.11258140206336975)","('Management_Of_Legal_And_Regulatory_Framework', 0.08865229040384293)","('Access_And_Affordability', 0.06962209194898605)","('NON-ESG', 0.11258140206336975)","('NON-ESG', 0.08865229040384293)","('NON-ESG', 0.06962209194898605)"
Line 1701,"Describe actions tak en to manage topics and related impacts, including a.
","('Business_Model_Resilience', 0.29075926542282104)","('Physical_Impacts_Of_Climate_Change', 0.11013726145029068)","('Human_Rights_And_Community_Relations', 0.08778087794780731)","('NON-ESG', 0.29075926542282104)","('NON-ESG', 0.11013726145029068)","('NON-ESG', 0.08778087794780731)"
Line 1702,"Actions to pr event or mitigate potential negative impacts b.
","('Physical_Impacts_Of_Climate_Change', 0.29464656114578247)","('Systemic_Risk_Management', 0.23987378180027008)","('Business_Model_Resilience', 0.09173007309436798)","('NON-ESG', 0.29464656114578247)","('NON-ESG', 0.23987378180027008)","('NON-ESG', 0.09173007309436798)"
Line 1703,"Actions to addr ess actual negative impacts, including actions to provide for or  cooperate in their remediation c.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4002867639064789)","('Physical_Impacts_Of_Climate_Change', 0.11589834839105606)","('Ecological_Impacts', 0.07703129947185516)","('NON-ESG', 0.4002867639064789)","('NON-ESG', 0.11589834839105606)","('NON-ESG', 0.07703129947185516)"
Line 1704,"Actions to manage actual and potential positive impactsW e partner externally to find and extend innovative solutions to global healthcare challenges.
","('Access_And_Affordability', 0.21106447279453278)","('Business_Model_Resilience', 0.1925140917301178)","('Systemic_Risk_Management', 0.09583724290132523)","('NON-ESG', 0.21106447279453278)","('NON-ESG', 0.1925140917301178)","('NON-ESG', 0.09583724290132523)"
Line 1705,"This starts at the innovation and new  product development stage, where we collaborate with peers, innovators, and academics.
","('Product_Design_And_Lifecycle_Management', 0.9361587762832642)","('Customer_Welfare', 0.006743348203599453)","('Product_Quality_And_Safety', 0.005923813208937645)","(['Product Stewardship'], 0.9361587762832642)","('NON-ESG', 0.006743348203599453)","('NON-ESG', 0.005923813208937645)"
Line 1706,"Through VBHC partnerships, we work with health systems to improve long-term patient outcomes per dollar spent.
","('Access_And_Affordability', 0.6360717415809631)","('Employee_Health_And_Safety', 0.11571959406137466)","('Critical_Incident_Risk_Management', 0.024804113432765007)","(['Health Outcome Contribution'], 0.6360717415809631)","('NON-ESG', 0.11571959406137466)","('NON-ESG', 0.024804113432765007)"
Line 1707,"We partner with healthcare organizations to develop new business models that improve patient outcomes and address healthcare disparities.
","('Access_And_Affordability', 0.6681098937988281)","('Employee_Health_And_Safety', 0.03596127778291702)","('Customer_Welfare', 0.03126600757241249)","(['Health Outcome Contribution'], 0.6681098937988281)","('NON-ESG', 0.03596127778291702)","('NON-ESG', 0.03126600757241249)"
Line 1708,"E.
","('Management_Of_Legal_And_Regulatory_Framework', 0.10841184854507446)","('Product_Design_And_Lifecycle_Management', 0.09176333993673325)","('Competitive_Behavior', 0.08798782527446747)","('NON-ESG', 0.10841184854507446)","('NON-ESG', 0.09176333993673325)","('NON-ESG', 0.08798782527446747)"
Line 1709,"R eport on tracking the effectiveness of actions taken a.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5443630814552307)","('Human_Rights_And_Community_Relations', 0.11589175462722778)","('Business_Ethics', 0.05138600990176201)","(['Corporate Governance'], 0.5443630814552307)","('NON-ESG', 0.11589175462722778)","('NON-ESG', 0.05138600990176201)"
Line 1710,"P rocesses used to track the effectiveness of the actions b.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5499942302703857)","('Business_Ethics', 0.12774807214736938)","('Competitive_Behavior', 0.0598081573843956)","(['Corporate Governance'], 0.5499942302703857)","('NON-ESG', 0.12774807214736938)","('NON-ESG', 0.0598081573843956)"
Line 1711,"Goals,  targets, and indicators used to evaluate progress c.
","('Human_Rights_And_Community_Relations', 0.3535557985305786)","('Management_Of_Legal_And_Regulatory_Framework', 0.11948598921298981)","('Business_Model_Resilience', 0.11248379200696945)","('NON-ESG', 0.3535557985305786)","('NON-ESG', 0.11948598921298981)","('NON-ESG', 0.11248379200696945)"
Line 1712,"T he effectiveness of the actions, including progress toward the goals and targets d.
","('Human_Rights_And_Community_Relations', 0.4061984717845917)","('Business_Model_Resilience', 0.14526352286338806)","('Management_Of_Legal_And_Regulatory_Framework', 0.10114128142595291)","('NON-ESG', 0.4061984717845917)","('NON-ESG', 0.14526352286338806)","('NON-ESG', 0.10114128142595291)"
Line 1713,"L essons learned and how these have been incorporated into the organization’s  operational policies and proceduresIntegrated care is a key component of our overall approach to increasing global access to our products and services.
","('Product_Design_And_Lifecycle_Management', 0.5256021618843079)","('Customer_Welfare', 0.10580473393201828)","('Product_Quality_And_Safety', 0.07378290593624115)","(['Product Stewardship'], 0.5256021618843079)","('NON-ESG', 0.10580473393201828)","('NON-ESG', 0.07378290593624115)"
Line 1714,"We monitor and adjust each program and partnership on a case-by-case basis — tracking patient outcomes and efficiencies and applying what we learn to enable continuous improvement.
","('Access_And_Affordability', 0.6655493378639221)","('Employee_Health_And_Safety', 0.03582341969013214)","('Human_Rights_And_Community_Relations', 0.02973896823823452)","(['Health Outcome Contribution'], 0.6655493378639221)","('NON-ESG', 0.03582341969013214)","('NON-ESG', 0.02973896823823452)"
Line 1715,"Read more about our actions in Global healthcare access.
","('Access_And_Affordability', 0.8499438166618347)","('Human_Rights_And_Community_Relations', 0.020941082388162613)","('Product_Quality_And_Safety', 0.015392651781439781)","(['Health Outcome Contribution'], 0.8499438166618347)","('NON-ESG', 0.020941082388162613)","('NON-ESG', 0.015392651781439781)"
Line 1716,"F.
","('GHG_Emissions', 0.15389062464237213)","('Management_Of_Legal_And_Regulatory_Framework', 0.11919295787811279)","('Competitive_Behavior', 0.11879564821720123)","('NON-ESG', 0.15389062464237213)","('NON-ESG', 0.11919295787811279)","('NON-ESG', 0.11879564821720123)"
Line 1717,"Describe how engagement with stak eholders has informed the actions taken and how it  has informed whether the actions have been effectiveEngagement with peers, innovators, healthcare systems, and governments forms the foundation for our actions to develop integrated  healthcare solutions.
","('Business_Model_Resilience', 0.359101265668869)","('Product_Design_And_Lifecycle_Management', 0.08459070324897766)","('Systemic_Risk_Management', 0.07942900061607361)","('NON-ESG', 0.359101265668869)","('NON-ESG', 0.08459070324897766)","('NON-ESG', 0.07942900061607361)"
Line 1718,"We work with these stakeholders to identify local needs and create effective solutions.
","('Human_Rights_And_Community_Relations', 0.8572019338607788)","('Access_And_Affordability', 0.02241954393684864)","('Critical_Incident_Risk_Management', 0.013257813639938831)","(['Community Relations'], 0.8572019338607788)","('NON-ESG', 0.02241954393684864)","('NON-ESG', 0.013257813639938831)"
Line 1719,"2022 Integrated Performance Report      GRI 110 SASB TCFD WEF Employee dataPatient safety and product quality A.
","('Product_Quality_And_Safety', 0.9015951156616211)","('Product_Design_And_Lifecycle_Management', 0.019572781398892403)","('Employee_Health_And_Safety', 0.011903529055416584)","(['Product Quality & Recall Management'], 0.9015951156616211)","('NON-ESG', 0.019572781398892403)","('NON-ESG', 0.011903529055416584)"
Line 1720,"Describe actual and potential nega tive and positive impacts on economy, environment,  and people, including impacts on their human rightsOur products and therapies provide vital healthcare services to our patients.
","('Human_Rights_And_Community_Relations', 0.8934230208396912)","('Access_And_Affordability', 0.032307084649801254)","('Employee_Health_And_Safety', 0.006790091749280691)","(['Community Relations'], 0.8934230208396912)","('NON-ESG', 0.032307084649801254)","('NON-ESG', 0.006790091749280691)"
Line 1721,"By ensuring the quality, safety, and reliability of our  products, we elevate positive impacts and reduce negative outcomes.
","('Product_Quality_And_Safety', 0.5248856544494629)","('Product_Design_And_Lifecycle_Management', 0.3314424753189087)","('Employee_Health_And_Safety', 0.02489493042230606)","(['Product Quality & Recall Management'], 0.5248856544494629)","('NON-ESG', 0.3314424753189087)","('NON-ESG', 0.02489493042230606)"
Line 1722,"B.
","('Competitive_Behavior', 0.13404199481010437)","('Management_Of_Legal_And_Regulatory_Framework', 0.12049221247434616)","('Access_And_Affordability', 0.1028861552476883)","('NON-ESG', 0.13404199481010437)","('NON-ESG', 0.12049221247434616)","('NON-ESG', 0.1028861552476883)"
Line 1723,"R eport whether negative impacts are created through its activities or as a result of  its business relationships, and describe the activities or business relationshipsAny positive or negative effects of our products are predominantly the result of our business activities but could also extend to the suppliers that manufacture our products.
","('Product_Design_And_Lifecycle_Management', 0.9493985176086426)","('Selling_Practices_And_Product_Labeling', 0.008108409121632576)","('Product_Quality_And_Safety', 0.007867791689932346)","(['Product Stewardship'], 0.9493985176086426)","('NON-ESG', 0.008108409121632576)","('NON-ESG', 0.007867791689932346)"
Line 1724,"C.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35686638951301575)","('Business_Ethics', 0.09611602127552032)","('Competitive_Behavior', 0.05494384095072746)","('NON-ESG', 0.35686638951301575)","('NON-ESG', 0.09611602127552032)","('NON-ESG', 0.05494384095072746)"
Line 1725,"Describe policies or commitments r egarding the material topic See our policies and commitments in Patient safety and product quality.
","('Product_Quality_And_Safety', 0.8178863525390625)","('Product_Design_And_Lifecycle_Management', 0.08190415799617767)","('Selling_Practices_And_Product_Labeling', 0.014539985917508602)","(['Product Quality & Recall Management'], 0.8178863525390625)","('NON-ESG', 0.08190415799617767)","('NON-ESG', 0.014539985917508602)"
Line 1726,"D.
","('Employee_Engagement_Inclusion_And_Diversity', 0.11258140206336975)","('Management_Of_Legal_And_Regulatory_Framework', 0.08865229040384293)","('Access_And_Affordability', 0.06962209194898605)","('NON-ESG', 0.11258140206336975)","('NON-ESG', 0.08865229040384293)","('NON-ESG', 0.06962209194898605)"
Line 1727,"Describe actions tak en to manage topics and related impacts, including a.
","('Business_Model_Resilience', 0.29075926542282104)","('Physical_Impacts_Of_Climate_Change', 0.11013726145029068)","('Human_Rights_And_Community_Relations', 0.08778087794780731)","('NON-ESG', 0.29075926542282104)","('NON-ESG', 0.11013726145029068)","('NON-ESG', 0.08778087794780731)"
Line 1728,"Actions to pr event or mitigate potential negative impacts b.
","('Physical_Impacts_Of_Climate_Change', 0.29464656114578247)","('Systemic_Risk_Management', 0.23987378180027008)","('Business_Model_Resilience', 0.09173007309436798)","('NON-ESG', 0.29464656114578247)","('NON-ESG', 0.23987378180027008)","('NON-ESG', 0.09173007309436798)"
Line 1729,"Actions to addr ess actual negative impacts, including actions to provide  for or cooperate in their remediation c.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4002867639064789)","('Physical_Impacts_Of_Climate_Change', 0.11589834839105606)","('Ecological_Impacts', 0.07703129947185516)","('NON-ESG', 0.4002867639064789)","('NON-ESG', 0.11589834839105606)","('NON-ESG', 0.07703129947185516)"
Line 1730,"Actions to manage actual and potential positive impactsOur approach to patient safety and product quality takes a patient-centered approach and ensures that we deliver consistent companywide quality.
","('Product_Quality_And_Safety', 0.7190970778465271)","('Product_Design_And_Lifecycle_Management', 0.15061555802822113)","('Selling_Practices_And_Product_Labeling', 0.018150029703974724)","(['Product Quality & Recall Management'], 0.7190970778465271)","('NON-ESG', 0.15061555802822113)","('NON-ESG', 0.018150029703974724)"
Line 1731,"Our processes and programs are described in Patient safety and product quality.
","('Product_Quality_And_Safety', 0.863797664642334)","('Product_Design_And_Lifecycle_Management', 0.0414801687002182)","('Selling_Practices_And_Product_Labeling', 0.01614605449140072)","(['Product Quality & Recall Management'], 0.863797664642334)","('NON-ESG', 0.0414801687002182)","('NON-ESG', 0.01614605449140072)"
Line 1732,"E.
","('Management_Of_Legal_And_Regulatory_Framework', 0.10841184854507446)","('Product_Design_And_Lifecycle_Management', 0.09176333993673325)","('Competitive_Behavior', 0.08798782527446747)","('NON-ESG', 0.10841184854507446)","('NON-ESG', 0.09176333993673325)","('NON-ESG', 0.08798782527446747)"
Line 1733,"R eport on tracking the effectiveness of actions taken a.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5443630814552307)","('Human_Rights_And_Community_Relations', 0.11589175462722778)","('Business_Ethics', 0.05138600990176201)","(['Corporate Governance'], 0.5443630814552307)","('NON-ESG', 0.11589175462722778)","('NON-ESG', 0.05138600990176201)"
Line 1734,"P rocesses used to track the effectiveness of the actions b.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5499942302703857)","('Business_Ethics', 0.12774807214736938)","('Competitive_Behavior', 0.0598081573843956)","(['Corporate Governance'], 0.5499942302703857)","('NON-ESG', 0.12774807214736938)","('NON-ESG', 0.0598081573843956)"
Line 1735,"Goals,  targets, and indicators used to evaluate progress c.
","('Human_Rights_And_Community_Relations', 0.3535557985305786)","('Management_Of_Legal_And_Regulatory_Framework', 0.11948598921298981)","('Business_Model_Resilience', 0.11248379200696945)","('NON-ESG', 0.3535557985305786)","('NON-ESG', 0.11948598921298981)","('NON-ESG', 0.11248379200696945)"
Line 1736,"T he effectiveness of the actions, including progress toward the goals and targets d.
","('Human_Rights_And_Community_Relations', 0.4061984717845917)","('Business_Model_Resilience', 0.14526352286338806)","('Management_Of_Legal_And_Regulatory_Framework', 0.10114128142595291)","('NON-ESG', 0.4061984717845917)","('NON-ESG', 0.14526352286338806)","('NON-ESG', 0.10114128142595291)"
Line 1737,"L essons learned and how these have been incorporated into the organization’s  operational policies and proceduresWe monitor compliance with our quality standards at every point in a product’s life cycle.
","('Product_Quality_And_Safety', 0.6042417883872986)","('Business_Ethics', 0.1342880129814148)","('Management_Of_Legal_And_Regulatory_Framework', 0.061272699385881424)","(['Product Quality & Recall Management'], 0.6042417883872986)","('NON-ESG', 0.1342880129814148)","('NON-ESG', 0.061272699385881424)"
Line 1738,"We track quality and safety by: •  E valuating actual and potential safety issues, harm, and health risks to patients or users of Medtronic products and therapies.
","('Product_Quality_And_Safety', 0.8973697423934937)","('Product_Design_And_Lifecycle_Management', 0.019888104870915413)","('Employee_Health_And_Safety', 0.013390043750405312)","(['Product Quality & Recall Management'], 0.8973697423934937)","('NON-ESG', 0.019888104870915413)","('NON-ESG', 0.013390043750405312)"
Line 1739,"•  Simula ting product use, forecasting performance, and pinpointing potential improvements.
","('Product_Design_And_Lifecycle_Management', 0.9490419030189514)","('Product_Quality_And_Safety', 0.006030222401022911)","('Business_Model_Resilience', 0.005436314269900322)","(['Product Stewardship'], 0.9490419030189514)","('NON-ESG', 0.006030222401022911)","('NON-ESG', 0.005436314269900322)"
Line 1740,"–   FY22 pr ogress: assessed more than 87% of all new products in our pipeline using this approach.
","('Product_Design_And_Lifecycle_Management', 0.948921263217926)","('Product_Quality_And_Safety', 0.008640388026833534)","('Selling_Practices_And_Product_Labeling', 0.005566972773522139)","(['Product Stewardship'], 0.948921263217926)","('NON-ESG', 0.008640388026833534)","('NON-ESG', 0.005566972773522139)"
Line 1741,"•   Using pr edictive and preventive risk assessments to reduce risk and optimize our supply base to avoid product supply disruptions  through SOAR.
","('Supply_Chain_Management', 0.9455763697624207)","('Systemic_Risk_Management', 0.0050822291523218155)","('Labor_Practices', 0.004490232095122337)","(['Supply Chain Management'], 0.9455763697624207)","('NON-ESG', 0.0050822291523218155)","('NON-ESG', 0.004490232095122337)"
Line 1742,"•   Under going external regulatory audits helps to keep us accountable, aware of regulatory priorities, and focused on making  necessary changes to policies and practices.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9707772731781006)","('Business_Ethics', 0.002536284737288952)","('Director_Removal', 0.0023718299344182014)","(['Corporate Governance'], 0.9707772731781006)","('NON-ESG', 0.002536284737288952)","('NON-ESG', 0.0023718299344182014)"
Line 1743,"–   FY22 pr ogress: 95% of external regulatory inspections at Medtronic facilities globally resulted in no findings.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5387895107269287)","('Business_Ethics', 0.3355705440044403)","('Product_Quality_And_Safety', 0.01792796701192856)","(['Corporate Governance'], 0.5387895107269287)","('NON-ESG', 0.3355705440044403)","('NON-ESG', 0.01792796701192856)"
Line 1744,"We have the following goal in place for product quality and patient safety improvements:•  10% r eduction in aggregate product complaint rate by FY25, compared with a FY20 baseline, for identified product families.
","('Product_Quality_And_Safety', 0.9159743785858154)","('Product_Design_And_Lifecycle_Management', 0.014491318725049496)","('Employee_Health_And_Safety', 0.00875922106206417)","(['Product Quality & Recall Management'], 0.9159743785858154)","('NON-ESG', 0.014491318725049496)","('NON-ESG', 0.00875922106206417)"
Line 1745,"–   FY22 pr ogress: 10% reduction in complaint rates compared to FY20.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5032235980033875)","('Business_Ethics', 0.2558629810810089)","('Systemic_Risk_Management', 0.05081542208790779)","(['Corporate Governance'], 0.5032235980033875)","('NON-ESG', 0.2558629810810089)","('NON-ESG', 0.05081542208790779)"
Line 1746,"F.
","('GHG_Emissions', 0.15389062464237213)","('Management_Of_Legal_And_Regulatory_Framework', 0.11919295787811279)","('Competitive_Behavior', 0.11879564821720123)","('NON-ESG', 0.15389062464237213)","('NON-ESG', 0.11919295787811279)","('NON-ESG', 0.11879564821720123)"
Line 1747,"Describe how engagement with stak eholders has informed the actions taken and how it  has informed whether the actions have been effectiveThe advancement of medical research depends upon transparent data sharing and collaboration.
","('Data_Security', 0.23694054782390594)","('Management_Of_Legal_And_Regulatory_Framework', 0.2177988439798355)","('Customer_Privacy', 0.06916540861129761)","('NON-ESG', 0.23694054782390594)","('NON-ESG', 0.2177988439798355)","('NON-ESG', 0.06916540861129761)"
Line 1748,"We continue to share knowledge  with the greater medical community.
","('Access_And_Affordability', 0.6045973300933838)","('Employee_Engagement_Inclusion_And_Diversity', 0.043877266347408295)","('Customer_Welfare', 0.0319683738052845)","(['Health Outcome Contribution'], 0.6045973300933838)","('NON-ESG', 0.043877266347408295)","('NON-ESG', 0.0319683738052845)"
Line 1749,"We also engage with regulatory bodies like the FDA to inform our quality systems and shape our approach in line with current guidelines.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9423729181289673)","('Product_Quality_And_Safety', 0.006578418426215649)","('Competitive_Behavior', 0.006050263065844774)","(['Corporate Governance'], 0.9423729181289673)","('NON-ESG', 0.006578418426215649)","('NON-ESG', 0.006050263065844774)"
Line 1750,"Learn more about how we engage stakeholders in Patient safety and product quality and Stakeholder engagement.
","('Product_Quality_And_Safety', 0.7574145197868347)","('Product_Design_And_Lifecycle_Management', 0.10554782301187515)","('Customer_Welfare', 0.019231634214520454)","(['Product Quality & Recall Management'], 0.7574145197868347)","('NON-ESG', 0.10554782301187515)","('NON-ESG', 0.019231634214520454)"
Line 1751,"2022 Integrated Performance Report      GRI 111 SASB TCFD WEF Employee dataProduct stewardship A.
","('Business_Model_Resilience', 0.3602466285228729)","('Supply_Chain_Management', 0.08328664302825928)","('Product_Design_And_Lifecycle_Management', 0.06533696502447128)","('NON-ESG', 0.3602466285228729)","('NON-ESG', 0.08328664302825928)","('NON-ESG', 0.06533696502447128)"
Line 1752,"Describe actual and potential nega tive and positive impacts on economy, environment,  and people, including impacts on their human rightsOur business of developing and delivering products supports local economies through the taxes we pay, the people we employ, the  suppliers we partner with, and the patients we serve.
","('Human_Rights_And_Community_Relations', 0.8047076463699341)","('Supply_Chain_Management', 0.03935956582427025)","('Product_Design_And_Lifecycle_Management', 0.015377070754766464)","(['Community Relations'], 0.8047076463699341)","('NON-ESG', 0.03935956582427025)","('NON-ESG', 0.015377070754766464)"
Line 1753,"We recognize that although our products provide a social benefit by improving patient health and well-being, they also have environmental impacts across their life cycle.
","('Product_Design_And_Lifecycle_Management', 0.461821049451828)","('Access_And_Affordability', 0.18083594739437103)","('Employee_Health_And_Safety', 0.06523136794567108)","('NON-ESG', 0.461821049451828)","('NON-ESG', 0.18083594739437103)","('NON-ESG', 0.06523136794567108)"
Line 1754,"B.
","('Competitive_Behavior', 0.13404199481010437)","('Management_Of_Legal_And_Regulatory_Framework', 0.12049221247434616)","('Access_And_Affordability', 0.1028861552476883)","('NON-ESG', 0.13404199481010437)","('NON-ESG', 0.12049221247434616)","('NON-ESG', 0.1028861552476883)"
Line 1755,"R eport whether negative impacts are created through its activities or as a result of its  business relationships, and describe the activities or business relationshipsThe majority of our product impacts occur within Medtronic during product design, with our suppliers during product manufacture, and with customers when they dispose of the product.
","('Product_Design_And_Lifecycle_Management', 0.9581331610679626)","('Product_Quality_And_Safety', 0.006068595219403505)","('Selling_Practices_And_Product_Labeling', 0.005498509854078293)","(['Product Stewardship'], 0.9581331610679626)","('NON-ESG', 0.006068595219403505)","('NON-ESG', 0.005498509854078293)"
Line 1756,"These effects include, but are not limited to, raw material extraction, energy demand, transportation emissions, and disposal.
","('Supply_Chain_Management', 0.49388906359672546)","('Product_Design_And_Lifecycle_Management', 0.225261390209198)","('Energy_Management', 0.04458187520503998)","('NON-ESG', 0.49388906359672546)","('NON-ESG', 0.225261390209198)","('NON-ESG', 0.04458187520503998)"
Line 1757,"C.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35686638951301575)","('Business_Ethics', 0.09611602127552032)","('Competitive_Behavior', 0.05494384095072746)","('NON-ESG', 0.35686638951301575)","('NON-ESG', 0.09611602127552032)","('NON-ESG', 0.05494384095072746)"
Line 1758,"Describe policies or commitments r egarding the material topic Read about our policies and commitments in Product stewardship.
","('Product_Design_And_Lifecycle_Management', 0.8601388335227966)","('Product_Quality_And_Safety', 0.029156947508454323)","('Selling_Practices_And_Product_Labeling', 0.016909010708332062)","(['Product Stewardship'], 0.8601388335227966)","('NON-ESG', 0.029156947508454323)","('NON-ESG', 0.016909010708332062)"
Line 1759,"D.
","('Employee_Engagement_Inclusion_And_Diversity', 0.11258140206336975)","('Management_Of_Legal_And_Regulatory_Framework', 0.08865229040384293)","('Access_And_Affordability', 0.06962209194898605)","('NON-ESG', 0.11258140206336975)","('NON-ESG', 0.08865229040384293)","('NON-ESG', 0.06962209194898605)"
Line 1760,"Describe actions tak en to manage topics and related impacts, including a.
","('Business_Model_Resilience', 0.29075926542282104)","('Physical_Impacts_Of_Climate_Change', 0.11013726145029068)","('Human_Rights_And_Community_Relations', 0.08778087794780731)","('NON-ESG', 0.29075926542282104)","('NON-ESG', 0.11013726145029068)","('NON-ESG', 0.08778087794780731)"
Line 1761,"Actions to pr event or mitigate potential negative impacts b.
","('Physical_Impacts_Of_Climate_Change', 0.29464656114578247)","('Systemic_Risk_Management', 0.23987378180027008)","('Business_Model_Resilience', 0.09173007309436798)","('NON-ESG', 0.29464656114578247)","('NON-ESG', 0.23987378180027008)","('NON-ESG', 0.09173007309436798)"
Line 1762,"Actions to addr ess actual negative impacts, including actions to provide for or  cooperate in their remediation c.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4002867639064789)","('Physical_Impacts_Of_Climate_Change', 0.11589834839105606)","('Ecological_Impacts', 0.07703129947185516)","('NON-ESG', 0.4002867639064789)","('NON-ESG', 0.11589834839105606)","('NON-ESG', 0.07703129947185516)"
Line 1763,"Actions to manage actual and potential positive impactsT he positive impacts of our business are reflected in the improved quality of life for those using our products or therapies.
","('Product_Design_And_Lifecycle_Management', 0.9619173407554626)","('Product_Quality_And_Safety', 0.005547450855374336)","('Selling_Practices_And_Product_Labeling', 0.004627036862075329)","(['Product Stewardship'], 0.9619173407554626)","('NON-ESG', 0.005547450855374336)","('NON-ESG', 0.004627036862075329)"
Line 1764,"We aim to  maintain and amplify these positive outcomes while minimizing our product environmental footprint.
","('Product_Design_And_Lifecycle_Management', 0.9620012044906616)","('Product_Quality_And_Safety', 0.004472797270864248)","('Business_Model_Resilience', 0.003601124742999673)","(['Product Stewardship'], 0.9620012044906616)","('NON-ESG', 0.004472797270864248)","('NON-ESG', 0.003601124742999673)"
Line 1765,"•   In FY22,  we launched the Sustainability Development Center (SDC) to focus on eliminating waste and materials of concern from our  packaging.
","('Waste_And_Hazardous_Materials_Management', 0.9584798812866211)","('Product_Design_And_Lifecycle_Management', 0.008428157307207584)","('Supply_Chain_Management', 0.0029085685964673758)","(['Operational Eco-Efficiency'], 0.9584798812866211)","('NON-ESG', 0.008428157307207584)","('NON-ESG', 0.0029085685964673758)"
Line 1766,"•   W e also continued our product takeback program — in FY22, we recycled or refurbished more than six million products, diverting  more than 280 metric tons of waste from landfills.
","('Waste_And_Hazardous_Materials_Management', 0.6155226230621338)","('Product_Design_And_Lifecycle_Management', 0.2608904242515564)","('Product_Quality_And_Safety', 0.02211712673306465)","(['Operational Eco-Efficiency'], 0.6155226230621338)","('NON-ESG', 0.2608904242515564)","('NON-ESG', 0.02211712673306465)"
Line 1767,"E.
","('Management_Of_Legal_And_Regulatory_Framework', 0.10841184854507446)","('Product_Design_And_Lifecycle_Management', 0.09176333993673325)","('Competitive_Behavior', 0.08798782527446747)","('NON-ESG', 0.10841184854507446)","('NON-ESG', 0.09176333993673325)","('NON-ESG', 0.08798782527446747)"
Line 1768,"R eport on tracking the effectiveness of actions taken a.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5443630814552307)","('Human_Rights_And_Community_Relations', 0.11589175462722778)","('Business_Ethics', 0.05138600990176201)","(['Corporate Governance'], 0.5443630814552307)","('NON-ESG', 0.11589175462722778)","('NON-ESG', 0.05138600990176201)"
Line 1769,"P rocesses used to track the effectiveness of the actions b.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5499942302703857)","('Business_Ethics', 0.12774807214736938)","('Competitive_Behavior', 0.0598081573843956)","(['Corporate Governance'], 0.5499942302703857)","('NON-ESG', 0.12774807214736938)","('NON-ESG', 0.0598081573843956)"
Line 1770,"Goals,  targets, and indicators used to evaluate progress c.
","('Human_Rights_And_Community_Relations', 0.3535557985305786)","('Management_Of_Legal_And_Regulatory_Framework', 0.11948598921298981)","('Business_Model_Resilience', 0.11248379200696945)","('NON-ESG', 0.3535557985305786)","('NON-ESG', 0.11948598921298981)","('NON-ESG', 0.11248379200696945)"
Line 1771,"T he effectiveness of the actions, including progress toward the goals and targets d.
","('Human_Rights_And_Community_Relations', 0.4061984717845917)","('Business_Model_Resilience', 0.14526352286338806)","('Management_Of_Legal_And_Regulatory_Framework', 0.10114128142595291)","('NON-ESG', 0.4061984717845917)","('NON-ESG', 0.14526352286338806)","('NON-ESG', 0.10114128142595291)"
Line 1772,"L essons learned and how these have been incorporated into the organization’s  operational policies and proceduresWe have two product stewardship targets:•   R educe packaging waste by 25% for targeted high-volume products (tied to weight, material selection, and sourcing)3 by FY25  compared to a FY21 baseline.
","('Product_Design_And_Lifecycle_Management', 0.8436171412467957)","('Waste_And_Hazardous_Materials_Management', 0.05131077393889427)","('Product_Quality_And_Safety', 0.024165425449609756)","(['Product Stewardship'], 0.8436171412467957)","('NON-ESG', 0.05131077393889427)","('NON-ESG', 0.024165425449609756)"
Line 1773,"•  Minimize the impact of  Instructions for Use through a 35% paper reduction by FY27 compared to a FY21 baseline.
","('Product_Design_And_Lifecycle_Management', 0.26269158720970154)","('Management_Of_Legal_And_Regulatory_Framework', 0.13602134585380554)","('Energy_Management', 0.12306991964578629)","('NON-ESG', 0.26269158720970154)","('NON-ESG', 0.13602134585380554)","('NON-ESG', 0.12306991964578629)"
Line 1774,"F.
","('GHG_Emissions', 0.15389062464237213)","('Management_Of_Legal_And_Regulatory_Framework', 0.11919295787811279)","('Competitive_Behavior', 0.11879564821720123)","('NON-ESG', 0.15389062464237213)","('NON-ESG', 0.11919295787811279)","('NON-ESG', 0.11879564821720123)"
Line 1775,"Describe how engagement with stak eholders has informed the actions taken and how it  has informed whether the actions have been effective We engage with customers, suppliers, and industry associates to shape our strategy for product stewardship.
","('Product_Design_And_Lifecycle_Management', 0.9020832180976868)","('Supply_Chain_Management', 0.015382724814116955)","('Product_Quality_And_Safety', 0.0150148319080472)","(['Product Stewardship'], 0.9020832180976868)","('NON-ESG', 0.015382724814116955)","('NON-ESG', 0.0150148319080472)"
Line 1776,"We have held meetings  and symposiums as a means to open dialogue on this issue, and we have established the Sustainability Development Center and identified packaging waste reduction as a priority in response to these engagements.
","('Waste_And_Hazardous_Materials_Management', 0.958051860332489)","('Product_Design_And_Lifecycle_Management', 0.005861079320311546)","('Air_Quality', 0.003366022137925029)","(['Operational Eco-Efficiency'], 0.958051860332489)","('NON-ESG', 0.005861079320311546)","('NON-ESG', 0.003366022137925029)"
Line 1777,"Read about how we engage stakeholders in Stakeholder engagement.
","('Human_Rights_And_Community_Relations', 0.7788622379302979)","('Business_Model_Resilience', 0.033938564360141754)","('Competitive_Behavior', 0.02694002538919449)","(['Community Relations'], 0.7788622379302979)","('NON-ESG', 0.033938564360141754)","('NON-ESG', 0.02694002538919449)"
Line 1778,"3 T he product families include: Tri-Staple; Polysorb; Absorbatack; Spinal Implants; Pulse Oximiter.
","('Product_Design_And_Lifecycle_Management', 0.7516589760780334)","('Customer_Welfare', 0.05562156066298485)","('Product_Quality_And_Safety', 0.04434561729431152)","(['Product Stewardship'], 0.7516589760780334)","('NON-ESG', 0.05562156066298485)","('NON-ESG', 0.04434561729431152)"
Line 1779,"2022 Integrated Performance Report      GRI 112 SASB TCFD WEF Employee dataResponsible supply management A.
","('Supply_Chain_Management', 0.9211612939834595)","('Product_Design_And_Lifecycle_Management', 0.008821142837405205)","('Waste_And_Hazardous_Materials_Management', 0.006994524504989386)","(['Supply Chain Management'], 0.9211612939834595)","('NON-ESG', 0.008821142837405205)","('NON-ESG', 0.006994524504989386)"
Line 1780,"Describe actual and potential nega tive and positive impacts on economy, environment,  and people, including impacts on their human rightsBy continuously improving our supply chain resiliency and engaging with a diverse pool of innovative partners, we are better able to  create and deliver high-quality, life-improving products and services while also minimizing disruptions and quality issues.
","('Supply_Chain_Management', 0.7240297198295593)","('Product_Design_And_Lifecycle_Management', 0.14472341537475586)","('Business_Model_Resilience', 0.034876395016908646)","(['Supply Chain Management'], 0.7240297198295593)","('NON-ESG', 0.14472341537475586)","('NON-ESG', 0.034876395016908646)"
Line 1781,"Partnerships within our supply chain stimulate economic benefits by the wages and taxes paid by suppliers as a result of our business with them.
","('Supply_Chain_Management', 0.7004614472389221)","('Labor_Practices', 0.1614779531955719)","('Energy_Management', 0.013479525223374367)","(['Supply Chain Management'], 0.7004614472389221)","('NON-ESG', 0.1614779531955719)","('NON-ESG', 0.013479525223374367)"
Line 1782,"We also collaborate to mitigate potential negative impacts, such as the environmental impacts associated with manufacturing, and the  human and labor rights concerns that are associated with supply chains.
","('Labor_Practices', 0.6190590858459473)","('Supply_Chain_Management', 0.21540392935276031)","('Human_Rights_And_Community_Relations', 0.029536781832575798)","(['Labor Practice Indicators'], 0.6190590858459473)","('NON-ESG', 0.21540392935276031)","('NON-ESG', 0.029536781832575798)"
Line 1783,"B.
","('Competitive_Behavior', 0.13404199481010437)","('Management_Of_Legal_And_Regulatory_Framework', 0.12049221247434616)","('Access_And_Affordability', 0.1028861552476883)","('NON-ESG', 0.13404199481010437)","('NON-ESG', 0.12049221247434616)","('NON-ESG', 0.1028861552476883)"
Line 1784,"R eport whether negative impacts are created through its activities or as a result of  its business relationships, and describe the activities or business relationshipsOur ability to improve lives hinges on the quality of our products.
","('Product_Design_And_Lifecycle_Management', 0.9526920914649963)","('Product_Quality_And_Safety', 0.008722897619009018)","('Selling_Practices_And_Product_Labeling', 0.005966657772660255)","(['Product Stewardship'], 0.9526920914649963)","('NON-ESG', 0.008722897619009018)","('NON-ESG', 0.005966657772660255)"
Line 1785,"We share this responsibility for quality and the associated impacts of product manufacture with our suppliers.
","('Product_Design_And_Lifecycle_Management', 0.948514461517334)","('Product_Quality_And_Safety', 0.011795089580118656)","('Supply_Chain_Management', 0.00488058989867568)","(['Product Stewardship'], 0.948514461517334)","('NON-ESG', 0.011795089580118656)","('NON-ESG', 0.00488058989867568)"
Line 1786,"C.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35686638951301575)","('Business_Ethics', 0.09611602127552032)","('Competitive_Behavior', 0.05494384095072746)","('NON-ESG', 0.35686638951301575)","('NON-ESG', 0.09611602127552032)","('NON-ESG', 0.05494384095072746)"
Line 1787,"Describe policies or commitments r egarding the material topic Read more about our policies and commitments in Supply chain responsibility.
","('Supply_Chain_Management', 0.9333328604698181)","('Product_Design_And_Lifecycle_Management', 0.009790861047804356)","('Business_Model_Resilience', 0.00594951119273901)","(['Supply Chain Management'], 0.9333328604698181)","('NON-ESG', 0.009790861047804356)","('NON-ESG', 0.00594951119273901)"
Line 1788,"D.
","('Employee_Engagement_Inclusion_And_Diversity', 0.11258140206336975)","('Management_Of_Legal_And_Regulatory_Framework', 0.08865229040384293)","('Access_And_Affordability', 0.06962209194898605)","('NON-ESG', 0.11258140206336975)","('NON-ESG', 0.08865229040384293)","('NON-ESG', 0.06962209194898605)"
Line 1789,"Describe actions tak en to manage topics and related impacts, including a.
","('Business_Model_Resilience', 0.29075926542282104)","('Physical_Impacts_Of_Climate_Change', 0.11013726145029068)","('Human_Rights_And_Community_Relations', 0.08778087794780731)","('NON-ESG', 0.29075926542282104)","('NON-ESG', 0.11013726145029068)","('NON-ESG', 0.08778087794780731)"
Line 1790,"Actions to pr event or mitigate potential negative impacts b.
","('Physical_Impacts_Of_Climate_Change', 0.29464656114578247)","('Systemic_Risk_Management', 0.23987378180027008)","('Business_Model_Resilience', 0.09173007309436798)","('NON-ESG', 0.29464656114578247)","('NON-ESG', 0.23987378180027008)","('NON-ESG', 0.09173007309436798)"
Line 1791,"Actions to addr ess actual negative impacts, including actions to provide for or  cooperate in their remediation c.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4002867639064789)","('Physical_Impacts_Of_Climate_Change', 0.11589834839105606)","('Ecological_Impacts', 0.07703129947185516)","('NON-ESG', 0.4002867639064789)","('NON-ESG', 0.11589834839105606)","('NON-ESG', 0.07703129947185516)"
Line 1792,"Actions to manage actual and potential positive impactsTo maintain our high standards for excellence and citizenship with our suppliers, we:  •   Adher e to our Responsible Supply Management program, which integrates responsible business practices into processes, such as  supplier selection and supplier performance management.
","('Supply_Chain_Management', 0.9388802647590637)","('Labor_Practices', 0.006203802302479744)","('Product_Design_And_Lifecycle_Management', 0.006125553045421839)","(['Supply Chain Management'], 0.9388802647590637)","('NON-ESG', 0.006203802302479744)","('NON-ESG', 0.006125553045421839)"
Line 1793,"•   C ommunicate our expectations and specifications to suppliers through our Global Supplier Standards and Supplier Quality  Excellence Manual.
","('Supply_Chain_Management', 0.9217575788497925)","('Labor_Practices', 0.01406114362180233)","('Product_Design_And_Lifecycle_Management', 0.005568165332078934)","(['Supply Chain Management'], 0.9217575788497925)","('NON-ESG', 0.01406114362180233)","('NON-ESG', 0.005568165332078934)"
Line 1794,"•  Engage suppliers on me asuring and reporting their greenhouse gas emissions and other impacts through CDP Supply Chain.
","('GHG_Emissions', 0.8654758334159851)","('Supply_Chain_Management', 0.03940781205892563)","('Physical_Impacts_Of_Climate_Change', 0.01260607410222292)","(['Climate Change'], 0.8654758334159851)","('NON-ESG', 0.03940781205892563)","('NON-ESG', 0.01260607410222292)"
Line 1795,"•  Monitor supplier compliance and performance thr ough our Supplier Sustainability Assessment.
","('Supply_Chain_Management', 0.932701587677002)","('Labor_Practices', 0.006867419462651014)","('Product_Design_And_Lifecycle_Management', 0.006682074628770351)","(['Supply Chain Management'], 0.932701587677002)","('NON-ESG', 0.006867419462651014)","('NON-ESG', 0.006682074628770351)"
Line 1796,"•   R equire suppliers to responsibly manage and disclose any materials of concern used in our manufacturing processes, final  products, or packaging.
","('Product_Design_And_Lifecycle_Management', 0.9404680132865906)","('Supply_Chain_Management', 0.009211314842104912)","('Selling_Practices_And_Product_Labeling', 0.007593912072479725)","(['Product Stewardship'], 0.9404680132865906)","('NON-ESG', 0.009211314842104912)","('NON-ESG', 0.007593912072479725)"
Line 1797,"•  C omply with U.S. Dodd-Frank Act on Conflict Minerals.
","('Management_Of_Legal_And_Regulatory_Framework', 0.47872287034988403)","('GHG_Emissions', 0.10752015560865402)","('Systemic_Risk_Management', 0.05610694736242294)","('NON-ESG', 0.47872287034988403)","('NON-ESG', 0.10752015560865402)","('NON-ESG', 0.05610694736242294)"
Line 1798,"•  C onduct an annual supplier survey to identify red flag smelters linked to conflict minerals.
","('Supply_Chain_Management', 0.9414342045783997)","('Labor_Practices', 0.006056950893253088)","('Product_Design_And_Lifecycle_Management', 0.004798182751983404)","(['Supply Chain Management'], 0.9414342045783997)","('NON-ESG', 0.006056950893253088)","('NON-ESG', 0.004798182751983404)"
Line 1799,"•   P iloted a new Supplier Risk Mapping tool to analyze suppliers for risks related to their geographic location, industry, and the  amount we spend with them annually.
","('Supply_Chain_Management', 0.951788604259491)","('Labor_Practices', 0.004744937177747488)","('Water_And_Wastewater_Management', 0.0035364783834666014)","(['Supply Chain Management'], 0.951788604259491)","('NON-ESG', 0.004744937177747488)","('NON-ESG', 0.0035364783834666014)"
Line 1800,"E.
","('Management_Of_Legal_And_Regulatory_Framework', 0.10841184854507446)","('Product_Design_And_Lifecycle_Management', 0.09176333993673325)","('Competitive_Behavior', 0.08798782527446747)","('NON-ESG', 0.10841184854507446)","('NON-ESG', 0.09176333993673325)","('NON-ESG', 0.08798782527446747)"
Line 1801,"R eport on tracking the effectiveness of actions taken a.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5443630814552307)","('Human_Rights_And_Community_Relations', 0.11589175462722778)","('Business_Ethics', 0.05138600990176201)","(['Corporate Governance'], 0.5443630814552307)","('NON-ESG', 0.11589175462722778)","('NON-ESG', 0.05138600990176201)"
Line 1802,"P rocesses used to track the effectiveness of the actions b.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5499942302703857)","('Business_Ethics', 0.12774807214736938)","('Competitive_Behavior', 0.0598081573843956)","(['Corporate Governance'], 0.5499942302703857)","('NON-ESG', 0.12774807214736938)","('NON-ESG', 0.0598081573843956)"
Line 1803,"Goals,  targets, and indicators used to evaluate progress c.
","('Human_Rights_And_Community_Relations', 0.3535557985305786)","('Management_Of_Legal_And_Regulatory_Framework', 0.11948598921298981)","('Business_Model_Resilience', 0.11248379200696945)","('NON-ESG', 0.3535557985305786)","('NON-ESG', 0.11948598921298981)","('NON-ESG', 0.11248379200696945)"
Line 1804,"T he effectiveness of the actions, including progress toward the goals and targets d.
","('Human_Rights_And_Community_Relations', 0.4061984717845917)","('Business_Model_Resilience', 0.14526352286338806)","('Management_Of_Legal_And_Regulatory_Framework', 0.10114128142595291)","('NON-ESG', 0.4061984717845917)","('NON-ESG', 0.14526352286338806)","('NON-ESG', 0.10114128142595291)"
Line 1805,"L essons learned and how these have been incorporated into the organization’s  operational policies and proceduresWe have the following goal in place: •   Assess the sustainability performance of  suppliers representing at least 80% of our annual managed spend by FY26.
","('Supply_Chain_Management', 0.912882924079895)","('Business_Model_Resilience', 0.00810654740780592)","('GHG_Emissions', 0.006591754965484142)","(['Supply Chain Management'], 0.912882924079895)","('NON-ESG', 0.00810654740780592)","('NON-ESG', 0.006591754965484142)"
Line 1806,"In FY22, we  assessed the sustainability performance of suppliers representing 66% of our annual managed spend.
","('Supply_Chain_Management', 0.8854204416275024)","('Product_Design_And_Lifecycle_Management', 0.027392761781811714)","('Energy_Management', 0.008380653336644173)","(['Supply Chain Management'], 0.8854204416275024)","('NON-ESG', 0.027392761781811714)","('NON-ESG', 0.008380653336644173)"
Line 1807,"F.
","('GHG_Emissions', 0.15389062464237213)","('Management_Of_Legal_And_Regulatory_Framework', 0.11919295787811279)","('Competitive_Behavior', 0.11879564821720123)","('NON-ESG', 0.15389062464237213)","('NON-ESG', 0.11919295787811279)","('NON-ESG', 0.11879564821720123)"
Line 1808,"Describe how engagement with stak eholders has informed the actions taken and how  it has informed whether the actions have been effectiveWe are dedicated to collaborating with peers on issues that impact our industry, which in turn helps us grow our knowledge and  benchmark our progress.
","('Management_Of_Legal_And_Regulatory_Framework', 0.455061137676239)","('Business_Model_Resilience', 0.10503438860177994)","('Human_Rights_And_Community_Relations', 0.10381263494491577)","('NON-ESG', 0.455061137676239)","('NON-ESG', 0.10503438860177994)","('NON-ESG', 0.10381263494491577)"
Line 1809,"Our collaboration in FY22 included engagements with the Sustainable Purchasing Leadership Council and the Conference Board’s Responsible Sourcing Council.
","('Product_Design_And_Lifecycle_Management', 0.6943455338478088)","('Supply_Chain_Management', 0.1331094205379486)","('Customer_Welfare', 0.03730366379022598)","(['Product Stewardship'], 0.6943455338478088)","('NON-ESG', 0.1331094205379486)","('NON-ESG', 0.03730366379022598)"
Line 1810,"We also participated in MedTech Europe working groups to discuss emerging human rights and environmental due diligence laws.
","('Human_Rights_And_Community_Relations', 0.9490907788276672)","('Labor_Practices', 0.007531613111495972)","('Management_Of_Legal_And_Regulatory_Framework', 0.004873074125498533)","(['Community Relations'], 0.9490907788276672)","('NON-ESG', 0.007531613111495972)","('NON-ESG', 0.004873074125498533)"
Line 1811,"Learn more about how we engage with our stakeholders in Supply chain responsibility and Stakeholder engagement.
","('Supply_Chain_Management', 0.9447177648544312)","('Labor_Practices', 0.00417608255520463)","('Product_Design_And_Lifecycle_Management', 0.003969264682382345)","(['Supply Chain Management'], 0.9447177648544312)","('NON-ESG', 0.00417608255520463)","('NON-ESG', 0.003969264682382345)"
Line 1812,"2022 Integrated Performance Report      GRI 113 SASB TCFD WEF Employee dataTalent A.
","('Data_Security', 0.3410870432853699)","('Customer_Privacy', 0.1273612082004547)","('Systemic_Risk_Management', 0.07009339332580566)","('NON-ESG', 0.3410870432853699)","('NON-ESG', 0.1273612082004547)","('NON-ESG', 0.07009339332580566)"
Line 1813,"Describe actual and potential nega tive and positive impacts on economy, environment,  and people, including impacts on their human rightsOur ability to offer innovative products and therapies that serve two people every second is a direct result of our employees.
","('Human_Rights_And_Community_Relations', 0.7516219019889832)","('Access_And_Affordability', 0.04576557129621506)","('Product_Design_And_Lifecycle_Management', 0.04239804670214653)","(['Community Relations'], 0.7516219019889832)","('NON-ESG', 0.04576557129621506)","('NON-ESG', 0.04239804670214653)"
Line 1814,"We  support our 95,000+ employees by offering competitive compensation and benefits and building a workplace where everyone is respected and offered development opportunities that allow them to thrive.
","('Employee_Engagement_Inclusion_And_Diversity', 0.46480071544647217)","('Labor_Practices', 0.37282708287239075)","('Employee_Health_And_Safety', 0.023503568023443222)","('NON-ESG', 0.46480071544647217)","('NON-ESG', 0.37282708287239075)","('NON-ESG', 0.023503568023443222)"
Line 1815,"Through these positive impacts, we aim to reduce potential negative effects on our employees, such as lack of engagement, low productivity, financial uncertainty, stress, and burnout.
","('Systemic_Risk_Management', 0.2884407341480255)","('Employee_Health_And_Safety', 0.1924770623445511)","('Labor_Practices', 0.1150137186050415)","('NON-ESG', 0.2884407341480255)","('NON-ESG', 0.1924770623445511)","('NON-ESG', 0.1150137186050415)"
Line 1816,"B.
","('Competitive_Behavior', 0.13404199481010437)","('Management_Of_Legal_And_Regulatory_Framework', 0.12049221247434616)","('Access_And_Affordability', 0.1028861552476883)","('NON-ESG', 0.13404199481010437)","('NON-ESG', 0.12049221247434616)","('NON-ESG', 0.1028861552476883)"
Line 1817,"R eport whether negative impacts are created through its activities or as a result of its  business relationships, and describe the activities or business relationshipsOur impacts on talent stem from our own operations and how we support, promote, and empower our employees.
","('Business_Model_Resilience', 0.252616822719574)","('Employee_Engagement_Inclusion_And_Diversity', 0.1416277140378952)","('Human_Rights_And_Community_Relations', 0.13479268550872803)","('NON-ESG', 0.252616822719574)","('NON-ESG', 0.1416277140378952)","('NON-ESG', 0.13479268550872803)"
Line 1818,"C.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35686638951301575)","('Business_Ethics', 0.09611602127552032)","('Competitive_Behavior', 0.05494384095072746)","('NON-ESG', 0.35686638951301575)","('NON-ESG', 0.09611602127552032)","('NON-ESG', 0.05494384095072746)"
Line 1819,"Describe policies or commitments r egarding the material topic Read about our policies and commitments in Inclusion, diversity and equity and Supporting a global workforce.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9758225679397583)","('Employee_Health_And_Safety', 0.0019107653060927987)","('Human_Rights_And_Community_Relations', 0.0018476198893040419)","(['Human Capital Development'], 0.9758225679397583)","('NON-ESG', 0.0019107653060927987)","('NON-ESG', 0.0018476198893040419)"
Line 1820,"D.
","('Employee_Engagement_Inclusion_And_Diversity', 0.11258140206336975)","('Management_Of_Legal_And_Regulatory_Framework', 0.08865229040384293)","('Access_And_Affordability', 0.06962209194898605)","('NON-ESG', 0.11258140206336975)","('NON-ESG', 0.08865229040384293)","('NON-ESG', 0.06962209194898605)"
Line 1821,"Describe actions tak en to manage topics and related impacts, including a.
","('Business_Model_Resilience', 0.29075926542282104)","('Physical_Impacts_Of_Climate_Change', 0.11013726145029068)","('Human_Rights_And_Community_Relations', 0.08778087794780731)","('NON-ESG', 0.29075926542282104)","('NON-ESG', 0.11013726145029068)","('NON-ESG', 0.08778087794780731)"
Line 1822,"Actions to pr event or mitigate potential negative impacts b.
","('Physical_Impacts_Of_Climate_Change', 0.29464656114578247)","('Systemic_Risk_Management', 0.23987378180027008)","('Business_Model_Resilience', 0.09173007309436798)","('NON-ESG', 0.29464656114578247)","('NON-ESG', 0.23987378180027008)","('NON-ESG', 0.09173007309436798)"
Line 1823,"Actions to addr ess actual negative impacts, including actions to provide for or  cooperate in their remediation c.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4002867639064789)","('Physical_Impacts_Of_Climate_Change', 0.11589834839105606)","('Ecological_Impacts', 0.07703129947185516)","('NON-ESG', 0.4002867639064789)","('NON-ESG', 0.11589834839105606)","('NON-ESG', 0.07703129947185516)"
Line 1824,"Actions to manage actual and potential positive impactsW e work hard to attract and retain world-class talent.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9209056496620178)","('Business_Model_Resilience', 0.006645983085036278)","('Employee_Health_And_Safety', 0.005159397143870592)","(['Human Capital Development'], 0.9209056496620178)","('NON-ESG', 0.006645983085036278)","('NON-ESG', 0.005159397143870592)"
Line 1825,"For example: •  In FY22,  we spent more than $49 million on learning and development — an average of $496 per employee.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3398555517196655)","('Access_And_Affordability', 0.27415406703948975)","('Employee_Health_And_Safety', 0.05617893114686012)","('NON-ESG', 0.3398555517196655)","('NON-ESG', 0.27415406703948975)","('NON-ESG', 0.05617893114686012)"
Line 1826,"•  W e offer robust healthcare and benefit plans.
","('Access_And_Affordability', 0.6813293695449829)","('Management_Of_Legal_And_Regulatory_Framework', 0.06141269579529762)","('Human_Rights_And_Community_Relations', 0.030722448602318764)","(['Health Outcome Contribution'], 0.6813293695449829)","('NON-ESG', 0.06141269579529762)","('NON-ESG', 0.030722448602318764)"
Line 1827,"•   T he Healthier Together program, available to nearly 100% of employees globally, supports the physical, emotional, social, and  financial well-being of our employees.
","('Employee_Health_And_Safety', 0.5614449381828308)","('Human_Rights_And_Community_Relations', 0.142596036195755)","('Employee_Engagement_Inclusion_And_Diversity', 0.06814650446176529)","(['Operational Eco-Efficiency'], 0.5614449381828308)","('NON-ESG', 0.142596036195755)","('NON-ESG', 0.06814650446176529)"
Line 1828,"•   W e design our compensation framework to support a culture of performance and to recognize and reward our employees in more  than 150 countries for their ongoing commitment.
","('Labor_Practices', 0.7136673331260681)","('Employee_Engagement_Inclusion_And_Diversity', 0.1532241404056549)","('Employee_Health_And_Safety', 0.024382907897233963)","(['Labor Practice Indicators'], 0.7136673331260681)","('NON-ESG', 0.1532241404056549)","('NON-ESG', 0.024382907897233963)"
Line 1829,"E.
","('Management_Of_Legal_And_Regulatory_Framework', 0.10841184854507446)","('Product_Design_And_Lifecycle_Management', 0.09176333993673325)","('Competitive_Behavior', 0.08798782527446747)","('NON-ESG', 0.10841184854507446)","('NON-ESG', 0.09176333993673325)","('NON-ESG', 0.08798782527446747)"
Line 1830,"R eport on tracking the effectiveness of actions taken a.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5443630814552307)","('Human_Rights_And_Community_Relations', 0.11589175462722778)","('Business_Ethics', 0.05138600990176201)","(['Corporate Governance'], 0.5443630814552307)","('NON-ESG', 0.11589175462722778)","('NON-ESG', 0.05138600990176201)"
Line 1831,"P rocesses used to track the effectiveness of the actions b.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5499942302703857)","('Business_Ethics', 0.12774807214736938)","('Competitive_Behavior', 0.0598081573843956)","(['Corporate Governance'], 0.5499942302703857)","('NON-ESG', 0.12774807214736938)","('NON-ESG', 0.0598081573843956)"
Line 1832,"Goals,  targets, and indicators used to evaluate progress c.
","('Human_Rights_And_Community_Relations', 0.3535557985305786)","('Management_Of_Legal_And_Regulatory_Framework', 0.11948598921298981)","('Business_Model_Resilience', 0.11248379200696945)","('NON-ESG', 0.3535557985305786)","('NON-ESG', 0.11948598921298981)","('NON-ESG', 0.11248379200696945)"
Line 1833,"T he effectiveness of the actions, including progress toward the goals and targets   d.
","('Human_Rights_And_Community_Relations', 0.4061984717845917)","('Business_Model_Resilience', 0.14526352286338806)","('Management_Of_Legal_And_Regulatory_Framework', 0.10114128142595291)","('NON-ESG', 0.4061984717845917)","('NON-ESG', 0.14526352286338806)","('NON-ESG', 0.10114128142595291)"
Line 1834,"L essons learned and how these have been incorporated into the organization’s  operational policies and proceduresWe value employee safety and satisfaction and monitor the effectiveness of our actions.
","('Employee_Health_And_Safety', 0.9738252758979797)","('Employee_Engagement_Inclusion_And_Diversity', 0.0036162936594337225)","('Product_Quality_And_Safety', 0.003086667275056243)","(['Operational Eco-Efficiency'], 0.9738252758979797)","('NON-ESG', 0.0036162936594337225)","('NON-ESG', 0.003086667275056243)"
Line 1835,"•  In FY22,  a record 83% of full- and part-time employees responded to our Organizational Health Survey.
","('Labor_Practices', 0.5081952214241028)","('Employee_Engagement_Inclusion_And_Diversity', 0.2692360579967499)","('Employee_Health_And_Safety', 0.07849360257387161)","(['Labor Practice Indicators'], 0.5081952214241028)","('NON-ESG', 0.2692360579967499)","('NON-ESG', 0.07849360257387161)"
Line 1836,"–   FY22 pr ogress: 90% of employees who took the survey reported that they feel proud to work at Medtronic and 93% of  respondents indicated that they feel Medtronic has a positive impact on the world.
","('Employee_Engagement_Inclusion_And_Diversity', 0.17587192356586456)","('Product_Design_And_Lifecycle_Management', 0.13737788796424866)","('Business_Model_Resilience', 0.12073461711406708)","('NON-ESG', 0.17587192356586456)","('NON-ESG', 0.13737788796424866)","('NON-ESG', 0.12073461711406708)"
Line 1837,"F.
","('GHG_Emissions', 0.15389062464237213)","('Management_Of_Legal_And_Regulatory_Framework', 0.11919295787811279)","('Competitive_Behavior', 0.11879564821720123)","('NON-ESG', 0.15389062464237213)","('NON-ESG', 0.11919295787811279)","('NON-ESG', 0.11879564821720123)"
Line 1838,"Describe how engagement with stak eholders has informed the actions taken and how it  has informed whether the actions have been effectiveWe engage with our employees to shape our approach to attracting and retaining talent through:•  F ormal evaluation and check-in processes.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9511423707008362)","('Employee_Health_And_Safety', 0.007060302887111902)","('Business_Ethics', 0.003017143812030554)","(['Human Capital Development'], 0.9511423707008362)","('NON-ESG', 0.007060302887111902)","('NON-ESG', 0.003017143812030554)"
Line 1839,"•  C areer development conversations.
","('Business_Model_Resilience', 0.2667991518974304)","('Management_Of_Legal_And_Regulatory_Framework', 0.13930866122245789)","('Human_Rights_And_Community_Relations', 0.0800091102719307)","('NON-ESG', 0.2667991518974304)","('NON-ESG', 0.13930866122245789)","('NON-ESG', 0.0800091102719307)"
Line 1840,"•  Our Or ganizational Health survey.
","('Employee_Health_And_Safety', 0.3023066818714142)","('Access_And_Affordability', 0.2650190591812134)","('Product_Quality_And_Safety', 0.04923415556550026)","('NON-ESG', 0.3023066818714142)","('NON-ESG', 0.2650190591812134)","('NON-ESG', 0.04923415556550026)"
Line 1841,"You can read more about how we engage in Supporting a global workforce.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9522621631622314)","('Employee_Health_And_Safety', 0.0044809430837631226)","('Labor_Practices', 0.004371051676571369)","(['Human Capital Development'], 0.9522621631622314)","('NON-ESG', 0.0044809430837631226)","('NON-ESG', 0.004371051676571369)"
Line 1842,"2022 Integrated Performance Report      GRI 114 SASB TCFD WEF Employee dataTechnology and device security   A.
","('Data_Security', 0.9540635943412781)","('Systemic_Risk_Management', 0.005652261897921562)","('Business_Ethics', 0.0037212881725281477)","(['Information Security/Cybersecurity & System Availability'], 0.9540635943412781)","('NON-ESG', 0.005652261897921562)","('NON-ESG', 0.0037212881725281477)"
Line 1843,"Describe actual and potential nega tive and positive impacts on economy, environment,  and people, including impacts on their human rightsWe work to identify, address, mitigate, and minimize vulnerabilities in our products that could potentially expose them to cyberattacks  that could impact device security, patient data, or the effectiveness of our products.
","('Data_Security', 0.9229204654693604)","('Systemic_Risk_Management', 0.009945174679160118)","('Business_Ethics', 0.008790742605924606)","(['Information Security/Cybersecurity & System Availability'], 0.9229204654693604)","('NON-ESG', 0.009945174679160118)","('NON-ESG', 0.008790742605924606)"
Line 1844,"B.
","('Competitive_Behavior', 0.13404199481010437)","('Management_Of_Legal_And_Regulatory_Framework', 0.12049221247434616)","('Access_And_Affordability', 0.1028861552476883)","('NON-ESG', 0.13404199481010437)","('NON-ESG', 0.12049221247434616)","('NON-ESG', 0.1028861552476883)"
Line 1845,"R eport whether negative impacts are created through its activities or as a result of its  business relationships, and describe the activities or business relationshipsOur Product Security Office works to minimize the potential for negative impacts associated with product security matters that may stem from our business activities or those of our suppliers and directly or indirectly impact our products.
","('Product_Design_And_Lifecycle_Management', 0.9170046448707581)","('Product_Quality_And_Safety', 0.01887899823486805)","('Selling_Practices_And_Product_Labeling', 0.009519523940980434)","(['Product Stewardship'], 0.9170046448707581)","('NON-ESG', 0.01887899823486805)","('NON-ESG', 0.009519523940980434)"
Line 1846,"C.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35686638951301575)","('Business_Ethics', 0.09611602127552032)","('Competitive_Behavior', 0.05494384095072746)","('NON-ESG', 0.35686638951301575)","('NON-ESG', 0.09611602127552032)","('NON-ESG', 0.05494384095072746)"
Line 1847,"Describe policies or commitments r egarding the material topic Read about our policies and commitments in Patient safety and product quality and Data privacy and security.
","('Product_Quality_And_Safety', 0.8075343370437622)","('Product_Design_And_Lifecycle_Management', 0.05831530690193176)","('Selling_Practices_And_Product_Labeling', 0.02479069121181965)","(['Product Quality & Recall Management'], 0.8075343370437622)","('NON-ESG', 0.05831530690193176)","('NON-ESG', 0.02479069121181965)"
Line 1848,"D.
","('Employee_Engagement_Inclusion_And_Diversity', 0.11258140206336975)","('Management_Of_Legal_And_Regulatory_Framework', 0.08865229040384293)","('Access_And_Affordability', 0.06962209194898605)","('NON-ESG', 0.11258140206336975)","('NON-ESG', 0.08865229040384293)","('NON-ESG', 0.06962209194898605)"
Line 1849,"Describe actions tak en to manage topics and related impacts, including a.
","('Business_Model_Resilience', 0.29075926542282104)","('Physical_Impacts_Of_Climate_Change', 0.11013726145029068)","('Human_Rights_And_Community_Relations', 0.08778087794780731)","('NON-ESG', 0.29075926542282104)","('NON-ESG', 0.11013726145029068)","('NON-ESG', 0.08778087794780731)"
Line 1850,"Actions to pr event or mitigate potential negative impacts b.
","('Physical_Impacts_Of_Climate_Change', 0.29464656114578247)","('Systemic_Risk_Management', 0.23987378180027008)","('Business_Model_Resilience', 0.09173007309436798)","('NON-ESG', 0.29464656114578247)","('NON-ESG', 0.23987378180027008)","('NON-ESG', 0.09173007309436798)"
Line 1851,"Actions to addr ess actual negative impacts, including actions to provide for or  cooperate in their remediation c.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4002867639064789)","('Physical_Impacts_Of_Climate_Change', 0.11589834839105606)","('Ecological_Impacts', 0.07703129947185516)","('NON-ESG', 0.4002867639064789)","('NON-ESG', 0.11589834839105606)","('NON-ESG', 0.07703129947185516)"
Line 1852,"Actions to manage actual and potential positive impactsTo avoid or mitigate technology and device security issues, we: •  Build security into our pr oducts and stay current on external cybersecurity factors that could impact our products.
","('Data_Security', 0.9537878632545471)","('Systemic_Risk_Management', 0.005712669342756271)","('Physical_Impacts_Of_Climate_Change', 0.0032787832897156477)","(['Information Security/Cybersecurity & System Availability'], 0.9537878632545471)","('NON-ESG', 0.005712669342756271)","('NON-ESG', 0.0032787832897156477)"
Line 1853,"•  P erform vulnerability testing, updates, remediation, and impact assessment for device functionality and patient safety.
","('Employee_Health_And_Safety', 0.5785963535308838)","('Product_Quality_And_Safety', 0.2603255808353424)","('Product_Design_And_Lifecycle_Management', 0.03233153373003006)","(['Operational Eco-Efficiency'], 0.5785963535308838)","('NON-ESG', 0.2603255808353424)","('NON-ESG', 0.03233153373003006)"
Line 1854,"•  Integr ate security considerations throughout the product life cycle.
","('Product_Design_And_Lifecycle_Management', 0.8978912234306335)","('Business_Model_Resilience', 0.01324373111128807)","('Product_Quality_And_Safety', 0.013026673346757889)","(['Product Stewardship'], 0.8978912234306335)","('NON-ESG', 0.01324373111128807)","('NON-ESG', 0.013026673346757889)"
Line 1855,"•  E valuate our quality systems and processes on an annual basis through our Quality Committee and Technology and Value Creation Committee.
","('Product_Quality_And_Safety', 0.17999489605426788)","('Business_Ethics', 0.17998772859573364)","('Management_Of_Legal_And_Regulatory_Framework', 0.10581689327955246)","('NON-ESG', 0.17999489605426788)","('NON-ESG', 0.17998772859573364)","('NON-ESG', 0.10581689327955246)"
Line 1856,"•   P articipate actively in external working groups and forums with companies like Joined Optum, Boston Scientific, Abbott Laboratories, GE,  J&J, Becton-Dickinson, and others to help to collaborate on industry topics that could impact product security in the healthcare industry.
","('Data_Security', 0.6986725330352783)","('Systemic_Risk_Management', 0.04215138033032417)","('Product_Design_And_Lifecycle_Management', 0.030209116637706757)","(['Information Security/Cybersecurity & System Availability'], 0.6986725330352783)","('NON-ESG', 0.04215138033032417)","('NON-ESG', 0.030209116637706757)"
Line 1857,"•  C ontribute to global product security and cybersecurity standards in collaboration with the U.S. FDA and other regulatory advocacy groups.
","('Data_Security', 0.835826575756073)","('Management_Of_Legal_And_Regulatory_Framework', 0.025280771777033806)","('Business_Ethics', 0.019674384966492653)","(['Information Security/Cybersecurity & System Availability'], 0.835826575756073)","('NON-ESG', 0.025280771777033806)","('NON-ESG', 0.019674384966492653)"
Line 1858,"•   R ecognize independent security researchers who have demonstrated ethical behavior and followed coordinated disclosure  processes to advance our product security.
","('Business_Ethics', 0.9495449066162109)","('Data_Security', 0.005853022914379835)","('Competitive_Behavior', 0.005551723763346672)","(['Business Ethics'], 0.9495449066162109)","('NON-ESG', 0.005853022914379835)","('NON-ESG', 0.005551723763346672)"
Line 1859,"•  T rain employees on product security best practices.
","('Business_Ethics', 0.5362771153450012)","('Data_Security', 0.20550040900707245)","('Product_Quality_And_Safety', 0.04769999533891678)","(['Business Ethics'], 0.5362771153450012)","('NON-ESG', 0.20550040900707245)","('NON-ESG', 0.04769999533891678)"
Line 1860,"•  P ublicly disclose security vulnerabilities through our Coordinated Disclosure Process.
","('Data_Security', 0.9221940636634827)","('Systemic_Risk_Management', 0.013415719382464886)","('Business_Ethics', 0.008871774189174175)","(['Information Security/Cybersecurity & System Availability'], 0.9221940636634827)","('NON-ESG', 0.013415719382464886)","('NON-ESG', 0.008871774189174175)"
Line 1861,"E.
","('Management_Of_Legal_And_Regulatory_Framework', 0.10841184854507446)","('Product_Design_And_Lifecycle_Management', 0.09176333993673325)","('Competitive_Behavior', 0.08798782527446747)","('NON-ESG', 0.10841184854507446)","('NON-ESG', 0.09176333993673325)","('NON-ESG', 0.08798782527446747)"
Line 1862,"R eport on tracking the effectiveness of actions taken a.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5443630814552307)","('Human_Rights_And_Community_Relations', 0.11589175462722778)","('Business_Ethics', 0.05138600990176201)","(['Corporate Governance'], 0.5443630814552307)","('NON-ESG', 0.11589175462722778)","('NON-ESG', 0.05138600990176201)"
Line 1863,"P rocesses used to track the effectiveness of the actions b.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5499942302703857)","('Business_Ethics', 0.12774807214736938)","('Competitive_Behavior', 0.0598081573843956)","(['Corporate Governance'], 0.5499942302703857)","('NON-ESG', 0.12774807214736938)","('NON-ESG', 0.0598081573843956)"
Line 1864,"Goals,  targets, and indicators used to evaluate progress c.
","('Human_Rights_And_Community_Relations', 0.3535557985305786)","('Management_Of_Legal_And_Regulatory_Framework', 0.11948598921298981)","('Business_Model_Resilience', 0.11248379200696945)","('NON-ESG', 0.3535557985305786)","('NON-ESG', 0.11948598921298981)","('NON-ESG', 0.11248379200696945)"
Line 1865,"T he effectiveness of the actions, including progress toward the goals and targets d.
","('Human_Rights_And_Community_Relations', 0.4061984717845917)","('Business_Model_Resilience', 0.14526352286338806)","('Management_Of_Legal_And_Regulatory_Framework', 0.10114128142595291)","('NON-ESG', 0.4061984717845917)","('NON-ESG', 0.14526352286338806)","('NON-ESG', 0.10114128142595291)"
Line 1866,"L essons learned and how these have been incorporated into the organization’s  operational policies and proceduresIn FY22, we publicly disclosed six security vulnerabilities, which included security bulletins, updates to previous bulletins, and security  notices responding to third-party risks that may not be applicable to Medtronic but helped address customer inquiries.
","('Data_Security', 0.9590199589729309)","('Systemic_Risk_Management', 0.00492681423202157)","('Customer_Privacy', 0.004017955623567104)","(['Information Security/Cybersecurity & System Availability'], 0.9590199589729309)","('NON-ESG', 0.00492681423202157)","('NON-ESG', 0.004017955623567104)"
Line 1867,"The Audit Committee of the Medtronic board of directors has oversight of cybersecurity risk within our organization and our  companywide security policies, standards, and procedures ensure consistency across our organization.
","('Data_Security', 0.922463059425354)","('Business_Ethics', 0.016780773177742958)","('Systemic_Risk_Management', 0.011205703020095825)","(['Information Security/Cybersecurity & System Availability'], 0.922463059425354)","('NON-ESG', 0.016780773177742958)","('NON-ESG', 0.011205703020095825)"
Line 1868,"We continuously scan our operational environment for cyber risks and vulnerabilities, and we also assess the risks of third-party partners, projects, and initiatives.
","('Data_Security', 0.5296652317047119)","('Systemic_Risk_Management', 0.34048306941986084)","('Physical_Impacts_Of_Climate_Change', 0.014675743877887726)","(['Information Security/Cybersecurity & System Availability'], 0.5296652317047119)","('NON-ESG', 0.34048306941986084)","('NON-ESG', 0.014675743877887726)"
Line 1869,"F.
","('GHG_Emissions', 0.15389062464237213)","('Management_Of_Legal_And_Regulatory_Framework', 0.11919295787811279)","('Competitive_Behavior', 0.11879564821720123)","('NON-ESG', 0.15389062464237213)","('NON-ESG', 0.11919295787811279)","('NON-ESG', 0.11879564821720123)"
Line 1870,"Describe how engagement with stak eholders has informed the actions taken and how it  has informed whether the actions have been effectiveWe engage with many stakeholders on technology and device security, including: •   Employees,  regulators, peers, healthcare delivery organizations, and security researchers to monitor current practices and emerging  risks through our product security program.
","('Data_Security', 0.908893883228302)","('Systemic_Risk_Management', 0.022820668295025826)","('Business_Ethics', 0.008370107971131802)","(['Information Security/Cybersecurity & System Availability'], 0.908893883228302)","('NON-ESG', 0.022820668295025826)","('NON-ESG', 0.008370107971131802)"
Line 1871,"•   U .S.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2931046485900879)","('GHG_Emissions', 0.1579560786485672)","('Competitive_Behavior', 0.0635477602481842)","('NON-ESG', 0.2931046485900879)","('NON-ESG', 0.1579560786485672)","('NON-ESG', 0.0635477602481842)"
Line 1872,"FDA, the Health Information Sharing and Analysis Center, the Advanced Medical Technology Association, the Health Sector  Coordinating Council Cyber Working Group, and several others.
","('Data_Security', 0.9376887083053589)","('Customer_Privacy', 0.007667177822440863)","('Water_And_Wastewater_Management', 0.004257092252373695)","(['Information Security/Cybersecurity & System Availability'], 0.9376887083053589)","('NON-ESG', 0.007667177822440863)","('NON-ESG', 0.004257092252373695)"
Line 1873,"•   He alth Information Sharing and Analysis Center (H-ISAC), the National Capital Region Threat Intelligence Consortium, and the  Medical Device Innovation Consortium.
","('Data_Security', 0.8955382704734802)","('Business_Ethics', 0.013703061267733574)","('Systemic_Risk_Management', 0.009431669488549232)","(['Information Security/Cybersecurity & System Availability'], 0.8955382704734802)","('NON-ESG', 0.013703061267733574)","('NON-ESG', 0.009431669488549232)"
Line 1874,"Read more about how we engage with stakeholders in Patient safety and product quality, Data privacy and security,   and Stakeholder engagement.
","('Product_Quality_And_Safety', 0.711400032043457)","('Product_Design_And_Lifecycle_Management', 0.1283474713563919)","('Selling_Practices_And_Product_Labeling', 0.03207199275493622)","(['Product Quality & Recall Management'], 0.711400032043457)","('NON-ESG', 0.1283474713563919)","('NON-ESG', 0.03207199275493622)"
Line 1875,"2022 Integrated Performance Report      GRI 115 SASB TCFD WEF Employee dataTransparency  A.
","('Systemic_Risk_Management', 0.2826424539089203)","('Business_Model_Resilience', 0.18572574853897095)","('Management_Of_Legal_And_Regulatory_Framework', 0.14035922288894653)","('NON-ESG', 0.2826424539089203)","('NON-ESG', 0.18572574853897095)","('NON-ESG', 0.14035922288894653)"
Line 1876,"Describe actual and potential nega tive and positive impacts on economy, environment,  and people, including impacts on their human rightsWe maintain a proactive approach to transparency to avoid the negative impacts associated with limited disclosures, and we believe  transparent communication and collaboration enable us to mitigate risks, meet challenges more effectively, and amplify the positive impact of our business.
","('Human_Rights_And_Community_Relations', 0.9296766519546509)","('Management_Of_Legal_And_Regulatory_Framework', 0.007245405577123165)","('Access_And_Affordability', 0.00664583221077919)","(['Community Relations'], 0.9296766519546509)","('NON-ESG', 0.007245405577123165)","('NON-ESG', 0.00664583221077919)"
Line 1877,"B.
","('Competitive_Behavior', 0.13404199481010437)","('Management_Of_Legal_And_Regulatory_Framework', 0.12049221247434616)","('Access_And_Affordability', 0.1028861552476883)","('NON-ESG', 0.13404199481010437)","('NON-ESG', 0.12049221247434616)","('NON-ESG', 0.1028861552476883)"
Line 1878,"R eport whether negative impacts are created through its activities or as a result of its  business relationships, and describe the activities or business relationshipWe work within our business activities and our partnerships to minimize negative impacts stemming from limited transparency.
","('Business_Ethics', 0.7576147317886353)","('Systemic_Risk_Management', 0.07587339729070663)","('Management_Of_Legal_And_Regulatory_Framework', 0.0382315069437027)","(['Business Ethics'], 0.7576147317886353)","('NON-ESG', 0.07587339729070663)","('NON-ESG', 0.0382315069437027)"
Line 1879,"C.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35686638951301575)","('Business_Ethics', 0.09611602127552032)","('Competitive_Behavior', 0.05494384095072746)","('NON-ESG', 0.35686638951301575)","('NON-ESG', 0.09611602127552032)","('NON-ESG', 0.05494384095072746)"
Line 1880,"Describe policies or commitments r egarding the material topic We remain committed to meeting best practices on ESG transparency, which is an area of continuous improvement for many companies due to the evolving landscape of ESG disclosures.
","('Business_Ethics', 0.928891658782959)","('Systemic_Risk_Management', 0.014683295972645283)","('Management_Of_Legal_And_Regulatory_Framework', 0.010001284070312977)","(['Business Ethics'], 0.928891658782959)","('NON-ESG', 0.014683295972645283)","('NON-ESG', 0.010001284070312977)"
Line 1881,"We use external frameworks and benchmarks to guide our sustainability strategy and reporting and to learn where we can do better.
","('Business_Model_Resilience', 0.28084689378738403)","('Management_Of_Legal_And_Regulatory_Framework', 0.18737733364105225)","('Systemic_Risk_Management', 0.15457424521446228)","('NON-ESG', 0.28084689378738403)","('NON-ESG', 0.18737733364105225)","('NON-ESG', 0.15457424521446228)"
Line 1882,"These include: •  CDP •  Global R eporting Initiative •  Sustainability  Accounting Standards Board •  T ask Force on Climate-Related Financial Disclosures •  W orld Economic Forum •  UN Sustainable Development Goals D .
","('Management_Of_Legal_And_Regulatory_Framework', 0.38157975673675537)","('Physical_Impacts_Of_Climate_Change', 0.11901861429214478)","('Systemic_Risk_Management', 0.11534789949655533)","('NON-ESG', 0.38157975673675537)","('NON-ESG', 0.11901861429214478)","('NON-ESG', 0.11534789949655533)"
Line 1883,"Describe actions tak en to manage topics and related impacts, including a.
","('Business_Model_Resilience', 0.29075926542282104)","('Physical_Impacts_Of_Climate_Change', 0.11013726145029068)","('Human_Rights_And_Community_Relations', 0.08778087794780731)","('NON-ESG', 0.29075926542282104)","('NON-ESG', 0.11013726145029068)","('NON-ESG', 0.08778087794780731)"
Line 1884,"Actions to pr event or mitigate potential negative impacts b.
","('Physical_Impacts_Of_Climate_Change', 0.29464656114578247)","('Systemic_Risk_Management', 0.23987378180027008)","('Business_Model_Resilience', 0.09173007309436798)","('NON-ESG', 0.29464656114578247)","('NON-ESG', 0.23987378180027008)","('NON-ESG', 0.09173007309436798)"
Line 1885,"Actions to addr ess actual negative impacts, including actions to provide for  or cooperate in their remediation c.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4002867639064789)","('Physical_Impacts_Of_Climate_Change', 0.11589834839105606)","('Ecological_Impacts', 0.07703129947185516)","('NON-ESG', 0.4002867639064789)","('NON-ESG', 0.11589834839105606)","('NON-ESG', 0.07703129947185516)"
Line 1886,"Actions to manage actual and potential positive impactsDuring the development of  our annual Integrated Performance Report, we assess our ESG disclosures for alignment with best practice  and evolving stakeholder needs.
","('Business_Model_Resilience', 0.6057195663452148)","('Human_Rights_And_Community_Relations', 0.08338213711977005)","('Systemic_Risk_Management', 0.060544274747371674)","(['Codes of Business Conduct'], 0.6057195663452148)","('NON-ESG', 0.08338213711977005)","('NON-ESG', 0.060544274747371674)"
Line 1887,"We are enhancing our data collection and reporting processes in preparation to meet emerging  regulatory expectations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9711819291114807)","('Competitive_Behavior', 0.0021211346611380577)","('Director_Removal', 0.0019445711513981223)","(['Corporate Governance'], 0.9711819291114807)","('NON-ESG', 0.0021211346611380577)","('NON-ESG', 0.0019445711513981223)"
Line 1888,"E.
","('Management_Of_Legal_And_Regulatory_Framework', 0.10841184854507446)","('Product_Design_And_Lifecycle_Management', 0.09176333993673325)","('Competitive_Behavior', 0.08798782527446747)","('NON-ESG', 0.10841184854507446)","('NON-ESG', 0.09176333993673325)","('NON-ESG', 0.08798782527446747)"
Line 1889,"R eport on tracking the effectiveness of actions taken a.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5443630814552307)","('Human_Rights_And_Community_Relations', 0.11589175462722778)","('Business_Ethics', 0.05138600990176201)","(['Corporate Governance'], 0.5443630814552307)","('NON-ESG', 0.11589175462722778)","('NON-ESG', 0.05138600990176201)"
Line 1890,"P rocesses used to track the effectiveness of the actions b.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5499942302703857)","('Business_Ethics', 0.12774807214736938)","('Competitive_Behavior', 0.0598081573843956)","(['Corporate Governance'], 0.5499942302703857)","('NON-ESG', 0.12774807214736938)","('NON-ESG', 0.0598081573843956)"
Line 1891,"Goals,  targets, and indicators used to evaluate progress c.
","('Human_Rights_And_Community_Relations', 0.3535557985305786)","('Management_Of_Legal_And_Regulatory_Framework', 0.11948598921298981)","('Business_Model_Resilience', 0.11248379200696945)","('NON-ESG', 0.3535557985305786)","('NON-ESG', 0.11948598921298981)","('NON-ESG', 0.11248379200696945)"
Line 1892,"T he effectiveness of the actions, including progress toward the goals and targets d.
","('Human_Rights_And_Community_Relations', 0.4061984717845917)","('Business_Model_Resilience', 0.14526352286338806)","('Management_Of_Legal_And_Regulatory_Framework', 0.10114128142595291)","('NON-ESG', 0.4061984717845917)","('NON-ESG', 0.14526352286338806)","('NON-ESG', 0.10114128142595291)"
Line 1893,"L essons learned and how these have been incorporated into the organization’s  operational policies and proceduresTransparency is central to all our interactions within and outside our business — including with employees, investors, healthcare professionals, suppliers, regulators, and other stakeholders.
","('Management_Of_Legal_And_Regulatory_Framework', 0.41584670543670654)","('Human_Rights_And_Community_Relations', 0.16198161244392395)","('Business_Ethics', 0.053098276257514954)","('NON-ESG', 0.41584670543670654)","('NON-ESG', 0.16198161244392395)","('NON-ESG', 0.053098276257514954)"
Line 1894,"Although we do not have external goals on transparency, we strive to meet stakeholder expectations related to sustainability/ESG disclosure and to comply with all related disclosure regulations.
","('Business_Ethics', 0.6113373041152954)","('Management_Of_Legal_And_Regulatory_Framework', 0.2525466978549957)","('Systemic_Risk_Management', 0.026784300804138184)","(['Business Ethics'], 0.6113373041152954)","('NON-ESG', 0.2525466978549957)","('NON-ESG', 0.026784300804138184)"
Line 1895,"F.
","('GHG_Emissions', 0.15389062464237213)","('Management_Of_Legal_And_Regulatory_Framework', 0.11919295787811279)","('Competitive_Behavior', 0.11879564821720123)","('NON-ESG', 0.15389062464237213)","('NON-ESG', 0.11919295787811279)","('NON-ESG', 0.11879564821720123)"
Line 1896,"Describe how engagement with stak eholders has informed the actions taken  and how it has informed whether the actions have been effectiveWe undertake regular reviews to keep track of our most significant sustainability issues, periodically updating our list of material issues by engaging with a broad range of internal and external stakeholders.
","('Business_Model_Resilience', 0.4623148739337921)","('Systemic_Risk_Management', 0.10545326769351959)","('Physical_Impacts_Of_Climate_Change', 0.06561784446239471)","('NON-ESG', 0.4623148739337921)","('NON-ESG', 0.10545326769351959)","('NON-ESG', 0.06561784446239471)"
Line 1897,"Our annual disclosures are centered on our identified material ESG issues.
","('Business_Model_Resilience', 0.43788981437683105)","('Systemic_Risk_Management', 0.11913526803255081)","('Human_Rights_And_Community_Relations', 0.08135669678449631)","('NON-ESG', 0.43788981437683105)","('NON-ESG', 0.11913526803255081)","('NON-ESG', 0.08135669678449631)"
Line 1898,"In addition, we receive feedback on the quality and usefulness of our annual Integrated Performance Report during engagements with key stakeholders, such as investors, which informs our reporting.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2841295003890991)","('Business_Model_Resilience', 0.2469380497932434)","('Systemic_Risk_Management', 0.11668269336223602)","('NON-ESG', 0.2841295003890991)","('NON-ESG', 0.2469380497932434)","('NON-ESG', 0.11668269336223602)"
Line 1899,"Learn more about how we engage with stakeholders in Stakeholder engagement.
","('Human_Rights_And_Community_Relations', 0.7892135381698608)","('Business_Model_Resilience', 0.04326017200946808)","('Competitive_Behavior', 0.01828661933541298)","(['Community Relations'], 0.7892135381698608)","('NON-ESG', 0.04326017200946808)","('NON-ESG', 0.01828661933541298)"
Line 1900,"2022 Integrated Performance Report      GRI 116 SASB TCFD WEF Employee dataGRI 1: FOUNDATION Disclosure number Disclosure Location GRI 1 Statement of use In accordance GRI 1 used GRI 1 foundation Applicable GRI Sector Standards NA GRI 2: GENERAL DISCLOSURES Disclosure number Disclosure Location 2-1 Organizational details Medtronic Public Limited Company 20 Lower Hatch Street, Dublin 2, IrelandOur business2022 Form 10-KMedtronic plc is a publicly traded company on the New York Stock Exchange Inc.
","('Systemic_Risk_Management', 0.19614842534065247)","('Business_Model_Resilience', 0.1871901899576187)","('Management_Of_Legal_And_Regulatory_Framework', 0.1276758462190628)","('NON-ESG', 0.19614842534065247)","('NON-ESG', 0.1871901899576187)","('NON-ESG', 0.1276758462190628)"
Line 1901,"under the ticker symbol MDT.
","('Systemic_Risk_Management', 0.31490200757980347)","('Business_Model_Resilience', 0.12140794098377228)","('Competitive_Behavior', 0.09553582966327667)","('NON-ESG', 0.31490200757980347)","('NON-ESG', 0.12140794098377228)","('NON-ESG', 0.09553582966327667)"
Line 1902,"2-2 Entities included in the organization’s sustainability reporting 2022 Form 10-KAbout this report 2-3 Reporting period, frequency and contact point About this report 2-4 Restatements of information Any restatements of information are noted in the relevant sections of our 2022 Integrated Performance Report.
","('Management_Of_Legal_And_Regulatory_Framework', 0.55608731508255)","('Business_Model_Resilience', 0.1103757992386818)","('Director_Removal', 0.03148200735449791)","(['Corporate Governance'], 0.55608731508255)","('NON-ESG', 0.1103757992386818)","('NON-ESG', 0.03148200735449791)"
Line 1903,"2-5 External assurance This report has not been independently verified except for our FY20-FY22 environmental, health, and safety data and our FY22  Scope 1 and 2 emissions data.
","('Air_Quality', 0.7874099612236023)","('GHG_Emissions', 0.03486093133687973)","('Energy_Management', 0.024371173232793808)","(['Operational Eco-Efficiency'], 0.7874099612236023)","('NON-ESG', 0.03486093133687973)","('NON-ESG', 0.024371173232793808)"
Line 1904,"We have practices in place to internally validate the data included in this report.2022 GRI Index 2022 Integrated Performance Report      GRI 117 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 2-6 Activities, value chain, and other business relationships 2022 Form 10-K Our businessOur economic impactSupply chain responsibility Omission Item omitted: Report the total number and the nature of critical concerns that were communicated to the highest governance body  during the reporting period.
","('Systemic_Risk_Management', 0.41984862089157104)","('Business_Model_Resilience', 0.3129562437534332)","('Supply_Chain_Management', 0.05714875087141991)","('NON-ESG', 0.41984862089157104)","('NON-ESG', 0.3129562437534332)","('NON-ESG', 0.05714875087141991)"
Line 1905,"We have practices in place to internally validate the data included in this report.2022 GRI Index 2022 Integrated Performance Report      GRI 117 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 2-6 Activities, value chain, and other business relationships 2022 Form 10-K Our businessOur economic impactSupply chain responsibility Omission Item omitted: Report the total number and the nature of critical concerns that were communicated to the highest governance body  during the reporting period.
","('Product_Design_And_Lifecycle_Management', 0.07696884870529175)","('Competitive_Behavior', 0.06801982969045639)","('Energy_Management', 0.06453041732311249)","('NON-ESG', 0.07696884870529175)","('NON-ESG', 0.06801982969045639)","('NON-ESG', 0.06453041732311249)"
Line 1906,"Reason: We consider this information confidential.
","('Customer_Privacy', 0.7768170237541199)","('Data_Security', 0.09762270003557205)","('Business_Ethics', 0.029316669330000877)","(['Privacy Protection'], 0.7768170237541199)","('NON-ESG', 0.09762270003557205)","('NON-ESG', 0.029316669330000877)"
Line 1907,"2-7 Employees 2022 Form 10-KOur businessOur economic impactEmployee data summary 2-8 Workers who are not employees Employee data summary 2-9 Governance structure and composition Corporate governanceCorporate governance websiteESG strategy 2-10 Nomination and selection of the highest governance body Corporate governanceCorporate governance website 2-11 Chair of the highest governance body Corporate governanceCorporate governance website 2-12 Role of the highest governance body in overseeing the  management of impactsCorporate governance ESG strategy 2-13 Delegation of responsibility for managing impacts ESG strategy 2-14 Role of the highest governance body in sustainability reporting ESG strategy 2022 Integrated Performance Report      GRI 118 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 2-15 Conflicts of interest Ethics in sales and marketing Corporate governance website 2-16 Communication of critical concerns Corporate governance website 2-17 Collective knowledge of the highest governance body ESG strategy 2-18 Evaluation of the performance of the highest governance body ESG strategy 2-19 Remuneration policies Inclusion, diversity, and equity2022 Proxy statement 2-20 Process to determine remuneration Inclusion, diversity, and equity2022 Proxy statement 2-21 Annual total compensation ratio 2022 Proxy statement 2-22 Statement on sustainable development strategy Letters to our stakeholders 2-23 Policy commitments ESG strategyPatient safety and product qualitySupply chain responsibilityEthical business conductEthics in sales and marketingCorporate governanceData privacy and security 2-24 Embedding policy commitments ESG strategyPatient safety and product qualitySupply chain responsibilityEthical business conductEthics in sales and marketingCorporate governanceData privacy and security 2-25 Processes to remediate negative impacts Evaluation of the management approach 2-26 Mechanisms for seeking advice and raising concerns Ethical business conduct 2022 Integrated Performance Report      GRI 119 SASB TCFD WEF Employee data Disclosure number Disclosure Location 2-27 Compliance with laws and regulations 2022 Form 10-K Ethics in sales and marketingReducing our operational footprint 2-28 Membership associations Climate risk and resilienceReducing our operational footprintGlobal healthcare accessSupply chain responsibilityPhilanthropyInclusion, diversity, and equity 2-29 Approach to stakeholder engagement ESG strategyCorporate governance 2-30 Collective bargaining agreements Medtronic complies with global laws regarding freedom of association and collective bargaining agreements, including  participating in work councils.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3428598940372467)","('Business_Ethics', 0.2560083866119385)","('Systemic_Risk_Management', 0.06648463010787964)","('NON-ESG', 0.3428598940372467)","('NON-ESG', 0.2560083866119385)","('NON-ESG', 0.06648463010787964)"
Line 1908,"2-7 Employees 2022 Form 10-KOur businessOur economic impactEmployee data summary 2-8 Workers who are not employees Employee data summary 2-9 Governance structure and composition Corporate governanceCorporate governance websiteESG strategy 2-10 Nomination and selection of the highest governance body Corporate governanceCorporate governance website 2-11 Chair of the highest governance body Corporate governanceCorporate governance website 2-12 Role of the highest governance body in overseeing the  management of impactsCorporate governance ESG strategy 2-13 Delegation of responsibility for managing impacts ESG strategy 2-14 Role of the highest governance body in sustainability reporting ESG strategy 2022 Integrated Performance Report      GRI 118 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 2-15 Conflicts of interest Ethics in sales and marketing Corporate governance website 2-16 Communication of critical concerns Corporate governance website 2-17 Collective knowledge of the highest governance body ESG strategy 2-18 Evaluation of the performance of the highest governance body ESG strategy 2-19 Remuneration policies Inclusion, diversity, and equity2022 Proxy statement 2-20 Process to determine remuneration Inclusion, diversity, and equity2022 Proxy statement 2-21 Annual total compensation ratio 2022 Proxy statement 2-22 Statement on sustainable development strategy Letters to our stakeholders 2-23 Policy commitments ESG strategyPatient safety and product qualitySupply chain responsibilityEthical business conductEthics in sales and marketingCorporate governanceData privacy and security 2-24 Embedding policy commitments ESG strategyPatient safety and product qualitySupply chain responsibilityEthical business conductEthics in sales and marketingCorporate governanceData privacy and security 2-25 Processes to remediate negative impacts Evaluation of the management approach 2-26 Mechanisms for seeking advice and raising concerns Ethical business conduct 2022 Integrated Performance Report      GRI 119 SASB TCFD WEF Employee data Disclosure number Disclosure Location 2-27 Compliance with laws and regulations 2022 Form 10-K Ethics in sales and marketingReducing our operational footprint 2-28 Membership associations Climate risk and resilienceReducing our operational footprintGlobal healthcare accessSupply chain responsibilityPhilanthropyInclusion, diversity, and equity 2-29 Approach to stakeholder engagement ESG strategyCorporate governance 2-30 Collective bargaining agreements Medtronic complies with global laws regarding freedom of association and collective bargaining agreements, including  participating in work councils.
","('Business_Ethics', 0.9091816544532776)","('Management_Of_Legal_And_Regulatory_Framework', 0.019759634509682655)","('Competitive_Behavior', 0.015139593742787838)","(['Business Ethics'], 0.9091816544532776)","('NON-ESG', 0.019759634509682655)","('NON-ESG', 0.015139593742787838)"
Line 1909,"2-7 Employees 2022 Form 10-KOur businessOur economic impactEmployee data summary 2-8 Workers who are not employees Employee data summary 2-9 Governance structure and composition Corporate governanceCorporate governance websiteESG strategy 2-10 Nomination and selection of the highest governance body Corporate governanceCorporate governance website 2-11 Chair of the highest governance body Corporate governanceCorporate governance website 2-12 Role of the highest governance body in overseeing the  management of impactsCorporate governance ESG strategy 2-13 Delegation of responsibility for managing impacts ESG strategy 2-14 Role of the highest governance body in sustainability reporting ESG strategy 2022 Integrated Performance Report      GRI 118 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 2-15 Conflicts of interest Ethics in sales and marketing Corporate governance website 2-16 Communication of critical concerns Corporate governance website 2-17 Collective knowledge of the highest governance body ESG strategy 2-18 Evaluation of the performance of the highest governance body ESG strategy 2-19 Remuneration policies Inclusion, diversity, and equity2022 Proxy statement 2-20 Process to determine remuneration Inclusion, diversity, and equity2022 Proxy statement 2-21 Annual total compensation ratio 2022 Proxy statement 2-22 Statement on sustainable development strategy Letters to our stakeholders 2-23 Policy commitments ESG strategyPatient safety and product qualitySupply chain responsibilityEthical business conductEthics in sales and marketingCorporate governanceData privacy and security 2-24 Embedding policy commitments ESG strategyPatient safety and product qualitySupply chain responsibilityEthical business conductEthics in sales and marketingCorporate governanceData privacy and security 2-25 Processes to remediate negative impacts Evaluation of the management approach 2-26 Mechanisms for seeking advice and raising concerns Ethical business conduct 2022 Integrated Performance Report      GRI 119 SASB TCFD WEF Employee data Disclosure number Disclosure Location 2-27 Compliance with laws and regulations 2022 Form 10-K Ethics in sales and marketingReducing our operational footprint 2-28 Membership associations Climate risk and resilienceReducing our operational footprintGlobal healthcare accessSupply chain responsibilityPhilanthropyInclusion, diversity, and equity 2-29 Approach to stakeholder engagement ESG strategyCorporate governance 2-30 Collective bargaining agreements Medtronic complies with global laws regarding freedom of association and collective bargaining agreements, including  participating in work councils.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8972256183624268)","('Product_Quality_And_Safety', 0.020533189177513123)","('Employee_Health_And_Safety', 0.008545287884771824)","(['Human Capital Development'], 0.8972256183624268)","('NON-ESG', 0.020533189177513123)","('NON-ESG', 0.008545287884771824)"
Line 1910,"2-7 Employees 2022 Form 10-KOur businessOur economic impactEmployee data summary 2-8 Workers who are not employees Employee data summary 2-9 Governance structure and composition Corporate governanceCorporate governance websiteESG strategy 2-10 Nomination and selection of the highest governance body Corporate governanceCorporate governance website 2-11 Chair of the highest governance body Corporate governanceCorporate governance website 2-12 Role of the highest governance body in overseeing the  management of impactsCorporate governance ESG strategy 2-13 Delegation of responsibility for managing impacts ESG strategy 2-14 Role of the highest governance body in sustainability reporting ESG strategy 2022 Integrated Performance Report      GRI 118 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 2-15 Conflicts of interest Ethics in sales and marketing Corporate governance website 2-16 Communication of critical concerns Corporate governance website 2-17 Collective knowledge of the highest governance body ESG strategy 2-18 Evaluation of the performance of the highest governance body ESG strategy 2-19 Remuneration policies Inclusion, diversity, and equity2022 Proxy statement 2-20 Process to determine remuneration Inclusion, diversity, and equity2022 Proxy statement 2-21 Annual total compensation ratio 2022 Proxy statement 2-22 Statement on sustainable development strategy Letters to our stakeholders 2-23 Policy commitments ESG strategyPatient safety and product qualitySupply chain responsibilityEthical business conductEthics in sales and marketingCorporate governanceData privacy and security 2-24 Embedding policy commitments ESG strategyPatient safety and product qualitySupply chain responsibilityEthical business conductEthics in sales and marketingCorporate governanceData privacy and security 2-25 Processes to remediate negative impacts Evaluation of the management approach 2-26 Mechanisms for seeking advice and raising concerns Ethical business conduct 2022 Integrated Performance Report      GRI 119 SASB TCFD WEF Employee data Disclosure number Disclosure Location 2-27 Compliance with laws and regulations 2022 Form 10-K Ethics in sales and marketingReducing our operational footprint 2-28 Membership associations Climate risk and resilienceReducing our operational footprintGlobal healthcare accessSupply chain responsibilityPhilanthropyInclusion, diversity, and equity 2-29 Approach to stakeholder engagement ESG strategyCorporate governance 2-30 Collective bargaining agreements Medtronic complies with global laws regarding freedom of association and collective bargaining agreements, including  participating in work councils.
","('Data_Security', 0.7808087468147278)","('Business_Ethics', 0.07562185078859329)","('Customer_Privacy', 0.03075886145234108)","(['Information Security/Cybersecurity & System Availability'], 0.7808087468147278)","('NON-ESG', 0.07562185078859329)","('NON-ESG', 0.03075886145234108)"
Line 1911,"2-7 Employees 2022 Form 10-KOur businessOur economic impactEmployee data summary 2-8 Workers who are not employees Employee data summary 2-9 Governance structure and composition Corporate governanceCorporate governance websiteESG strategy 2-10 Nomination and selection of the highest governance body Corporate governanceCorporate governance website 2-11 Chair of the highest governance body Corporate governanceCorporate governance website 2-12 Role of the highest governance body in overseeing the  management of impactsCorporate governance ESG strategy 2-13 Delegation of responsibility for managing impacts ESG strategy 2-14 Role of the highest governance body in sustainability reporting ESG strategy 2022 Integrated Performance Report      GRI 118 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 2-15 Conflicts of interest Ethics in sales and marketing Corporate governance website 2-16 Communication of critical concerns Corporate governance website 2-17 Collective knowledge of the highest governance body ESG strategy 2-18 Evaluation of the performance of the highest governance body ESG strategy 2-19 Remuneration policies Inclusion, diversity, and equity2022 Proxy statement 2-20 Process to determine remuneration Inclusion, diversity, and equity2022 Proxy statement 2-21 Annual total compensation ratio 2022 Proxy statement 2-22 Statement on sustainable development strategy Letters to our stakeholders 2-23 Policy commitments ESG strategyPatient safety and product qualitySupply chain responsibilityEthical business conductEthics in sales and marketingCorporate governanceData privacy and security 2-24 Embedding policy commitments ESG strategyPatient safety and product qualitySupply chain responsibilityEthical business conductEthics in sales and marketingCorporate governanceData privacy and security 2-25 Processes to remediate negative impacts Evaluation of the management approach 2-26 Mechanisms for seeking advice and raising concerns Ethical business conduct 2022 Integrated Performance Report      GRI 119 SASB TCFD WEF Employee data Disclosure number Disclosure Location 2-27 Compliance with laws and regulations 2022 Form 10-K Ethics in sales and marketingReducing our operational footprint 2-28 Membership associations Climate risk and resilienceReducing our operational footprintGlobal healthcare accessSupply chain responsibilityPhilanthropyInclusion, diversity, and equity 2-29 Approach to stakeholder engagement ESG strategyCorporate governance 2-30 Collective bargaining agreements Medtronic complies with global laws regarding freedom of association and collective bargaining agreements, including  participating in work councils.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5451492667198181)","('Business_Model_Resilience', 0.17515036463737488)","('Human_Rights_And_Community_Relations', 0.032673951238393784)","(['Human Capital Development'], 0.5451492667198181)","('NON-ESG', 0.17515036463737488)","('NON-ESG', 0.032673951238393784)"
Line 1912,"2-7 Employees 2022 Form 10-KOur businessOur economic impactEmployee data summary 2-8 Workers who are not employees Employee data summary 2-9 Governance structure and composition Corporate governanceCorporate governance websiteESG strategy 2-10 Nomination and selection of the highest governance body Corporate governanceCorporate governance website 2-11 Chair of the highest governance body Corporate governanceCorporate governance website 2-12 Role of the highest governance body in overseeing the  management of impactsCorporate governance ESG strategy 2-13 Delegation of responsibility for managing impacts ESG strategy 2-14 Role of the highest governance body in sustainability reporting ESG strategy 2022 Integrated Performance Report      GRI 118 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 2-15 Conflicts of interest Ethics in sales and marketing Corporate governance website 2-16 Communication of critical concerns Corporate governance website 2-17 Collective knowledge of the highest governance body ESG strategy 2-18 Evaluation of the performance of the highest governance body ESG strategy 2-19 Remuneration policies Inclusion, diversity, and equity2022 Proxy statement 2-20 Process to determine remuneration Inclusion, diversity, and equity2022 Proxy statement 2-21 Annual total compensation ratio 2022 Proxy statement 2-22 Statement on sustainable development strategy Letters to our stakeholders 2-23 Policy commitments ESG strategyPatient safety and product qualitySupply chain responsibilityEthical business conductEthics in sales and marketingCorporate governanceData privacy and security 2-24 Embedding policy commitments ESG strategyPatient safety and product qualitySupply chain responsibilityEthical business conductEthics in sales and marketingCorporate governanceData privacy and security 2-25 Processes to remediate negative impacts Evaluation of the management approach 2-26 Mechanisms for seeking advice and raising concerns Ethical business conduct 2022 Integrated Performance Report      GRI 119 SASB TCFD WEF Employee data Disclosure number Disclosure Location 2-27 Compliance with laws and regulations 2022 Form 10-K Ethics in sales and marketingReducing our operational footprint 2-28 Membership associations Climate risk and resilienceReducing our operational footprintGlobal healthcare accessSupply chain responsibilityPhilanthropyInclusion, diversity, and equity 2-29 Approach to stakeholder engagement ESG strategyCorporate governance 2-30 Collective bargaining agreements Medtronic complies with global laws regarding freedom of association and collective bargaining agreements, including  participating in work councils.
","('Labor_Practices', 0.9754301905632019)","('Director_Removal', 0.002427480649203062)","('Air_Quality', 0.0017353486036881804)","(['Labor Practice Indicators'], 0.9754301905632019)","('NON-ESG', 0.002427480649203062)","('NON-ESG', 0.0017353486036881804)"
Line 1913,"In FY22, approximately 9% of our employees were covered by collective bargaining agreements or independent trade unions where applicable.
","('Labor_Practices', 0.9758912324905396)","('Director_Removal', 0.002863239264115691)","('Supply_Chain_Management', 0.0014900584938004613)","(['Labor Practice Indicators'], 0.9758912324905396)","('NON-ESG', 0.002863239264115691)","('NON-ESG', 0.0014900584938004613)"
Line 1914,"GRI 3: MATERIAL TOPICS  Disclosure number Disclosure Location 3-1 Process to determine material topics ESG strategy 3-2 List of material topics ESG strategy 3-3 Management of material topics Evaluation of the management approach 2022 Integrated Performance Report      GRI 120 SASB TCFD WEF Employee dataTOPIC STANDARDS Disclosure number Disclosure Location 201-1 Direct economic value generated and distributed 2022 Form 10-K Our economic impactPhilanthropyCompensation, benefits, and wellness 201-2 Financial implications and other risks and opportunities due to  climate change ESG strategy Climate risk and resilience 201-3 Defined benefit plan obligations and other retirement plans Compensation, benefits, and wellness 203-1 Infrastructure investments and services supported PhilanthropySupply chain responsibilityGlobal healthcare accessESG strategyOur economic impact 203-2 Significant indirect economic impacts Evaluation of the management approachSupply chain responsibility 204-1 Proportion of spending on local suppliers Supply chain responsibility 205-1 Operations assessed for risks related to corruption Ethics in sales and marketing 205-2 Communication and training about anti-corruption policies   and proceduresEthics in sales and marketing Ethical business conduct 205-3 Confirmed incidents of corruption and actions taken Ethics in sales and marketingEthical business conduct 206-1 Legal actions for anti-competitive behavior, anti-trust, and  monopoly practices2022 Form 10-K 301-3 Reclaimed products and their packaging materials Product stewardship 302-1 Energy consumption within the organization Reducing our operational footprint 302-2 Energy consumption outside of the organization Reducing our operational footprint 302-3 Energy intensity Reducing our operational footprint 2022 Integrated Performance Report      GRI 121 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 302-4 Reduction of energy consumption Reducing our operational footprint 302-5 Reductions in energy requirements of products and services Most Medtronic products consume relatively low energy as is, and safety requirements often prevent us from reducing a product's  energy use.
","('Business_Model_Resilience', 0.5486424565315247)","('Systemic_Risk_Management', 0.1524590402841568)","('Management_Of_Legal_And_Regulatory_Framework', 0.03973560407757759)","(['Codes of Business Conduct'], 0.5486424565315247)","('NON-ESG', 0.1524590402841568)","('NON-ESG', 0.03973560407757759)"
Line 1915,"GRI 3: MATERIAL TOPICS  Disclosure number Disclosure Location 3-1 Process to determine material topics ESG strategy 3-2 List of material topics ESG strategy 3-3 Management of material topics Evaluation of the management approach 2022 Integrated Performance Report      GRI 120 SASB TCFD WEF Employee dataTOPIC STANDARDS Disclosure number Disclosure Location 201-1 Direct economic value generated and distributed 2022 Form 10-K Our economic impactPhilanthropyCompensation, benefits, and wellness 201-2 Financial implications and other risks and opportunities due to  climate change ESG strategy Climate risk and resilience 201-3 Defined benefit plan obligations and other retirement plans Compensation, benefits, and wellness 203-1 Infrastructure investments and services supported PhilanthropySupply chain responsibilityGlobal healthcare accessESG strategyOur economic impact 203-2 Significant indirect economic impacts Evaluation of the management approachSupply chain responsibility 204-1 Proportion of spending on local suppliers Supply chain responsibility 205-1 Operations assessed for risks related to corruption Ethics in sales and marketing 205-2 Communication and training about anti-corruption policies   and proceduresEthics in sales and marketing Ethical business conduct 205-3 Confirmed incidents of corruption and actions taken Ethics in sales and marketingEthical business conduct 206-1 Legal actions for anti-competitive behavior, anti-trust, and  monopoly practices2022 Form 10-K 301-3 Reclaimed products and their packaging materials Product stewardship 302-1 Energy consumption within the organization Reducing our operational footprint 302-2 Energy consumption outside of the organization Reducing our operational footprint 302-3 Energy intensity Reducing our operational footprint 2022 Integrated Performance Report      GRI 121 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 302-4 Reduction of energy consumption Reducing our operational footprint 302-5 Reductions in energy requirements of products and services Most Medtronic products consume relatively low energy as is, and safety requirements often prevent us from reducing a product's  energy use.
","('Physical_Impacts_Of_Climate_Change', 0.7437333464622498)","('Business_Model_Resilience', 0.1603078991174698)","('Systemic_Risk_Management', 0.0164453387260437)","(['Climate Change'], 0.7437333464622498)","('NON-ESG', 0.1603078991174698)","('NON-ESG', 0.0164453387260437)"
Line 1916,"GRI 3: MATERIAL TOPICS  Disclosure number Disclosure Location 3-1 Process to determine material topics ESG strategy 3-2 List of material topics ESG strategy 3-3 Management of material topics Evaluation of the management approach 2022 Integrated Performance Report      GRI 120 SASB TCFD WEF Employee dataTOPIC STANDARDS Disclosure number Disclosure Location 201-1 Direct economic value generated and distributed 2022 Form 10-K Our economic impactPhilanthropyCompensation, benefits, and wellness 201-2 Financial implications and other risks and opportunities due to  climate change ESG strategy Climate risk and resilience 201-3 Defined benefit plan obligations and other retirement plans Compensation, benefits, and wellness 203-1 Infrastructure investments and services supported PhilanthropySupply chain responsibilityGlobal healthcare accessESG strategyOur economic impact 203-2 Significant indirect economic impacts Evaluation of the management approachSupply chain responsibility 204-1 Proportion of spending on local suppliers Supply chain responsibility 205-1 Operations assessed for risks related to corruption Ethics in sales and marketing 205-2 Communication and training about anti-corruption policies   and proceduresEthics in sales and marketing Ethical business conduct 205-3 Confirmed incidents of corruption and actions taken Ethics in sales and marketingEthical business conduct 206-1 Legal actions for anti-competitive behavior, anti-trust, and  monopoly practices2022 Form 10-K 301-3 Reclaimed products and their packaging materials Product stewardship 302-1 Energy consumption within the organization Reducing our operational footprint 302-2 Energy consumption outside of the organization Reducing our operational footprint 302-3 Energy intensity Reducing our operational footprint 2022 Integrated Performance Report      GRI 121 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 302-4 Reduction of energy consumption Reducing our operational footprint 302-5 Reductions in energy requirements of products and services Most Medtronic products consume relatively low energy as is, and safety requirements often prevent us from reducing a product's  energy use.
","('Business_Ethics', 0.9740033745765686)","('Competitive_Behavior', 0.0025933694560080767)","('Product_Quality_And_Safety', 0.002121403580531478)","(['Business Ethics'], 0.9740033745765686)","('NON-ESG', 0.0025933694560080767)","('NON-ESG', 0.002121403580531478)"
Line 1917,"GRI 3: MATERIAL TOPICS  Disclosure number Disclosure Location 3-1 Process to determine material topics ESG strategy 3-2 List of material topics ESG strategy 3-3 Management of material topics Evaluation of the management approach 2022 Integrated Performance Report      GRI 120 SASB TCFD WEF Employee dataTOPIC STANDARDS Disclosure number Disclosure Location 201-1 Direct economic value generated and distributed 2022 Form 10-K Our economic impactPhilanthropyCompensation, benefits, and wellness 201-2 Financial implications and other risks and opportunities due to  climate change ESG strategy Climate risk and resilience 201-3 Defined benefit plan obligations and other retirement plans Compensation, benefits, and wellness 203-1 Infrastructure investments and services supported PhilanthropySupply chain responsibilityGlobal healthcare accessESG strategyOur economic impact 203-2 Significant indirect economic impacts Evaluation of the management approachSupply chain responsibility 204-1 Proportion of spending on local suppliers Supply chain responsibility 205-1 Operations assessed for risks related to corruption Ethics in sales and marketing 205-2 Communication and training about anti-corruption policies   and proceduresEthics in sales and marketing Ethical business conduct 205-3 Confirmed incidents of corruption and actions taken Ethics in sales and marketingEthical business conduct 206-1 Legal actions for anti-competitive behavior, anti-trust, and  monopoly practices2022 Form 10-K 301-3 Reclaimed products and their packaging materials Product stewardship 302-1 Energy consumption within the organization Reducing our operational footprint 302-2 Energy consumption outside of the organization Reducing our operational footprint 302-3 Energy intensity Reducing our operational footprint 2022 Integrated Performance Report      GRI 121 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 302-4 Reduction of energy consumption Reducing our operational footprint 302-5 Reductions in energy requirements of products and services Most Medtronic products consume relatively low energy as is, and safety requirements often prevent us from reducing a product's  energy use.
","('Energy_Management', 0.9508992433547974)","('Product_Design_And_Lifecycle_Management', 0.015001575462520123)","('Product_Quality_And_Safety', 0.003115657716989517)","(['Operational Eco-Efficiency'], 0.9508992433547974)","('NON-ESG', 0.015001575462520123)","('NON-ESG', 0.003115657716989517)"
Line 1918,"GRI 3: MATERIAL TOPICS  Disclosure number Disclosure Location 3-1 Process to determine material topics ESG strategy 3-2 List of material topics ESG strategy 3-3 Management of material topics Evaluation of the management approach 2022 Integrated Performance Report      GRI 120 SASB TCFD WEF Employee dataTOPIC STANDARDS Disclosure number Disclosure Location 201-1 Direct economic value generated and distributed 2022 Form 10-K Our economic impactPhilanthropyCompensation, benefits, and wellness 201-2 Financial implications and other risks and opportunities due to  climate change ESG strategy Climate risk and resilience 201-3 Defined benefit plan obligations and other retirement plans Compensation, benefits, and wellness 203-1 Infrastructure investments and services supported PhilanthropySupply chain responsibilityGlobal healthcare accessESG strategyOur economic impact 203-2 Significant indirect economic impacts Evaluation of the management approachSupply chain responsibility 204-1 Proportion of spending on local suppliers Supply chain responsibility 205-1 Operations assessed for risks related to corruption Ethics in sales and marketing 205-2 Communication and training about anti-corruption policies   and proceduresEthics in sales and marketing Ethical business conduct 205-3 Confirmed incidents of corruption and actions taken Ethics in sales and marketingEthical business conduct 206-1 Legal actions for anti-competitive behavior, anti-trust, and  monopoly practices2022 Form 10-K 301-3 Reclaimed products and their packaging materials Product stewardship 302-1 Energy consumption within the organization Reducing our operational footprint 302-2 Energy consumption outside of the organization Reducing our operational footprint 302-3 Energy intensity Reducing our operational footprint 2022 Integrated Performance Report      GRI 121 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 302-4 Reduction of energy consumption Reducing our operational footprint 302-5 Reductions in energy requirements of products and services Most Medtronic products consume relatively low energy as is, and safety requirements often prevent us from reducing a product's  energy use.
","('Product_Quality_And_Safety', 0.7000390291213989)","('Product_Design_And_Lifecycle_Management', 0.16815844178199768)","('Selling_Practices_And_Product_Labeling', 0.01712755858898163)","(['Product Quality & Recall Management'], 0.7000390291213989)","('NON-ESG', 0.16815844178199768)","('NON-ESG', 0.01712755858898163)"
Line 1919,"303-1 Interactions with water as a shared resource CDP Water Disclosure Reducing our operational footprint 303-5 Water consumption CDP Water DisclosureReducing our operational footprint 305-1 Direct (Scope 1) GHG emissions Reducing our operational footprint 305-2 Energy indirect (Scope 2) GHG emissions Reducing our operational footprint 305-4 GHG emissions intensity Reducing our operational footprint2022 TCFD 305-5 Reduction of GHG emissions Reducing our operational footprint 306-3 Waste generated Reducing our operational footprint 306-4 Waste diverted from disposal Product stewardship 308-1 New suppliers that were screened using environmental criteria Supply chain responsibility 308-2 Negative environmental impacts in the supply chain  and actions takenSupply chain responsibility Evaluation of the management approach 401-1 New employee hires and employee turnover Employee data summary 401-2 Benefits provided to full-time employees that are not provided to  temporary or part-time employeesSupporting a global workforce 401-3 Parental leave Supporting a global workforce 403-1 Occupational health and safety management system Supporting a global workforce 403-2 Hazard identification, risk assessment, and incident investigation Supporting a global workforce 403-3 Occupational health services Supporting a global workforce 403-4 Worker participation, consultation, and communication on occupational health and safety Supporting a global workforce 2022 Integrated Performance Report      GRI 122 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 403-5 Worker training on occupational health and safety Supporting a global workforce 403-9 Work-related injuries Supporting a global workforce 403-10 Work-related ill health Supporting a global workforce 404-1 Average hours of training per year per employee Supporting a global workforce 404-2 Programs for upgrading employee skills and transition assistance  programSupporting a global workforce 404-3 Percentage of employees receiving regular performance and career development reviews Supporting a global workforce 405-1 Diversity of governance bodies and employees Corporate governance Inclusion, diversity, and equity 405-2 Ratio of basic salary and remuneration of women to men Inclusion, diversity, and equity 406-1 Incidents of discrimination and corrective actions taken Omission Topic omitted: Total number of incidents of discrimination and corrective actions taken.Reason: The information is currently unavailable 407-1 Operations and suppliers in which the right of freedom of  association and collective bargaining may be at risk Global Human Rights and Labor Policy Program Report 408-1 Operations and suppliers at significant risk for incidents  of child labor Global Human Rights and Labor Policy Program Report 409-1 Operations and suppliers at significant risk for incidents of forced or compulsory labor Supply chain responsibility 413-1 Operations with local community engagement, impact assessments, and development programs Global healthcare access PhilanthropyOur economic impact 414-1 New suppliers that were screened using social criteria Supply chain responsibility 414-2 Negative social impacts in the supply chain and actions taken Supply chain responsibilityEvaluation of the management approach 2022 Integrated Performance Report      GRI 123 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 415-1 Political contributions Corporate governance Corporate governance website 416-1 Assessment of the health and safety impacts of product and  service categoriesPatient safety and product quality 416-2 Incidents of noncompliance concerning the health and safety impacts of products and servicesOf inspections that occurred across Medtronic in FY22, 95% resulted in no findings.
","('GHG_Emissions', 0.9605181217193604)","('Air_Quality', 0.004581944551318884)","('Water_And_Wastewater_Management', 0.004030373878777027)","(['Climate Change'], 0.9605181217193604)","('NON-ESG', 0.004581944551318884)","('NON-ESG', 0.004030373878777027)"
Line 1920,"303-1 Interactions with water as a shared resource CDP Water Disclosure Reducing our operational footprint 303-5 Water consumption CDP Water DisclosureReducing our operational footprint 305-1 Direct (Scope 1) GHG emissions Reducing our operational footprint 305-2 Energy indirect (Scope 2) GHG emissions Reducing our operational footprint 305-4 GHG emissions intensity Reducing our operational footprint2022 TCFD 305-5 Reduction of GHG emissions Reducing our operational footprint 306-3 Waste generated Reducing our operational footprint 306-4 Waste diverted from disposal Product stewardship 308-1 New suppliers that were screened using environmental criteria Supply chain responsibility 308-2 Negative environmental impacts in the supply chain  and actions takenSupply chain responsibility Evaluation of the management approach 401-1 New employee hires and employee turnover Employee data summary 401-2 Benefits provided to full-time employees that are not provided to  temporary or part-time employeesSupporting a global workforce 401-3 Parental leave Supporting a global workforce 403-1 Occupational health and safety management system Supporting a global workforce 403-2 Hazard identification, risk assessment, and incident investigation Supporting a global workforce 403-3 Occupational health services Supporting a global workforce 403-4 Worker participation, consultation, and communication on occupational health and safety Supporting a global workforce 2022 Integrated Performance Report      GRI 122 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 403-5 Worker training on occupational health and safety Supporting a global workforce 403-9 Work-related injuries Supporting a global workforce 403-10 Work-related ill health Supporting a global workforce 404-1 Average hours of training per year per employee Supporting a global workforce 404-2 Programs for upgrading employee skills and transition assistance  programSupporting a global workforce 404-3 Percentage of employees receiving regular performance and career development reviews Supporting a global workforce 405-1 Diversity of governance bodies and employees Corporate governance Inclusion, diversity, and equity 405-2 Ratio of basic salary and remuneration of women to men Inclusion, diversity, and equity 406-1 Incidents of discrimination and corrective actions taken Omission Topic omitted: Total number of incidents of discrimination and corrective actions taken.Reason: The information is currently unavailable 407-1 Operations and suppliers in which the right of freedom of  association and collective bargaining may be at risk Global Human Rights and Labor Policy Program Report 408-1 Operations and suppliers at significant risk for incidents  of child labor Global Human Rights and Labor Policy Program Report 409-1 Operations and suppliers at significant risk for incidents of forced or compulsory labor Supply chain responsibility 413-1 Operations with local community engagement, impact assessments, and development programs Global healthcare access PhilanthropyOur economic impact 414-1 New suppliers that were screened using social criteria Supply chain responsibility 414-2 Negative social impacts in the supply chain and actions taken Supply chain responsibilityEvaluation of the management approach 2022 Integrated Performance Report      GRI 123 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 415-1 Political contributions Corporate governance Corporate governance website 416-1 Assessment of the health and safety impacts of product and  service categoriesPatient safety and product quality 416-2 Incidents of noncompliance concerning the health and safety impacts of products and servicesOf inspections that occurred across Medtronic in FY22, 95% resulted in no findings.
","('Supply_Chain_Management', 0.8803615570068359)","('Product_Design_And_Lifecycle_Management', 0.025564225390553474)","('Labor_Practices', 0.016629545018076897)","(['Supply Chain Management'], 0.8803615570068359)","('NON-ESG', 0.025564225390553474)","('NON-ESG', 0.016629545018076897)"
Line 1921,"303-1 Interactions with water as a shared resource CDP Water Disclosure Reducing our operational footprint 303-5 Water consumption CDP Water DisclosureReducing our operational footprint 305-1 Direct (Scope 1) GHG emissions Reducing our operational footprint 305-2 Energy indirect (Scope 2) GHG emissions Reducing our operational footprint 305-4 GHG emissions intensity Reducing our operational footprint2022 TCFD 305-5 Reduction of GHG emissions Reducing our operational footprint 306-3 Waste generated Reducing our operational footprint 306-4 Waste diverted from disposal Product stewardship 308-1 New suppliers that were screened using environmental criteria Supply chain responsibility 308-2 Negative environmental impacts in the supply chain  and actions takenSupply chain responsibility Evaluation of the management approach 401-1 New employee hires and employee turnover Employee data summary 401-2 Benefits provided to full-time employees that are not provided to  temporary or part-time employeesSupporting a global workforce 401-3 Parental leave Supporting a global workforce 403-1 Occupational health and safety management system Supporting a global workforce 403-2 Hazard identification, risk assessment, and incident investigation Supporting a global workforce 403-3 Occupational health services Supporting a global workforce 403-4 Worker participation, consultation, and communication on occupational health and safety Supporting a global workforce 2022 Integrated Performance Report      GRI 122 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 403-5 Worker training on occupational health and safety Supporting a global workforce 403-9 Work-related injuries Supporting a global workforce 403-10 Work-related ill health Supporting a global workforce 404-1 Average hours of training per year per employee Supporting a global workforce 404-2 Programs for upgrading employee skills and transition assistance  programSupporting a global workforce 404-3 Percentage of employees receiving regular performance and career development reviews Supporting a global workforce 405-1 Diversity of governance bodies and employees Corporate governance Inclusion, diversity, and equity 405-2 Ratio of basic salary and remuneration of women to men Inclusion, diversity, and equity 406-1 Incidents of discrimination and corrective actions taken Omission Topic omitted: Total number of incidents of discrimination and corrective actions taken.Reason: The information is currently unavailable 407-1 Operations and suppliers in which the right of freedom of  association and collective bargaining may be at risk Global Human Rights and Labor Policy Program Report 408-1 Operations and suppliers at significant risk for incidents  of child labor Global Human Rights and Labor Policy Program Report 409-1 Operations and suppliers at significant risk for incidents of forced or compulsory labor Supply chain responsibility 413-1 Operations with local community engagement, impact assessments, and development programs Global healthcare access PhilanthropyOur economic impact 414-1 New suppliers that were screened using social criteria Supply chain responsibility 414-2 Negative social impacts in the supply chain and actions taken Supply chain responsibilityEvaluation of the management approach 2022 Integrated Performance Report      GRI 123 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 415-1 Political contributions Corporate governance Corporate governance website 416-1 Assessment of the health and safety impacts of product and  service categoriesPatient safety and product quality 416-2 Incidents of noncompliance concerning the health and safety impacts of products and servicesOf inspections that occurred across Medtronic in FY22, 95% resulted in no findings.
","('Employee_Health_And_Safety', 0.9847870469093323)","('Critical_Incident_Risk_Management', 0.002034320030361414)","('Employee_Engagement_Inclusion_And_Diversity', 0.001596003887243569)","(['Operational Eco-Efficiency'], 0.9847870469093323)","('NON-ESG', 0.002034320030361414)","('NON-ESG', 0.001596003887243569)"
Line 1922,"303-1 Interactions with water as a shared resource CDP Water Disclosure Reducing our operational footprint 303-5 Water consumption CDP Water DisclosureReducing our operational footprint 305-1 Direct (Scope 1) GHG emissions Reducing our operational footprint 305-2 Energy indirect (Scope 2) GHG emissions Reducing our operational footprint 305-4 GHG emissions intensity Reducing our operational footprint2022 TCFD 305-5 Reduction of GHG emissions Reducing our operational footprint 306-3 Waste generated Reducing our operational footprint 306-4 Waste diverted from disposal Product stewardship 308-1 New suppliers that were screened using environmental criteria Supply chain responsibility 308-2 Negative environmental impacts in the supply chain  and actions takenSupply chain responsibility Evaluation of the management approach 401-1 New employee hires and employee turnover Employee data summary 401-2 Benefits provided to full-time employees that are not provided to  temporary or part-time employeesSupporting a global workforce 401-3 Parental leave Supporting a global workforce 403-1 Occupational health and safety management system Supporting a global workforce 403-2 Hazard identification, risk assessment, and incident investigation Supporting a global workforce 403-3 Occupational health services Supporting a global workforce 403-4 Worker participation, consultation, and communication on occupational health and safety Supporting a global workforce 2022 Integrated Performance Report      GRI 122 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 403-5 Worker training on occupational health and safety Supporting a global workforce 403-9 Work-related injuries Supporting a global workforce 403-10 Work-related ill health Supporting a global workforce 404-1 Average hours of training per year per employee Supporting a global workforce 404-2 Programs for upgrading employee skills and transition assistance  programSupporting a global workforce 404-3 Percentage of employees receiving regular performance and career development reviews Supporting a global workforce 405-1 Diversity of governance bodies and employees Corporate governance Inclusion, diversity, and equity 405-2 Ratio of basic salary and remuneration of women to men Inclusion, diversity, and equity 406-1 Incidents of discrimination and corrective actions taken Omission Topic omitted: Total number of incidents of discrimination and corrective actions taken.Reason: The information is currently unavailable 407-1 Operations and suppliers in which the right of freedom of  association and collective bargaining may be at risk Global Human Rights and Labor Policy Program Report 408-1 Operations and suppliers at significant risk for incidents  of child labor Global Human Rights and Labor Policy Program Report 409-1 Operations and suppliers at significant risk for incidents of forced or compulsory labor Supply chain responsibility 413-1 Operations with local community engagement, impact assessments, and development programs Global healthcare access PhilanthropyOur economic impact 414-1 New suppliers that were screened using social criteria Supply chain responsibility 414-2 Negative social impacts in the supply chain and actions taken Supply chain responsibilityEvaluation of the management approach 2022 Integrated Performance Report      GRI 123 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 415-1 Political contributions Corporate governance Corporate governance website 416-1 Assessment of the health and safety impacts of product and  service categoriesPatient safety and product quality 416-2 Incidents of noncompliance concerning the health and safety impacts of products and servicesOf inspections that occurred across Medtronic in FY22, 95% resulted in no findings.
","('Employee_Health_And_Safety', 0.9830599427223206)","('Employee_Engagement_Inclusion_And_Diversity', 0.0025371345691382885)","('Labor_Practices', 0.0013011993141844869)","(['Operational Eco-Efficiency'], 0.9830599427223206)","('NON-ESG', 0.0025371345691382885)","('NON-ESG', 0.0013011993141844869)"
Line 1923,"303-1 Interactions with water as a shared resource CDP Water Disclosure Reducing our operational footprint 303-5 Water consumption CDP Water DisclosureReducing our operational footprint 305-1 Direct (Scope 1) GHG emissions Reducing our operational footprint 305-2 Energy indirect (Scope 2) GHG emissions Reducing our operational footprint 305-4 GHG emissions intensity Reducing our operational footprint2022 TCFD 305-5 Reduction of GHG emissions Reducing our operational footprint 306-3 Waste generated Reducing our operational footprint 306-4 Waste diverted from disposal Product stewardship 308-1 New suppliers that were screened using environmental criteria Supply chain responsibility 308-2 Negative environmental impacts in the supply chain  and actions takenSupply chain responsibility Evaluation of the management approach 401-1 New employee hires and employee turnover Employee data summary 401-2 Benefits provided to full-time employees that are not provided to  temporary or part-time employeesSupporting a global workforce 401-3 Parental leave Supporting a global workforce 403-1 Occupational health and safety management system Supporting a global workforce 403-2 Hazard identification, risk assessment, and incident investigation Supporting a global workforce 403-3 Occupational health services Supporting a global workforce 403-4 Worker participation, consultation, and communication on occupational health and safety Supporting a global workforce 2022 Integrated Performance Report      GRI 122 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 403-5 Worker training on occupational health and safety Supporting a global workforce 403-9 Work-related injuries Supporting a global workforce 403-10 Work-related ill health Supporting a global workforce 404-1 Average hours of training per year per employee Supporting a global workforce 404-2 Programs for upgrading employee skills and transition assistance  programSupporting a global workforce 404-3 Percentage of employees receiving regular performance and career development reviews Supporting a global workforce 405-1 Diversity of governance bodies and employees Corporate governance Inclusion, diversity, and equity 405-2 Ratio of basic salary and remuneration of women to men Inclusion, diversity, and equity 406-1 Incidents of discrimination and corrective actions taken Omission Topic omitted: Total number of incidents of discrimination and corrective actions taken.Reason: The information is currently unavailable 407-1 Operations and suppliers in which the right of freedom of  association and collective bargaining may be at risk Global Human Rights and Labor Policy Program Report 408-1 Operations and suppliers at significant risk for incidents  of child labor Global Human Rights and Labor Policy Program Report 409-1 Operations and suppliers at significant risk for incidents of forced or compulsory labor Supply chain responsibility 413-1 Operations with local community engagement, impact assessments, and development programs Global healthcare access PhilanthropyOur economic impact 414-1 New suppliers that were screened using social criteria Supply chain responsibility 414-2 Negative social impacts in the supply chain and actions taken Supply chain responsibilityEvaluation of the management approach 2022 Integrated Performance Report      GRI 123 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 415-1 Political contributions Corporate governance Corporate governance website 416-1 Assessment of the health and safety impacts of product and  service categoriesPatient safety and product quality 416-2 Incidents of noncompliance concerning the health and safety impacts of products and servicesOf inspections that occurred across Medtronic in FY22, 95% resulted in no findings.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9731360673904419)","('Employee_Health_And_Safety', 0.0030627669766545296)","('Labor_Practices', 0.002045560162514448)","(['Human Capital Development'], 0.9731360673904419)","('NON-ESG', 0.0030627669766545296)","('NON-ESG', 0.002045560162514448)"
Line 1924,"303-1 Interactions with water as a shared resource CDP Water Disclosure Reducing our operational footprint 303-5 Water consumption CDP Water DisclosureReducing our operational footprint 305-1 Direct (Scope 1) GHG emissions Reducing our operational footprint 305-2 Energy indirect (Scope 2) GHG emissions Reducing our operational footprint 305-4 GHG emissions intensity Reducing our operational footprint2022 TCFD 305-5 Reduction of GHG emissions Reducing our operational footprint 306-3 Waste generated Reducing our operational footprint 306-4 Waste diverted from disposal Product stewardship 308-1 New suppliers that were screened using environmental criteria Supply chain responsibility 308-2 Negative environmental impacts in the supply chain  and actions takenSupply chain responsibility Evaluation of the management approach 401-1 New employee hires and employee turnover Employee data summary 401-2 Benefits provided to full-time employees that are not provided to  temporary or part-time employeesSupporting a global workforce 401-3 Parental leave Supporting a global workforce 403-1 Occupational health and safety management system Supporting a global workforce 403-2 Hazard identification, risk assessment, and incident investigation Supporting a global workforce 403-3 Occupational health services Supporting a global workforce 403-4 Worker participation, consultation, and communication on occupational health and safety Supporting a global workforce 2022 Integrated Performance Report      GRI 122 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 403-5 Worker training on occupational health and safety Supporting a global workforce 403-9 Work-related injuries Supporting a global workforce 403-10 Work-related ill health Supporting a global workforce 404-1 Average hours of training per year per employee Supporting a global workforce 404-2 Programs for upgrading employee skills and transition assistance  programSupporting a global workforce 404-3 Percentage of employees receiving regular performance and career development reviews Supporting a global workforce 405-1 Diversity of governance bodies and employees Corporate governance Inclusion, diversity, and equity 405-2 Ratio of basic salary and remuneration of women to men Inclusion, diversity, and equity 406-1 Incidents of discrimination and corrective actions taken Omission Topic omitted: Total number of incidents of discrimination and corrective actions taken.Reason: The information is currently unavailable 407-1 Operations and suppliers in which the right of freedom of  association and collective bargaining may be at risk Global Human Rights and Labor Policy Program Report 408-1 Operations and suppliers at significant risk for incidents  of child labor Global Human Rights and Labor Policy Program Report 409-1 Operations and suppliers at significant risk for incidents of forced or compulsory labor Supply chain responsibility 413-1 Operations with local community engagement, impact assessments, and development programs Global healthcare access PhilanthropyOur economic impact 414-1 New suppliers that were screened using social criteria Supply chain responsibility 414-2 Negative social impacts in the supply chain and actions taken Supply chain responsibilityEvaluation of the management approach 2022 Integrated Performance Report      GRI 123 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 415-1 Political contributions Corporate governance Corporate governance website 416-1 Assessment of the health and safety impacts of product and  service categoriesPatient safety and product quality 416-2 Incidents of noncompliance concerning the health and safety impacts of products and servicesOf inspections that occurred across Medtronic in FY22, 95% resulted in no findings.
","('Labor_Practices', 0.9767905473709106)","('Human_Rights_And_Community_Relations', 0.0020850589498877525)","('Director_Removal', 0.0019004133064299822)","(['Labor Practice Indicators'], 0.9767905473709106)","('NON-ESG', 0.0020850589498877525)","('NON-ESG', 0.0019004133064299822)"
Line 1925,"303-1 Interactions with water as a shared resource CDP Water Disclosure Reducing our operational footprint 303-5 Water consumption CDP Water DisclosureReducing our operational footprint 305-1 Direct (Scope 1) GHG emissions Reducing our operational footprint 305-2 Energy indirect (Scope 2) GHG emissions Reducing our operational footprint 305-4 GHG emissions intensity Reducing our operational footprint2022 TCFD 305-5 Reduction of GHG emissions Reducing our operational footprint 306-3 Waste generated Reducing our operational footprint 306-4 Waste diverted from disposal Product stewardship 308-1 New suppliers that were screened using environmental criteria Supply chain responsibility 308-2 Negative environmental impacts in the supply chain  and actions takenSupply chain responsibility Evaluation of the management approach 401-1 New employee hires and employee turnover Employee data summary 401-2 Benefits provided to full-time employees that are not provided to  temporary or part-time employeesSupporting a global workforce 401-3 Parental leave Supporting a global workforce 403-1 Occupational health and safety management system Supporting a global workforce 403-2 Hazard identification, risk assessment, and incident investigation Supporting a global workforce 403-3 Occupational health services Supporting a global workforce 403-4 Worker participation, consultation, and communication on occupational health and safety Supporting a global workforce 2022 Integrated Performance Report      GRI 122 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 403-5 Worker training on occupational health and safety Supporting a global workforce 403-9 Work-related injuries Supporting a global workforce 403-10 Work-related ill health Supporting a global workforce 404-1 Average hours of training per year per employee Supporting a global workforce 404-2 Programs for upgrading employee skills and transition assistance  programSupporting a global workforce 404-3 Percentage of employees receiving regular performance and career development reviews Supporting a global workforce 405-1 Diversity of governance bodies and employees Corporate governance Inclusion, diversity, and equity 405-2 Ratio of basic salary and remuneration of women to men Inclusion, diversity, and equity 406-1 Incidents of discrimination and corrective actions taken Omission Topic omitted: Total number of incidents of discrimination and corrective actions taken.Reason: The information is currently unavailable 407-1 Operations and suppliers in which the right of freedom of  association and collective bargaining may be at risk Global Human Rights and Labor Policy Program Report 408-1 Operations and suppliers at significant risk for incidents  of child labor Global Human Rights and Labor Policy Program Report 409-1 Operations and suppliers at significant risk for incidents of forced or compulsory labor Supply chain responsibility 413-1 Operations with local community engagement, impact assessments, and development programs Global healthcare access PhilanthropyOur economic impact 414-1 New suppliers that were screened using social criteria Supply chain responsibility 414-2 Negative social impacts in the supply chain and actions taken Supply chain responsibilityEvaluation of the management approach 2022 Integrated Performance Report      GRI 123 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 415-1 Political contributions Corporate governance Corporate governance website 416-1 Assessment of the health and safety impacts of product and  service categoriesPatient safety and product quality 416-2 Incidents of noncompliance concerning the health and safety impacts of products and servicesOf inspections that occurred across Medtronic in FY22, 95% resulted in no findings.
","('Product_Design_And_Lifecycle_Management', 0.4553588628768921)","('Product_Quality_And_Safety', 0.1987116038799286)","('Supply_Chain_Management', 0.15366020798683167)","('NON-ESG', 0.4553588628768921)","('NON-ESG', 0.1987116038799286)","('NON-ESG', 0.15366020798683167)"
Line 1926,"303-1 Interactions with water as a shared resource CDP Water Disclosure Reducing our operational footprint 303-5 Water consumption CDP Water DisclosureReducing our operational footprint 305-1 Direct (Scope 1) GHG emissions Reducing our operational footprint 305-2 Energy indirect (Scope 2) GHG emissions Reducing our operational footprint 305-4 GHG emissions intensity Reducing our operational footprint2022 TCFD 305-5 Reduction of GHG emissions Reducing our operational footprint 306-3 Waste generated Reducing our operational footprint 306-4 Waste diverted from disposal Product stewardship 308-1 New suppliers that were screened using environmental criteria Supply chain responsibility 308-2 Negative environmental impacts in the supply chain  and actions takenSupply chain responsibility Evaluation of the management approach 401-1 New employee hires and employee turnover Employee data summary 401-2 Benefits provided to full-time employees that are not provided to  temporary or part-time employeesSupporting a global workforce 401-3 Parental leave Supporting a global workforce 403-1 Occupational health and safety management system Supporting a global workforce 403-2 Hazard identification, risk assessment, and incident investigation Supporting a global workforce 403-3 Occupational health services Supporting a global workforce 403-4 Worker participation, consultation, and communication on occupational health and safety Supporting a global workforce 2022 Integrated Performance Report      GRI 122 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 403-5 Worker training on occupational health and safety Supporting a global workforce 403-9 Work-related injuries Supporting a global workforce 403-10 Work-related ill health Supporting a global workforce 404-1 Average hours of training per year per employee Supporting a global workforce 404-2 Programs for upgrading employee skills and transition assistance  programSupporting a global workforce 404-3 Percentage of employees receiving regular performance and career development reviews Supporting a global workforce 405-1 Diversity of governance bodies and employees Corporate governance Inclusion, diversity, and equity 405-2 Ratio of basic salary and remuneration of women to men Inclusion, diversity, and equity 406-1 Incidents of discrimination and corrective actions taken Omission Topic omitted: Total number of incidents of discrimination and corrective actions taken.Reason: The information is currently unavailable 407-1 Operations and suppliers in which the right of freedom of  association and collective bargaining may be at risk Global Human Rights and Labor Policy Program Report 408-1 Operations and suppliers at significant risk for incidents  of child labor Global Human Rights and Labor Policy Program Report 409-1 Operations and suppliers at significant risk for incidents of forced or compulsory labor Supply chain responsibility 413-1 Operations with local community engagement, impact assessments, and development programs Global healthcare access PhilanthropyOur economic impact 414-1 New suppliers that were screened using social criteria Supply chain responsibility 414-2 Negative social impacts in the supply chain and actions taken Supply chain responsibilityEvaluation of the management approach 2022 Integrated Performance Report      GRI 123 SASB TCFD WEF Employee dataDisclosure number Disclosure Location 415-1 Political contributions Corporate governance Corporate governance website 416-1 Assessment of the health and safety impacts of product and  service categoriesPatient safety and product quality 416-2 Incidents of noncompliance concerning the health and safety impacts of products and servicesOf inspections that occurred across Medtronic in FY22, 95% resulted in no findings.
","('Product_Quality_And_Safety', 0.9111340641975403)","('Product_Design_And_Lifecycle_Management', 0.015791425481438637)","('Employee_Health_And_Safety', 0.01520081702619791)","(['Product Quality & Recall Management'], 0.9111340641975403)","('NON-ESG', 0.015791425481438637)","('NON-ESG', 0.01520081702619791)"
Line 1927,"417-1 Requirements for product and service Ethics in sales and marketing 417-2 Incidents of noncompliance concerning product and service information and labeling Ethics in sales and marketing 417-3 Incidents of noncompliance concerning marketing communications Ethics in sales and marketing 418-1 Substantiated complaints concerning breaches of customer  privacy and losses of customer dataThe company investigates all potential breaches and takes corrective and preventive action in order to ensure customer privacy  and data protection and reduce potential risks.
","('Data_Security', 0.32415419816970825)","('Customer_Privacy', 0.2405707836151123)","('Business_Ethics', 0.18305741250514984)","('NON-ESG', 0.32415419816970825)","('NON-ESG', 0.2405707836151123)","('NON-ESG', 0.18305741250514984)"
Line 1928,"417-1 Requirements for product and service Ethics in sales and marketing 417-2 Incidents of noncompliance concerning product and service information and labeling Ethics in sales and marketing 417-3 Incidents of noncompliance concerning marketing communications Ethics in sales and marketing 418-1 Substantiated complaints concerning breaches of customer  privacy and losses of customer dataThe company investigates all potential breaches and takes corrective and preventive action in order to ensure customer privacy  and data protection and reduce potential risks.
","('Data_Security', 0.7003812789916992)","('Systemic_Risk_Management', 0.1272430121898651)","('Business_Ethics', 0.03334543853998184)","(['Information Security/Cybersecurity & System Availability'], 0.7003812789916992)","('NON-ESG', 0.1272430121898651)","('NON-ESG', 0.03334543853998184)"
Line 1929,"2022 Integrated Performance Report      GRI 124 SASB TCFD WEF Employee dataMEDICAL EQUIPMENT AND SUPPLIES AFFORDABILITY AND PRICING  SASB code Metric Response  HC-MS-240a.1 Ratio of weighted average rate of net price increases (for all  products) to the annual increase in the U.S. Consumer Price IndexThe U.S. Consumer Price Index measures the average change over time in the prices paid by urban consumers for a market basket  of consumer goods and services, such as food, energy, and housing.
","('Product_Design_And_Lifecycle_Management', 0.4939882457256317)","('Selling_Practices_And_Product_Labeling', 0.10532936453819275)","('Customer_Welfare', 0.09580077975988388)","('NON-ESG', 0.4939882457256317)","('NON-ESG', 0.10532936453819275)","('NON-ESG', 0.09580077975988388)"
Line 1930,"In contrast, pricing at global medical technology companies that provide a breadth of therapies to health systems around the world moves on innovation, competition, and value.
","('Competitive_Behavior', 0.9678801894187927)","('Business_Model_Resilience', 0.0027411384508013725)","('Customer_Welfare', 0.0026767246890813112)","(['Business Ethics'], 0.9678801894187927)","('NON-ESG', 0.0027411384508013725)","('NON-ESG', 0.0026767246890813112)"
Line 1931,"Consequently, Medtronic offers a variety of pricing models based on the principles of fairness, sustainability, and value aligned with  the local market environment — these include volume pricing or rebate options for hospitals, adaptive pricing for treating long-term conditions, and programs to assist new and existing patients and customers.
","('Competitive_Behavior', 0.8980093598365784)","('Management_Of_Legal_And_Regulatory_Framework', 0.0302544254809618)","('Customer_Welfare', 0.009798365645110607)","(['Business Ethics'], 0.8980093598365784)","('NON-ESG', 0.0302544254809618)","('NON-ESG', 0.009798365645110607)"
Line 1932,"HC-MS-240a.2 Description of how price information (such as average and  median) for each product is disclosed to customers or their agents (e.g., group purchasing organizations or consultants) Global healthcare access PRODUCT SAFETY SASB code Metric Response  HC-MS-250a.1 Number of recalls issued, total units recalled Patient safety and product quality  In FY22, we had 55 total Class I and II recalls and retrieved approximately 35,506 recalled units.
","('Product_Quality_And_Safety', 0.900439441204071)","('Selling_Practices_And_Product_Labeling', 0.021573849022388458)","('Employee_Health_And_Safety', 0.008559003472328186)","(['Product Quality & Recall Management'], 0.900439441204071)","('NON-ESG', 0.021573849022388458)","('NON-ESG', 0.008559003472328186)"
Line 1933,"Sustainability Accounting Standards  Board (SASB) index  U.S. FDA recalls by fiscal year FY20 FY21 FYFDA Class I recalls 6 10 FDA Class II recalls 25 46††  The data has been recast from our 2021 Integrated Performance Report due to recalls that occurred in a select fiscal year but were not confirmed until after the report was published.
","('Product_Quality_And_Safety', 0.1575997918844223)","('Critical_Incident_Risk_Management', 0.15102918446063995)","('Systemic_Risk_Management', 0.14181050658226013)","('NON-ESG', 0.1575997918844223)","('NON-ESG', 0.15102918446063995)","('NON-ESG', 0.14181050658226013)"
Line 1934,"2022 Integrated Performance Report      GRI 125 SASB TCFD WEF Employee dataSASB code Metric Response  HC-MS-250a.1 Number of recalls issued, total units recalled HC-MS-250a.2 List of products listed in the FDA’s MedWatch Safety Alerts for  Human Medical Products databaseSee the FDA’s MedWatch Safety Alerts for Human Medical Products database.
","('Product_Quality_And_Safety', 0.8563090562820435)","('Selling_Practices_And_Product_Labeling', 0.033928282558918)","('Product_Design_And_Lifecycle_Management', 0.01793459989130497)","(['Product Quality & Recall Management'], 0.8563090562820435)","('NON-ESG', 0.033928282558918)","('NON-ESG', 0.01793459989130497)"
Line 1935,"HC-MS-250a.3 Number of fatalities related to products as reported in the FDA Manufacturer and User Facility Device Experience We report all necessary data as required by the U.S. FDA.
","('Product_Quality_And_Safety', 0.4717704951763153)","('Employee_Health_And_Safety', 0.2528884708881378)","('Product_Design_And_Lifecycle_Management', 0.06511320173740387)","('NON-ESG', 0.4717704951763153)","('NON-ESG', 0.2528884708881378)","('NON-ESG', 0.06511320173740387)"
Line 1936,"This information is available here.
","('Customer_Privacy', 0.26997271180152893)","('Waste_And_Hazardous_Materials_Management', 0.12346313893795013)","('Data_Security', 0.07987993955612183)","('NON-ESG', 0.26997271180152893)","('NON-ESG', 0.12346313893795013)","('NON-ESG', 0.07987993955612183)"
Line 1937,"HC-MS-250a.4 Number of FDA enforcement actions taken in response to violations of current Good Manufacturing Practices (cGMP),  by typeIn FY22, Medtronic received:  •  1  Warning letter •  0 Seizur es •  0 C onsent decrees ETHICAL MARKETING SASB code Metric Response  HC-MS-270a.1 Total amount of monetary losses as a result of legal proceedings  associated with false marketing claimsEthics in sales and marketing HC-MS-270a.2 Description of code of ethics governing promotion of off-label use of products Ethics in sales and marketing PRODUCT DESIGN AND LIFECYCLE MANAGEMENT  SASB code Metric Response  HC-MS-410a.1 Discussion of process to assess and manage environmental and human health considerations associated with chemicals in products and meet demand for sustainable products Product stewardship HC-MS-410a.2 Total amount of products accepted for takeback and reused, recycled, or donated, broken down by: (1) devices and equipment and (2) supplies Product stewardship SUPPLY CHAIN MANAGEMENT SASB code Metric Response  HC-MS-430a.1 Percentage of (1) entity's facilities and (2) Tier I suppliers' facilities participating in third-party audit programs for manufacturing and product qualityAll Medtronic contract manufacturers and original equipment manufacturers are annually audited by regulators.
","('Business_Ethics', 0.46474647521972656)","('Selling_Practices_And_Product_Labeling', 0.14848282933235168)","('Product_Quality_And_Safety', 0.10833848267793655)","('NON-ESG', 0.46474647521972656)","('NON-ESG', 0.14848282933235168)","('NON-ESG', 0.10833848267793655)"
Line 1938,"HC-MS-250a.4 Number of FDA enforcement actions taken in response to violations of current Good Manufacturing Practices (cGMP),  by typeIn FY22, Medtronic received:  •  1  Warning letter •  0 Seizur es •  0 C onsent decrees ETHICAL MARKETING SASB code Metric Response  HC-MS-270a.1 Total amount of monetary losses as a result of legal proceedings  associated with false marketing claimsEthics in sales and marketing HC-MS-270a.2 Description of code of ethics governing promotion of off-label use of products Ethics in sales and marketing PRODUCT DESIGN AND LIFECYCLE MANAGEMENT  SASB code Metric Response  HC-MS-410a.1 Discussion of process to assess and manage environmental and human health considerations associated with chemicals in products and meet demand for sustainable products Product stewardship HC-MS-410a.2 Total amount of products accepted for takeback and reused, recycled, or donated, broken down by: (1) devices and equipment and (2) supplies Product stewardship SUPPLY CHAIN MANAGEMENT SASB code Metric Response  HC-MS-430a.1 Percentage of (1) entity's facilities and (2) Tier I suppliers' facilities participating in third-party audit programs for manufacturing and product qualityAll Medtronic contract manufacturers and original equipment manufacturers are annually audited by regulators.
","('Product_Design_And_Lifecycle_Management', 0.9591106176376343)","('Product_Quality_And_Safety', 0.006652983371168375)","('Selling_Practices_And_Product_Labeling', 0.0046625398099422455)","(['Product Stewardship'], 0.9591106176376343)","('NON-ESG', 0.006652983371168375)","('NON-ESG', 0.0046625398099422455)"
Line 1939,"HC-MS-250a.4 Number of FDA enforcement actions taken in response to violations of current Good Manufacturing Practices (cGMP),  by typeIn FY22, Medtronic received:  •  1  Warning letter •  0 Seizur es •  0 C onsent decrees ETHICAL MARKETING SASB code Metric Response  HC-MS-270a.1 Total amount of monetary losses as a result of legal proceedings  associated with false marketing claimsEthics in sales and marketing HC-MS-270a.2 Description of code of ethics governing promotion of off-label use of products Ethics in sales and marketing PRODUCT DESIGN AND LIFECYCLE MANAGEMENT  SASB code Metric Response  HC-MS-410a.1 Discussion of process to assess and manage environmental and human health considerations associated with chemicals in products and meet demand for sustainable products Product stewardship HC-MS-410a.2 Total amount of products accepted for takeback and reused, recycled, or donated, broken down by: (1) devices and equipment and (2) supplies Product stewardship SUPPLY CHAIN MANAGEMENT SASB code Metric Response  HC-MS-430a.1 Percentage of (1) entity's facilities and (2) Tier I suppliers' facilities participating in third-party audit programs for manufacturing and product qualityAll Medtronic contract manufacturers and original equipment manufacturers are annually audited by regulators.
","('Product_Design_And_Lifecycle_Management', 0.8381336331367493)","('Product_Quality_And_Safety', 0.041458453983068466)","('Supply_Chain_Management', 0.035522982478141785)","(['Product Stewardship'], 0.8381336331367493)","('NON-ESG', 0.041458453983068466)","('NON-ESG', 0.035522982478141785)"
Line 1940,"Additionally, many  of our direct material suppliers are ISO certified (ISO9001 or ISO13485) and go through certification audits.
","('Supply_Chain_Management', 0.8202521204948425)","('Product_Design_And_Lifecycle_Management', 0.05931517109274864)","('Waste_And_Hazardous_Materials_Management', 0.016075527295470238)","(['Supply Chain Management'], 0.8202521204948425)","('NON-ESG', 0.05931517109274864)","('NON-ESG', 0.016075527295470238)"
Line 1941,"Medtronic is also a member of MedAccred — an industry managed, consensus-driven approach to ensuring critical manufacturing process quality throughout the medical device supply chain.U.S. FDA recalls by calendar year CY20 CY21 CY22† FDA Class I recalls 6 12‡FDA Class II recalls 34‡52‡†  Data as of September 12, 2022.
","('Supply_Chain_Management', 0.7938010692596436)","('Product_Quality_And_Safety', 0.0328931100666523)","('Product_Design_And_Lifecycle_Management', 0.022708289325237274)","(['Supply Chain Management'], 0.7938010692596436)","('NON-ESG', 0.0328931100666523)","('NON-ESG', 0.022708289325237274)"
Line 1942,"‡  The data has been recast from our 2021 Integrated Performance Report due to recalls that occurred in a select calendar year but were not confirmed until after the report was published.
","('Management_Of_Legal_And_Regulatory_Framework', 0.28568679094314575)","('Systemic_Risk_Management', 0.2375704050064087)","('Business_Model_Resilience', 0.06519743800163269)","('NON-ESG', 0.28568679094314575)","('NON-ESG', 0.2375704050064087)","('NON-ESG', 0.06519743800163269)"
Line 1943,"2022 Integrated Performance Report      GRI 126 SASB TCFD WEF Employee dataSASB code Metric Response  HC-MS-430a.2 Description of efforts to maintain traceability within the  distribution chain Medtronic maintains traceability within the manufacturing and distribution chain through either serial or batch control of finished  products.
","('Product_Design_And_Lifecycle_Management', 0.8938879370689392)","('Product_Quality_And_Safety', 0.026351820677518845)","('Supply_Chain_Management', 0.011463778093457222)","(['Product Stewardship'], 0.8938879370689392)","('NON-ESG', 0.026351820677518845)","('NON-ESG', 0.011463778093457222)"
Line 1944,"We: •   L everage product identification technologies, such as barcoding and radiofrequency identification, to track identifying  information of products.
","('Product_Design_And_Lifecycle_Management', 0.3573252558708191)","('Selling_Practices_And_Product_Labeling', 0.27411240339279175)","('Product_Quality_And_Safety', 0.11144419759511948)","('NON-ESG', 0.3573252558708191)","('NON-ESG', 0.27411240339279175)","('NON-ESG', 0.11144419759511948)"
Line 1945,"•   Utilize enterprise r esource planning (ERP) solutions to support identification and control of products once they leave  manufacturing sites — including supporting specific patient tracking if required.
","('Product_Design_And_Lifecycle_Management', 0.9007361531257629)","('Product_Quality_And_Safety', 0.020533349364995956)","('Customer_Welfare', 0.01695767603814602)","(['Product Stewardship'], 0.9007361531257629)","('NON-ESG', 0.020533349364995956)","('NON-ESG', 0.01695767603814602)"
Line 1946,"Our ERP solutions ensure compliance with  regulatory, quality, and customs control requirements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9511523246765137)","('Business_Ethics', 0.011737543158233166)","('Competitive_Behavior', 0.0033303373493254185)","(['Corporate Governance'], 0.9511523246765137)","('NON-ESG', 0.011737543158233166)","('NON-ESG', 0.0033303373493254185)"
Line 1947,"HC-MS-430a.3 Description of the management of risks associated with the use  of critical materialsUnexpected events can cause both everyday and exceptional supply disruptions to materials critical to Medtronic.
","('Supply_Chain_Management', 0.9013293385505676)","('Waste_And_Hazardous_Materials_Management', 0.013943502679467201)","('Physical_Impacts_Of_Climate_Change', 0.007629937957972288)","(['Supply Chain Management'], 0.9013293385505676)","('NON-ESG', 0.013943502679467201)","('NON-ESG', 0.007629937957972288)"
Line 1948,"To protect and  enable the Medtronic Mission, the company has developed and deployed a comprehensive supply risk management approach —including methodology, tools, and governance — to proactively identify, assess, prioritize, and mitigate supply risk.
","('Supply_Chain_Management', 0.9460363984107971)","('Systemic_Risk_Management', 0.005461233668029308)","('Labor_Practices', 0.004456706345081329)","(['Supply Chain Management'], 0.9460363984107971)","('NON-ESG', 0.005461233668029308)","('NON-ESG', 0.004456706345081329)"
Line 1949,"•   Supply risk management is a critical par t of overall Medtronic business continuity, crisis management, and supply management  strategies.
","('Supply_Chain_Management', 0.9433565735816956)","('Waste_And_Hazardous_Materials_Management', 0.004874900449067354)","('Water_And_Wastewater_Management', 0.00445517199113965)","(['Supply Chain Management'], 0.9433565735816956)","('NON-ESG', 0.004874900449067354)","('NON-ESG', 0.00445517199113965)"
Line 1950,"•   Supply critical to Medtr onic is routinely identified via risk assessment of suppliers and components required to make the  finished product.
","('Supply_Chain_Management', 0.7641945481300354)","('Product_Design_And_Lifecycle_Management', 0.1060425192117691)","('Waste_And_Hazardous_Materials_Management', 0.01667206548154354)","(['Supply Chain Management'], 0.7641945481300354)","('NON-ESG', 0.1060425192117691)","('NON-ESG', 0.01667206548154354)"
Line 1951,"•   Medtr onic continually monitors external risks, such as natural disasters, operational risk, political risk, and environmental and  social risks, and internal risks, such as single/sole-sourced suppliers, single manufacturing location, investigation of sub-tier  suppliers, quality and delivery data, and capacity assessments.
","('Supply_Chain_Management', 0.9477508068084717)","('Product_Design_And_Lifecycle_Management', 0.00544707290828228)","('Physical_Impacts_Of_Climate_Change', 0.00408174516633153)","(['Supply Chain Management'], 0.9477508068084717)","('NON-ESG', 0.00544707290828228)","('NON-ESG', 0.00408174516633153)"
Line 1952,"–   Once risk mitiga tions are approved, Medtronic proactively implements mitigation strategies, including identification of  alternate suppliers, adding additional supplier manufacturing locations, increasing inventory levels, and partnering with suppliers to improve quality and delivery.
","('Supply_Chain_Management', 0.953003466129303)","('Water_And_Wastewater_Management', 0.0036721392534673214)","('Systemic_Risk_Management', 0.003588954685255885)","(['Supply Chain Management'], 0.953003466129303)","('NON-ESG', 0.0036721392534673214)","('NON-ESG', 0.003588954685255885)"
Line 1953,"BUSINESS ETHICS  SASB code Metric Response  HC-MS-510a.1 Total amount of monetary losses as a result of legal proceedings  associated with bribery or corruptionEthics in sales and marketing HC-MS-510a.2 Description of code of ethics governing interactions with healthcare professionals Ethics in sales and marketing Ethical business conduct ACTIVITY METRIC SASB code Metric Response  HC-MS-000.A Number of units sold by product category Not reported 2022 Integrated Performance Report      GRI 127 SASB TCFD WEF Employee dataTask Force on Climate-Related   Financial Disclosures (TCFD) Category and recommended disclosure Medtronic disclosure Governance Disclose the Organization’s  governance around climate-related risks and opportunities a)   Describe the boar d’s oversight   of climate-related risks and  opportunities b)   Describe management ’s role in  assessing and managing climate-related risks and opportunitiesMedtronic operates in a complex, dynamic, highly competitive, and regulated environment.
","('Business_Ethics', 0.9741199016571045)","('Product_Quality_And_Safety', 0.0022530551068484783)","('Management_Of_Legal_And_Regulatory_Framework', 0.0017616032855585217)","(['Business Ethics'], 0.9741199016571045)","('NON-ESG', 0.0022530551068484783)","('NON-ESG', 0.0017616032855585217)"
Line 1954,"BUSINESS ETHICS  SASB code Metric Response  HC-MS-510a.1 Total amount of monetary losses as a result of legal proceedings  associated with bribery or corruptionEthics in sales and marketing HC-MS-510a.2 Description of code of ethics governing interactions with healthcare professionals Ethics in sales and marketing Ethical business conduct ACTIVITY METRIC SASB code Metric Response  HC-MS-000.A Number of units sold by product category Not reported 2022 Integrated Performance Report      GRI 127 SASB TCFD WEF Employee dataTask Force on Climate-Related   Financial Disclosures (TCFD) Category and recommended disclosure Medtronic disclosure Governance Disclose the Organization’s  governance around climate-related risks and opportunities a)   Describe the boar d’s oversight   of climate-related risks and  opportunities b)   Describe management ’s role in  assessing and managing climate-related risks and opportunitiesMedtronic operates in a complex, dynamic, highly competitive, and regulated environment.
","('Physical_Impacts_Of_Climate_Change', 0.9373118281364441)","('Business_Model_Resilience', 0.01603788509964943)","('Systemic_Risk_Management', 0.008474207483232021)","(['Climate Change'], 0.9373118281364441)","('NON-ESG', 0.01603788509964943)","('NON-ESG', 0.008474207483232021)"
Line 1955,"The business and affairs of the Company are governed by a board of directors.
","('Director_Removal', 0.6602075695991516)","('Management_Of_Legal_And_Regulatory_Framework', 0.09422004222869873)","('Business_Ethics', 0.02387392893433571)","(['Anti-Crime Policy & Measures'], 0.6602075695991516)","('NON-ESG', 0.09422004222869873)","('NON-ESG', 0.02387392893433571)"
Line 1956,"Our approach to governance is detailed at https://www.medtronic.com/us-en/about/corporategovernance/overview.html.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8797221183776855)","('Business_Ethics', 0.021170178428292274)","('Competitive_Behavior', 0.018521292135119438)","(['Corporate Governance'], 0.8797221183776855)","('NON-ESG', 0.021170178428292274)","('NON-ESG', 0.018521292135119438)"
Line 1957,"Although the full board of directors maintains ultimate risk oversight responsibilities, the Nominating and Corporate Governance Committee of the Medtronic board of directors is the lead  committee responsible for environmental, social, and governance (ESG) oversight and regularly reviews ESG topics that are a priority for the company.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2644098401069641)","('Director_Removal', 0.24760013818740845)","('Human_Rights_And_Community_Relations', 0.09478267282247543)","('NON-ESG', 0.2644098401069641)","('NON-ESG', 0.24760013818740845)","('NON-ESG', 0.09478267282247543)"
Line 1958,"In addition, other committees (such as the Audit Committee) engage in climate-related discussions as appropriate.
","('Physical_Impacts_Of_Climate_Change', 0.9337155818939209)","('Business_Model_Resilience', 0.013024820946156979)","('GHG_Emissions', 0.009078290313482285)","(['Climate Change'], 0.9337155818939209)","('NON-ESG', 0.013024820946156979)","('NON-ESG', 0.009078290313482285)"
Line 1959,"Medtronic includes the assessment and ranking of potential impacts associated with transitional and physical climate risks on Medtronic as part of our Enterprise Risk Management (ERM)  program.
","('Physical_Impacts_Of_Climate_Change', 0.920896053314209)","('Business_Model_Resilience', 0.022864222526550293)","('Systemic_Risk_Management', 0.010120620019733906)","(['Climate Change'], 0.920896053314209)","('NON-ESG', 0.022864222526550293)","('NON-ESG', 0.010120620019733906)"
Line 1960,"This allows us a standard mechanism to elevate the most significant risks identified to Executive Management and the Medtronic Board of Directors, which recently completed a risk prioritization survey that included a number of climate-related risks identified through this process.
","('Physical_Impacts_Of_Climate_Change', 0.9342186450958252)","('Business_Model_Resilience', 0.012853410094976425)","('Systemic_Risk_Management', 0.009924240410327911)","(['Climate Change'], 0.9342186450958252)","('NON-ESG', 0.012853410094976425)","('NON-ESG', 0.009924240410327911)"
Line 1961,"Climate-related issues that pose a significant risk to the company’s ability to meet our strategic goals and financial targets are escalated to the Medtronic board through our ERM  framework as well as through the Nominating and Corporate Governance Committee’s oversight of ESG topics.
","('Physical_Impacts_Of_Climate_Change', 0.9313035011291504)","('Business_Model_Resilience', 0.021750811487436295)","('Supply_Chain_Management', 0.005578433163464069)","(['Climate Change'], 0.9313035011291504)","('NON-ESG', 0.021750811487436295)","('NON-ESG', 0.005578433163464069)"
Line 1962,"At the management level, embedding and evolving a strong sustainability strategy requires clear leadership and broad organizational participation.
","('Business_Model_Resilience', 0.3371694087982178)","('Director_Removal', 0.13831286132335663)","('Employee_Engagement_Inclusion_And_Diversity', 0.1172809973359108)","('NON-ESG', 0.3371694087982178)","('NON-ESG', 0.13831286132335663)","('NON-ESG', 0.1172809973359108)"
Line 1963,"Coordinated leadership oversight and  support for identifying and addressing sustainability priority issues, including climate-related risks and opportunities, are embedded into our organization.
","('Physical_Impacts_Of_Climate_Change', 0.9448344707489014)","('Business_Model_Resilience', 0.012050298042595387)","('Supply_Chain_Management', 0.004991126712411642)","(['Climate Change'], 0.9448344707489014)","('NON-ESG', 0.012050298042595387)","('NON-ESG', 0.004991126712411642)"
Line 1964,"Our Sustainability Steering Committee (SSC), which meets quarterly, oversees our sustainability program, including strategic plans related to ESG performance, risk, engagement and  disclosure, and recognition.
","('Business_Model_Resilience', 0.7447145581245422)","('Systemic_Risk_Management', 0.05231113359332085)","('Physical_Impacts_Of_Climate_Change', 0.03431601822376251)","(['Codes of Business Conduct'], 0.7447145581245422)","('NON-ESG', 0.05231113359332085)","('NON-ESG', 0.03431601822376251)"
Line 1965,"Among other responsibilities, the SSC participates in the identification of material ESG issues and oversees the company’s performance related to those issues, including establishing or monitoring metrics, commitments, and performance aspirations/targets.
","('Business_Model_Resilience', 0.5189918279647827)","('Systemic_Risk_Management', 0.10591595619916916)","('Human_Rights_And_Community_Relations', 0.08285731077194214)","(['Codes of Business Conduct'], 0.5189918279647827)","('NON-ESG', 0.10591595619916916)","('NON-ESG', 0.08285731077194214)"
Line 1966,"For example, the SSC contributes to our corporate environmental strategy, including our long-term targets for energy use/greenhouse gas emissions reduction, renewable energy, and water conservation.
","('GHG_Emissions', 0.9632453322410583)","('Management_Of_Legal_And_Regulatory_Framework', 0.0038862586952745914)","('Ecological_Impacts', 0.003640611656010151)","(['Climate Change'], 0.9632453322410583)","('NON-ESG', 0.0038862586952745914)","('NON-ESG', 0.003640611656010151)"
Line 1967,"The executive sponsor of the SSC is our Chief Financial Officer, who serves on the company's Executive Committee and ERM Steering Committee, and is responsible for leading the  Medtronic global finance organization and key supporting functions, including Treasury, Controllership, Tax, Internal Audit, Investor Relations, Corporate Strategy, Business Development, Portfolio Management, and IT.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3940131962299347)","('Director_Removal', 0.1844271719455719)","('Business_Model_Resilience', 0.0843779444694519)","('NON-ESG', 0.3940131962299347)","('NON-ESG', 0.1844271719455719)","('NON-ESG', 0.0843779444694519)"
Line 1968,"The SSC membership also includes other executive committee members and senior leaders of key operations and business functions who provide a broad range of perspectives and expertise in risk management; finance; legal; government affairs; investor relations; compliance; corporate governance; human resources; communications; philanthropy; quality; procurement; operations and supply chain; and environmental, health, and safety.
","('Supply_Chain_Management', 0.8305850028991699)","('Business_Model_Resilience', 0.028501154854893684)","('Product_Design_And_Lifecycle_Management', 0.014679632149636745)","(['Supply Chain Management'], 0.8305850028991699)","('NON-ESG', 0.028501154854893684)","('NON-ESG', 0.014679632149636745)"
Line 1969,"Our Enterprise Sustainability Program, led by our Director of Enterprise Sustainability, who reports to our Vice President, Chief Counsel Corporate Governance, collaborates with the SSC and leaders from  across the organization to conduct regular reviews of our ESG strategies, identify emerging trends, and monitor performance related to the company’s material ESG issues.
","('Business_Model_Resilience', 0.655849039554596)","('Systemic_Risk_Management', 0.16556257009506226)","('Physical_Impacts_Of_Climate_Change', 0.028688758611679077)","(['Codes of Business Conduct'], 0.655849039554596)","('NON-ESG', 0.16556257009506226)","('NON-ESG', 0.028688758611679077)"
Line 1970,"Routine quarterly reporting to the SSC includes progress on goals and targets, changes in the regulatory landscape, and updates on programs and operations designed to address key ESG issues, including those that are climate related.
","('Physical_Impacts_Of_Climate_Change', 0.6194751858711243)","('Business_Model_Resilience', 0.11693427711725235)","('Management_Of_Legal_And_Regulatory_Framework', 0.06707669049501419)","(['Climate Change'], 0.6194751858711243)","('NON-ESG', 0.11693427711725235)","('NON-ESG', 0.06707669049501419)"
Line 1971,"2022 Integrated Performance Report      GRI 128 SASB TCFD WEF Employee dataCategory and recommended disclosure Medtronic disclosure Governance (continued) Risk Management Disclose how the organization  identifies, assesses and manages  climate-related risks.
","('Physical_Impacts_Of_Climate_Change', 0.9160864353179932)","('Systemic_Risk_Management', 0.020649336278438568)","('Business_Model_Resilience', 0.018165165558457375)","(['Climate Change'], 0.9160864353179932)","('NON-ESG', 0.020649336278438568)","('NON-ESG', 0.018165165558457375)"
Line 1972,"a)   Describe the or ganization’s  processes for identifying and  assessing climate-related risks.
","('Physical_Impacts_Of_Climate_Change', 0.9491514563560486)","('Business_Model_Resilience', 0.010742773301899433)","('GHG_Emissions', 0.004634305369108915)","(['Climate Change'], 0.9491514563560486)","('NON-ESG', 0.010742773301899433)","('NON-ESG', 0.004634305369108915)"
Line 1973,"b)   Describe the or ganization’s  processes for managing  climate-related risks c)   Describe how pr ocesses for  identifying, assessing, and managing climate-related risks are integrated into the organization’s overall risk management.Our ERM function works with senior leaders across the organization to enable risk identification, develop risk tolerances, establish key metrics to evaluate risk, escalate risk topics based on criticality, and drive risk mitigation plans.
","('Physical_Impacts_Of_Climate_Change', 0.9322056174278259)","('Business_Model_Resilience', 0.017902858555316925)","('Systemic_Risk_Management', 0.009422330185770988)","(['Climate Change'], 0.9322056174278259)","('NON-ESG', 0.017902858555316925)","('NON-ESG', 0.009422330185770988)"
Line 1974,"Quarterly, ERM summarizes and creates a report on critical risks to present to the ERM Steering Committee.
","('Systemic_Risk_Management', 0.8129470348358154)","('Physical_Impacts_Of_Climate_Change', 0.04937434569001198)","('Supply_Chain_Management', 0.0411904901266098)","(['Risk & Crisis Management'], 0.8129470348358154)","('NON-ESG', 0.04937434569001198)","('NON-ESG', 0.0411904901266098)"
Line 1975,"This committee has ultimate responsibility for risk monitoring and is made up of seven direct reports to the CEO: EVP and CFO, EVP Global Operation and Supply Chain, Chief Quality Officer, General Counsel, EVP and EMEA and APAC Regional President, Chief Clinical and Regulatory Officer, EVP and President for Medical Surgical Portfolio.
","('Supply_Chain_Management', 0.9395712018013)","('Systemic_Risk_Management', 0.006585337687283754)","('Physical_Impacts_Of_Climate_Change', 0.0060588340274989605)","(['Supply Chain Management'], 0.9395712018013)","('NON-ESG', 0.006585337687283754)","('NON-ESG', 0.0060588340274989605)"
Line 1976,"Additionally, functional leadership within Environmental, Health and Safety, Enterprise Risk and Continuity, Facilities, and Global Energy all report directly to the Vice President of Enterprise Risk and Facilities, who oversees reporting on risk issues, projects, and other risk-related results to the ERM Steering Committee.
","('Systemic_Risk_Management', 0.3321286737918854)","('Employee_Health_And_Safety', 0.20192766189575195)","('Critical_Incident_Risk_Management', 0.14602753520011902)","('NON-ESG', 0.3321286737918854)","('NON-ESG', 0.20192766189575195)","('NON-ESG', 0.14602753520011902)"
Line 1977,"Medtronic Enterprise Risk Management (ERM) uses a structured risk identification and assessment process that incorporates both quantitative and qualitative factors to score and prioritize  identified risks.
","('Systemic_Risk_Management', 0.9445995688438416)","('Business_Model_Resilience', 0.008679050952196121)","('Physical_Impacts_Of_Climate_Change', 0.006941479630768299)","(['Risk & Crisis Management'], 0.9445995688438416)","('NON-ESG', 0.008679050952196121)","('NON-ESG', 0.006941479630768299)"
Line 1978,"Medtronic ERM assesses established and emerging enterprise risks based on scoring criteria that includes the potential for negative impacts to Medtronic, the likelihood of risk  occurrence, the preparedness of the organization to address potential risks, and the velocity or speed of onset for which Medtronic will realize the potential impact(s) of the risk event.
","('Systemic_Risk_Management', 0.7928053140640259)","('Physical_Impacts_Of_Climate_Change', 0.06220076605677605)","('Business_Model_Resilience', 0.04739512503147125)","(['Risk & Crisis Management'], 0.7928053140640259)","('NON-ESG', 0.06220076605677605)","('NON-ESG', 0.04739512503147125)"
Line 1979,"Each of the scoring criteria include supporting evaluation elements that, when considered collectively, produce an overall inherent score as well as a residual risk score after considering the effectiveness of Medtronic’s preparedness and risk mitigation plans.
","('Critical_Incident_Risk_Management', 0.31258705258369446)","('Physical_Impacts_Of_Climate_Change', 0.2163907140493393)","('Systemic_Risk_Management', 0.14001964032649994)","('NON-ESG', 0.31258705258369446)","('NON-ESG', 0.2163907140493393)","('NON-ESG', 0.14001964032649994)"
Line 1980,"For example, although the impact score includes ratings based on financial impact, there are other considerations that drive risk assessments, including organizational impacts relating to  reputational/brand, quality, regulatory/legal/compliance, operations, and the ability to achieve strategic objectives and maximize beneficial outcomes based on managed risks.
","('Systemic_Risk_Management', 0.7659637928009033)","('Business_Model_Resilience', 0.06871241331100464)","('Management_Of_Legal_And_Regulatory_Framework', 0.04747743159532547)","(['Risk & Crisis Management'], 0.7659637928009033)","('NON-ESG', 0.06871241331100464)","('NON-ESG', 0.04747743159532547)"
Line 1981,"Examples of risk themes/areas aligned to ERM processes include: Capacity for Innovation, Product Safety, Market Disruptions, Global Political and Regulatory Shifts, and Operations Interruption.
","('Product_Quality_And_Safety', 0.8137407898902893)","('Product_Design_And_Lifecycle_Management', 0.0558667853474617)","('Selling_Practices_And_Product_Labeling', 0.01870100572705269)","(['Product Quality & Recall Management'], 0.8137407898902893)","('NON-ESG', 0.0558667853474617)","('NON-ESG', 0.01870100572705269)"
Line 1982,"ESG risks — inclusive of climate-related risks — are included in Medtronic’s ERM processes and are assessed consistently with other enterprise and emerging risks.
","('Physical_Impacts_Of_Climate_Change', 0.923428475856781)","('Systemic_Risk_Management', 0.018053051084280014)","('Business_Model_Resilience', 0.012793932110071182)","(['Climate Change'], 0.923428475856781)","('NON-ESG', 0.018053051084280014)","('NON-ESG', 0.012793932110071182)"
Line 1983,"As an example, physical and transitional climate risks were included in a recent ERM risk survey distributed to our ERM Steering Committee and other key Medtronic business and functional leaders.
","('Physical_Impacts_Of_Climate_Change', 0.9420341849327087)","('Business_Model_Resilience', 0.011500713415443897)","('Systemic_Risk_Management', 0.00826365128159523)","(['Climate Change'], 0.9420341849327087)","('NON-ESG', 0.011500713415443897)","('NON-ESG', 0.00826365128159523)"
Line 1984,"Medtronic’s Business Continuity Management (BCM) program focuses on operational risk — the risk of loss resulting from interruptions of critical processes, supply, people, and systems  or from internal or external events — including climate risks associated with natural disasters, such as hurricanes and wildfires.
","('Supply_Chain_Management', 0.5968483686447144)","('Physical_Impacts_Of_Climate_Change', 0.17914648354053497)","('Systemic_Risk_Management', 0.056101180613040924)","(['Supply Chain Management'], 0.5968483686447144)","('NON-ESG', 0.17914648354053497)","('NON-ESG', 0.056101180613040924)"
Line 1985,"The BCM program prioritizes Medtronic's critical products and services end-to-end value streams, focusing on resiliency and the identification and effective management of key operational risks.
","('Business_Model_Resilience', 0.8751130700111389)","('Product_Design_And_Lifecycle_Management', 0.027813460677862167)","('Supply_Chain_Management', 0.020420530810952187)","(['Codes of Business Conduct'], 0.8751130700111389)","('NON-ESG', 0.027813460677862167)","('NON-ESG', 0.020420530810952187)"
Line 1986,"Product and service criticality is evaluated based on patient and commercial market impact.
","('Product_Design_And_Lifecycle_Management', 0.9062556624412537)","('Customer_Welfare', 0.017209768295288086)","('Selling_Practices_And_Product_Labeling', 0.012602576054632664)","(['Product Stewardship'], 0.9062556624412537)","('NON-ESG', 0.017209768295288086)","('NON-ESG', 0.012602576054632664)"
Line 1987,"The program includes an annual risk assessment to determine and prioritize top risks and align on mitigation options and business continuity and resiliency strategies.
","('Business_Model_Resilience', 0.9021949768066406)","('Systemic_Risk_Management', 0.016375994309782982)","('Physical_Impacts_Of_Climate_Change', 0.015867384150624275)","(['Codes of Business Conduct'], 0.9021949768066406)","('NON-ESG', 0.016375994309782982)","('NON-ESG', 0.015867384150624275)"
Line 1988,"During FY22, Medtronic began integrating physical climate risk into its BCM risk assessment platform.
","('Physical_Impacts_Of_Climate_Change', 0.9100333452224731)","('Business_Model_Resilience', 0.0220833420753479)","('Systemic_Risk_Management', 0.011628751643002033)","(['Climate Change'], 0.9100333452224731)","('NON-ESG', 0.0220833420753479)","('NON-ESG', 0.011628751643002033)"
Line 1989,"The BCM Program is governed by the ERM Steering Committee (comprising Executive Committee leaders) and the Audit Committee of the board of directors.
","('Director_Removal', 0.7023240923881531)","('Management_Of_Legal_And_Regulatory_Framework', 0.076941579580307)","('Employee_Engagement_Inclusion_And_Diversity', 0.02058911696076393)","(['Anti-Crime Policy & Measures'], 0.7023240923881531)","('NON-ESG', 0.076941579580307)","('NON-ESG', 0.02058911696076393)"
Line 1990,"It is the collective  responsibility of these groups to ensure that Medtronic's critical operations are resilient and that key operational risks are being effectively assessed and managed.
","('Business_Model_Resilience', 0.9095413684844971)","('Physical_Impacts_Of_Climate_Change', 0.013625072315335274)","('Systemic_Risk_Management', 0.010841100476682186)","(['Codes of Business Conduct'], 0.9095413684844971)","('NON-ESG', 0.013625072315335274)","('NON-ESG', 0.010841100476682186)"
Line 1991,"The Enterprise Sustainability Program leads periodic risk assessments conducted by external experts to identify priority sustainability/ESG issues based on input from internal leadership,  external customers, investors, NGOs, and industry associations.
","('Business_Model_Resilience', 0.5363000631332397)","('Systemic_Risk_Management', 0.17787417769432068)","('Supply_Chain_Management', 0.04143814370036125)","(['Codes of Business Conduct'], 0.5363000631332397)","('NON-ESG', 0.17787417769432068)","('NON-ESG', 0.04143814370036125)"
Line 1992,"The most recent risk assessment was completed in FY19 and included identification of a broad range of potential risk issues that could impact Medtronic’s long-term business success — including climate risk and resilience.
","('Business_Model_Resilience', 0.8465486764907837)","('Physical_Impacts_Of_Climate_Change', 0.05731968954205513)","('Systemic_Risk_Management', 0.018917491659522057)","(['Codes of Business Conduct'], 0.8465486764907837)","('NON-ESG', 0.05731968954205513)","('NON-ESG', 0.018917491659522057)"
Line 1993,"Each identified issue was individually scored based on input from interviews, surveys, and the external expert’s analysis and insights.
","('Management_Of_Legal_And_Regulatory_Framework', 0.601123034954071)","('Competitive_Behavior', 0.05603598430752754)","('Business_Ethics', 0.030373603105545044)","(['Corporate Governance'], 0.601123034954071)","('NON-ESG', 0.05603598430752754)","('NON-ESG', 0.030373603105545044)"
Line 1994,"Factors assessed included importance to business based on revenue generation, operational efficiency/cost savings, regulatory risk, credibility, trust or reputation, innovation and growth, and employee productivity, hiring, or retention and impact on stakeholders.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5272183418273926)","('Business_Model_Resilience', 0.049191854894161224)","('Systemic_Risk_Management', 0.043788842856884)","(['Human Capital Development'], 0.5272183418273926)","('NON-ESG', 0.049191854894161224)","('NON-ESG', 0.043788842856884)"
Line 1995,"This assessment focused on both risks and opportunities.
","('Systemic_Risk_Management', 0.8768867254257202)","('Physical_Impacts_Of_Climate_Change', 0.017080027610063553)","('Business_Model_Resilience', 0.016361026093363762)","(['Risk & Crisis Management'], 0.8768867254257202)","('NON-ESG', 0.017080027610063553)","('NON-ESG', 0.016361026093363762)"
Line 1996,"We plan on conducting our next sustainability/ESG risk assessment during FY24.
","('Business_Model_Resilience', 0.45139679312705994)","('Systemic_Risk_Management', 0.30981722474098206)","('Physical_Impacts_Of_Climate_Change', 0.06332174688577652)","('NON-ESG', 0.45139679312705994)","('NON-ESG', 0.30981722474098206)","('NON-ESG', 0.06332174688577652)"
Line 1997,"We identify and address transitional climate risks through routine monitoring of carbon regulations, including carbon taxes and greenhouse gas emissions data.
","('GHG_Emissions', 0.9200511574745178)","('Physical_Impacts_Of_Climate_Change', 0.023604068905115128)","('Management_Of_Legal_And_Regulatory_Framework', 0.008595823310315609)","(['Climate Change'], 0.9200511574745178)","('NON-ESG', 0.023604068905115128)","('NON-ESG', 0.008595823310315609)"
Line 1998,"Our Government Affairs; Human Resources; Environmental, Health, and Safety; and Procurement groups monitor relevant regulations in global markets — including regulations relating  to climate change, such as emissions limits.
","('Physical_Impacts_Of_Climate_Change', 0.922961413860321)","('GHG_Emissions', 0.015597916208207607)","('Business_Model_Resilience', 0.011388908140361309)","(['Climate Change'], 0.922961413860321)","('NON-ESG', 0.015597916208207607)","('NON-ESG', 0.011388908140361309)"
Line 1999,"2022 Integrated Performance Report      GRI 129 SASB TCFD WEF Employee dataCategory and recommended disclosure Medtronic disclosure Strategy Disclose the actual and potential  impacts of climate-related risks and opportunities on the organization’s businesses, strategy, and financial planning where such information is material.
","('Physical_Impacts_Of_Climate_Change', 0.934341549873352)","('Business_Model_Resilience', 0.017821019515395164)","('Systemic_Risk_Management', 0.0089747728779912)","(['Climate Change'], 0.934341549873352)","('NON-ESG', 0.017821019515395164)","('NON-ESG', 0.0089747728779912)"
Line 2000,"a)   Describe the impact of  climate- related risks and opportunities  on the organization’s businesses, strategy, and financial planning.
","('Physical_Impacts_Of_Climate_Change', 0.9509366750717163)","('Business_Model_Resilience', 0.010302256792783737)","('GHG_Emissions', 0.00427971500903368)","(['Climate Change'], 0.9509366750717163)","('NON-ESG', 0.010302256792783737)","('NON-ESG', 0.00427971500903368)"
Line 2001,"Describe the climate-related risks and opportunities the organization has identified over the short, medium, and long term.
","('Physical_Impacts_Of_Climate_Change', 0.9377194046974182)","('Business_Model_Resilience', 0.013083928264677525)","('GHG_Emissions', 0.008005356416106224)","(['Climate Change'], 0.9377194046974182)","('NON-ESG', 0.013083928264677525)","('NON-ESG', 0.008005356416106224)"
Line 2002,"b)   Describe the impact of  climate- related risks and opportunities on the organization's businesses, strategy and financial planning.
","('Physical_Impacts_Of_Climate_Change', 0.9520400762557983)","('Business_Model_Resilience', 0.009706835262477398)","('GHG_Emissions', 0.004162841010838747)","(['Climate Change'], 0.9520400762557983)","('NON-ESG', 0.009706835262477398)","('NON-ESG', 0.004162841010838747)"
Line 2003,"c)   Describe the r esilience of the  organization’s strategy, taking into consideration different climate-related scenarios, including a 2°C or lower scenario.In the World Economic Forum’s 2022 Global Risks Report, climate action failure was identified as the most severe global risk over the next 10 years, followed by extreme weather and biodiversity loss.
","('Physical_Impacts_Of_Climate_Change', 0.9107053279876709)","('Business_Model_Resilience', 0.03163255378603935)","('GHG_Emissions', 0.008474535308778286)","(['Climate Change'], 0.9107053279876709)","('NON-ESG', 0.03163255378603935)","('NON-ESG', 0.008474535308778286)"
Line 2004,"Human environmental damage and natural resource crises were ranked seventh and eighth.
","('Supply_Chain_Management', 0.44755637645721436)","('Ecological_Impacts', 0.2133799046278)","('Physical_Impacts_Of_Climate_Change', 0.07270925492048264)","('NON-ESG', 0.44755637645721436)","('NON-ESG', 0.2133799046278)","('NON-ESG', 0.07270925492048264)"
Line 2005,"Climate-Related Risks Significant climate-related risks to Medtronic are consistent with these findings and center on transition risks, including rapid changes in customer and investor preferences, policy and  regulations, such as those around carbon emissions and climate disclosure, and physical risks associated with natural disasters, such as hurricanes and wildfires, which can cause significant business disruption.
","('Physical_Impacts_Of_Climate_Change', 0.9491252303123474)","('Business_Model_Resilience', 0.010764098726212978)","('GHG_Emissions', 0.0059757474809885025)","(['Climate Change'], 0.9491252303123474)","('NON-ESG', 0.010764098726212978)","('NON-ESG', 0.0059757474809885025)"
Line 2006,"For example, in 2017, Hurricane Maria shut down four Medtronic facilities and negatively impacted sales as production across all business lines was interrupted.
","('Physical_Impacts_Of_Climate_Change', 0.736230194568634)","('Supply_Chain_Management', 0.038253314793109894)","('Systemic_Risk_Management', 0.0379929393529892)","(['Climate Change'], 0.736230194568634)","('NON-ESG', 0.038253314793109894)","('NON-ESG', 0.0379929393529892)"
Line 2007,"Additional costs were incurred to restore operations in Puerto Rico and provide humanitarian aid to Medtronic employees.
","('Critical_Incident_Risk_Management', 0.9059892296791077)","('Human_Rights_And_Community_Relations', 0.013228307478129864)","('Physical_Impacts_Of_Climate_Change', 0.01136178057640791)","(['Risk & Crisis Management'], 0.9059892296791077)","('NON-ESG', 0.013228307478129864)","('NON-ESG', 0.01136178057640791)"
Line 2008,"An analysis of potential physical climate risks at the company’s highest impact sites also identified potential risks related to increased temperatures/heat stress, drought, and water stress.
","('Physical_Impacts_Of_Climate_Change', 0.8623563051223755)","('Business_Model_Resilience', 0.028030257672071457)","('GHG_Emissions', 0.016282062977552414)","(['Climate Change'], 0.8623563051223755)","('NON-ESG', 0.028030257672071457)","('NON-ESG', 0.016282062977552414)"
Line 2009,"Medtronic global operations identifies climate-related risks and opportunities based on short-, medium-, and long-term time horizons.
","('Physical_Impacts_Of_Climate_Change', 0.9266456365585327)","('Business_Model_Resilience', 0.01791311241686344)","('Systemic_Risk_Management', 0.010715694166719913)","(['Climate Change'], 0.9266456365585327)","('NON-ESG', 0.01791311241686344)","('NON-ESG', 0.010715694166719913)"
Line 2010,"Short-term horizon is 1-3 years and specifically  centers on annual financial planning within global operations.
","('Business_Model_Resilience', 0.6132476329803467)","('Systemic_Risk_Management', 0.14724548161029816)","('Physical_Impacts_Of_Climate_Change', 0.04710949584841728)","(['Codes of Business Conduct'], 0.6132476329803467)","('NON-ESG', 0.14724548161029816)","('NON-ESG', 0.04710949584841728)"
Line 2011,"Medium-term horizon is 3-10 years and is primarily focused on operational footprint planning within global operations.
","('Business_Model_Resilience', 0.7910001277923584)","('Physical_Impacts_Of_Climate_Change', 0.027242591604590416)","('Supply_Chain_Management', 0.024293091148138046)","(['Codes of Business Conduct'], 0.7910001277923584)","('NON-ESG', 0.027242591604590416)","('NON-ESG', 0.024293091148138046)"
Line 2012,"Our long-term horizon is 10 years and beyond and primarily relates to operational footprint and global market risks and opportunities.
","('Systemic_Risk_Management', 0.8582851886749268)","('Business_Model_Resilience', 0.06585897505283356)","('Supply_Chain_Management', 0.013884966261684895)","(['Risk & Crisis Management'], 0.8582851886749268)","('NON-ESG', 0.06585897505283356)","('NON-ESG', 0.013884966261684895)"
Line 2013,"We address climate-related risk predominantly through business strategies within our enterprise global operations functions, including Facilities; Environmental, Health, and Safety;  Business Continuity Management; and Global Energy.
","('Physical_Impacts_Of_Climate_Change', 0.9374869465827942)","('Business_Model_Resilience', 0.012622244656085968)","('GHG_Emissions', 0.006016222760081291)","(['Climate Change'], 0.9374869465827942)","('NON-ESG', 0.012622244656085968)","('NON-ESG', 0.006016222760081291)"
Line 2014,"For example, recent climate adaptation investments have included simple things, such as landscape design at a Colorado facility, to mitigate wildfire exposure or generator power for  locations in Puerto Rico with hurricane exposure.
","('Physical_Impacts_Of_Climate_Change', 0.9120292663574219)","('Business_Model_Resilience', 0.022882729768753052)","('GHG_Emissions', 0.013415501452982426)","(['Climate Change'], 0.9120292663574219)","('NON-ESG', 0.022882729768753052)","('NON-ESG', 0.013415501452982426)"
Line 2015,"We also invest in energy and water efficiency projects, renewable and clean energy sources, on-site energy installations, and capital investments that improve facility resilience.
","('Energy_Management', 0.9309894442558289)","('Product_Design_And_Lifecycle_Management', 0.008730944246053696)","('Physical_Impacts_Of_Climate_Change', 0.007182785775512457)","(['Operational Eco-Efficiency'], 0.9309894442558289)","('NON-ESG', 0.008730944246053696)","('NON-ESG', 0.007182785775512457)"
Line 2016,"The enterprise annual financial planning process prioritizes enterprise and functional expenditures related to these types of projects.
","('Management_Of_Legal_And_Regulatory_Framework', 0.645926833152771)","('Energy_Management', 0.07627861201763153)","('Business_Model_Resilience', 0.04760247468948364)","(['Corporate Governance'], 0.645926833152771)","('NON-ESG', 0.07627861201763153)","('NON-ESG', 0.04760247468948364)"
Line 2017,"Medtronic has a dedicated budget for energy efficiency projects that can be utilized by all operations for qualified projects.
","('Energy_Management', 0.9809391498565674)","('Management_Of_Legal_And_Regulatory_Framework', 0.0018985403003171086)","('Air_Quality', 0.0016515707829967141)","(['Operational Eco-Efficiency'], 0.9809391498565674)","('NON-ESG', 0.0018985403003171086)","('NON-ESG', 0.0016515707829967141)"
Line 2018,"Applying our ERM framework, we have identified two additional climate risks:•   R eputation: Stakeholder concern or negative feedback regarding our climate impacts and strategy could result in unfavorable perceptions that could reduce shareholder investment  and lead to a reduction in capital availability that allows Medtronic to execute on long-term business strategy.
","('Physical_Impacts_Of_Climate_Change', 0.9376868009567261)","('Business_Model_Resilience', 0.01534940954297781)","('Systemic_Risk_Management', 0.009867267683148384)","(['Climate Change'], 0.9376868009567261)","('NON-ESG', 0.01534940954297781)","('NON-ESG', 0.009867267683148384)"
Line 2019,"It could also affect the company’s position as a preferred supplier with  customers.
","('Supply_Chain_Management', 0.9133698344230652)","('Product_Design_And_Lifecycle_Management', 0.012796078808605671)","('Labor_Practices', 0.008589361794292927)","(['Supply Chain Management'], 0.9133698344230652)","('NON-ESG', 0.012796078808605671)","('NON-ESG', 0.008589361794292927)"
Line 2020,"•   Incr eased pricing of greenhouse gas emissions: Medtronic operates globally, and in many countries where policy changes are under consideration, increased pricing could have an  immediate impact on operating costs.
","('GHG_Emissions', 0.9672147631645203)","('Air_Quality', 0.004448423627763987)","('Management_Of_Legal_And_Regulatory_Framework', 0.0037436075508594513)","(['Climate Change'], 0.9672147631645203)","('NON-ESG', 0.004448423627763987)","('NON-ESG', 0.0037436075508594513)"
Line 2021,"Climate-related opportunities Physical climate opportunities are identified and addressed through structured EHS and Global Energy management processes that include goal setting and strategic objectives.
","('Physical_Impacts_Of_Climate_Change', 0.9400623440742493)","('Business_Model_Resilience', 0.014964486472308636)","('GHG_Emissions', 0.005894316826015711)","(['Climate Change'], 0.9400623440742493)","('NON-ESG', 0.014964486472308636)","('NON-ESG', 0.005894316826015711)"
Line 2022,"Through this process, Medtronic has identified multiple climate-related opportunities relating to energy sources, resilience, and product development, manufacturing, and distribution.
","('Product_Design_And_Lifecycle_Management', 0.7821815609931946)","('Business_Model_Resilience', 0.0851561650633812)","('Supply_Chain_Management', 0.031710732728242874)","(['Product Stewardship'], 0.7821815609931946)","('NON-ESG', 0.0851561650633812)","('NON-ESG', 0.031710732728242874)"
Line 2023,"Medtronic operates numerous renewable and alternative energy installations, including solar, cogeneration, and fuel cell technologies, totaling over 70,000 MWh of electricity.
","('Energy_Management', 0.9779478907585144)","('Management_Of_Legal_And_Regulatory_Framework', 0.0032640721183270216)","('Product_Design_And_Lifecycle_Management', 0.0017938620876520872)","(['Operational Eco-Efficiency'], 0.9779478907585144)","('NON-ESG', 0.0032640721183270216)","('NON-ESG', 0.0017938620876520872)"
Line 2024,"As the  carbon markets mature, the environmental attributes of these installations grow, making the existing installations financially more attractive and future installations more feasible.
","('Management_Of_Legal_And_Regulatory_Framework', 0.39665329456329346)","('Systemic_Risk_Management', 0.13529175519943237)","('Competitive_Behavior', 0.13119502365589142)","('NON-ESG', 0.39665329456329346)","('NON-ESG', 0.13529175519943237)","('NON-ESG', 0.13119502365589142)"
Line 2025,"We view investments in on-site renewable and alternative energy, such as solar, cogeneration plants, and geothermal, as strategic for building business resilience because of their potential  to decrease interruptions to operations and reduce company dependence on utility providers.
","('Business_Model_Resilience', 0.5111963748931885)","('Energy_Management', 0.14546190202236176)","('Supply_Chain_Management', 0.06396923959255219)","(['Codes of Business Conduct'], 0.5111963748931885)","('NON-ESG', 0.14546190202236176)","('NON-ESG', 0.06396923959255219)"
Line 2026,"Medtronic continues to consider these installations as part of its overarching manufacturing footprint strategy and invests in them accordingly.
","('Business_Model_Resilience', 0.48500552773475647)","('Supply_Chain_Management', 0.0992479994893074)","('Product_Design_And_Lifecycle_Management', 0.09653685986995697)","('NON-ESG', 0.48500552773475647)","('NON-ESG', 0.0992479994893074)","('NON-ESG', 0.09653685986995697)"
Line 2027,"We see potential for innovations in sustainable product and packaging design and manufacturing network design to yield additional climate-related opportunities.
","('Product_Design_And_Lifecycle_Management', 0.9637096524238586)","('Product_Quality_And_Safety', 0.0035380208864808083)","('Energy_Management', 0.0029998328536748886)","(['Product Stewardship'], 0.9637096524238586)","('NON-ESG', 0.0035380208864808083)","('NON-ESG', 0.0029998328536748886)"
Line 2028,"During FY22,  we established a Sustainability Development Center to pursue packaging waste reductions aligned with our public targets.
","('Waste_And_Hazardous_Materials_Management', 0.9594405293464661)","('Water_And_Wastewater_Management', 0.004863209556788206)","('Product_Design_And_Lifecycle_Management', 0.004056844860315323)","(['Operational Eco-Efficiency'], 0.9594405293464661)","('NON-ESG', 0.004863209556788206)","('NON-ESG', 0.004056844860315323)"
Line 2029,"2022 Integrated Performance Report      GRI 130 SASB TCFD WEF Employee dataCategory and recommended disclosure Medtronic disclosure Strategy (continued) Disclose the actual and potential  impacts of climate-related risks and opportunities on the organization’s businesses, strategy, and financial planning where such information is material.
","('Physical_Impacts_Of_Climate_Change', 0.9379753470420837)","('Business_Model_Resilience', 0.015902388840913773)","('Systemic_Risk_Management', 0.008505614474415779)","(['Climate Change'], 0.9379753470420837)","('NON-ESG', 0.015902388840913773)","('NON-ESG', 0.008505614474415779)"
Line 2030,"a)   Describe the impact of  climate- related risks and opportunities  on the organization’s businesses, strategy, and financial planning.
","('Physical_Impacts_Of_Climate_Change', 0.9509366750717163)","('Business_Model_Resilience', 0.010302256792783737)","('GHG_Emissions', 0.00427971500903368)","(['Climate Change'], 0.9509366750717163)","('NON-ESG', 0.010302256792783737)","('NON-ESG', 0.00427971500903368)"
Line 2031,"Describe the climate-related risks and opportunities the organization has identified over the short, medium, and long term.
","('Physical_Impacts_Of_Climate_Change', 0.9377194046974182)","('Business_Model_Resilience', 0.013083928264677525)","('GHG_Emissions', 0.008005356416106224)","(['Climate Change'], 0.9377194046974182)","('NON-ESG', 0.013083928264677525)","('NON-ESG', 0.008005356416106224)"
Line 2032,"b)   Describe the impact of  climate- related risks and opportunities on the organization's businesses, strategy and financial planning.
","('Physical_Impacts_Of_Climate_Change', 0.9520400762557983)","('Business_Model_Resilience', 0.009706835262477398)","('GHG_Emissions', 0.004162841010838747)","(['Climate Change'], 0.9520400762557983)","('NON-ESG', 0.009706835262477398)","('NON-ESG', 0.004162841010838747)"
Line 2033,"c)   Describe the r esilience of the  organization’s strategy, taking into consideration different climate-related scenarios, including a 2°C or lower scenario.Scenario analysis Medtronic leverages a third-party system to perform scenario analysis on natural hazards (tropical cyclone, extra-tropical cyclone, tornado, hail, wildfire, and flood).
","('Physical_Impacts_Of_Climate_Change', 0.7276325821876526)","('Business_Model_Resilience', 0.1348259598016739)","('GHG_Emissions', 0.019233770668506622)","(['Climate Change'], 0.7276325821876526)","('NON-ESG', 0.1348259598016739)","('NON-ESG', 0.019233770668506622)"
Line 2034,"As an example, short- term wildfire is assessed with an exposure rating based on climatic condition and vegetation data linked with historical data.
","('Physical_Impacts_Of_Climate_Change', 0.5234423875808716)","('Critical_Incident_Risk_Management', 0.11756309121847153)","('Air_Quality', 0.10081274062395096)","(['Climate Change'], 0.5234423875808716)","('NON-ESG', 0.11756309121847153)","('NON-ESG', 0.10081274062395096)"
Line 2035,"Long-term scenarios add heat stress, which could exacerbate or reduce the overall threat of wildfire.
","('Physical_Impacts_Of_Climate_Change', 0.6822301149368286)","('Critical_Incident_Risk_Management', 0.05744662880897522)","('Business_Model_Resilience', 0.045777760446071625)","(['Climate Change'], 0.6822301149368286)","('NON-ESG', 0.05744662880897522)","('NON-ESG', 0.045777760446071625)"
Line 2036,"This allows us to prepare immediate climate adaptation based on the changing risk associated with the latest weather patterns and to understand where our exposure is changing over time.
","('Physical_Impacts_Of_Climate_Change', 0.8426719307899475)","('Business_Model_Resilience', 0.07866150885820389)","('GHG_Emissions', 0.009964137338101864)","(['Climate Change'], 0.8426719307899475)","('NON-ESG', 0.07866150885820389)","('NON-ESG', 0.009964137338101864)"
Line 2037,"Water stress continues to be among the largest global risks in terms of potential impact over the next decade.
","('Water_And_Wastewater_Management', 0.9720081090927124)","('Waste_And_Hazardous_Materials_Management', 0.0027493489906191826)","('GHG_Emissions', 0.0021980153396725655)","(['Operational Eco-Efficiency'], 0.9720081090927124)","('NON-ESG', 0.0027493489906191826)","('NON-ESG', 0.0021980153396725655)"
Line 2038,"Changes in precipitation patterns and extreme variability in weather patterns  can result in chronic increased temperatures, decreased water availability, and elevated operations costs from increased cooling and restricted water use.
","('Water_And_Wastewater_Management', 0.9753515124320984)","('Energy_Management', 0.002550604986026883)","('GHG_Emissions', 0.00244252011179924)","(['Operational Eco-Efficiency'], 0.9753515124320984)","('NON-ESG', 0.002550604986026883)","('NON-ESG', 0.00244252011179924)"
Line 2039,"We know that water stress and scarcity is a growing global concern, and Medtronic is preparing our business for a time when water resources are critically challenged in some regions.
","('Water_And_Wastewater_Management', 0.9746890664100647)","('GHG_Emissions', 0.002381890546530485)","('Supply_Chain_Management', 0.0019867941737174988)","(['Operational Eco-Efficiency'], 0.9746890664100647)","('NON-ESG', 0.002381890546530485)","('NON-ESG', 0.0019867941737174988)"
Line 2040,"Assessing this risk allows us to identify the significance and potential impact to our business.
","('Systemic_Risk_Management', 0.6280199885368347)","('Business_Model_Resilience', 0.21527953445911407)","('Supply_Chain_Management', 0.0359211303293705)","(['Risk & Crisis Management'], 0.6280199885368347)","('NON-ESG', 0.21527953445911407)","('NON-ESG', 0.0359211303293705)"
Line 2041,"We leverage our biennial operational water stress analysis to integrate scenario analysis into our climate-related strategies.
","('Water_And_Wastewater_Management', 0.9727181196212769)","('GHG_Emissions', 0.0035984341520816088)","('Ecological_Impacts', 0.002521214308217168)","(['Operational Eco-Efficiency'], 0.9727181196212769)","('NON-ESG', 0.0035984341520816088)","('NON-ESG', 0.002521214308217168)"
Line 2042,"Our FY22 analysis, which uses data from the World Resources  Institute Aqueduct Water Risk Atlas, yielded information about current and future water stress (through 2040) at key Medtronic locations around the globe that use three million or more gallons per year.
","('Water_And_Wastewater_Management', 0.9761083722114563)","('Waste_And_Hazardous_Materials_Management', 0.002376813907176256)","('GHG_Emissions', 0.0019471340347081423)","(['Operational Eco-Efficiency'], 0.9761083722114563)","('NON-ESG', 0.002376813907176256)","('NON-ESG', 0.0019471340347081423)"
Line 2043,"Assessment of future stress aligned with three specific temperature pathways: optimistic, business as usual, and pessimistic.
","('Systemic_Risk_Management', 0.9175502061843872)","('Business_Model_Resilience', 0.02255016751587391)","('Physical_Impacts_Of_Climate_Change', 0.014004598371684551)","(['Risk & Crisis Management'], 0.9175502061843872)","('NON-ESG', 0.02255016751587391)","('NON-ESG', 0.014004598371684551)"
Line 2044,"In FY22, we expanded the scope of our assessment from Medtronic facilities that use five million gallons of water or more annually to Medtronic facilities that use three million gallons of water or more annually.
","('Water_And_Wastewater_Management', 0.9703555107116699)","('Energy_Management', 0.003686601296067238)","('Waste_And_Hazardous_Materials_Management', 0.0031971167773008347)","(['Operational Eco-Efficiency'], 0.9703555107116699)","('NON-ESG', 0.003686601296067238)","('NON-ESG', 0.0031971167773008347)"
Line 2045,"We conducted a similar analysis of our top five contract manufacturers, scoping the assessment to locations relevant to Medtronic.
","('Supply_Chain_Management', 0.5548893809318542)","('Product_Design_And_Lifecycle_Management', 0.14234723150730133)","('Competitive_Behavior', 0.056381843984127045)","(['Supply Chain Management'], 0.5548893809318542)","('NON-ESG', 0.14234723150730133)","('NON-ESG', 0.056381843984127045)"
Line 2046,"Each outcome of these scenarios is included in risk assessments that support our Business Continuity Program.
","('Systemic_Risk_Management', 0.88578861951828)","('Business_Model_Resilience', 0.029950084164738655)","('Physical_Impacts_Of_Climate_Change', 0.016084900125861168)","(['Risk & Crisis Management'], 0.88578861951828)","('NON-ESG', 0.029950084164738655)","('NON-ESG', 0.016084900125861168)"
Line 2047,"This program is leveraged to prioritize site investment in climate adaptation  and risk mitigation, which led to the implementation of water conservation objectives at additional Medtronic sites in Mexico.
","('Water_And_Wastewater_Management', 0.5029135942459106)","('Ecological_Impacts', 0.37510553002357483)","('GHG_Emissions', 0.029979949817061424)","(['Operational Eco-Efficiency'], 0.5029135942459106)","('NON-ESG', 0.37510553002357483)","('NON-ESG', 0.029979949817061424)"
Line 2048,"In addition, the longer-term risks are incorporated into our global manufacturing network strategy beginning in FY23.
","('Systemic_Risk_Management', 0.8598269820213318)","('Supply_Chain_Management', 0.03273111954331398)","('Business_Model_Resilience', 0.03165946155786514)","(['Risk & Crisis Management'], 0.8598269820213318)","('NON-ESG', 0.03273111954331398)","('NON-ESG', 0.03165946155786514)"
Line 2049,"This includes key contract manufacturers that have been assessed as high risk based on their location and shared conservation and preparedness strategies.
","('Ecological_Impacts', 0.9562825560569763)","('GHG_Emissions', 0.005679760128259659)","('Water_And_Wastewater_Management', 0.004762609954923391)","(['Natural Capital'], 0.9562825560569763)","('NON-ESG', 0.005679760128259659)","('NON-ESG', 0.004762609954923391)"
Line 2050,"Climate action Our response to identified climate risks and opportunities includes strategic initiatives around achieving carbon neutrality in our operations and net zero across our value chain.
","('Physical_Impacts_Of_Climate_Change', 0.9472030401229858)","('Business_Model_Resilience', 0.011090464890003204)","('GHG_Emissions', 0.005334306042641401)","(['Climate Change'], 0.9472030401229858)","('NON-ESG', 0.011090464890003204)","('NON-ESG', 0.005334306042641401)"
Line 2051,"In FY20,  Medtronic announced an ambition to be carbon neutral in our owned and operated facilities by FY30.
","('Competitive_Behavior', 0.14354708790779114)","('Product_Design_And_Lifecycle_Management', 0.13707882165908813)","('Energy_Management', 0.0967063158750534)","('NON-ESG', 0.14354708790779114)","('NON-ESG', 0.13707882165908813)","('NON-ESG', 0.0967063158750534)"
Line 2052,"Our approach includes a continued focus on energy efficiency, on-site renewable and clean energy installations, and purchases of renewable energy credits (RECs) and carbon offsets, which should transition to virtual power purchase agreements (VPPAs) by FY25.
","('Energy_Management', 0.9815302491188049)","('Management_Of_Legal_And_Regulatory_Framework', 0.002384458901360631)","('Critical_Incident_Risk_Management', 0.0013979002833366394)","(['Operational Eco-Efficiency'], 0.9815302491188049)","('NON-ESG', 0.002384458901360631)","('NON-ESG', 0.0013979002833366394)"
Line 2053,"In 2021, we announced our ambition to be net zero across our value chain by FY45.
","('Business_Model_Resilience', 0.46435436606407166)","('Systemic_Risk_Management', 0.19302360713481903)","('Supply_Chain_Management', 0.08937789499759674)","('NON-ESG', 0.46435436606407166)","('NON-ESG', 0.19302360713481903)","('NON-ESG', 0.08937789499759674)"
Line 2054,"Our Decarbonization Roadmap provides a high-level overview of our strategy, which includes  announcing science-based greenhouse gas (GHG) emissions reduction targets by FY25 in three key areas: operational carbon neutrality, supply chain GHG emissions reduction, and ongoing logistics improvements.
","('GHG_Emissions', 0.9705634713172913)","('Ecological_Impacts', 0.0038234738167375326)","('Air_Quality', 0.0028113028965890408)","(['Climate Change'], 0.9705634713172913)","('NON-ESG', 0.0038234738167375326)","('NON-ESG', 0.0028113028965890408)"
Line 2055,"We plan to work with the Science-based Targets initiative (SBTi) to ensure alignment with the Paris Agreement.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7475007772445679)","('GHG_Emissions', 0.044691022485494614)","('Human_Rights_And_Community_Relations', 0.03974732384085655)","(['Corporate Governance'], 0.7475007772445679)","('NON-ESG', 0.044691022485494614)","('NON-ESG', 0.03974732384085655)"
Line 2056,"2022 Integrated Performance Report      GRI 131 SASB TCFD WEF Employee dataCategory and recommended disclosure Medtronic disclosure Metrics and Targets Disclose the metrics and targets   used to assess and manage relevant climate-related risks and opportunities where such information is material.
","('Physical_Impacts_Of_Climate_Change', 0.830264151096344)","('Systemic_Risk_Management', 0.0591522678732872)","('Business_Model_Resilience', 0.04320216551423073)","(['Climate Change'], 0.830264151096344)","('NON-ESG', 0.0591522678732872)","('NON-ESG', 0.04320216551423073)"
Line 2057,"a)   Disclose the metrics used by  the or ganization to assess climate- related risks and opportunities in line with its strategy and risk management process.
","('Physical_Impacts_Of_Climate_Change', 0.9050729274749756)","('Business_Model_Resilience', 0.02966986410319805)","('Systemic_Risk_Management', 0.01796724647283554)","(['Climate Change'], 0.9050729274749756)","('NON-ESG', 0.02966986410319805)","('NON-ESG', 0.01796724647283554)"
Line 2058,"b)   Disclose Scope 1,  Scope 2, and if  appropriate, Scope 3 greenhouse gas (GHG) emissions and the related risks.
","('GHG_Emissions', 0.9677772521972656)","('Ecological_Impacts', 0.0042565977200865746)","('Water_And_Wastewater_Management', 0.0029803267680108547)","(['Climate Change'], 0.9677772521972656)","('NON-ESG', 0.0042565977200865746)","('NON-ESG', 0.0029803267680108547)"
Line 2059,"c)   Describe the tar gets used by the  organization to manage climate-related risks and opportunities and performance against targets.We have established companywide environmental targets since 2007, with a focus on reductions in energy use and GHG emissions throughout our operations.
","('GHG_Emissions', 0.9387847781181335)","('Physical_Impacts_Of_Climate_Change', 0.017560934647917747)","('Air_Quality', 0.005741476081311703)","(['Climate Change'], 0.9387847781181335)","('NON-ESG', 0.017560934647917747)","('NON-ESG', 0.005741476081311703)"
Line 2060,"In FY20, we reached the end of our second set of long-term targets based on an FY13 baseline and exceeded all of them.
","('Business_Model_Resilience', 0.3266724944114685)","('GHG_Emissions', 0.29943859577178955)","('Physical_Impacts_Of_Climate_Change', 0.04506370425224304)","('NON-ESG', 0.3266724944114685)","('NON-ESG', 0.29943859577178955)","('NON-ESG', 0.04506370425224304)"
Line 2061,"We set new targets through FY25, which include a 50% reduction in GHG intensity, 20% reduction in energy intensity, sourcing 50% of our energy from renewable and alternative sources, and 15% reduction in water and waste intensity from a FY20 baseline.
","('GHG_Emissions', 0.9149538278579712)","('Energy_Management', 0.025185970589518547)","('Water_And_Wastewater_Management', 0.008302608504891396)","(['Climate Change'], 0.9149538278579712)","('NON-ESG', 0.025185970589518547)","('NON-ESG', 0.008302608504891396)"
Line 2062,"We evaluate progress toward our environmental performance goals on an annual basis.
","('Human_Rights_And_Community_Relations', 0.5261445641517639)","('Business_Model_Resilience', 0.13589949905872345)","('Management_Of_Legal_And_Regulatory_Framework', 0.060794584453105927)","(['Community Relations'], 0.5261445641517639)","('NON-ESG', 0.13589949905872345)","('NON-ESG', 0.060794584453105927)"
Line 2063,"Our new emission and energy goals move us toward our ambition of being carbon neutral in our operations by 2030.
","('Energy_Management', 0.6540935635566711)","('Air_Quality', 0.1644064486026764)","('GHG_Emissions', 0.061684105545282364)","(['Operational Eco-Efficiency'], 0.6540935635566711)","('NON-ESG', 0.1644064486026764)","('NON-ESG', 0.061684105545282364)"
Line 2064,"We aim to reduce nearly 250,000 tons of emissions annually.
","('GHG_Emissions', 0.4355534613132477)","('Air_Quality', 0.3692963719367981)","('Energy_Management', 0.08722969144582748)","('NON-ESG', 0.4355534613132477)","('NON-ESG', 0.3692963719367981)","('NON-ESG', 0.08722969144582748)"
Line 2065,"Over the next decade, these reductions will be approximately equal to emissions generated by 80,000 U.S. homes over the same time period.
","('GHG_Emissions', 0.7673016786575317)","('Air_Quality', 0.11262292414903641)","('Energy_Management', 0.03703171759843826)","(['Climate Change'], 0.7673016786575317)","('NON-ESG', 0.11262292414903641)","('NON-ESG', 0.03703171759843826)"
Line 2066,"As part of our aspiration to be net zero across our value chain by FY45, in FY22, we began engaging our top 100 suppliers on GHG emissions measurement, disclosure, and reduction  through CDP Supply Chain, which will help us establish baseline and move toward Scope 3 emissions targets.
","('GHG_Emissions', 0.9631348848342896)","('Air_Quality', 0.005407222546637058)","('Physical_Impacts_Of_Climate_Change', 0.003377928864210844)","(['Climate Change'], 0.9631348848342896)","('NON-ESG', 0.005407222546637058)","('NON-ESG', 0.003377928864210844)"
Line 2067,"Medtronic also engaged our top five logistics partners around emissions reduction and partnered with one on a project to analyze order consolidation.
","('Air_Quality', 0.4514501392841339)","('Energy_Management', 0.2130797952413559)","('GHG_Emissions', 0.19671574234962463)","('NON-ESG', 0.4514501392841339)","('NON-ESG', 0.2130797952413559)","('NON-ESG', 0.19671574234962463)"
Line 2068,"Our annual CDP submission provides additional information about our GHG emissions targets and progress, emission reduction initiatives, and other climate-related activities.
","('GHG_Emissions', 0.9668385982513428)","('Air_Quality', 0.00515905674546957)","('Management_Of_Legal_And_Regulatory_Framework', 0.0030503426678478718)","(['Climate Change'], 0.9668385982513428)","('NON-ESG', 0.00515905674546957)","('NON-ESG', 0.0030503426678478718)"
Line 2069,"Other relevant information about how we collect data and calculate emissions is included in the metrics and targets disclosures in our 2022 CDP submission and on pages 30-34 of this report.
","('Air_Quality', 0.3613109290599823)","('GHG_Emissions', 0.35154974460601807)","('Energy_Management', 0.107447050511837)","('NON-ESG', 0.3613109290599823)","('NON-ESG', 0.35154974460601807)","('NON-ESG', 0.107447050511837)"
Line 2070,"2022 Integrated Performance Report      GRI 132 SASB TCFD WEF Employee dataGOVERNANCE  Theme Disclosure Response  Governing purpose The company’s stated purpose, as the expression of the means by which a business proposes solutions to  economic, environmental, and social issues.
","('Human_Rights_And_Community_Relations', 0.9298868775367737)","('Business_Model_Resilience', 0.006460106931626797)","('Physical_Impacts_Of_Climate_Change', 0.00530649209395051)","(['Community Relations'], 0.9298868775367737)","('NON-ESG', 0.006460106931626797)","('NON-ESG', 0.00530649209395051)"
Line 2071,"Corporate purpose should create value for all stakeholders, including shareholders.Material issues and targets Corporate governance Quality of governing body Composition of the highest governance body and its committees by: competencies relating to economic,  environmental, and social topics; executive or nonexecutive; independence; tenure on the governance body; number of each individual’s other significant positions and commitments, and the nature of the commitments; gender; membership of under-represented social groups; stakeholder representation.Sustainability governance Corporate governance2022 TCFD Stakeholder engagement A list of the topics that are material to key stakeholders and the company, how the topics were identified and how  the stakeholders were engaged.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4158293306827545)","('Business_Ethics', 0.12485415488481522)","('Human_Rights_And_Community_Relations', 0.1208643689751625)","('NON-ESG', 0.4158293306827545)","('NON-ESG', 0.12485415488481522)","('NON-ESG', 0.1208643689751625)"
Line 2072,"Corporate purpose should create value for all stakeholders, including shareholders.Material issues and targets Corporate governance Quality of governing body Composition of the highest governance body and its committees by: competencies relating to economic,  environmental, and social topics; executive or nonexecutive; independence; tenure on the governance body; number of each individual’s other significant positions and commitments, and the nature of the commitments; gender; membership of under-represented social groups; stakeholder representation.Sustainability governance Corporate governance2022 TCFD Stakeholder engagement A list of the topics that are material to key stakeholders and the company, how the topics were identified and how  the stakeholders were engaged.
","('Human_Rights_And_Community_Relations', 0.49782320857048035)","('Management_Of_Legal_And_Regulatory_Framework', 0.11462631821632385)","('Business_Model_Resilience', 0.0706220343708992)","('NON-ESG', 0.49782320857048035)","('NON-ESG', 0.11462631821632385)","('NON-ESG', 0.0706220343708992)"
Line 2073,"Material issues and targets Ethical behavior 1.
","('Business_Ethics', 0.8755555748939514)","('Competitive_Behavior', 0.020379969850182533)","('Human_Rights_And_Community_Relations', 0.01291887927800417)","(['Business Ethics'], 0.8755555748939514)","('NON-ESG', 0.020379969850182533)","('NON-ESG', 0.01291887927800417)"
Line 2074,"T otal percentage of governance body members, employees and business partners who have received training  on the organization’s anti-corruption policies and procedures, broken down by region.
","('Business_Ethics', 0.9688094258308411)","('Management_Of_Legal_And_Regulatory_Framework', 0.0038857231847941875)","('Data_Security', 0.0022501444909721613)","(['Business Ethics'], 0.9688094258308411)","('NON-ESG', 0.0038857231847941875)","('NON-ESG', 0.0022501444909721613)"
Line 2075,"2.
","('Competitive_Behavior', 0.15795664489269257)","('Customer_Welfare', 0.10852150619029999)","('Energy_Management', 0.08616163581609726)","('NON-ESG', 0.15795664489269257)","('NON-ESG', 0.10852150619029999)","('NON-ESG', 0.08616163581609726)"
Line 2076,"a)   T otal number and nature of incidents of corruption confirmed during the current year, but related to  previous years.
","('Business_Ethics', 0.9664646983146667)","('Data_Security', 0.003521759295836091)","('Employee_Health_And_Safety', 0.00275097182020545)","(['Business Ethics'], 0.9664646983146667)","('NON-ESG', 0.003521759295836091)","('NON-ESG', 0.00275097182020545)"
Line 2077,"b)   Total number and nature of incidents of corruption confirmed during the current year, related to this year.
","('Business_Ethics', 0.9675093293190002)","('Data_Security', 0.0034657504875212908)","('Employee_Health_And_Safety', 0.0025577957276254892)","(['Business Ethics'], 0.9675093293190002)","('NON-ESG', 0.0034657504875212908)","('NON-ESG', 0.0025577957276254892)"
Line 2078,"3.
","('Competitive_Behavior', 0.1465800553560257)","('Customer_Welfare', 0.10041514039039612)","('Product_Design_And_Lifecycle_Management', 0.07025990635156631)","('NON-ESG', 0.1465800553560257)","('NON-ESG', 0.10041514039039612)","('NON-ESG', 0.07025990635156631)"
Line 2079,"Discussion of  initiatives and stakeholder engagement to improve the broader operating environment and  culture in order to combat corruption.Nearly 100% of governance body members and employees have received training on our anti-corruption policies across all regions.
","('Business_Ethics', 0.9691557288169861)","('Management_Of_Legal_And_Regulatory_Framework', 0.003593157511204481)","('Data_Security', 0.002570447279140353)","(['Business Ethics'], 0.9691557288169861)","('NON-ESG', 0.003593157511204481)","('NON-ESG', 0.002570447279140353)"
Line 2080,"We had zero incidents of corruption during the current  year related to previous year, and zero incidents of corruption during the current year related to this year.
","('Business_Ethics', 0.9667400121688843)","('Data_Security', 0.0034843103494495153)","('Employee_Health_And_Safety', 0.00252932240255177)","(['Business Ethics'], 0.9667400121688843)","('NON-ESG', 0.0034843103494495153)","('NON-ESG', 0.00252932240255177)"
Line 2081,"Read Ethics in sales and marketing for how we engage  stakeholders to combat corruption.
","('Business_Ethics', 0.9739397168159485)","('Management_Of_Legal_And_Regulatory_Framework', 0.002280061598867178)","('Competitive_Behavior', 0.002255388768389821)","(['Business Ethics'], 0.9739397168159485)","('NON-ESG', 0.002280061598867178)","('NON-ESG', 0.002255388768389821)"
Line 2082,"A description of internal and external mechanisms for: 1.
","('Supply_Chain_Management', 0.1413390338420868)","('Human_Rights_And_Community_Relations', 0.0976111888885498)","('Competitive_Behavior', 0.08548012375831604)","('NON-ESG', 0.1413390338420868)","('NON-ESG', 0.0976111888885498)","('NON-ESG', 0.08548012375831604)"
Line 2083,"Seeking advice about ethical and lawful behavior and or ganizational integrity; and 2.
","('Business_Ethics', 0.9374812245368958)","('Management_Of_Legal_And_Regulatory_Framework', 0.011048187501728535)","('Competitive_Behavior', 0.005910646636039019)","(['Business Ethics'], 0.9374812245368958)","('NON-ESG', 0.011048187501728535)","('NON-ESG', 0.005910646636039019)"
Line 2084,"R eporting concerns about unethical or unlawful behavior and lack of organizational integrity.Ethical business conduct World Economic Forum (WEF)   Stakeholder Capitalism Metrics  2022 Integrated Performance Report      GRI 133 SASB TCFD WEF Employee dataRisk and opportunity oversight Company risk factor and opportunity disclosures that clearly identify the principal material risks and opportunities  facing the company specifically (as opposed to generic sector risks), the company appetite in respect of these risks, how these risks and opportunities have moved over time and the response to those changes.
","('Business_Ethics', 0.9573481678962708)","('Data_Security', 0.00412380788475275)","('Systemic_Risk_Management', 0.004022631328552961)","(['Business Ethics'], 0.9573481678962708)","('NON-ESG', 0.00412380788475275)","('NON-ESG', 0.004022631328552961)"
Line 2085,"R eporting concerns about unethical or unlawful behavior and lack of organizational integrity.Ethical business conduct World Economic Forum (WEF)   Stakeholder Capitalism Metrics  2022 Integrated Performance Report      GRI 133 SASB TCFD WEF Employee dataRisk and opportunity oversight Company risk factor and opportunity disclosures that clearly identify the principal material risks and opportunities  facing the company specifically (as opposed to generic sector risks), the company appetite in respect of these risks, how these risks and opportunities have moved over time and the response to those changes.
","('Systemic_Risk_Management', 0.922227680683136)","('Business_Model_Resilience', 0.025462064892053604)","('Physical_Impacts_Of_Climate_Change', 0.007506164256483316)","(['Risk & Crisis Management'], 0.922227680683136)","('NON-ESG', 0.025462064892053604)","('NON-ESG', 0.007506164256483316)"
Line 2086,"These opportunities and risks should integrate material economic, environmental and social issues, including climate change and data stewardship.2022 Form 10-K Sustainability governance PLANET  Theme Disclosure Response  Climate change For all relevant greenhouse gases (GHG), e.g. carbon dioxide, methane, nitrous oxide, F-gases etc., report in  metric tons of carbon dioxide equivalent (MT CO2e) GHG Protocol Scope 1 and Scope 2 emissions.
","('GHG_Emissions', 0.9522919058799744)","('Physical_Impacts_Of_Climate_Change', 0.01055943313986063)","('Ecological_Impacts', 0.006162590812891722)","(['Climate Change'], 0.9522919058799744)","('NON-ESG', 0.01055943313986063)","('NON-ESG', 0.006162590812891722)"
Line 2087,"Estimate  and report material upstream and downstream (GHG Protocol Scope 3) emissions where appropriate.Reducing our operational footprint In FY22, we joined the CDP Supply Chain, a consortium  of more than 280 global companies, working to help 40,000 suppliers quantify their environmental impact.
","('GHG_Emissions', 0.8529298901557922)","('Supply_Chain_Management', 0.04580661281943321)","('Water_And_Wastewater_Management', 0.011565199121832848)","(['Climate Change'], 0.8529298901557922)","('NON-ESG', 0.04580661281943321)","('NON-ESG', 0.011565199121832848)"
Line 2088,"Our membership will help us better understand our Scope 3 emissions and inform the development of our science-based targets.
","('GHG_Emissions', 0.8741928935050964)","('Management_Of_Legal_And_Regulatory_Framework', 0.027609001845121384)","('Air_Quality', 0.022018486633896828)","(['Climate Change'], 0.8741928935050964)","('NON-ESG', 0.027609001845121384)","('NON-ESG', 0.022018486633896828)"
Line 2089,"Fully implement the recommendations of the Task Force on Climate-Related Financial Disclosures (TCFD).
","('Physical_Impacts_Of_Climate_Change', 0.9084575772285461)","('Business_Model_Resilience', 0.02113349176943302)","('GHG_Emissions', 0.015817729756236076)","(['Climate Change'], 0.9084575772285461)","('NON-ESG', 0.02113349176943302)","('NON-ESG', 0.015817729756236076)"
Line 2090,"If necessary, disclose a timeline of at most three years for full implementation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6770645976066589)","('Director_Removal', 0.033009447157382965)","('Human_Rights_And_Community_Relations', 0.031162414699792862)","(['Corporate Governance'], 0.6770645976066589)","('NON-ESG', 0.033009447157382965)","('NON-ESG', 0.031162414699792862)"
Line 2091,"Disclose whether you have set, or have committed to set, GHG emissions targets that are in line with the goals of the Paris Agreement – to limit global warming to well below 2°C above pre-industrial levels and pursue efforts to limit warming to 1.5°C – and to achieve net-zero emissions before 2050.
","('GHG_Emissions', 0.9666681289672852)","('Air_Quality', 0.005554539617151022)","('Management_Of_Legal_And_Regulatory_Framework', 0.0028788703493773937)","(['Climate Change'], 0.9666681289672852)","('NON-ESG', 0.005554539617151022)","('NON-ESG', 0.0028788703493773937)"
Line 2092,"2022 CDP Climate Disclosure  2022 TCFDIn FY22, we announced our ambition to reduce our  carbon emissions to net zero across Scopes 1, 2, and 3 by FY45.
","('GHG_Emissions', 0.8395418524742126)","('Management_Of_Legal_And_Regulatory_Framework', 0.030641568824648857)","('Physical_Impacts_Of_Climate_Change', 0.025916652753949165)","(['Climate Change'], 0.8395418524742126)","('NON-ESG', 0.030641568824648857)","('NON-ESG', 0.025916652753949165)"
Line 2093,"To achieve this ambition, we created a Decarbonization Roadmap that outlines our focus areas — operations, supply chain, and logistics — where we intend to set reduction targets through the Science-Based Targets initiative (SBTi).
","('Supply_Chain_Management', 0.952573835849762)","('Business_Model_Resilience', 0.003967429976910353)","('Product_Design_And_Lifecycle_Management', 0.0037392403464764357)","(['Supply Chain Management'], 0.952573835849762)","('NON-ESG', 0.003967429976910353)","('NON-ESG', 0.0037392403464764357)"
Line 2094,"Nature loss Report the number and area (in hectares) of sites owned, leased or managed in or adjacent to protected areas and/or key biodiversity areas (KBA).We are currently evaluating methods for tracking and reporting our adjacency to key biodiversity areas.
","('Ecological_Impacts', 0.9803050756454468)","('GHG_Emissions', 0.002963320817798376)","('Water_And_Wastewater_Management', 0.0015895501710474491)","(['Natural Capital'], 0.9803050756454468)","('NON-ESG', 0.002963320817798376)","('NON-ESG', 0.0015895501710474491)"
Line 2095,"Freshwater availability Report for operations where material: megalitres of water withdrawn, megalitres of water consumed and the percentage of each in regions with high or extremely high baseline water stress, according to WRI Aqueduct water risk atlas tool.
","('Water_And_Wastewater_Management', 0.9779528975486755)","('GHG_Emissions', 0.00182833313010633)","('Waste_And_Hazardous_Materials_Management', 0.0017357447650283575)","(['Operational Eco-Efficiency'], 0.9779528975486755)","('NON-ESG', 0.00182833313010633)","('NON-ESG', 0.0017357447650283575)"
Line 2096,"Estimate and report the same information for the full value chain (upstream and downstream) where appropriate.
","('Supply_Chain_Management', 0.4485347867012024)","('Business_Model_Resilience', 0.17196132242679596)","('Systemic_Risk_Management', 0.09389283508062363)","('NON-ESG', 0.4485347867012024)","('NON-ESG', 0.17196132242679596)","('NON-ESG', 0.09389283508062363)"
Line 2097,"2022 CDP Water Disclosure Reducing our operational footprint 2022 Integrated Performance Report      GRI 134 SASB TCFD WEF Employee dataPEOPLE  Theme Disclosure Response  Dignity and equality Percentage of employees per employee category, by age group, gender and other indicators of diversity   (e.g., ethnicity).Employee data summary Additional information about ethnicity by employee  category for U.S. employees is available in our EEO1 report on medtronic.com.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9748054146766663)","('Customer_Privacy', 0.002064519328996539)","('Employee_Health_And_Safety', 0.002053298521786928)","(['Human Capital Development'], 0.9748054146766663)","('NON-ESG', 0.002064519328996539)","('NON-ESG', 0.002053298521786928)"
Line 2098,"Ratio of the basic salary and remuneration for each employee category by significant locations of operation for priority areas of equality: women to men, minor to major ethnic groups, and other relevant equality areas.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9408988356590271)","('Labor_Practices', 0.019790727645158768)","('Human_Rights_And_Community_Relations', 0.00401795981451869)","(['Human Capital Development'], 0.9408988356590271)","('NON-ESG', 0.019790727645158768)","('NON-ESG', 0.00401795981451869)"
Line 2099,"Inclusion, diversity, and equity Supporting a global workforce  Global gender pay equity by region (adjusted for job title) Region Pay equity as of  August Asia-Pacific 101% Europe, Middle East, Africa 98% Latin America 97% North America and Puerto Rico 100%Global gender pay equity by level (adjusted for country  and job title) Level Pay equity as of  August Professional and management 99% Support 100% U.S. ethnically diverse pay equity by level (adjusted for  job title) Level Pay equity as of  August Professional and management 101% Support 99% 2022 Integrated Performance Report      GRI 135 SASB TCFD WEF Employee dataPEOPLE Theme Disclosure Response  Dignity and equality (continued) 1.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9754891991615295)","('Labor_Practices', 0.002322455169633031)","('Employee_Health_And_Safety', 0.0020040825475007296)","(['Human Capital Development'], 0.9754891991615295)","('NON-ESG', 0.002322455169633031)","('NON-ESG', 0.0020040825475007296)"
Line 2100,"Inclusion, diversity, and equity Supporting a global workforce  Global gender pay equity by region (adjusted for job title) Region Pay equity as of  August Asia-Pacific 101% Europe, Middle East, Africa 98% Latin America 97% North America and Puerto Rico 100%Global gender pay equity by level (adjusted for country  and job title) Level Pay equity as of  August Professional and management 99% Support 100% U.S. ethnically diverse pay equity by level (adjusted for  job title) Level Pay equity as of  August Professional and management 101% Support 99% 2022 Integrated Performance Report      GRI 135 SASB TCFD WEF Employee dataPEOPLE Theme Disclosure Response  Dignity and equality (continued) 1.
","('Employee_Engagement_Inclusion_And_Diversity', 0.48595309257507324)","('Data_Security', 0.05644906312227249)","('Business_Ethics', 0.04952708259224892)","('NON-ESG', 0.48595309257507324)","('NON-ESG', 0.05644906312227249)","('NON-ESG', 0.04952708259224892)"
Line 2101,"R atios of standard entry-level wage by gender compared to local minimum wage.
","('Labor_Practices', 0.9717118740081787)","('Director_Removal', 0.002378712873905897)","('Waste_And_Hazardous_Materials_Management', 0.0021165255457162857)","(['Labor Practice Indicators'], 0.9717118740081787)","('NON-ESG', 0.002378712873905897)","('NON-ESG', 0.0021165255457162857)"
Line 2102,"2.
","('Competitive_Behavior', 0.15795664489269257)","('Customer_Welfare', 0.10852150619029999)","('Energy_Management', 0.08616163581609726)","('NON-ESG', 0.15795664489269257)","('NON-ESG', 0.10852150619029999)","('NON-ESG', 0.08616163581609726)"
Line 2103,"R atio of the annual total compensation of the CEO to the median of the annual total compensation  of all its employees, except the CEO.Our CEO-to-employee annual total compensation ratio is  disclosed in our 2022 Proxy statement.
","('Labor_Practices', 0.8976873159408569)","('Employee_Engagement_Inclusion_And_Diversity', 0.02695983089506626)","('Employee_Health_And_Safety', 0.01745665818452835)","(['Labor Practice Indicators'], 0.8976873159408569)","('NON-ESG', 0.02695983089506626)","('NON-ESG', 0.01745665818452835)"
Line 2104,"An explanation of the operations and suppliers considered to have significant risk for incidents of child labor, forced or compulsory labor.
","('Labor_Practices', 0.9773886203765869)","('Director_Removal', 0.002010523807257414)","('Waste_And_Hazardous_Materials_Management', 0.0015984824858605862)","(['Labor Practice Indicators'], 0.9773886203765869)","('NON-ESG', 0.002010523807257414)","('NON-ESG', 0.0015984824858605862)"
Line 2105,"Such risks could emerge in relation to:  a)  type of  operation (such as manufacturing plant) and type of supplier; and  b)  countries or geogr aphic areas with operations and suppliers considered at risk.Supply chain responsibility  Global Human Rights and Labor Policy Program Report Health and well-being The number and rate of fatalities as a result of work-related injury; high-consequence work-related injuries  (excluding fatalities); recordable work-related injuries; main types of work-related injury; and the number of hours worked.
","('Employee_Health_And_Safety', 0.9788652658462524)","('Labor_Practices', 0.0023624254390597343)","('Employee_Engagement_Inclusion_And_Diversity', 0.001882543321698904)","(['Operational Eco-Efficiency'], 0.9788652658462524)","('NON-ESG', 0.0023624254390597343)","('NON-ESG', 0.001882543321698904)"
Line 2106,"Such risks could emerge in relation to:  a)  type of  operation (such as manufacturing plant) and type of supplier; and  b)  countries or geogr aphic areas with operations and suppliers considered at risk.Supply chain responsibility  Global Human Rights and Labor Policy Program Report Health and well-being The number and rate of fatalities as a result of work-related injury; high-consequence work-related injuries  (excluding fatalities); recordable work-related injuries; main types of work-related injury; and the number of hours worked.
","('Labor_Practices', 0.9495998024940491)","('Employee_Health_And_Safety', 0.0077941021881997585)","('Waste_And_Hazardous_Materials_Management', 0.004154898226261139)","(['Labor Practice Indicators'], 0.9495998024940491)","('NON-ESG', 0.0077941021881997585)","('NON-ESG', 0.004154898226261139)"
Line 2107,"An explanation of how the organization facilitates workers’ access to non-occupational medical and healthcare  services, and the scope of access provided for employees and workers.Supporting a global workforce In FY22, the most common work-related injuries were:slip, trip, or fall (19.3%); injury through manual handling  or lifting (12.6%); struck by/cut by sharp object (11.4%); and hit against something fixed or stationary (6.3%).
","('Employee_Health_And_Safety', 0.9821199774742126)","('Employee_Engagement_Inclusion_And_Diversity', 0.002279331674799323)","('Labor_Practices', 0.0014224102487787604)","(['Operational Eco-Efficiency'], 0.9821199774742126)","('NON-ESG', 0.002279331674799323)","('NON-ESG', 0.0014224102487787604)"
Line 2108,"In FY22, we maintained our best-in-class level of safety  across our global operations.
","('Employee_Health_And_Safety', 0.9478719234466553)","('Critical_Incident_Risk_Management', 0.01063129398971796)","('Product_Quality_And_Safety', 0.00864417850971222)","(['Operational Eco-Efficiency'], 0.9478719234466553)","('NON-ESG', 0.01063129398971796)","('NON-ESG', 0.00864417850971222)"
Line 2109,"Our overall safety record improved with high-consequence work-related injuries and lost workdays declining compared to the previous two years.
","('Employee_Health_And_Safety', 0.9812020063400269)","('Employee_Engagement_Inclusion_And_Diversity', 0.001956653781235218)","('Labor_Practices', 0.0019168277503922582)","(['Operational Eco-Efficiency'], 0.9812020063400269)","('NON-ESG', 0.001956653781235218)","('NON-ESG', 0.0019168277503922582)"
Line 2110,"We experienced zero work-related fatalities.
","('Employee_Health_And_Safety', 0.9639090299606323)","('Critical_Incident_Risk_Management', 0.006426421459764242)","('Labor_Practices', 0.004913249984383583)","(['Operational Eco-Efficiency'], 0.9639090299606323)","('NON-ESG', 0.006426421459764242)","('NON-ESG', 0.004913249984383583)"
Line 2111,"Skills for the future 1.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3950656056404114)","('Product_Design_And_Lifecycle_Management', 0.10788590461015701)","('Access_And_Affordability', 0.06875760853290558)","('NON-ESG', 0.3950656056404114)","('NON-ESG', 0.10788590461015701)","('NON-ESG', 0.06875760853290558)"
Line 2112,"A verage hours of training per person that the organization’s employees have undertaken during the reporting  period, by gender and employee category (total number of hours of training provided to employees divided by the number of employees).
","('Employee_Engagement_Inclusion_And_Diversity', 0.45802345871925354)","('Labor_Practices', 0.2464984953403473)","('Employee_Health_And_Safety', 0.12569648027420044)","('NON-ESG', 0.45802345871925354)","('NON-ESG', 0.2464984953403473)","('NON-ESG', 0.12569648027420044)"
Line 2113,"2.
","('Competitive_Behavior', 0.15795664489269257)","('Customer_Welfare', 0.10852150619029999)","('Energy_Management', 0.08616163581609726)","('NON-ESG', 0.15795664489269257)","('NON-ESG', 0.10852150619029999)","('NON-ESG', 0.08616163581609726)"
Line 2114,"A verage training and development expenditure per full-time employee (total cost of training provided to  employees divided by the number of employees).Supporting a global workforce We do not currently track all training by gender and  employee category.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8159513473510742)","('Labor_Practices', 0.07649998366832733)","('Employee_Health_And_Safety', 0.030451267957687378)","(['Human Capital Development'], 0.8159513473510742)","('NON-ESG', 0.07649998366832733)","('NON-ESG', 0.030451267957687378)"
Line 2115,"We are exploring solutions for tracking this information companywide in the future.
","('Customer_Privacy', 0.6092896461486816)","('Data_Security', 0.1858328878879547)","('Business_Model_Resilience', 0.0279434435069561)","(['Privacy Protection'], 0.6092896461486816)","('NON-ESG', 0.1858328878879547)","('NON-ESG', 0.0279434435069561)"
Line 2116,"2022 Integrated Performance Report      GRI 136 SASB TCFD WEF Employee dataPROSPERITY Theme Disclosure Response  Employment and wealth   generation1.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9189615249633789)","('Labor_Practices', 0.019989073276519775)","('Employee_Health_And_Safety', 0.006706887390464544)","(['Human Capital Development'], 0.9189615249633789)","('NON-ESG', 0.019989073276519775)","('NON-ESG', 0.006706887390464544)"
Line 2117,"T otal number and rate of new employee hires during the reporting period, by age group, gender, other  indicators of diversity and region.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9740245342254639)","('Labor_Practices', 0.0026318116579204798)","('Employee_Health_And_Safety', 0.0020265604835003614)","(['Human Capital Development'], 0.9740245342254639)","('NON-ESG', 0.0026318116579204798)","('NON-ESG', 0.0020265604835003614)"
Line 2118,"2.
","('Competitive_Behavior', 0.15795664489269257)","('Customer_Welfare', 0.10852150619029999)","('Energy_Management', 0.08616163581609726)","('NON-ESG', 0.15795664489269257)","('NON-ESG', 0.10852150619029999)","('NON-ESG', 0.08616163581609726)"
Line 2119,"T otal number and rate of employee turnover during the reporting period, by age group, gender, other  indicators of diversity and region.Employee data summary Inclusion, diversity, and equity 1.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9755668640136719)","('Employee_Health_And_Safety', 0.002363193081691861)","('Labor_Practices', 0.0019485033117234707)","(['Human Capital Development'], 0.9755668640136719)","('NON-ESG', 0.002363193081691861)","('NON-ESG', 0.0019485033117234707)"
Line 2120,"Dir ect economic value generated and distributed (EVG&D), on an accrual basis, covering the basic  components for the organization’s global operations, ideally split out by:•  r evenue •  oper ating costs •  employee wages and benefits •  payments to pr oviders of capital •  payments to government •  community investment   F inancial assistance received from the government: total monetary value of financial assistance received by the  organization from any government during the reporting period.
","('Labor_Practices', 0.8911453485488892)","('Management_Of_Legal_And_Regulatory_Framework', 0.0282377190887928)","('Human_Rights_And_Community_Relations', 0.015534203499555588)","(['Labor Practice Indicators'], 0.8911453485488892)","('NON-ESG', 0.0282377190887928)","('NON-ESG', 0.015534203499555588)"
Line 2121,"2022 Form 10-KOur economic impact At this time, we do not disclose financial assistance  received from the government.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6397005319595337)","('Access_And_Affordability', 0.09717165678739548)","('Human_Rights_And_Community_Relations', 0.059642937034368515)","(['Corporate Governance'], 0.6397005319595337)","('NON-ESG', 0.09717165678739548)","('NON-ESG', 0.059642937034368515)"
Line 2122,"1.
","('Competitive_Behavior', 0.08736830949783325)","('Energy_Management', 0.08274902403354645)","('Management_Of_Legal_And_Regulatory_Framework', 0.0740576833486557)","('NON-ESG', 0.08736830949783325)","('NON-ESG', 0.08274902403354645)","('NON-ESG', 0.0740576833486557)"
Line 2123,"T otal capital expenditures (CapEx) minus depreciation, supported by narrative to describe the company’s  investment strategy.
","('Business_Model_Resilience', 0.27507224678993225)","('Systemic_Risk_Management', 0.2743243873119354)","('Competitive_Behavior', 0.1206497848033905)","('NON-ESG', 0.27507224678993225)","('NON-ESG', 0.2743243873119354)","('NON-ESG', 0.1206497848033905)"
Line 2124,"2.
","('Competitive_Behavior', 0.15795664489269257)","('Customer_Welfare', 0.10852150619029999)","('Energy_Management', 0.08616163581609726)","('NON-ESG', 0.15795664489269257)","('NON-ESG', 0.10852150619029999)","('NON-ESG', 0.08616163581609726)"
Line 2125,"Shar e buybacks plus dividend payments, supported by narrative to describe the company’s strategy for returns  of capital to shareholders.2022 Form 10-K SEC Filings FY22 capital expenditures less depreciation were  $394 million (CapEx additions of $1.368 billion; less depreciation of $974 million).
","('Systemic_Risk_Management', 0.5980119109153748)","('Management_Of_Legal_And_Regulatory_Framework', 0.13066621124744415)","('Business_Ethics', 0.05396764352917671)","(['Risk & Crisis Management'], 0.5980119109153748)","('NON-ESG', 0.13066621124744415)","('NON-ESG', 0.05396764352917671)"
Line 2126,"Our capital investment strategy is focused on supporting revenue generation, R&D, and margin expansion initiatives.
","('Business_Model_Resilience', 0.8185590505599976)","('Systemic_Risk_Management', 0.028027452528476715)","('Supply_Chain_Management', 0.015996338799595833)","(['Codes of Business Conduct'], 0.8185590505599976)","('NON-ESG', 0.028027452528476715)","('NON-ESG', 0.015996338799595833)"
Line 2127,"Our priority is to continue to fund critical strategic growth investments, such as product development and capacity expansion, while executing on existing initiatives.
","('Product_Design_And_Lifecycle_Management', 0.9032357931137085)","('Business_Model_Resilience', 0.014834707602858543)","('Product_Quality_And_Safety', 0.010346991010010242)","(['Product Stewardship'], 0.9032357931137085)","('NON-ESG', 0.014834707602858543)","('NON-ESG', 0.010346991010010242)"
Line 2128,"Innovation of better products and services Total costs related to research and development.
","('Product_Design_And_Lifecycle_Management', 0.9667358994483948)","('Customer_Welfare', 0.003429207019507885)","('Product_Quality_And_Safety', 0.0033693951554596424)","(['Product Stewardship'], 0.9667358994483948)","('NON-ESG', 0.003429207019507885)","('NON-ESG', 0.0033693951554596424)"
Line 2129,"2022 Form 10-K Global healthcare access  Community and social vitality The total global tax borne by the company, including corporate income taxes, property taxes, non-creditable  VAT and other sales taxes, employer-paid payroll taxes, and other taxes that constitute costs to the company, by category of taxes.2022 Form 10-K Our economic impact 2022 Integrated Performance Report      GRI 137 SASB TCFD WEF Employee dataEmployee data summary GLOBAL AND U.S. LEADERSHIP DIVERSITY FY20†FY21 FYCEO and global CEO direct reports who are women 22% 22% 24% CEO and U.S. CEO direct reports who are ethnically diverse 19% 25% 33% GLOBAL FEMALE TALENT REPRESENTATION FY20 FY21 FYWoman employees 49% 50% 50% Manager-and-above positions held by women 39% 40% 42% Management positions in revenue-generating functions   (i.e., sales) held by women32% 32% 34% U.S. ETHNICALLY DIVERSE TALENT REPRESENTATION† FY20 FY21 FYEthnically diverse employees 37% 38% 39% Manager-and-above positions held by ethnically diverse talent 23% 25%‡27% NEW EMPLOYEE HIRES† FY20 FY21 FYWoman (global) 51%‡ 50%§52%Ω Ethnically diverse (U.S.) 52% 46% 47%†  At FY20 year-end, we went through a transition  phase and had two acting CEOs. Calculation was completed by capturing retiring CEO and Direct Reports.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9351416826248169)","('Human_Rights_And_Community_Relations', 0.00564560666680336)","('Business_Model_Resilience', 0.004995752591639757)","(['Human Capital Development'], 0.9351416826248169)","('NON-ESG', 0.00564560666680336)","('NON-ESG', 0.004995752591639757)"
Line 2130,"2022 Form 10-K Global healthcare access  Community and social vitality The total global tax borne by the company, including corporate income taxes, property taxes, non-creditable  VAT and other sales taxes, employer-paid payroll taxes, and other taxes that constitute costs to the company, by category of taxes.2022 Form 10-K Our economic impact 2022 Integrated Performance Report      GRI 137 SASB TCFD WEF Employee dataEmployee data summary GLOBAL AND U.S. LEADERSHIP DIVERSITY FY20†FY21 FYCEO and global CEO direct reports who are women 22% 22% 24% CEO and U.S. CEO direct reports who are ethnically diverse 19% 25% 33% GLOBAL FEMALE TALENT REPRESENTATION FY20 FY21 FYWoman employees 49% 50% 50% Manager-and-above positions held by women 39% 40% 42% Management positions in revenue-generating functions   (i.e., sales) held by women32% 32% 34% U.S. ETHNICALLY DIVERSE TALENT REPRESENTATION† FY20 FY21 FYEthnically diverse employees 37% 38% 39% Manager-and-above positions held by ethnically diverse talent 23% 25%‡27% NEW EMPLOYEE HIRES† FY20 FY21 FYWoman (global) 51%‡ 50%§52%Ω Ethnically diverse (U.S.) 52% 46% 47%†  At FY20 year-end, we went through a transition  phase and had two acting CEOs. Calculation was completed by capturing retiring CEO and Direct Reports.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9719355702400208)","('Employee_Health_And_Safety', 0.002128808991983533)","('Customer_Privacy', 0.0019231491023674607)","(['Human Capital Development'], 0.9719355702400208)","('NON-ESG', 0.002128808991983533)","('NON-ESG', 0.0019231491023674607)"
Line 2131,"2022 Form 10-K Global healthcare access  Community and social vitality The total global tax borne by the company, including corporate income taxes, property taxes, non-creditable  VAT and other sales taxes, employer-paid payroll taxes, and other taxes that constitute costs to the company, by category of taxes.2022 Form 10-K Our economic impact 2022 Integrated Performance Report      GRI 137 SASB TCFD WEF Employee dataEmployee data summary GLOBAL AND U.S. LEADERSHIP DIVERSITY FY20†FY21 FYCEO and global CEO direct reports who are women 22% 22% 24% CEO and U.S. CEO direct reports who are ethnically diverse 19% 25% 33% GLOBAL FEMALE TALENT REPRESENTATION FY20 FY21 FYWoman employees 49% 50% 50% Manager-and-above positions held by women 39% 40% 42% Management positions in revenue-generating functions   (i.e., sales) held by women32% 32% 34% U.S. ETHNICALLY DIVERSE TALENT REPRESENTATION† FY20 FY21 FYEthnically diverse employees 37% 38% 39% Manager-and-above positions held by ethnically diverse talent 23% 25%‡27% NEW EMPLOYEE HIRES† FY20 FY21 FYWoman (global) 51%‡ 50%§52%Ω Ethnically diverse (U.S.) 52% 46% 47%†  At FY20 year-end, we went through a transition  phase and had two acting CEOs. Calculation was completed by capturing retiring CEO and Direct Reports.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9741016626358032)","('Employee_Health_And_Safety', 0.0018286112463101745)","('Customer_Privacy', 0.00176340586040169)","(['Human Capital Development'], 0.9741016626358032)","('NON-ESG', 0.0018286112463101745)","('NON-ESG', 0.00176340586040169)"
Line 2132,"Calculation also includes our new CEO (who had reported to the retiring CEO) and his Direct Reports.
","('Director_Removal', 0.619499921798706)","('Business_Model_Resilience', 0.07194896787405014)","('Management_Of_Legal_And_Regulatory_Framework', 0.041636787354946136)","(['Anti-Crime Policy & Measures'], 0.619499921798706)","('NON-ESG', 0.07194896787405014)","('NON-ESG', 0.041636787354946136)"
Line 2133,"Some employees were transitioned from the retiring CEO to the new CEO.
","('Director_Removal', 0.6058594584465027)","('Employee_Engagement_Inclusion_And_Diversity', 0.08728401362895966)","('Labor_Practices', 0.03677583858370781)","(['Anti-Crime Policy & Measures'], 0.6058594584465027)","('NON-ESG', 0.08728401362895966)","('NON-ESG', 0.03677583858370781)"
Line 2134,"†  United States, excluding Puerto Rico (excludes blank, no data, or did not disclose).
","('Management_Of_Legal_And_Regulatory_Framework', 0.4094756245613098)","('Competitive_Behavior', 0.12633393704891205)","('Employee_Engagement_Inclusion_And_Diversity', 0.05342923477292061)","('NON-ESG', 0.4094756245613098)","('NON-ESG', 0.12633393704891205)","('NON-ESG', 0.05342923477292061)"
Line 2135,"‡  This number is based on fiscal year 2021 and therefore is different than the number reported for our calendar year 2020 target, where we achieved 24% ethnically diverse talent in  manager-and-above positions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9739830493927002)","('Customer_Privacy', 0.001968305790796876)","('Human_Rights_And_Community_Relations', 0.0016417893348261714)","(['Human Capital Development'], 0.9739830493927002)","('NON-ESG', 0.001968305790796876)","('NON-ESG', 0.0016417893348261714)"
Line 2136,"†  Employee population data expressed here may vary from our 10-K form depending on the time of year in which the data was gathered.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8818140625953674)","('Customer_Privacy', 0.017537416890263557)","('Labor_Practices', 0.01743159256875515)","(['Human Capital Development'], 0.8818140625953674)","('NON-ESG', 0.017537416890263557)","('NON-ESG', 0.01743159256875515)"
Line 2137,"‡   Zero records have values out-of-bounds (e.g., age=0).
","('Employee_Engagement_Inclusion_And_Diversity', 0.22318489849567413)","('Customer_Privacy', 0.12667161226272583)","('Labor_Practices', 0.0956500694155693)","('NON-ESG', 0.22318489849567413)","('NON-ESG', 0.12667161226272583)","('NON-ESG', 0.0956500694155693)"
Line 2138,"Forty-nine records do not specify gender.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8757842779159546)","('Labor_Practices', 0.033007439225912094)","('Customer_Privacy', 0.013248606584966183)","(['Human Capital Development'], 0.8757842779159546)","('NON-ESG', 0.033007439225912094)","('NON-ESG', 0.013248606584966183)"
Line 2139,"§  Zero records have values out-of-bounds (e.g., age=0).
","('Customer_Privacy', 0.16474565863609314)","('Business_Ethics', 0.14903490245342255)","('Data_Security', 0.1155751645565033)","('NON-ESG', 0.16474565863609314)","('NON-ESG', 0.14903490245342255)","('NON-ESG', 0.1155751645565033)"
Line 2140,"Thirty-four records do not specify gender.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8854466080665588)","('Labor_Practices', 0.02618441730737686)","('Customer_Privacy', 0.01414745207875967)","(['Human Capital Development'], 0.8854466080665588)","('NON-ESG', 0.02618441730737686)","('NON-ESG', 0.01414745207875967)"
Line 2141,"Ω  Zero records have values out-of-bounds (e.g., age=0).
","('Competitive_Behavior', 0.12773087620735168)","('Employee_Engagement_Inclusion_And_Diversity', 0.12167637795209885)","('Business_Ethics', 0.11855929344892502)","('NON-ESG', 0.12773087620735168)","('NON-ESG', 0.12167637795209885)","('NON-ESG', 0.11855929344892502)"
Line 2142,"Twenty-four records do not specify gender.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8836983442306519)","('Labor_Practices', 0.028602171689271927)","('Customer_Privacy', 0.013572659343481064)","(['Human Capital Development'], 0.8836983442306519)","('NON-ESG', 0.028602171689271927)","('NON-ESG', 0.013572659343481064)"
Line 2143,"2022 Integrated Performance Report      GRI 138 SASB TCFD WEF Employee dataMEDTRONIC GLOBAL WORKFORCE   FY20†FY21‡FY22§ Total 93,919 95,612 101,Woman 46,460 47,844 51,Asia-Pacific 13,619 13,728 14,Woman 5,923 6,200 6,Canada 1,366 1,316 1,Woman 801 788 Europe/Central Asia/Middle East/Africa 18,983 18,890 20,Woman 9,516 9,391 10,Latin America 18,222 20,126 21,Woman 11,013 12,375 13,U.S. and Puerto Rico 41,729 41,552 43,Woman 19,207 19,090 20,228†  Forty-five records do not specify gender.
","('Employee_Engagement_Inclusion_And_Diversity', 0.903380811214447)","('Labor_Practices', 0.018800416961312294)","('Employee_Health_And_Safety', 0.012081862427294254)","(['Human Capital Development'], 0.903380811214447)","('NON-ESG', 0.018800416961312294)","('NON-ESG', 0.012081862427294254)"
Line 2144,"‡  Thirty-eight records do not specify gender.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8946598172187805)","('Labor_Practices', 0.022777898237109184)","('Customer_Privacy', 0.009981788694858551)","(['Human Capital Development'], 0.8946598172187805)","('NON-ESG', 0.022777898237109184)","('NON-ESG', 0.009981788694858551)"
Line 2145,"§  Thirty-four records do not specify gender.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8711274266242981)","('Labor_Practices', 0.033669065684080124)","('Customer_Privacy', 0.015011413022875786)","(['Human Capital Development'], 0.8711274266242981)","('NON-ESG', 0.033669065684080124)","('NON-ESG', 0.015011413022875786)"
Line 2146,"2022 Integrated Performance Report      GRI 139 SASB TCFD WEF Employee dataEMPLOYMENT TYPE  FY20†FY21‡FY22§ Support staff 38,325 39,118 40,Woman 22,362 23,026 23,Professional 44,393 45,387 48,Woman 19,749 20,357 22,ManagementΩ10,664 10,551 11,Woman 4,183 4,284 4,VPs and higher 537 556 Woman 166 177 GLOBAL FULL-TIME  FY20†FY21 FY22§ Total 89,703 93,763 99,24 and under 5,588 6,118 6,25-39 41,523 42,898 45,40-54 32,452 34,142 35,55-69 9,980 10,479 11,70+ 160 126 Woman‡44,904 46,329 49,Asia-Pacific 5,844 6,123 6,Canada 789 772 Europe/Central/Asia/Middle East/Africa 8,235 8,131 8,Latin America 11,021 12,374 13,U.S. and Puerto Rico 19,015 18,929 20,070†  F orty-five employees do not have a job category  designation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.848906397819519)","('Employee_Health_And_Safety', 0.0246200542896986)","('Labor_Practices', 0.02059841714799404)","(['Human Capital Development'], 0.848906397819519)","('NON-ESG', 0.0246200542896986)","('NON-ESG', 0.02059841714799404)"
Line 2147,"2022 Integrated Performance Report      GRI 139 SASB TCFD WEF Employee dataEMPLOYMENT TYPE  FY20†FY21‡FY22§ Support staff 38,325 39,118 40,Woman 22,362 23,026 23,Professional 44,393 45,387 48,Woman 19,749 20,357 22,ManagementΩ10,664 10,551 11,Woman 4,183 4,284 4,VPs and higher 537 556 Woman 166 177 GLOBAL FULL-TIME  FY20†FY21 FY22§ Total 89,703 93,763 99,24 and under 5,588 6,118 6,25-39 41,523 42,898 45,40-54 32,452 34,142 35,55-69 9,980 10,479 11,70+ 160 126 Woman‡44,904 46,329 49,Asia-Pacific 5,844 6,123 6,Canada 789 772 Europe/Central/Asia/Middle East/Africa 8,235 8,131 8,Latin America 11,021 12,374 13,U.S. and Puerto Rico 19,015 18,929 20,070†  F orty-five employees do not have a job category  designation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8780286312103271)","('Labor_Practices', 0.02431577630341053)","('Employee_Health_And_Safety', 0.01003800705075264)","(['Human Capital Development'], 0.8780286312103271)","('NON-ESG', 0.02431577630341053)","('NON-ESG', 0.01003800705075264)"
Line 2148,"‡  Thirty-eight employees do not have a job category  designation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8155723810195923)","('Labor_Practices', 0.06863517314195633)","('Employee_Health_And_Safety', 0.011785069480538368)","(['Human Capital Development'], 0.8155723810195923)","('NON-ESG', 0.06863517314195633)","('NON-ESG', 0.011785069480538368)"
Line 2149,"§  Thirty-eight employees do not have a job category designation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7583034634590149)","('Labor_Practices', 0.10990510880947113)","('Director_Removal', 0.014836117625236511)","(['Human Capital Development'], 0.7583034634590149)","('NON-ESG', 0.10990510880947113)","('NON-ESG', 0.014836117625236511)"
Line 2150,"Ω Management = managers and above.
","('Employee_Engagement_Inclusion_And_Diversity', 0.23492589592933655)","('Director_Removal', 0.1499113142490387)","('Business_Ethics', 0.08054041117429733)","('NON-ESG', 0.23492589592933655)","('NON-ESG', 0.1499113142490387)","('NON-ESG', 0.08054041117429733)"
Line 2151,"†  Zero records have out of bound values, so are not included in age breaks.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2556552290916443)","('Competitive_Behavior', 0.2525396943092346)","('Business_Ethics', 0.10737618058919907)","('NON-ESG', 0.2556552290916443)","('NON-ESG', 0.2525396943092346)","('NON-ESG', 0.10737618058919907)"
Line 2152,"Twenty-six records do not specify gender.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8906994462013245)","('Labor_Practices', 0.025980183854699135)","('Customer_Privacy', 0.0121150529012084)","(['Human Capital Development'], 0.8906994462013245)","('NON-ESG', 0.025980183854699135)","('NON-ESG', 0.0121150529012084)"
Line 2153,"‡  Numbers by region are based on female  employees only.
","('Labor_Practices', 0.5423699617385864)","('Employee_Engagement_Inclusion_And_Diversity', 0.21656467020511627)","('Director_Removal', 0.04872202128171921)","(['Labor Practice Indicators'], 0.5423699617385864)","('NON-ESG', 0.21656467020511627)","('NON-ESG', 0.04872202128171921)"
Line 2154,"§  Thirty-four records do not specify gender.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8711274266242981)","('Labor_Practices', 0.033669065684080124)","('Customer_Privacy', 0.015011413022875786)","(['Human Capital Development'], 0.8711274266242981)","('NON-ESG', 0.033669065684080124)","('NON-ESG', 0.015011413022875786)"
Line 2155,"2022 Integrated Performance Report      GRI 140 SASB TCFD WEF Employee dataGLOBAL PART-TIME  FY20 FY21 FYTotal 1,853 1,849 1,24 and under 19 25 25-39 592 513 40-54 958 974 55-69 278 333 70+ 6 4 Woman†1,555 1,515 1,Asia-Pacific 79 77 Canada 11 16 Europe/Central/Asia/Middle East/Africa 1,277 1,260 1,Latin America 1 1 U.S. and Puerto Rico 187 161 NEW EMPLOYEE HIRES  FY20†FY21‡FY22§ Total 18,452 14,874 21,24 and under 4,784 4,373 5,25-39 10,334 7,876 12,40-54 2,843 2,251 3,55-69 478 368 70+ 13 6 WomanΩ9,465 7,470 11,126  Asia-Pacific 1,177 1,031 1,Canada 103 94 Europe/Central/Asia/Middle East/Africa 1,193 680 1,Latin America 4,562 3,757 4,U.S. and Puerto Rico 2,430 1,908 3,519†   Numbers by region are based on female employees  only.
","('Employee_Engagement_Inclusion_And_Diversity', 0.832880973815918)","('Labor_Practices', 0.03536337614059448)","('Employee_Health_And_Safety', 0.022856146097183228)","(['Human Capital Development'], 0.832880973815918)","('NON-ESG', 0.03536337614059448)","('NON-ESG', 0.022856146097183228)"
Line 2156,"2022 Integrated Performance Report      GRI 140 SASB TCFD WEF Employee dataGLOBAL PART-TIME  FY20 FY21 FYTotal 1,853 1,849 1,24 and under 19 25 25-39 592 513 40-54 958 974 55-69 278 333 70+ 6 4 Woman†1,555 1,515 1,Asia-Pacific 79 77 Canada 11 16 Europe/Central/Asia/Middle East/Africa 1,277 1,260 1,Latin America 1 1 U.S. and Puerto Rico 187 161 NEW EMPLOYEE HIRES  FY20†FY21‡FY22§ Total 18,452 14,874 21,24 and under 4,784 4,373 5,25-39 10,334 7,876 12,40-54 2,843 2,251 3,55-69 478 368 70+ 13 6 WomanΩ9,465 7,470 11,126  Asia-Pacific 1,177 1,031 1,Canada 103 94 Europe/Central/Asia/Middle East/Africa 1,193 680 1,Latin America 4,562 3,757 4,U.S. and Puerto Rico 2,430 1,908 3,519†   Numbers by region are based on female employees  only.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7042868137359619)","('Labor_Practices', 0.05992617830634117)","('Business_Model_Resilience', 0.024210672825574875)","(['Human Capital Development'], 0.7042868137359619)","('NON-ESG', 0.05992617830634117)","('NON-ESG', 0.024210672825574875)"
Line 2157,"† Forty-nine records do not specify gender.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8660693168640137)","('Labor_Practices', 0.03389313444495201)","('Customer_Privacy', 0.012554805725812912)","(['Human Capital Development'], 0.8660693168640137)","('NON-ESG', 0.03389313444495201)","('NON-ESG', 0.012554805725812912)"
Line 2158,"‡ Thirty-four records do not specify gender.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9070929884910583)","('Labor_Practices', 0.017806757241487503)","('Customer_Privacy', 0.009207749739289284)","(['Human Capital Development'], 0.9070929884910583)","('NON-ESG', 0.017806757241487503)","('NON-ESG', 0.009207749739289284)"
Line 2159,"§ Twenty-four records do not specify gender.
","('Employee_Engagement_Inclusion_And_Diversity', 0.874760091304779)","('Labor_Practices', 0.03456037491559982)","('Customer_Privacy', 0.013165829703211784)","(['Human Capital Development'], 0.874760091304779)","('NON-ESG', 0.03456037491559982)","('NON-ESG', 0.013165829703211784)"
Line 2160,"Ω  Numbers by region are based on female  employees only.
","('Labor_Practices', 0.5436373353004456)","('Employee_Engagement_Inclusion_And_Diversity', 0.21922121942043304)","('Director_Removal', 0.0451035238802433)","(['Labor Practice Indicators'], 0.5436373353004456)","('NON-ESG', 0.21922121942043304)","('NON-ESG', 0.0451035238802433)"
Line 2161,"2022 Integrated Performance Report      GRI 141 SASB TCFD WEF Employee dataGLOBAL EMPLOYEE TURNOVER (VOLUNTARY AND INVOLUNTARY)  FY20 FY21 FYTotal employee turnover rate (total employees/# employee turnovers) 16% 16% 16% 24 and under 2,864 3,029 3,25-39 7,149 6,943 8,40-54 3,399 2,931 3,55-69 1,325 2,018 1,70+ 46 98 Voluntary employee turnover rate (total employees/# voluntary employee turnovers) 13% 13% 15% Woman†7,488 7,399 8,Asia-Pacific 872 907 Canada 95 125 Europe/Central/Asia/Middle East/Africa 997 747 Latin America 3,411 3,413 3,U.S. and Puerto Rico 2,113 2,207 2,U.S. EMPLOYEE DEMOGRAPHICS†  FY20 FY21 FYAmerican Indian or Alaska Native 138 133 Asian 5,664 5,647 6,Black or African American 2,109 2,208 2,Hispanic or Latino 3,010 3,169 3,Native Hawaiian or Other Pacific Islander 125 131 White 20,486 19,863 20,Two or More Races 751 812 Unspecified‡5,377 5,520 10,386†  Numbers by region are based on female employees  only.
","('Labor_Practices', 0.4829460680484772)","('Employee_Engagement_Inclusion_And_Diversity', 0.21047963201999664)","('Employee_Health_And_Safety', 0.14275521039962769)","('NON-ESG', 0.4829460680484772)","('NON-ESG', 0.21047963201999664)","('NON-ESG', 0.14275521039962769)"
Line 2162,"2022 Integrated Performance Report      GRI 141 SASB TCFD WEF Employee dataGLOBAL EMPLOYEE TURNOVER (VOLUNTARY AND INVOLUNTARY)  FY20 FY21 FYTotal employee turnover rate (total employees/# employee turnovers) 16% 16% 16% 24 and under 2,864 3,029 3,25-39 7,149 6,943 8,40-54 3,399 2,931 3,55-69 1,325 2,018 1,70+ 46 98 Voluntary employee turnover rate (total employees/# voluntary employee turnovers) 13% 13% 15% Woman†7,488 7,399 8,Asia-Pacific 872 907 Canada 95 125 Europe/Central/Asia/Middle East/Africa 997 747 Latin America 3,411 3,413 3,U.S. and Puerto Rico 2,113 2,207 2,U.S. EMPLOYEE DEMOGRAPHICS†  FY20 FY21 FYAmerican Indian or Alaska Native 138 133 Asian 5,664 5,647 6,Black or African American 2,109 2,208 2,Hispanic or Latino 3,010 3,169 3,Native Hawaiian or Other Pacific Islander 125 131 White 20,486 19,863 20,Two or More Races 751 812 Unspecified‡5,377 5,520 10,386†  Numbers by region are based on female employees  only.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9713574647903442)","('Labor_Practices', 0.0022259880788624287)","('Employee_Health_And_Safety', 0.0022216117940843105)","(['Human Capital Development'], 0.9713574647903442)","('NON-ESG', 0.0022259880788624287)","('NON-ESG', 0.0022216117940843105)"
Line 2163,"†  Calculated actual headcount at the end of the FY21.
","('Systemic_Risk_Management', 0.43976837396621704)","('Business_Model_Resilience', 0.1644783914089203)","('Supply_Chain_Management', 0.06269526481628418)","('NON-ESG', 0.43976837396621704)","('NON-ESG', 0.1644783914089203)","('NON-ESG', 0.06269526481628418)"
Line 2164,"United States only, excluding Puerto Rico.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2694541811943054)","('Competitive_Behavior', 0.1527697890996933)","('Ecological_Impacts', 0.08885179460048676)","('NON-ESG', 0.2694541811943054)","('NON-ESG', 0.1527697890996933)","('NON-ESG', 0.08885179460048676)"
Line 2165,"‡  Includes records coded as “Do Not Want to Disclose,” “Unspecified,” or “Blank.” 2022 Integrated Performance Report      GRI 142 SASB TCFD WEF Employee dataU.S. EMPLOYEE TURNOVER (VOLUNTARY AND INVOLUNTARY) BY RACE AND ETHNICITY  FY20 FY21 FYTotal U.S. employee turnover rate (total employees/# employee turnovers) 11% 12% 10% American Indian or Alaska Native 11% 16% 9% Asian 10% 12% 11% Black or African American 14% 13% 13% Hispanic or Latino 13% 13% 10% Native Hawaiian or Other Pacific Islander 19% 8% 11% White 11% 11% 9% Two or more races 15% 9% 13% Unspecified†16% 14% 11%†  Includes records coded as “Do Not Want to  Disclose,” “Unspecified,” or “Blank.” 2022 Integrated Performance Report      GRI 143 SASB TCFD WEF Employee data","('Employee_Engagement_Inclusion_And_Diversity', 0.9579668045043945)","('Employee_Health_And_Safety', 0.0060334051959216595)","('Labor_Practices', 0.005625428166240454)","(['Human Capital Development'], 0.9579668045043945)","('NON-ESG', 0.0060334051959216595)","('NON-ESG', 0.005625428166240454)"
Line 2166,"‡  Includes records coded as “Do Not Want to Disclose,” “Unspecified,” or “Blank.” 2022 Integrated Performance Report      GRI 142 SASB TCFD WEF Employee dataU.S. EMPLOYEE TURNOVER (VOLUNTARY AND INVOLUNTARY) BY RACE AND ETHNICITY  FY20 FY21 FYTotal U.S. employee turnover rate (total employees/# employee turnovers) 11% 12% 10% American Indian or Alaska Native 11% 16% 9% Asian 10% 12% 11% Black or African American 14% 13% 13% Hispanic or Latino 13% 13% 10% Native Hawaiian or Other Pacific Islander 19% 8% 11% White 11% 11% 9% Two or more races 15% 9% 13% Unspecified†16% 14% 11%†  Includes records coded as “Do Not Want to  Disclose,” “Unspecified,” or “Blank.” 2022 Integrated Performance Report      GRI 143 SASB TCFD WEF Employee data","('Employee_Engagement_Inclusion_And_Diversity', 0.8441250324249268)","('Customer_Privacy', 0.023921573534607887)","('Competitive_Behavior', 0.01592416688799858)","(['Human Capital Development'], 0.8441250324249268)","('NON-ESG', 0.023921573534607887)","('NON-ESG', 0.01592416688799858)"
